drugbank_id	name	type	groups	categories
DB00001	Lepirudin	biotech	approved	Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombin Proteins|Antithrombins|Blood and Blood Forming Organs|Cardiovascular Agents|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Peptides|Protease Inhibitors|Proteins|Serine Proteinase Inhibitors|Serpins|Thrombin Inhibitors
DB00002	Cetuximab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Epidermal Growth Factor Receptor Antagonist|Globulins|HER1 Antagonists|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB00003	Dornase alfa	biotech	approved	Amino Acids, Peptides, and Proteins|Cough and Cold Preparations|Decreased Respiratory Secretion Viscosity|Deoxyribonucleases|Endodeoxyribonucleases|Endonucleases|Enzymes|Enzymes and Coenzymes|Esterases|Expectorants|Hydrolases|Proteins|Recombinant Human Deoxyribonuclease 1
DB00004	Denileukin diftitox	biotech	approved|investigational	ADP Ribose Transferases|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bacterial Toxins|Biological Factors|CD25-directed Cytotoxin|Cytokines|Enzymes|Enzymes and Coenzymes|Glycosyltransferases|Intercellular Signaling Peptides and Proteins|Interleukins|Lymphokines|Pentosyltransferases|Peptides|Proteins|Recombinant Proteins|Toxins, Biological|Transferases
DB00005	Etanercept	biotech	approved|investigational	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies|Biologics for Rheumatoid Arthritis Treatment|Disease-modifying Antirheumatic Agents|Immunoglobulin Isotypes|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Membrane Proteins|Proteins|Receptors, Cell Surface|Receptors, Cytokine|Receptors, Immunologic|Receptors, Tumor Necrosis Factor|Serum Globulins|Tumor Necrosis Factor Alpha (TNF-Î±) Inhibitors|Tumor Necrosis Factor Blocker|Tumor Necrosis Factor Receptor Blocking Activity
DB00006	Bivalirudin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombin Proteins|Antithrombins|Blood and Blood Forming Organs|Enzyme Inhibitors|Hematologic Agents|Peptides|Proteins|Serine Proteinase Inhibitors|Serpins|Thrombin Inhibitors
DB00007	Leuprolide	biotech	approved|investigational	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Endocrine Therapy|Fertility Agents|Fertility Agents, Female|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Moderate Risk QTc-Prolonging Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|QTc Prolonging Agents|Reproductive Control Agents
DB00008	Peginterferon alfa-2a	biotech	approved|investigational	Adjuvants, Immunologic|Alcohols|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Biological Factors|Biomedical and Dental Materials|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytokines|Drug Carriers|Ethylene Glycols|Glycols|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon alpha|Interferon Type I|Interferons|Macromolecular Substances|Myelosuppressive Agents|Pegylated agents|Peptides|Polymers|Proteins
DB00009	Alteplase	biotech	approved	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Ophthalmologicals|Peptide Hydrolases|Plasminogen Activators|Proteins|Sensory Organs|Serine Endopeptidases|Serine Proteases
DB00010	Sermorelin	biotech	approved|withdrawn	Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Diagnostic Agents|Growth Hormone-Releasing Hormone|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Somatropin and Somatropin Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Tests for Pituitary Function
DB00011	Interferon alfa-n1	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Biological Factors|Cytokines|Immunologic Factors|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon Type I|Interferons|Myelosuppressive Agents|Peptides|Proteins
DB00012	Darbepoetin alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antianemic Preparations|Biological Factors|Blood and Blood Forming Organs|Carbohydrates|Colony-Stimulating Factors|Cytokines|Erythropoiesis-Stimulating Agents|Erythropoietin|Glycoconjugates|Glycoproteins|Hematinics|Hematologic Agents|Hematopoietic Cell Growth Factors|Increased Erythroid Cell Production|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB00013	Urokinase	biotech	approved|investigational|withdrawn	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrinolytic Agents|Hydrolases|Increased Thrombolysis|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB00014	Goserelin	small molecule	approved	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Gonadotropins|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Miscellaneous Therapeutic Agents|Moderate Risk QTc-Prolonging Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|QTc Prolonging Agents
DB00015	Reteplase	biotech	approved|investigational	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB00016	Erythropoietin	biotech	approved	Amino Acids, Peptides, and Proteins|Antianemic Preparations|Biological Factors|Blood and Blood Forming Organs|Carbohydrates|Colony-Stimulating Factors|Cytokines|Erythropoiesis-Stimulating Agents|Erythropoietin|Glycoconjugates|Glycoproteins|Hematinics|Hematologic Agents|Hematopoietic Cell Growth Factors|Increased Erythroid Cell Production|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB00017	Salmon Calcitonin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Bone Density Conservation Agents|Bone Density, drug effects|Calcitonin Preparations|Calcium Homeostasis|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Parathyroid Hormones and Analogues|Peptide Hormones|Peptides|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB00018	Interferon alfa-n3	biotech	approved|investigational	Alfa Interferons|Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon alpha|Interferon Type I|Interferon-alpha|Interferons|Myelosuppressive Agents|Peptides|Proteins
DB00019	Pegfilgrastim	biotech	approved	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematinics|Hematopoietic Cell Growth Factors|Increased Myeloid Cell Production|Intercellular Signaling Peptides and Proteins|Leukocyte Growth Factor|Peptides|Proteins
DB00020	Sargramostim	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Immunologic Factors|Increased Myeloid Cell Production|Intercellular Signaling Peptides and Proteins|Leukocyte Growth Factor|Peptides|Proteins
DB00022	Peginterferon alfa-2b	biotech	approved	Adjuvants, Immunologic|Alcohols|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Biological Factors|Biomedical and Dental Materials|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytokines|Drug Carriers|Ethylene Glycols|Glycols|Hepatitis C|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon alpha|Interferon Type I|Interferons|Macromolecular Substances|Myelosuppressive Agents|Pegylated agents|Peptides|Polymers|Proteins
DB00023	Asparaginase Escherichia coli	biotech	approved|investigational	Amidohydrolases|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Asparaginase|Asparagine-specific Enzyme|Enzymes|Enzymes and Coenzymes|Hydrolases
DB00024	Thyrotropin alfa	biotech	approved|vet_approved	Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB00025	Antihemophilic factor, human recombinant	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Carbohydrates|Disaccharides|Hemostatics|Human Antihemophilic Factor|Increased Coagulation Activity|Oligosaccharides|Polysaccharides|Proteins
DB00026	Anakinra	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Biologics for Rheumatoid Arthritis Treatment|Cytokines|Disease-modifying Antirheumatic Agents|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interleukin 1 Receptor Antagonists|Interleukin Inhibitors|Interleukin-1 Receptor Antagonist|Peptides|Proteins
DB00027	Gramicidin D	small molecule	approved	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Membrane Proteins|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic|Pore Forming Cytotoxic Proteins|Proteins|Throat Preparations|Tyrothricin
DB00028	Immune Globulin Human	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antigen Neutralization|Blood Proteins|Globulins|Human Immunoglobulin G|Immunoglobulin G|Immunoglobulin Isotypes|Immunoglobulins|Immunologic Factors|Immunoproteins|Passively Acquired Immunity|Proteins|Serum|Serum Globulins
DB00029	Anistreplase	biotech	approved	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases|Streptokinase
DB00030	Insulin Human	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Insulin|Insulin, Long-Acting|Insulins and Analogues|Insulins and Analogues for Inhalation|Insulins and Analogues for Injection, Fast-Acting|Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting|Insulins and Analogues for Injection, Intermediate-Acting|Insulins and Analogues for Injection, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides
DB00031	Tenecteplase	biotech	approved	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB00032	Menotropins	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Products|Complex Mixtures|Fertility Agents|Fertility Agents, Female|Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins, Pituitary|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System
DB00033	Interferon gamma-1b	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon gamma|Interferons|Lymphokines|Macrophage-Activating Factors|Myelosuppressive Agents|Peptides|Proteins
DB00034	Interferon Alfa-2a, Recombinant	biotech	approved|investigational	Adjuvants, Immunologic|Alfa Interferons|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytokines|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon alpha|Interferon Type I|Interferons|Myelosuppressive Agents|Peptides|Proteins
DB00035	Desmopressin	small molecule	approved	Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Arginine Vasopressin|Cardiovascular Agents|Coagulants|Factor VIII Activator|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Increased Coagulation Factor VIII Activity|Increased Coagulation Factor VIII Concentration|Natriuretic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasopressin Analog|Vasopressin and Analogues|Vasopressins
DB00036	Coagulation factor VIIa Recombinant Human	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Factor VII|Hemostatics|Hydrolases|Increased Coagulation Factor IX Activity|Increased Coagulation Factor X Activity|Peptide Hydrolases|Proteins|Serine Endopeptidases|Serine Proteases
DB00038	Oprelvekin	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Interleukins|Megakaryocyte Growth Factor|Peptides|Proteins
DB00039	Palifermin	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Factors|Detoxifying Agents for Antineoplastic Treatment|Fibroblast Growth Factors|Increased Epithelial Proliferation|Intercellular Signaling Peptides and Proteins|Mucocutaneous Epithelial Cell Growth Factor|Peptides|Proteins
DB00040	Glucagon	biotech	approved	Amino Acids, Peptides, and Proteins|Antihypoglycemic Agent|Decreased GI Motility|Decreased GI Smooth Muscle Tone|Decreased Glycolysis|Gastrointestinal Agents|Gastrointestinal Hormones|Gastrointestinal Motility Inhibitor|Glycogenolytic Agents|Glycogenolytic Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Increased Gluconeogenesis|Increased Glycogenolysis|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00041	Aldesleukin	biotech	approved	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytokines|Hypotensive Agents|Immunosuppressive Agents|Increased Lymphocyte Activation|Increased Lymphocyte Cell Production|Intercellular Signaling Peptides and Proteins|Interleukins|Lymphocyte Growth Factor|Lymphokines|Myelosuppressive Agents|Peptides|Proteins
DB00042	Botulinum Toxin Type B	biotech	approved|investigational	Acetylcholine Release Inhibitors|Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Amphibian Venoms|Anti-Dyskinesia Agents|Bacterial Proteins|Bacterial Toxins|Biological Factors|Bodily Secretions|Botulinum Toxins|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Complex Mixtures|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fluids and Secretions|Ganglion Blockers|Hydrolases|Membrane Transport Modulators|Metalloendopeptidases|Metalloproteases|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neurotoxins|Neurotransmitter Agents|Other Miscellaneous Therapeutic Agents|Peptide Hydrolases|Proteins|Toxins, Biological|Venoms
DB00043	Omalizumab	biotech	approved|investigational	Agents to Treat Airway Disease|Amino Acids, Peptides, and Proteins|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-IgE|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Blood Proteins|Decreased IgE Activity|Globulins|IgE-directed Antibody Interactions|Immunoglobulins|Immunoproteins|Proteins|Respiratory Agents, Miscellaneous|Respiratory System Agents|Serum Globulins
DB00044	Lutropin alfa	biotech	approved	Genito Urinary System and Sex Hormones|Gonadotropins|Sex Hormones and Modulators of the Genital System
DB00045	Lyme disease vaccine (recombinant OspA)	biotech	approved|withdrawn	
DB00046	Insulin Lispro	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Insulin|Insulin Analog|Insulin, Short-Acting|Insulins and Analogues|Insulins and Analogues for Injection, Fast-Acting|Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting|Insulins and Analogues for Injection, Intermediate-Acting|Pancreatic Hormones|Peptide Hormones|Peptides
DB00047	Insulin Glargine	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Insulin|Insulin Analog|Insulin, Long-Acting|Insulins and Analogues|Insulins and Analogues for Injection, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides
DB00048	Collagenase clostridium histolyticum	biotech	approved|investigational	Collagen-specific Enzyme|Collagenases|Dermatologicals|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Metalloendopeptidases|Metalloproteases|Misc. Skin and Mucous Membrane Agents|Musculo-Skeletal System|Peptide Hydrolases|Preparations for Treatment of Wounds and Ulcers
DB00049	Rasburicase	biotech	approved|investigational	Antigout Preparations|Detoxifying Agents for Antineoplastic Treatment|Enzymes|Enzymes and Coenzymes|Musculo-Skeletal System|Oxidoreductases|Recombinant Proteins|Uric Acid-specific Enzyme
DB00050	Cetrorelix	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Gonadotropin-Releasing Hormones|Decreased GnRH Secretion|Fertility Agents|Fertility Agents, Female|Gonadotropin Releasing Hormone Receptor Antagonists|Gonadotropin-releasing Hormone Antagonists|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00051	Adalimumab	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|Disease-modifying Antirheumatic Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Proteins|Serum Globulins|Tumor Necrosis Factor Alpha (TNF-Î±) Inhibitors|Tumor Necrosis Factor Blocker|Tumor Necrosis Factor Receptor Blocking Activity
DB00052	Somatotropin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Growth Hormone|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Recombinant Human Growth Hormone|Somatotropin Agonists|Somatropin and Somatropin Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00053	Imiglucerase	biotech	approved	Alimentary Tract and Metabolism|Enzyme Replacement Therapy|Enzymes|Enzymes and Coenzymes|Gaucher Disease|Glucosidases|Glycoside Hydrolases|Hydrolases|Hydrolytic Lysosomal Glucocerebroside-specific Enzyme|Recombinant Proteins
DB00054	Abciximab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Blood Proteins|Fibrinolytic Agents|Globulins|Hematologic Agents|Immunoglobulin Fragments|Immunoglobulins|Immunoproteins|Miscellaneous Therapeutic Agents|Peptide Fragments|Peptides|Platelet Aggregation Inhibitors Excl. Heparin|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors|Proteins|Serum Globulins
DB00055	Drotrecogin alfa	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factor Inhibitors|Blood Proteins|Carbohydrates|Enzyme Precursors|Enzymes|Enzymes and Coenzymes|Fibrinolytic Agents|Glycoconjugates|Glycoproteins|Proteins|Recombinant Activated Protein C
DB00056	Gemtuzumab ozogamicin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Carbohydrates|CD33-directed Antibody Interactions|CD33-directed Cytotoxin|Globulins|Glycosides|Immunoconjugates|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Immunotoxins|Myelosuppressive Agents|Noxae|Proteins|Serum Globulins|Toxic Actions
DB00057	Indium In-111 satumomab pendetide	biotech	experimental|withdrawn	Acetates|Acids, Acyclic|Amines|Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Diagnostic Radiopharmaceuticals|Fatty Acids|Fatty Acids, Volatile|Globulins|Immunoglobulins|Immunoproteins|Indium (111In) Compounds|Indium Radioisotopes|Lipids|Peptides|Polyamines|Proteins|Serum Globulins|Tumour Detection
DB00058	Alpha-1-proteinase inhibitor	biotech	approved	Acute-Phase Proteins|Alpha-Globulins|Amino Acids, Peptides, and Proteins|Antifibrinolytic Agents|Blood and Blood Forming Organs|Blood Proteins|Carbohydrates|Enzyme Inhibitors|Enzymes|Globulins|Glycoconjugates|Glycoproteins|Hemostatics|Human alpha-1 Proteinase Inhibitor|Peptides|Proteinase Inhibitors|Proteins|Serine Proteinase Inhibitors|Serpins|Serum Globulins|Trypsin Inhibitors
DB00059	Pegaspargase	biotech	approved|investigational	Alcohols|Amidohydrolases|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Asparaginase|Asparagine-specific Enzyme|Biomedical and Dental Materials|Delayed-Action Preparations|Enzymes|Enzymes and Coenzymes|Enzymes, Immobilized|Ethylene Glycols|Glycols|Hydrolases|Immunosuppressive Agents|Macromolecular Substances|Pegylated agents|Polymers
DB00060	Interferon beta-1a	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Biological Factors|Cytokines|Immunologic Factors|Immunomodulatory Agents|Intercellular Signaling Peptides and Proteins|Interferon Type I|Interferon-beta|Interferons|Peptides|Proteins|Recombinant Human Interferon beta
DB00061	Pegademase bovine	biotech	approved	Aminohydrolases|Bovine Intestinal Adenosine Deaminase|Drug Carriers|Enzymes|Enzymes and Coenzymes|Hydrolases|Nucleoside Deaminases|Pegylated agents|Severe Combined Immunodeficiency
DB00062	Human Serum Albumin	biotech	approved	Albumins|Amino Acids, Peptides, and Proteins|Blood Derivatives|Blood Proteins|Cardiac Function|Diluents|Human Serum Albumin|Increased Intravascular Volume|Increased Oncotic Pressure|Osmotic Activity|Proteins|Serum Albumin
DB00063	Eptifibatide	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antiplatelet agents|Blood and Blood Forming Organs|Decreased Platelet Aggregation|Hematologic Agents|Platelet Aggregation Inhibitors Excl. Heparin|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors
DB00065	Infliximab	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|Dermatologicals|Disease-modifying Antirheumatic Agents|Gastrointestinal Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Proteins|Serum Globulins|Tumor Necrosis Factor Alpha (TNF-Î±) Inhibitors|Tumor Necrosis Factor Blocker|Tumor Necrosis Factor Receptor Blocking Activity
DB00066	Follitropin	biotech	approved	Amino Acids, Peptides, and Proteins|Chorionic Gonadotropin|Follicle Stimulating Hormone|Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins, Pituitary|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Luteinizing Hormone|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Placental Hormones|Pregnancy Proteins|Proteins|Sex Hormones and Modulators of the Genital System|Thyroid Products
DB00067	Vasopressin	small molecule	approved	Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Cardiovascular Agents|Coagulants|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins
DB00068	Interferon beta-1b	biotech	approved	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytokines|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon Type I|Interferon-beta|Interferons|Myelosuppressive Agents|Peptides|Proteins|Recombinant Human Interferon beta
DB00069	Interferon alfacon-1	biotech	approved|investigational	Adjuvants, Immunologic|Alfa Interferons|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Biological Factors|Cytokines|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon alpha|Interferon Type I|Interferons|Myelosuppressive Agents|Peptides|Proteins
DB00070	Hyaluronidase	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antigens|Antigens, Surface|Biological Factors|Blood and Blood Forming Organs|Carbohydrates|Carbon-Oxygen Lyases|Enzymes|Enzymes and Coenzymes|Glycoconjugates|Glycoproteins|Glycoside Hydrolases|Hydrolases|Lyases|Membrane Glycoproteins|Membrane Proteins|Polysaccharide-Lyases|Proteins
DB00071	Insulin Pork	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Insulin|Insulins and Analogues|Insulins and Analogues for Injection, Fast-Acting|Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting|Insulins and Analogues for Injection, Intermediate-Acting|Insulins and Analogues for Injection, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides|Proinsulin|Protein Precursors|Proteins
DB00072	Trastuzumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Cardiotoxic antineoplastic agents|Globulins|HER2 Receptor Antagonist|HER2/Neu/cerbB2 Antagonists|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Proteins|Serum Globulins
DB00073	Rituximab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Murine-Derived|Antineoplastic Agents|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|CD20-directed Antibody Interactions|CD20-directed Cytolytic Antibody|Globulins|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Myelosuppressive Agents|Proteins|Serum Globulins
DB00074	Basiliximab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Blocking|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Interleukin 2 Receptor Antagonists|Interleukin 2 Receptor-directed Antibody Interactions|Interleukin Inhibitors|Interleukin-2 Receptor Blocking Antibody|Proteins|Recombinant Proteins|Serum Globulins
DB00075	Muromonab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Murine-Derived|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD3 Blocker Immunosuppressant|CD3 Receptor Antagonists|CD3-directed Antibody Interactions|Decreased Immunologic Activity|Globulins|Immunoglobulin G|Immunoglobulin Isotypes|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Proteins|Selective Immunosuppressants|Serum Globulins
DB00076	Digoxin Immune Fab (Ovine)	biotech	approved	Antidotes|Digoxin Binding Activity|Immunoglobulin G|Immunoglobulins|Serum|Serum Globulins
DB00078	Ibritumomab tiuxetan	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antigens, CD20|Blood Proteins|CD20-directed Antibody Interactions|CD20-directed Radiotherapeutic Antibody|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Lymphoma, B-Cell|Myelosuppressive Agents|Proteins|Radiopharmaceutical Activity|Serum Globulins|Therapeutic Radiopharmaceuticals|Various Therapeutic Radiopharmaceuticals|Yttrium Radioisotopes
DB00080	Daptomycin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cyclic Lipopeptides|Lipids|Lipopeptide Antibacterial|Lipopeptides|Peptides|Peptides, Cyclic
DB00081	Tositumomab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antigens, CD20|Antineoplastic Agents|Blood Proteins|CD20-directed Antibody Interactions|CD20-directed Radiotherapeutic Antibody|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Iodine (131I) Compounds|Iodine Radioisotopes|Myelosuppressive Agents|Proteins|Radioimmunotherapy|Radiopharmaceutical Activity|Serum Globulins|Therapeutic Radiopharmaceuticals
DB00082	Pegvisomant	biotech	approved	Acromegaly|Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Cholinesterase Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Growth Hormone Receptor Antagonist|Growth Hormone Receptor Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Pegylated agents|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Receptors, Somatotropin, antagonists & inhibitors|Somatotropin Antagonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00083	Botulinum Toxin Type A	biotech	approved|investigational	Acetylcholine Release Inhibitors|Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Bacterial Proteins|Bacterial Toxins|Biological Factors|Botulinum Toxins|Central Nervous System Depressants|Cholinergic Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Ganglion Blockers|Hydrolases|Membrane Transport Modulators|Metalloendopeptidases|Metalloproteases|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neurotoxins|Neurotransmitter Agents|Noxae|Other Miscellaneous Therapeutic Agents|Peptide Hydrolases|Peripheral Nervous System Agents|Proteins|Toxic Actions|Toxins, Biological
DB00085	Pancrelipase	biotech	approved|investigational	Alimentary Tract and Metabolism|Carboxylic Ester Hydrolases|Complex Mixtures|Digestives, Incl. Enzymes|Enzyme Preparations|Enzymes|Enzymes and Coenzymes|Esterases|Gastrointestinal Agents|Hydrolases|Lipase|Pancreatic Extracts|Tissue Extracts
DB00086	Streptokinase	biotech	approved|investigational	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Hypotensive Agents|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB00087	Alemtuzumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD52-directed Antibody Interactions|CD52-directed Cytolytic Antibody|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Myelosuppressive Agents|Proteins|Selective Immunosuppressants|Serum Globulins
DB00088	Alglucerase	biotech	approved|investigational	Alimentary Tract and Metabolism|Enzyme Replacement Therapy|Enzymes|Enzymes and Coenzymes|Gaucher Disease|Glucosidases|Glycoside Hydrolases|Hydrolases|Hydrolytic Lysosomal Glucocerebroside-specific Enzyme|Recombinant Proteins
DB00089	Capromab pendetide	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Diagnostic Radiopharmaceuticals|Globulins|Immunoglobulins|Immunoproteins|Indicators and Reagents|Indium (111In) Compounds|Indium Radioisotopes|Laboratory Chemicals|Prostatic Neoplasms|Proteins|Serum Globulins|Tumour Detection
DB00090	Laronidase	biotech	approved	Alimentary Tract and Metabolism|Enzymes|Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
DB00091	Ciclosporin	small molecule	approved|investigational|vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-inflammatory Agents, Miscellaneous|Antifungal Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Calcineurin Inhibitor Immunosuppressant|Calcineurin Inhibitors|Cyclosporins|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (moderate)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Dermatologicals|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Neurotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Ophthalmologicals|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic|Sensory Organs
DB00092	Alefacept	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|CD2-directed Antibody Interactions|CD2-directed LFA-3/Fc Fusion Protein|Dermatologicals|Immunosuppressive Agents|Proteins|Psoriasis|Recombinant Proteins|Selective Immunosuppressants
DB00093	Felypressin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lypressin|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Posterior|Proteins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins
DB00094	Urofollitropin	biotech	approved|vet_approved	Amino Acids, Peptides, and Proteins|Biological Products|Complex Mixtures|Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins, Pituitary|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Menotropins|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Sex Hormones and Modulators of the Genital System
DB00095	Efalizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antigens, CD11|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD11a-directed Antibody Interactions|CD11a-directed Humanized IgG1 Antibody|Cell Migration Inhibition|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Proteins|Selective Immunosuppressants|Serum Globulins
DB00097	Choriogonadotropin alfa	biotech	approved	Genito Urinary System and Sex Hormones|Gonadotropins|Sex Hormones and Modulators of the Genital System
DB00098	Antithymocyte immunoglobulin (rabbit)	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibody-Surface Protein Interactions|Antineoplastic and Immunomodulating Agents|Biological Products|Blood|Blood Proteins|Body Fluids|Complex Mixtures|Fluids and Secretions|Globulins|Hemic and Immune Systems|Immune Sera|Immunoglobulin G|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Increased T Lymphocyte Destruction|Lymphocyte Function Alteration|Miscellaneous Therapeutic Agents|Proteins|Selective Immunosuppressants|Serum|Serum Globulins
DB00099	Filgrastim	biotech	approved	Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Colony-Stimulating Factors|Glycoconjugates|Glycoproteins|Granulocyte Colony-Stimulating Factor|Hematologic Agents|Hematopoietic Cell Growth Factors|Increased Myeloid Cell Production|Leukocyte Growth Factor|Peptides|Proteins
DB00100	Coagulation Factor IX (Recombinant)	biotech	approved|investigational	Blood and Blood Forming Organs|Blood Coagulation Factors|Hemostatics|Increased Coagulation Activity
DB00102	Becaplermin	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Angiogenesis Inducing Agents|Angiogenesis Modulating Agents|Biological Factors|Blood Proteins|Cicatrizants|Dermatologicals|DNA-Binding Proteins|Growth Substances|Human Platelet-derived Growth Factor|Intercellular Signaling Peptides and Proteins|Neoplasm Proteins|Oncogene Proteins|Peptides|Platelet-Derived Growth Factor|Preparations for Treatment of Wounds and Ulcers|Proteins|Proto-Oncogene Proteins|Recombinant Proteins|Stomatological Preparations
DB00103	Agalsidase beta	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Enzymes|Enzymes and Coenzymes|Fabry Disease|Galactosidases|Glycoside Hydrolases|Hydrolases|Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme|Protein Isoforms|Proteins
DB00104	Octreotide	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Hypothalamic Hormones|Miscellaneous Therapeutic Agents|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic|Pituitary and Hypothalamic Hormones and Analogues|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Somatostatin and Analogues|Somatostatin Receptor Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00105	Interferon Alfa-2b, Recombinant	biotech	approved	Adjuvants, Immunologic|Alfa Interferons|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytokines|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon alpha|Interferon Type I|Interferons|Myelosuppressive Agents|Peptides|Proteins
DB00106	Abarelix	small molecule	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptides
DB00107	Oxytocin	biotech	approved|vet_approved	Amino Acids, Peptides, and Proteins|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Increased Uterine Smooth Muscle Contraction or Tone|Oxytocin and Analogues|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Uterotonic agents
DB00108	Natalizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunologic Factors|Immunomodulatory Agents|Immunoproteins|Immunosuppressive Agents|Integrin Receptor Antagonist|Integrin Receptor Antagonists|Proteins|Selective Immunosuppressants|Serum Globulins
DB00109	Enfuvirtide	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antigens|Antigens, Viral|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Biological Factors|Direct Acting Antivirals|env Gene Products, Human Immunodeficiency Virus|Fusion Protein Inhibitors|Gene Products, env|HIV Antigens|HIV Fusion Inhibitors|Human Immunodeficiency Virus 1 Fusion Inhibitor|Human Immunodeficiency Virus Proteins|Membrane Fusion Proteins|Membrane Proteins|Peptides|Polyproteins|Proteins|Retroviridae Proteins|Viral Envelope Proteins|Viral Fusion Protein Inhibitors|Viral Fusion Proteins|Viral Proteins|Viral Structural Proteins
DB00110	Palivizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antiinfectives for Systemic Use|Antiviral Agents|Blood Proteins|Fusion Protein Inhibitors|Globulins|Immune Sera and Immunoglobulins|Immunoglobulins|Immunoproteins|Proteins|Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody|Serum Globulins|Specific Immunoglobulins
DB00111	Daclizumab	biotech	investigational|withdrawn	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulin Isotypes|Immunoglobulins|Immunologic Factors|Immunomodulatory Agents|Immunoproteins|Immunosuppressive Agents|Interleukin 2 Receptor Antagonists|Interleukin 2 Receptor-directed Antibody Interactions|Interleukin Inhibitors|Interleukin-2 Receptor Blocking Antibody|Proteins|Serum Globulins
DB00112	Bevacizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Cardiotoxic antineoplastic agents|Globulins|Growth Inhibitors|Growth Substances|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Myelosuppressive Agents|Proteins|Serum Globulins|Vascular Endothelial Growth Factor Inhibitor|Vascular Endothelial Growth Factor Inhibitors|Vascular Endothelial Growth Factor-directed Antibody Interactions
DB00113	Technetium Tc-99m arcitumomab	biotech	experimental	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Diagnostic Radiopharmaceuticals|Globulins|Immunoglobulins|Immunoproteins|Organometallic Compounds|Proteins|Serum Globulins|Technetium (99Mtc) Compounds|Tumour Detection
DB00114	Pyridoxal Phosphate	small molecule	approved|investigational|nutraceutical	Alimentary Tract and Metabolism|Coenzymes|Diet, Food, and Nutrition|Dietary Supplements|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Pyridoxal|Supplements|Vitamin B Complex|Vitamins
DB00115	Cyanocobalamin	small molecule	approved|nutraceutical	Antianemic Preparations|Blood and Blood Forming Organs|Corrinoids|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Iron Preparations|Micronutrients|Physiological Phenomena|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins
DB00116	Tetrahydrofolic acid	small molecule	nutraceutical	Biological Factors|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Folic Acid|Folic Acid and Derivatives|Pigments, Biological|Pteridines|Pterins|Supplements|Vitamin B Complex|Vitamins
DB00117	Histidine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00118	Ademetionine	small molecule	approved|investigational|nutraceutical	Adenosine|Alimentary Tract and Metabolism|Amino Acids|Amino Acids and Derivatives|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Carbohydrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dietary Supplements|Glycosides|Methionine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds|Supplements
DB00119	Pyruvic acid	small molecule	approved|investigational|nutraceutical	Dietary Supplements|Keto Acids|Pyruvates|Supplements
DB00120	L-Phenylalanine	small molecule	approved|investigational|nutraceutical	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Immunosuppressive Agents|Myelosuppressive Agents|Supplements
DB00121	Biotin	small molecule	approved|investigational|nutraceutical	Alimentary Tract and Metabolism|Coenzymes|Diet, Food, and Nutrition|Dietary Supplements|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Imidazoles|Micronutrients|Physiological Phenomena|Supplements|Vitamin B Complex|Vitamins
DB00122	Choline	small molecule	approved|nutraceutical	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Antimetabolites|Central Nervous System Agents|Dietary Supplements|Ethanolamines|Gastrointestinal Agents|Hypolipidemic Agents|Lipid Regulating Agents|Lipotropic Agents|Nervous System|Nitrogen Compounds|Nootropic Agents|Noxae|OCT2 Inhibitors|OCT2 Substrates|Onium Compounds|Other Nutritional Agents|Quaternary Ammonium Compounds|Salicylic Acid and Derivatives|Supplements|Toxic Actions|Trimethyl Ammonium Compounds|Vitamin B Complex|Vitamins
DB00123	L-Lysine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dietary Supplements|I.V. Solution Additives|Supplements
DB00125	L-Arginine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dietary Supplements|I.V. Solution Additives|Pituitary Function|Supplements
DB00126	Ascorbic acid	small molecule	approved|nutraceutical	Acids, Acyclic|Alimentary Tract and Metabolism|Antioxidants|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Gastrointestinal Acidifying Agents|Genito Urinary System and Sex Hormones|Growth Substances|Gynecological Antiinfectives and Antiseptics|Hydroxy Acids|Micronutrients|Ophthalmologicals|Organic Acids|P-glycoprotein/ABCB1 Substrates|Physiological Phenomena|Protective Agents|Sensory Organs|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins
DB00127	Spermine	small molecule	experimental|nutraceutical	Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Dietary Supplements|Polyamines|Putrescine|Spermidine|Supplements
DB00128	L-Aspartic Acid	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Excitatory Amino Acids|Supplements
DB00129	Ornithine	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Bile and Liver Therapy|Dietary Supplements|Liver Therapy|Liver Therapy, Lipotropics|Supplements
DB00130	L-Glutamine	small molecule	approved|investigational|nutraceutical	Alimentary Tract and Metabolism|Amino Acids|Amino Acids and Derivatives|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00131	Adenosine phosphate	small molecule	approved|investigational|nutraceutical	Adenine Nucleotides|Carbohydrates|Dietary Supplements|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Supplements
DB00132	Alpha-Linolenic Acid	small molecule	approved|nutraceutical	Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Dietary Supplements|Fats|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Linolenic Acids|Lipids|Oils|Physiological Phenomena|Supplements
DB00133	Serine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00134	Methionine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antidotes|Dietary Supplements|Sulfur Compounds|Supplements
DB00135	L-Tyrosine	small molecule	approved|investigational|nutraceutical	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00136	Calcitriol	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Antipsoriatics|Antipsoriatics for Topical Use|Bone Density Conservation Agents|Calcium Channel Agonists|Cardiovascular Agents|Cholestanes|Cholestenes|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Lipids|Membrane Lipids|Membrane Transport Modulators|Micronutrients|Misc. Skin and Mucous Membrane Agents|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB00137	Lutein	small molecule	approved|investigational|nutraceutical	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dietary Supplements|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Supplements|Terpenes|Xanthophylls
DB00138	Cystine	small molecule	approved|nutraceutical	Acids|Acids, Noncarboxylic|Amino Acids|Amino Acids, Diamino|Amino Acids, Dicarboxylic|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anions|Cysteine|Dietary Supplements|Disulfides|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfhydryl Compounds|Sulfides|Sulfur Compounds|Supplements
DB00139	Succinic acid	small molecule	approved|nutraceutical	Acids, Acyclic|Dicarboxylic Acids|Dietary Supplements|OAT3/SLC22A8 Substrates|Succinates|Supplements
DB00140	Riboflavin	small molecule	approved|investigational|nutraceutical|vet_approved	Alimentary Tract and Metabolism|Biological Factors|Coenzymes|Dermatologicals|Diet, Food, and Nutrition|Enzymes and Coenzymes|Flavins|Food|Food and Beverages|Growth Substances|Micronutrients|Photosensitizing Agents|Physiological Phenomena|Pigments, Biological|Pteridines|Radiation-Sensitizing Agents|Vitamin B Complex|Vitamins
DB00141	N-Acetylglucosamine	small molecule	approved|investigational|nutraceutical	Amino Sugars|Carbohydrates|Dietary Supplements|Glucosamine|Hexosamines|Supplements
DB00142	Glutamic Acid	small molecule	approved|nutraceutical	Acid Preparations|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Digestives, Incl. Enzymes|Excitatory Amino Acids|Gastrointestinal Acidifying Agents|Gastrointestinal Agents|Glutamates|Supplements
DB00143	Glutathione	small molecule	approved|investigational|nutraceutical	Amino Acids, Peptides, and Proteins|Antidotes|Dietary Supplements|Oligopeptides|Peptides|Supplements
DB00144	Phosphatidyl serine	small molecule	approved|investigational|nutraceutical	Dietary Supplements|Supplements
DB00145	Glycine	small molecule	approved|nutraceutical|vet_approved	Amino Acids|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dietary Supplements|Glycine Agents|Irrigating Solutions|Neurotransmitter Agents|Supplements
DB00146	Calcifediol	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB00147	Pyridoxal	small molecule	experimental|nutraceutical	Diet, Food, and Nutrition|Dietary Supplements|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Supplements|Vitamin B Complex|Vitamins
DB00148	Creatine	small molecule	approved|investigational|nutraceutical	Amidines|Amino Acids|Amino Acids, Peptides, and Proteins|Dietary Supplements|Guanidines|Supplements
DB00149	L-Leucine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00150	L-Tryptophan	small molecule	approved|nutraceutical|withdrawn	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Dietary Supplements|Miscellaneous Antidepressants|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Supplements
DB00151	L-Cysteine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Caloric Agents|Dietary Supplements|Nutritional Support|Sulfhydryl Compounds|Sulfur Compounds|Supplements
DB00152	Thiamine	small molecule	approved|investigational|nutraceutical|vet_approved	Alimentary Tract and Metabolism|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|OCT2 Inhibitors|Physiological Phenomena|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins
DB00153	Ergocalciferol	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB00154	Dihomo-gamma-linolenic acid	small molecule	investigational|nutraceutical	Autacoids|Biological Factors|Dietary Supplements|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Supplements
DB00155	L-Citrulline	small molecule	approved|investigational|nutraceutical	Amino Acids|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Dietary Supplements|OAT3/SLC22A8 Substrates|Proteins|Supplements
DB00156	L-Threonine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00157	NADH	small molecule	approved|nutraceutical	Adenine Nucleotides|Carbohydrates|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Supplements
DB00158	Folic Acid	small molecule	approved|nutraceutical|vet_approved	Antianemic Preparations|Autacoids|BCRP/ABCG2 Substrates|Biological Factors|Blood and Blood Forming Organs|Diet, Food, and Nutrition|Dietary Supplements|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Folic Acid and Derivatives|Food|Food and Beverages|Growth Substances|Hematinics|Hematologic Agents|Inflammation Mediators|Iron Preparations|Laxatives|Lipids|Micronutrients|Osmotic Laxative|Physiological Phenomena|Pigments, Biological|Pteridines|Pterins|Supplements|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins
DB00159	Icosapent	small molecule	approved|nutraceutical	Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Dietary Supplements|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Hypolipidemic Agents|Inflammation Mediators|Lipids|Nephrotoxic agents|Oils|Physiological Phenomena|Supplements
DB00160	L-Alanine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00161	L-Valine	small molecule	approved|nutraceutical	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements
DB00162	Vitamin A	small molecule	approved|nutraceutical|vet_approved	Adjuvants, Immunologic|Alimentary Tract and Metabolism|Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anticarcinogenic Agents|Antioxidants|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Diagnostic Agents|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydrocarbons, Acyclic|Immunologic Factors|Micronutrients|Nasal Preparations|Ophthalmologicals|Physiological Phenomena|Pigments, Biological|Polyenes|Protective Agents|Retinoids|Retinoids for Topical Use in Acne|Sensory Organs|Terpenes|Tests for Fat Absorption|Vitamin A|Vitamins|Vitamins (Fat Soluble)
DB00163	Vitamin E	small molecule	approved|nutraceutical|vet_approved	Antioxidants|Basic Ointments and Protectants|Benzopyrans|Diet, Food, and Nutrition|Dietary Supplements|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Supplements|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB00165	Pyridoxine	small molecule	approved|investigational|nutraceutical|vet_approved	Alimentary Tract and Metabolism|Analogs/Derivatives|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Vitamin B Complex|Vitamins
DB00166	Lipoic Acid	small molecule	approved|investigational|nutraceutical	Alimentary Tract and Metabolism|Antioxidants|Coenzymes|Diet, Food, and Nutrition|Dietary Supplements|Enzymes and Coenzymes|Fatty Acids|Food|Food and Beverages|Growth Substances|Hypoglycemia-Associated Agents|Lipids|Micronutrients|Physiological Phenomena|Protective Agents|Sulfur Compounds|Supplements|Thiophenes|Various Alimentary Tract and Metabolism Products|Vitamin B Complex|Vitamins
DB00167	L-Isoleucine	small molecule	approved|investigational|nutraceutical	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00168	Aspartame	small molecule	investigational|nutraceutical	Amino Acids, Peptides, and Proteins|Diet, Food, and Nutrition|Dietary Supplements|Dipeptides|Flavoring Agents|Food|Food Additives|Food and Beverages|OAT3/SLC22A8 Inhibitors|Oligopeptides|Peptides|Physiological Phenomena|Supplements|Sweetening Agents
DB00169	Cholecalciferol	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Food|Food and Beverages|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Musculo-Skeletal System|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB00170	Menadione	small molecule	approved|nutraceutical	Antifibrinolytic Agents|Blood and Blood Forming Organs|Coagulants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Dietary Supplements|Diterpenes|Fibrin Modulating Agents|Food|Food and Beverages|Growth Substances|Hematologic Agents|Hemostatics|Micronutrients|Naphthalenes|Naphthoquinones|Physiological Phenomena|Phytol|Quinones|Supplements|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble)
DB00171	ATP	small molecule	investigational|nutraceutical	Adenine Nucleotides|Carbohydrates|Dietary Supplements|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides|Supplements
DB00172	Proline	small molecule	approved|nutraceutical	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dietary Supplements|Imines|Imino Acids|Supplements
DB00173	Adenine	small molecule	approved|nutraceutical	Dietary Supplements|Purines|Supplements|UGT1A1 Inhibitors
DB00174	L-Asparagine	small molecule	approved|investigational|nutraceutical	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Dietary Supplements|Supplements
DB00175	Pravastatin	small molecule	approved	Anticholesteremic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Naphthalenes|Noxae|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Toxic Actions
DB00176	Fluvoxamine	small molecule	approved|investigational	Amines|Anti-Anxiety Agents|Antidepressive Agents, Second-Generation|BSEP/ABCB11 Substrates|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydroxylamines|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Oximes|P-glycoprotein/ABCB1 Inhibitors|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tranquilizing Agents
DB00177	Valsartan	small molecule	approved|investigational	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Lipid Modifying Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Tetrazoles|Valine
DB00178	Ramipril	small molecule	approved	ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Hypotensive Agents|Lipid Modifying Agents|Protease Inhibitors
DB00179	Masoprocol	small molecule	approved|investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antioxidants|Benzene Derivatives|Benzyl Compounds|Catechols|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Lignans|Lipoxygenase Inhibitors|Peripheral Nervous System Agents|Phenols|Protective Agents|Sensory System Agents
DB00180	Flunisolide	small molecule	approved|investigational	Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Drugs for Obstructive Airway Diseases|Immunosuppressive Agents|Nasal Preparations|Pregnadienes|Pregnanes|Respiratory System Agents|Steroids|Steroids, Fluorinated
DB00181	Baclofen	small molecule	approved	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|GABA-B Receptor Agonists|Gaba-derivative Skeletal Muscle Relaxants|gamma-Aminobutyric Acid|gamma-Aminobutyric Acid-ergic Agonist|Lipids|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|Peripheral Nervous System Agents
DB00182	Amphetamine	small molecule	approved|illicit|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Amphetamines|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Membrane Transport Modulators|Monoamine Oxidase Inhibitors|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB00183	Pentagastrin	small molecule	approved	Amino Acids, Peptides, and Proteins|Diagnostic Agents|Gastrins|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins|Tests for Gastric Secretion
DB00184	Nicotine	small molecule	approved	Agents producing tachycardia|Alkaloids|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Nicotinic Agonist|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Addictive Disorders|Drugs Used in Nicotine Dependence|Ganglion Blockers|Ganglionic Stimulants|Miscellaneous Autonomic Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Agonists|OCT2 Inhibitors|Peripheral Nervous System Agents|Pyridines|Solanaceous Alkaloids
DB00185	Cevimeline	small molecule	approved	Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Muscarinic Agonists|Nervous System|Neurotransmitter Agents|Parasympathomimetics|Peripheral Nervous System Agents|Sulfur Compounds
DB00186	Lorazepam	small molecule	approved	Anti-Anxiety Agents|Anticonvulsants|Antiemetics|Autonomic Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Gastrointestinal Agents|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00187	Esmolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Selective|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Propanols|QTc Prolonging Agents
DB00188	Bortezomib	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Boron Compounds|Boronic Acids|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Immunosuppressive Agents|Myelosuppressive Agents|Potential QTc-Prolonging Agents|Proteasome Inhibitors|Pyrazines|QTc Prolonging Agents
DB00189	Ethchlorvynol	small molecule	approved|illicit|withdrawn	Alcohols|Central Nervous System Agents|Central Nervous System Depressants|Chlorohydrins|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB00190	Carbidopa	small molecule	approved	Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Aromatic Amino Acid Decarboxylase Inhibitors|Biogenic Amines|Biogenic Monoamines|Catecholamines|Central Nervous System Agents|Dihydroxyphenylalanine|Dopamine Agents|Enzyme Inhibitors|Hydrazines|Methyldopa|Neurotransmitter Agents|Phenylalanine|Tyrosine
DB00191	Phentermine	small molecule	approved|illicit	Adrenergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Amphetamines|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Appetite Suppression|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ethylamines|Increased Sympathetic Activity|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Stimulants|Sympathomimetic Amine Anorectic|Sympathomimetics
DB00192	Indecainide	small molecule	approved	
DB00193	Tramadol	small molecule	approved|investigational	Agents producing tachycardia|Agents that reduce seizure threshold|Alcohols|Amines|Analgesics|Anticholinergic Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dimethylamines|Fatty Alcohols|Hexanols|Lipids|Methylamines|Muscarinic Antagonists|Narcotics|Nervous System|NMDA Receptor Antagonists|Opiate Agonists|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|UGT1A1 Substrates
DB00194	Vidarabine	small molecule	approved|investigational	Adenosine|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Arabinonucleosides|Carbohydrates|Direct Acting Antivirals|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ophthalmologicals|Purine Nucleosides|Purines|Ribonucleosides|Sensory Organs|Toxic Actions
DB00195	Betaxolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents, Selective|Beta-adrenergic Agents|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sensory Organs|Sympatholytics
DB00196	Fluconazole	small molecule	approved|investigational	14-alpha Demethylase Inhibitors|Agents causing hyperkalemia|Anti-Infective Agents|Antibacterials for Systemic Use|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A4 Inhibitors|Dermatologicals|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Triazoles
DB00197	Troglitazone	small molecule	investigational|withdrawn	Alimentary Tract and Metabolism|Benzopyrans|Blood Glucose Lowering Agents|BSEP/ABCB11 Inhibitors|Chemically-Induced Disorders|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Diabetes|OATP1B1/SLCO1B1 Inhibitors|Oral Hypoglycemics|Peroxisome Proliferator-Activated Receptors, agonists|Pyrans|Sulfur Compounds|Thiazoles|Thiazolidinediones|UGT1A1 Substrates|UGT1A6 Inhibitors|UGT1A6 substrate|UGT1A9 Substrates
DB00198	Oseltamivir	small molecule	approved	Acetamides|Acetates|Acids, Acyclic|Amides|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cyclohexanes|Cyclohexenes|Cycloparaffins|Direct Acting Antivirals|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Neuraminidase Inhibitors|OAT3/SLC22A8 Substrates
DB00199	Erythromycin	small molecule	approved|investigational|vet_approved	Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiinfectives for Treatment of Acne|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Sebaceous Gland Activity|Dermatologicals|Enzyme Inhibitors|Erythromycin|Erythromycins|Gastrointestinal Agents|Gastroparesis|Lactones|Macrolide Antimicrobial|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|Ophthalmologicals|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Polyketides|Protein Synthesis Inhibitors|QTc Prolonging Agents|Sensory Organs
DB00200	Hydroxocobalamin	small molecule	approved	Antianemic Preparations|Antidotes|Blood and Blood Forming Organs|Corrinoids|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hematinics|Hematologic Agents|Micronutrients|Nutritional Support|Physiological Phenomena|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins
DB00201	Caffeine	small molecule	approved	Acids, Acyclic|Alkaloids|Anorexigenic Agents & Respiratory and CNS Stimulants|Apnea|Caffeine and Caffeine Containing Products|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diagnostic Agents|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phosphodiesterase Inhibitors|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory and CNS Stimulants|Tests for Gastric Secretion|Tricarboxylic Acids|Xanthine derivatives
DB00202	Succinylcholine	small molecule	approved	Acids, Acyclic|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Central Nervous System Depressants|Choline|Choline Derivatives|Cholinesterase substrates|Dicarboxylic Acids|Ethanolamines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Depolarizing Agents|Neuromuscular Depolarizing Blockade|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Succinates|Trimethyl Ammonium Compounds
DB00203	Sildenafil	small molecule	approved|investigational	Amides|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Piperazines|Purines|Sulfonamides|Sulfones|Sulfur Compounds|Urological Agents|Urologicals|Vasodilating Agents
DB00204	Dofetilide	small molecule	approved|investigational	Amides|Amines|Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Highest Risk QTc-Prolonging Agents|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|OCT2 Substrates|Potassium Channel Blockers|QTc Prolonging Agents|Sulfones|Sulfur Compounds
DB00205	Pyrimethamine	small molecule	approved|investigational|vet_approved	Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Diaminopyrimidines|Enzyme Inhibitors|Folic Acid Antagonists|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Pyrimidines
DB00206	Reserpine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Alkaloids|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Antipsychotic Agents|BSEP/ABCB11 Inhibitors|Cardiovascular Agents|Catecholamine-depleting Sympatholytic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 Enzyme Inducers|Decreased Sympathetic Activity|Gastrointestinal Acidifying Agents|Hypotensive Agents|Indole Alkaloids|Indoles|Membrane Transport Modulators|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT2 Substrates|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Psychotropic Drugs|Secologanin Tryptamine Alkaloids|Tranquilizing Agents|Yohimbine
DB00207	Azithromycin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Erythromycin|Lactones|Macrolide Antimicrobial|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|Other Macrolides|P-glycoprotein/ABCB1 Inhibitors|Polyketides|QTc Prolonging Agents|Sensory Organs
DB00208	Ticlopidine	small molecule	approved	Antiplatelet agents|Blood and Blood Forming Organs|Cardiovascular Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Platelet Aggregation|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Neurotransmitter Agents|Platelet Aggregation Inhibitors Excl. Heparin|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Pyridines|Sulfur Compounds|Thienopyridines|Thiophenes
DB00209	Trospium	small molecule	approved	Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Cholinergic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Tropanes|Urological Agents|Urologicals
DB00210	Adapalene	small molecule	approved	Analgesics|Analgesics, Non-Narcotic|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Inflammatory Agents|Central Nervous System Agents|Dermatologicals|Misc. Skin and Mucous Membrane Agents|Naphthalenes|Peripheral Nervous System Agents|Retinoids|Retinoids for Topical Use in Acne|Sensory System Agents
DB00211	Midodrine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Bradycardia-Causing Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Sympathomimetics|Vasoconstrictor Agents
DB00212	Remikiren	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors|Renin-Inhibitors
DB00213	Pantoprazole	small molecule	approved	Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds
DB00214	Torasemide	small molecule	approved	Amides|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|High-Ceiling Diuretics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB00215	Citalopram	small molecule	approved	Amines|Antidepressive Agents, Second-Generation|Benzofurans|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nitriles|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Propylamines|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Vasodilating Agents
DB00216	Eletriptan	small molecule	approved|investigational	Agents that produce hypertension|Amines|Analgesics|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Indoles|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans
DB00217	Bethanidine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Guanidine Derivatives|Guanidines|Neurotransmitter Agents|Peripheral Nervous System Agents|Sympatholytics
DB00218	Moxifloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00219	Oxyphenonium	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Mydriatics|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB00220	Nelfinavir	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Isoquinolines|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protease Inhibitors|QTc Prolonging Agents|UGT1A1 Inducers
DB00221	Isoetarine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB00222	Glimepiride	small molecule	approved	Alimentary Tract and Metabolism|Antiarrhythmic agents|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Oral Hypoglycemics|Sulfones|Sulfonylureas|Sulfur Compounds|Urea
DB00223	Diflorasone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB00224	Indinavir	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (weak)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Pyridines|UGT1A1 Inhibitors
DB00225	Gadodiamide	small molecule	approved|investigational	Acetates|Acids, Acyclic|Amines|Contrast Media|Diagnostic Uses of Chemicals|Fatty Acids|Fatty Acids, Volatile|Injections, Intravenous|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Miscellaneous Therapeutic Agents|Organometallic Compounds|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Pentetic Acid|Polyamines
DB00226	Guanadrel	small molecule	approved	Adrenergic Antagonists|Amidines|Antihypertensive Agents|Cardiovascular Agents
DB00227	Lovastatin	small molecule	approved|investigational	Anticholesteremic Agents|BSEP/ABCB11 Substrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Naphthalenes|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Toxic Actions|UGT1A1 Substrates
DB00228	Enflurane	small molecule	approved|investigational|vet_approved	Agents that produce hypertension|Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Substrates|Ethers|Hydrocarbons, Halogenated|Methyl Ethers|Nervous System
DB00229	Cefotiam	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB00230	Pregabalin	small molecule	approved|illicit|investigational	Acids, Acyclic|Agents causing angioedema|Agents causing hyperkalemia|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Analgesics|Anti-Anxiety Agents|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Butyrates|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Fatty Acids|Fatty Acids, Volatile|gamma-Aminobutyric Acid|Hypoglycemia-Associated Agents|Lipids|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Tranquilizing Agents|Vasodilating Agents
DB00231	Temazepam	small molecule	approved|investigational	Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00232	Methyclothiazide	small molecule	approved	Amides|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB00233	Aminosalicylic Acid	small molecule	approved	Acids, Carbocyclic|Aminobenzoates|Aminosalicylic Acid and Derivatives|Aminosalicylic Acids|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Benzene Derivatives|Benzoates|Drugs for Treatment of Tuberculosis|Hydroxy Acids|Hydroxybenzoates|para-Aminobenzoates|Phenols|Salicylates
DB00234	Reboxetine	small molecule	approved|experimental	Adrenergic Agents|Adrenergic Uptake Inhibitors|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Oxazines|P-glycoprotein/ABCB1 Inhibitors|Psychoanaleptics|Psychotropic Drugs
DB00235	Milrinone	small molecule	approved	Amines|Aminopyridines|Amrinone|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Hematologic Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Pyridines|Vasodilating Agents
DB00236	Pipobroman	small molecule	approved	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Noxae|Piperazines|Toxic Actions
DB00237	Butabarbital	small molecule	approved|illicit	Anticholinergic Agents|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nicotinic Antagonists|Pyrimidines|Pyrimidinones
DB00238	Nevirapine	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Inducers of Drug Clearance|Non-Nucleoside Analog|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|Pyridines|Reverse Transcriptase Inhibitors
DB00239	Oxiconazole	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives
DB00240	Alclometasone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Ophthalmologicals|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids
DB00241	Butalbital	small molecule	approved|illicit	Anticholinergic Agents|Anticonvulsants|Barbiturates|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Hypnotics and Sedatives|Methemoglobinemia Associated Agents|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB00242	Cladribine	small molecule	approved|investigational	2-Chloroadenosine|Adenosine|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Deoxyadenosines|Deoxyribonucleosides|Glycosides|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Analogues|Purine Antimetabolite|Purine Nucleosides|Purines|Ribonucleosides
DB00243	Ranolazine	small molecule	approved|investigational	Acetanilides|Amides|Anilides|Antianginal Agents|BSEP/ABCB11 Substrates|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Membrane Transport Modulators|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers|Vasodilating Agents
DB00244	Mesalazine	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Aminobenzoates|Aminosalicylate|Aminosalicylic Acids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Intestinal Antiinflammatory Agents|meta-Aminobenzoates|Nephrotoxic agents|Peripheral Nervous System Agents|Phenols|Salicylates|Sensory System Agents
DB00245	Benzatropine	small molecule	approved	Agents producing tachycardia|Alkaloids|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Ethers of Tropine or Tropine Derivatives|Histamine Antagonists|Histamine H1 Antagonists|Histamine Receptor Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Tropanes
DB00246	Ziprasidone	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Indole Derivatives|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB00247	Methysergide	small molecule	approved	Agents that produce hypertension|Alkaloids|Analgesics|Antimigraine Preparations|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Lysergic Acid|Nervous System|Neurotransmitter Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Vasoconstrictor Agents
DB00248	Cabergoline	small molecule	approved	Agents that produce hypertension|Alkaloids|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antineoplastic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Genito Urinary System and Sex Hormones|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Prolactine Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists
DB00249	Idoxuridine	small molecule	approved|investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Dermatologicals|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside Analog Antiviral|Nucleosides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ophthalmologicals|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Sensory Organs|Uridine
DB00250	Dapsone	small molecule	approved|investigational	Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimalarials|Antimycobacterials|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Drugs for Treatment of Lepra|Enzyme Inhibitors|Folic Acid Antagonists|Leprostatic Agents|Methemoglobinemia Associated Agents|Miscellaneous Antimycobacterials|Miscellaneous Local Anti-infectives|Sulfones|Sulfur Compounds
DB00251	Terconazole	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Azole Antifungals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Triazole Derivatives
DB00252	Phenytoin	small molecule	approved|vet_approved	Anti-epileptic Agent|Anticonvulsants|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C19 Substrates (moderate)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2D6 Inducers (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inducers|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 2D6 Inducers|Cytochrome P450 3A Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|Hydantoins|Imidazoles|Imidazolidines|Inducers of Drug Clearance|Membrane Transport Modulators|Methemoglobinemia Associated Agents|Narrow Therapeutic Index Drugs|Nervous System|P-glycoprotein/ABCB1 Substrates|Sodium Channel Blockers|UGT1A1 Inducers|UGT1A6 Inhibitors|UGT1A9 Inhibitors|Voltage-Gated Sodium Channel Blockers
DB00253	Medrysone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnanes|Pregnenes|Sensory Organs|Steroids
DB00254	Doxycycline	small molecule	approved|investigational|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antimalarials|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Naphthacenes|OAT3/SLC22A8 Inhibitors|P-glycoprotein/ABCB1 Substrates|Stomatological Preparations|Tetracyclines
DB00255	Diethylstilbestrol	small molecule	approved|investigational	Adrenal Cortex Hormones|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Benzylidene Compounds|BSEP/ABCB11 Substrates|Carcinogens|COMT Substrates|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Postcoital|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Estrogen Contraceptives|Estrogens|Estrogens, Non-Steroidal|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Noxae|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Sex Hormones and Modulators of the Genital System|Stilbenes|Synthetic Estrogens, Plain|Toxic Actions
DB00256	Lymecycline	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines
DB00257	Clotrimazole	small molecule	approved|vet_approved	14-alpha Demethylase Inhibitors|Alimentary Tract and Metabolism|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Azole Antifungals|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|Steroid Synthesis Inhibitors|Stomatological Preparations
DB00258	Calcium acetate	small molecule	approved|investigational	Acids|Acids, Acyclic|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Blood Coagulation Factors|Calcium Salts|Chelating Agents|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Fatty Acids|Fatty Acids, Volatile|Lipids|Minerals|Phosphate Binder|Phosphate-removing Agents|Sequestering Agents|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB00259	Sulfanilamide	small molecule	approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Short-Acting Sulfonamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB00260	Cycloserine	small molecule	approved	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimetabolites|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Isoxazoles|Neurotoxic agents|Noxae|Oxazoles|Oxazolidinones|Renal Agents|Toxic Actions
DB00261	Anagrelide	small molecule	approved	Agents producing tachycardia|Anticoagulants|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiplatelet agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Platelet Production|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Highest Risk QTc-Prolonging Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Platelet-reducing Agents|QTc Prolonging Agents|Thrombocytosis|Vasodilating Agents
DB00262	Carmustine	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Immunosuppressive Agents|Myelosuppressive Agents|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Noxae|Toxic Actions|Urea
DB00263	Sulfisoxazole	small molecule	approved|vet_approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypoglycemia-Associated Agents|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|QTc Prolonging Agents|Sensory Organs|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB00264	Metoprolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sympatholytics
DB00265	Crotamiton	small molecule	approved	Agrochemicals|Amines|Aniline Compounds|Benzene Derivatives|Pesticides|Scabicides and Pediculicides|Toluene|Toxic Actions
DB00266	Dicoumarol	small molecule	approved	4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Fibrinolytic Agents|Hematologic Agents|Narrow Therapeutic Index Drugs|Pyrans|Uncoupling Agents|Vitamin K Antagonists
DB00267	Cefmenoxime	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB00268	Ropinirole	small molecule	approved|investigational	Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Hypotensive Agents|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB00269	Chlorotrianisene	small molecule	investigational|withdrawn	Antineoplastic Agents|Antineoplastic Agents, Hormonal|Benzene Derivatives|Benzylidene Compounds|Estrogens|Estrogens, Non-Steroidal|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|Sex Hormones and Modulators of the Genital System|Stilbenes
DB00270	Isradipine	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB00271	Diatrizoate	small molecule	approved|vet_approved	Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Contrast Media|Diagnostic Uses of Chemicals|Diatrizoate|Hexosamines|Iodinated Contrast Agents|Iodobenzoates|Meglumine|Radiographic Contrast Agent|Roentgenography|Sorbitol|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB00272	Betazole	small molecule	approved	Diagnostic Agents|Gastrointestinal Agents|Histamine Agents|Histamine Agonists|Neurotransmitter Agents|Pyrazoles|Tests for Gastric Secretion
DB00273	Topiramate	small molecule	approved	Anti-Obesity Agents|Anticonvulsants|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|Hexoses|Ketoses|Miscellaneous Anticonvulsants|Monosaccharides|Nervous System|Neuroprotective Agents|P-glycoprotein/ABCB1 Substrates|Protective Agents
DB00274	Cefmetazole	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Cephamycins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB00275	Olmesartan	small molecule	approved|investigational	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Hypotensive Agents|Imidazoles|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Tetrazoles
DB00276	Amsacrine	small molecule	approved|investigational	Acridines|Aminoacridines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Immunosuppressive Agents|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals|Myelosuppressive Agents|P-glycoprotein/ABCB1 Inhibitors
DB00277	Theophylline	small molecule	approved	Agents that reduce seizure threshold|Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Peripheral Nervous System Agents|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory Smooth Muscle Relaxants|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives|Xanthines and Adrenergics
DB00278	Argatroban	small molecule	approved|investigational	Anticoagulants|Antithrombins|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Enzyme Inhibitors|Fibrinolytic Agents|Hematologic Agents|Narrow Therapeutic Index Drugs|Piperidines|Serine Proteinase Inhibitors|Thrombin Inhibitors
DB00279	Liothyronine	small molecule	approved|vet_approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|l-Triiodothyronine|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inducers|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products|Thyronines
DB00280	Disopyramide	small molecule	approved	Agents producing tachycardia|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Anticholinergic Agents|Blood Glucose Lowering Agents|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|OCT2 Inhibitors|Pyridines|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB00281	Lidocaine	small molecule	approved|vet_approved	Acetanilides|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Agents that reduce seizure threshold|Amide Local Anesthetic|Amides|Analgesics and Anesthetics|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Anilides|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Local Anesthesia|Membrane Transport Modulators|Methemoglobinemia Associated Agents|Nervous System|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Sodium Channel Blockers|Throat Preparations|Vasoprotectives|Voltage-Gated Sodium Channel Blockers
DB00282	Pamidronate	small molecule	approved	Anti-Inflammatory Agents|Antineoplastic Agents|Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|GTP Phosphohydrolases|Musculo-Skeletal System|Nephrotoxic agents|Organophosphonates|Organophosphorus Compounds
DB00283	Clemastine	small molecule	approved|investigational	Aminoalkyl Ethers|Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Highest Risk QTc-Prolonging Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Pyrrolidines|QTc Prolonging Agents
DB00284	Acarbose	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Carbohydrates|Drugs Used in Diabetes|Enzyme Inhibitors|Glycoside Hydrolase Inhibitors|Hypoglycemia-Associated Agents|Oligosaccharides|Oral Hypoglycemics|Polysaccharides|Trisaccharides
DB00285	Venlafaxine	small molecule	approved	Agents producing tachycardia|Agents that reduce seizure threshold|Alcohols|Amines|Antidepressive Agents, Second-Generation|BCRP/ABCG2 Inducers|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ethylamines|Fatty Alcohols|Hexanols|Hypoglycemia-Associated Agents|Lipids|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phenethylamines|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators
DB00286	Conjugated estrogens	small molecule	approved	Agents causing angioedema|BCRP/ABCG2 Substrates|COMT Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estrogens|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Sex Hormones and Modulators of the Genital System
DB00287	Travoprost	small molecule	approved	Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Cloprostenol|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Ophthalmics|Ophthalmologicals|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Sensory Organs
DB00288	Amcinonide	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated
DB00289	Atomoxetine	small molecule	approved	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Central Nervous System Depressants|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Miscellaneous Central Nervous System Agents|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Reuptake Inhibitor|Norepinephrine Uptake Inhibitors|Potential QTc-Prolonging Agents|Propylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|QTc Prolonging Agents
DB00290	Bleomycin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytoprotective Agent|Cytotoxic Antibiotics and Related Substances|Glycoconjugates|Glycopeptides|Immunosuppressive Agents|Peptides
DB00291	Chlorambucil	small molecule	approved	Agents that reduce seizure threshold|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Hydrocarbons, Halogenated|Immunosuppressive Agents|Mustard Compounds|Myelosuppressive Agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|P-glycoprotein/ABCB1 Substrates|Toxic Actions
DB00292	Etomidate	small molecule	approved	Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Imidazoles|Nervous System
DB00293	Raltitrexed	small molecule	approved|investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Sulfur Compounds|Thymidylate Synthase, antagonists & inhibitors|Toxic Actions
DB00294	Etonogestrel	small molecule	approved|investigational	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Intravaginal Contraceptives|Norpregnanes|Norpregnenes|Norsteroids|Progesterone Congeners|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00295	Morphine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Alkaloids|Analgesics|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates
DB00296	Ropivacaine	small molecule	approved	Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Local Anesthesia|Nervous System|Peripheral Nervous System Agents|Sensory System Agents
DB00297	Bupivacaine	small molecule	approved|investigational	Agents that reduce seizure threshold|Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Anilides|Central Nervous System Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Local Anesthesia|Nervous System|Peripheral Nervous System Agents|Pipecolic Acids|Piperidines|Sensory System Agents
DB00298	Dapiprazole	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiglaucoma Preparations and Miotics|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Tranquilizing Agents
DB00299	Penciclovir	small molecule	approved	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Dermatologicals|Direct Acting Antivirals|Guanine|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Purines|Purinones|Reverse Transcriptase Inhibitors
DB00300	Tenofovir disoproxil	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Substrates|Organophosphonates|Organophosphorus Compounds|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Purines|Reverse Transcriptase Inhibitors|Tenofovir and prodrugs
DB00301	Flucloxacillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|BSEP/ABCB11 Substrates|Cloxacillin|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Lactams|Oxacillin|Penicillins|Sulfur Compounds
DB00302	Tranexamic acid	small molecule	approved	Acids, Carbocyclic|Amino Acids|Antifibrinolytic Agents|Blood and Blood Forming Organs|Coagulants|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Decreased Fibrinolysis|Fibrin Modulating Agents|Hematologic Agents|Hemostatics
DB00303	Ertapenem	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Carbapenems|Lactams|Penem Antibacterial|Sulfur Compounds
DB00304	Desogestrel	small molecule	approved	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00305	Mitomycin	small molecule	approved	Alkylating Activity|Alkylating Drugs|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Azirines|Cardiotoxic antineoplastic agents|Cross-Linking Reagents|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Immunosuppressive Agents|Indicators and Reagents|Indolequinones|Indoles|Laboratory Chemicals|Mitomycins|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|P-glycoprotein/ABCB1 Substrates|Quinones|Toxic Actions
DB00306	Talbutal	small molecule	approved|illicit	Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB00307	Bexarotene	small molecule	approved|investigational	Anticarcinogenic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|Naphthalenes|Protective Agents|Retinoids
DB00308	Ibutilide	small molecule	approved	Amides|Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiovascular Agents|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Sulfones|Sulfur Compounds
DB00309	Vindesine	small molecule	approved|investigational	Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Myelosuppressive Agents|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids
DB00310	Chlorthalidone	small molecule	approved	Acids, Carbocyclic|Amides|Antihypertensive Agents|Benzene Derivatives|Benzhydryl Compounds|Benzophenones|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Imides|Increased Diuresis|Isoindoles|Ketones|Low-Ceiling Diuretics and Potassium-Sparing Agents|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Phthalic Acids|Phthalimides|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide-like Diuretic
DB00311	Ethoxzolamide	small molecule	withdrawn	Amides|Benzothiazoles|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Diuretics|Enzyme Inhibitors|Natriuretic Agents|Sulfonamides|Sulfones|Sulfur Compounds|Thiazoles
DB00312	Pentobarbital	small molecule	approved|investigational|vet_approved	Adjuvants, Anesthesia|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2A6 Inducers (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB00313	Valproic Acid	small molecule	approved|investigational	Acids, Acyclic|Anti-epileptic Agent|Anticonvulsants|Antimanic Agents|Antineoplastic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inhibitors|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|GABA Agents|Highest Risk QTc-Prolonging Agents|Histone Deacetylase Inhibitors|Lipids|Methemoglobinemia Associated Agents|Miscellaneous Anticonvulsants|Mood Stabilizer|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Pentanoic Acids|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Tranquilizing Agents|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates|Valerates
DB00314	Capreomycin	small molecule	approved	Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Enzyme Inhibitors|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors
DB00315	Zolmitriptan	small molecule	approved|investigational	Agents that produce hypertension|Amines|Analgesics|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Indoles|Nervous System|Neurotransmitter Agents|Oxazoles|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans
DB00316	Acetaminophen	small molecule	approved	Acetanilides|Acetates|Acids, Acyclic|Amides|Analgesics|Analgesics, Non-Narcotic|Anilides|Antipyretics|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Methemoglobinemia Associated Agents|Miscellaneous Analgesics and Antipyretics|Nervous System|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Sensory System Agents|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates
DB00317	Gefitinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Receptor, Epidermal Growth Factor, antagonists & inhibitors|Tyrosine Kinase Inhibitors
DB00318	Codeine	small molecule	approved|illicit	Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates
DB00319	Piperacillin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Extended-spectrum Penicillins|Lactams|OAT3/SLC22A8 Substrates|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB00320	Dihydroergotamine	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Antimigraine Preparations|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamine Derivative|Ergotamines|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Sympatholytic (Adrenergic Blocking) Agents|Vasoconstrictor Agents
DB00321	Amitriptyline	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Analgesics|Analgesics, Non-Narcotic|Anticholinergic Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzocycloheptenes|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|UGT1A1 Substrates
DB00322	Floxuridine	small molecule	approved	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Carbohydrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Deoxyribonucleosides|Deoxyuridine|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions|Uridine
DB00323	Tolcapone	small molecule	approved|withdrawn	Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|COMT Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Enzyme Inhibitors|Hypotensive Agents|Ketones|Nervous System|Nitro Compounds|Phenols
DB00324	Fluorometholone	small molecule	approved|investigational	Adrenal Cortex Hormones|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnadienediols|Pregnadienes|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated|Vasoprotectives
DB00325	Nitroprusside	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Anions|Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Cyanides|Direct Vasodilators|Electrolytes|Ferric Compounds|Ferricyanides|Hydrogen Cyanide|Hypotensive Agents|Indicators and Reagents|Ions|Iron Compounds|Laboratory Chemicals|Methemoglobinemia Associated Agents|Nitric Oxide Donors|Nitroferricyanide Derivatives|Nitrogen Compounds|Organometallic Compounds|Vasodilating Agents|Vasodilation
DB00326	Calcium glucoheptonate	small molecule	approved	Acids, Acyclic|Alimentary Tract and Metabolism|Calcium Salts|Carbohydrates|Copper|Hydroxy Acids|Mineral Supplements|Supplements
DB00327	Hydromorphone	small molecule	approved|illicit	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A9 Substrates
DB00328	Indometacin	small molecule	approved|investigational	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|BSEP/ABCB11 Substrates|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hypoglycemia-Associated Agents|Immunosuppressive Agents|Indoles|Musculo-Skeletal System|Myelosuppressive Agents|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Other Nonsteroidal Antiimflammatory Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Reproductive Control Agents|Sensory Organs|Sensory System Agents|Tocolytic Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates
DB00330	Ethambutol	small molecule	approved	Amines|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Diamines|Drugs for Treatment of Tuberculosis|Ethylenediamines|Polyamines
DB00331	Metformin	small molecule	approved	Alimentary Tract and Metabolism|Amidines|Biguanides|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Guanidines|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|OCT2 Inhibitors|OCT2 Substrates|Oral Hypoglycemics
DB00332	Ipratropium	small molecule	approved	Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Alkaloids|Anti-Asthmatic Agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Atropine Derivatives|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Bronchodilator Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Nasal Preparations|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Solanaceous Alkaloids|Tropanes
DB00333	Methadone	small molecule	approved	Analgesics|Anticholinergic Agents|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diphenylpropylamine Derivatives|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Ketones|Moderate Risk QTc-Prolonging Agents|Narcotics|Nervous System|Nicotinic Antagonists|NMDA Receptor Antagonists|Opiate Agonists|Opioid Agonist|Opioids|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|QTc Prolonging Agents|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00334	Olanzapine	small molecule	approved|investigational	Acid Reducers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Autonomic Agents|Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Diazepines, Oxazepines, Thiazepines and Oxepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Hyperglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents|UGT1A1 Substrates
DB00335	Atenolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sympatholytics
DB00336	Nitrofural	small molecule	approved|investigational|vet_approved	Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antiseptics and Disinfectants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dermatologicals|Furans|Irrigating Solutions|Medicated Dressings|Medicated Dressings With Antiinfectives|Nitro Compounds|Nitrofuran Derivatives|Nitrofurans|Ophthalmologicals|Otologicals|Sensory Organs
DB00337	Pimecrolimus	small molecule	approved|investigational	Agents for Dermatitis, Excluding Corticosteroids|Analgesics|Analgesics, Non-Narcotic|Anti-Bacterial Agents|Anti-Inflammatory Agents|Calcineurin Inhibitor Immunosuppressant|Calcineurin Inhibitors|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Lactones|Misc. Skin and Mucous Membrane Agents|Peptidylprolyl Isomerase, antagonists & inhibitors|Peripheral Nervous System Agents|Polyketides|Sensory System Agents
DB00338	Omeprazole	small molecule	approved|investigational|vet_approved	2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzimidazoles|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds
DB00339	Pyrazinamide	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Treatment of Tuberculosis|Pyrazines
DB00340	Metixene	small molecule	approved	Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Muscarinic Antagonists|Nervous System|Sulfur Compounds|Tertiary Amines|Xanthenes
DB00341	Cetirizine	small molecule	approved	Anti-Allergic Agents|Anticholinergic Agents|Antihistamines for Systemic Use|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Hydroxyzine|Neurotransmitter Agents|Piperazine Derivatives|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00342	Terfenadine	small molecule	approved|withdrawn	Anticholinergic Agents|Antihistamines for Systemic Use|Benzene Derivatives|Benzhydryl Compounds|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Muscarinic Antagonists|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperidines|QTc Prolonging Agents
DB00343	Diltiazem	small molecule	approved|investigational	Agents causing hyperkalemia|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Antiarrhythmic agents|Antihypertensive Agents|Benzazepines|Benzothiazepine Derivatives|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Nondihydropyridine)|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Membrane Transport Modulators|Miscellaneous Calcium-channel Blocking Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Selective Calcium Channel Blockers With Direct Cardiac Effects|Vasodilating Agents|Vasoprotectives
DB00344	Protriptyline	small molecule	approved	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Substrates|Dibenzocycloheptenes|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00345	Aminohippuric acid	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Aminobenzoates|Aminohippuric Acids|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Diagnostic Agents|Hippurates|Indicators and Reagents|Keto Acids|Laboratory Chemicals|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|para-Aminobenzoates|Tests for Renal Function and Ureteral Injuries
DB00346	Alfuzosin	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Prostatic Hyperplasia|QTc Prolonging Agents|Selective Alfa-1-adrenergic Blocking Agents|Urological Agents|Urologicals
DB00347	Trimethadione	small molecule	approved	Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Nervous System|Oxazoles|Oxazolidine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00348	Nitisinone	small molecule	approved|investigational	4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor|4-Hydroxyphenylpyruvate Dioxygenase, antagonists & inhibitors|Acids, Carbocyclic|Alimentary Tract and Metabolism|Benzene Derivatives|Benzoates|Cyclohexanes|Cycloparaffins|Cytochrome P450 2C9 Inhibitors|Enzyme Inhibitors|Hydroxyphenylpyruvate Dioxygenase Inhibitors|Ketones|Other Miscellaneous Therapeutic Agents|Various Alimentary Tract and Metabolism Products
DB00349	Clobazam	small molecule	approved|illicit	Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Nervous System|P-glycoprotein/ABCB1 Substrates|Psycholeptics
DB00350	Minoxidil	small molecule	approved|investigational	Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Arteriolar Vasodilation|Arteriolar Vasodilator|Cardiovascular Agents|Dermatologicals|Direct Vasodilators|Hypotensive Agents|Misc. Skin and Mucous Membrane Agents|Piperidines|Pyrimidine Derivatives|Pyrimidines|UGT1A1 Substrates|Vasodilating Agents
DB00351	Megestrol acetate	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Appetite Stimulants|Central Nervous System Agents|Central Nervous System Stimulants|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Endocrine Therapy|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones and Related Agents|Hyperglycemia-Associated Agents|Megestrol|P-glycoprotein/ABCB1 Inhibitors|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00352	Tioguanine	small molecule	approved	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Purine Analogues|Purines|Thiopurine Analogs|Toxic Actions
DB00353	Methylergometrine	small molecule	approved	Agents that produce hypertension|Alkaloids|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Antagonists|Ergolines|Ergonovine|Ergot Alkaloids and Derivatives|Genito Urinary System and Sex Hormones|Reproductive Control Agents|Uterotonic agents
DB00354	Buclizine	small molecule	approved	Agents producing tachycardia|Anticholinergic Agents|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Piperazine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00355	Aztreonam	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Lactams|Monobactam Antibacterial|Monobactams|Sulfur Compounds
DB00356	Chlorzoxazone	small molecule	approved	Benzoxazoles|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Oxazol, Thiazine, and Triazine Derivatives|Peripheral Nervous System Agents
DB00357	Aminoglutethimide	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Glutethimide|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Piperidines|Piperidones|Steroid Synthesis Inhibitors
DB00358	Mefloquine	small molecule	approved|investigational	Agents that reduce seizure threshold|Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Methanolquinolines|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines
DB00359	Sulfadiazine	small molecule	approved|investigational|vet_approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Blood Glucose Lowering Agents|Coccidiostats|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypoglycemia-Associated Agents|Intermediate-Acting Sulfonamides|Methemoglobinemia Associated Agents|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB00360	Sapropterin	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amines|Biological Factors|Breast Cancer Resistance Protein Inhibitors|Coenzymes|Dietary Supplements|Enzymes and Coenzymes|Ethylamines|Nitric Oxide|Nitric Oxide Synthase|Other Miscellaneous Therapeutic Agents|P-glycoprotein/ABCB1 Inhibitors|Phenethylamines|Phenylalanine Hydroxylase Activator|Phenylalanine Hydroxylase Activators|Pigments, Biological|Pteridines|Pterins|Supplements|Various Alimentary Tract and Metabolism Products
DB00361	Vinorelbine	small molecule	approved|investigational	Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Indole Alkaloids|Indoles|Myelosuppressive Agents|Neurotoxic agents|P-glycoprotein/ABCB1 Substrates|Radiation-Sensitizing Agents|Secologanin Tryptamine Alkaloids|Vinca Alkaloids
DB00362	Anidulafungin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Echinocandin Antifungal|Echinocandins|Peptides|Peptides, Cyclic
DB00363	Clozapine	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diazepines, Oxazepines, Thiazepines and Oxepines|Dibenzazepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|GABA Agents|GABA Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB00364	Sucralfate	small molecule	approved	Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum Complex|Anti-Ulcer Agents|Carbohydrates|Disaccharides|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Glycosides|Oligosaccharides|Organometallic Compounds|Polysaccharides|Protectants|Sucrose|Sulfur Compounds|Thioglycosides
DB00365	Grepafloxacin	small molecule	approved|investigational|withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Fluoroquinolones|Highest Risk QTc-Prolonging Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00366	Doxylamine	small molecule	approved|vet_approved	Agents producing tachycardia|Aminoalkyl Ethers|Anticholinergic Agents|Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Ethanolamine Derivatives|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine Receptor Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents
DB00367	Levonorgestrel	small molecule	approved|investigational	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Inhibit Ovum Fertilization|Norgestrel|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestin-containing Intrauterine Device|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00368	Norepinephrine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|COMT Substrates|Epinephrine|Ethanolamines|Neurotransmitter Agents|OCT2 Inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Sympathomimetics|Vasoconstrictor Agents
DB00369	Cidofovir	small molecule	approved	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|Direct Acting Antivirals|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Organophosphorus Compounds|Pyrimidines|Pyrimidinones
DB00370	Mirtazapine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents, Tetracyclic|Carbon Radioisotopes|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzazepines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Miscellaneous Antidepressants|Nervous System|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB00371	Meprobamate	small molecule	approved|illicit	Acids, Acyclic|Anti-Anxiety Agents|Carbamates|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00372	Thiethylperazine	small molecule	approved|withdrawn	Antiemetics|Antihistamines for Systemic Use|Antipsychotic Agents|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazine Derivatives|Phenothiazines|Piperazines|Sulfur Compounds
DB00373	Timolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Beta-adrenergic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|EENT Drugs, Miscellaneous|Hypotensive Agents|Morpholines|Neurotransmitter Agents|Ophthalmologicals|Oxazines|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Sensory Organs|Sulfur Compounds|Thiadiazoles|Thiazoles
DB00374	Treprostinil	small molecule	approved|investigational	Antihypertensive Agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Substrates|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Potential QTc-Prolonging Agents|Prostacyclin Analogues|Prostacycline Vasodilator|Prostaglandins|Prostaglandins I|QTc Prolonging Agents|Vasodilating Agents|Vasodilation
DB00375	Colestipol	small molecule	approved	Amines|Anion Exchange Resins|Bile Acid Sequestrants|Bile-acid Binding Activity|Biomedical and Dental Materials|Hypolipidemic Agents|Ion Exchange Resins|Laboratory Chemicals|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Macromolecular Substances|Noxae|Polyamines|Polymers|Sequestering Agents|Toxic Actions
DB00376	Trihexyphenidyl	small molecule	approved	Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Central Nervous System Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Piperidines|Tertiary Amines
DB00377	Palonosetron	small molecule	approved|investigational	Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB00378	Dydrogesterone	small molecule	approved|investigational|withdrawn	Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestins|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids
DB00379	Mexiletine	small molecule	approved|investigational	Amines|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Benzene Derivatives|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ethers|Membrane Transport Modulators|Phenols|Phenyl Ethers|Propylamines|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB00380	Dexrazoxane	small molecule	approved|withdrawn	Cardiotonic Agents|Cardiovascular Agents|Cytoprotective Agent|Detoxifying Agents for Antineoplastic Treatment|Diketopiperazines|Enzyme Inhibitors|Immunosuppressive Agents|Miscellaneous Therapeutic Agents|Myelosuppressive Agents|Piperazines|Protective Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00381	Amlodipine	small molecule	approved	ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Angiotensin II Antagonists and Calcium Channel Blockers|Antianginal Agents|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium Channel Blockers and Diuretics|Cardiovascular Agents|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Lipid Modifying Agents|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB00382	Tacrine	small molecule	approved|investigational|withdrawn	Acridines|Aminoacridines|Anti-Dementia Drugs|Autonomic Agents|Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Nootropic Agents|P-glycoprotein/ABCB1 Substrates|Parasympathomimetics|Peripheral Nervous System Agents|Psychoanaleptics
DB00383	Oxyphencyclimine	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Esters With Tertiary Amino Group
DB00384	Triamterene	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Decreased Renal K+ Excretion|Diuretics|Diuretics, Potassium Sparing|Epithelial Sodium Channel Blockers|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Potassium-Sparing Agents|Potassium-Sparing Diuretics|Pteridines|Sodium Channel Blockers
DB00385	Valrubicin	small molecule	approved	Anthracyclines|Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Daunorubicin|Enzyme Inhibitors|Glycosides|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00387	Procyclidine	small molecule	approved	Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Central Nervous System Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Pyrrolidines|Tertiary Amines
DB00388	Phenylephrine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 Enzyme Inducers|Decongestants and Antiallergics|Ethanolamines|Mydriatics|Mydriatics and Cycloplegics|Nasal Decongestants|Nasal Decongestants for Systemic Use|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Sensory Organs|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Sympathomimetics Excl. Antiglaucoma Preparations|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents
DB00389	Carbimazole	small molecule	approved|investigational	Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles|Sulfur-Containing Imidazole Derivatives|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB00390	Digoxin	small molecule	approved	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Digitalis Glycosides|Digoxin|Enzyme Inhibitors|Glycosides|Narrow Therapeutic Index Drugs|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Serum Globulins|Steroids
DB00391	Sulpiride	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Antidepressive Agents, Second-Generation|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents
DB00392	Profenamine	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Agents producing tachycardia|Anti-Parkinson Drugs|Anticholinergic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Histamine Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Sulfur Compounds|Tertiary Amines
DB00393	Nimodipine	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nicotinic Acids|P-glycoprotein/ABCB1 Inhibitors|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB00394	Beclomethasone dipropionate	small molecule	approved|investigational	Adrenal Cortex Hormones|Adrenals|Adrenergics, Inhalants|Agents to Treat Airway Disease|Alimentary Tract and Metabolism|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Drugs for Obstructive Airway Diseases|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|Pregnadienes|Pregnadienetriols|Pregnanes|Respiratory System Agents|Steroids|Steroids, Chlorinated
DB00395	Carisoprodol	small molecule	approved	Acids, Acyclic|Carbamates|Carbamic Acid Esters|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Cytochrome P-450 CYP2C19 Substrates|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Peripheral Nervous System Agents
DB00396	Progesterone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|BCRP/ABCG2 Inducers|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Corpus Luteum Hormones|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Pregnanes|Pregnen (4) Derivatives|Pregnenediones|Pregnenes|Progesterone|Progesterone Congeners|Progestin-containing Intrauterine Device|Progestins|Sex Hormones and Modulators of the Genital System|Steroids
DB00397	Phenylpropanolamine	small molecule	approved|vet_approved|withdrawn	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Alcohols|Amines|Amino Alcohols|Anti-Obesity Agents|Appetite Depressants|Autonomic Agents|Cardiovascular Agents|Central Nervous System Agents|Nasal Decongestants|Nasal Decongestants for Systemic Use|Nasal Preparations|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanolamines|Propanols|Respiratory System Agents|Sympathomimetics|Vasoconstrictor Agents
DB00398	Sorafenib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzene Derivatives|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Miscellaneous Therapeutic Agents|Myelosuppressive Agents|Nicotinic Acids|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|Pyridines|QTc Prolonging Agents|raf Kinases|Receptors, Vascular Endothelial Growth Factor|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Inhibitors|UGT1A9 Substrates|Urea
DB00399	Zoledronic acid	small molecule	approved	Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds
DB00400	Griseofulvin	small molecule	approved|investigational|vet_approved	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Systemic Use|Antifungals for Topical Use|Benzofurans|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Decreased Mitosis|Dermatologicals|Microtubule Inhibition|Tubulin Inhibiting Agent
DB00401	Nisoldipine	small molecule	approved	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Decreased Blood Pressure|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB00402	Eszopiclone	small molecule	approved|investigational	Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Piperazines|Psycholeptics|Pyrazines|Pyridines
DB00403	Ceruletide	small molecule	approved	Amino Acids, Peptides, and Proteins|Diagnostic Agents|Oligopeptides|Peptides|Tests for Bile Duct Patency
DB00404	Alprazolam	small molecule	approved|illicit|investigational	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00405	Dexbrompheniramine	small molecule	approved	Antihistamines for Systemic Use|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Pheniramine|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Substituted Alkylamines
DB00406	Gentian violet cation	small molecule	approved	Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Miscellaneous Antifungals
DB00407	Ardeparin	small molecule	approved|investigational|withdrawn	Agents causing hyperkalemia|Anticoagulants|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Heparins|Polysaccharides
DB00408	Loxapine	small molecule	approved	Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Diazepines, Oxazepines, Thiazepines and Oxepines|Dibenzoxazepines|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Miscellaneous Antipsychotics|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB00409	Remoxipride	small molecule	approved|withdrawn	Acids, Carbocyclic|Amides|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Bromobenzoates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00410	Mupirocin	small molecule	approved|investigational|vet_approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Topical Use|Dermatologicals|Enzyme Inhibitors|Epoxy Compounds|Ethers|Ethers, Cyclic|Fatty Acids|Lipids|Nasal Preparations|Protein Synthesis Inhibitors|Pyrans|RNA Synthetase Inhibitor Antibacterial|RNA Synthetase Inhibitors
DB00411	Carbamoylcholine	small molecule	approved	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Analgesics, Non-Narcotic|Antiglaucoma Preparations and Miotics|Autonomic Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Choline|Choline Esters|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Ethanolamines|Miotics|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Ophthalmologicals|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Protective Agents|Quaternary Ammonium Compounds|Sensory Organs|Sensory System Agents|Trimethyl Ammonium Compounds
DB00412	Rosiglitazone	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|Oral Hypoglycemics|Peroxisome Proliferator Receptor gamma Agonist|Peroxisome Proliferator-activated Receptor Activity|PPAR gamma|Sulfur Compounds|Thiazoles|Thiazolidinediones|Vasodilating Agents
DB00413	Pramipexole	small molecule	approved|investigational	Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Antioxidants|Central Nervous System Agents|Dopamine Agents|Dopamine Agonists|Hypotensive Agents|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|OCT2 Substrates|Protective Agents|Restless Legs Syndrome|Sulfur Compounds|Thiazoles
DB00414	Acetohexamide	small molecule	approved|investigational|withdrawn	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Oral Hypoglycemics|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|Urea
DB00415	Ampicillin	small molecule	approved|vet_approved	Amides|Aminopenicillins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Ophthalmologicals|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sensory Organs|Sulfur Compounds
DB00416	Metocurine Iodide	small molecule	approved|withdrawn	Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Drugs, Chinese Herbal|Isoquinolines|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines
DB00417	Phenoxymethylpenicillin	small molecule	approved|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Lactams|Natural Penicillins|Penicillin G|Penicillins|Sulfur Compounds
DB00418	Secobarbital	small molecule	approved|vet_approved	Adjuvants|Adjuvants, Anesthesia|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB00419	Miglustat	small molecule	approved	Alimentary Tract and Metabolism|Alkaloids|Anti-HIV Agents|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Gaucher Disease|Glucosylceramide Synthase Inhibitor|Glucosylceramide Synthase Inhibitors|Glycoside Hydrolase Inhibitors|Imines|Imino Pyranoses|Imino Sugars|Miscellaneous Therapeutic Agents|Monosaccharides|Piperidines|Various Alimentary Tract and Metabolism Products
DB00420	Promazine	small molecule	approved|vet_approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anticholinergic Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB00421	Spironolactone	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Diuretics, Potassium Sparing|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Lactones|Mineralocorticoid (Aldosterone) Receptor Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|P-glycoprotein/ABCB1 Inducers|Potassium-Sparing Agents|Potassium-Sparing Diuretics|Pregnanes|Pregnenes|Steroids
DB00422	Methylphenidate	small molecule	approved|investigational	Acids, Carbocyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Dopamine Agents|Dopamine Uptake Inhibitors|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenylacetates|Piperidines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Respiratory and CNS Stimulants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00423	Methocarbamol	small molecule	approved|vet_approved	Acids, Acyclic|Benzene Derivatives|Carbamates|Carbamic Acid Esters|Catechols|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Ethers|Guaiacol|Guaifenesin|Methyl Ethers|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Phenylcarbamates
DB00424	Hyoscyamine	small molecule	approved	Adjuvants, Anesthesia|Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anti-Asthmatic Agents|Antiarrhythmic agents|Anticholinergic Agents|Atropine|Atropine Derivatives|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Tertiary Amines|Belladonna and Derivatives, Plain|Bronchodilator Agents|Cardiovascular Agents|Central Nervous System Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Mydriatics|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Solanaceous Alkaloids|Tropanes
DB00425	Zolpidem	small molecule	approved	Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Depression|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|gamma-Aminobutyric Acid-ergic Agonist|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Psycholeptics
DB00426	Famciclovir	small molecule	approved|investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Direct Acting Antivirals|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ophthalmologicals|Prodrugs|Purines|Sensory Organs
DB00427	Triprolidine	small molecule	approved	Anti-Allergic Agents|Antihistamines for Systemic Use|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents
DB00428	Streptozocin	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 Enzyme Inducers|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|P-glycoprotein/ABCB1 Inducers|Urea
DB00429	Carboprost tromethamine	small molecule	approved	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Alcohols|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Glycols|Inflammation Mediators|Lipids|Pharmaceutical Preparations|Propylene Glycols|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Reproductive Control Agents|Tromethamine|Uterotonic agents
DB00430	Cefpiramide	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB00431	Lindane	small molecule	approved|withdrawn	Agents that reduce seizure threshold|Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Chlorine Containing Products|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Insecticides|Pesticides|Toxic Actions
DB00432	Trifluridine	small molecule	approved|investigational	Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Glycosides|Immunosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside Analog Antiviral|Nucleoside Metabolic Inhibitor|Nucleosides|OAT3/SLC22A8 Substrates|Ophthalmologicals|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Sensory Organs|Thymidine|Toxic Actions
DB00433	Prochlorperazine	small molecule	approved|vet_approved	Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents
DB00434	Cyproheptadine	small molecule	approved	Agents producing tachycardia|Agents that reduce seizure threshold|Anti-Allergic Agents|Anticholinergic Agents|Antihistamines for Systemic Use|Antipruritics|Benzocycloheptenes|Central Nervous System Depressants|Dermatologicals|Dibenzocycloheptenes|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Miscellaneous Derivatives|Muscarinic Antagonists|Neurotransmitter Agents|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB00435	Nitric Oxide	small molecule	approved	Anions|Anti-Asthmatic Agents|Antioxidants|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Electrolytes|Endothelium-Dependent Relaxing Factors|Free Radical Scavengers|Free Radicals|Gases|Gasotransmitters|Hypotensive Agents|Ions|Methemoglobinemia Associated Agents|Neurotransmitter Agents|Nitrates and Nitrites|Nitrogen Compounds|Nitrogen Oxides|Nitroso Compounds|Oxides|Oxygen Compounds|Peripheral Nervous System Agents|Protective Agents|Reactive Nitrogen Species|Respiratory System Agents|Vasodilating Agents
DB00436	Bendroflumethiazide	small molecule	approved	Amides|Antihypertensive Agents|Benzothiadiazines|Bradycardia-Causing Agents|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB00437	Allopurinol	small molecule	approved	Antigout Preparations|Antimetabolites|Antioxidants|Enzyme Inhibitors|Free Radical Scavengers|Musculo-Skeletal System|Noxae|OAT3/SLC22A8 Substrates|Preparations Inhibiting Uric Acid Production|Protective Agents|Purines|Toxic Actions|Xanthine Oxidase Inhibitors
DB00438	Ceftazidime	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephaloridine|Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB00439	Cerivastatin	small molecule	approved|withdrawn	Anticholesteremic Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Substrates|Toxic Actions|UGT1A1 Substrates
DB00440	Trimethoprim	small molecule	approved|vet_approved	Agents causing hyperkalemia|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Chemically-Induced Disorders|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Folic Acid Antagonists|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyrimidines|QTc Prolonging Agents|Renal Agents|Trimethoprim and Derivatives
DB00441	Gemcitabine	small molecule	approved	Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytidine|Deoxyribonucleosides|Enzyme Inhibitors|Glycosides|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|P-glycoprotein/ABCB1 Substrates|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Radiation-Sensitizing Agents|Ribonucleosides|Ribonucleotide Reductases, antagonists & inhibitors|Toxic Actions
DB00442	Entecavir	small molecule	approved|investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Direct Acting Antivirals|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides and Nucleotides|Purines|Purinones
DB00443	Betamethasone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Betamethasone|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Drugs for Obstructive Airway Diseases|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Respiratory System Agents|Sensory Organs|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives
DB00444	Teniposide	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Glucosides|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Neurotoxic agents|P-glycoprotein/ABCB1 Substrates|Podophyllotoxin Derivatives|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00445	Epirubicin	small molecule	approved	Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytotoxic Antibiotics and Related Substances|Daunorubicin|Doxorubicin|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00446	Chloramphenicol	small molecule	approved|vet_approved	Alcohols|Amphenicols|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Antiinfectives for Treatment of Acne|Benzene Derivatives|Chloramphenicol|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Glycols|Gynecological Antiinfectives and Antiseptics|Immunosuppressive Agents|Myelosuppressive Agents|Nitro Compounds|Nitrobenzenes|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Propylene Glycols|Protein Synthesis Inhibitors|Sensory Organs
DB00447	Loracarbef	small molecule	approved|investigational|withdrawn	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB00448	Lansoprazole	small molecule	approved|investigational	2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Inhibition Gastric Acid Secretion|OAT3/SLC22A8 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds
DB00449	Dipivefrin	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Alcohols|Amines|Amino Alcohols|Antiglaucoma Preparations and Miotics|Biogenic Amines|Biogenic Monoamines|Catecholamines|Cholinesterase substrates|Ethanolamines|Mydriatics|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Sympathomimetics in Glaucoma Therapy
DB00450	Droperidol	small molecule	approved|vet_approved	Adjuvants, Anesthesia|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Benzimidazoles|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Ketones|Miscellaneous Anxiolytics Sedatives and Hypnotics|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents
DB00451	Levothyroxine	small molecule	approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inducers|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products|UGT1A1 Inhibitors|UGT1A1 Substrates
DB00452	Framycetin	small molecule	approved	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Dermatologicals|Glycosides|Medicated Dressings|Medicated Dressings With Antiinfectives|Narrow Therapeutic Index Drugs|Nasal Preparations|Neomycin|Nephrotoxic agents|Ophthalmologicals|Sensory Organs
DB00453	Clomocycline	small molecule	experimental	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines
DB00454	Meperidine	small molecule	approved	Adjuvants|Adjuvants, Anesthesia|Agents that reduce seizure threshold|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Isonipecotic Acids|Narcotics|Narrow Therapeutic Index Drugs|Nervous System|NMDA Receptor Antagonists|Opiate Agonists|Opioid Agonist|Opioids|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Phenylpiperidine Derivatives|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00455	Loratadine	small molecule	approved|investigational	Anti-Allergic Agents|Antihistamines for Systemic Use|Antipruritics|Benzocycloheptenes|BSEP/ABCB11 Substrates|Central Nervous System Depressants|Cyproheptadine|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Dibenzocycloheptenes|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Piperidines|QTc Prolonging Agents
DB00456	Cefalotin	small molecule	approved|investigational|vet_approved	Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephacetrile|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines
DB00457	Prazosin	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alpha-Adrenoreceptor Antagonists and Diuretics|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|BCRP/ABCG2 Substrates|Cardiovascular Agents|Hypotensive Agents|Neurotransmitter Agents|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Quinazolines|Vasodilating Agents
DB00458	Imipramine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzazepines|Histamine Antagonists|Histamine H1 Antagonists|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB00459	Acitretin	small molecule	approved	Alkenes|Antipsoriatics|Antipsoriatics for Systemic Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Hydrocarbons, Acyclic|Keratolytic Agents|Misc. Skin and Mucous Membrane Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Treatment of Psoriasis|Terpenes
DB00460	Verteporfin	small molecule	approved|investigational	Antineovascularisation Agents|Biological Factors|Dermatologicals|EENT Drugs, Miscellaneous|Macular Degeneration|Ocular Vascular Disorder Agents|Ophthalmologicals|Photoabsorption|Photochemotherapy|Photoenhancer|Photosensitizing Activity|Photosensitizing Agents|Pigments, Biological|Radiation-Sensitizing Agents|Sensory Organs
DB00461	Nabumetone	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Enzyme Inhibitors|Ketones|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents
DB00462	Methscopolamine bromide	small molecule	approved	Agents producing tachycardia|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Scopolamine Derivatives|Tropanes
DB00463	Metharbital	small molecule	withdrawn	Anticholinergic Agents|Anticonvulsants|Barbiturates and Derivatives|Central Nervous System Depressants|Nervous System|Nicotinic Antagonists|Pyrimidines|Pyrimidinones
DB00464	Sodium Tetradecyl Sulfate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Antivaricose Therapy|Cardiovascular Agents|Fatty Alcohols|Hydrocarbons, Acyclic|Lipids|Pharmaceutical Preparations|Pharmaceutical Solutions|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents|Vasoprotectives
DB00465	Ketorolac	small molecule	approved	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Indoles|Indomethacin|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Ophthalmologicals|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Tromethamine
DB00466	Picrotoxin	small molecule	experimental	Antidotes|Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|Cyclohexanes|Cycloparaffins|GABA Agents|GABA Antagonists|Lactones|Neurotransmitter Agents|Protective Agents|Stimulants
DB00467	Enoxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00468	Quinine	small molecule	approved	Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Blood Glucose Lowering Agents|Central Nervous System Agents|Central Nervous System Depressants|Cinchona Alkaloids|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Herbs (Hypotensive Properties)|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Methanolquinolines|Methemoglobinemia Associated Agents|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|QTc Prolonging Agents|Quinine and Derivatives|Quinolines|Quinuclidines|Sensory System Agents
DB00469	Tenoxicam	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|Other Nonsteroidal Antiimflammatory Agents|Oxicams|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines
DB00470	Dronabinol	small molecule	approved|illicit	Agents producing tachycardia|Alimentary Tract and Metabolism|Analgesics|Analgesics, Non-Narcotic|Antiemetics and Antinauseants|BCRP/ABCG2 Inhibitors|Cannabinoid Receptor Agonists|Cannabinoids and similars|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hallucinogens|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Miscellaneous Antiemetics|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Psychotropic Drugs|Sensory System Agents|Terpenes
DB00471	Montelukast	small molecule	approved	Acids, Acyclic|Agents to Treat Airway Disease|Anti-Asthmatic Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Fatty Acids|Fatty Acids, Volatile|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Leukotriene Modifiers|Lipids|Respiratory System Agents
DB00472	Fluoxetine	small molecule	approved|vet_approved	Agents that reduce seizure threshold|Amines|Anticholinergic Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nicotinic Antagonists|P-glycoprotein/ABCB1 Inhibitors|Propylamines|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Vasodilating Agents
DB00473	Hexylcaine	small molecule	approved|withdrawn	Amines|Cyclohexanes|Cycloparaffins
DB00474	Methohexital	small molecule	approved	Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P450 3A4 Inducers|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrimidines|Pyrimidinones
DB00475	Chlordiazepoxide	small molecule	approved|illicit|investigational	Adjuvants, Anesthesia|Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytosine Nucleotides|GABA Agents|GABA Modulators|Glycosides|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Psycholeptics|Psychotropic Drugs|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Tranquilizing Agents
DB00476	Duloxetine	small molecule	approved	Agents producing tachycardia|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators|Sulfur Compounds|Thiophenes
DB00477	Chlorpromazine	small molecule	approved|investigational|vet_approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|BSEP/ABCB11 Inhibitors|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB00478	Rimantadine	small molecule	approved|investigational	Adamantane|Adamantanes|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Cyclic Amines|Cycloparaffins|Enzyme Inhibitors|Influenza A M2 Protein Inhibitor|M2 Protein Inhibitors|Nucleic Acid Synthesis Inhibitors
DB00479	Amikacin	small molecule	approved|investigational|vet_approved	Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Glycosides|Kanamycin|Narrow Therapeutic Index Drugs|Nephrotoxic agents
DB00480	Lenalidomide	small molecule	approved	Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Growth Inhibitors|Growth Substances|Imides|Immunologic Factors|Immunosuppressive Agents|Isoindoles|Myelosuppressive Agents|P-glycoprotein/ABCB1 Substrates|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Thalidomide Analog
DB00481	Raloxifene	small molecule	approved|investigational	Benzene Derivatives|Benzylidene Compounds|Bone Density Conservation Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Estrogen Agonist-antagonists|Estrogen Agonist/Antagonist|Estrogen Antagonists|Estrogen Receptor Modulators|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|Stilbenes|Tamoxifen|UGT1A1 Substrates
DB00482	Celecoxib	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antineoplastic and Immunomodulating Agents|BSEP/ABCB11 Substrates|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cyclooxygenase-2 (COX-2) Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Peripheral Nervous System Agents|Pyrazoles|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfonamides|Sulfones|Sulfur Compounds
DB00483	Gallamine Triethiodide	small molecule	approved	Agents producing tachycardia|Amines|Ammonium Compounds|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Muscarinic Antagonists|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds
DB00484	Brimonidine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Cardiovascular Agents|Central Nervous System Depressants|Dermatologicals|Hypotensive Agents|Misc. Skin and Mucous Membrane Agents|Neurotransmitter Agents|Ophthalmologicals|Quinoxalines|Sensory Organs|Sympathomimetics in Glaucoma Therapy
DB00485	Dicloxacillin	small molecule	approved|investigational|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Cloxacillin|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Lactams|Oxacillin|Penicillins|Sulfur Compounds
DB00486	Nabilone	small molecule	approved|investigational	Agents producing tachycardia|Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Cannabinoids and similars|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Hypotensive Agents|Miscellaneous Antiemetics|Peripheral Nervous System Agents|Psychotropic Drugs|Terpenes|Tranquilizing Agents
DB00487	Pefloxacin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00488	Altretamine	small molecule	approved	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Toxic Actions|Triazines
DB00489	Sotalol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiac Rhythm Alteration|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Ethanolamines|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Peripheral Nervous System Agents|QTc Prolonging Agents|Sympatholytics
DB00490	Buspirone	small molecule	approved|investigational	Agents that produce hypertension|Anti-Anxiety Agents|Azaspirodecanedione Derivatives|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Piperazines|Psycholeptics|Psychotropic Drugs|Pyrimidines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Spiro Compounds|Tranquilizing Agents
DB00491	Miglitol	small molecule	approved	Alimentary Tract and Metabolism|Alkaloids|Blood Glucose Lowering Agents|Carbohydrates|Drugs Used in Diabetes|Enzyme Inhibitors|Glycoside Hydrolase Inhibitors|Hypoglycemia-Associated Agents|Imines|Imino Pyranoses|Imino Sugars|Monosaccharides|Oral Hypoglycemics|Piperidines
DB00492	Fosinopril	small molecule	approved	ACE Inhibitors and Diuretics|Acids|Acids, Acyclic|Acids, Noncarboxylic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|Imines|Imino Acids|Organophosphorus Compounds|Phosphinic Acids|Phosphorus Acids|Phosphorus Compounds|Proline|Protease Inhibitors
DB00493	Cefotaxime	small molecule	approved	Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB00494	Entacapone	small molecule	approved|investigational	Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|COMT Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Enzyme Inhibitors|Nervous System|Phenols|UGT1A9 Substrates
DB00495	Zidovudine	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Carbohydrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|P-glycoprotein/ABCB1 Substrates|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Thymidine|Toxic Actions|UGT1A1 Inducers|UGT1A1 Substrates
DB00496	Darifenacin	small molecule	approved|investigational	Agents producing tachycardia|Anticholinergic Agents|Cholinergic Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Muscarinic Antagonists|Neurotransmitter Agents|Urological Agents|Urologicals
DB00497	Oxycodone	small molecule	approved|illicit|investigational	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Codeine|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00498	Phenindione	small molecule	approved|investigational	Anticoagulants|Blood and Blood Forming Organs|Hematologic Agents|Indans|Indenes|Narrow Therapeutic Index Drugs|Vitamin K Antagonists
DB00499	Flutamide	small molecule	approved|investigational	Amides|Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Anilides|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Methemoglobinemia Associated Agents
DB00500	Tolmetin	small molecule	approved	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB00501	Cimetidine	small molecule	approved|investigational	Acid Reducers|Adjuvants|Alimentary Tract and Metabolism|Amidines|Anti-Ulcer Agents|BSEP/ABCB11 Inhibitors|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Guanidines|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Imidazoles|Immunosuppressive Agents|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE 2 Substrates|MATE inhibitors|MATE substrates|Myelosuppressive Agents|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates
DB00502	Haloperidol	small molecule	approved	Agents that reduce seizure threshold|Anti-Dyskinesia Agents|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Hyperglycemia-Associated Agents|Ketones|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|NMDA Receptor Antagonists|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents|UGT1A9 Substrates
DB00503	Ritonavir	small molecule	approved|investigational	Acids, Acyclic|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inducers|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A Inducers|Cytochrome P450 3A Inhibitors|Cytochrome P450 3A4 Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protease Inhibitors|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sulfur Compounds|Thiazoles|UDP Glucuronosyltransferases Inducers|UGT1A1 Inducers
DB00504	Levallorphan	small molecule	approved	Alkaloids|Central Nervous System Agents|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents
DB00505	Tridihexethyl	small molecule	withdrawn	Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Nitrogen Compounds|Onium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB00507	Nitazoxanide	small molecule	approved|investigational|vet_approved	Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Sulfur Compounds
DB00508	Triflupromazine	small molecule	approved|vet_approved	Agents producing tachycardia|Anticholinergic Agents|Antiemetics|Antipsychotic Agents|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB00509	Dextrothyroxine	small molecule	approved|investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipid Modifying Agents|Lipid Modifying Agents, Plain
DB00511	Acetyldigitoxin	small molecule	approved	Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Digitalis Glycosides|Digitoxin|Enzyme Inhibitors|Glycosides|Protective Agents|Steroids
DB00512	Vancomycin	small molecule	approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Carbohydrates|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Peptides
DB00513	Aminocaproic Acid	small molecule	approved|investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminocaproates|Antifibrinolytic Agents|Blood and Blood Forming Organs|Caproates|Coagulants|Decreased Fibrinolysis|Fatty Acids|Fatty Acids, Volatile|Fibrin Modulating Agents|Hematologic Agents|Hemostatics|Lipids
DB00514	Dextromethorphan	small molecule	approved	Alkaloids|Anticholinergic Agents|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cough and Cold Preparations|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Expectorants|Morphinans|Narcotics|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|NMDA Receptor Antagonists|Opiate Alkaloids|Opium Alkaloids and Derivatives|Phenanthrenes|Respiratory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sigma-1 Agonist|Sigma-1 Receptor Agonists|Uncompetitive N-methyl-D-aspartate Receptor Antagonist|Uncompetitive NMDA Receptor Antagonists
DB00515	Cisplatin	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Chlorine Compounds|Cholinesterase Inhibitors|Cross-Linking Reagents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Indicators and Reagents|Laboratory Chemicals|Myelosuppressive Agents|Nephrotoxic agents|Nitrogen Compounds|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein/ABCB1 Substrates|Platinum Compounds|Platinum-containing Compounds|Radiation-Sensitizing Agents
DB00516	Bentoquatam	small molecule	approved	Acids|Acids, Noncarboxylic|Aluminium Compounds|Aluminum Silicates|Anions|Dermatologicals|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Silicates|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB00517	Anisotropine methylbromide	small molecule	approved	Agents producing tachycardia|Alkaloids|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Cholinergic Agents|Muscarinic Antagonists|Neurotransmitter Agents
DB00518	Albendazole	small molecule	approved|vet_approved	Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Antihelminthic|Antimitotic Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Benzimidazole Derivatives|Benzimidazoles|Carbamates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P450 1A Inducers|Mitosis Modulators|P-glycoprotein/ABCB1 Inhibitors|Tubulin Modulators
DB00519	Trandolapril	small molecule	approved	ACE Inhibitors and Calcium Channel Blockers|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|Protease Inhibitors
DB00520	Caspofungin	small molecule	approved	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Echinocandin Antifungal|Echinocandins|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inhibitors|Peptides|Peptides, Cyclic
DB00521	Carteolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Quinolines|Quinolones|Sensory Organs|Sympatholytics
DB00522	Bentiromide	small molecule	investigational|withdrawn	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Diagnostic Agents|Indicators and Reagents|Laboratory Chemicals|Pancreatic Function Tests|Tests for Pancreatic Function
DB00523	Alitretinoin	small molecule	approved|investigational	Agents for Dermatitis, Excluding Corticosteroids|Alkenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Hydrocarbons, Acyclic|Misc. Skin and Mucous Membrane Agents|P-glycoprotein/ABCB1 Substrates|Pigments, Biological|Polyenes|Retinoid X Receptors|Retinoids|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)
DB00524	Metolazone	small molecule	approved	Amides|Antihypertensive Agents|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Low-Ceiling Diuretics and Potassium-Sparing Agents|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Quinazolines|Quinazolinones|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide-like Diuretic
DB00525	Tolnaftate	small molecule	approved|investigational|vet_approved	Acids, Acyclic|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Carbamates|Dermatologicals|Naphthalenes|Sulfur Compounds|Thiocarbamates
DB00526	Oxaliplatin	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Immunosuppressive Agents|Moderate Risk QTc-Prolonging Agents|Myelosuppressive Agents|OCT2 Substrates|Organometallic Compounds|Platinum Compounds|Platinum-containing Compounds|QTc Prolonging Agents
DB00527	Cinchocaine	small molecule	approved|vet_approved	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Amides|Analgesics and Anesthetics|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cell-mediated Immunity|Central Nervous System Agents|Cholinesterase Inhibitors|Dermatologicals|Increased Histamine Release|Nervous System|Ophthalmologicals|Otologicals|Peripheral Nervous System Agents|Quinolines|Sensory Organs|Sensory System Agents|Standardized Chemical Allergen|Vasoprotectives
DB00528	Lercanidipine	small molecule	approved|investigational	ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Angiotensin II Antagonists and Calcium Channel Blockers|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Hypotensive Agents|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB00529	Foscarnet	small molecule	approved	Acetates|Acids, Acyclic|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Chelating Activity|Direct Acting Antivirals|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Organophosphonates|Organophosphorus Compounds|Phosphonic Acid Derivatives|Phosphonoacetic Acid|Potential QTc-Prolonging Agents|Pyrophosphate Analog|Pyrophosphate Analog DNA Polymerase Inhibitor|QTc Prolonging Agents|Reverse Transcriptase Inhibitors
DB00530	Erlotinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Quinazolines|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors
DB00531	Cyclophosphamide	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alkylating Activity|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Electrolytes|Hydrocarbons, Halogenated|Immunologic Factors|Immunosuppressive Agents|Ions|Methemoglobinemia Associated Agents|Mustard Compounds|Mutagens|Myeloablative Agonists|Myelosuppressive Agents|Neurotoxic agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Phosphate salts|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions
DB00532	Mephenytoin	small molecule	approved|investigational|withdrawn	Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Hydantoins|Imidazoles|Imidazolidines|Narrow Therapeutic Index Drugs|Nervous System
DB00533	Rofecoxib	small molecule	approved|investigational|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfur Compounds
DB00534	Chlormerodrin	small molecule	approved|withdrawn	Alkylmercury Compounds|Organomercury Compounds|Organometallic Compounds
DB00535	Cefdinir	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB00536	Guanidine	small molecule	approved	Acetylcholine Releasing Agent|Amidines|Guanidines|Increased Acetylcholine Activity|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|OAT3/SLC22A8 Inhibitors|OCT2 Inhibitors
DB00537	Ciprofloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE inhibitors|MATE substrates|Moderate Risk QTc-Prolonging Agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00538	Gadoversetamide	small molecule	approved|investigational	Contrast Media|Diagnostic Uses of Chemicals|Gadolinium|Gadolinium-based Contrast Agent|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media
DB00539	Toremifene	small molecule	approved|investigational	Anti-Estrogens|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Benzylidene Compounds|Bone Density Conservation Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Endocrine Therapy|Estrogen Agonist/Antagonist|Estrogen Receptor Modulators|Highest Risk QTc-Prolonging Agents|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Selective Estrogen Receptor Modulators|Stilbenes|Tamoxifen
DB00540	Nortriptyline	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzocycloheptenes|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB00541	Vincristine	small molecule	approved|investigational	Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Neurotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids
DB00542	Benazepril	small molecule	approved|investigational	ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Decreased Blood Pressure|Enzyme Inhibitors|Hypotensive Agents
DB00543	Amoxapine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Tetracyclic|Antidepressive Agents, Tricyclic|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Substrates|Dibenzoxazepines|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB00544	Fluorouracil	small molecule	approved	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Fluoropyrimidines|Fluorouracil and prodrugs|Immunologic Factors|Immunosuppressive Agents|Misc. Skin and Mucous Membrane Agents|Moderate Risk QTc-Prolonging Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleoside Metabolic Inhibitor|Pyrimidine Analogues|Pyrimidines|Pyrimidinones|QTc Prolonging Agents|Toxic Actions|Uracil
DB00545	Pyridostigmine	small molecule	approved|investigational	Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Pyridines|Pyridinium Compounds
DB00546	Adinazolam	small molecule	experimental	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Nervous System|Psycholeptics|Psychotropic Drugs
DB00547	Desoximetasone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Dexamethasone|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB00548	Azelaic acid	small molecule	approved	Acids, Acyclic|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Decreased Protein Synthesis|Decreased Sebaceous Gland Activity|Dermatologicals|Misc. Skin and Mucous Membrane Agents
DB00549	Zafirlukast	small molecule	approved|investigational	Agents to Treat Airway Disease|Anti-Asthmatic Agents|Benzene Derivatives|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C9 Inhibitors|Drugs for Obstructive Airway Diseases|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Leukotriene Modifiers|Respiratory System Agents|Sulfones|Sulfur Compounds|Toluene
DB00550	Propylthiouracil	small molecule	approved|investigational	Antimetabolites|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Pyrimidines|Pyrimidinones|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thiouracil|Thiouracils|Thyroid Hormone Synthesis Inhibitor|Thyroid Hormone Synthesis Inhibitors|Thyroid Products|Toxic Actions|Uracil
DB00551	Acetohydroxamic acid	small molecule	approved	Amines|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hydroxy Acids|Hydroxylamines|Urease Inhibitor|Urease Inhibitors|Urologicals
DB00552	Pentostatin	small molecule	approved|investigational	Adenosine Deaminase Inhibitors|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Coformycin|Deoxyribonucleosides|Enzyme Inhibitors|Formycins|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB00553	Methoxsalen	small molecule	approved	Antipsoriatics|Antipsoriatics for Systemic Use|Antipsoriatics for Topical Use|Benzopyrans|Coloring Agents|Cross-Linking Reagents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Furocoumarins|Indicators and Reagents|Laboratory Chemicals|Photoabsorption|Photoactivated Radical Generator|Photosensitizing Activity|Photosensitizing Agents|Psoralens for Systemic Use|Psoralens for Topical Use|Pyrans|Radiation-Sensitizing Agents
DB00554	Piroxicam	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Other Nonsteroidal Antiimflammatory Agents|Oxicams|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Sulfur Compounds|Thiazines|Topical Products for Joint and Muscular Pain
DB00555	Lamotrigine	small molecule	approved|investigational	Agents causing hyperkalemia|Agents producing tachycardia|Anti-epileptic Agent|Antiarrhythmic agents|Anticholinergic Agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Mood Stabilizer|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers|UGT1A1 Inducers|UGT1A1 Substrates|Voltage-Gated Sodium Channel Blockers
DB00556	Perflutren	small molecule	approved	Amino Acids, Peptides, and Proteins|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Microspheres|Moderate Risk QTc-Prolonging Agents|Other Diagnostics|Proteins|QTc Prolonging Agents|Ultrasound Contrast Activity|Ultrasound Contrast Media
DB00557	Hydroxyzine	small molecule	approved	Anti-Anxiety Agents|Antipruritics|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Diphenylmethane Derivatives|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine Receptor Antagonists|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Piperazines|Potential QTc-Prolonging Agents|Psycholeptics|QTc Prolonging Agents
DB00558	Zanamivir	small molecule	approved|investigational	Acids, Acyclic|Amidines|Amino Sugars|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Direct Acting Antivirals|Enzyme Inhibitors|Guanidines|Hydroxy Acids|Neuraminic Acids|Neuraminidase Inhibitors|Pyrans|Sialic Acids|Sugar Acids
DB00559	Bosentan	small molecule	approved|investigational	Amides|Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|BSEP/ABCB11 Inhibitors|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 3A Inducers|Endothelin Receptor Antagonists|OATP1B1/SLCO1B1 Substrates|Sulfones|Sulfur Compounds|Vasodilating Agents
DB00560	Tigecycline	small molecule	approved	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Glycylcyclines|Naphthacenes|Tetracyclines
DB00561	Doxapram	small molecule	approved|vet_approved	Agents that produce hypertension|Central Nervous System Agents|Central Nervous System Stimulants|Increased Medullary Respiratory Drive|Pyrrolidines|Pyrrolidinones|Respiratory System Agents
DB00562	Benzthiazide	small molecule	approved	Amides|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Sodium Chloride Symporter Inhibitors|Stimulants|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB00563	Methotrexate	small molecule	approved	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Aminopterin|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Biological Factors|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Nephrotoxic agents|Noxae|Nucleic Acid Synthesis Inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Pigments, Biological|Pteridines|Pterins|Reproductive Control Agents|Toxic Actions
DB00564	Carbamazepine	small molecule	approved|investigational	Analgesics|Analgesics, Non-Narcotic|Anticonvulsants|Antimanic Agents|Carboxamide Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inducers|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 3A4 Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Dibenzazepines|Enzyme Inducing Antiepileptic Drugs|Immunosuppressive Agents|Inducers of Drug Clearance|Miscellaneous Anticonvulsants|Mood Stabilizer|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nervous System|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Psychotropic Drugs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Tranquilizing Agents|UGT1A1 Inducers
DB00565	Cisatracurium	small molecule	approved	Alkaloids|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents
DB00566	Succimer	small molecule	approved	Acids, Acyclic|Antidotes|Chelating Agents|Dicarboxylic Acids|Lead Chelating Activity|Lead Chelator|Protective Agents|Sequestering Agents|Succinates|Sulfhydryl Compounds|Sulfur Compounds
DB00567	Cephalexin	small molecule	approved|investigational|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|First-Generation Cephalosporins|Lactams|MATE 1 Substrates|MATE substrates|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines
DB00568	Cinnarizine	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antivertigo Preparations|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotransmitter Agents|Piperazines|QTc Prolonging Agents|Vasodilating Agents
DB00569	Fondaparinux	small molecule	approved|investigational	Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Factor X|Factor Xa Inhibitors|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Polysaccharides
DB00570	Vinblastine	small molecule	approved	Alkaloids|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Indole Alkaloids|Indoles|Mitosis Modulators|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Secologanin Tryptamine Alkaloids|Tubulin Modulators|Vinca Alkaloids
DB00571	Propranolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Naphthalenes|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Vasodilating Agents
DB00572	Atropine	small molecule	approved|vet_approved	Adjuvants, Anesthesia|Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Alkaloids|Anti-Asthmatic Agents|Antiarrhythmic agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Atropine Derivatives|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Tertiary Amines|Belladonna and Derivatives, Plain|Bronchodilator Agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Central Nervous System Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Neurotransmitter Agents|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Respiratory System Agents|Sensory Organs|Solanaceous Alkaloids|Tropanes
DB00573	Fenoprofen	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents
DB00574	Fenfluramine	small molecule	approved|illicit|investigational|withdrawn	Alimentary Tract and Metabolism|Amines|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ethylamines|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Stimulants
DB00575	Clonidine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Antiadrenergic Agents, Centrally Acting|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Antimigraine Preparations|Autonomic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Central alpha-2 Adrenergic Agonist|Central Alpha-agonists|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Hypotensive Agents|Imidazoles|Imidazoline Receptor Agonists|Imidazolines|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Sympatholytics|Sympathomimetics in Glaucoma Therapy
DB00576	Sulfamethizole	small molecule	approved|investigational|vet_approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Irrigating Solutions|Ophthalmologicals|Sensory Organs|Short-Acting Sulfonamides|Sulfanilamides|Sulfathiazoles|Sulfonamides|Sulfones|Sulfur Compounds|Thiazoles
DB00577	Valaciclovir	small molecule	approved|investigational	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Guanine|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Substrates|Prodrugs|Purines|Purinones
DB00578	Carbenicillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB00579	Mazindol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Alimentary Tract and Metabolism|Anorexigenic Agents & Respiratory and Cerebral Stimulants, Miscellaneous|Anorexigenic Agents & Respiratory and CNS Stimulants|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Dopamine Agents|Dopamine Uptake Inhibitors|Isoindoles|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00580	Valdecoxib	small molecule	approved|investigational|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfones|Sulfur Compounds|UGT1A9 Substrates
DB00581	Lactulose	small molecule	approved	Acidifying Activity|Alimentary Tract and Metabolism|Ammonia Detoxicants|Carbohydrates|Disaccharides|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Oligosaccharides|Osmotic Activity|Osmotic Laxative|Polysaccharides|Stimulation Large Intestine Fluid/Electrolyte Secretion
DB00582	Voriconazole	small molecule	approved|investigational	14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A4 Inhibitors|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Triazoles
DB00583	Levocarnitine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amines|Amino Acids and Derivatives|Ammonium Compounds|Caloric Agents|Carnitine Analog|Dietary Supplements|Nitrogen Compounds|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB00584	Enalapril	small molecule	approved|vet_approved	ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Blood Pressure|Dipeptides|Enzyme Inhibitors|Hypotensive Agents|Mineralocorticoid (Aldosterone) Receptor Antagonists|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|Oligopeptides|P-glycoprotein/ABCB1 Inhibitors|Peptides|Protease Inhibitors
DB00585	Nizatidine	small molecule	approved	Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Cholinesterase Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Sulfur Compounds|Thiazoles
DB00586	Diclofenac	small molecule	approved|vet_approved	Acetic Acid Derivatives and Related Substances|Acids, Carbocyclic|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Allergic Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|BSEP/ABCB11 Substrates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cyclooxygenase-2 (COX-2) Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Prostaglandin Production|Dermatologicals|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Other Nonsteroidal Antiimflammatory Agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Phenylacetates|Sensory Organs|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates
DB00587	Cinalukast	small molecule	experimental	Sulfur Compounds
DB00588	Fluticasone propionate	small molecule	approved	Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Autonomic Agents|Bronchodilator Agents|Central Nervous System Depressants|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Immunosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Respiratory System Agents|Steroids
DB00589	Lisuride	small molecule	approved|investigational	Agents that produce hypertension|Alkaloids|Analgesics|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antimigraine Preparations|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Agonists|Dopamine Antagonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Genito Urinary System and Sex Hormones|Nervous System|Neurotransmitter Agents|Prolactine Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists
DB00590	Doxazosin	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Prazosin|Quinazolines
DB00591	Fluocinolone acetonide	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Ophthalmologicals|Otologicals|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated|Vasoprotectives
DB00592	Piperazine	small molecule	approved|vet_approved	Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Cytochrome P-450 CYP2D6 Substrates|Hyperglycemia-Associated Agents|Piperazine and Derivatives
DB00593	Ethosuximide	small molecule	approved	Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Imides|Narrow Therapeutic Index Drugs|Nervous System|Potential QTc-Prolonging Agents|Pyrrolidines|Pyrrolidinones|QTc Prolonging Agents|Succinimide Derivatives|Succinimides
DB00594	Amiloride	small molecule	approved	Acid Sensing Ion Channel Blockers|Agents causing hyperkalemia|Agents that produce hypertension|Cardiovascular Agents|Decreased Renal K+ Excretion|Diuretics|Diuretics, Potassium Sparing|Epithelial Sodium Channel Blockers|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|OCT2 Inhibitors|Potassium-Sparing Agents|Potassium-Sparing Diuretics|Pyrazines|Sodium Channel Blockers
DB00595	Oxytetracycline	small molecule	approved|investigational|vet_approved	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Naphthacenes|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Sensory Organs|Tetracyclines
DB00596	Ulobetasol	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Betamethasone|Cardiovascular Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Psoriasis|Steroids|Steroids, Fluorinated|Vasoconstrictor Agents
DB00597	Gadoteridol	small molecule	approved|investigational	Contrast Media|Diagnostic Uses of Chemicals|Elements|Lanthanoid Series Elements|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Metals|Metals, Rare Earth|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media
DB00598	Labetalol	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha and Beta Blocking Agents|Alpha and Beta Blocking Agents and Thiazides|Amides|Amines|Amino Alcohols|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ethanolamines|Hypotensive Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Salicylamides|Sympathomimetics|Vasodilating Agents
DB00599	Thiopental	small molecule	approved|vet_approved	Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones|Thiobarbiturates
DB00600	Monobenzone	small molecule	approved	alpha-Galactosidase, antagonists & inhibitors|Benzene Derivatives|Depigmenting Activity|Depigmenting Agents|Dermatologicals|Melanin Synthesis Inhibitors|Phenols
DB00601	Linezolid	small molecule	approved|investigational	Acetamides|Acetates|Acids, Acyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Central Nervous System Depressants|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Immunosuppressive Agents|Lipids|Monoamine Oxidase Inhibitors|Myelosuppressive Agents|Oxazoles|Oxazolidinone Antibacterial|Oxazolidinones|Protein Synthesis Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00602	Ivermectin	small molecule	approved|investigational|vet_approved	Agrochemicals|Anthelmintics|Anti-Bacterial Agents|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Avermectines|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Insecticides|Lactones|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Pediculicides|Pesticides|Polyketides|Scabicides and Pediculicides|Toxic Actions
DB00603	Medroxyprogesterone acetate	small molecule	approved|investigational	Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Corpus Luteum Hormones|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxyprogesterones|Hyperglycemia-Associated Agents|Medroxyprogesterone|Pregnanes|Pregnenediones|Pregnenes|Progesterone|Progesterone Congeners|Progestin Contraceptives|Progestins|Reproductive Control Agents|Steroids
DB00604	Cisapride	small molecule	approved|investigational|withdrawn	Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Aminobenzoates|Anti-Ulcer Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Chlorobenzoates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Highest Risk QTc-Prolonging Agents|Neurotransmitter Agents|para-Aminobenzoates|Piperidines|Propulsives|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists
DB00605	Sulindac	small molecule	approved|investigational	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Indenes|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Sensory System Agents
DB00606	Cyclothiazide	small molecule	approved	Amides|Antihypertensive Agents|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Natriuretic Agents|Receptors, AMPA|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB00607	Nafcillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Lactams|Penicillins|Sulfur Compounds
DB00608	Chloroquine	small molecule	approved|investigational|vet_approved	Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|alpha-Galactosidase, antagonists & inhibitors|Amebicides|Aminoquinolines|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antimalarials|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Central Nervous System Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Filaricides|Methemoglobinemia Associated Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|QTc Prolonging Agents|Quinolines|Sensory System Agents
DB00609	Ethionamide	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Isonicotinic Acids|Lipid Regulating Agents|Noxae|Pyridines|Thiocarbamide Derivatives|Toxic Actions
DB00610	Metaraminol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenylpropanolamine|Propanolamines|Propanols|Sympathomimetics|Vasoconstrictor Agents
DB00611	Butorphanol	small molecule	approved|illicit|vet_approved	Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Mixed Agonist / Antagonist Opioids|Morphinan Derivatives|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Agonist/Antagonist|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00612	Bisoprolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sympatholytics
DB00613	Amodiaquine	small molecule	approved|investigational	Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines
DB00614	Furazolidone	small molecule	experimental|vet_approved	Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Infective Agents|Anti-Infective Agents, Local|Anti-Infective Agents, Urinary|Antiparasitic Agents|Antiprotozoals|Antitrichomonal Agents|Central Nervous System Depressants|Enzyme Inhibitors|Furans|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Monoamine Oxidase Inhibitors|Nitro Compounds|Nitrofurans|Oxazoles|Oxazolidinones|Renal Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00615	Rifabutin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Drugs for Treatment of Tuberculosis|Lactams|Lactams, Macrocyclic|Rifamycin Antimycobacterial|Rifamycins
DB00616	Candoxatril	small molecule	experimental	Acids, Acyclic|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Indenes|Lipids|Neprilysin, antagonists & inhibitors|Prodrugs
DB00617	Paramethadione	small molecule	approved	Anticonvulsants|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Nervous System|Oxazolidine Derivatives
DB00618	Demeclocycline	small molecule	approved	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Dermatologicals|Naphthacenes|Tetracyclines
DB00619	Imatinib	small molecule	approved	Acids, Carbocyclic|Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|BSEP/ABCB11 Substrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Immunosuppressive Agents|Kinase Inhibitor|Miscellaneous Therapeutic Agents|Myelosuppressive Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperazines|Protein Kinase Inhibitors|Pyrimidines|QTc Prolonging Agents|Tyrosine Kinase Inhibitors
DB00620	Triamcinolone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Agents to Treat Airway Disease|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Nasal Preparations|Ophthalmologicals|Otologicals|Pregnadienes|Pregnanes|Protein-Lysine 6-Oxidase, antagonists & inhibitors|Sensory Organs|Steroids|Steroids, Fluorinated|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Triamcinolone|Vasoprotectives
DB00621	Oxandrolone	small molecule	approved|investigational	Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB00622	Nicardipine	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Antiarrhythmic agents|Anticholinergic Agents|Antihypertensive Agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 3A4 Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Muscarinic Antagonists|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB00623	Fluphenazine	small molecule	approved	Agents that reduce seizure threshold|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Delayed-Action Preparations|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Phenothiazines|Phenothiazines With Piperazine Structure|Prodrugs|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents
DB00624	Testosterone	small molecule	approved|investigational	3-Oxoandrosten (4) Derivatives|Androgens|Androgens and Estrogens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein/ABCB1 Inhibitors|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners
DB00625	Efavirenz	small molecule	approved|investigational	Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A Inducers|Cytochrome P450 3A4 Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Inducers of Drug Clearance|Moderate Risk QTc-Prolonging Agents|Non-Nucleoside Analog|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|Oxazines|QTc Prolonging Agents|Reverse Transcriptase Inhibitors|UGT1A1 Inducers
DB00626	Bacitracin	small molecule	approved|vet_approved	Acids, Carbocyclic|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Bacitracins|Benzene Derivatives|Benzoates|Decreased Cell Wall Synthesis & Repair|Dermatologicals|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Peptides|Peptides, Cyclic|Phenols|Throat Preparations
DB00627	Niacin	small molecule	approved|investigational|nutraceutical	Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hyperglycemia-Associated Agents|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Micronutrients|Miscellaneous Antilipemic Agents|Nicotinic Acid and Derivatives|Nicotinic Acids|Noxae|Peripheral Vasodilators|Physiological Phenomena|Pyridines|Toxic Actions|Vasodilating Agents|Vitamin B Complex|Vitamins
DB00628	Clorazepate	small molecule	approved|illicit	Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents
DB00629	Guanabenz	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amidines|Antihypertensive Agents|Cardiovascular Agents|Central alpha-2 Adrenergic Agonist|Cytochrome P-450 CYP1A2 Substrates|Guanidines|Neurotransmitter Agents
DB00630	Alendronic acid	small molecule	approved	Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds
DB00631	Clofarabine	small molecule	approved|investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Glycosides|Hypotensive Agents|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Nucleotides|Purine Analogues|Purine Nucleotides|Purines|Ribonucleotides|Toxic Actions
DB00632	Docosanol	small molecule	approved|investigational	Alcohols|Anti-Infective Agents|Antiviral Agents|Dermatologicals|Lipids
DB00633	Dexmedetomidine	small molecule	approved|vet_approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anesthetics|Anesthetics, General|Bradycardia-Causing Agents|Central alpha-2 Adrenergic Agonist|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hypnotics and Sedatives|Hypotensive Agents|Imidazoles|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Psycholeptics|Sensory System Agents
DB00634	Sulfacetamide	small molecule	approved	Amides|Amines|Aniline Compounds|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Anti-Infective Agents, Urinary|Antiinfectives for Treatment of Acne|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Ophthalmologicals|Renal Agents|Sensory Organs|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB00635	Prednisone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00636	Clofibrate	small molecule	approved|investigational	Acids, Acyclic|Anticholesteremic Agents|Benzene Derivatives|Butyrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Phenols|Phenyl Ethers|Toxic Actions
DB00637	Astemizole	small molecule	approved|withdrawn	Anti-Allergic Agents|Antihistamines for Systemic Use|Benzimidazoles|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|QTc Prolonging Agents
DB00638	Inulin	small molecule	approved|investigational|nutraceutical	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Diagnostic Agents|Fructans|Glucans|Macromolecular Substances|Polymers|Polysaccharides|Starch|Tests for Renal Function and Ureteral Injuries
DB00639	Butoconazole	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Azole Antifungals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives
DB00640	Adenosine	small molecule	approved|investigational	Agents producing tachycardia|Alkenes|Analgesics|Antiarrhythmic agents|Antiarrhythmics, Class V|Biological Factors|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Class IV Antiarrythmics|Cyclohexanes|Cyclohexenes|Cycloparaffins|Enzymes|Enzymes and Coenzymes|Glycosides|Hydrocarbons, Acyclic|Miscellaneous Cardiac Drugs|Miscellaneous Therapeutic Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Oxidoreductases|Peripheral Nervous System Agents|Pigments, Biological|Polyenes|Purine Nucleosides|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists|Purines|QTc Prolonging Agents|Ribonucleosides|Sensory System Agents|Terpenes|Vasodilating Agents
DB00641	Simvastatin	small molecule	approved	Alimentary Tract and Metabolism|Anticholesteremic Agents|BSEP/ABCB11 Substrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Naphthalenes|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Toxic Actions|UGT1A1 Substrates
DB00642	Pemetrexed	small molecule	approved|investigational	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Enzyme Inhibitors|Folic Acid Analogues|Folic Acid Antagonists|Glutamates|Guanine|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|OAT3/SLC22A8 Substrates|Purines|Purinones
DB00643	Mebendazole	small molecule	approved|vet_approved	Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antihelminthic|Antimitotic Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Carbamates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Mitosis Modulators|Tubulin Modulators
DB00644	Gonadorelin	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Diagnostic Agents|Gonadotropin-releasing hormone agonist|Gonadotropins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Function|Pituitary Hormone-Releasing Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Tests for Fertility Disturbances
DB00645	Dyclonine	small molecule	approved	Anesthetics|Anesthetics, Local|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Nervous System|Peripheral Nervous System Agents|Sensory System Agents|Throat Preparations
DB00646	Nystatin	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Ionophores|Lactones|Membrane Transport Modulators|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Polyene Antifungal|Polyenes|Polyketides
DB00647	Dextropropoxyphene	small molecule	approved|illicit|investigational|withdrawn	Acids, Acyclic|Agents that reduce seizure threshold|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diphenylpropylamine Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Narcotics|Nervous System|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Propionates|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00648	Mitotane	small molecule	approved	Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Cytochrome P450 3A4 Inducers|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|P-glycoprotein/ABCB1 Inhibitors
DB00649	Stavudine	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Neurotoxic agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Thymidine|Toxic Actions
DB00650	Leucovorin	small molecule	approved	Analogs/Derivatives|Antidotes|Biological Factors|Coenzymes|Detoxifying Agents for Antineoplastic Treatment|Diet, Food, and Nutrition|Enzymes and Coenzymes|Folate Analog|Folic Acid|Folic Acid and Derivatives|Food|Food and Beverages|Growth Substances|Micronutrients|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Physiological Phenomena|Pigments, Biological|Protective Agents|Pteridines|Pterins|Tetrahydrofolates|Vitamin B Complex|Vitamins
DB00651	Dyphylline	small molecule	approved	Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Peripheral Nervous System Agents|Phosphodiesterase Inhibitors|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives|Xanthines and Adrenergics
DB00652	Pentazocine	small molecule	approved|vet_approved	Adjuvants, Anesthesia|Agents that reduce seizure threshold|Alkaloids|Analgesics|Benzomorphan Derivatives|Benzomorphans|Central Nervous System Agents|Central Nervous System Depressants|Mixed Agonist / Antagonist Opioids|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Antagonists|Opioids|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Partial Opioid Agonist/Antagonist|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00653	Magnesium sulfate	small molecule	approved|investigational|vet_approved	Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Analgesics|Anesthetics|Anions|Antiarrhythmic agents|Anticonvulsants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Bradycardia-Causing Agents|Calcium Channel Blockers|Calculi Dissolution Agent|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Dermatologicals|Diagnostic Agents|Drugs for Constipation|Electrolyte Solutions|Electrolytes|I.V. Solution Additives|Ions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Magnesium Salts|Membrane Transport Modulators|Mineral Supplements|Miscellaneous Anticonvulsants|Osmotic Laxative|Paramagnetic Contrast Agent|Peripheral Nervous System Agents|Replacement Preparations|Reproductive Control Agents|Sensory System Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Tests for Bile Duct Patency|Tocolytic Agents|Vasodilating Agents
DB00654	Latanoprost	small molecule	approved|investigational	Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Intraocular Pressure, drug effects|Lipids|Neuroprotective Agents|Ophthalmologicals|Prostaglandins|Prostaglandins, Synthetic|Sensory Organs
DB00655	Estrone	small molecule	approved	17-Ketosteroids|Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Estradiol Congeners|Estranes|Estrenes|Estrogens|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Natural and Semisynthetic Estrogens, Plain|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates|Sex Hormones and Modulators of the Genital System|Steroids
DB00656	Trazodone	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Anxiety Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Triazolopyridine|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Histamine Antagonists|Histamine H1 Antagonists|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein/ABCB1 Inducers|Piperazines|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|Pyridines|Pyridones|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tranquilizing Agents
DB00657	Mecamylamine	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Antiadrenergic Agents, Ganglion-Blocking|Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Autonomic Ganglionic Blocker|Cardiovascular Agents|Cholinergic Agents|Decreased Autonomic Ganglionic Activity|Ganglion Blockers|Hypotensive Agents|Monoterpenes|Neurotransmitter Agents|Nicotinic Antagonists|Norbornanes|Peripheral Nervous System Agents|Secondary and Tertiary Amines|Terpenes
DB00658	Sevelamer	small molecule	approved	Amines|Bile Acid Sequestrants|Chelating Agents|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Lipid Regulating Agents|Phosphate Binder|Phosphate Chelating Activity|Phosphate-removing Agents|Polyamines|Sequestering Agents
DB00659	Acamprosate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alcohol Deterrents|Alkanes|Alkanesulfonic Acids|Central Nervous System Agents|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Hydrocarbons, Acyclic|Miscellaneous Central Nervous System Agents|Nervous System|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB00660	Metaxalone	small molecule	approved	Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Oxazoles|Peripheral Nervous System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00661	Verapamil	small molecule	approved	ACE Inhibitors and Calcium Channel Blockers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Antiarrhythmic agents|BCRP/ABCG2 Inhibitors|Bradycardia-Causing Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Nondihydropyridine)|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (moderate)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Cytochrome P450 3A4 Inhibitors|Ethylamines|Hypotensive Agents|Membrane Transport Modulators|Miscellaneous Calcium-channel Blocking Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phenethylamines|Phenylalkylamine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Calcium Channel Blockers With Direct Cardiac Effects|Vasodilating Agents|Verapamil and analogues
DB00662	Trimethobenzamide	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Aminoalkyl Ethers|Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Emesis Suppression|Gastrointestinal Agents|Peripheral Nervous System Agents
DB00663	Flumethasone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Otologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated
DB00664	Sulfametopyrazine	small molecule	approved|withdrawn	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Renal Agents|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB00665	Nilutamide	small molecule	approved|investigational	Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles
DB00666	Nafarelin	small molecule	approved	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Fertility Agents|Fertility Agents, Female|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Gonadotropins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00668	Epinephrine	small molecule	approved|vet_approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alpha-and Beta-adrenergic Agonists|Amines|Anti-Asthmatic Agents|Antiglaucoma Preparations and Miotics|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|COMT Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dental Agents|Drugs for Obstructive Airway Diseases|Hemostatics|Hyperglycemia-Associated Agents|Local Hemostatics|Mydriatics|Nasal Preparations|Neurotransmitter Agents|OCT2 Inhibitors|OCT2 Substrates|Ophthalmologicals|Peripheral Nervous System Agents|Respiratory System Agents|Stomatological Preparations|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Sympathomimetics in Glaucoma Therapy|Sympathomimetics, Plain|Vasoconstrictor Agents
DB00669	Sumatriptan	small molecule	approved|investigational	Agents that produce hypertension|Amides|Amines|Analgesics|Antimigraine Preparations|BCRP/ABCG2 Substrates|Biogenic Amines|Biogenic Monoamines|Cardiovascular Agents|Central Nervous System Depressants|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Indoles|Nervous System|Neurotransmitter Agents|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Substrates|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Sulfonamides|Sulfones|Sulfur Compounds|Triptans|Tryptamines|Vasoconstrictor Agents
DB00670	Pirenzepine	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Anticholinergic Agents|Benzazepines|Benzodiazepinones|Cholinergic Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Muscarinic Antagonists|Neurotransmitter Agents
DB00671	Cefixime	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB00672	Chlorpropamide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Oral Hypoglycemics|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|Urea
DB00673	Aprepitant	small molecule	approved|investigational	Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C9 Inducers|Cytochrome P450 3A4 Inducers|Cytochrome P450 3A4 Inhibitors|Gastrointestinal Agents|Neurokinin 1 Antagonists|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Oxazines|Peripheral Nervous System Agents|Substance P/Neurokinin-1 Receptor Antagonist
DB00674	Galantamine	small molecule	approved	Alkaloids|Amaryllidaceae Alkaloids|Anti-Dementia Drugs|Autonomic Agents|Benzazepines|Bradycardia-Causing Agents|Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Nootropic Agents|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychoanaleptics|QTc Prolonging Agents
DB00675	Tamoxifen	small molecule	approved	Anti-Estrogens|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|Benzylidene Compounds|BSEP/ABCB11 Inhibitors|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Estrogen Agonist/Antagonist|Estrogen Antagonists|Estrogen Receptor Modulators|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Estrogen Receptor Modulators|Stilbenes
DB00676	Benzyl Benzoate	small molecule	approved	Acaricides|Acids, Carbocyclic|Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Benzene Derivatives|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Pesticides|Toxic Actions
DB00677	Isoflurophate	small molecule	approved|investigational|withdrawn	Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Ophthalmics|Organofluorophosphonates|Organophosphonates|Organophosphorus Compounds|Protease Inhibitors
DB00678	Losartan	small molecule	approved	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antiarrhythmic agents|Antihypertensive Agents|Benzene Derivatives|Biphenyl Compounds|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Imidazoles|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Tetrazoles|UGT1A1 Substrates
DB00679	Thioridazine	small molecule	approved|withdrawn	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperidine Structure|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB00680	Moricizine	small molecule	approved|investigational|withdrawn	Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Antipsychotic Agents|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Depressants|Membrane Transport Modulators|Morpholines|Neurotoxic agents|Oxazines|Phenothiazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers|Sulfur Compounds|Voltage-Gated Sodium Channel Blockers
DB00681	Amphotericin B	small molecule	approved|investigational	Agents that reduce seizure threshold|Alimentary Tract and Metabolism|Amebicides|Anti-Bacterial Agents|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Antiparasitic Agents|Antiprotozoals|Biomedical and Dental Materials|Biomimetic Materials|Carbohydrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Drug Carriers|Drug Delivery Systems|Genito Urinary System and Sex Hormones|Glycosides|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Intestinal Antiinfectives|Investigative Techniques|Lactones|Lipid-based Polyene Antifungal|Liposomes|Membranes, Artificial|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Pharmaceutical Preparations|Polyene Antifungal|Polyenes|Polyketides|Stomatological Preparations
DB00682	Warfarin	small molecule	approved	4-Hydroxycoumarins|Agrochemicals|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hematologic Agents|Narrow Therapeutic Index Drugs|Pesticides|Pyrans|Rodenticides|Toxic Actions|Vitamin K Antagonists|Vitamin K Inhibitors
DB00683	Midazolam	small molecule	approved|illicit	Adjuvants, Anesthesia|Anesthetics|Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|BSEP/ABCB11 Substrates|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00684	Tobramycin	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycosides|Kanamycin|Narrow Therapeutic Index Drugs|Nebramycin|Nephrotoxic agents|Ophthalmologicals|Sensory Organs
DB00685	Trovafloxacin	small molecule	approved|investigational|withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00686	Pentosan Polysulfate	small molecule	approved	Acids|Acids, Noncarboxylic|Anticoagulants|Antivaricose Therapy|Carbohydrates|Genito Urinary System and Sex Hormones|Glycosaminoglycans|Hematologic Agents|Miscellaneous Therapeutic Agents|Polysaccharides|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Urologicals|Vasoprotectives
DB00687	Fludrocortisone	small molecule	approved|investigational	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Adrenals|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Mineralocorticoids|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Pregnanes|Pregnenediones|Pregnenes|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00688	Mycophenolate mofetil	small molecule	approved|investigational	Acids, Acyclic|Antimetabolite Immunosuppressant|BCRP/ABCG2 Substrates|Caproates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Immunologic Factors|Immunosuppressive Agents|IMP Dehydrogenase, antagonists & inhibitors|Lipids|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates
DB00689	Cephaloglycin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalexin|Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB00690	Flurazepam	small molecule	approved|illicit|investigational	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00691	Moexipril	small molecule	approved	ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|Isoquinolines|Potential QTc-Prolonging Agents|Protease Inhibitors|QTc Prolonging Agents
DB00692	Phentolamine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidotes|Antihypertensive Agents|Cardiovascular Agents|Hypotensive Agents|Imidazoles|Imidazoline Derivatives|Neurotransmitter Agents|Non-selective Alfa-adrenergic Blocking Agents|Peripheral Vasodilators|Sympatholytic (Adrenergic Blocking) Agents|Vasodilating Agents
DB00693	Fluorescein	small molecule	approved	BSEP/ABCB11 Substrates|Coloring Agents|Colouring Agents|Contrast Media|Diagnostic Agents|Diagnostic Dye|Diagnostic Uses of Chemicals|Fluoresceins|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|OAT3/SLC22A8 Substrates|Ocular Disorders|Ophthalmologicals|Other Diagnostics|Sensory Organs|Spiro Compounds|Xanthenes
DB00694	Daunorubicin	small molecule	approved	Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00695	Furosemide	small molecule	approved|vet_approved	Acids, Carbocyclic|Amides|Amines|Aminobenzoates|Aniline Compounds|Benzene Derivatives|Benzoates|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|High-Ceiling Diuretics|High-Ceiling Diuretics and Potassium-Sparing Agents|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|OAT3/SLC22A8 Inhibitors|Ototoxic agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds|UGT1A1 Substrates
DB00696	Ergotamine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Antimigraine Preparations|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ergot Alkaloids and Derivatives|Ergotamine Derivative|Ergotamines|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Reproductive Control Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Sympatholytic (Adrenergic Blocking) Agents|Uterotonic agents|Vasoconstrictor Agents
DB00697	Tizanidine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Anticonvulsants|Autonomic Agents|Bradycardia-Causing Agents|Central alpha-2 Adrenergic Agonist|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Hypotensive Agents|Imidazoles|Imidazolines|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory System Agents
DB00698	Nitrofurantoin	small molecule	approved|vet_approved	Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Furans|Methemoglobinemia Associated Agents|Nitro Compounds|Nitrofuran Antibacterial|Nitrofuran Derivatives|Nitrofurans|Renal Agents
DB00699	Nicergoline	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP2D6 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Neurotransmitter Agents|Nootropic Agents|Peripheral Vasodilators|Vasodilating Agents
DB00700	Eplerenone	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Diuretics|Diuretics, Potassium Sparing|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Lactones|Mineralocorticoid (Aldosterone) Receptor Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Potassium-Sparing Agents|Potassium-Sparing Diuretics|Pregnanes|Pregnenes|Steroids
DB00701	Amprenavir	small molecule	approved|investigational	Acids, Acyclic|Amides|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antituberculosis Agents|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inducers|Cytochrome P450 3A4 Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein inducers|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Sulfones|Sulfur Compounds
DB00702	Icodextrin	small molecule	approved|investigational	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Dialysis Solutions|Hemodialysis Solutions|Hexoses|Macromolecular Substances|Monosaccharides|Pharmaceutical Preparations|Pharmaceutical Solutions|Polymers|Polysaccharides|Solutions|Ultrafiltration
DB00703	Methazolamide	small molecule	approved	Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Enzyme Inhibitors|Hypotensive Agents|Natriuretic Agents|Ophthalmologicals|Sensory Organs|Sulfur Compounds|Thiadiazoles|Thiazoles
DB00704	Naltrexone	small molecule	approved|investigational|vet_approved	Alimentary Tract and Metabolism|Alkaloids|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Centrally Acting Antiobesity Products|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Morphinans|Naloxone|Nervous System|Opiate Alkaloids|Opiate Antagonists|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates
DB00705	Delavirdine	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Indoles|Non-Nucleoside Analog|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|Piperazines|Reverse Transcriptase Inhibitors
DB00706	Tamsulosin	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amides|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Hypotensive Agents|Neurotransmitter Agents|Selective Alfa-1-adrenergic Blocking Agents|Sulfones|Sulfur Compounds|Urological Agents|Urologicals
DB00707	Porfimer sodium	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Dermatologicals|Hematoporphyrin Derivative|Hematoporphyrins|Photoabsorption|Photoactivated Radical Generator|Photosensitizing Activity|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy
DB00708	Sufentanil	small molecule	approved|investigational	Adjuvants, Anesthesia|Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Fentanyl|Hypotensive Agents|Narcotics|Nervous System|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00709	Lamivudine	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Carbohydrates|Cytidine|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|OCT2 Substrates|P-glycoprotein/ABCB1 Substrates|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides
DB00710	Ibandronate	small molecule	approved|investigational	Bisphosphonates|Bone Density Conservation Agents|Bone Resorption|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00711	Diethylcarbamazine	small molecule	approved|investigational|vet_approved	Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antihelminthic|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Carbamates|Cholinesterase Inhibitors|Enzyme Inhibitors|Filaricides|Lipoxygenase Inhibitors|Piperazine and Derivatives|Piperazines
DB00712	Flurbiprofen	small molecule	approved|investigational	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Benzene Derivatives|Biphenyl Compounds|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Ophthalmologicals|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Propionates|Sensory Organs|Sensory System Agents|Throat Preparations|Topical Products for Joint and Muscular Pain|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates
DB00713	Oxacillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Lactams|Penicillins|Sulfur Compounds
DB00714	Apomorphine	small molecule	approved|investigational	Alkaloids|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Aporphines|Autonomic Agents|Benzylisoquinolines|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Agonists|Drugs Used in Erectile Dysfunction|Emetics|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Hypotensive Agents|Isoquinolines|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Opiate Agonists|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Antagonists|Urologicals
DB00715	Paroxetine	small molecule	approved|investigational	Agents producing tachycardia|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Piperidines|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00716	Nedocromil	small molecule	approved|investigational	4-Quinolones|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antiallergic Agents, Excl. Corticosteroids|Decongestants and Antiallergics|Decreased Histamine Release|Drugs for Obstructive Airway Diseases|Mast Cell Stabilizers|Nasal Preparations|Ophthalmologicals|Quinolines|Quinolones|Respiratory Agents, Miscellaneous|Respiratory System Agents|Sensory Organs
DB00717	Norethisterone	small molecule	approved	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Estren Derivatives|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|P-glycoprotein/ABCB1 Inducers|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00718	Adefovir Dipivoxil	small molecule	approved|investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleosides and Nucleotides|Organophosphorus Compounds|Purines|Reverse Transcriptase Inhibitors
DB00719	Azatadine	small molecule	approved	Agents that reduce seizure threshold|Antihistamines for Systemic Use|Benzocycloheptenes|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Dibenzocycloheptenes|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00720	Clodronic acid	small molecule	approved|investigational|vet_approved	Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds
DB00721	Procaine	small molecule	approved|investigational|vet_approved	Acids, Carbocyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Agents that reduce seizure threshold|Aminobenzoates|Anesthetics|Anesthetics, Local|Anticholinergic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Cholinesterase substrates|Esters of Aminobenzoic Acid|Monoamine Oxidase Inhibitors|Nervous System|Nicotinic Antagonists|NMDA Receptor Antagonists|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Vasoprotectives
DB00722	Lisinopril	small molecule	approved|investigational	ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiotonic Agents|Cardiovascular Agents|Dipeptides|Enzyme Inhibitors|Hypotensive Agents|Lipid Modifying Agents|Oligopeptides|Peptides|Protease Inhibitors|Protective Agents
DB00723	Methoxamine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Sympathomimetics|Vasoconstrictor Agents
DB00724	Imiquimod	small molecule	approved|investigational	Adjuvants, Immunologic|Antineoplastic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Immunologic Factors|Immunosuppressive Agents|Increased Cytokine Activity|Increased Cytokine Production|Interferon Inducers|Misc. Skin and Mucous Membrane Agents|Quinolines
DB00725	Homatropine Methylbromide	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Drugs for Functional Gastrointestinal Disorders|Muscarinic Agonists|Muscarinic Antagonists
DB00726	Trimipramine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic Uptake Inhibitors|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dibenzazepines|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB00727	Nitroglycerin	small molecule	approved|investigational	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Explosive Agents|Glycerol|Hypotensive Agents|Methemoglobinemia Associated Agents|Nitrate Vasodilator|Nitrates and Nitrites|Nitro Compounds|Organic Nitrates|Sugar Alcohols|Vasodilating Agents|Vasodilation|Vasodilators Used in Cardiac Diseases|Vasoprotectives
DB00728	Rocuronium	small molecule	approved	Agents producing tachycardia|Androstanes|Anticholinergic Agents|Central Nervous System Depressants|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents|Steroids
DB00729	Diphemanil Methylsulfate	small molecule	approved|vet_approved|withdrawn	Agents producing tachycardia|Anti-Asthmatic Agents|Anticholinergic Agents|Autonomic Agents|Bronchodilator Agents|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Respiratory System Agents
DB00730	Thiabendazole	small molecule	approved|vet_approved	Anthelmintics|Anti-Infective Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antihelminthic|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives|Sulfur Compounds|Thiazoles
DB00731	Nateglinide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cycloparaffins|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Drugs Used in Diabetes|Glinide|Hypoglycemia-Associated Agents|Oral Hypoglycemics|Potassium Channel Antagonists|UGT1A9 Substrates
DB00732	Atracurium besylate	small molecule	approved	Alkaloids|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Cholinergic Agents|Isoquinolines|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents
DB00733	Pralidoxime	small molecule	approved|vet_approved	Amines|Antidotes|Cholinergic Agents|Cholinesterase Reactivators|Enzyme Reactivators|Hydroxylamines|Neurotransmitter Agents|Oximes|Protective Agents
DB00734	Risperidone	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Agents that reduce seizure threshold|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|Pyrimidines|Pyrimidinones|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB00735	Naftifine	small molecule	approved	Alkenes|Allyl Compounds|Allylamine Antifungal|Amines|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Hydrocarbons, Acyclic
DB00736	Esomeprazole	small molecule	approved|investigational	2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Musculo-Skeletal System|Omeprazole|P-glycoprotein/ABCB1 Inhibitors|Propionates|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds
DB00737	Meclizine	small molecule	approved	Anti-Allergic Agents|Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Emesis Suppression|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Piperazine Derivatives|Piperazines
DB00738	Pentamidine	small molecule	approved|investigational	Agents Against Leishmaniasis and Trypanosomiasis|Agents causing hyperkalemia|Amidines|Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Benzamidines|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Miscellaneous Antiprotozoals|Moderate Risk QTc-Prolonging Agents|Nephrotoxic agents|QTc Prolonging Agents|Trypanocidal Agents
DB00739	Hetacillin	small molecule	approved|vet_approved|withdrawn	Amides|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillins With Extended Spectrum|Sulfur Compounds
DB00740	Riluzole	small molecule	approved|investigational	Anticonvulsants|BCRP/ABCG2 Substrates|Benzothiazoles|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Miscellaneous Central Nervous System Agents|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Sulfur Compounds|Thiazoles
DB00741	Hydrocortisone	small molecule	approved|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|BCRP/ABCG2 Inhibitors|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Weak (Group I)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|OAT3/SLC22A8 Substrates|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Substrates|Pregnanes|Pregnenediones|Pregnenes|Sensory Organs|Steroids|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives
DB00742	Mannitol	small molecule	approved|investigational	Agents causing hyperkalemia|Alcohols|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Cardiovascular Agents|Cough and Cold Preparations|Diet, Food, and Nutrition|Diuretics|Diuretics, Osmotic|Drugs for Constipation|Expectorants|Flavoring Agents|Food|Food Additives|Food and Beverages|Hypotensive Agents|i.v. Solutions|Increased Diuresis|Irrigating Solutions|Kidney Function|Laxatives|Natriuretic Agents|Nephrotoxic agents|Osmotic Activity|Osmotic Laxative|P-glycoprotein/ABCB1 Substrates|Physiological Phenomena|Solutions Producing Osmotic Diuresis|Sugar Alcohols|Sweetening Agents
DB00743	Gadobenic acid	small molecule	approved|investigational	Alcohols|Amino Sugars|Carbohydrates|Contrast Media|Diagnostic Uses of Chemicals|Gadolinium|Gadolinium-based Contrast Agent|Hexosamines|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Moderate Risk QTc-Prolonging Agents|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|QTc Prolonging Agents|Sorbitol|Sugar Alcohols
DB00744	Zileuton	small molecule	approved|investigational|withdrawn	Agents to Treat Airway Disease|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Decreased Leukotriene Production|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Lipoxygenase Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|UGT1A9 Substrates|Urea
DB00745	Modafinil	small molecule	approved|investigational	Benzene Derivatives|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Increased Sympathetic Activity|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Stimulants|Sympathomimetic-like Agent|Wakefulness-Promoting Agents
DB00746	Deferoxamine	small molecule	approved|investigational	Amines|Chelating Agents|Heavy Metal Antagonists|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Iron Chelating Activity|Iron Chelating Agents|Sequestering Agents|Siderophores
DB00747	Scopolamine	small molecule	approved|investigational	Adjuvants|Adjuvants, Anesthesia|Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Antiemetics and Antinauseants|Antimuscarinics Antispasmodics|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Hypnotics and Sedatives|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Nervous System|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Psycholeptics|Scopolamine Derivatives|Sensory Organs|Solanaceous Alkaloids|Tropanes
DB00748	Carbinoxamine	small molecule	approved	Aminoalkyl Ethers|Antihistamines for Systemic Use|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|QTc Prolonging Agents
DB00749	Etodolac	small molecule	approved|investigational|vet_approved	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Indoleacetic Acids|Indoles|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|UGT1A9 Substrates
DB00750	Prilocaine	small molecule	approved	Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Anilides|Central Nervous System Agents|Local Anesthesia|Methemoglobinemia Associated Agents|Nervous System|Peripheral Nervous System Agents|Sensory System Agents
DB00751	Epinastine	small molecule	approved|investigational	Acid Reducers|Antihistamines for Systemic Use|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decongestants and Antiallergics|Decreased Histamine Release|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Inhibitors|Histamine H2 Antagonists|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB00752	Tranylcypromine	small molecule	approved|investigational	Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hypotensive Agents|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Propylamines|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Tranquilizing Agents
DB00753	Isoflurane	small molecule	approved|vet_approved	Agents that produce hypertension|Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Anticholinergic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Ethers|Hydrocarbons, Halogenated|Hypotensive Agents|Methyl Ethers|Nervous System|Nicotinic Antagonists|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00754	Ethotoin	small molecule	approved	Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Hydantoins|Imidazoles|Imidazolidines|Nervous System
DB00755	Tretinoin	small molecule	approved|investigational|nutraceutical	Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Cardiotoxic antineoplastic agents|Carotenoids|Cell Stimulants and Proliferants|Cyclohexanes|Cyclohexenes|Cycloparaffins|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dermatologicals|Hydrocarbons, Acyclic|Hypotensive Agents|Immunosuppressive Agents|Keratolytic Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Topical Use in Acne|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)
DB00756	Hexachlorophene	small molecule	approved|withdrawn	Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzene Derivatives|Chlorobenzenes|Chlorophenols|Dermatologicals|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenol and Derivatives|Phenols
DB00757	Dolasetron	small molecule	approved|investigational	Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gastrointestinal Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB00758	Clopidogrel	small molecule	approved	Antiplatelet agents|Blood and Blood Forming Organs|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Platelet Aggregation|Hematologic Agents|Neurotransmitter Agents|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|P2Y12 Platelet Inhibitor|Platelet Aggregation Inhibitors Excl. Heparin|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Pyridines|Sulfur Compounds|Thienopyridines|Thiophenes
DB00759	Tetracycline	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Naphthacenes|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Substrates|Protein Synthesis Inhibitors|Sensory Organs|Stomatological Preparations|Tetracyclines
DB00760	Meropenem	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Carbapenems|Lactams|Penem Antibacterial|Sulfur Compounds
DB00761	Potassium Chloride	small molecule	approved|withdrawn	Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorides|Chlorine Compounds|Electrolyte Solutions|Electrolytes|Hemodialysis Solution|Hydrochloric Acid|I.V. Solution Additives|Ions|Mineral Supplements|Minerals|Potassium|Potassium Compounds|Potassium Salt|Replacement Preparations
DB00762	Irinotecan	small molecule	approved|investigational	Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Carbohydrates|Cholinesterase substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Disaccharides|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|Oligosaccharides|P-glycoprotein/ABCB1 Substrates|Pharmaceutical Preparations|Polysaccharides|Prodrugs|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates
DB00763	Methimazole	small molecule	approved	Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles|Immunosuppressive Agents|Myelosuppressive Agents|Sulfhydryl Compounds|Sulfur Compounds|Sulfur-Containing Imidazole Derivatives|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Hormone Synthesis Inhibitor|Thyroid Hormone Synthesis Inhibitors|Thyroid Products
DB00764	Mometasone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Adrenergics, Inhalants|Agents to Treat Airway Disease|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs for Obstructive Airway Diseases|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|Pregnadienediols|Pregnadienes|Pregnanes|Steroids
DB00765	Metyrosine	small molecule	approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antihypertensive Agents|Catecholamine Synthesis Inhibitor|Catecholamine Synthesis Inhibitors|Enzyme Inhibitors|Methyltyrosines|Tyrosine|Tyrosine Hydroxylase Inhibitors
DB00766	Clavulanic acid	small molecule	approved|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Aza Compounds|Azabicyclo Compounds|beta-Lactamase Inhibitors|beta-Lactams|Clavulanic Acids|Enzyme Inhibitors|Lactams|Sulfur Compounds
DB00767	Benzquinamide	small molecule	withdrawn	Agents producing tachycardia|Anticholinergic Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|P-glycoprotein/ABCB1 Inhibitors
DB00768	Olopatadine	small molecule	approved	Analgesics|Analgesics, Non-Narcotic|Anti-Allergic Agents|Anti-Inflammatory Agents|Antiallergic Agents, Excl. Corticosteroids|Antihistamine Drugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decongestants and Antiallergics|Decreased Histamine Release|Dibenzoxepins|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Histamine H1 Inhibitors|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Sensory System Agents
DB00769	Hydrocortamate	small molecule	approved	Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers
DB00770	Alprostadil	small molecule	approved|investigational	Autacoids|Biological Factors|Cardiac Therapy|Cardiovascular Agents|Drugs Used in Erectile Dysfunction|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Genitourinary Arterial Vasodilation|Hematologic Agents|Inflammation Mediators|Lipids|Miscellaneous Vasodilatating Agents|OAT3/SLC22A8 Substrates|Prostaglandin E1 Agonist|Prostaglandin Receptor Agonists|Prostaglandins|Prostaglandins E|Prostaglandins, Synthetic|Urological Agents|Urologicals|Vasodilating Agents|Venous Vasodilation
DB00771	Clidinium	small molecule	approved	Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Autonomic Agents|Benzilates|Central Nervous System Depressants|Decreased Parasympathetic Acetylcholine Activity|Digestive/GI System Activity Alteration|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|GI Motility Alteration|Hydroxy Acids|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Quinuclidines
DB00772	Malathion	small molecule	approved|investigational	Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions
DB00773	Etoposide	small molecule	approved	Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|Benzyl Compounds|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Glucosides|Glycosides|Immunosuppressive Agents|Lignans|Myelosuppressive Agents|Naphthalenes|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Podophyllotoxin|Podophyllotoxin Derivatives|Tetrahydronaphthalenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors|UGT1A1 Substrates
DB00774	Hydroflumethiazide	small molecule	approved|investigational	Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB00775	Tirofiban	small molecule	approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiplatelet agents|Blood and Blood Forming Organs|Cardiovascular Agents|Decreased Platelet Aggregation|Fibrin Modulating Agents|Hematologic Agents|Platelet Aggregation Inhibitors Excl. Heparin|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors
DB00776	Oxcarbazepine	small molecule	approved	Anti-epileptic Agent|Anticonvulsants|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Dibenzazepines|Enzyme Inducing Antiepileptic Drugs|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Nervous System|P-glycoprotein/ABCB1 Inducers|Sodium Channel Blockers|UGT1A1 Inducers|UGT1A1 Substrates|Voltage-Gated Sodium Channel Blockers
DB00777	Propiomazine	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Muscarinic Antagonists|Nervous System|Psycholeptics|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds
DB00778	Roxithromycin	small molecule	approved|investigational|withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Erythromycin|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Polyketides|QTc Prolonging Agents
DB00779	Nalidixic acid	small molecule	approved|investigational	4-Quinolones|Agents that reduce seizure threshold|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|Naphthyridines|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00780	Phenelzine	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydrazines|Hypotensive Agents|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00781	Polymyxin B Sulfate	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Antimicrobial Cationic Peptides|Intestinal Antiinfectives|Lipids|Lipopeptides|Membrane Proteins|Nephrotoxic agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Peptides|Peptides, Cyclic|Polymyxin-class Antibacterial|Polymyxins|Pore Forming Cytotoxic Proteins|Proteins|Sensory Organs
DB00782	Propantheline	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anti-Ulcer Agents|Anticholinergic Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Xanthenes
DB00783	Estradiol	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|Androgens and Estrogens|Antiandrogens and Estrogens|BCRP/ABCG2 Inducers|BCRP/ABCG2 Inhibitors|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estranes|Estrenes|Estrogen Contraceptives|Estrogens|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Intravaginal Contraceptives|Natural and Semisynthetic Estrogens, Plain|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids|UGT1A1 Substrates
DB00784	Mefenamic acid	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|ortho-Aminobenzoates|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Sensory System Agents|UGT1A9 Inhibitors
DB00785	Cryptenamine	small molecule	approved	Alkaloids|Antihypertensive Agents|Cardiovascular Agents|Cevanes|Veratrum Alkaloids
DB00786	Marimastat	small molecule	investigational	Amines|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines|Metalloendopeptidases, antagonists & inhibitors
DB00787	Acyclovir	small molecule	approved	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Dermatologicals|Direct Acting Antivirals|Guanine|Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor|Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Ophthalmologicals|Purines|Purinones|Sensory Organs
DB00788	Naproxen	small molecule	approved|vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiinflammatory Products for Vaginal Administration|BSEP/ABCB11 Substrates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Musculo-Skeletal System|Naphthaleneacetic Acids|Naphthalenes|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates
DB00789	Gadopentetic acid	small molecule	approved	Acetates|Acids, Acyclic|Amines|Contrast Media|Diagnostic Uses of Chemicals|Fatty Acids|Fatty Acids, Volatile|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Miscellaneous Therapeutic Agents|Organometallic Compounds|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Pentetic Acid|Polyamines
DB00790	Perindopril	small molecule	approved	ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Hypotensive Agents|Indoles|Lipid Modifying Agents|Protease Inhibitors
DB00791	Uracil mustard	small molecule	approved	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Hydrocarbons, Halogenated|Mustard Compounds|Nitrogen Mustard Compounds|Noxae|Pyrimidines|Pyrimidinones|Toxic Actions|Uracil
DB00792	Tripelennamine	small molecule	approved|vet_approved	Amines|Aminopyridines|Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Diamines|Ethylenediamine Derivatives|Ethylenediamines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Polyamines|Pyridines|Substituted Ethylene Diamines
DB00793	Haloprogin	small molecule	approved|withdrawn	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Dermatologicals|Ethers|Phenols
DB00794	Primidone	small molecule	approved|vet_approved	Anti-epileptic Agent|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates and Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Phenobarbital and similars|Psycholeptics|Pyrimidines|Pyrimidinones|UGT1A1 Inducers
DB00795	Sulfasalazine	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amides|Aminosalicylate|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Central Nervous System Agents|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Methemoglobinemia Associated Agents|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Peripheral Nervous System Agents|Salicylates|Sensory System Agents|Sulfonamides|Sulfones|Sulfur Compounds
DB00796	Candesartan cilexetil	small molecule	approved	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Diuretics|Angiotensin Receptor Antagonists|Antihypertensive Agents|Benzene Derivatives|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|P-glycoprotein/ABCB1 Inhibitors
DB00797	Tolazoline	small molecule	approved|vet_approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antihypertensive Agents|Cardiovascular Agents|Hypotensive Agents|Imidazoles|Imidazoline Derivatives|Imidazolines|Musculo-Skeletal System|Neurotransmitter Agents|Peripheral Vasodilators|Topical Products for Joint and Muscular Pain|Vasodilating Agents
DB00798	Gentamicin	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|alpha-Galactosidase, antagonists & inhibitors|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|Carbohydrates|Dermatologicals|Enzyme Inhibitors|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Protein Synthesis Inhibitors|Sensory Organs
DB00799	Tazarotene	small molecule	approved|investigational	Antipsoriatics|Antipsoriatics for Topical Use|Cytochrome P-450 CYP2C8 Substrates|Dermatologicals|Keratolytic Agents|Misc. Skin and Mucous Membrane Agents|Noxae|Prodrugs|Pyridines|Retinoids|Teratogens|Toxic Actions
DB00800	Fenoldopam	small molecule	approved	Adrenergic and Dopaminergic Agents|Antihypertensive Agents|Benzazepines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Dopamine Agents|Dopamine Agonists|Dopamine D1 Receptor Agonists|Hypotensive Agents|Neurotransmitter Agents|Vasodilating Agents
DB00801	Halazepam	small molecule	approved|illicit|withdrawn	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00802	Alfentanil	small molecule	approved|illicit	Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Fentanyl|Narcotics|Narrow Therapeutic Index Drugs|Nervous System|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00803	Colistin	small molecule	approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Antimicrobial Cationic Peptides|Intestinal Antiinfectives|Lipids|Lipopeptides|Membrane Proteins|Nephrotoxic agents|Peptides|Peptides, Cyclic|Polymyxins|Pore Forming Cytotoxic Proteins|Proteins
DB00804	Dicyclomine	small molecule	approved	Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Cholinergic Agents|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group
DB00805	Minaprine	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Monoamine Oxidase Inhibitors|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00806	Pentoxifylline	small molecule	approved|investigational	Alkaloids|Antioxidants|Antiplatelet agents|Blood Viscosity Reducer|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Free Radical Scavengers|Hematologic Activity Alteration|Hematologic Agents|Hemorrheologic Agents|Peripheral Vasodilators|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Purine Derivatives|Purines|Purinones|Radiation-Protective Agents|Theobromine|Vasodilating Agents|Xanthine derivatives
DB00807	Proparacaine	small molecule	approved|vet_approved	Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Isomerism|Local Anesthesia|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Sensory Organs|Sensory System Agents
DB00808	Indapamide	small molecule	approved	Amides|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Indoles|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide-like Diuretic
DB00809	Tropicamide	small molecule	approved|investigational	Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Pyridines|Sensory Organs
DB00810	Biperiden	small molecule	approved|investigational	Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Piperidines|Tertiary Amines
DB00811	Ribavirin	small molecule	approved	Anti-Infective Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Direct Acting Antivirals|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside Analog Antiviral|Nucleosides|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Ribonucleosides|Toxic Actions
DB00812	Phenylbutazone	small molecule	approved|vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Butylpyrazolidines|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB00813	Fentanyl	small molecule	approved|illicit|investigational|vet_approved	Adjuvants|Adjuvants, Anesthesia|Agents that produce hypertension|Agents that reduce seizure threshold|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Narcotics|Narrow Therapeutic Index Drugs|Nervous System|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Phenylpiperidine Derivatives|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00814	Meloxicam	small molecule	approved|vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Isoenzymes, antagonists & inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Oxicams|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfur Compounds
DB00815	Sodium lauryl sulfate	small molecule	approved	Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Dodecanol|Fatty Alcohols|Hydrocarbons, Acyclic|Lipids|Sulfones|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents
DB00816	Orciprenaline	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Catecholamines|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Non-selective Beta-adrenergic Agonists|Peripheral Nervous System Agents|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics|Tocolytic Agents
DB00817	Rosoxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines
DB00818	Propofol	small molecule	approved|investigational|vet_approved	Agents that produce hypertension|Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hypnotics and Sedatives|Hypotensive Agents|Miscellaneous General Anesthetics|Nervous System|P-glycoprotein/ABCB1 Inhibitors|Phenols|Potential QTc-Prolonging Agents|QTc Prolonging Agents|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates
DB00819	Acetazolamide	small molecule	approved|vet_approved	Anticonvulsants|Antiglaucoma Agents|Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Natriuretic Agents|Ophthalmologicals|Sensory Organs|Sulfonamides|Sulfur Compounds|Thiadiazoles|Thiazoles
DB00820	Tadalafil	small molecule	approved|investigational	Carbolines|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Indoles|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Pyridines|Urological Agents|Urologicals|Vasodilating Agents
DB00821	Carprofen	small molecule	approved|vet_approved|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Central Nervous System Agents|Dermatologicals|Indoles|Nephrotoxic agents|Peripheral Nervous System Agents|Photosensitizing Agents|Radiation-Sensitizing Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents
DB00822	Disulfiram	small molecule	approved	Acetaldehyde Dehydrogenase Inhibitors|Acetyl Aldehyde Dehydrogenase Inhibitors|Acids|Acids, Acyclic|Acids, Noncarboxylic|Agents that reduce seizure threshold|Alcohol Deterrents|Aldehyde Dehydrogenase Inhibitor|Anions|Antiparasitic Products, Insecticides and Repellents|BSEP/ABCB11 Substrates|Carbamates|Central Nervous System Agents|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Disulfides|Ditiocarb|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Electrolytes|Enzyme Inhibitors|Gases|Hydrogen Sulfide|Ions|Nervous System|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfides|Sulfur Compounds|Sulfur Containing Products|Thiocarbamates
DB00823	Ethynodiol diacetate	small molecule	approved	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00824	Enprofylline	small molecule	approved|experimental	Adenosine A2 Receptor Antagonists|Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory System Agents
DB00825	Levomenthol	small molecule	approved	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents
DB00826	Natamycin	small molecule	approved	Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Lactones|Ophthalmologicals|Polyene Antifungal|Polyene Antimicrobial|Polyketides|Sensory Organs|Stomatological Preparations
DB00827	Cinoxacin	small molecule	approved|investigational|withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00828	Fosfomycin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Organophosphonates|Organophosphorus Compounds
DB00829	Diazepam	small molecule	approved|illicit|investigational|vet_approved	Adjuvants, Anesthesia|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anti-Anxiety Agents|Anticonvulsants|Antiemetics|Autonomic Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Gastrointestinal Agents|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00830	Phenmetrazine	small molecule	approved|illicit	Agents producing tachycardia|Agents that produce hypertension|Anti-Obesity Agents|Appetite Depressants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Stimulants|Morpholines|Oxazines|Peripheral Nervous System Agents|Sympathomimetics
DB00831	Trifluoperazine	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiemetics|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Gastrointestinal Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents
DB00832	Phensuximide	small molecule	approved	Anticonvulsants|Central Nervous System Depressants|Imides|Nervous System|Pyrrolidines|Pyrrolidinones|Succinimide Derivatives
DB00833	Cefaclor	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|BSEP/ABCB11 Substrates|Cephalexin|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB00834	Mifepristone	small molecule	approved|investigational	Abortifacient Agents|Abortifacient Agents, Steroidal|Adrenal Cortex Hormones|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estranes|Estrenes|Genito Urinary System and Sex Hormones|Highest Risk QTc-Prolonging Agents|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Luteolytic Agents|Menstruation-Inducing Agents|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|Progestational Hormone Receptor Antagonists|Progesterone Receptor Modulators|Progestin Antagonist|QTc Prolonging Agents|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00835	Brompheniramine	small molecule	approved	Agents producing tachycardia|Anti-Allergic Agents|Anticholinergic Agents|Antihistamines for Systemic Use|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Pheniramine|Potential QTc-Prolonging Agents|Propylamine Derivatives|Pyridines|QTc Prolonging Agents|Substituted Alkylamines
DB00836	Loperamide	small molecule	approved	Agents causing hyperkalemia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Moderate Risk QTc-Prolonging Agents|Opioid Agonist|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperidines|QTc Prolonging Agents
DB00837	Progabide	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticonvulsants|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|Lipids|Nervous System|Neurotransmitter Agents|Psychotropic Drugs
DB00838	Clocortolone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated
DB00839	Tolazamide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Oral Hypoglycemics|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|Urea
DB00840	Hydroxypropyl cellulose	small molecule	approved	Artificial Tears|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Demulcent|Demulcent Activity|Glucans|Macromolecular Substances|Ophthalmics|Polymers|Polysaccharides
DB00841	Dobutamine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|COMT Substrates|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Protective Agents|Selective Beta 1-adrenergic Agonists|Sympathomimetic (Adrenergic) Agents|Sympathomimetics
DB00842	Oxazepam	small molecule	approved	Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|UGT1A9 Substrates
DB00843	Donepezil	small molecule	approved	Anti-Dementia Drugs|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Indenes|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Nootropic Agents|Parasympathomemetic (Cholinergic) Agents|Potential QTc-Prolonging Agents|Psychoanaleptics|QTc Prolonging Agents
DB00844	Nalbuphine	small molecule	approved	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Mixed Agonist / Antagonist Opioids|Morphinan Derivatives|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Agonist/Antagonist|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00845	Clofazimine	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Anti-Inflammatory Agents|Antiinfectives for Systemic Use|Antimycobacterials|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Drugs for Treatment of Lepra|Leprostatic Agents|P-glycoprotein/ABCB1 Inhibitors|Phenazines
DB00846	Flurandrenolide	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids|Steroids, Fluorinated
DB00847	Cysteamine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amines|Amino Acids and Derivatives|Cystine Depleting Agents|Cystine Disulfide Reduction|Ethylamines|Mercaptoethylamines|Ophthalmics|Ophthalmologicals|Other Miscellaneous Therapeutic Agents|Sensory Organs|Sulfhydryl Compounds|Sulfur Compounds
DB00848	Levamisole	small molecule	approved|investigational|vet_approved|withdrawn	Adjuvants, Immunologic|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Imidazoles|Imidazothiazole Derivatives|Immunologic Factors|Sulfur Compounds|Thiazoles
DB00849	Methylphenobarbital	small molecule	approved	Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates and Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Phenobarbital and similars|Psycholeptics|Pyrimidines|Pyrimidinones
DB00850	Perphenazine	small molecule	approved	Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents
DB00851	Dacarbazine	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Imidazoles|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Toxic Actions|Triazenes
DB00852	Pseudoephedrine	small molecule	approved	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Amphetamines|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Ethylamines|Hyperglycemia-Associated Agents|Nasal Decongestants|Nasal Decongestants for Systemic Use|Nasal Preparations|Norepinephrine Releasing Agent|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Respiratory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Vasoconstrictor Agents
DB00853	Temozolomide	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Imidazoles|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Toxic Actions|Triazenes
DB00854	Levorphanol	small molecule	approved	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Morphinans|Narcotics|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00855	Aminolevulinic acid	small molecule	approved	Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Dermatologicals|Enkephalins|Keto Acids|Levulinic Acids|Nerve Tissue Proteins|Neuropeptides|Opioid Peptides|Peptides|Photosensitizing Agents|Porphyrin Precursor|Proteins|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy
DB00856	Chlorphenesin	small molecule	approved|experimental	Alcohols|Antifungals for Dermatological Use|Antifungals for Topical Use|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Glycols|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Peripheral Nervous System Agents|Propylene Glycols
DB00857	Terbinafine	small molecule	approved|investigational|vet_approved	Allylamine Antifungal|Allylamines|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Systemic Use|Antifungals for Topical Use|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Trypanocidal Agents
DB00858	Drostanolone	small molecule	illicit	Androstanes|Steroids
DB00859	Penicillamine	small molecule	approved	Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antidotes|Antiinflammatory and Antirheumatic Products|Chelating Agents|Heavy Metal Antagonists|Immunosuppressive Agents|Musculo-Skeletal System|Myelosuppressive Agents|OATP1B1/SLCO1B1 Substrates|Penicillamine and Similar Agents|Protective Agents|Sequestering Agents|Specific Antirheumatic Agents|Sulfur Compounds
DB00860	Prednisolone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Weak (Group I)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Substrates|Pregnadienes|Pregnadienetriols|Pregnanes|Prodrugs|Sensory Organs|Steroids|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives
DB00861	Diflunisal	small molecule	approved|investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Phenols|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents|UGT1A9 Inhibitors
DB00862	Vardenafil	small molecule	approved	Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Imidazoles|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Urological Agents|Urologicals|Vasodilating Agents
DB00863	Ranitidine	small molecule	approved	Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Elements|Furans|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Metals|Metals, Heavy|Neurotransmitter Agents|OAT3/SLC22A8 Substrates|OCT2 Inhibitors|OCT2 Substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates
DB00864	Tacrolimus	small molecule	approved|investigational	Agents causing hyperkalemia|Agents for Dermatitis, Excluding Corticosteroids|Anti-Bacterial Agents|Antineoplastic and Immunomodulating Agents|Calcineurin Inhibitor Immunosuppressant|Calcineurin Inhibitors|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dermatologicals|Enzyme Inhibitors|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Lactones|Misc. Skin and Mucous Membrane Agents|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Polyketides
DB00865	Benzphetamine	small molecule	approved|illicit	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Appetite Suppression|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Increased Sympathetic Activity|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetic Amine Anorectic|Sympathomimetics
DB00866	Alprenolol	small molecule	experimental|withdrawn	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sympatholytics
DB00867	Ritodrine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Ethylamines|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Reproductive Control Agents|Sympathomimetics|Sympathomimetics, Labour Repressants|Tocolytic Agents
DB00868	Benzonatate	small molecule	approved	Amines|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Decreased Tracheobronchial Stretch Receptor Activity|Non-narcotic Antitussive|Respiratory System Agents
DB00869	Dorzolamide	small molecule	approved	Amides|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Carbonic Anhydrase Inhibitors|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diuretics|Enzyme Inhibitors|Ophthalmologicals|Sensory Organs|Sulfones|Sulfur Compounds
DB00870	Suprofen	small molecule	approved|withdrawn	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents|UGT1A1 Substrates
DB00871	Terbutaline	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cholinesterase Inhibitors|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics|Tocolytic Agents
DB00872	Conivaptan	small molecule	approved|investigational	Antidiuretic Hormone Receptor Antagonists|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Diuretics|Hypotensive Agents|Natriuretic Agents|P-glycoprotein/ABCB1 Inhibitors
DB14596	Loteprednol etabonate	small molecule	approved	Adrenal Cortex Hormones|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Corticosteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Immunosuppressive Agents|Steroids
DB00874	Guaifenesin	small molecule	approved|investigational|vet_approved	Benzene Derivatives|Catechols|Cough and Cold Preparations|Ethers|Expectorants|Guaiacol|Methyl Ethers|Phenols|Phenyl Ethers|Respiratory System Agents
DB00875	Flupentixol	small molecule	approved|investigational|withdrawn	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperazines|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes
DB00876	Eprosartan	small molecule	approved	Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Cardiovascular Agents|Hypotensive Agents|Sulfur Compounds
DB00877	Sirolimus	small molecule	approved|investigational	Agents causing angioedema|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Antifungal Agents|Antineoplastic and Immunomodulating Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Decreased Immunologic Activity|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Kinase Inhibitor|Lactones|Macrolides|mTOR Inhibitor Immunosuppressant|mTOR Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Polyketides|Protein Kinase Inhibitors|Selective Immunosuppressants|Sensory Organs
DB00878	Chlorhexidine	small molecule	approved|vet_approved	Aerosols|Alimentary Tract and Metabolism|Amidines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Biguanides|Biguanides and Amidines|Biomedical and Dental Materials|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Cosmetics|Decreased Cell Wall Integrity|Dental Agents|Dermatologicals|Disinfectants|Guanidines|Household Products|Irrigating Solutions|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Anti-infectives|Miscellaneous Local Anti-infectives|Mouthwashes|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Sensory Organs|Stomatological Preparations|Throat Preparations
DB00879	Emtricitabine	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Cytidine|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides
DB00880	Chlorothiazide	small molecule	approved|vet_approved	Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB00881	Quinapril	small molecule	approved|investigational	ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|Isoquinolines|OAT3/SLC22A8 Substrates|Protease Inhibitors
DB00882	Clomifene	small molecule	approved|investigational	Benzene Derivatives|Benzylidene Compounds|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Estrogen Agonist-antagonists|Estrogen Agonist/Antagonist|Estrogen Antagonists|Estrogen Receptor Modulators|Fertility Agents|Fertility Agents, Female|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Ovulation Stimulants, Synthetic|P-glycoprotein/ABCB1 Substrates|Reproductive Control Agents|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|Stilbenes
DB00883	Isosorbide dinitrate	small molecule	approved|investigational	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Isosorbide|Methemoglobinemia Associated Agents|Nitrate Vasodilator|Nitrates and Nitrites|Nitric Oxide Donors|Organic Nitrates|Sorbitol|Sugar Alcohols|Vasodilating Agents|Vasodilation|Vasodilators Used in Cardiac Diseases|Vasoprotectives
DB00884	Risedronate	small molecule	approved|investigational	Bisphosphonates|Bone Density Conservation Agents|Cardiovascular Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Membrane Transport Modulators|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds
DB00885	Pemirolast	small molecule	approved|investigational	Decreased Histamine Release|Histamine Agents|Mast Cell Stabilizers|Neurotransmitter Agents|Ophthalmics|Pyrimidines
DB00886	Omapatrilat	small molecule	investigational	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Azepines|Cardiovascular Agents|Enzyme Inhibitors|Metalloendopeptidases, antagonists & inhibitors|Protease Inhibitors|Sulfur Compounds|Thiepins
DB00887	Bumetanide	small molecule	approved	Acids, Carbocyclic|Amides|Aminobenzoates|Benzene Derivatives|Benzoates|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|High-Ceiling Diuretics|High-Ceiling Diuretics and Potassium-Sparing Agents|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Membrane Transport Modulators|meta-Aminobenzoates|Natriuretic Agents|Non Potassium Sparing Diuretics|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB00888	Mechlorethamine	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cholinesterase Inhibitors|Hydrocarbons, Halogenated|Immunosuppressive Agents|Irritants|Mustard Compounds|Myelosuppressive Agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Poisons|Toxic Actions
DB00889	Granisetron	small molecule	approved|investigational	Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gastrointestinal Agents|Indazoles|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Pyrazoles|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB00890	Dienestrol	small molecule	approved|investigational	Benzene Derivatives|Estrogens|Estrogens, Non-Steroidal|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phenols|Sex Hormones and Modulators of the Genital System|Synthetic Estrogens, Plain
DB00891	Sulfapyridine	small molecule	approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB00892	Oxybuprocaine	small molecule	approved|investigational	Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cholinesterase substrates|Dermatologicals|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents
DB00893	Iron Dextran	small molecule	approved|vet_approved	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Dextrans|Ferric Compounds|Glucans|Hematinics|Hematologic Agents|Iron Compounds|Macromolecular Substances|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Polymers|Polysaccharides|Supplements
DB00894	Testolactone	small molecule	approved|investigational	Androstadienes|Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Aromatase Inhibitors|Homosteroids|Steroids
DB00895	Benzylpenicilloyl Polylysine	small molecule	approved	Acetamides|Acetates|Acids, Acyclic|Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Benzene Derivatives|beta-Lactams|Drug Hypersensitivity|Fatty Acids|Fatty Acids, Volatile|Lactams|Lipids|Penicillins|Sulfur Compounds
DB00896	Rimexolone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnanes|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00897	Triazolam	small molecule	approved|investigational	Adjuvants, Anesthesia|Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB00898	Ethanol	small molecule	approved	Alcohols|Anti-Infective Agents|Anti-Infective Agents, Local|Antidotes|Antiseptics and Disinfectants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (moderate)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Ethanol|Miscellaneous Local Anti-infectives|Miscellaneous Therapeutic Agents|Nerve Depressants|Neurotoxic agents|NMDA Receptor Antagonists|Solvents
DB00899	Remifentanil	small molecule	approved	Agents producing tachycardia|Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Hypotensive Agents|Narcotics|Nervous System|Opiate Agonists|Opioid Agonist|Opioid Anesthetics|Opioids|Opioids, Anilidopiperidine|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00900	Didanosine	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Inosine|Neurotoxic agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Purine Nucleosides|Purines|Reverse Transcriptase Inhibitors|Ribonucleosides|Toxic Actions
DB00901	Bitolterol	small molecule	withdrawn	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB00902	Methdilazine	small molecule	approved	Agents that reduce seizure threshold|Antihistamines for Systemic Use|Histamine Antagonists|Histamine H1 Antagonists|Phenothiazine Derivatives|Sulfur Compounds
DB00903	Etacrynic acid	small molecule	approved|investigational	Acetates|Acids, Acyclic|Agents that produce neuromuscular block (indirect)|Aryloxyacetic Acid Derivatives|Cardiovascular Agents|Diuretics|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Glycolates|High-Ceiling Diuretics|Hydroxy Acids|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis at Loop of Henle|Lipids|Natriuretic Agents|Non Potassium Sparing Diuretics|Ototoxic agents|Phenoxyacetates|Sodium Potassium Chloride Symporter Inhibitors
DB00904	Ondansetron	small molecule	approved	Alimentary Tract and Metabolism|Anti-Anxiety Agents|Antiemetics|Antiemetics and Antinauseants|Antipruritics|Autonomic Agents|Carbazoles|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Gastrointestinal Agents|Imidazoles|Indoles|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB00905	Bimatoprost	small molecule	approved|investigational	Amides|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Cloprostenol|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Ophthalmologicals|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic|Sensory Organs
DB00906	Tiagabine	small molecule	approved|investigational	Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Fatty Acid Derivatives|GABA Agents|GABA Agonists|Membrane Transport Modulators|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Piperidines|UGT1A1 Substrates
DB00907	Cocaine	small molecule	approved|illicit	Agents producing tachycardia|Agents that reduce seizure threshold|Alkaloids|Analgesics and Anesthetics|Anesthetics|Anesthetics, Local|Anticholinergic Agents|Aza Compounds|Azabicyclo Compounds|Cardiovascular Agents|Central Nervous System Agents|Cholinesterase substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Uptake Inhibitors|Esters of Benzoic Acid|Highest Risk QTc-Prolonging Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|OCT2 Inhibitors|Ophthalmologicals|Otologicals|Peripheral Nervous System Agents|QTc Prolonging Agents|Sensory Organs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Throat Preparations|Tropanes|Vasoconstrictor Agents
DB00908	Quinidine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that produce neuromuscular block (indirect)|Agents that reduce seizure threshold|Alkaloids|Anti-Infective Agents|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Anticholinergic Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Biological Products|Biomedical and Dental Materials|Biopolymers|BSEP/ABCB11 Inhibitors|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Chemically-Induced Disorders|Cholinergic Agents|Cinchona Alkaloids|Complex Mixtures|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Macromolecular Substances|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Polymers|Polysaccharides|QTc Prolonging Agents|Quinolines|Quinuclidines|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB00909	Zonisamide	small molecule	approved|investigational	Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Antioxidants|Bradycardia-Causing Agents|Calcium Channel Blockers|Carbonic Anhydrase Inhibitors|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Nervous System|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Sulfonamides|UGT1A1 Substrates
DB00910	Paricalcitol	small molecule	approved|investigational	Anti-Parathyroid Agents|Bone Density Conservation Agents|Calcium Homeostasis|Cholestanes|Cholestenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB00911	Tinidazole	small molecule	approved|investigational	Alimentary Tract and Metabolism|Alkylating Drugs|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antitrichomonal Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Nitro Compounds|Nitroimidazole Antimicrobial|Nitroimidazole Derivatives|Nitroimidazoles|Noxae|Toxic Actions
DB00912	Repaglinide	small molecule	approved|investigational	Acids, Acyclic|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Diabetes|Glinide|Hypoglycemia-Associated Agents|Meglitinides|OATP1B1/SLCO1B1 Substrates|Oral Hypoglycemics|Potassium Channel Antagonists|Stereoisomerism
DB00913	Anileridine	small molecule	approved|illicit	Anesthetics|Anesthetics, General|Nervous System|Opioid Anesthetics|Piperidines
DB00914	Phenformin	small molecule	approved|investigational|withdrawn	Alimentary Tract and Metabolism|Amidines|Biguanides|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2D6 Substrates|Drugs Used in Diabetes|Guanidines|Indoles|OCT2 Inhibitors|Oral Hypoglycemics
DB00915	Amantadine	small molecule	approved	Adamantane|Adamantane Derivatives|Adamantanes|Analgesics|Analgesics, Non-Narcotic|Anti-Dyskinesia Agents|Anti-Infective Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Antiviral Agents|Central Nervous System Agents|Cycloparaffins|Dopamine Agents|Influenza A M2 Protein Inhibitor|M2 Protein Inhibitors|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|NMDA Receptor Antagonists|OCT2 Inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00916	Metronidazole	small molecule	approved	Agents that reduce seizure threshold|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antifungal Agents (Vaginal)|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Miscellaneous Antiprotozoals|Miscellaneous Local Anti-infectives|Nitro Compounds|Nitroimidazole Antimicrobial|Nitroimidazole Derivatives|Nitroimidazoles|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Radiation-Sensitizing Agents|Stomatological Preparations|UGT1A1 Substrates
DB00917	Dinoprostone	small molecule	approved	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|OCT2 Inhibitors|Prostaglandins|Prostaglandins E|Prostaglandins, Synthetic|Reproductive Control Agents|Uterotonic agents
DB00918	Almotriptan	small molecule	approved|investigational	Agents that produce hypertension|Amines|Analgesics|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Indoles|Migraine Disorders|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans
DB00919	Spectinomycin	small molecule	approved|investigational|vet_approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Dioxanes|Dioxins|Glycosides
DB00920	Ketotifen	small molecule	approved	Anti-Allergic Agents|Antihistamine Drugs|Antihistamines for Systemic Use|Antipruritics|Decongestants and Antiallergics|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Inhibitors|Neurotransmitter Agents|Ophthalmologicals|Other Antihistamines|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Sulfur Compounds|Thiophenes
DB00921	Buprenorphine	small molecule	approved|illicit|investigational|vet_approved	Alkaloids|Analgesics|BCRP/ABCG2 Inhibitors|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Mixed Agonist / Antagonist Opioids|Morphinans|Narcotics|Nervous System|Opiate Alkaloids|Opiate Partial Agonists|Opioid Antagonists|Opioids|Oripavine Derivatives|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A1 Substrates|UGT1A9 Substrates
DB00922	Levosimendan	small molecule	approved|investigational	Antiarrhythmic agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Hydrazines|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Phosphodiesterase Inhibitors|Protective Agents|QTc Prolonging Agents|Vasodilating Agents
DB00923	Ceforanide	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB00924	Cyclobenzaprine	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dibenzocycloheptenes|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Narrow Therapeutic Index Drugs|Neurotoxic agents|Peripheral Nervous System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tranquilizing Agents|UGT1A1 Substrates
DB00925	Phenoxybenzamine	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amines|Antihypertensive Agents|Cardiovascular Agents|Ethylamines|Hypotensive Agents|Neurotransmitter Agents|OCT2 Inhibitors|Peripheral Vasodilators|Vasodilating Agents
DB00926	Etretinate	small molecule	withdrawn	Alkenes|Antipsoriatics|Antipsoriatics for Systemic Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Hydrocarbons, Acyclic|Keratolytic Agents|Pigments, Biological|Polyenes|Retinoids|Retinoids for Treatment of Psoriasis|Terpenes
DB00927	Famotidine	small molecule	approved	Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OCT2 Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Thiazoles
DB00928	Azacitidine	small molecule	approved|investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aza Compounds|Carbohydrates|Cytidine|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions
DB00929	Misoprostol	small molecule	approved	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Autacoids|Biological Factors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Musculo-Skeletal System|Propionates|Prostaglandin E1 Analog|Prostaglandins|Prostaglandins E, Synthetic|Prostaglandins, Synthetic|Reproductive Control Agents|Uterotonic agents
DB00930	Colesevelam	small molecule	approved	Alkenes|Allyl Compounds|Allylamine|Amines|Anticholesteremic Agents|Bile Acid Sequestrants|Bile-acid Binding Activity|Hydrocarbons, Acyclic|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|Toxic Actions
DB00931	Metacycline	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines
DB00932	Tipranavir	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protease Inhibitors|Pyrans|UGT1A1 Inducers
DB00933	Mesoridazine	small molecule	approved|investigational	Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperidine Structure|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB00934	Maprotiline	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that reduce seizure threshold|Anthracenes|Anticholinergic Agents|Antidepressive Agents, Second-Generation|Antidepressive Agents, Tetracyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB00935	Oxymetazoline	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Cardiovascular Agents|Decongestants and Antiallergics|Imidazoles|Increased Sympathetic Activity|Nasal Decongestants|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Respiratory System Agents|Sensory Organs|Sympathomimetics|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstriction|Vasoconstrictor Agents
DB00936	Salicylic acid	small molecule	approved|investigational|vet_approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Dermatologicals|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Keratolytic Agents|Nephrotoxic agents|Nervous System|Nitrogen Binding Agent|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Peripheral Nervous System Agents|Phenols|Salicylates|Salicylic Acid|Salicylic Acid and Derivatives|Sclerosing Solutions|Sensory Organs|Sensory System Agents
DB00937	Diethylpropion	small molecule	approved|illicit	Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Amphetamines|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Appetite Suppression|Central Nervous System Agents|Centrally Acting Antiobesity Products|Ethylamines|Increased Sympathetic Activity|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Stimulants|Sympathomimetic Amine Anorectic|Sympathomimetics
DB00938	Salmeterol	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Albuterol|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Ethanolamines|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetic (Adrenergic) Agents
DB00939	Meclofenamic acid	small molecule	approved|vet_approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|ortho-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB00940	Methantheline	small molecule	approved|investigational	Acid Reducers|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Gastric Acid Lowering Agents|Histamine Antagonists|Histamine H2 Antagonists|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB00941	Hexafluronium	small molecule	approved	Amines|Ammonium Compounds|Bis-Trimethylammonium Compounds|Central Nervous System Depressants|Cholinesterase Inhibitors|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds
DB00942	Cycrimine	small molecule	approved	Agents producing tachycardia|Anticholinergic Agents|Muscarinic Antagonists
DB00943	Zalcitabine	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antimetabolites|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Cytidine|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors|Ribonucleosides|Toxic Actions
DB00944	Demecarium	small molecule	approved	Amines|Ammonium Compounds|Antiglaucoma Preparations and Miotics|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Ophthalmologicals|Parasympathomimetics|Sensory Organs
DB00945	Acetylsalicylic acid	small molecule	approved|vet_approved	Acids, Carbocyclic|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Anticoagulants|Antiinflammatory and Antirheumatic Products|Antiplatelet agents|Antipyretics|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Cardiovascular Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inducers|Decreased Platelet Aggregation|Decreased Prostaglandin Production|Enzyme Inhibitors|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydroxy Acids|Hydroxybenzoates|Lipid Modifying Agents|Musculo-Skeletal System|Nephrotoxic agents|Nervous System|Nonsteroidal Anti-inflammatory Compounds|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenols|Platelet Aggregation Inhibitors Excl. Heparin|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents|Stomatological Preparations
DB00946	Phenprocoumon	small molecule	approved|investigational	4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|Narrow Therapeutic Index Drugs|Pyrans|Vitamin K Antagonists|Vitamin K Inhibitors
DB00947	Fulvestrant	small molecule	approved|investigational	Anti-Estrogens|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Endocrine Therapy|Estradiol Congeners|Estranes|Estrenes|Estrogen Antagonists|Estrogen Receptor Antagonists|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators|Steroids|UGT1A1 Substrates
DB00948	Mezlocillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB00949	Felbamate	small molecule	approved	Acids, Acyclic|Alcohols|Anti-epileptic Agent|Anticonvulsants|Carbamates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Glycols|Nervous System|Neuroprotective Agents|NMDA Receptor Antagonists|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB00950	Fexofenadine	small molecule	approved|investigational	Anti-Allergic Agents|Antihistamines for Systemic Use|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperidines|QTc Prolonging Agents
DB00951	Isoniazid	small molecule	approved|investigational	Agents that reduce seizure threshold|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Treatment of Tuberculosis|Fatty Acid Synthesis Inhibitors|Hydrazides|Hydrazines|Hypolipidemic Agents|Isonicotinic Acids|Lipid Regulating Agents|Noxae|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Toxic Actions
DB00952	Naratriptan	small molecule	approved|investigational	Agents that produce hypertension|Amines|Analgesics|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Cardiovascular Agents|Central Nervous System Depressants|Indoles|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans|Vasoconstrictor Agents
DB00953	Rizatriptan	small molecule	approved	Agents that produce hypertension|Amines|Analgesics|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Indoles|Migraine Disorders|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans
DB00954	Dirithromycin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides
DB00955	Netilmicin	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Enzyme Inhibitors|Gentamicins|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmologicals|Protein Synthesis Inhibitors|Sensory Organs|Sisomicin
DB00956	Hydrocodone	small molecule	approved|illicit|investigational	Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Codeine|Cough and Cold Preparations|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Opioid Agonist|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB00957	Norgestimate	small molecule	approved|investigational	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB00958	Carboplatin	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cross-Linking Reagents|Immunosuppressive Agents|Indicators and Reagents|Laboratory Chemicals|Myelosuppressive Agents|Nephrotoxic agents|Organometallic Compounds|Platinum Compounds|Platinum-containing Compounds
DB00959	Methylprednisolone	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Inflammatory Agents|Antiemetics|Antineoplastic Agents|Autonomic Agents|Central Nervous System Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Weak (Group I)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Gastrointestinal Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Neuroprotective Agents|Ophthalmologicals|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Protective Agents|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB00960	Pindolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Vasodilating Agents
DB00961	Mepivacaine	small molecule	approved|vet_approved	Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Central Nervous System Agents|Local Anesthesia|Nervous System|Peripheral Nervous System Agents|Piperidines|Sensory System Agents
DB00962	Zaleplon	small molecule	approved|illicit|investigational	Acetates|Acids, Acyclic|Amides|Anticonvulsants|Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Depression|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|GABA Modulators|GABA-A Receptor Agonists|gamma-Aminobutyric Acid A Receptor Agonist|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Lipids|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Neurotransmitter Agents|Psycholeptics
DB00963	Bromfenac	small molecule	approved	Agents causing hyperkalemia|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Cyclooxygenase Inhibitors|Hydrocarbons, Brominated|Hydrocarbons, Halogenated|Ketones|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Ophthalmologicals|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory Organs|Sensory System Agents
DB00964	Apraclonidine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Antiglaucoma Preparations and Miotics|Cytochrome P-450 CYP2D6 Substrates|EENT Drugs, Miscellaneous|Hypotensive Agents|Imidazoles|Imidazolines|Neurotransmitter Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Sympathomimetics in Glaucoma Therapy
DB00965	Ethiodized oil	small molecule	approved|investigational	Biological Products|Complex Mixtures|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodized Oil|Lipids|Oils|Plant Oils|Plant Preparations|Radiographic Contrast Agent|Roentgenography|X-Ray Contrast Activity
DB00966	Telmisartan	small molecule	approved|investigational	Acids, Carbocyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|P-glycoprotein/ABCB1 Inhibitors
DB00967	Desloratadine	small molecule	approved|investigational	Anticholinergic Agents|Antihistamines for Systemic Use|Benzocycloheptenes|Central Nervous System Depressants|Cholinergic Agents|Cyproheptadine|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dibenzocycloheptenes|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Piperidines|QTc Prolonging Agents
DB00968	Methyldopa	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antihypertensive Agents|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bradycardia-Causing Agents|Cardiovascular Agents|Catecholamines|Central alpha-2 Adrenergic Agonist|Central Alpha-agonists|COMT Substrates|Dihydroxyphenylalanine|Hypotensive Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenylalanine|Sympatholytics|Tyrosine
DB00969	Alosetron	small molecule	approved|withdrawn	Alimentary Tract and Metabolism|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Indoles|Neurotransmitter Agents|Pyridines|Serotonin 3 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB00970	Dactinomycin	small molecule	approved|investigational	Actinomycin|Actinomycines|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors
DB00971	Selenium Sulfide	small molecule	approved	Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals
DB00972	Azelastine	small molecule	approved	Anti-Allergic Agents|Anti-Asthmatic Agents|Antiallergic Agents, Excl. Corticosteroids|Antihistamines for Systemic Use|Autonomic Agents|Bronchodilator Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decongestants and Antiallergics|Enzyme Inhibitors|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Lipoxygenase Inhibitors|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Pyridazines|QTc Prolonging Agents|Respiratory System Agents|Sensory Organs
DB00973	Ezetimibe	small molecule	approved	Anticholesteremic Agents|Azetidines|Azetines|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cholesterol Absorption Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Decreased Cholesterol Absorption|Dietary Cholesterol Absorption Inhibitor|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Substrates|Toxic Actions|UGT1A1 Substrates
DB00974	Edetic Acid	small molecule	approved|vet_approved	Acetates|Acids, Acyclic|Amines|Anticoagulants|Calcium Chelating Activity|Calcium Chelating Agents|Chelating Agents|Decreased Coagulation Factor Activity|Diamines|Diet, Food, and Nutrition|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Food|Food Additives|Food and Beverages|Heavy Metal Antagonists|Hematologic Agents|Lead Chelating Activity|Lead Chelator|Physiological Phenomena|Polyamines|Sequestering Agents
DB00975	Dipyridamole	small molecule	approved	Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|BSEP/ABCB11 Substrates|Cardiovascular Agents|Decreased Platelet Aggregation|Enzyme Inhibitors|Hematologic Agents|Hypotensive Agents|Miscellaneous Vasodilatating Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Platelet Aggregation Inhibitors Excl. Heparin|Pyrimidines|Vasodilating Agents
DB00976	Telithromycin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Erythromycin|Ketolide Antibacterial|Ketolides|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Polyketides|Protein Synthesis Inhibitors|QTc Prolonging Agents|RNA, Ribosomal, 23S
DB00977	Ethinylestradiol	small molecule	approved	Adrenal Cortex Hormones|Antineoplastic and Immunomodulating Agents|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Postcoital|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Estradiol Congeners|Estrogen Contraceptives|Estrogenic Steroids, Alkylated|Estrogens|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Natural and Semisynthetic Estrogens, Plain|Norpregnanes|Norpregnatrienes|Norsteroids|P-glycoprotein/ABCB1 Substrates|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids|UGT1A1 Inducers|UGT1A1 Substrates
DB00978	Lomefloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|QTc Prolonging Agents|Quinolines|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00979	Cyclopentolate	small molecule	approved	Acids, Carbocyclic|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Cholinesterase substrates|Muscarinic Antagonists|Mydriatics|Mydriatics and Cycloplegics|Neurotransmitter Agents|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Sensory Organs
DB00980	Ramelteon	small molecule	approved|investigational	Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics and Sedatives|Melatonin Receptor Agonists|Nervous System|Psycholeptics
DB00981	Physostigmine	small molecule	approved|investigational	Acids, Acyclic|Alkaloids|Antidotes|Antiglaucoma Preparations and Miotics|Autonomic Agents|Carbamates|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Indole Alkaloids|Indoles|Miotics|Neurotransmitter Agents|Ophthalmologicals|Parasympathomimetics|Peripheral Nervous System Agents|Phenylcarbamates|Sensory Organs
DB00982	Isotretinoin	small molecule	approved	Alkenes|Anti-Acne Preparations|Anti-Acne Preparations for Systemic Use|Anti-Acne Preparations for Topical Use|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Hydrocarbons, Acyclic|Misc. Skin and Mucous Membrane Agents|Narrow Therapeutic Index Drugs|Noxae|Pigments, Biological|Polyenes|Retinoids|Retinoids for Topical Use in Acne|Retinoids for Treatment of Acne|Teratogens|Terpenes|Toxic Actions
DB00983	Formoterol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB00984	Nandrolone phenpropionate	small molecule	approved|illicit|investigational	Anabolic Agents|Androgens|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nandrolone|Steroids|Testosterone Congeners
DB00985	Dimenhydrinate	small molecule	approved	Alkaloids|Amines|Antiemetics|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Diphenhydramine|Ethylamines|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Purines|Purinones|QTc Prolonging Agents
DB00986	Glycopyrronium	small molecule	approved|investigational|vet_approved	Adjuvants, Anesthesia|Adrenergics, Inhalants|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Antimuscarinics Antispasmodics|Central Nervous System Agents|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Pyrrolidines|Quaternary Ammonium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB00987	Cytarabine	small molecule	approved|investigational	Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Arabinonucleosides|Carbohydrates|Cardiotoxic antineoplastic agents|Cytidine|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Glycosides|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|P-glycoprotein/ABCB1 Substrates|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions
DB00988	Dopamine	small molecule	approved	Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|COMT Substrates|Dopamine Agents|Neurotransmitter Agents|OCT2 Inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Protective Agents|Selective Beta 1-adrenergic Agonists|Sympathomimetics
DB00989	Rivastigmine	small molecule	approved|investigational	Acids, Acyclic|Anti-Dementia Drugs|Bradycardia-Causing Agents|Carbamates|Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Parasympathomemetic (Cholinergic) Agents|Phenylcarbamates|Protective Agents|Psychoanaleptics
DB00990	Exemestane	small molecule	approved|investigational	Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Steroids
DB00991	Oxaprozin	small molecule	approved	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents
DB00992	Methyl aminolevulinate	small molecule	approved|investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Keto Acids|Levulinic Acids|Misc. Skin and Mucous Membrane Agents|Porphyrin Precursor|Sensitizers Used in Photodynamic/radiation Therapy
DB00993	Azathioprine	small molecule	approved	Antimetabolites|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytochrome P-450 CYP1A2 Substrates|Glycosides|Immunologic Factors|Immunosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleosides|Purine Antimetabolite|Purines|Sulfhydryl Compounds|Sulfur Compounds|Thionucleosides|Thiopurine Analogs|Toxic Actions
DB00994	Neomycin	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Dermatologicals|Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Irrigating Solutions|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|Protein Synthesis Inhibitors|Sensory Organs|Stomatological Preparations|Throat Preparations
DB00995	Auranofin	small molecule	approved|investigational	Antiinflammatory and Antirheumatic Products|Aurothioglucose|Gold Compounds|Gold Preparations|Musculo-Skeletal System|Organogold Compounds|Organometallic Compounds|Specific Antirheumatic Agents
DB00996	Gabapentin	small molecule	approved|investigational	Acids, Acyclic|Acids, Carbocyclic|Agents causing hyperkalemia|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Analgesics|Anti-Anxiety Agents|Anti-Dyskinesia Agents|Anti-epileptic Agent|Anti-Parkinson Drugs|Antiarrhythmic agents|Anticonvulsants|Antimanic Agents|Bradycardia-Causing Agents|Butyrates|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Fatty Acids|Fatty Acids, Volatile|Lipids|Membrane Transport Modulators|Miscellaneous Anticonvulsants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Tranquilizing Agents
DB00997	Doxorubicin	small molecule	approved|investigational	Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytotoxic Antibiotics and Related Substances|Daunorubicin|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB00998	Frovatriptan	small molecule	approved|investigational	Agents that produce hypertension|Amines|Analgesics|Antimigraine Preparations|Biogenic Amines|Biogenic Monoamines|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Indoles|Migraine Disorders|Nervous System|Neurotransmitter Agents|Selective Serotonin 5-HT1 Receptor Agonists|Selective Serotonin Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 1b Receptor Agonists|Serotonin 1d Receptor Agonists|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin-1b and Serotonin-1d Receptor Agonist|Triptans
DB00999	Hydrochlorothiazide	small molecule	approved|vet_approved	Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Chlorothiazide|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Hypotensive Agents|Increased Diuresis|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Non Potassium Sparing Diuretics|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB01000	Cyclacillin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillins|Sulfur Compounds
DB01001	Salbutamol	small molecule	approved|vet_approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Ethanolamines|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetic (Adrenergic) Agents|Tocolytic Agents
DB01002	Levobupivacaine	small molecule	approved|investigational	Amides|Anesthetics|Anesthetics, Local|Anilides|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Nervous System|Peripheral Nervous System Agents|Pipecolic Acids|Piperidines|Sensory System Agents
DB01003	Cromoglicic acid	small molecule	approved	Adrenergics, Inhalants|Agents for Dermatitis, Excluding Corticosteroids|Alimentary Tract and Metabolism|Anti-Allergic Agents|Anti-Asthmatic Agents|Antiallergic Agents, Excl. Corticosteroids|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzopyrans|Chromones|Decongestants and Antiallergics|Decreased Histamine Release|Dermatologicals|Drugs for Obstructive Airway Diseases|Intestinal Antiinflammatory Agents|Mast Cell Stabilizers|Mast-cell Stabilizers|Nasal Preparations|Ophthalmologicals|Pyrans|Respiratory System Agents|Sensory Organs
DB01004	Ganciclovir	small molecule	approved|investigational	Acyclovir|Agents that reduce seizure threshold|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|Direct Acting Antivirals|Guanine|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleoside Analog Antiviral|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|OAT3/SLC22A8 Inhibitors|Ophthalmologicals|Purines|Purinones|Sensory Organs
DB01005	Hydroxyurea	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antisickling Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hematologic Agents|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|P-glycoprotein/ABCB1 Substrates|Urea
DB01006	Letrozole	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors
DB01007	Tioconazole	small molecule	approved	14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Steroid Synthesis Inhibitors
DB01008	Busulfan	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Butylene Glycols|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Glycols|Hydrocarbons, Acyclic|Immunologic Factors|Immunosuppressive Agents|Mesylates|Myeloablative Agonists|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|Noxae|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Toxic Actions
DB01009	Ketoprofen	small molecule	approved|vet_approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|OAT3/SLC22A8 Inhibitors|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates
DB01010	Edrophonium	small molecule	approved	Amines|Ammonium Compounds|Antidotes|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Phenylammonium Compounds|Protective Agents|Quaternary Ammonium Compounds
DB01011	Metyrapone	small molecule	approved|investigational	Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Diagnostic Agents|Enzyme Inhibitors|Noxae|Pyridines|Steroid Synthesis Inhibitors|Tests for Pituitary Function|Toxic Actions
DB01012	Cinacalcet	small molecule	approved	Anti-Parathyroid Agents|Calcimimetic Agents|Calcium Homeostasis|Calcium-sensing Receptor Agonist|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Increased Calcium-sensing Receptor Sensitivity|Naphthalenes|Other Miscellaneous Therapeutic Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB01013	Clobetasol propionate	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Betamethasone|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB01014	Balsalazide	small molecule	approved|investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Aminobenzoates|Aminosalicylate|Aminosalicylic Acids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Colitis, Ulcerative|Gastrointestinal Agents|Hydrazines|Hydroxy Acids|Hydroxybenzoates|Inflammatory Bowel Diseases|Intestinal Antiinflammatory Agents|meta-Aminobenzoates|Nephrotoxic agents|Peripheral Nervous System Agents|Phenols|Prodrugs|Salicylates|Sensory System Agents
DB01015	Sulfamethoxazole	small molecule	approved	Agents causing hyperkalemia|Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C9 Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypoglycemia-Associated Agents|Intermediate-Acting Sulfonamides|Methemoglobinemia Associated Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds|UGT1A9 Substrates
DB01016	Glyburide	small molecule	approved	Alimentary Tract and Metabolism|BCRP/ABCG2 Substrates|Blood Glucose Lowering Agents|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Oral Hypoglycemics|P-glycoprotein/ABCB1 Inhibitors|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|Urea
DB01017	Minocycline	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Naphthacenes|OAT3/SLC22A8 Inhibitors|Stomatological Preparations|Tetracyclines
DB01018	Guanfacine	small molecule	approved|investigational	Acids, Carbocyclic|Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amidines|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Central alpha-2 Adrenergic Agonist|Central Alpha-agonists|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Guanidines|Hypotensive Agents|Imidazoline Receptor Agonists|Neurotransmitter Agents|Phenylacetates
DB01019	Bethanechol	small molecule	approved	Amines|Ammonium Compounds|Autonomic Agents|Bethanechol Compounds|Choline Esters|Cholinergic Agents|Cholinergic Agonists|Muscarinic Agonists|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB01020	Isosorbide Mononitrate	small molecule	approved	Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Delayed-Action Preparations|Hypotensive Agents|Isosorbide|Methemoglobinemia Associated Agents|Nitrate Vasodilator|Nitrates and Nitrites|Nitric Oxide Donors|Organic Nitrates|Sorbitol|Sugar Alcohols|Vasodilating Agents|Vasodilation|Vasodilators Used in Cardiac Diseases
DB01021	Trichlormethiazide	small molecule	approved|vet_approved	Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Chlorothiazide|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrochlorothiazide|Hyperglycemia-Associated Agents|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB01022	Phylloquinone	small molecule	approved|investigational	Antifibrinolytic Agents|Blood and Blood Forming Organs|Coagulants|Diet, Food, and Nutrition|Diterpenes|Fibrin Modulating Agents|Food|Food and Beverages|Growth Substances|Hematologic Agents|Hemostatics|Increased Prothrombin Activity|Micronutrients|Naphthalenes|Naphthoquinones|Physiological Phenomena|Phytol|Quinones|Reversed Anticoagulation Activity|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble)|Warfarin Reversal Agent
DB01023	Felodipine	small molecule	approved|investigational	ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB01024	Mycophenolic acid	small molecule	approved	Acids, Acyclic|Antibiotics, Antineoplastic|Antimetabolite Immunosuppressant|Antineoplastic and Immunomodulating Agents|Caproates|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Immunologic Factors|Immunosuppressive Agents|IMP Dehydrogenase, antagonists & inhibitors|Lipids|Narrow Therapeutic Index Drugs|Selective Immunosuppressants|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates
DB01025	Amlexanox	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amines|Anti-Allergic Agents|Decreased Histamine Release|Drugs for Obstructive Airway Diseases|Ophthalmic Solutions|Pyridines|Stomatological Preparations
DB01026	Ketoconazole	small molecule	approved|investigational	14-alpha Demethylase Inhibitors|Agents causing hyperkalemia|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A5 Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|UGT1A1 Inhibitors
DB01028	Methoxyflurane	small molecule	approved|investigational|vet_approved	Agents that produce hypertension|Analgesics|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethers|Ethyl Ethers|Methyl Ethers|Miscellaneous Analgesics and Antipyretics|Nervous System
DB01029	Irbesartan	small molecule	approved|investigational	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Benzene Derivatives|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents
DB01030	Topotecan	small molecule	approved|investigational	Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Camptothecin|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Substrates|MATE inhibitors|MATE substrates|Myelosuppressive Agents|P-glycoprotein/ABCB1 Substrates|Topoisomerase I Inhibitors|Topoisomerase Inhibitors
DB01031	Ethinamate	small molecule	approved|illicit|withdrawn	Acids, Acyclic
DB01032	Probenecid	small molecule	approved|investigational	Adjuvants, Pharmaceutic|Amides|Antigout Preparations|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Musculo-Skeletal System|OAT3/SLC22A8 Inhibitors|OCT2 Inhibitors|Pharmaceutic Aids|Pharmaceutical Preparations|Preparations Increasing Uric Acid Excretion|Renal Agents|Sulfonamides|Sulfones|Sulfur Compounds|UGT1A1 Inhibitors|Uricosuric Agents
DB01033	Mercaptopurine	small molecule	approved	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleoside Metabolic Inhibitor|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Purine Analogues|Purines|Sulfhydryl Compounds|Sulfur Compounds|Thiopurine Analogs|Toxic Actions
DB01034	Cerulenin	small molecule	experimental	Amides|Anti-Infective Agents|Antifungal Agents|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions
DB01035	Procainamide	small molecule	approved	Acids, Carbocyclic|Agents that produce neuromuscular block (indirect)|Amides|Aminobenzoates|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Cardiac Therapy|Cardiovascular Agents|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Highest Risk QTc-Prolonging Agents|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|OCT2 Inhibitors|para-Aminobenzoates|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01036	Tolterodine	small molecule	approved|investigational	Agents producing tachycardia|Alcohols|Amines|Amino Alcohols|Anticholinergic Agents|Benzene Derivatives|Benzhydryl Compounds|Cholinergic Agents|Cresols|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Genitourinary Smooth Muscle Relaxants|Muscarinic Antagonists|Neurotransmitter Agents|Phenols|Phenylpropanolamine|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Urological Agents|Urologicals
DB01037	Selegiline	small molecule	approved|investigational|vet_approved	Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Enzyme Inhibitors|Ethylamines|Hypotensive Agents|Monoamine Oxidase B Inhibitors|Monoamine Oxidase Inhibitors|Monoamine Oxidase-B Inhibitors|Nervous System|Neuroprotective Agents|P-glycoprotein/ABCB1 Inhibitors|Phenethylamines|Protective Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01038	Carphenazine	small molecule	withdrawn	Dopamine Antagonists|Dopamine D2 Receptor Antagonists
DB01039	Fenofibrate	small molecule	approved	Acids, Acyclic|Benzene Derivatives|Benzhydryl Compounds|Benzophenones|BSEP/ABCB11 Substrates|Butyrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Fribic Acid Derivatives|Hypolipidemic Agents|Isobutyrates|Ketones|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|P-glycoprotein/ABCB1 Inhibitors|Peroxisome Proliferator Receptor alpha Agonist|Peroxisome Proliferator-activated Receptor alpha Agonists|Phenols|Phenyl Ethers|Toxic Actions|UGT1A1 Substrates
DB01040	Hydroxystilbamidine Isethionate	small molecule	experimental	Antimycotic Agents
DB01041	Thalidomide	small molecule	approved|investigational|withdrawn	Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Decreased Immunologically Active Molecule Activity|Growth Inhibitors|Growth Substances|Hypotensive Agents|Imides|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|Isoindoles|Leprostatic Agents|Myelosuppressive Agents|Noxae|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Teratogens|Toxic Actions
DB01042	Melphalan	small molecule	approved	Alkylating Activity|Alkylating Drugs|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Hydrocarbons, Halogenated|Immunologic Factors|Immunosuppressive Agents|Mustard Compounds|Myeloablative Agonists|Myelosuppressive Agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|P-glycoprotein/ABCB1 Substrates|Phenylalanine|Toxic Actions
DB01043	Memantine	small molecule	approved|investigational	Adamantane|Amantadine|Anti-Dementia Drugs|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|Cholinesterase Inhibitors|Cycloparaffins|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (weak)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Miscellaneous Central Nervous System Agents|N-methyl-D-aspartate Receptor Antagonist|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|OCT2 Substrates|Psychoanaleptics
DB01044	Gatifloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Hypoglycemia-Associated Agents|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01045	Rifampicin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|BSEP/ABCB11 Inhibitors|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2A6 Inducers (moderate)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Drugs for Treatment of Tuberculosis|Enzyme Inhibitors|Lactams|Lactams, Macrocyclic|Leprostatic Agents|Narrow Therapeutic Index Drugs|Nucleic Acid Synthesis Inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OATP1B3 substrates|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Rifamycin Antibacterial|Rifamycins|UGT1A1 Inducers|UGT1A9 Inducers
DB01046	Lubiprostone	small molecule	approved|investigational	Alimentary Tract and Metabolism|Alprostadil|Autacoids|Biological Factors|Chloride Channel Agonists|Drugs for Constipation|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Inflammation Mediators|Laxatives|Lipids|Membrane Transport Modulators|Miscellaneous GI Drugs|Prostaglandins E
DB01047	Fluocinonide	small molecule	approved|investigational	Adrenal Cortex Hormones|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Fluocinolone Acetonide|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated
DB01048	Abacavir	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Reverse Transcriptase Inhibitors|UGT1A1 Substrates
DB01049	Ergoloid mesylate	small molecule	approved	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dihydroergotoxine|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Neurotransmitter Agents|Nootropic Agents|Peripheral Vasodilators|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sympatholytic (Adrenergic Blocking) Agents|Vasodilating Agents
DB01050	Ibuprofen	small molecule	approved	Acids, Carbocyclic|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiinflammatory Products for Vaginal Administration|Central Nervous System Agents|COX-1 Inhibitors|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|OAT3/SLC22A8 Inhibitors|Other Nonsteroidal Antiimflammatory Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents|Throat Preparations|Topical Products for Joint and Muscular Pain|UGT1A1 Substrates|UGT1A9 Substrates
DB01051	Novobiocin	small molecule	approved|investigational|vet_approved	Aminocoumarins|Anti-Bacterial Agents|Anti-Infective Agents|BCRP/ABCG2 Inhibitors|Benzopyrans|Carbohydrates|Coumarins|Enzyme Inhibitors|Glycosides|Nucleic Acid Synthesis Inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Pyrans
DB01053	Benzylpenicillin	small molecule	approved|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Lactams|Natural Penicillins|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Substrates|Ophthalmologicals|Penicillin G|Penicillins|Sensory Organs|Sulfur Compounds
DB01054	Nitrendipine	small molecule	approved|investigational	ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB01055	Mimosine	small molecule	experimental	Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Pyridines|Pyridones
DB01056	Tocainide	small molecule	approved	Amides|Anilides|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01057	Echothiophate	small molecule	approved	Antiglaucoma Preparations and Miotics|Autonomic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Miotics|Neurotransmitter Agents|Ophthalmologicals|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Parasympathomimetics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs|Sulfur Compounds
DB01058	Praziquantel	small molecule	approved|investigational|vet_approved	Anthelmintics|Anti-Infective Agents|Antihelminthic|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antitrematodals|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Isoquinolines|Quinoline Derivatives and Related Substances
DB01059	Norfloxacin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01060	Amoxicillin	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Amides|Aminopenicillins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB01061	Azlocillin	small molecule	approved	Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB01062	Oxybutynin	small molecule	approved|investigational	Acids, Carbocyclic|Agents producing tachycardia|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Urological Agents|Urologicals
DB01063	Acetophenazine	small molecule	approved	Antipsychotic Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Sulfur Compounds
DB01064	Isoprenaline	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Catecholamines|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Non-selective Beta-adrenergic Agonists|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Sympathomimetics
DB01065	Melatonin	small molecule	approved|nutraceutical|vet_approved	Amines|Antioxidants|Biogenic Amines|Biogenic Monoamines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypnotics and Sedatives|Indoles|Melatonin Receptor Agonists|Nervous System|OAT3/SLC22A8 Inhibitors|Protective Agents|Psycholeptics|Tryptamines
DB01066	Cefditoren	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB01067	Glipizide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Oral Hypoglycemics|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|UGT1A1 Substrates|Urea
DB01068	Clonazepam	small molecule	approved|illicit	Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents
DB01069	Promethazine	small molecule	approved|investigational	Acid Reducers|Agents producing tachycardia|Agents that reduce seizure threshold|Amines|Anti-Allergic Agents|Anticholinergic Agents|Antidotes|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Miscellaneous Anxiolytics Sedatives and Hypnotics|Muscarinic Antagonists|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Phenothiazine Derivatives|Phenothiazines|Potential QTc-Prolonging Agents|Propylamines|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sulfur Compounds
DB01070	Dihydrotachysterol	small molecule	approved	Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB01071	Mequitazine	small molecule	experimental	Anti-Allergic Agents|Antihistamines for Systemic Use|Bronchodilator Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Phenothiazine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds
DB01072	Atazanavir	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Cytochrome P450 3A4 Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Oligopeptides|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Potential QTc-Prolonging Agents|Protease Inhibitors|Pyridines|QTc Prolonging Agents|UDP Glucuronosyltransferases Inhibitors|UGT1A1 Inhibitors
DB01073	Fludarabine	small molecule	approved	Adenine Nucleotides|Adenosine|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Arabinonucleosides|Arabinonucleotides|Carbohydrates|Cardiotoxic antineoplastic agents|DNA (Cytosine-5-)-Methyltransferase, antagonists & inhibitors|Enzyme Inhibitors|Glycosides|Immunologic Factors|Immunosuppressive Agents|Myeloablative Agonists|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Nucleotides|Purine Analogues|Purine Nucleosides|Purine Nucleotides|Purines|Ribonucleosides|Ribonucleotides|Toxic Actions
DB01074	Perhexiline	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Non-Selective Calcium Channel Blockers|Piperidines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents
DB01075	Diphenhydramine	small molecule	approved|investigational	Agents producing tachycardia|Amines|Aminoalkyl Ethers|Anesthetics|Anesthetics, Local|Anti-Allergic Agents|Anticholinergic Agents|Antiemetics|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Ethanolamine Derivatives|Ethylamines|First Generation Antihistamines|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Muscarinic Antagonists|Neurotransmitter Agents|OCT2 Inhibitors|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sleep Aids, Pharmaceutical
DB01076	Atorvastatin	small molecule	approved	Anticholesteremic Agents|BSEP/ABCB11 Substrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fatty Acids|Heptanoic Acids|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Toxic Actions|UGT1A1 Substrates
DB01077	Etidronic acid	small molecule	approved	Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Miscellaneous Therapeutic Agents|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds
DB01078	Deslanoside	small molecule	approved	Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Digitalis Glycosides|Enzyme Inhibitors|Glycosides|Lanatosides|Protective Agents|Steroids
DB01079	Tegaserod	small molecule	approved|investigational|withdrawn	Alimentary Tract and Metabolism|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 4 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Serotonin-4 Receptor Antagonist
DB01080	Vigabatrin	small molecule	approved	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Anti-epileptic Agent|Anticonvulsants|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|GABA Agents|gamma-Aminobutyric Acid|Lipids|Miscellaneous Anticonvulsants|Nervous System|Neurotransmitter Agents
DB01081	Diphenoxylate	small molecule	approved|illicit	Alimentary Tract and Metabolism|Analgesics|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Isonipecotic Acids|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01082	Streptomycin	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Carbohydrates|Drugs for Treatment of Tuberculosis|Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Protein Synthesis Inhibitors|Streptomycins
DB01083	Orlistat	small molecule	approved|investigational	Alimentary Tract and Metabolism|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Intestinal Lipase Inhibitor|Lipase Inhibitors|Lipase, antagonists & inhibitors|Miscellaneous GI Drugs|Peripherally Acting Antiobesity Products
DB01084	Emedastine	small molecule	approved	Anti-Allergic Agents|Decongestants and Antiallergics|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Inhibitors|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Ophthalmologicals|QTc Prolonging Agents|Sensory Organs
DB01085	Pilocarpine	small molecule	approved|investigational	Alkaloids|Antiglaucoma Preparations and Miotics|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Miotics|Muscarinic Agonists|Nervous System|Neurotransmitter Agents|Ophthalmologicals|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Sensory Organs
DB01086	Benzocaine	small molecule	approved|investigational	Acids, Carbocyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Aminobenzoates|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Central Nervous System Agents|Dermatologicals|Esters of Aminobenzoic Acid|Increased Histamine Release|Methemoglobinemia Associated Agents|Nervous System|P-glycoprotein/ABCB1 Inhibitors|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents|Standardized Chemical Allergen|Throat Preparations|Vasoprotectives
DB01087	Primaquine	small molecule	approved	Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Methemoglobinemia Associated Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Inhibitors|QTc Prolonging Agents|Quinolines
DB01088	Iloprost	small molecule	approved|investigational	Anticoagulants|Antiplatelet agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Fibrinolytic Agents|Hematologic Agents|Hypotensive Agents|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Prostacyclin Analogues|Prostaglandins|Prostaglandins, Synthetic|Vasodilating Agents
DB01089	Deserpidine	small molecule	approved	Alkaloids|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Catecholamine-depleting Sympatholytic|Decreased Sympathetic Activity|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids|Yohimbine
DB01090	Pentolinium	small molecule	approved	Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Cholinergic Agents|Ganglion Blockers|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Pyrrolidines
DB01091	Butenafine	small molecule	approved	Amines|Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Benzene Derivatives|Benzyl Compounds|Benzylamine Antifungal|Benzylamines|Dermatologicals
DB01092	Ouabain	small molecule	approved	Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Glycosides|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Protective Agents|Steroids|Strophanthins|Strophanthus Glycosides
DB01093	Dimethyl sulfoxide	small molecule	approved|vet_approved	Antioxidants|Cryoprotective Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Free Radical Scavengers|Genito Urinary System and Sex Hormones|Miscellaneous Therapeutic Agents|Musculo-Skeletal System|Protective Agents|Solvents|Sulfoxides|Sulfur Compounds|Topical Products for Joint and Muscular Pain|Urologicals
DB01094	Hesperetin	small molecule	experimental	BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Cytochrome P-450 CYP1A2 Substrates|Flavanones|Flavonoids|Pyrans
DB01095	Fluvastatin	small molecule	approved	Anticholesteremic Agents|Antioxidants|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Unsaturated|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|Toxic Actions|UGT1A1 Substrates
DB01096	Oxamniquine	small molecule	approved	Anthelmintics|Anti-Infective Agents|Antihelminthic|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antitrematodals|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Hydroxyquinolines|Nitro Compounds|Nitroquinolines|Quinoline Derivatives and Related Substances|Quinolines|Schistosomicides
DB01097	Leflunomide	small molecule	approved|investigational	Adjuvants|Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Disease-modifying Antirheumatic Agents|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Selective Immunosuppressants
DB01098	Rosuvastatin	small molecule	approved	Amides|Anticholesteremic Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluorobenzenes|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|Pyrimidines|Sulfonamides|Sulfones|Sulfur Compounds|Toxic Actions
DB01099	Flucytosine	small molecule	approved|investigational	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives for Systemic Use|Antimetabolites|Antimycotics for Systemic Use|Cytosine|Dermatologicals|Fluorouracil and prodrugs|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleoside Analog|Nucleoside Analog Antifungal|Pyrimidines|Pyrimidinones|Toxic Actions
DB01100	Pimozide	small molecule	approved	Agents that reduce seizure threshold|Anti-Dyskinesia Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Benzimidazoles|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diphenylbutylpiperidine Derivatives|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Miscellaneous Antipsychotics|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents
DB01101	Capecitabine	small molecule	approved|investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytidine|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Deoxycytidine|Deoxyribonucleosides|Fluoropyrimidines|Fluorouracil and prodrugs|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Pyrimidinones|Ribonucleosides|Toxic Actions|Uracil
DB01102	Arbutamine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Neurotransmitter Agents|Protective Agents
DB01103	Quinacrine	small molecule	investigational	Acridines|Aminoacridines|Anti-Infective Agents|Anticestodal Agents|Antimalarials|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Enzyme Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB01104	Sertraline	small molecule	approved	1-Naphthylamine|Agents that reduce seizure threshold|Amines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Naphthalenes|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01105	Sibutramine	small molecule	approved|illicit|investigational|withdrawn	Agents producing tachycardia|Alimentary Tract and Metabolism|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Appetite Suppression|Central Nervous System Agents|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators|Stimulants
DB01106	Levocabastine	small molecule	approved|investigational	Anti-Allergic Agents|Antiallergic Agents, Excl. Corticosteroids|Central Nervous System Depressants|Decongestants and Antiallergics|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs
DB01107	Methyprylon	small molecule	approved|illicit|withdrawn	Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Piperidinedione Derivatives|Piperidines|Psycholeptics
DB01108	Trilostane	small molecule	approved|investigational|vet_approved|withdrawn	3-Hydroxysteroid Dehydrogenases, antagonists & inhibitors|Abortifacient Agents|Abortifacient Agents, Steroidal|Adrenal Cortex Hormones|Androstanes|Androstanols|Antiadrenal Preparations|Anticorticosteroids|Antineoplastic Agents|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Oxidative Phosphorylation Coupling Factors|Reproductive Control Agents|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Testosterone Congeners
DB01109	Heparin	small molecule	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Antivaricose Therapy|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin and similars|Heparin Group|Heparins|Heparins or Heparinoids for Topical Use|Miscellaneous Therapeutic Agents|Narrow Therapeutic Index Drugs|Ophthalmologicals|Polysaccharides|Sensory Organs|Vasoprotectives
DB01110	Miconazole	small molecule	approved|investigational|vet_approved	14-alpha Demethylase Inhibitors|Alimentary Tract and Metabolism|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|Intestinal Antiinfectives|Otologicals|P-glycoprotein/ABCB1 Inhibitors|Sensory Organs|Steroid Synthesis Inhibitors|Stomatological Preparations|Vaginal Creams, Foams, and Jellies
DB01111	Colistimethate	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Antimicrobial Cationic Peptides|Lipids|Lipopeptides|Membrane Proteins|Nephrotoxic agents|Peptides|Peptides, Cyclic|Polymyxin-class Antibacterial|Polymyxins|Pore Forming Cytotoxic Proteins|Proteins
DB01112	Cefuroxime	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|Ophthalmologicals|Second-Generation Cephalosporins|Sensory Organs|Sulfur Compounds|Thiazines
DB01113	Papaverine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Alkaloids|Benzylisoquinolines|Cardiovascular Agents|Drugs for Functional Gastrointestinal Disorders|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hypotensive Agents|Isoquinolines|Miscellaneous Vasodilatating Agents|Moderate Risk QTc-Prolonging Agents|Opiate Alkaloids|Papaverine and Derivatives|Phosphodiesterase Inhibitors|QTc Prolonging Agents|Urological Agents|Urologicals|Vasodilating Agents
DB01114	Chlorphenamine	small molecule	approved	Anti-Allergic Agents|Antihistamines for Systemic Use|Antipruritics|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT2 Inhibitors|Pheniramine|Propylamine Derivatives|Pyridines|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Substituted Alkylamines
DB01115	Nifedipine	small molecule	approved	Adrenal Cortex Hormones|Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Calcium Channel Blockers and Diuretics|Cardiovascular Agents|Contraceptive Agents, Male|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hormonal Contraceptives for Systemic Use|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Pyridines|QTc Prolonging Agents|Reproductive Control Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Tocolytic Agents|Vasodilating Agents
DB01116	Trimethaphan	small molecule	approved|investigational	Adjuvants, Anesthesia|Antiadrenergic Agents, Ganglion-Blocking|Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Central Nervous System Agents|Cholinergic Agents|Cholinesterase substrates|Ganglion Blockers|Imidazoles|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Sulfonium Derivatives|Vasodilating Agents
DB01117	Atovaquone	small molecule	approved	Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Miscellaneous Antiprotozoals|Naphthalenes|Naphthoquinones|Quinones
DB01118	Amiodarone	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that reduce seizure threshold|alpha-Galactosidase, antagonists & inhibitors|Antiarrhythmic agents|Antiarrhythmics, Class III|Benzofurans|Bradycardia-Causing Agents|BSEP/ABCB11 Substrates|Calcium Channel Blockers|Cardiac Therapy|Cardiovascular Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2A6 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A4 Inhibitors|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|Potassium Channel Blockers|QTc Prolonging Agents|Sodium Channel Blockers|Vasodilating Agents
DB01119	Diazoxide	small molecule	approved	Amides|Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Benzothiadiazines|Cardiovascular Agents|Direct Vasodilators|Diuretics|Drugs for Treatment of Hypoglycemia|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Sulfonamides|Sulfones|Sulfur Compounds|Thiazide Derivatives|Thiazides|Vasodilating Agents
DB01120	Gliclazide	small molecule	approved	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Oral Hypoglycemics|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|Urea
DB01121	Phenacemide	small molecule	approved	Acetamides|Acetates|Acids, Acyclic|Amides|Anticonvulsants|Benzene Derivatives|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System
DB01122	Ambenonium	small molecule	approved	Amines|Ammonium Compounds|Autonomic Agents|Benzylammonium Compounds|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympathomimetics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds
DB01123	Proflavine	small molecule	approved	Acridines|Aminoacridines|Anti-Infective Agents|Anti-Infective Agents, Local
DB01124	Tolbutamide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Diagnostic Agents|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|Oral Hypoglycemics|Sulfones|Sulfonylurea Compounds|Sulfonylureas|Sulfur Compounds|Tests for Diabetes|Urea
DB01125	Anisindione	small molecule	approved	Indans|Indenes
DB01126	Dutasteride	small molecule	approved|investigational	5-alpha Reductase Inhibitors|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Azasteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Steroids|Urologicals
DB01127	Econazole	small molecule	approved	14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antifungal Agents (Vaginal)|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|P-glycoprotein/ABCB1 Inhibitors|Steroid Synthesis Inhibitors
DB01128	Bicalutamide	small molecule	approved	Amides|Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Inhibitors|Sulfones|Sulfur Compounds|Toluene
DB01129	Rabeprazole	small molecule	approved|investigational	2-Pyridinylmethylsulfinylbenzimidazoles|Acetates|Acid Reducers|Acids, Acyclic|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|BCRP/ABCG2 Inhibitors|Benzimidazoles|Butylpyrazolidines|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxy Acids|Lipids|Musculo-Skeletal System|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyrazoles|Pyrazolones|Pyridines|Sulfoxides|Sulfur Compounds|Topical Products for Joint and Muscular Pain
DB01130	Prednicarbate	small molecule	approved|investigational	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids
DB01131	Proguanil	small molecule	approved	Amidines|Anti-Infective Agents|Antimalarials|Antimetabolites|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Biguanides|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Folic Acid Antagonists|Guanidines|Noxae|Toxic Actions
DB01132	Pioglitazone	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs Used in Diabetes|Hypoglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Oral Hypoglycemics|Peroxisome Proliferator Receptor alpha Agonist|Peroxisome Proliferator Receptor gamma Agonist|Peroxisome Proliferator-activated Receptor Activity|Sulfur Compounds|Thiazoles|Thiazolidinediones
DB01133	Tiludronic acid	small molecule	approved|investigational|vet_approved	Bisphosphonates|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Organophosphonates|Organophosphorus Compounds|Phospholipases A, antagonists & inhibitors
DB01134	Desoxycorticosterone pivalate	small molecule	experimental|vet_approved	Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB01135	Doxacurium	small molecule	approved	Anticholinergic Agents|Central Nervous System Depressants|Cholinesterase substrates|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents
DB01136	Carvedilol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Adrenergic beta2-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Alpha and Beta Blocking Agents|Amines|Amino Alcohols|Antihypertensive Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypotensive Agents|Indoles|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Propanols|UGT1A1 Substrates|Vasodilating Agents
DB01137	Levofloxacin	small molecule	approved|investigational	Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Fluoroquinolones|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE inhibitors|MATE substrates|Moderate Risk QTc-Prolonging Agents|OCT2 Inhibitors|Ofloxacin|Ophthalmologicals|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Renal Agents|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01138	Sulfinpyrazone	small molecule	approved	Antigout Preparations|Antiplatelet agents|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Musculo-Skeletal System|Preparations Increasing Uric Acid Excretion|Pyrazoles|Pyrazolones|Renal Agents|Uricosuric Agents
DB01139	Cefapirin	small molecule	approved|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephacetrile|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB01140	Cefadroxil	small molecule	approved|vet_approved|withdrawn	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalexin|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|Sulfur Compounds|Thiazines
DB01141	Micafungin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|COMT Substrates|Echinocandin Antifungal|Echinocandins|Lipids|Peptides|Peptides, Cyclic
DB01142	Doxepin	small molecule	approved|investigational	Acid Reducers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Tricyclic|Antipruritics and Local Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzoxepins|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Ethers|Ethers, Cyclic|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Non-Selective Monoamine Reuptake Inhibitors|Oxepins|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Sleep Aids, Pharmaceutical
DB01143	Amifostine	small molecule	approved|investigational	Cytoprotective Agent|Detoxifying Agents for Antineoplastic Treatment|Free Radical Scavenging Activity|Hypotensive Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Protective Agents|Radiation-Protective Agents|Sulfur Compounds
DB01144	Diclofenamide	small molecule	approved|investigational	Amides|Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Diuretics|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hypotensive Agents|Ophthalmics|Ophthalmologicals|Sensory Organs|Sulfonamides|Sulfones|Sulfur Compounds
DB01145	Sulfoxone	small molecule	approved	Antiinfectives for Systemic Use|Antimycobacterials|Drugs for Treatment of Lepra|Sulfones|Sulfur Compounds
DB01146	Diphenylpyraline	small molecule	approved|investigational	Aminoalkyl Ethers|Antihistamines for Systemic Use|Histamine Antagonists|Histamine H1 Antagonists
DB01147	Cloxacillin	small molecule	approved|investigational|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Lactams|Oxacillin|Penicillinase-resistant Penicillins|Penicillins|Sulfur Compounds
DB01148	Flavoxate	small molecule	approved	Agents producing tachycardia|Anticholinergic Agents|Autonomic Agents|Benzopyrans|Chromones|Drugs for Urinary Frequency and Incontinence|Flavones|Flavonoids|Genito Urinary System and Sex Hormones|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Pyrans|Urological Agents|Urologicals
DB01149	Nefazodone	small molecule	approved|withdrawn	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Analgesics|Antidepressive Agents, Second-Generation|Antidepressive Agents, Triazolopyridine|BSEP/ABCB11 Substrates|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Nervous System|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inducers|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB01150	Cefprozil	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB01151	Desipramine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzazepines|Enzyme Inhibitors|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB01152	Candicidin	small molecule	withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antifungal Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Lactones|Macrolides|Polyketides
DB01153	Sertaconazole	small molecule	approved|investigational	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives|Sulfur Compounds
DB01154	Thiamylal	small molecule	approved|vet_approved	Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Anticonvulsants|Barbiturates|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Pyrimidines|Pyrimidinones|Thiobarbiturates
DB01155	Gemifloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01156	Bupropion	small molecule	approved	Agents that reduce seizure threshold|Alimentary Tract and Metabolism|Aminoketone|Anticholinergic Agents|Antidepressive Agents, Second-Generation|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Agents|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Chemically-Induced Disorders|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Uptake Inhibitors|Enzyme Inhibitors|Increased Dopamine Activity|Increased Norepinephrine Activity|Ketones|Membrane Transport Modulators|Miscellaneous Antidepressants|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nicotinic Antagonists|Norepinephrine Uptake Inhibitors|OCT2 Inhibitors|Propiophenones|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01157	Trimetrexate	small molecule	approved|investigational	Acids, Acyclic|Acids, Aldehydic|Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Carbohydrates|Enzyme Inhibitors|Folic Acid Antagonists|Hydroxy Acids|Noxae|Pharmaceutical Preparations|Quinazolines|Sugar Acids|Toxic Actions|Uronic Acids
DB01158	Bretylium	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Amines|Ammonium Compounds|Antiarrhythmic agents|Antiarrhythmics, Class III|Antihypertensive Agents|Benzylammonium Compounds|Bradycardia-Causing Agents|Bretylium Compounds|Cardiovascular Agents|Hypotensive Agents|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quaternary Ammonium Compounds
DB01159	Halothane	small molecule	approved|vet_approved	Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hydrocarbons, Halogenated|Hypotensive Agents|Nervous System|NMDA Receptor Antagonists
DB01160	Dinoprost Tromethamine	small molecule	approved|vet_approved	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Angiography|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins F|Reproductive Control Agents|Tromethamine|Uterotonic agents
DB01161	Chloroprocaine	small molecule	approved	Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Anticholinergic Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cholinesterase substrates|Ester Local Anesthetic|Esters of Aminobenzoic Acid|Local Anesthesia|Nervous System|Nicotinic Antagonists|NMDA Receptor Antagonists|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents
DB01162	Terazosin	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antihypertensive Agents|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Hypotensive Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Quinazolines|Urological Agents|Urologicals
DB01163	Amdinocillin	small molecule	investigational|withdrawn	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillins|Penicillins With Extended Spectrum|Renal Agents|Sulfur Compounds
DB01164	Calcium Chloride	small molecule	approved	Acidifiers|Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Substitutes and Perfusion Solutions|Calcium Compounds|Calcium Salts|Chlorides|Chlorine Compounds|Electrolyte Solutions|Electrolytes|Genito Urinary System and Sex Hormones|Hemodialysis Solution|Hydrochloric Acid|I.V. Solution Additives|Ions|Mineral Supplements|Phosphate Binder|Replacement Preparations|Supplements|Urologicals
DB01165	Ofloxacin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|Otologicals|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Renal Agents|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01166	Cilostazol	small molecule	approved|investigational	Agents producing tachycardia|Anti-Asthmatic Agents|Antiplatelet agents|Autonomic Agents|Blood and Blood Forming Organs|Bronchodilator Agents|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Neuroprotective Agents|Peripheral Nervous System Agents|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Platelet Aggregation Inhibitors Excl. Heparin|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Respiratory System Agents|Vasodilating Agents
DB01167	Itraconazole	small molecule	approved|investigational	14-alpha Demethylase Inhibitors|Agents causing hyperkalemia|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Triazoles
DB01168	Procarbazine	small molecule	approved|investigational	Acids, Carbocyclic|Alkylating Activity|Alkylating Drugs|Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Immunosuppressive Agents|Methylhydrazines|Monoamine Oxidase Inhibitors|Myelosuppressive Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01169	Arsenic trioxide	small molecule	approved|investigational	Anions|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Electrolytes|Growth Inhibitors|Highest Risk QTc-Prolonging Agents|Hyperglycemia-Associated Agents|Hypotensive Agents|Immunosuppressive Agents|Ions|Myelosuppressive Agents|Organometallic Compounds|Oxygen Compounds|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents
DB01170	Guanethidine	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Amidines|Antiadrenergic Agents, Peripherally Acting|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Gastrointestinal Acidifying Agents|Guanidine Derivatives|Guanidine Derivatives and Diuretics|Guanidines|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Sensory Organs|Sympatholytics
DB01171	Moclobemide	small molecule	approved|investigational	Acids, Carbocyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Amides|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Chlorobenzoates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors|Monoamine Oxidase Inhibitors|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01172	Kanamycin	small molecule	approved|investigational|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiinfectives for Systemic Use|Carbohydrates|Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmologicals|Protein Synthesis Inhibitors|Sensory Organs
DB01173	Orphenadrine	small molecule	approved	Agents producing tachycardia|Amines|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Benzene Derivatives|Benzhydryl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Centrally-mediated Muscle Relaxation|Chemically-Induced Disorders|Cholinergic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Ethers, Chemically Close to Antihistamines|Ethylamines|Histamine Antagonists|Histamine H1 Antagonists|Miscellaneous Skeletal Muscle Relaxants|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB01174	Phenobarbital	small molecule	approved|investigational	Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates and Derivatives|BSEP/ABCB11 inducers|Central Nervous System Agents|Central Nervous System Depressants|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (strong)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (strong)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 Enzyme Inducers|Enzyme Inducing Antiepileptic Drugs|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Methemoglobinemia Associated Agents|Narrow Therapeutic Index Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates|Phenobarbital and similars|Psycholeptics|Pyrimidines|Pyrimidinones|UGT1A1 Inducers
DB01175	Escitalopram	small molecule	approved|investigational	Amines|Anticholinergic Agents|Antidepressive Agents, Second-Generation|Benzofurans|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Nitriles|Propylamines|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01176	Cyclizine	small molecule	approved	Antiemetics|Antihistamines for Systemic Use|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Piperazine Derivatives|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB01177	Idarubicin	small molecule	approved	Anthracycline Topoisomerase Inhibitor|Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytotoxic Antibiotics and Related Substances|Daunorubicin|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01178	Chlormezanone	small molecule	approved|investigational|withdrawn	Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Oxazol, Thiazine, and Triazine Derivatives|Peripheral Nervous System Agents|Psychotropic Drugs|Sulfur Compounds|Thiazines|Tranquilizing Agents
DB01179	Podofilox	small molecule	approved	Antimitotic Agents|Antineoplastic Agents, Phytogenic|Antiviral Agents|Benzene Derivatives|Benzyl Compounds|Decreased Mitosis|Dermatologicals|Keratolytic Agents|Lignans|Misc. Skin and Mucous Membrane Agents|Mitosis Modulators|Naphthalenes|Tetrahydronaphthalenes|Tubulin Modulators
DB01180	Rescinnamine	small molecule	approved	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Alkaloids|Angiotensin-Converting Enzyme Inhibitors|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids|Yohimbine
DB01181	Ifosfamide	small molecule	approved	Acids|Acids, Noncarboxylic|Alkylating Activity|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cyclophosphamide|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Electrolytes|Hydrocarbons, Halogenated|Immunosuppressive Agents|Ions|Methemoglobinemia Associated Agents|Mustard Compounds|Myelosuppressive Agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Oxazines|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions
DB01182	Propafenone	small molecule	approved	Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Bradycardia-Causing Agents|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ketones|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Inhibitors|Propiophenones|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01183	Naloxone	small molecule	approved|vet_approved	Alkaloids|Antidotes|Central Nervous System Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Morphinans|Opiate Alkaloids|Opiate Antagonists|Opioid Antagonists|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|UGT1A1 Substrates
DB01184	Domperidone	small molecule	approved|investigational|vet_approved	Alimentary Tract and Metabolism|Antiemetics|Autonomic Agents|Benzimidazoles|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Highest Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Piperidines|Prokinetic Agents|Propulsives|QTc Prolonging Agents
DB01185	Fluoxymesterone	small molecule	approved|illicit	3-Oxoandrosten (4) Derivatives|Anabolic Agents|Androgens|Androstanes|Androstenediols|Androstenes|Androstenols|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Sex Hormones and Modulators of the Genital System|Steroids|Steroids, Fluorinated
DB01186	Pergolide	small molecule	approved|investigational|vet_approved|withdrawn	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Parkinson Drugs|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergot-derived Dopamine Receptor Agonist|Nervous System|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB01187	Iophendylate	small molecule	approved	Benzene Derivatives|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Non-Watersoluble X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB01188	Ciclopirox	small molecule	approved|investigational	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Decreased DNA Replication|Decreased Protein Synthesis|Decreased RNA Replication|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxypyridones|Protein Synthesis Inhibitors|Pyridines|Vaginal Creams, Foams, and Jellies
DB01189	Desflurane	small molecule	approved	Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Ethers|Hydrocarbons, Halogenated|Hypotensive Agents|Methyl Ethers|Nervous System|Neuroprotective Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB01190	Clindamycin	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiinfectives for Treatment of Acne|Carbohydrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Sebaceous Gland Activity|Dermatologicals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Glycosides|Gynecological Antiinfectives and Antiseptics|Lincomycin|Lincomycins|Lincosamide Antibacterial|Lincosamides|Macrolides, Lincosamides and Streptogramins|Narrow Therapeutic Index Drugs|Neurotoxic agents|Protein Synthesis Inhibitors|Pyrrolidines
DB01191	Dexfenfluramine	small molecule	approved|illicit|investigational|withdrawn	Alimentary Tract and Metabolism|Amines|Antiobesity Preparations, Excl. Diet Products|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Ethylamines|Neurotransmitter Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01192	Oxymorphone	small molecule	approved|investigational|vet_approved	Adjuvants|Adjuvants, Anesthesia|Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Morphinans|Morphine Derivatives|Narcotics|Opiate Agonists|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01193	Acebutolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sympathomimetics
DB01194	Brinzolamide	small molecule	approved	Amides|Antiglaucoma Preparations and Miotics|Carbonic Anhydrase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diuretics|Enzyme Inhibitors|Ophthalmics|Ophthalmologicals|Sensory Organs|Sulfones|Sulfur Compounds
DB01195	Flecainide	small molecule	approved|withdrawn	Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Narrow Therapeutic Index Drugs|Piperidines|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01196	Estramustine	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estradiol|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocarbons, Halogenated|Immunosuppressive Agents|Mustard Compounds|Nitrogen Mustard Compounds|Noxae|P-glycoprotein/ABCB1 Inhibitors|Steroids|Toxic Actions
DB01197	Captopril	small molecule	approved	ACE Inhibitors and Diuretics|Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Enzyme Inhibitors|Hypotensive Agents|Imines|Imino Acids|OAT3/SLC22A8 Substrates|P-glycoprotein/ABCB1 Inhibitors|Proline
DB01198	Zopiclone	small molecule	approved	Aza Compounds|Benzodiazepine hypnotics and sedatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Methemoglobinemia Associated Agents|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Psycholeptics|Sleep Initiation and Maintenance Disorders
DB01199	Tubocurarine	small molecule	approved	Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Cholinesterase substrates|Curare Alkaloids|Ganglion Blockers|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines
DB01200	Bromocriptine	small molecule	approved|investigational	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Blood Glucose Lowering Agents|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Nervous System|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Prolactine Inhibitors|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists
DB01201	Rifapentine	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Drugs for Treatment of Tuberculosis|Lactams|Lactams, Macrocyclic|Leprostatic Agents|Rifamycin Antimycobacterial|Rifamycins
DB01202	Levetiracetam	small molecule	approved|investigational	Acetamides|Acetates|Acids, Acyclic|Agents causing hyperkalemia|Amides|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Fatty Acids|Fatty Acids, Volatile|Lipids|Miscellaneous Anticonvulsants|Nervous System|Nootropic Agents|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Pyrrolidines|Pyrrolidinones|QTc Prolonging Agents|Vasodilating Agents
DB01203	Nadolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sympatholytics
DB01204	Mitoxantrone	small molecule	approved|investigational	Analgesics|Anthracenes|Anthracyclines and Related Substances|Anthraquinones|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Quinones|Sensory System Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01205	Flumazenil	small molecule	approved	Antidotes|Benzazepines|Benzodiazepine Antagonist|Benzodiazepinones|GABA Agents|GABA Modulators|Miscellaneous Central Nervous System Agents|Neurotransmitter Agents|Protective Agents
DB01206	Lomustine	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Noxae|Toxic Actions|Urea
DB01207	Ridogrel	small molecule	experimental	Acids, Acyclic|Antiplatelet agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Gastrointestinal Agents|Hematologic Agents|Lipids|Thromboxane-A Synthase, antagonists & inhibitors|Valerates
DB01208	Sparfloxacin	small molecule	approved|investigational|withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antituberculosis Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Highest Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01209	Dezocine	small molecule	approved|investigational	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Naphthalenes|Narcotics|Nervous System|Opioid Antagonists|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01210	Levobunolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiglaucoma Preparations and Miotics|Autonomic Agents|Beta-adrenergic Agents|Bradycardia-Causing Agents|Bunolol|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Naphthalenes|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sensory Organs|Sympatholytics|Tetrahydronaphthalenes
DB01211	Clarithromycin	small molecule	approved	Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Cytochrome P450 3A4 Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Erythromycin|Lactones|Macrolide Antimicrobial|Macrolides|Macrolides, Lincosamides and Streptogramins|Moderate Risk QTc-Prolonging Agents|Other Macrolides|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Polyketides|Protein Synthesis Inhibitors|QTc Prolonging Agents
DB01212	Ceftriaxone	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB01213	Fomepizole	small molecule	approved|vet_approved	Antidotes|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Protective Agents
DB01214	Metipranolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|Sensory Organs|Sympatholytics
DB01215	Estazolam	small molecule	approved|illicit	Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01216	Finasteride	small molecule	approved	5-alpha Reductase Inhibitors|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Androstanes|Androstenes|Azasteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dermatologicals|Drugs Used in Benign Prostatic Hypertrophy|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Misc. Skin and Mucous Membrane Agents|Steroid Synthesis Inhibitors|Steroids|Urological Agents|Urologicals
DB01217	Anastrozole	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cardiotoxic antineoplastic agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors
DB01218	Halofantrine	small molecule	approved	Agents that reduce seizure threshold|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB01219	Dantrolene	small molecule	approved|investigational	Agents causing hyperkalemia|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dantrolene and Derivatives|Decreased Striated Muscle Contraction|Decreased Striated Muscle Tone|Direct-acting Skeletal Muscle Relaxants|Hydantoins|Imidazoles|Imidazolidines|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents
DB01220	Rifaximin	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics for Topical Use|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Enzyme Inhibitors|Gastrointestinal Agents|Intestinal Antiinfectives|Lactams|Lactams, Macrocyclic|Nucleic Acid Synthesis Inhibitors|Rifamycin Antibacterial|Rifamycins
DB01221	Ketamine	small molecule	approved|vet_approved	Agents producing tachycardia|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Analgesics|Anesthetics|Anesthetics, Dissociative|Anesthetics, General|Anesthetics, Intravenous|Aspartic Acid|Central Nervous System Agents|Central Nervous System Depressants|Cholinesterase Inhibitors|Cyclohexanes|Cycloparaffins|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Excitatory Amino Acid Agents|Excitatory Amino Acid Agonists|Excitatory Amino Acid Antagonists|Excitatory Amino Acids|Miscellaneous General Anesthetics|Nervous System|Neurotransmitter Agents|NMDA Receptor Antagonists|Peripheral Nervous System Agents|Sensory System Agents|Vasodilating Agents
DB01222	Budesonide	small molecule	approved	Adrenal Cortex Hormones|Adrenals|Adrenergics, Inhalants|Agents to Treat Airway Disease|Alimentary Tract and Metabolism|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Autonomic Agents|Bronchodilator Agents|BSEP/ABCB11 Substrates|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids Acting Locally|Corticosteroids for Systemic Use|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Drugs for Obstructive Airway Diseases|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Intestinal Antiinflammatory Agents|Nasal Preparations|Peripheral Nervous System Agents|Pregnanes|Pregnenediones|Pregnenes|Respiratory System Agents|Steroids
DB01223	Aminophylline	small molecule	approved	Agents that reduce seizure threshold|Alkaloids|Amines|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiotonic Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diamines|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Ethylenediamines|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Phosphodiesterase Inhibitors|Polyamines|Protective Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones|Respiratory Smooth Muscle Relaxants|Respiratory System Agents|Xanthine derivatives|Xanthines and Adrenergics
DB01224	Quetiapine	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Azepines|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Diazepines, Oxazepines, Thiazepines and Oxepines|Dibenzothiazepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Hypotensive Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|P-glycoprotein/ABCB1 Substrates|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiazepines|Thiepins|Tranquilizing Agents
DB01225	Enoxaparin	small molecule	approved	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Heparin Group|Heparins|Polysaccharides
DB01226	Mivacurium	small molecule	approved	Agents producing tachycardia|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Peripheral Nervous System Agents
DB01227	Levacetylmethadol	small molecule	approved|investigational	Analgesics|Anticholinergic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Ketones|Moderate Risk QTc-Prolonging Agents|Narcotics|Nervous System|Nicotinic Antagonists|Opioids|Peripheral Nervous System Agents|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01228	Encainide	small molecule	approved|investigational|withdrawn	Amides|Anilides|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Membrane Transport Modulators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01229	Paclitaxel	small molecule	approved|vet_approved	Albumins|Amino Acids, Peptides, and Proteins|Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Diterpenes|Hypotensive Agents|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Mitosis Modulators|Myelosuppressive Agents|Neurotoxic agents|OATP1B3 substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Proteins|Taxane Derivatives|Taxoids|Terpenes|Tubulin Modulators
DB01230	Pemoline	small molecule	approved|illicit|investigational|withdrawn	Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Nervous System|Oxazoles|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics
DB01231	Diphenidol	small molecule	approved|investigational|withdrawn	Agents producing tachycardia|Anticholinergic Agents|Antiemetics|Autonomic Agents|Central Nervous System Agents|Emesis Suppression|Gastrointestinal Agents|Muscarinic Antagonists|Peripheral Nervous System Agents
DB01232	Saquinavir	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Isoquinolines|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|QTc Prolonging Agents|Quinolines
DB01233	Metoclopramide	small molecule	approved|investigational	Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Aminobenzoates|Antiemetics|Autonomic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Chlorobenzoates|Cholinesterase Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Ethers|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Methemoglobinemia Associated Agents|Neurotransmitter Agents|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Potential QTc-Prolonging Agents|Prokinetic Agents|Propulsives|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01234	Dexamethasone	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|Adrenals|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Inflammatory Agents|Antiemetics|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Autonomic Agents|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 inducers|Central Nervous System Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Local Oral Treatment|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Gastrointestinal Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Inducers of Drug Clearance|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated|Stomatological Preparations|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives
DB01235	Levodopa	small molecule	approved	Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Biogenic Amines|Biogenic Monoamines|Catecholamines|Central Nervous System Agents|Central Nervous System Depressants|Dihydroxyphenylalanine|Dopa and Dopa Derivatives|Dopamine Agents|Hypotensive Agents|Nervous System|Neurotransmitter Agents|Phenylalanine|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Tyrosine
DB01236	Sevoflurane	small molecule	approved|vet_approved	Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Antiplatelet agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethers|Hematologic Agents|Hydrocarbons, Halogenated|Hypotensive Agents|Nervous System|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB01237	Bromodiphenhydramine	small molecule	approved	Amines|Aminoalkyl Ethers|Antihistamines for Systemic Use|Benzene Derivatives|Benzhydryl Compounds|Ethylamines|Histamine Antagonists|Histamine H1 Antagonists
DB01238	Aripiprazole	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Piperazines|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Quinolines|Quinolones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB01239	Chlorprothixene	small molecule	experimental|investigational|withdrawn	Agents producing tachycardia|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes
DB01240	Epoprostenol	small molecule	approved	Anticoagulants|Antihypertensive Agents|Antiplatelet agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Hematologic Agents|Hypotensive Agents|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Prostacyclin Analogues|Prostacycline Vasodilator|Prostaglandins|Prostaglandins I|Vasodilating Agents|Vasodilation
DB01241	Gemfibrozil	small molecule	approved	Acids, Acyclic|Benzene Derivatives|Butyrates|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Fribic Acid Derivatives|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|OATP1B1/SLCO1B1 Inhibitors|Pentanoic Acids|Peroxisome Proliferator Receptor alpha Agonist|Peroxisome Proliferator-activated Receptor alpha Agonists|Phenols|Phenyl Ethers|Toxic Actions|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A3 Inhibitors|Valerates
DB01242	Clomipramine	small molecule	approved|investigational|vet_approved	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzazepines|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB01243	Chloroxine	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antifungal Agents|Hydroxyquinolines|Oxyquinoline|Quinolines
DB01244	Bepridil	small molecule	approved|withdrawn	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Highest Risk QTc-Prolonging Agents|Hypotensive Agents|Membrane Transport Modulators|Non-Selective Calcium Channel Blockers|P-glycoprotein/ABCB1 Inhibitors|Phenylalkylamine Derivatives|Pyrrolidines|QTc Prolonging Agents|Vasodilating Agents
DB01245	Decamethonium	small molecule	approved	Amines|Ammonium Compounds|Bis-Trimethylammonium Compounds|Central Nervous System Depressants|Cholinesterase Inhibitors|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Depolarizing Agents|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds
DB01246	Alimemazine	small molecule	approved|vet_approved	Antihistamines for Systemic Use|Antipruritics|Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotoxic agents|Neurotransmitter Agents|Phenothiazine Derivatives|Phenothiazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds
DB01247	Isocarboxazid	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Hypotensive Agents|Isoxazoles|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01248	Docetaxel	small molecule	approved|investigational	Antimitotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diterpenes|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Mitosis Modulators|Myelosuppressive Agents|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Taxane Derivatives|Taxoids|Terpenes|Tubulin Modulators
DB01249	Iodixanol	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB01250	Olsalazine	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Aminosalicylate|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoates|Intestinal Antiinflammatory Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Phenols|Salicylates|Sensory System Agents
DB01251	Gliquidone	small molecule	approved|investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Oral Hypoglycemics|Sulfones|Sulfonylureas|Sulfur Compounds|Urea
DB01252	Mitiglinide	small molecule	investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Oral Hypoglycemics
DB01253	Ergometrine	small molecule	approved	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ergolines|Ergot Alkaloids and Derivatives|Genito Urinary System and Sex Hormones|P-glycoprotein/ABCB1 Inhibitors|Reproductive Control Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Uterotonic agents
DB01254	Dasatinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|Pyrimidines|QTc Prolonging Agents|Sulfur Compounds|Thiazoles|Tyrosine Kinase Inhibitors
DB01255	Lisdexamfetamine	small molecule	approved|investigational	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB01256	Retapamulin	small molecule	approved	Anti-Bacterial Agents|Antibiotics for Topical Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Pleuromutilin Antibacterial
DB01257	Eculizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Blood Proteins|Complement Inactivating Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Proteins|Selective Immunosuppressants|Serum Globulins
DB01259	Lapatinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors
DB01260	Desonide	small molecule	approved|investigational	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Immunosuppressive Agents|Ophthalmologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids
DB01261	Sitagliptin	small molecule	approved|investigational	Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Incretins|OAT3/SLC22A8 Substrates|Oral Hypoglycemics|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Pyrazines|Triazoles
DB01262	Decitabine	small molecule	approved|investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aza Compounds|Carbohydrates|Cytidine|DNA Modification Methylases, antagonists & inhibitors|Enzyme Inhibitors|Glycosides|Immunosuppressive Agents|Myelodysplastic Syndromes|Myelosuppressive Agents|Noxae|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Pyrimidine Analogues|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Teratogens|Toxic Actions
DB01263	Posaconazole	small molecule	approved|investigational|vet_approved	14-alpha Demethylase Inhibitors|Anti-Infective Agents|Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Antiparasitic Agents|Antiprotozoals|Azole Antifungals|Chemically-Induced Disorders|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Steroid Synthesis Inhibitors|Triazole Derivatives|Trypanocidal Agents
DB01264	Darunavir	small molecule	approved	Acids, Acyclic|Amides|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbamates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Furans|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protease Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB01265	Telbivudine	small molecule	approved|investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Direct Acting Antivirals|Enzyme Inhibitors|Glycosides|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Hepatitis B, Chronic|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleoside Reverse Transcriptase Inhibitors|Nucleosides|Nucleosides and Nucleotides|Pyrimidine Nucleosides|Pyrimidines
DB01266	Sinecatechins	small molecule	approved|investigational|nutraceutical	Antiviral Agents|Dermatologicals
DB01267	Paliperidone	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Hyperglycemia-Associated Agents|Isoxazoles|Nervous System|Neurotoxic agents|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Psycholeptics|Psychotropic Drugs|Pyrimidines|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB01268	Sunitinib	small molecule	approved|investigational	Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Blood Glucose Lowering Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Hypoglycemia-Associated Agents|Immunosuppressive Agents|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors
DB01269	Panitumumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Colonic Neoplasms|Epidermal Growth Factor Receptor Antagonist|Globulins|HER1 Antagonists|Immunoglobulins|Immunoproteins|Proteins|Receptor, Epidermal Growth Factor|Serum Globulins
DB01270	Ranibizumab	biotech	approved	Amino Acids, Peptides, and Proteins|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineovascularisation Agents|Blood Proteins|EENT Drugs, Miscellaneous|Globulins|Growth Inhibitors|Growth Substances|Immunoglobulins|Immunologic Factors|Immunoproteins|Ocular Vascular Disorder Agents|Ophthalmics|Ophthalmologicals|Proteins|Sensory Organs|Serum Globulins|Vascular Endothelial Growth Factor Inhibitor|Vascular Endothelial Growth Factor Inhibitors
DB01271	Idursulfase	biotech	approved	Alimentary Tract and Metabolism|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme|Sulfatases
DB01272	Alglucosidase alfa	biotech	approved	Alimentary Tract and Metabolism|Enzymes|Enzymes and Coenzymes|Glucosidases|Glycogen Storage Disease Type II|Glycoside Hydrolases|Hydrolases|Hydrolytic Lysosomal Glycogen-specific Enzyme
DB01273	Varenicline	small molecule	approved|investigational	Benzazepines|Cholinergic Agents|Cholinergic Agonists|Drugs Used in Addictive Disorders|Drugs Used in Nicotine Dependence|Miscellaneous Autonomic Drugs|Nervous System|Neurotransmitter Agents|Nicotinic Agonists|OCT2 Inhibitors|OCT2 Substrates|Partial Cholinergic Nicotinic Agonist|Partial Cholinergic Nicotinic Agonists|Quinoxalines
DB01274	Arformoterol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents
DB01275	Hydralazine	small molecule	approved	Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Arteriolar Vasodilation|Arteriolar Vasodilator|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Direct Vasodilators|Hydrazinophthalazine Derivatives|Hydrazinophthalazine Derivatives and Diuretics|Hypotensive Agents|Phthalazines|Pyridazines|Vasodilating Agents
DB01276	Exenatide	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Biological Factors|Blood Glucose Lowering Agents|Bodily Secretions|Complex Mixtures|Drugs Used in Diabetes|Fluids and Secretions|GLP-1 Agonists|Glucagon-Like Peptide 1|Glucagon-like Peptide-1 (GLP-1) Agonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Incretin Mimetics|Incretins|Toxins, Biological|Venoms
DB01277	Mecasermin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Biological Factors|Blood Glucose Lowering Agents|Blood Proteins|Hypoglycemia-Associated Agents|Intercellular Signaling Peptides and Proteins|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Proteins|Somatomedins|Somatropin and Somatropin Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB01278	Pramlintide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Amylin Agonists|Amylin Analog|Amyloid|Amyloidogenic Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Macromolecular Substances|Multiprotein Complexes|Pancreatic Hormones|Peptide Hormones|Peptides|Proteins
DB01279	Galsulfase	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Arylsulfatases|Carbon-Oxygen Lyases|Chondroitinases and Chondroitin Lyases|Chondroitinsulfatases|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme|Lyases|Polysaccharide-Lyases|Proteins|Sulfatases
DB01280	Nelarabine	small molecule	approved|investigational	Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycosides|Immunosuppressive Agents|Myelosuppressive Agents|Nucleic Acid Synthesis Inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Metabolic Inhibitor|Nucleosides|Purine Analogues
DB01281	Abatacept	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|Decreased Cytokine Activity|Disease-modifying Antirheumatic Agents|Globulins|Immunoconjugates|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Proteins|Selective Immunosuppressants|Selective T Cell Costimulation Modulator|Serum Globulins
DB01282	Carbetocin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Delayed-Action Preparations|Drug Delivery Systems|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Investigative Techniques|Oxytocin and Analogues|Peptide Hormones|Peptides|Pharmaceutical Preparations|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Reproductive Control Agents|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Uterotonic agents
DB01283	Lumiracoxib	small molecule	approved|investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Phenylacetates|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|UGT1A9 Substrates
DB01284	Tetracosactide	small molecule	approved	Adrenals|Adrenocortical Insufficiency|Adrenocorticotropic Hormone|Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Melanocortins|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB01285	Corticotropin	biotech	approved|investigational|vet_approved	Adrenal Cortex Hormones|Adrenocorticotropic Hormone|Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Melanocortins|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB01288	Fenoterol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Anticholinergic Agents|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Genito Urinary System and Sex Hormones|Metaproterenol|Neurotransmitter Agents|Peripheral Nervous System Agents|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics|Sympathomimetics, Labour Repressants|Tocolytic Agents
DB01289	Glisoxepide	small molecule	investigational	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Oral Hypoglycemics|Sulfones|Sulfonylureas|Sulfur Compounds|Urea
DB01291	Pirbuterol	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiotonic Agents|Cardiovascular Agents|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB01294	Bismuth Subsalicylate	small molecule	approved|vet_approved	Acids, Carbocyclic|Antacids and Adsorbents|Antidiarrheals|Benzene Derivatives|Benzoates|Bismuth containing drugs|Elements|Gastrointestinal Agents|Helicobacter Infections|Hydroxy Acids|Hydroxybenzoates|Metals|Metals, Heavy|Neurotoxic agents|Phenols|Salicylates
DB01295	Bevantolol	small molecule	experimental	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antihypertensive Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Propanols
DB01296	Glucosamine	small molecule	approved|investigational	Amino Sugars|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Carbohydrates|Hexosamines|Musculo-Skeletal System
DB01297	Practolol	small molecule	approved	Acetanilides|Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amides|Amines|Amino Alcohols|Anilides|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols
DB01298	Sulfacytine	small molecule	approved	Amides|Amines|Aniline Compounds|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Sulfonamides|Sulfones|Sulfur Compounds
DB01299	Sulfadoxine	small molecule	approved|investigational	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antimalarials|Antiparasitic Agents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Renal Agents|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB01301	Rolitetracycline	small molecule	approved	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|Tetracyclines
DB01303	Oxtriphylline	small molecule	approved	Alcohols|Alkaloids|Amines|Amino Alcohols|Ammonium Compounds|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP1A2 Substrates|Drugs for Obstructive Airway Diseases|Ethanolamines|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Purines|Purinones|Quaternary Ammonium Compounds|Respiratory Smooth Muscle Relaxants|Respiratory System Agents|Trimethyl Ammonium Compounds|Xanthine derivatives|Xanthines and Adrenergics
DB01306	Insulin Aspart	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Insulin|Insulin Analog|Insulin, Short-Acting|Insulins and Analogues|Insulins and Analogues for Injection, Fast-Acting|Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting|Pancreatic Hormones|Peptide Hormones|Peptides
DB01307	Insulin Detemir	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Insulin|Insulin Analog|Insulin, Long-Acting|Insulins and Analogues|Insulins and Analogues for Injection, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides
DB01309	Insulin Glulisine	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Insulin|Insulin Analog|Insulins and Analogues|Insulins and Analogues for Injection, Fast-Acting|Pancreatic Hormones|Peptide Hormones|Peptides|Proinsulin|Protein Precursors|Proteins
DB01319	Fosamprenavir	small molecule	approved	Acids, Acyclic|Amides|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Organophosphorus Compounds|P-glycoprotein/ABCB1 Inhibitors|Protease Inhibitors|Sulfones|Sulfur Compounds
DB01320	Fosphenytoin	small molecule	approved|investigational	Anti-epileptic Agent|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (strong)|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2D6 Inducers (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Decreased Central Nervous System Disorganized Electrical Activity|Enzyme Inducing Antiepileptic Drugs|Hydantoins|Imidazoles|Imidazolidines|Narrow Therapeutic Index Drugs|Nervous System|Prodrugs|UGT1A6 Inhibitors|UGT1A9 Inhibitors
DB01321	Josamycin	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides
DB01322	Kava	small molecule	approved|investigational|nutraceutical	
DB01323	St. John's Wort	small molecule	approved|investigational|nutraceutical	Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Herbs and Natural Products|Hyperglycemia-Associated Agents|Nervous System|P-glycoprotein/ABCB1 Inducers|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01324	Polythiazide	small molecule	approved	Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Increased Diuresis|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB01325	Quinethazone	small molecule	approved	Amides|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Low-Ceiling Diuretics, Excl. Thiazides|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB01326	Cefamandole	small molecule	approved|experimental	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB01327	Cefazolin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines
DB01328	Cefonicid	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB01329	Cefoperazone	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefamandole|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB01330	Cefotetan	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Cephamycins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Tetrazoles|Thiazines
DB01331	Cefoxitin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Cephamycins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB01332	Ceftizoxime	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB01333	Cefradine	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalexin|Cephalosporins|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|First-Generation Cephalosporins|Lactams|MATE 1 Substrates|MATE substrates|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB01336	Metocurine	small molecule	approved	Agents producing tachycardia|Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Curare Alkaloids|Drugs, Chinese Herbal|Isoquinolines|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Tetrahydroisoquinolines
DB01337	Pancuronium	small molecule	approved	Agents producing tachycardia|Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Steroids
DB01338	Pipecuronium	small molecule	approved	Agents producing tachycardia|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Cholinesterase Inhibitors|Muscarinic Antagonists|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents|Piperazines
DB01339	Vecuronium	small molecule	approved	Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Cholinergic Agents|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Steroids
DB01340	Cilazapril	small molecule	approved	ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|P-glycoprotein/ABCB1 Inhibitors|Pyridazines
DB01341	Dihydroquinidine barbiturate	small molecule	experimental	
DB01342	Forasartan	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists
DB01344	Tolevamer	small molecule	approved|investigational	Benzene Derivatives|Benzylidene Compounds|Biomedical and Dental Materials|Cation Exchange Resins|Chelating Agents|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Ion Exchange Resins|Laboratory Chemicals|Macromolecular Substances|Plastics|Polymers|Potassium Binder|Potassium Ion Exchange Activity|Potassium-removing Agents|Sequestering Agents|Styrene|Styrenes
DB01345	Potassium cation	small molecule	approved|investigational	Agents causing hyperkalemia|Diuretics|Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Minerals|Osmotic Activity|Potassium Salt|Replacement Preparations
DB01346	Quinidine barbiturate	small molecule	approved	
DB01347	Saprisartan	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Cardiovascular Agents
DB01348	Spirapril	small molecule	approved	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Dipeptides|Enzyme Inhibitors|Oligopeptides|Peptides|Protease Inhibitors
DB01349	Tasosartan	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin II Antagonists, Plain|Angiotensin Receptor Antagonists|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates
DB01351	Amobarbital	small molecule	approved|illicit	Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB01352	Aprobarbital	small molecule	experimental|illicit	Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB01353	Butethal	small molecule	approved|illicit	Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB01354	Heptabarbital	small molecule	experimental	Anticholinergic Agents|Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB01355	Hexobarbital	small molecule	experimental	Adjuvants|Anesthetics|Anesthetics, General|Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB01356	Lithium cation	small molecule	experimental	Antimanic Agents|Antipsychotic Agents|Central Nervous System Depressants|Highest Risk QTc-Prolonging Agents|Lithium Compounds|Mood Stabilizer|Nephrotoxic agents|Neurotoxic agents|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01357	Mestranol	small molecule	approved	Adrenal Cortex Hormones|Contraceptive Agents, Female|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estradiol Congeners|Estrogen Contraceptives|Estrogenic Steroids, Alkylated|Estrogens|Ethinyl Estradiol|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Norpregnanes|Norpregnatrienes|Norsteroids|Steroids
DB01359	Penbutolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB01362	Iohexol	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB01363	Ephedra	small molecule	approved|nutraceutical|withdrawn	Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alpha-and Beta-adrenergic Agonists|Herbs and Natural Products|Hyperglycemia-Associated Agents|Sympathomimetic (Adrenergic) Agents
DB01364	Ephedrine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alimentary Tract and Metabolism|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Antiobesity Preparations, Excl. Diet Products|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Cholinesterase substrates|Drugs for Obstructive Airway Diseases|Ethylamines|Herbs and Natural Products|Increased Norepinephrine Activity|Mydriatics and Cycloplegics|Nasal Preparations|Neurotransmitter Agents|Norepinephrine Releasing Agent|Ophthalmologicals|Peripheral Nervous System Agents|Phenethylamines|Propanolamines|Propanols|Sensory Organs|Sympathomimetic (Adrenergic) Agents|Sympathomimetics|Sympathomimetics Excl. Antiglaucoma Preparations|Sympathomimetics, Plain|Vasoconstrictor Agents
DB01365	Mephentermine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Phentermine|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics|Vasoconstrictor Agents
DB01366	Procaterol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Hydroxyquinolines|Neurotransmitter Agents|Peripheral Nervous System Agents|Quinolines|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics
DB01367	Rasagiline	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Anti-Parkinson Drugs|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Dopamine Agents|Enzyme Inhibitors|Hypotensive Agents|Indenes|Monoamine Oxidase B Inhibitors|Monoamine Oxidase Inhibitors|Nervous System|Neuroprotective Agents|Protective Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB01369	Quinupristin	small molecule	approved	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Peptides|Peptides, Cyclic|Streptogramin Antibacterial|Streptogramins
DB01370	Aluminium	small molecule	approved|investigational	Aluminium Compounds|Antacids|Elements|Gastric Acid Lowering Agents|Metals|Metals, Light
DB01373	Calcium	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Antacids and Adsorbents|Biological Factors|Blood Coagulation Factors|Blood Proteins|Calcium Salts|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Elements|Metals|Metals, Alkaline Earth|Minerals|Musculo-Skeletal System|Phosphate Binder|Phosphate Chelating Activity|Proteins|Replacement Preparations
DB01375	Aluminium monostearate	small molecule	experimental	Fatty Acids|Lipids
DB01377	Magnesium oxide	small molecule	approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anions|Antacids|Calculi Dissolution Agent|Drugs for Acid Related Disorders|Drugs for Constipation|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Ions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Magnesium Salts|Mineral Supplements|Minerals|Osmotic Laxative|Oxides|Oxygen Compounds
DB01378	Magnesium cation	small molecule	approved|nutraceutical	Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Inhibition Small Intestine Fluid/Electrolyte Absorption|Laxatives|Magnesium Ion Exchange Activity|Minerals|Osmotic Activity|Osmotic Laxative|Stimulation Large Intestine Fluid/Electrolyte Secretion
DB01380	Cortisone acetate	small molecule	approved|investigational	17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Adrenals|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnanes|Pregnenes|Sensory Organs|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB01381	Ginkgo biloba	biotech	approved|investigational|nutraceutical	Anti-Dementia Drugs|Biological Products|Blood Circulation|Cardiovascular Agents|Cholinesterase Inhibitors|Complex Mixtures|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ginkgo biloba|Ginkgolides|Nervous System|Pharmaceutical Preparations|Plant Preparations|Psychoanaleptics
DB01382	Glycodiazine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amides|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Oral Hypoglycemics|Sulfonamides|Sulfones|Sulfur Compounds
DB01384	Paramethasone	small molecule	experimental	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB01388	Mibefradil	small molecule	investigational|withdrawn	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Benzimidazoles|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Naphthalenes|P-glycoprotein/ABCB1 Inhibitors|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Tetrahydronaphthalenes|Vasodilating Agents
DB01390	Sodium bicarbonate	small molecule	approved	Acids|Acids, Noncarboxylic|Alkalies|Anions|Antacids|Antacids and Adsorbents|Bicarbonates|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Electrolyte Solutions|Electrolytes|Gastric Acid Lowering Agents|Hemodialysis Solution|I.V. Solution Additives|Ions|Irrigating Solutions|Radiographic Contrast Agent|Salt Solutions|Sodium Compounds|Urinary Alkalinisers
DB01392	Yohimbine	small molecule	approved|investigational|vet_approved	Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|Autonomic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs Used in Erectile Dysfunction|Genito Urinary System and Sex Hormones|Indole Alkaloids|Indoles|Mydriatics|Neurotransmitter Agents|Other Miscellaneous Therapeutic Agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Secologanin Tryptamine Alkaloids|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Urological Agents|Urologicals
DB01393	Bezafibrate	small molecule	approved|investigational	Acids, Acyclic|Acids, Carbocyclic|Amides|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Butyrates|Chlorobenzoates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Fribic Acid Derivatives|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|OATP1B1/SLCO1B1 Inhibitors|Phenols|Phenyl Ethers|Toxic Actions
DB01394	Colchicine	small molecule	approved	Alkaloids|Antigout Preparations|Antimitotic Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Immunosuppressive Agents|Mitosis Modulators|Musculo-Skeletal System|Myelosuppressive Agents|P-Glycoprotein Interactions|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Preparations With No Effect on Uric Acid Metabolism|Tubulin Modulators
DB01395	Drospirenone	small molecule	approved	Adrenal Cortex Hormones|Agents causing hyperkalemia|Androstanes|Cardiovascular Agents|Cholinesterase substrates|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Diuretics|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Progesterone Congeners|Progestin Contraceptives|Progestins|Sex Hormones and Modulators of the Genital System|Steroids
DB01396	Digitoxin	small molecule	approved|investigational	Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Digitalis Glycosides|Enzyme Inhibitors|Glycosides|Narrow Therapeutic Index Drugs|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Steroids
DB01397	Magnesium salicylate	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Hydroxy Acids|Hydroxybenzoates|Magnesium Compounds|Magnesium Salts|Nephrotoxic agents|Peripheral Nervous System Agents|Phenols|Sensory System Agents
DB01399	Salsalate	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzoates|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Phenols|Salicylic Acid and Derivatives|Sensory System Agents
DB01400	Neostigmine	small molecule	approved|vet_approved	Amines|Ammonium Compounds|Antiglaucoma Preparations and Miotics|Autonomic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Ophthalmologicals|P-glycoprotein/ABCB1 Substrates|Parasympathomemetic (Cholinergic) Agents|Parasympathomimetics|Peripheral Nervous System Agents|Phenylammonium Compounds|Quaternary Ammonium Compounds|Sensory Organs
DB01401	Choline magnesium trisalicylate	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethanolamines|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Phenols|Quaternary Ammonium Compounds|Sensory System Agents|Trimethyl Ammonium Compounds
DB01403	Methotrimeprazine	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anticholinergic Agents|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Muscarinic Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB01404	Ginseng	small molecule	approved|investigational|nutraceutical	Herbs and Natural Products
DB01405	Temafloxacin	small molecule	withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Substrates|Enzyme Inhibitors|Fluoroquinolones|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB01406	Danazol	small molecule	approved	Androgens|Antigonadotropins and Similar Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Estrogen Antagonists|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Pregnadienes|Pregnanes|Sex Hormones and Modulators of the Genital System|Steroids
DB01407	Clenbuterol	small molecule	approved|investigational|vet_approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Sympathomimetics
DB01408	Bambuterol	small molecule	investigational	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cholinesterase Inhibitors|Cholinesterase substrates|Delayed-Action Preparations|Drugs for Obstructive Airway Diseases|Ethanolamines|Peripheral Nervous System Agents|Prodrugs|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB01409	Tiotropium	small molecule	approved	Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Alkaloids|Anti-Asthmatic Agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Bronchodilator Agents|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Respiratory System Agents|Scopolamine Derivatives|Tropanes
DB01410	Ciclesonide	small molecule	approved|investigational	Adrenal Cortex Hormones|Adrenals|Agents to Treat Airway Disease|Anti-Allergic Agents|Corticosteroids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|Pregnanes|Pregnenes|Steroids
DB01411	Pranlukast	small molecule	investigational	Agents to Treat Airway Disease|Anti-Asthmatic Agents|Benzopyrans|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Leukotriene Antagonists|Pyrans|Respiratory System Agents
DB01412	Theobromine	small molecule	investigational	Alkaloids|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Diuretics|Drugs for Obstructive Airway Diseases|Low-Ceiling Diuretics, Excl. Thiazides|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives
DB01413	Cefepime	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Fourth-Generation Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB01414	Cefacetrile	small molecule	experimental	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines
DB01415	Ceftibuten	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB01416	Cefpodoxime	small molecule	approved|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cefotaxime|Cephacetrile|Cephalosporins|Lactams|Nephrotoxic agents|Prodrugs|Sulfur Compounds|Thiazines|Third-Generation Cephalosporins
DB01418	Acenocoumarol	small molecule	approved|investigational	4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|Narrow Therapeutic Index Drugs|Pyrans|Vitamin K Antagonists
DB01419	Antrafenine	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Nephrotoxic agents
DB01420	Testosterone propionate	small molecule	approved|investigational|vet_approved|withdrawn	Androgens|Androstanes|Androstenes|Androstenols|COMT Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Substrates|Steroids|Testosterone Congeners|UGT1A1 Inducers
DB01421	Paromomycin	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amebicides|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Glycosides|Intestinal Antiinfectives|Narrow Therapeutic Index Drugs|Neomycin|Nephrotoxic agents
DB01422	Nitroxoline	small molecule	experimental	Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antifungal Agents|Antiinfectives for Systemic Use|Nitro Compounds|Quinolines|Renal Agents
DB01423	Stepronin	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Cough and Cold Preparations|Expectorants|Immunologic Factors|Immunosuppressive Agents|Respiratory System Agents
DB01424	Aminophenazone	small molecule	approved|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Nephrotoxic agents|Nervous System|Pyrazoles|Pyrazolones
DB01425	Alizapride	small molecule	investigational	Alimentary Tract and Metabolism|Antiemetics|Autonomic Agents|Central Nervous System Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Peripheral Nervous System Agents|Propulsives
DB01426	Ajmaline	small molecule	approved|experimental	Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Antiarrhythmics, Class Ic|Cardiac Therapy|Cardiovascular Agents|Indole Alkaloids|Indoles|Membrane Transport Modulators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Secologanin Tryptamine Alkaloids|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01427	Amrinone	small molecule	approved	Amines|Aminopyridines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Membrane Transport Modulators|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Pyridines|Vasodilating Agents
DB01428	Oxybenzone	small molecule	approved|investigational	Benzene Derivatives|Benzhydryl Compounds|Cosmetics|Dermatologicals|Household Products|Ketones|Protective Agents|Radiation-Protective Agents|Sunscreening Agents
DB01429	Aprindine	small molecule	experimental	Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ib|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Indans|Indenes|Membrane Transport Modulators|Sodium Channel Blockers|Voltage-Gated Sodium Channel Blockers
DB01430	Almitrine	small molecule	approved	Piperazines|Respiratory System Agents|Triazines
DB01431	Allylestrenol	small molecule	experimental	Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estranes|Estren Derivatives|Estrenes|Genito Urinary System and Sex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progestins|Sex Hormones and Modulators of the Genital System|Steroids
DB01432	Cholestyramine	small molecule	approved|investigational	Anion Exchange Resins|Anticholesteremic Agents|Benzene Derivatives|Benzylidene Compounds|Bile Acid Sequestrants|Bile-acid Binding Activity|Biomedical and Dental Materials|Hypolipidemic Agents|Ion Exchange Resins|Laboratory Chemicals|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Macromolecular Substances|Noxae|Plastics|Polymers|Polystyrenes|Styrene|Styrenes|Toxic Actions
DB01433	Methadyl acetate	small molecule	experimental|illicit	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Narcotics|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01434	19-norandrostenedione	small molecule	experimental|illicit	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB01435	Antipyrine	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics and Anesthetics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Methemoglobinemia Associated Agents|Nephrotoxic agents|Nervous System|Otologicals|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory Organs|Sensory System Agents
DB01436	Alfacalcidol	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Bone Density Conservation Agents|Cholestanes|Cholestenes|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Lipids|Membrane Lipids|Musculo-Skeletal System|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB01437	Glutethimide	small molecule	approved|illicit	Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 Enzyme Inducers|Hypnotics and Sedatives|Nervous System|Piperidinedione Derivatives|Piperidines|Piperidones|Psycholeptics
DB01438	Phenazopyridine	small molecule	approved	Amines|Aminopyridines|Antipruritics and Local Anesthetics|Genito Urinary System and Sex Hormones|Methemoglobinemia Associated Agents|Pyridines|Urologicals
DB01439	3-Methylthiofentanyl	small molecule	experimental|illicit	
DB01440	gamma-Hydroxybutyric acid	small molecule	approved|illicit|investigational	Acids, Acyclic|Adjuvants, Anesthesia|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Depression|Decreased Central Nervous System Organized Electrical Activity|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Hydroxybutyrates|Lipids
DB01441	5-Methoxy-N,N-diisopropyltryptamine	small molecule	experimental|illicit	Alkaloids|Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Indoles|Inflammation Mediators|Morphinans|Morphine Derivatives|Opiate Alkaloids|Phenanthrenes|Tryptamines
DB01442	MMDA	small molecule	experimental|illicit	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Depressants|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics
DB01443	19-Nor-5-androstenedione	small molecule	experimental|illicit	
DB01444	Dimethylthiambutene	small molecule	experimental|illicit	
DB01445	Bufotenine	small molecule	experimental|illicit	Amines|Amphibian Venoms|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Bodily Secretions|Central Nervous System Agents|Central Nervous System Depressants|Complex Mixtures|Fluids and Secretions|Hallucinogens|Indoles|Inflammation Mediators|N,N-Dimethyltryptamine|Neurotransmitter Agents|Psychotropic Drugs|Toxins, Biological|Tryptamines|Venoms
DB01446	Alpha-methyltryptamine	small molecule	experimental|illicit	Amines|Biogenic Amines|Biogenic Monoamines|Indoles|Stimulants
DB01447	4-Methylaminorex	small molecule	experimental|illicit	Street Drugs
DB01448	19-Nor-4-androstenedione	small molecule	experimental|illicit	
DB01450	Dihydroetorphine	small molecule	experimental|illicit	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Morphinans|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01451	1-Androstenedione	small molecule	experimental|illicit	
DB01452	Diamorphine	small molecule	approved|illicit|investigational	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Morphinans|Morphine Derivatives|Narcotics|Nervous System|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents
DB01453	Beta-hydroxyfentanyl	small molecule	experimental|illicit	
DB01454	Midomafetamine	small molecule	experimental|illicit|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Ethylamines|Hallucinogens|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics
DB01455	19-Nor-5-androstenediol	small molecule	experimental|illicit	
DB01456	5-androstenedione	small molecule	experimental|illicit	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB01458	2,5-Dimethoxy-4-(n)-propylthiophenethylamine	small molecule	experimental|illicit	
DB01459	Bezitramide	small molecule	experimental|illicit|withdrawn	Analgesics|Central Nervous System Agents|Diphenylpropylamine Derivatives|Nervous System|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01460	Diethyltryptamine	small molecule	experimental|illicit	
DB01461	Dimenoxadol	small molecule	experimental|illicit	Acids, Carbocyclic|Diphenylacetic Acids|Hydroxy Acids|Phenylacetates
DB01462	Etonitazene	small molecule	experimental|illicit	
DB01463	Fencamfamine	small molecule	experimental|illicit|withdrawn	Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Monoterpenes|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs|Terpenes|Tranquilizing Agents
DB01464	Furethidine	small molecule	experimental|illicit	
DB01465	2,5-Dimethoxyamphetamine	small molecule	experimental|illicit	Amines|Ethylamines|Phenethylamines
DB01466	Ethylmorphine	small molecule	experimental|illicit	Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Morphinans|Morphine Derivatives|Narcotics|Ophthalmologicals|Opiate Alkaloids|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory Organs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01467	2,5-Dimethoxy-4-ethylamphetamine	small molecule	experimental|illicit	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB01468	Ethylmethylthiambutene	small molecule	experimental|illicit	
DB01469	Acetorphine	small molecule	experimental|illicit	
DB01470	Î±-methylthiofentanyl	small molecule	illicit	
DB01471	Bolasterone	small molecule	experimental|illicit	Anabolic Agents|Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01472	4-Methoxyamphetamine	small molecule	experimental|illicit	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Ethylamines|Hallucinogens|Phenethylamines|Psychotropic Drugs
DB01473	Betaprodine	small molecule	experimental|illicit	
DB01474	17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene	small molecule	experimental|illicit	
DB01475	Dioxaphetyl butyrate	small molecule	experimental|illicit	
DB01476	Haloxazolam	small molecule	experimental|illicit	Benzazepines
DB01477	Codeine methylbromide	small molecule	experimental|illicit	
DB01478	Desmethylprodine	small molecule	experimental|illicit	Isonipecotic Acids|Piperidines
DB01479	BA-2664	small molecule	experimental|illicit	
DB01480	Cyprenorphine	small molecule	experimental|illicit	Alkaloids|Opiate Alkaloids|Phenanthrenes
DB01481	1-Testosterone	small molecule	experimental|illicit|investigational	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01482	Fenethylline	small molecule	experimental	Alkaloids|Amines|Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP1A2 Substrates|Ethylamines|Nervous System|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Purines|Purinones|Xanthine derivatives
DB01483	Barbital	small molecule	illicit	Anticholinergic Agents|Anticonvulsants|Barbiturates|Barbiturates, Plain|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neurotransmitter Agents|Nicotinic Antagonists|Psycholeptics|Pyrimidines|Pyrimidinones
DB01484	4-Bromo-2,5-dimethoxyamphetamine	small molecule	experimental|illicit	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Depressants|Ethylamines|Hallucinogens|Neurotransmitter Agents|Phenethylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics
DB01485	4-Hydroxytestosterone	small molecule	experimental|illicit	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01486	Cathine	small molecule	experimental|illicit	Alcohols|Alimentary Tract and Metabolism|Amines|Amino Alcohols|Anti-Obesity Agents|Antiobesity Preparations, Excl. Diet Products|Appetite Depressants|Central Nervous System Agents|Centrally Acting Antiobesity Products|Propanolamines|Propanols
DB01487	Embutramide	small molecule	experimental|illicit	Acids, Carbocyclic|Amines|Aminobenzoates|Ammonium Compounds|Benzene Derivatives|Benzoates|Nitrogen Compounds|Onium Compounds|para-Aminobenzoates|Pharmaceutical Preparations
DB01488	Dimethyltryptamine	small molecule	experimental|illicit	Amines|Biogenic Amines|Biogenic Monoamines|Central Nervous System Agents|Central Nervous System Depressants|Hallucinogens|Indoles|Neurotransmitter Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tryptamines
DB01489	Camazepam	small molecule	experimental|illicit	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Depressants|Nervous System|Psycholeptics
DB01490	Aminorex	small molecule	experimental|illicit	Oxazoles
DB01491	Dipipanone	small molecule	experimental|illicit	Ketones
DB01493	Ethylestrenol	small molecule	withdrawn	Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Estren Derivatives|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnenes|Norsteroids|Steroids
DB01494	Chloral betaine	small molecule	illicit|withdrawn	
DB01495	Dichloralphenazone	small molecule	approved|illicit	Alcohols|Central Nervous System Depressants|Ethylene Glycols|Glycols|Hypnotics and Sedatives|Nervous System|Psycholeptics|Pyrazoles|Pyrazolones
DB01496	Barbituric acid derivative	small molecule	experimental|illicit	Anticholinergic Agents|Nicotinic Antagonists
DB01497	Etorphine	small molecule	illicit|vet_approved	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Morphinans|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01498	Alphamethadol	small molecule	experimental|illicit	
DB01499	Alphameprodine	small molecule	experimental|illicit	
DB01500	Oxabolone	small molecule	experimental|illicit	
DB01501	Difenoxin	small molecule	approved|illicit	Alimentary Tract and Metabolism|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Central Nervous System Depressants|Isonipecotic Acids|Piperidines
DB01502	Diampromide	small molecule	experimental|illicit	
DB01503	1-Androstenediol	small molecule	experimental|illicit	
DB01505	Etoxeridine	small molecule	experimental|illicit	
DB01506	1-Phenylcyclohexylamine	small molecule	experimental|illicit	Amines|Cyclohexanes|Cycloparaffins
DB01509	3,4-Methylenedioxyamphetamine	small molecule	experimental|illicit	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Depressants|Ethylamines|Hallucinogens|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sympathomimetics
DB01510	Dehydrochloromethyltestosterone	small molecule	experimental|illicit	
DB01511	Delorazepam	small molecule	experimental|illicit	Anticonvulsants|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants
DB01512	Hydromorphinol	small molecule	experimental|illicit	
DB01513	17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane	small molecule	experimental|illicit	
DB01514	Furazabol	small molecule	illicit	Androstanes|Steroids
DB01515	Benzoylecgonine	small molecule	experimental|illicit	Alkaloids|Aza Compounds|Azabicyclo Compounds|Tropanes
DB01516	3,4,5-Trimethoxyamphetamine	small molecule	experimental|illicit	
DB01518	Benzethidine	small molecule	experimental|illicit	
DB01520	Tenocyclidine	small molecule	experimental|illicit|investigational	Central Nervous System Agents|Neuroprotective Agents|NMDA Receptor Antagonists|Piperidines|Protective Agents|Street Drugs
DB01521	Clostebol	small molecule	experimental|illicit	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01522	Betacetylmethadol	small molecule	experimental|illicit	
DB01523	Clonitazene	small molecule	experimental|illicit	
DB01524	Androstenediol	small molecule	experimental|illicit	Anabolic Agents|Androstanes|Androstenediols|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01525	Ecgonine	small molecule	experimental|illicit	Alkaloids|Analgesics|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Narcotics|Peripheral Nervous System Agents|Sensory System Agents|Tropanes
DB01526	4-Androstenediol	small molecule	experimental|illicit	
DB01527	Clortermine	small molecule	experimental	
DB01528	4-Methyl-2,5-dimethoxyamphetamine	small molecule	experimental|illicit	
DB01529	Dextromoramide	small molecule	experimental|illicit	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Diphenylpropylamine Derivatives|Morpholines|Narcotics|Nervous System|Opioids|Oxazines|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01530	5alpha-androstane-3alpha,17beta-diol	small molecule	experimental|illicit	
DB01531	Desomorphine	small molecule	experimental|illicit	Alkaloids|Morphinans|Morphine Derivatives|Opiate Alkaloids|Phenanthrenes|Street Drugs
DB01532	Î±-Methylacetylfentanyl	small molecule	illicit	
DB01533	Diethylthiambutene	small molecule	experimental|illicit	Sulfur Compounds
DB01534	Chlorhexadol	small molecule	experimental|illicit	Aldehydes|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB01535	Carfentanil	small molecule	illicit|investigational|vet_approved	Analgesics|Carbon Radioisotopes|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01536	Androstenedione	small molecule	experimental|illicit	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB01537	4-Bromo-2,5-dimethoxyphenethylamine	small molecule	experimental|illicit	Amines|Ethylamines|Phenethylamines
DB01538	Acetyldihydrocodeine	small molecule	experimental|illicit	Cough and Cold Preparations|Opium Alkaloids and Derivatives
DB01539	1-Piperidinocyclohexanecarbonitrile	small molecule	experimental|illicit	Piperidines
DB01540	17alpha-methyl-4-hydroxynandrolone	small molecule	illicit	
DB01541	Boldenone	small molecule	illicit|vet_approved	Anabolic Agents|Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01542	Allylprodine	small molecule	experimental|illicit	
DB01543	18-methyl-19-nortestosterone	small molecule	experimental|illicit	
DB01544	Flunitrazepam	small molecule	approved|illicit	Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents|UGT1A1 Inhibitors|UGT1A3 Inhibitors
DB01545	Ethyl loflazepate	small molecule	experimental|illicit	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01546	Etryptamine	small molecule	illicit|investigational|withdrawn	Amines|Biogenic Amines|Biogenic Monoamines|Indoles|Stimulants
DB01547	Drotebanol	small molecule	experimental|illicit	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents
DB01548	Diprenorphine	small molecule	illicit|vet_approved	Alkaloids|Central Nervous System Agents|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents
DB01549	Rolicyclidine	small molecule	experimental|illicit	Piperidines
DB01550	Fenproporex	small molecule	experimental|illicit|withdrawn	Amines|Ethylamines|Phenethylamines|Stimulants
DB01551	Dihydrocodeine	small molecule	approved|illicit	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Morphinans|Morphine Derivatives|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Alkaloids|Opioid Agonist|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01552	Betameprodine	small molecule	experimental|illicit	
DB01553	Cloxazolam	small molecule	experimental	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Nervous System|Psycholeptics
DB01554	Bolandiol	small molecule	experimental|illicit	Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01555	Alphacetylmethadol	small molecule	experimental|illicit	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Narcotics|Opioids|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01556	Chlorphentermine	small molecule	illicit|withdrawn	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Autonomic Agents|Ethylamines|Peripheral Nervous System Agents|Phenethylamines|Phentermine|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB01557	Î±-Methylfentanyl	small molecule	illicit	Designer Drugs|Piperidines|Street Drugs
DB01558	Bromazepam	small molecule	approved|illicit|investigational	Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01559	Clotiazepam	small molecule	approved|illicit	Anti-Anxiety Agents|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Nervous System|Psycholeptics
DB01560	Cathinone	small molecule	illicit	Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Psychotropic Drugs
DB01561	Androstanedione	small molecule	experimental|illicit	
DB01562	1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine	small molecule	experimental|illicit	
DB01563	Chloral hydrate	small molecule	approved|illicit|investigational|vet_approved	Alcohols|Central Nervous System Agents|Central Nervous System Depressants|Ethylene Glycols|Glycols|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Psycholeptics
DB01564	Calusterone	small molecule	experimental|illicit	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB01565	Dihydromorphine	small molecule	experimental|illicit	Alkaloids|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Morphinans|Morphine Derivatives|Narcotics|Opiate Alkaloids|Opioids|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01566	Methylenedioxyethamphetamine	small molecule	experimental|illicit	
DB01567	Fludiazepam	small molecule	experimental|illicit	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Peripheral Nervous System Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01568	Codeine-N-oxide	small molecule	experimental|illicit	
DB01569	Formebolone	small molecule	experimental|illicit	Androstanes|Androstenes|Androstenols|Steroids
DB01570	Ohmefentanyl	small molecule	illicit	Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Piperidines|Sensory System Agents
DB01571	3-Methylfentanyl	small molecule	illicit	Analgesics|Central Nervous System Agents|Peripheral Nervous System Agents|Piperidines|Sensory System Agents
DB01572	Methyl-1-testosterone	small molecule	experimental|illicit	
DB01573	Benzylmorphine	small molecule	experimental|illicit	
DB01574	Attapulgite	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Intestinal Adsorbents|Protective Agents
DB01575	Kaolin	small molecule	approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum Silicates|Anions|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Electrolytes|Gastrointestinal Agents|Intestinal Adsorbents|Ions|Minerals|Oxides|Oxygen Compounds|Silicates|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB01576	Dextroamphetamine	small molecule	approved|illicit	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Agents|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB01577	Metamfetamine	small molecule	approved|illicit	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamine Anorectic|Amphetamines|Appetite Suppression|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP2D6 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Ethylamines|Increased Sympathetic Activity|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Phenethylamines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB01578	Metrizamide	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Carbohydrates|Contrast Media|Diagnostic Uses of Chemicals|Glycosides|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB01579	Phendimetrazine	small molecule	approved|illicit	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Appetite Suppression|Central Nervous System Agents|Central Nervous System Stimulants|Increased Sympathetic Activity|Oxazines|Sympathomimetic Amine Anorectic
DB01580	Oxprenolol	small molecule	approved	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Anti-Anxiety Agents|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Non-Selective|Beta Blocking Agents, Non-Selective, and Thiazides|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypotensive Agents|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT2 Inhibitors|Peripheral Nervous System Agents|Phenoxypropanolamines|Propanolamines|Propanols|QTc Prolonging Agents|Sympatholytics|Tranquilizing Agents|Vasodilating Agents
DB01581	Sulfamerazine	small molecule	approved|vet_approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB01582	Sulfamethazine	small molecule	approved|investigational|vet_approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB01583	Liotrix	small molecule	approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|l-Triiodothyronine|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inducers|Pharmaceutical Preparations|Thyroid Products|Thyronines
DB01584	Thyroglobulin	biotech	approved|withdrawn	Amino Acids, Peptides, and Proteins|Carbohydrates|Globulins|Glycoconjugates|Glycoproteins|Iodoproteins|Proteins
DB01586	Ursodeoxycholic acid	small molecule	approved|investigational	Alimentary Tract and Metabolism|Bile Acid Preparations|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cholagogues and Choleretics|Cholanes|Cholelitholytic Agents|Cholic Acids|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Deoxycholic Acid|Gastrointestinal Agents|Steroids
DB01587	Ketazolam	small molecule	approved	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Nervous System|P-glycoprotein/ABCB1 Substrates|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01588	Prazepam	small molecule	approved|illicit	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01589	Quazepam	small molecule	approved|illicit	Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB01590	Everolimus	small molecule	approved	Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A4 Inhibitors|Decreased Immunologic Activity|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Kinase Inhibitor|Lactones|Macrolides|mTOR Inhibitor Immunosuppressant|mTOR Inhibitors|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|Polyketides|Protein Kinase Inhibitors|Selective Immunosuppressants|Sirolimus
DB01591	Solifenacin	small molecule	approved	Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Cholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Urinary Frequency and Incontinence|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Isoquinolines|Muscarinic Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinuclidines|Tetrahydroisoquinolines|Urological Agents|Urologicals
DB01592	Iron	small molecule	approved	Alimentary Tract and Metabolism|Antianemic Preparations|Blood and Blood Forming Organs|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Iron Compounds|Iron Preparations|Metals|Metals, Heavy|Micronutrients|Minerals|Organometallic Compounds|Physiological Phenomena|Supplements|Trace Elements|Transition Elements
DB01593	Zinc	small molecule	approved|investigational	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Copper Absorption Inhibitor|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Laxatives|Metals|Metals, Heavy|Micronutrients|Minerals|Osmotic Laxative|Physiological Phenomena|Replacement Preparations|Trace Elements|Transition Elements|Vasoprotectives|Zinc Compounds
DB01594	Cinolazepam	small molecule	experimental	Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB01595	Nitrazepam	small molecule	approved	Anti-Anxiety Agents|Anticonvulsants|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01597	Cilastatin	small molecule	approved|investigational	Cycloparaffins|Cyclopropanes|Dipeptidase Inhibitors|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|OAT3/SLC22A8 Inhibitors|Renal Dehydropeptidase Inhibitor
DB01598	Imipenem	small molecule	approved	Agents that reduce seizure threshold|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Carbapenems|Lactams|Neurotoxic agents|Penem Antibacterial|Sulfur Compounds|Thienamycins
DB01599	Probucol	small molecule	approved|investigational	Anticholesteremic Agents|Antioxidants|Benzene Derivatives|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Moderate Risk QTc-Prolonging Agents|Noxae|Phenols|Protective Agents|QTc Prolonging Agents|Toxic Actions
DB01600	Tiaprofenic acid	small molecule	approved	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Photosensitizing Agents|Propionates|Prostaglandin Antagonists|Sensory System Agents
DB01601	Lopinavir	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BSEP/ABCB11 Substrates|Chemically-Induced Disorders|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|HIV Protease Inhibitors|Hyperglycemia-Associated Agents|Nephrotoxic agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protease Inhibitors|Pyrimidines|Pyrimidinones|QTc Prolonging Agents
DB01602	Bacampicillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB01603	Meticillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Resistant Penicillins|beta-Lactams|Lactams|Penicillins|Sulfur Compounds
DB01604	Pivampicillin	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB01605	Pivmecillinam	small molecule	approved	Amdinocillin|Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillins|Penicillins With Extended Spectrum|Renal Agents|Sulfur Compounds
DB01606	Tazobactam	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactamase Inhibitors|beta-Lactams|Enzyme Inhibitors|Lactams|OAT3/SLC22A8 Substrates|Sulfur Compounds
DB01607	Ticarcillin	small molecule	approved|investigational|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB01608	Periciazine	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Depressants|Dopamine Antagonists|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperidine Structure|Psycholeptics|Sulfur Compounds
DB01609	Deferasirox	small molecule	approved|investigational	Acids, Carbocyclic|Benzene Derivatives|Chelating Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 3A4 Inducers|Heavy Metal Antagonists|Iron Chelating Activity|Iron Chelating Agents|Sequestering Agents|UGT1A1 Inhibitors|UGT1A3 Inhibitors|UGT1A9 Inhibitors
DB01610	Valganciclovir	small molecule	approved|investigational	Acyclovir|Agents that reduce seizure threshold|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor|Direct Acting Antivirals|Guanine|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleoside Analog Antiviral|Nucleosides and Nucleotides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Purines|Purinones
DB01611	Hydroxychloroquine	small molecule	approved	Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Chloroquine|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines
DB01612	Amyl Nitrite	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Antianginal Agents|Antidotes|Cardiovascular Agents|Electrolytes|Hypotensive Agents|Ions|Methemoglobinemia Associated Agents|Nitrites|Nitrogen Compounds|Nitrous Acid|Organic Nitrates|Vasodilating Agents
DB01613	Erythrityl tetranitrate	small molecule	approved|experimental|investigational	Acids|Acids, Noncarboxylic|Alcohols|Anions|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Electrolytes|Erythritol|Ions|Nitrates|Nitric Acid|Nitrogen Compounds|Organic Nitrates|Sugar Alcohols|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB01614	Acepromazine	small molecule	experimental|vet_approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Psycholeptics|Psychotropic Drugs|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB01615	Aceprometazine	small molecule	experimental	Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Psychotropic Drugs|QTc Prolonging Agents|Sulfur Compounds|Tranquilizing Agents
DB01616	Alverine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Amines|Autonomic Agents|Central Nervous System Depressants|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB01618	Molindone	small molecule	approved	Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Indole Derivatives|Indoles|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB01619	Phenindamine	small molecule	approved	Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents
DB01620	Pheniramine	small molecule	approved	Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Substituted Alkylamines
DB01621	Pipotiazine	small molecule	approved|investigational	Antipsychotic Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperidine Structure|Psycholeptics|Sulfur Compounds
DB01622	Thioproperazine	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds
DB01623	Thiothixene	small molecule	approved	Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes
DB01624	Zuclopenthixol	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes
DB01625	Isopropamide	small molecule	approved|vet_approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Nitrogen Compounds|Onium Compounds|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB01626	Pargyline	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Antihypertensive Agents|Benzene Derivatives|Benzyl Compounds|Benzylamines|Cardiovascular Agents|Central Nervous System Depressants|Enzyme Inhibitors|MAO Inhibitors and Diuretics|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB01627	Lincomycin	small molecule	approved|vet_approved	Agents that produce neuromuscular block (indirect)|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Enzyme Inhibitors|Glycosides|Lincosamides|Macrolides, Lincosamides and Streptogramins|Neurotoxic agents|Protein Synthesis Inhibitors|Pyrrolidines
DB01628	Etoricoxib	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfur Compounds
DB01629	5-Fluorouridine	small molecule	experimental	Carbohydrates|Fluorouracil and prodrugs|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB01630	SC-74020	small molecule	experimental	Amides|Amines|Hydroxy Acids|Hydroxylamines|Sulfones|Sulfur Compounds
DB01631	Methyl Nonanoate (Ester)	small molecule	experimental	
DB01632	5-O-phosphono-alpha-D-ribofuranosyl diphosphate	small molecule	approved|experimental|investigational	Carbohydrates|Pentosephosphates|Sugar Phosphates
DB01633	Deoxy-2-Fluoro-B-D-Cellotrioside	small molecule	experimental|investigational	
DB01634	2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine	small molecule	experimental	
DB01635	2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine	small molecule	experimental	
DB01636	Clorocruoro Hem	small molecule	experimental	
DB01637	3,7,11,15-Tetramethyl-Hexadecan-1-Ol	small molecule	experimental|investigational	
DB01638	Sorbitol	small molecule	approved	Alcohols|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Diagnostic Agents|Diet, Food, and Nutrition|Drugs for Constipation|Enemas|Flavoring Agents|Food|Food Additives|Food and Beverages|Gastrointestinal Agents|Indicators and Reagents|Irrigating Solutions|Laboratory Chemicals|Laxatives|Osmotic Laxative|Physiological Phenomena|Sugar Alcohols|Sweetening Agents|Tests for Bile Duct Patency
DB01639	N-Methyl-Pyridoxal-5'-Phosphate	small molecule	experimental	
DB01640	(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One	small molecule	experimental	
DB01641	(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One	small molecule	experimental	
DB01642	O1-Methyl-Glucose	small molecule	experimental	
DB01643	Thymidine monophosphate	small molecule	experimental	Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Thymine Nucleotides
DB01644	3,6-Dihydroxy-Xanthene-9-Propionic Acid	small molecule	experimental	
DB01645	Genistein	small molecule	investigational	Anticarcinogenic Agents|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Estrogens, Non-Steroidal|Flavonoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Isoflavones|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Phytoestrogens|Protective Agents|Protein Kinase Inhibitors|Pyrans|Tyrosine Kinase Inhibitors
DB01646	N-Acetylmethionine	small molecule	experimental	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds
DB01647	Daxalipram	small molecule	experimental	
DB01648	O1-Methyl-4-Deoxy-4-Thio-Beta-D-Glucose	small molecule	experimental	
DB01649	7-Methyl-Gpppa	small molecule	experimental	
DB01650	trans-2-hydroxycinnamic acid	small molecule	experimental	OAT3/SLC22A8 Inhibitors
DB01651	Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside	small molecule	experimental	
DB01652	4-Hydroxybenzoyl Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB01655	L-gulonic acid 6-phosphate	small molecule	experimental	
DB01656	Roflumilast	small molecule	approved	Acids, Carbocyclic|Agents to Treat Airway Disease|Amides|Amines|Benzene Derivatives|Benzoates|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Pyridines
DB01657	2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid	small molecule	experimental	
DB01658	1'-Deazo-Thiamin Diphosphate	small molecule	experimental	
DB01659	3-(1,10-Phenanthrol-2-Yl)-L-Alanine	small molecule	experimental	
DB01661	1-(5-phospho-D-ribosyl)-ATP	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB01662	Trans-O-Hydroxy-Alpha-Methyl Cinnamate	small molecule	experimental	
DB01663	Lambda-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (II)	small molecule	experimental	
DB01664	(S)-Des-Me-Ampa	small molecule	experimental	
DB01665	ZK-800270	small molecule	experimental	
DB01666	D-Myo-Inositol-Hexasulphate	small molecule	experimental	
DB01667	8-azaguanine	small molecule	experimental	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Aza Compounds|Cytochrome P-450 CYP1A2 Substrates|Guanine|Noxae|Purines|Purinones|Toxic Actions|Xanthine derivatives
DB01668	Nanaomycin D	small molecule	experimental	Naphthalenes|Quinones
DB01669	Virginiamycin M1	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Peptides, Cyclic|Streptogramin Group A|Streptogramins|Virginiamycin
DB01670	Propyl acetate	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB01671	4-(Hydroxymercury)Benzoic Acid	small molecule	experimental	
DB01672	2,3-Dihydroxy-Benzoic Acid	small molecule	experimental	
DB01673	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine	small molecule	experimental	
DB01674	[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid	small molecule	experimental	
DB01675	Methacrylyl-Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB01676	Trinitrotoluene	small molecule	experimental	Benzene Derivatives|Explosive Agents|Toluene
DB01677	Fumaric Acid	small molecule	experimental|investigational	Acids, Acyclic|Antipsoriatics|Antipsoriatics for Topical Use|Dermatologicals|Dicarboxylic Acids
DB01678	RU84687	small molecule	experimental	
DB01679	Propyl Trihydrogen Diphosphate	small molecule	experimental	
DB01681	Benzene Hexacarboxylic Acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives
DB01682	6'-Methyl-Thiamin Diphosphate	small molecule	experimental	
DB01683	Chymostatin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Chymotrypsin, antagonists & inhibitors|Enzyme Inhibitors|Peptides|Serine Proteinase Inhibitors
DB01684	1-Hydroxy-1-Thio-Glycerol	small molecule	experimental	
DB01685	Topiroxostat	small molecule	experimental	BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|OAT3/SLC22A8 Inhibitors|UGT1A9 Substrates
DB01686	N,N-dimethylarginine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors
DB01687	beta-Mannobiose	small molecule	experimental	
DB01688	P-Cresol	small molecule	experimental	Benzene Derivatives|Phenols
DB01689	Inhibitor Idd 384	small molecule	experimental	
DB01690	Bis(Adenosine)-5'-Triphosphate	small molecule	experimental	
DB01691	Indole Naphthyridinone	small molecule	experimental	
DB01692	Dithioerythritol	small molecule	experimental	Alcohols|Carbohydrates|Glycosides|Indicators and Reagents|Laboratory Chemicals|Sugar Alcohols|Sulfhydryl Reagents|Sulfur Compounds|Thioglycosides
DB01694	D-tartaric acid	small molecule	experimental	
DB01695	N-Hydroxy-4-Phosphono-Butanamide	small molecule	experimental	
DB01697	beta-cellotriose	small molecule	experimental	
DB01698	Rutin	small molecule	approved|experimental|investigational	Benzopyrans|Capillary Stabilizing Agents|Chromones|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Flavonoids|Flavonols|Pyrans|Vasoprotectives
DB01699	(4e)-4-Aminohex-4-Enoic Acid	small molecule	experimental	
DB01700	AICA ribonucleotide	small molecule	experimental|investigational	Blood Glucose Lowering Agents|Carbohydrates|Glycosides|Imidazoles|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides
DB01701	1,2-Dichloro-Propane	small molecule	experimental	
DB01702	2-(3,4-Dihydroxyphenyl)Acetic Acid	small molecule	experimental	
DB01703	N-(2-Ferrocenylethyl)Maleimide	small molecule	experimental	
DB01704	2,4-Dihydroxy-Trans Cinnamic Acid	small molecule	experimental	
DB01705	Bis(5-Amidino-Benzimidazolyl)Methane	small molecule	experimental	
DB01706	2-Bromo-6-Chloro-Purine	small molecule	experimental	
DB01707	L-Alfa-Lysophosphatidylcholine, Lauroyl	small molecule	experimental	
DB01708	Prasterone	small molecule	approved|investigational|nutraceutical	17-Ketosteroids|Adjuvants, Immunologic|Adrenal Cortex Hormones|Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens and Estrogens|Androstan Derivatives|Androstanes|Androstenes|Androstenols|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Ketosteroids|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners
DB01709	2-phospho-D-glyceric acid	small molecule	experimental	
DB01710	Porphyrin Fe(III)	small molecule	experimental	
DB01711	2,3,4,5,6-Pentafluorobenzyl Alcohol	small molecule	experimental	Alcohols|Benzene Derivatives|Benzyl Compounds
DB01712	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester	small molecule	experimental	
DB01713	Udp-Alpha-D-Xylopyranose	small molecule	experimental	
DB01714	N-Methyl-Lysine	small molecule	experimental	
DB01715	7,8-Diamino-Nonanoic Acid	small molecule	experimental	
DB01716	2-Propenyl-N-Acetyl-Neuramic Acid	small molecule	experimental	
DB01717	Bis(Adenosine)-5'-Pentaphosphate	small molecule	experimental	
DB01718	Cetrimonium	small molecule	approved	Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Detergents|Household Products|Medicated Shampoos|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Surface-Active Agents|Throat Preparations|Trimethyl Ammonium Compounds
DB01719	Thio-Maltopentaose	small molecule	experimental	
DB01720	(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid	small molecule	experimental	
DB01721	Analogue of Indinavir Drug	small molecule	experimental	
DB01723	{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid	small molecule	experimental	
DB01724	Reduced Threonine	small molecule	experimental	
DB01725	2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide	small molecule	experimental	
DB01726	2-Aminophenol	small molecule	experimental	Amines|Aniline Compounds|Benzene Derivatives|Phenols
DB01727	Isocitric Acid	small molecule	experimental	Acids, Acyclic|Citrates|Tricarboxylic Acids
DB01728	3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol	small molecule	experimental	
DB01729	(1s,3s,4s)-1,3,4-Triphospho-Myo-Inositol	small molecule	experimental	
DB01731	(S)-Wiskostatin	small molecule	experimental	
DB01732	(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One	small molecule	experimental	
DB01733	L-Phospholactate	small molecule	experimental	
DB01734	3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid	small molecule	experimental	
DB01735	3-Chloroalaninate	small molecule	experimental	
DB01736	[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium	small molecule	experimental	
DB01737	Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester	small molecule	experimental	
DB01738	Phosphorylcolamine	small molecule	experimental	Alcohols|Amines|Amino Alcohols
DB01739	Allo-Isoleucine	small molecule	experimental	
DB01740	2-Amino-4-Butyl-5-Propylselenazole	small molecule	experimental	
DB01741	CRA_17693	small molecule	experimental	
DB01742	(3r)-1-Acetyl-3-Methylpiperidine	small molecule	experimental	
DB01744	Camphor	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Antipruritics and Local Anesthetics|Basic Lotions and Liniments|Biological Products|Bornanes|Cardiac Therapy|Complex Mixtures|Ketones|Monoterpenes|Norbornanes|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Terpenes
DB01745	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester	small molecule	experimental	
DB01746	D-Leucine	small molecule	experimental	
DB01747	Coprogen	small molecule	experimental	Amines|Hydroxy Acids|Hydroxylamines|Siderophores
DB01748	N-Benzyl-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB01749	1,2-Dimethoxyethane	small molecule	experimental	Ethers
DB01750	1-naphthaleneacetic acid	small molecule	experimental	Naphthalenes
DB01751	3,3',5,5'-Tetraiodothyroacetic Acid	small molecule	experimental	
DB01752	S-adenosyl-L-homocysteine	small molecule	experimental	Adenosine|Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Carbohydrates|Glycosides|Homocysteine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds
DB01753	4-Oxo-Nicotinamide-Adenine Dinucleotide Phosphate	small molecule	experimental	
DB01754	3,4-Dihydroxy-1-Methylquinolin-2(1h)-One	small molecule	experimental	
DB01755	N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone	small molecule	experimental	
DB01756	4-phospho-L-threonic acid	small molecule	experimental	
DB01758	3-Iodo-Tyrosine	small molecule	experimental	
DB01759	Kojic acid	small molecule	experimental	Antioxidants|Mycotoxins|Protective Agents|Pyrans
DB01760	2-Methoxy-3-Isopropylpyrazine	small molecule	experimental	
DB01761	4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine	small molecule	experimental	
DB01762	Acetoacetic Acid	small molecule	experimental	Keto Acids|Ketone Bodies|Ketones
DB01763	7-thionicotinamide-adenine-dinucleotide phosphate	small molecule	experimental	
DB01764	Dalfopristin	small molecule	approved	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Peptides|Peptides, Cyclic|Streptogramin Antibacterial|Streptogramins
DB01765	(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid	small molecule	experimental	
DB01766	Beta-(2-Naphthyl)-Alanine	small molecule	experimental	
DB01767	Hemi-Babim	small molecule	experimental	
DB01768	Methylumbelliferyl Sialic Acid	small molecule	experimental	
DB01771	CRA_10991	small molecule	experimental	
DB01772	3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione	small molecule	experimental	
DB01773	4-[3-Carboxymethyl-3-(4-Phosphonooxy-Benzyl)-Ureido]-4-[(3-Cyclohexyl-Propyl)-Methyl-Carbamoyl]Butyric Acid	small molecule	experimental	
DB01774	Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester	small molecule	experimental	
DB01775	Dihydroxyacetone	small molecule	experimental	Carbohydrates|Ketoses|Monosaccharides|Trioses
DB01776	M-Cresol	small molecule	experimental	Benzene Derivatives|Phenols
DB01777	Coa-S-Trimethylene-Acetyl-Tryptamine	small molecule	experimental	
DB01778	8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione	small molecule	experimental	
DB01779	Glycerol-2-Phosphate	small molecule	experimental	
DB01780	Fusicoccin	small molecule	experimental	Carbohydrates|Mycotoxins
DB01782	2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One	small molecule	experimental	
DB01783	Pantothenic acid	small molecule	approved|nutraceutical|vet_approved	Alanine|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|beta-Alanine|Blood Coagulation Factors|Cicatrizants|Dermatologicals|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Imides|Micronutrients|Physiological Phenomena|Preparations for Treatment of Wounds and Ulcers|Vitamin B Complex|Vitamins
DB01784	4-Flourobenzenesulfonamide	small molecule	experimental	
DB01785	Dimethylallyl Diphosphate	small molecule	experimental	Terpenes
DB01786	D-Alanine	small molecule	experimental	
DB01788	4-Imino-5-Methidyl-2-Methylpyrimidine	small molecule	experimental	
DB01789	1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene	small molecule	experimental	
DB01790	Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate	small molecule	experimental	
DB01791	Piclamilast	small molecule	experimental	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors
DB01792	Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate	small molecule	experimental	
DB01793	SB-409513	small molecule	experimental	
DB01794	bis(molybdopterin)tungsten cofactor	small molecule	experimental	
DB01795	Phenyl Boronic Acid	small molecule	experimental	
DB01796	Quinolinic Acid	small molecule	experimental	Pyridines|Quinolinic Acids
DB01797	(2R)-2-(aminomethyl)-2,4-dihydroxy-5-oxo-3-(2-oxoethyl)-2,5-dihydro-1h-imidazol-3-ium	small molecule	experimental	
DB01798	Ethyl Dihydrogen Diphosphate	small molecule	experimental	
DB01799	4-Hydroxy-3-Methyl Butyl Diphosphate	small molecule	experimental	
DB01800	N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium	small molecule	experimental	
DB01802	(4r)-7aza-7,8-Dihydrolimonene	small molecule	experimental	
DB01803	2-(Trimethylammonium)Ethyl Thiol	small molecule	experimental	
DB01804	2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate	small molecule	experimental	
DB01805	Monoisopropylphosphorylserine	small molecule	experimental	
DB01806	10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Yloxy)-Tetrahydro-Pyrane-2-Yloxy]-6-Methyl-Tetrahydro-Pyran-2-Yloxy}-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	small molecule	experimental	
DB01807	N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea	small molecule	experimental	
DB01808	Thiarsahydroxy-Cysteine	small molecule	experimental	
DB01809	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	small molecule	experimental	
DB01810	[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester	small molecule	experimental	
DB01811	3h-Indole-5,6-Diol	small molecule	experimental	
DB01812	Adenosine-3'-5'-Diphosphate	small molecule	experimental	
DB01813	Pyridoxyl-Glutamic Acid-5'-Monophosphate	small molecule	experimental	
DB01814	2-Tridecanoyloxy-Pentadecanoic Acid	small molecule	experimental	
DB01815	Nz-(Dicarboxymethyl)Lysine	small molecule	experimental	
DB01816	Castanospermine	small molecule	experimental	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|beta-Glucosidase, antagonists & inhibitors|Central Nervous System Agents|Enzyme Inhibitors|Glucosylceramidase, antagonists & inhibitors|Glycoside Hydrolase Inhibitors|Immunologic Factors|Immunosuppressive Agents|Peripheral Nervous System Agents|Sensory System Agents|Stereoisomerism
DB01817	Threonine-Aspartic Ester	small molecule	experimental	
DB01818	O3-Sulfonylgalactose	small molecule	experimental	
DB01819	Phosphoenolpyruvate	small molecule	experimental	Hydroxy Acids
DB01820	Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide	small molecule	experimental	
DB01821	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	small molecule	experimental	
DB01822	(4R,5R)-1,2-dithiane-4,5-diol	small molecule	experimental	
DB01823	Beta-D-Glucopyranose Spirohydantoin	small molecule	experimental	
DB01824	(3s)-Tetrahydrofuran-3-Yl (1r,2s)-3-[4-((1r)-2-{[(S)-Amino(Hydroxy)Methyl]Oxy}-2,3-Dihydro-1h-Inden-1-Yl)-2-Benzyl-3-Oxopyrrolidin-2-Yl]-1-Benzyl-2-Hydroxypropylcarbamate	small molecule	experimental	
DB01825	2-Amino-8-Methylquinazolin-4(3h)-One	small molecule	experimental	
DB01826	N-Butyl Isocyanide	small molecule	experimental	
DB01827	2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide	small molecule	experimental	
DB01828	Methylamine	small molecule	experimental	Amines
DB01829	Desulfo-Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB01830	{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid	small molecule	experimental	
DB01831	Tryptophanyl-5'amp	small molecule	experimental	
DB01832	4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid	small molecule	experimental	
DB01833	L-2-Amino-4-(Guanidinooxy)Butyric Acid	small molecule	experimental	
DB01834	(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene	small molecule	experimental	
DB01835	4r-Fluoro-N6-Ethanimidoyl-L-Lysine	small molecule	experimental	
DB01836	[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone	small molecule	experimental	
DB01837	O-acetyl-L-serine	small molecule	experimental	
DB01838	6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone	small molecule	experimental	
DB01839	Propylene glycol	small molecule	approved|investigational	Alcohols|Drug Delivery Systems|Glycols|Pegylated agents|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Propylene Glycols|Solvents
DB01840	2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate	small molecule	experimental	Alcohols|Carbohydrates|Myo-Inositol-1-Phosphate Synthase, antagonists & inhibitors|Sugar Alcohols
DB01841	4,6-Dideoxyglucose	small molecule	experimental	
DB01842	3'-Phosphate-Adenosine-5'-Diphosphate	small molecule	experimental	
DB01843	3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	small molecule	experimental	
DB01844	N,N-dimethylformamide	small molecule	experimental	Acids, Acyclic|Amides|Formamides|Formates
DB01846	Oxidized Coenzyme A	small molecule	experimental	
DB01847	N-Carbamyl-D-Valine	small molecule	experimental	
DB01849	3,4-Dihydrouracil	small molecule	experimental	
DB01850	(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid	small molecule	experimental	
DB01851	Tetrabutylammonium Ion	small molecule	experimental	
DB01852	Kaempherol	small molecule	experimental	
DB01853	Bacteriochlorophyll A	small molecule	experimental	Amino Acids, Peptides, and Proteins|Bacteriochlorophylls|Biological Factors|Chlorophyll|Metalloporphyrins|Photoreceptors, Microbial|Pigments, Biological|Porphyrins|Proteins
DB01854	5-Bromonicotinamide	small molecule	experimental	
DB01855	5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid	small molecule	experimental	
DB01856	Pimelic Acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids
DB01857	Phosphoaspartate	small molecule	experimental	
DB01858	[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate	small molecule	experimental	
DB01859	4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate	small molecule	experimental	Alcohols|Carbohydrates|Sugar Alcohols
DB01860	Cordycepin Triphosphate	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB01861	Uridine diphosphate glucose	small molecule	experimental	Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Diphosphate Sugars|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides|Uridine Diphosphate|Uridine Diphosphate Sugars
DB01862	Isopropyl beta-D-thiogalactopyranoside	small molecule	experimental	Carbohydrates|Galactosides|Glycosides|Sulfur Compounds|Thiogalactosides|Thioglycosides
DB01863	Inositol 1,3,4,5-Tetrakisphosphate	small molecule	experimental	Alcohols|Carbohydrates|Inositol|Sugar Alcohols|Sugar Phosphates
DB01864	5'-Guanosine-Diphosphate-Monothiophosphate	small molecule	experimental	
DB01865	3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide	small molecule	experimental	
DB01866	RU79256	small molecule	experimental	
DB01868	Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate	small molecule	experimental	
DB01870	1,4-dithio-alpha-D-glucopyranose	small molecule	experimental	
DB01871	[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester	small molecule	experimental	
DB01872	2-deoxy-2-acetamido-beta-D-galactose-4-sulfate	small molecule	experimental	
DB01873	Epothilone D	small molecule	experimental|investigational	Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides|Tubulin Modulators
DB01874	Tropinone	small molecule	experimental	Alkaloids|Aza Compounds|Azabicyclo Compounds
DB01875	8-Azaxanthine	small molecule	experimental	Alkaloids|Purines|Purinones
DB01876	Bis(5-Amidino-2-Benzimidazolyl)Methanone	small molecule	experimental	
DB01877	N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide	small molecule	experimental	
DB01878	Benzophenone	small molecule	approved	Benzene Derivatives|Benzhydryl Compounds|Dermatologicals|Ketones|Photosensitizing Agents|Radiation-Sensitizing Agents
DB01879	(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid	small molecule	experimental	
DB01880	3,4-Dihydroxycinnamic Acid	small molecule	experimental|investigational	Acids, Carbocyclic|Antioxidants|Cinnamates|Protective Agents
DB01881	2-Methylpentane-1,2,4-Triol	small molecule	experimental	
DB01882	(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol	small molecule	experimental	
DB01883	N-(Sulfanylacetyl)Tyrosylprolylmethioninamide	small molecule	experimental	
DB01884	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	small molecule	experimental	
DB01885	D-Galctopyranosyl-1-On	small molecule	experimental	
DB01887	Inhibitor BEA369	small molecule	experimental	
DB01888	4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide	small molecule	experimental	
DB01889	16,17-Androstene-3-Ol	small molecule	experimental	
DB01890	N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide	small molecule	experimental	
DB01891	Tl-3-093	small molecule	experimental	
DB01892	Hyperforin	small molecule	nutraceutical	Benzene Derivatives|OATP1B1/SLCO1B1 Inhibitors|Phenols
DB01893	N6-Benzyl Adenosine-5'-Diphosphate	small molecule	experimental	
DB01895	Aspartyl-Adenosine-5'-Monophosphate	small molecule	experimental	
DB01896	M-Aminophenylboronic Acid	small molecule	experimental	
DB01897	2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride	small molecule	experimental	
DB01898	(2S,3S)-2-azanyl-3-methyl-pentanedioic acid	small molecule	experimental	
DB01899	Nd1-Phosphonohistidine	small molecule	experimental	
DB01901	Sucrosofate	small molecule	experimental	Anti-Ulcer Agents|Carbohydrates|Disaccharides|Gastrointestinal Agents|Oligosaccharides|Polysaccharides
DB01902	1-Ethyl-Pyrrolidine-2,5-Dione	small molecule	experimental	
DB01903	5-Bromo-2'-Deoxyuridine-5'-Monophosphate	small molecule	experimental	
DB01905	2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine	small molecule	experimental	
DB01906	3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid	small molecule	experimental	
DB01908	RU85493	small molecule	experimental	
DB01909	Alpha-Cyclodextrin (Cyclohexa-Amylose)	small molecule	experimental	
DB01910	Sinefungin	small molecule	experimental	Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB01911	N-Methylmesoporphyrin	small molecule	experimental	Biological Factors|Pigments, Biological|Porphyrins
DB01912	2,2':6',2''-Terpyridine Platinum(Ii)	small molecule	experimental	
DB01914	D-glucose	small molecule	approved|investigational|vet_approved	Carbohydrates|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Hexoses|Monosaccharides|Physiological Phenomena|Sweetening Agents
DB01915	S-Hydroxycysteine	small molecule	experimental	
DB01917	Putrescine	small molecule	experimental	Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Polyamines
DB01918	[Methyltelluro]Acetate	small molecule	experimental	
DB01919	Pentanal	small molecule	experimental	
DB01920	1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose	small molecule	experimental	
DB01921	Xylose-Derived Lactam Oxime	small molecule	experimental	
DB01922	Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam	small molecule	experimental	
DB01923	L-Xylulose 5-Phosphate	small molecule	experimental	
DB01924	Benzhydroxamic Acid	small molecule	experimental	Amines|Benzoates|Hydroxy Acids|Hydroxylamines
DB01925	2'-Chloro-Biphenyl-2,3-Diol	small molecule	experimental	
DB01926	Carboxymycobactin S	small molecule	experimental	
DB01927	Duroquinone	small molecule	experimental	Quinones
DB01929	5-Chloryl-2,4,6-Quinazolinetriamine	small molecule	experimental	
DB01930	2,4-Dihydroxy-3,3-Dimethyl-Butyrate	small molecule	experimental	
DB01931	Dcka, 5,7-Dichlorokynurenic Acid	small molecule	experimental	
DB01932	5-Methylpyrrole	small molecule	experimental	
DB01933	7-Hydroxystaurosporine	small molecule	experimental|investigational	Alkaloids|Antineoplastic Agents|Carbazoles|Enzyme Inhibitors|Indole Alkaloids|Indoles|Protein Kinase C, antagonists & inhibitors|Protein Kinase Inhibitors
DB01934	N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide	small molecule	experimental	
DB01935	3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid	small molecule	experimental	
DB01936	alpha-D-arabinofuranose	small molecule	experimental|investigational	
DB01937	Guanosine-2'-Monophosphate	small molecule	experimental	
DB01938	L-Histidine Beta Naphthylamide	small molecule	experimental	
DB01939	5-Amidino-Benzimidazole	small molecule	experimental	
DB01940	Balanol Analog 2	small molecule	experimental	
DB01941	6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid	small molecule	experimental	Ligands|Naphthalenes|Pyridines
DB01942	Formic Acid	small molecule	approved|experimental|investigational	Acids, Acyclic|Blood Coagulation Factors|Hemostatics
DB01944	(S)-blebbistatin	small molecule	experimental	
DB01945	4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate	small molecule	experimental	
DB01946	3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione	small molecule	experimental	
DB01947	RU78262	small molecule	experimental	
DB01948	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One	small molecule	experimental	
DB01949	2-Amino-N,3,3-Trimethylbutanamide	small molecule	experimental	
DB01950	N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea	small molecule	experimental	Glycogen Synthase Kinase 3, antagonists & inhibitors|Sulfur Compounds
DB01951	Gpi-1046	small molecule	experimental	
DB01952	1,N6-Ethenoadenine	small molecule	experimental	
DB01953	Inhibitor of P38 Kinase	small molecule	experimental	
DB01954	Rolipram	small molecule	investigational	Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Psychotropic Drugs|Pyrrolidines|Pyrrolidinones
DB01955	1,4-Butanediol	small molecule	experimental	Alcohols|Glycols
DB01956	Taurine	small molecule	approved|nutraceutical	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB01957	3-Chlorophenol	small molecule	experimental	Benzene Derivatives|Chlorobenzenes|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenols
DB01958	5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine	small molecule	experimental	
DB01959	3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	small molecule	experimental	
DB01960	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	small molecule	experimental	
DB01961	Cytidine 3'-monophosphate	small molecule	experimental	Carbohydrates|Cytosine Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides
DB01962	Phosphonotyrosine	small molecule	experimental	
DB01963	Phenylethane Boronic Acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Boron Compounds
DB01964	AL5424	small molecule	experimental	
DB01965	2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate	small molecule	experimental	
DB01966	Di-Stearoyl-3-Sn-Phosphatidylethanolamine	small molecule	experimental	
DB01967	N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide	small molecule	experimental	
DB01968	2-Thioethenamine	small molecule	experimental	
DB01969	Trifluoroacetonyl Coenzyme A	small molecule	experimental	
DB01970	Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide	small molecule	experimental	
DB01971	trans-urocanic acid	small molecule	experimental	Acids, Acyclic|Acrylates|Imidazoles
DB01972	Guanosine-5'-Monophosphate	small molecule	experimental	
DB01973	O-Benzylsulfonyl-Serine	small molecule	experimental	
DB01974	2-Amino-3-[5-(Amino-Carboxy-Methyl)-2,3-Dihydro-Isoxazol-3-Ylsulfanyl]-Propionic Acid	small molecule	experimental	
DB01975	AMPCPR	small molecule	experimental	
DB01976	Aminoanthracene	small molecule	experimental	
DB01977	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	small molecule	experimental	
DB01978	7,9-Dimethylguanine	small molecule	experimental	Purines|Purinones|Xanthine derivatives
DB01979	Methyl alpha-D-mannoside	small molecule	experimental	
DB01980	Para-Iodo-D-Phenylalanine Hydroxamic Acid	small molecule	experimental	
DB01981	3,6-Anhydro-D-Galactose-2-Sulfate	small molecule	experimental	
DB01982	D-Mannuronic Acid	small molecule	experimental	
DB01983	2(S)-Amino-6-Boronohexanoic Acid	small molecule	experimental	
DB01984	4-[2-(3-Benzyloxycarbonylamino-4-Cyclohexyl-1-Hydroxy-2-Oxo-Butylamino)-5-Guanidino-Pentanoylamino]-4-(1-Carboxy-2-Cyclohexyl-Ethylcarbamoyl)-Butyric Acid	small molecule	experimental	
DB01985	N-Alpha-L-Acetyl-Arginine	small molecule	experimental	
DB01986	3-Fluoro-2-Methyl-Aniline	small molecule	experimental	
DB01987	Cocarboxylase	small molecule	approved|experimental	Coenzymes|Diet, Food, and Nutrition|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins
DB01988	6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine	small molecule	experimental	
DB01989	Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome	small molecule	experimental	
DB01990	Cholesterol sulfate	small molecule	experimental	Anticarcinogenic Agents|Antineoplastic Agents|Cholestanes|Cholestenes|Cholesterol|Enzyme Inhibitors|Lipids|Membrane Lipids|Protease Inhibitors|Protective Agents|Serine Proteinase Inhibitors|Steroids|Sterols
DB01991	Tu-514	small molecule	experimental	Carbohydrates|Glycoconjugates|Lipids
DB01992	Coenzyme A	small molecule	investigational|nutraceutical	Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB01993	N-(5'-Phosphopyridoxyl)-D-Alanine	small molecule	experimental	
DB01994	2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol	small molecule	experimental	
DB01995	5-Methylcytidine-5'-Monophosphate	small molecule	experimental	
DB01996	3-Methylpyridine	small molecule	experimental	Pyridines
DB01997	3-Bromo-7-Nitroindazole	small molecule	experimental	Nitric Oxide Synthase, antagonists & inhibitors|Pyrazoles
DB01998	2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol	small molecule	experimental	
DB01999	5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine	small molecule	experimental	
DB02001	5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine	small molecule	experimental	
DB02002	2-Aminoprop-2-Enamide	small molecule	experimental	
DB02004	5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine	small molecule	experimental	
DB02005	2-Oxo-3-Pentenoic Acid	small molecule	experimental	
DB02006	Br-Coeleneterazine	small molecule	experimental	
DB02007	alpha-D-glucose 6-phosphate	small molecule	experimental	
DB02008	1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	small molecule	experimental	
DB02009	L-756,423	small molecule	experimental	Indenes
DB02010	Staurosporine	small molecule	experimental	Alkaloids|Carbazoles|Enzyme Inhibitors|Indole Alkaloids|Indoles|P-glycoprotein/ABCB1 Inhibitors
DB02011	N-(Phosphonoacetyl)-L-Ornithine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins
DB02013	Monoazido-Mu-Oxo-Diiron	small molecule	experimental	
DB02014	Compound 9	small molecule	experimental	
DB02015	Dihydrofolic Acid	small molecule	experimental	
DB02016	R048-8071	small molecule	experimental	
DB02017	Imidazole-Derived Cellobiose	small molecule	experimental	
DB02018	Amido Phenyl Pyruvic Acid	small molecule	experimental	
DB02019	Acetyl Dithranol	small molecule	experimental	
DB02020	Alrestatin	small molecule	experimental	Autonomic Agents|Enzyme Inhibitors|Parasympatholytics|Peripheral Nervous System Agents
DB02021	Fidarestat	small molecule	experimental	Aldehyde Reductase, antagonists & inhibitors|Imidazoles
DB02022	4-Amino-5-Hydroxymethyl-2-Methylpyrimidine	small molecule	experimental	
DB02023	8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate	small molecule	experimental	
DB02024	3-phenylpropionic acid	small molecule	experimental	Acids, Carbocyclic
DB02025	L-D-(a-Aminoadipoyl)-L-Cysteinyl-D-Valine	small molecule	experimental	
DB02026	Furo[2,3d]Pyrimidine Antifolate	small molecule	experimental	
DB02027	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	small molecule	experimental	
DB02028	(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]	small molecule	experimental	
DB02029	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	small molecule	experimental	
DB02030	Alpha-Ribazole-5'-Phosphate	small molecule	experimental	
DB02031	(6S)-5,6,7,8-tetrahydrofolate	small molecule	experimental	Folic Acid and Derivatives|Vitamin B Complex|Vitamins
DB02032	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	small molecule	experimental	Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents that produce hypertension|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Imines|Imino Acids|Proline|Protease Inhibitors
DB02033	N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide	small molecule	experimental	
DB02034	Tridolgosir	small molecule	experimental	
DB02035	1-Hexadecylsulfonyl Fluoride	small molecule	experimental	
DB02036	2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide	small molecule	experimental	
DB02037	2,4-Diamino-4,6-Dihydroxypyrimidine	small molecule	experimental	
DB02038	D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide	small molecule	experimental	
DB02039	S-Acetyl-Cysteine	small molecule	experimental	
DB02041	Isoluminol	small molecule	experimental	Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Luminescent Measurements|Pyridazines
DB02042	2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol	small molecule	experimental	
DB02043	1,2-Dipalmitoyl-Phosphatidyl-Glycerole	small molecule	experimental	
DB02044	N-(3-(Aminomethyl)Benzyl)Acetamidine	small molecule	experimental	Amines|Benzene Derivatives|Benzyl Compounds|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors
DB02045	Amylamine	small molecule	experimental	
DB02046	N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid	small molecule	experimental	
DB02047	2-(1,1'-Biphenyl-4-Yl)Propanoic Acid	small molecule	experimental	
DB02048	1,2,4-Triazole-Carboxamidine	small molecule	experimental	
DB02049	2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide	small molecule	experimental	
DB02051	3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid 4-Nitro-Phenyl Ester	small molecule	experimental	
DB02052	Indirubin-3'-Monoxime	small molecule	experimental	Amines|Hydroxylamines
DB02053	Ribose-5-phosphate	small molecule	experimental	Carbohydrates|Pentosephosphates|Sugar Phosphates
DB02054	Gabaculine	small molecule	experimental	Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Enzyme Inhibitors|Transaminases, antagonists & inhibitors
DB02055	N-Butyl-Benzenesulfonamide	small molecule	experimental	
DB02056	Prostaglandin D2	small molecule	investigational	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins D
DB02057	(S)-AMPA	small molecule	experimental	
DB02058	SU4984	small molecule	experimental	Tyrosine Kinase Inhibitors
DB02059	Adenosine-5-Diphosphoribose	small molecule	experimental	
DB02060	Cyclohexanone	small molecule	experimental	Cyclohexanes|Cycloparaffins|Ketones
DB02061	Cellobiose	small molecule	experimental	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cellulose|Disaccharides|Glucans|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides
DB02062	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	small molecule	experimental	
DB02063	CRA_16847	small molecule	experimental	
DB02065	4-Deoxylactose	small molecule	experimental	
DB02066	N7-Methyl-Formycin A	small molecule	experimental	
DB02067	Triglu-5-Formyl-Tetrahydrofolate	small molecule	experimental	Folic Acid and Derivatives|Vitamin B Complex|Vitamins
DB02068	Delta-Amino Valeric Acid	small molecule	experimental	
DB02069	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB02070	L-2-Amino-4-[2-Aminophenyl]-4-Oxobutanoic Acid	small molecule	experimental	
DB02071	WAY-151693	small molecule	experimental	Amides|Amines|Hydroxy Acids|Hydroxylamines|Sulfones|Sulfur Compounds
DB02072	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid	small molecule	experimental	
DB02073	Biliverdine IX Alpha	small molecule	experimental	
DB02074	Butenoic Acid	small molecule	experimental	
DB02075	(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate	small molecule	experimental	
DB02076	6-phospho-D-gluconic acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids
DB02077	L-N(omega)-Nitroarginine-(4R)-Amino-L-Proline Amide	small molecule	experimental	
DB02078	Triglyme	small molecule	experimental	Alcohols|Biomedical and Dental Materials|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers
DB02079	Aminooxyacetic acid	small molecule	experimental	Acetates|Acids, Acyclic|Amines|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|GABA Agents|Hydroxylamines|Lipids|Neurotransmitter Agents
DB02080	1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene	small molecule	experimental	
DB02081	Bis-Benzamidine	small molecule	experimental	
DB02082	Phosphoaminophosphonic Acid Guanylate Ester	small molecule	experimental	
DB02083	N,N-dimethylglycine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Epilepsy, drug therapy|Glycine|N-substituted Glycines|Peptides|Peptoids
DB02084	CRA_17312	small molecule	experimental	
DB02085	1-Aminocyclopropanecarboxylic Acid	small molecule	experimental	
DB02086	(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium	small molecule	experimental	
DB02087	3,5-Difluorobenzenesulfonamide	small molecule	experimental	
DB02088	Norleucine Phosphonate	small molecule	experimental	
DB02089	CP-526423	small molecule	experimental	
DB02090	A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor	small molecule	experimental	
DB02091	4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine	small molecule	experimental	
DB02092	Cholesteryl Linoleate	small molecule	experimental	Cholestanes|Cholestenes|Cholesterol|Lipids|Membrane Lipids|Steroids|Sterols
DB02093	5-Phospho-D-Arabinohydroxamic Acid	small molecule	experimental	
DB02094	N-2-Thiophen-2-Yl-Acetamide Boronic Acid	small molecule	experimental	
DB02095	Isatin	small molecule	experimental	Indoles
DB02096	FR221647	small molecule	experimental	
DB02097	Cytidine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB02098	Adenosine-2'-5'-Diphosphate	small molecule	experimental	
DB02099	S-azabisabolene	small molecule	experimental	
DB02100	Methyl alpha-galactoside	small molecule	experimental	
DB02101	(S,R)-fidarestat	small molecule	experimental	
DB02102	DMP450	small molecule	experimental	
DB02103	2-Chlorodideoxyadenosine	small molecule	experimental	
DB02104	2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine	small molecule	experimental	
DB02105	3,5-Dinitrocatechol	small molecule	experimental	Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Benzene Derivatives|Central Nervous System Agents|COMT Inhibitors|Enzyme Inhibitors|Phenols
DB02106	[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid	small molecule	experimental	
DB02107	Leucine - Reduced Carbonyl	small molecule	experimental	
DB02108	2-Aminoethanimidic Acid	small molecule	experimental	
DB02109	Hadacidin	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Noxae|Teratogens|Toxic Actions
DB02110	Protoporphyrin Ix Containing Co	small molecule	experimental	
DB02111	3-Hydroxyisoxazole-4-Carboxylic Acid	small molecule	experimental	
DB02112	Zk-806450	small molecule	experimental	
DB02113	6-Methylpurine	small molecule	experimental	
DB02114	Para-Isopropylaniline	small molecule	experimental	
DB02115	Daidzin	small molecule	experimental	Alcohol Deterrents|BCRP/ABCG2 Inhibitors|Benzopyrans|Central Nervous System Agents|Chromones|Enzyme Inhibitors|Flavonoids|Pyrans
DB02116	Olomoucine	small molecule	experimental	Cyclin-Dependent Kinases, antagonists & inhibitors|Cytokinins|Enzyme Inhibitors|Purines
DB02118	CP-271485	small molecule	experimental	
DB02119	6-Hydroxymethyl-7,8-Dihydropterin	small molecule	experimental	Biological Factors|Pigments, Biological|Pteridines
DB02120	6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol	small molecule	experimental	
DB02121	Butyramide	small molecule	experimental	
DB02122	4-iodo-acetamido phenylboronic acid	small molecule	experimental	
DB02123	Glycochenodeoxycholic Acid	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Bile Acids and Salts|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Chenodeoxycholic Acid|Cholanes|Cholic Acids|Deoxycholic Acid|Detergents|Glycine|Glycocholic Acid|Glycodeoxycholic Acid|Household Products|N-substituted Glycines|Peptides|Peptoids|Steroids|Surface-Active Agents
DB02124	(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid	small molecule	experimental	
DB02125	Adamantanone	small molecule	experimental	Cycloparaffins
DB02126	4-Carboxycinnamic Acid	small molecule	experimental	
DB02127	Methylphosphonic Acid Diisopropyl Ester	small molecule	experimental	
DB02128	[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester	small molecule	experimental	
DB02129	Dihydroorotic Acid	small molecule	experimental	
DB02130	Vanillic acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Phenols|Phenyl Ethers
DB02131	N-1-Methylheptylformamide	small molecule	experimental	
DB02132	Zenarestat	small molecule	experimental	Aldehyde Reductase, antagonists & inhibitors|Enzyme Inhibitors
DB02133	Chlorophyll A	small molecule	experimental	Biological Factors|Metalloporphyrins|Pigments, Biological|Porphyrins
DB02134	Xanthine	small molecule	experimental	Alkaloids|Cytochrome P-450 CYP1A2 Substrates|Purines|Purinones|Xanthine derivatives
DB02135	4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate	small molecule	experimental	
DB02136	Cephalosporin Analog	small molecule	experimental	Agents that reduce seizure threshold
DB02137	Molybdenum Cofactor	small molecule	experimental	Amino Acids, Peptides, and Proteins|Enzymes and Coenzymes|Proteins
DB02138	Diethyl 4-Methylbenzylphosphonate	small molecule	experimental	Organophosphorus Compounds
DB02139	(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine	small molecule	experimental	
DB02140	N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide	small molecule	experimental	
DB02141	S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	small molecule	experimental	
DB02142	Pyridoxamine-5'-Phosphate	small molecule	experimental	
DB02143	N-Isopropyl-N'-Hydroxyguanidine	small molecule	experimental	
DB02144	1,2-diacyl-sn-glycero-3-phosphoinositol	small molecule	experimental	
DB02145	Butyl alcohol	small molecule	experimental	Alcohols|Butanols|Fatty Alcohols|Lipids
DB02146	Atrazine Glutathione Conjugate	small molecule	experimental	
DB02147	Cyclo-Tetrametavanadate	small molecule	experimental	
DB02148	3-Amino-4-Oxybenzyl-2-Butanone	small molecule	experimental	
DB02151	Methionine Phosphonate	small molecule	experimental	
DB02152	K-252a	small molecule	experimental	Alkaloids|Enzyme Inhibitors|Indoles|Protein Kinase C, antagonists & inhibitors
DB02153	3-Sulfinoalanine	small molecule	experimental	
DB02154	2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid	small molecule	experimental	
DB02155	Balanol Analog 8	small molecule	experimental	
DB02156	Sulfopyruvate	small molecule	experimental	
DB02158	(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol	small molecule	experimental	
DB02159	(R)-Propylene glycol	small molecule	experimental	
DB02160	S-Butyryl-Cystein	small molecule	experimental	
DB02161	Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester	small molecule	experimental	
DB02162	5'-O-(N-Ethyl-Sulfamoyl)Adenosine	small molecule	experimental	
DB02163	2,5-Xylidine	small molecule	experimental	
DB02164	N-Sulfo-Flavin Mononucleotide	small molecule	experimental	
DB02165	Zinc Trihydroxide	small molecule	experimental	Zinc Compounds
DB02166	Propidium	small molecule	experimental	Coloring Agents|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals|Phenanthridines
DB02167	N,N-Dimethyl-L-Alanine	small molecule	experimental	
DB02168	Bromopurine	small molecule	experimental	
DB02169	9,10-Deepithio-9,10-Didehydroacanthifolicin	small molecule	experimental	
DB02170	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	small molecule	experimental	
DB02172	2,5-Dideoxy-2,5-Imino-D-Glucitol	small molecule	experimental	Alcohols|Carbohydrates|Sugar Alcohols
DB02173	Co(III)-(Deuteroporphyrin IX)	small molecule	experimental	
DB02174	D-Glutamine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins
DB02175	Malonic acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids|Thallium
DB02176	Mercury Acetate Ion	small molecule	experimental	
DB02177	1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine	small molecule	experimental	
DB02178	Phenylacetaldehyde	small molecule	experimental	Aldehydes|Oils, Volatile
DB02179	O-Trifluoromethylphenyl Anthranilic Acid	small molecule	experimental	
DB02180	Myristoyl-Coa	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB02181	2'-Deoxyguanosine-5'-Triphosphate	small molecule	experimental	
DB02182	Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe)	small molecule	experimental	
DB02183	Adenosine-5'-Ditungstate	small molecule	experimental	
DB02184	D-1,4-dithiothreitol	small molecule	experimental	
DB02185	2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One	small molecule	experimental	
DB02186	N-Acetyl-D-Galactosamine 6-Sulfate	small molecule	experimental	
DB02187	Equilin	small molecule	experimental	17-Ketosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids
DB02188	N-Methylmesoporphyrin Containing Copper	small molecule	experimental	
DB02189	2',3'-Dideoxyadenosine-5'-Triphosphate	small molecule	experimental	
DB02190	(S)-oxalosuccinic acid	small molecule	experimental	
DB02191	(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One	small molecule	experimental	
DB02192	Phenylethyl alcohol	small molecule	experimental	Alcohols|Anti-Infective Agents|Anti-Infective Agents, Local|Disinfectants|Ethanol|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical
DB02194	8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One	small molecule	experimental	
DB02195	3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine	small molecule	experimental	
DB02196	Uridine-Diphosphate-N-Acetylgalactosamine	small molecule	experimental	
DB02197	4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide	small molecule	experimental	
DB02198	2-Bromoacetyl Group	small molecule	experimental	
DB02199	1,3-Dedimethyl-1,3-Divinyl Heme	small molecule	experimental	
DB02200	3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonylmethylbenzene	small molecule	experimental	
DB02201	Malonate Ion	small molecule	experimental	
DB02202	(S)-butane-1,3-diol	small molecule	experimental	
DB02203	Acetone Cyanohydrin	small molecule	experimental	
DB02205	6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One	small molecule	experimental	
DB02207	7-Nitroindazole	small molecule	experimental	Analgesics|Anti-Anxiety Agents|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Neuroprotective Agents|Nitric Oxide Synthase, antagonists & inhibitors|Peripheral Nervous System Agents|Protective Agents|Psychotropic Drugs|Pyrazoles|Sensory System Agents|Tranquilizing Agents
DB02209	Pyridoxine phosphate	small molecule	experimental	Coenzymes|Enzymes and Coenzymes|Picolines|Pyridines|Pyridoxal|Vitamin B Complex|Vitamins
DB02210	Hexane-1,6-Diol	small molecule	experimental	
DB02211	N-Methyl-N-Propargyl-1(R)-Aminoindan	small molecule	experimental	
DB02213	Metanitrophenyl-Alpha-D-Galactoside	small molecule	experimental	
DB02214	6,7-Dioxo-5h-8-Ribitylaminolumazine	small molecule	experimental	
DB02215	Furoyl-Leucine	small molecule	experimental	
DB02216	S-Methylcysteine	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Carbon Radioisotopes|Sulfhydryl Compounds|Sulfur Compounds
DB02217	Dpb-T	small molecule	experimental	
DB02218	N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside	small molecule	experimental	
DB02219	3-Cyclohexyl-1-Propylsulfonic Acid	small molecule	experimental	
DB02220	AL7089A	small molecule	experimental	
DB02221	4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide	small molecule	experimental	
DB02222	2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine	small molecule	experimental	
DB02223	LY231514 Tetra Glu	small molecule	experimental	
DB02224	Taxifolin	small molecule	experimental	Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Benzopyrans|Central Nervous System Agents|Chromones|Flavonoids|Flavonols|Peripheral Nervous System Agents|Pyrans|Sensory System Agents
DB02225	1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine	small molecule	experimental	
DB02226	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium	small molecule	experimental	
DB02227	4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid	small molecule	experimental	
DB02228	2-deoxy-2-fluoro-Î²-D-galactose	small molecule	experimental	
DB02229	5'-O-[(L-methionyl)-sulphamoyl]adenosine	small molecule	experimental	
DB02230	Immucillin-G	small molecule	experimental	Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Pyrimidines
DB02232	1,2-Dihydroxybenzene	small molecule	experimental	Benzene Derivatives|Phenols
DB02233	6-hydroxy-D-norleucine	small molecule	experimental	
DB02234	S-Ethylisothiourea	small molecule	experimental	Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Hypnotics and Sedatives|Nitric Oxide Synthase, antagonists & inhibitors|Sulfur Compounds|Thiourea|Urea|Vasoconstrictor Agents
DB02235	L-methionine (R)-S-oxide	small molecule	experimental	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds
DB02236	Glycinamide Ribonucleotide	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides
DB02237	Maltotetraose	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Disaccharides|Glucans|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides
DB02238	4-(Methylsulfanyl)-2-Oxobutanoic Acid	small molecule	experimental	
DB02239	Laevulinic Acid	small molecule	experimental	
DB02240	Quinacrine mustard	small molecule	experimental	Acridines|Aminoacridines|Coloring Agents|Fluorescent Dyes|Hydrocarbons, Halogenated|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Mustard Compounds|Nitrogen Mustard Compounds|Quinacrine
DB02241	8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One	small molecule	experimental	
DB02242	Cyclohexane Propionic Acid	small molecule	experimental	
DB02243	4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide	small molecule	experimental	
DB02245	7-Deazaguanine	small molecule	experimental	Purines|Purinones|Xanthine derivatives
DB02247	Hydrolyzed Cephalothin	small molecule	experimental	Nephrotoxic agents
DB02248	3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid	small molecule	experimental	
DB02249	2-Ethoxyethanol	small molecule	experimental	Alcohols|Glycols|Solvents
DB02251	O-Succinylbenzoate	small molecule	experimental	Acids, Carbocyclic
DB02252	Iodophenyl	small molecule	experimental	
DB02253	(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol	small molecule	experimental	
DB02254	Trifluoro-thiamin phosphate	small molecule	experimental	Carbohydrates|Coloring Agents|Fluorescent Dyes|Glycosides|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB02255	GM6001	small molecule	experimental	Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Oligopeptides|Peptides|Protease Inhibitors
DB02256	2'-Deoxyuridine	small molecule	experimental	
DB02257	N-Bromoacetyl-Aminoethyl Phosphate	small molecule	experimental	
DB02258	SR11254	small molecule	experimental	
DB02259	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide	small molecule	experimental	
DB02260	4-Oxosebacic Acid	small molecule	experimental	Fatty Acids|Lipids|Porphobilinogen Synthase, antagonists & inhibitors
DB02261	Platelet Activating Factor	small molecule	experimental	Adrenergic Agents|Alcohols|Amines|Amino Acids, Peptides, and Proteins|Amino Alcohols|Ammonium Compounds|Autacoids|Biological Factors|Blood Coagulation Factors|Blood Proteins|Carbohydrates|Cardiovascular Agents|Choline|Ethanolamines|Ethers|Glycerol|Glycerophosphates|Glycerophospholipids|Glyceryl Ethers|Inflammation Mediators|Lipids|Membrane Lipids|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|P-glycoprotein/ABCB1 Inducers|Phosphatidic Acids|Phospholipid Ethers|Phospholipids|Proteins|Quaternary Ammonium Compounds|Sugar Alcohols|Sugar Phosphates|Trimethyl Ammonium Compounds
DB02262	Orotic Acid	small molecule	experimental|investigational	Pyrimidines|Pyrimidinones|Uracil
DB02263	Glyceraldehyde-3-Phosphate	small molecule	experimental	
DB02264	O2-Sulfo-Glucuronic Acid	small molecule	experimental	
DB02265	Ethyl-Trimethyl-Silane	small molecule	experimental	
DB02266	Flufenamic Acid	small molecule	approved	Acids, Carbocyclic|Amines|Aminobenzoates|Aniline Compounds|Anti-Inflammatory Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Benzoates|Fenamates|Musculo-Skeletal System|ortho-Aminobenzoates
DB02267	Argininosuccinate	small molecule	experimental	
DB02268	4-(Acetylamino)-3-Amino Benzoic Acid	small molecule	experimental	
DB02269	[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium	small molecule	experimental	
DB02270	Dimethylallyl S-Thiolodiphosphate	small molecule	experimental	
DB02271	S-(2-Oxo)Pentadecylcoa	small molecule	experimental	
DB02272	Porphobilinogen	small molecule	experimental	
DB02273	2,6-Dimethyl-7-Octen-2-Ol	small molecule	experimental	
DB02274	7-Keto-8-Aminopelargonic Acid	small molecule	experimental	Amino Acids, Peptides, and Proteins
DB02275	[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde	small molecule	experimental	
DB02276	(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide	small molecule	experimental	
DB02277	1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea	small molecule	experimental	
DB02278	7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin	small molecule	experimental	
DB02279	Benzoylformic Acid	small molecule	experimental	Acids, Aldehydic|Acids, Carbocyclic|Hydroxy Acids
DB02280	(R)-Mandelic acid	small molecule	experimental	
DB02281	Formycin	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB02282	5'-Deoxy-5'-Methylthioadenosine	small molecule	experimental	Adenosine|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Deoxyribonucleosides|Enzyme Inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Protein O-Methyltransferase, antagonists & inhibitors|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds
DB02283	2-Phenylamino-Ethanesulfonic Acid	small molecule	experimental	
DB02285	Protoporphyrin	small molecule	experimental	Biological Factors|Dermatologicals|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents
DB02286	2-Amino-3-(4-Amino-1h-Indol-3-Yl)Propanoic Acid	small molecule	experimental	
DB02287	2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine	small molecule	experimental	
DB02288	CRA_9334	small molecule	experimental	
DB02289	2-Aminopropanedioic Acid	small molecule	experimental	
DB02290	3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	small molecule	experimental	
DB02292	Irosustat	small molecule	investigational	Acids|Acids, Noncarboxylic|Steryl-Sulfatase, antagonists & inhibitors|Sulfur Acids|Sulfur Compounds
DB02293	(2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato)oxy]propyl phosphate	small molecule	experimental	
DB02294	(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine	small molecule	experimental	
DB02295	N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide	small molecule	experimental	
DB02296	Isoamyl alcohol	small molecule	experimental	Alcohols|Fatty Alcohols|Lipids
DB02297	2-Amino-6-Chloropyrazine	small molecule	experimental	
DB02298	5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid	small molecule	experimental	
DB02299	Arginineamide	small molecule	experimental	
DB02300	Calcipotriol	small molecule	approved	Antipsoriatics|Antipsoriatics for Topical Use|Cholestanes|Cholestenes|Dermatologicals|Lipids|Membrane Lipids|Misc. Skin and Mucous Membrane Agents|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB02301	5,10-Methylene-6-Hydrofolic Acid	small molecule	experimental	
DB02302	N3, N4-Dimethylarginine	small molecule	experimental	
DB02303	(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione	small molecule	experimental	
DB02304	Prostaglandin B2	small molecule	experimental	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins
DB02305	4,5-Dehydro-D-Glucuronic Acid	small molecule	experimental	
DB02306	Palmitoyl-Linoleoyl Phosphatidylcholine	small molecule	experimental	
DB02307	N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine	small molecule	experimental	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB02308	4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium	small molecule	experimental	
DB02309	5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine	small molecule	experimental	
DB02310	3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium	small molecule	experimental	
DB02311	Methyl Methylsulfinylmethyl Sulfide	small molecule	experimental	
DB02312	beta-D-galactose 6-phosphate	small molecule	experimental	
DB02313	4-{2-(4-Fluoro-Benzyl)-6-Methyl-5-[(5-Methyl-Isoxazole-3-Carbonyl)-Amino]-4-Oxo-Heptanoylamino}-5-(2-Oxo-Pyrrolidin-3-Yl)-Pentanoic Acid Ethyl Ester	small molecule	experimental	
DB02314	Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate	small molecule	experimental	
DB02315	Cyclic Guanosine Monophosphate	small molecule	experimental	
DB02316	1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid	small molecule	experimental	
DB02317	Alpha-D-Galactose-1-Phosphate	small molecule	experimental	
DB02318	2-deoxy-2-fluoro-alpha-D-mannosyl fluoride	small molecule	experimental	
DB02319	5,6-Dihydroxy-Nadp	small molecule	experimental	
DB02320	1-N-Acetyl-Beta-D-Glucosamine	small molecule	experimental	
DB02321	5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol	small molecule	experimental	
DB02322	Heparin Disaccharide I-S	small molecule	experimental	
DB02323	EM-1745	small molecule	experimental	17-Hydroxysteroid Dehydrogenases, antagonists & inhibitors|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB02324	5-Iodo-2'-Deoxyuridine-5'-Monophosphate	small molecule	experimental	
DB02325	Isopropyl Alcohol	small molecule	approved|investigational	Alcohols|Antiseptics and Disinfectants|Dermatologicals|Miscellaneous Local Anti-infectives|Propanols|Solvents
DB02326	1-Hydroxyamine-2-Isobutylmalonic Acid	small molecule	experimental	
DB02327	Triethylene glycol	small molecule	experimental	Alcohols|Biomedical and Dental Materials|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers
DB02328	2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid	small molecule	experimental	
DB02329	Carbenoxolone	small molecule	experimental	Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastrointestinal Agents|Glycyrrhetinic Acid|Pentacyclic Triterpenes|Terpenes|Triterpenes
DB02331	(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid	small molecule	experimental	
DB02332	Flavin-N7 Protonated-Adenine Dinucleotide	small molecule	experimental	
DB02333	Deoxyuridine-5'-Triphosphate	small molecule	experimental	
DB02334	(R)-2-Hydroxy-3-Sulfopropanoic Acid	small molecule	experimental	
DB02335	2-Aminothiazoline	small molecule	experimental	Sulfur Compounds
DB02336	RU83876	small molecule	experimental	
DB02337	S-(D-Carboxybutyl)-L-Homocysteine	small molecule	experimental	
DB02338	Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate	small molecule	experimental	
DB02339	Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin	small molecule	experimental	
DB02340	N-Acetyl-Serine	small molecule	experimental	
DB02341	Mdl 101,146	small molecule	experimental	Amino Acids, Peptides, and Proteins|Oxazines|Pancreatic Elastase, antagonists & inhibitors|Peptides
DB02342	2-Methoxyestradiol	small molecule	investigational	Antimitotic Agents|Antineoplastic Agents|Carbon Radioisotopes|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Mitosis Modulators|Steroids|Tubulin Modulators
DB02343	3,6,9,12,15-Pentaoxaheptadecane	small molecule	experimental	
DB02345	Selenocysteine	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Cysteine|Organoselenium Compounds|Sulfhydryl Compounds|Sulfur Compounds
DB02346	3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside	small molecule	experimental	
DB02347	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	small molecule	experimental	Organophosphorus Compounds|Receptors, AMPA, antagonists & inhibitors
DB02348	Monofluorophosphate ion	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Biomedical and Dental Materials|Cariostatic Agents|Electrolytes|Fluorine Compounds|Hydrofluoric Acid|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Protective Agents|Toothpastes
DB02349	Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline	small molecule	experimental	
DB02350	N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide	small molecule	experimental	
DB02352	3-(Benzyloxy)Pyridin-2-Amine	small molecule	experimental	
DB02353	Heparin Disaccharide Iii-S	small molecule	experimental	
DB02354	4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine	small molecule	experimental	
DB02355	Adenosine-5'-Rp-Alpha-Thio-Triphosphate	small molecule	experimental	
DB02356	4-Imidazolmethylene-5-Imidazolone Chromophore	small molecule	experimental	
DB02357	Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose	small molecule	experimental	
DB02358	LY374571	small molecule	experimental	
DB02359	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine	small molecule	experimental	
DB02360	Bis-Napthyl Beta-Ketophosphonic Acid	small molecule	experimental	
DB02361	S-Methyl Thiocysteine Group	small molecule	experimental	
DB02362	Aminobenzoic acid	small molecule	approved|experimental	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Dermatologicals|Emollients and Protectives|para-Aminobenzoates|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Topical Use|Vitamin B Complex|Vitamins
DB02363	2'-Monophosphoadenosine-5'-Diphosphate	small molecule	experimental	
DB02364	2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid	small molecule	experimental	
DB02365	1,10-Phenanthroline	small molecule	experimental	Chelating Agents|Cholinergic Agents|Cholinesterase Inhibitors|Copper|Cross-Linking Reagents|Enzyme Inhibitors|Indicators and Reagents|Intercalating Agents|Iron Chelating Agents|Laboratory Chemicals|Neurotransmitter Agents|Sequestering Agents
DB02366	CRA_10762	small molecule	experimental	
DB02367	(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine	small molecule	experimental	
DB02368	N-Acetyl-L-Citrulline	small molecule	experimental	
DB02369	3-Aza-2,3-Dihydrogeranyl Diphosphate	small molecule	experimental	Phosphate salts
DB02370	Nz-(1-Carboxyethyl)-Lysine	small molecule	experimental	
DB02371	2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid	small molecule	experimental	
DB02372	2,5-Dimethylpyrimidin-4-Amine	small molecule	experimental	
DB02373	Adenosine Monotungstate	small molecule	experimental	
DB02374	Xylose-Derived Imidazole	small molecule	experimental	
DB02375	Myricetin	small molecule	experimental	Benzopyrans|Chromones|Pyrans
DB02376	D-gluconhydroximo-1,5-lactam	small molecule	experimental	
DB02377	Guanine	small molecule	experimental	Purines|Purinones|Xanthine derivatives
DB02378	MMI-175	small molecule	experimental	
DB02379	Beta-D-Glucose	small molecule	experimental	
DB02380	2'-Deoxyinosine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB02381	nor-NOHA	small molecule	investigational	
DB02382	Namn	small molecule	experimental	
DB02383	Tolrestat	small molecule	withdrawn	Aldehyde Reductase, antagonists & inhibitors|Aldose Reductase Inhibitors|Alimentary Tract and Metabolism|Drugs Used in Diabetes|Enzyme Inhibitors
DB02384	(E)-2-Fluoro-P-Hydroxycinnamate	small molecule	experimental	
DB02385	D-threo-neopterin	small molecule	experimental	Biological Factors|Biopterin|Coenzymes|Enzymes and Coenzymes|Pigments, Biological|Pteridines|Pterins
DB02386	Leucine Phosphonic Acid	small molecule	experimental	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Organophosphorus Compounds
DB02388	Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	small molecule	experimental	
DB02390	5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide	small molecule	experimental	
DB02391	2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One	small molecule	experimental	
DB02393	D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate	small molecule	experimental	
DB02394	Oxiranpseudoglucose	small molecule	experimental	
DB02395	3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol	small molecule	experimental	
DB02396	Methylethylamine	small molecule	experimental	
DB02397	O-(2-Acetamido-2-Deoxy-Alpha-D-Galactopyranosyl)-L-Serine	small molecule	experimental	
DB02398	6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine	small molecule	experimental	
DB02399	L-Rhamnitol	small molecule	experimental	
DB02400	5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione	small molecule	experimental	
DB02401	4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid	small molecule	experimental	Oxazoles
DB02402	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	small molecule	experimental	
DB02403	2-Fluoroaniline	small molecule	experimental	Amines
DB02404	1-Deoxy-1-Thio-Heptaethylene Glycol	small molecule	experimental	
DB02405	12-Bromododecanoic Acid	small molecule	experimental	Fatty Acids|Lipids
DB02406	N-Valeric Acid	small molecule	experimental	
DB02407	6-O-Cyclohexylmethyl Guanine	small molecule	experimental	
DB02408	(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol	small molecule	experimental	
DB02409	(1r,4s)-2-Azabornane	small molecule	experimental	
DB02410	2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide	small molecule	experimental	
DB02411	2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2	small molecule	experimental	
DB02412	Tetrahydropyran	small molecule	experimental	
DB02413	Hydroxyethylcysteine	small molecule	experimental	
DB02414	(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione	small molecule	experimental	
DB02415	N-Octyl-2-Hydroxyethyl Sulfoxide	small molecule	experimental	
DB02416	2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	small molecule	experimental	
DB02417	2,4,6-Tribromophenol	small molecule	experimental	Benzene Derivatives
DB02418	(R,R)-2,3-Butanediol	small molecule	experimental	
DB02419	Ethyl Oxo(Piperidin-1-Yl)Acetate	small molecule	experimental	
DB02420	[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,	small molecule	experimental	
DB02421	Uridine-5'-Diphosphate-Mannose	small molecule	experimental	
DB02422	Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside	small molecule	experimental	
DB02423	Thiopyrophosphate	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates
DB02424	Geldanamycin	small molecule	experimental|investigational	Amides|Anti-Infective Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|HSP90 Heat-Shock Proteins|Lactams|Protease Inhibitors|Quinones|Tyrosine Kinase Inhibitors
DB02425	Hexadecyl Octanoate	small molecule	experimental	
DB02426	Carboxyatractyloside	small molecule	experimental	Carbohydrates|Diterpenes|Glycosides|Terpenes
DB02427	2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline	small molecule	experimental	
DB02428	Quinaldic Acid	small molecule	experimental	
DB02429	4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide	small molecule	experimental	
DB02430	Trehalose-6-Phosphate	small molecule	experimental	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Disaccharides|Enzyme Inhibitors|Glucans|Hexokinase, antagonists & inhibitors|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides
DB02431	Cytidine-5'-Triphosphate	small molecule	experimental	
DB02432	RU90395	small molecule	experimental	
DB02433	{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid	small molecule	experimental	
DB02434	4-(2-Thienyl)Butyric Acid	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds
DB02435	Aminomethylcyclohexane	small molecule	experimental	
DB02436	2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid	small molecule	experimental	
DB02437	(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid	small molecule	experimental	
DB02438	3-O-Methylfructose in Linear Form	small molecule	experimental	
DB02441	2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione	small molecule	experimental	
DB02442	Dioxyselenocysteine	small molecule	experimental	
DB02443	Methicillin Acyl-Serine	small molecule	experimental	
DB02445	2-Deoxy-2-Amino Glucitol-6-Phosphate	small molecule	experimental	
DB02446	Glutamine Hydroxamate	small molecule	experimental	
DB02447	3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	small molecule	experimental	
DB02448	N-Tridecanoic Acid	small molecule	experimental	
DB02449	3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid	small molecule	experimental	
DB02450	2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid	small molecule	experimental	
DB02451	B-nonylglucoside	small molecule	experimental	
DB02452	Thymidine-5'-Triphosphate	small molecule	experimental	
DB02453	Trihydroxyantimonite(Iii)	small molecule	experimental	
DB02454	5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate	small molecule	experimental	
DB02455	Fluoresceinylthioureido	small molecule	experimental	
DB02456	Aracytidine 5'-monophosphate	small molecule	experimental	
DB02457	Undecyl-Phosphinic Acid Butyl Ester	small molecule	experimental	
DB02458	S-(2,4-dinitrophenyl)glutathione	small molecule	experimental	Amino Acids, Peptides, and Proteins|Haptens|Oligopeptides|Peptides
DB02459	4-Guanidinobenzoic Acid	small molecule	experimental	
DB02460	Hydrogenobyrinic Acid	small molecule	experimental	Biological Factors|Pigments, Biological|Porphyrins
DB02461	S-Methyl Phosphocysteine	small molecule	experimental	
DB02462	Thiocoumarin	small molecule	experimental	
DB02463	2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine	small molecule	experimental	
DB02464	Benzylamine	small molecule	experimental	Amines|Benzene Derivatives|Benzyl Compounds
DB02465	Methoxy arachidonyl fluorophosphonate	small molecule	experimental	
DB02466	4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid	small molecule	experimental	
DB02467	L-methionine (S)-S-oxide	small molecule	experimental	
DB02468	12-Phenylheme	small molecule	experimental	
DB02469	4,6-dideoxy-4-amino-beta-D-glucopyranoside	small molecule	experimental	
DB02470	D-Glycero-D-Mannopyranose-7-Phosphate	small molecule	experimental	
DB02471	Nojirimycine Tetrazole	small molecule	experimental	
DB02472	6-Hydroxy-7,8-Dihydro Purine Nucleoside	small molecule	experimental	
DB02473	6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	small molecule	experimental	
DB02474	Bmsc-0013	small molecule	experimental	
DB02475	Deoxyguanidinoproclavaminic acid	small molecule	experimental	
DB02477	[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine	small molecule	experimental	
DB02479	(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB02480	(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate	small molecule	experimental	
DB02481	N-Benzylformamide	small molecule	experimental	Acids, Acyclic|Amides|Formates
DB02482	Phosphonothreonine	small molecule	experimental	
DB02483	Etheno-Nad	small molecule	experimental	
DB02484	Cytidine 5'-Diphosphoglycerol	small molecule	experimental	
DB02485	Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid	small molecule	experimental	
DB02486	2-Hydroxyethyl Disulfide	small molecule	experimental	Acids|Acids, Noncarboxylic|Alcohols|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfides|Sulfur Compounds
DB02488	1-(2-Ethanone)-2-Hydroxy-2-(1-Amino-2-Methyl-2-Ethanol)-4-(2-Dimethyl)Ethane-Imidazoline-5-One;Chromophore (Thr-Leu-Gly)	small molecule	experimental	
DB02489	9-Methylguanine	small molecule	experimental	Cytochrome P-450 CYP1A2 Substrates|Purines|Purinones|Xanthine derivatives
DB02490	(Diaminomethyl-Methyl-Amino)-Acetic Acid	small molecule	experimental	
DB02491	4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine	small molecule	experimental	
DB02492	Ghavamiol	small molecule	experimental	Alcohols|Amines|Ammonium Compounds|Carbohydrates|Glycoside Hydrolases, antagonists & inhibitors|Imines|Imino Sugars|Monosaccharides|Nitrogen Compounds|Onium Compounds|Pentoses|Pyrrolidines|Sugar Alcohols
DB02493	Hydantocidin-5'-Phosphate	small molecule	experimental	
DB02494	Alpha-Hydroxy-Beta-Phenyl-Propionic Acid	small molecule	experimental	
DB02495	9-(4-hydroxybutyl)-N2-phenylguanine	small molecule	experimental	
DB02496	1-Deoxy-D-xylulose 5-phosphate	small molecule	experimental	Carbohydrates|Sugar Phosphates
DB02497	L-Alpha-Glycerophosphorylserine	small molecule	experimental	
DB02498	Carba-Nicotinamide-Adenine-Dinucleotide	small molecule	experimental	
DB02499	Dinor-N(Omega)-Hydroxy-L-Arginine	small molecule	experimental	
DB02500	6-(Dihydroxy-Isobutyl)-Thymine	small molecule	experimental	
DB02501	N~2~-Succinylarginine	small molecule	experimental	
DB02502	8-Hydroxy-2'-Deoxyguanosine	small molecule	experimental	Carbohydrates|Deoxyribonucleosides|Glycosides|Guanosine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB02503	4-(Carboxyvin-2-Yl)Phenylboronic Acid	small molecule	experimental	
DB02504	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	small molecule	experimental	
DB02505	N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)	small molecule	experimental	
DB02506	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid	small molecule	experimental	
DB02507	4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One	small molecule	experimental	
DB02508	Isopentyl Pyrophosphate	small molecule	experimental	
DB02509	Farnesol	small molecule	experimental	Alcohols|Fatty Alcohols|Lipids|Sesquiterpenes|Terpenes
DB02510	'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine	small molecule	experimental	
DB02511	2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine	small molecule	experimental	
DB02512	1,6-Fructose Diphosphate (Linear Form)	small molecule	experimental	
DB02513	Thymol	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents|Benzene Derivatives|Monoterpenes|Terpenes
DB02514	(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate	small molecule	experimental	
DB02515	3-Phosphoglycerol	small molecule	experimental	
DB02516	O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine	small molecule	experimental	
DB02517	D-Glutamic Acid	small molecule	experimental	
DB02518	N-Acetylalanine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins
DB02519	Indirubin-5-Sulphonate	small molecule	experimental	
DB02520	Ditiocarb	small molecule	experimental	Acids, Acyclic|Adjuvants, Immunologic|Anti-Infective Agents|Carbamates|Chelating Agents|Immunologic Factors|Sequestering Agents|Sulfur Compounds|Thiocarbamates
DB02521	2,5,7-Trihydroxynaphthoquinone	small molecule	experimental	
DB02522	Phosphonopyruvate	small molecule	experimental	
DB02523	2-aminooxyethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-methyl-sulfonium	small molecule	experimental	
DB02524	2',3'-O-{4-[Hydroxy(oxido)-Î»5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)	small molecule	experimental	
DB02525	D-galactohydroximo-1,5-lactam	small molecule	experimental	
DB02526	CRA_10655	small molecule	experimental	
DB02527	Cyclic Adenosine Monophosphate	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|OAT3/SLC22A8 Substrates|Purine Nucleotides|Purines|Ribonucleotides
DB02528	Tetrazolyl Histidine	small molecule	experimental	
DB02529	5-N-Acetyl-4-Amino-6-Diethylcarboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid	small molecule	experimental	
DB02530	gamma-Aminobutyric acid	small molecule	approved|investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Fatty Acids|Fatty Acids, Volatile|GABA Agents|Lipids|Neurotransmitter Agents
DB02531	Isobutyric Acid	small molecule	experimental	Acids, Acyclic|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids
DB02532	2,4,6-Triaminoquinazoline	small molecule	experimental	
DB02534	2-Allylphenol	small molecule	experimental	Benzene Derivatives
DB02535	Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide	small molecule	experimental	
DB02536	(2r)-2,3-Dihydroxypropanal	small molecule	experimental	
DB02537	2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine	small molecule	experimental	
DB02538	N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide	small molecule	experimental	
DB02540	(10S)-10-Formyl-5,8,10-Trideazafolic Acid	small molecule	experimental	
DB02541	4-Hydroxybutan-1-Aminium	small molecule	experimental	
DB02542	(4s)-5-Fluoro-L-Leucine	small molecule	experimental	
DB02543	Pyrrole-2-Carboxylate	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids
DB02544	N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine	small molecule	experimental	
DB02545	Fexaramine	small molecule	experimental	
DB02546	Vorinostat	small molecule	approved|investigational	Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Fluorine Radioisotopes|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Myelosuppressive Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB02547	Guanosine-5'-Diphosphate-Rhamnose	small molecule	experimental	
DB02548	D-glucitol 6-phosphate	small molecule	experimental	Carbohydrates|Sugar Phosphates
DB02549	3'-O-Acetylthymidine-5'-Diphosphate	small molecule	experimental	
DB02550	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	small molecule	experimental	
DB02551	6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	small molecule	experimental	
DB02552	Geranyl Diphosphate	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates|Terpenes
DB02553	Glutathionylspermidine Disulfide	small molecule	experimental	
DB02554	Sulfoquinovose-Uridine-C1,5'-Diphosphate	small molecule	experimental	
DB02555	SP4160	small molecule	experimental	
DB02556	D-Phenylalanine	small molecule	experimental	
DB02557	Phosphoramidon	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Glycoconjugates|Metalloendopeptidases, antagonists & inhibitors|Peptides|Protease Inhibitors
DB02558	N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine	small molecule	experimental	
DB02559	6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine	small molecule	experimental	
DB02560	[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron	small molecule	experimental	
DB02561	Beta-D-Fructopyranose	small molecule	experimental	
DB02562	Quinonoid 7,8-Tetrahydrobiopterin	small molecule	experimental	
DB02563	Hexanoyl-CoA	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB02565	4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide	small molecule	experimental	
DB02566	8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid	small molecule	experimental	
DB02567	PD173955	small molecule	experimental	Pyridines|Tyrosine Kinase Inhibitors
DB02568	Peldesine	small molecule	experimental|investigational	Cytochrome P-450 CYP1A2 Substrates|N-Glycosyl Hydrolases, antagonists & inhibitors|Purines|Purinones|Xanthine derivatives
DB02569	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate	small molecule	experimental	
DB02570	PD150606	small molecule	experimental	Acids, Acyclic
DB02571	2-Amino-6-Oxo-Hexanoic Acid	small molecule	experimental	
DB02572	BV4	small molecule	experimental	
DB02573	2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate	small molecule	experimental	
DB02574	BV2	small molecule	experimental	
DB02576	F-Loop of Vitamin B12	small molecule	experimental	
DB02577	Mesoheme	small molecule	experimental	Biological Factors|Pigments, Biological|Porphyrins
DB02578	Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-Alanine	small molecule	experimental	Amino Acids, Peptides, and Proteins|Peptides
DB02579	Acrylic Acid	small molecule	experimental	Acids, Acyclic|Biomedical and Dental Materials|Equipment and Supplies|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives
DB02580	Pentaglyme	small molecule	experimental	
DB02581	5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid	small molecule	experimental	
DB02582	D-(L-a-Aminoadipoyl)-L-Cysteinyl-D-Isodehydrovaline	small molecule	experimental	
DB02583	N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine	small molecule	experimental	
DB02585	4-(Hydroxymethyl)Benzamidine	small molecule	experimental	
DB02586	4,7-Dimethyl-[1,10]Phenanthroline	small molecule	experimental	
DB02587	Colforsin	small molecule	experimental|investigational	Adjuvants, Immunologic|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiotonic Agents|Cardiovascular Agents|Diterpenes|Immunologic Factors|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Protective Agents|Respiratory System Agents|Terpenes|Vasodilating Agents
DB02588	Moxalactam Derivative	small molecule	experimental	
DB02589	Se-Ethyl-Isoselenourea	small molecule	experimental	
DB02590	Abequose	small molecule	experimental	Carbohydrates|Monosaccharides
DB02591	5,6-Dimethylbenzimidazole	small molecule	experimental	
DB02592	Carbaphosphonate	small molecule	experimental	
DB02593	7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid	small molecule	experimental	
DB02594	2'-Deoxycytidine	small molecule	experimental|investigational	
DB02595	Bulgecin A	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Amino Sugars|Carbohydrates|Glucosamine|Hexosamines|Imines|Imino Acids
DB02596	Alpha,Beta-Methyleneadenosine-5'-Triphosphate	small molecule	experimental	
DB02597	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	small molecule	experimental	
DB02598	N-Alpha-Acetyl-3,5-Diiodotyrosylglycine	small molecule	experimental	
DB02599	2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One	small molecule	experimental	
DB02600	Oseltamivir acid	small molecule	experimental	Acetamides|Acetates|Acids, Acyclic|Amides|Anti-Infective Agents|Antiviral Agents|Cyclohexanes|Cyclohexenes|Cycloparaffins|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids
DB02601	4-Hydroxyphenylglycine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Carnitine O-Palmitoyltransferase, antagonists & inhibitors|Enzyme Inhibitors
DB02602	AL7182	small molecule	experimental	
DB02603	1-Amino-6-Cyclohex-3-Enylmethyloxypurine	small molecule	experimental	
DB02604	2-Deoxy-Glucose-6-Phosphate	small molecule	experimental	
DB02606	2-Butanol	small molecule	experimental|investigational	Alcohols|Fatty Alcohols|Lipids
DB02607	Adenosine Phosphonoacetic Acid	small molecule	experimental	Acetates|Acids, Acyclic|Adenine Nucleotides|Carbohydrates|Fatty Acids|Fatty Acids, Volatile|Glycosides|Lipids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Organophosphonates|Organophosphorus Compounds|Purine Nucleotides|Purines|Ribonucleotides
DB02608	N-Acetyl-P-Nitrophenylserinol	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins
DB02609	4-Hydroxy-L-Threonine-5-Monophosphate	small molecule	experimental	
DB02610	N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB02611	Balanol Analog 1	small molecule	experimental	
DB02613	Decylamine-N,N-Dimethyl-N-Oxide	small molecule	experimental	
DB02614	1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid	small molecule	experimental	
DB02615	Compound 19	small molecule	experimental	
DB02616	FR117016	small molecule	experimental	
DB02617	1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane	small molecule	experimental	
DB02618	Ethyl Dimethyl Ammonio Propane Sulfonate	small molecule	experimental	
DB02619	Bromo-Dodecanol	small molecule	experimental	
DB02620	Sp7343-Sp7964	small molecule	experimental	
DB02621	Latrunculin A	small molecule	experimental	Marine Toxins|Porifera|Sulfur Compounds|Thiazoles
DB02622	2-(Oxalyl-Amino)-Benzoic Acid	small molecule	experimental	
DB02623	Aminophosphonic Acid-Guanylate Ester	small molecule	experimental	
DB02624	Homoserine Lactone	small molecule	experimental	Furans|Lactones|Luminescent Proteins|Quorum Sensing
DB02625	(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid	small molecule	experimental	
DB02626	Phenylferricrocin-Iron	small molecule	experimental	
DB02627	4,4'-Biphenyldiboronic Acid	small molecule	experimental	
DB02628	1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide	small molecule	experimental	
DB02629	Inhibitor Bea403	small molecule	experimental	
DB02630	L-xylitol 5-phosphate	small molecule	experimental	Carbohydrates|Sugar Phosphates
DB02632	4-nitrophenyl-beta-D-galactoside	small molecule	experimental	Affinity Labels|Carbohydrates|Galactosides|Glycosides|Indicators and Reagents|Laboratory Chemicals|Photoaffinity Labels
DB02633	Cibacron Blue	small molecule	experimental	
DB02635	N-[O-Phosphono-Pyridoxyl]-Isoleucine	small molecule	experimental	
DB02636	9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid	small molecule	experimental	
DB02637	Oxaloacetate Ion	small molecule	experimental	
DB02638	Terlipressin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Moderate Risk QTc-Prolonging Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|QTc Prolonging Agents|Shock, Septic|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins
DB02639	4-methylumbelliferyl Î±-D-glucoside	small molecule	experimental	
DB02640	Fumagillin	small molecule	experimental	Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cycloparaffins|Fatty Acids|Growth Inhibitors|Growth Substances|Lipids|Terpenes
DB02641	Heptanamide	small molecule	experimental	
DB02642	[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate	small molecule	experimental	
DB02643	N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate	small molecule	experimental	Amines|Ammonium Compounds|Detergents|Household Products|Nitrogen Compounds|Onium Compounds|Surface-Active Agents
DB02644	N-Omega-Propyl-L-Arginine	small molecule	experimental	
DB02645	3,4-Epoxybutyl-Alpha-D-Glucopyranoside	small molecule	experimental	
DB02646	Nitrosoethane	small molecule	experimental	
DB02647	N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide	small molecule	experimental	
DB02648	(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium	small molecule	experimental	
DB02649	3-Amino-3-Oxopropanoic Acid	small molecule	experimental	
DB02650	Trichloroacetaldehyde	small molecule	experimental	Alcohols|Ethylene Glycols|Glycols
DB02651	{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)	small molecule	experimental	
DB02652	L-[(N-Hydroxyamino)Carbonyl]Phenylalanine	small molecule	experimental	
DB02654	6-Hydroxy-Flavin-Adenine Dinucleotide	small molecule	experimental	
DB02655	D-Aspartic Acid	small molecule	experimental	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Aspartic Acid|Excitatory Amino Acids
DB02656	LY-294002	small molecule	experimental	Benzopyrans|Enzyme Inhibitors|Oxazines|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Pyrans
DB02657	Glucosamine 6-Phosphate	small molecule	experimental	Amino Sugars|Carbohydrates|Glucosephosphates|Hexosamines|Hexosephosphates|Sugar Phosphates
DB02658	2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside	small molecule	experimental	
DB02659	Cholic Acid	small molecule	approved	Alimentary Tract and Metabolism|Bile Acid Preparations|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|BSEP/ABCB11 inducers|BSEP/ABCB11 Inhibitors|BSEP/ABCB11 Substrates|Cholanes|Cholic Acids|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inducers|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inducers|Steroids
DB02660	Filaminast	small molecule	experimental	Amines|Hydroxylamines
DB02661	Adenosine-5'-Diphosphate-2',3'-Vanadate	small molecule	experimental	
DB02662	Novo Nordisk a/S Compound	small molecule	experimental	
DB02663	2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid	small molecule	experimental	
DB02664	1-Butane Boronic Acid	small molecule	experimental	
DB02665	(1R,2S)-2-Phenylcyclopropanaminium	small molecule	experimental	
DB02666	(C8-R)-Hydantocidin 5'-Phosphate	small molecule	experimental	
DB02667	Factor IIIm	small molecule	experimental	
DB02668	Je-2147, Ag1776, Kni-764	small molecule	experimental	
DB02669	RB106	small molecule	experimental	
DB02670	4-Deoxy-Alpha-D-Glucose	small molecule	experimental	
DB02671	1-Methylimidazole	small molecule	experimental	
DB02673	(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium	small molecule	experimental	
DB02674	4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid	small molecule	experimental	
DB02675	(4-Hydroxymaltosephenyl)Glycine	small molecule	experimental	
DB02676	2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol	small molecule	experimental	
DB02677	D-naphthyl-1-acetamido boronic acid alanine	small molecule	experimental	
DB02678	2-Deoxy-2-Aminogalactose	small molecule	experimental	
DB02679	Cyanamide	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Carbodiimides|Cyanides|Electrolytes|Hydrogen Cyanide|Imines|Ions|Nitrogen Compounds
DB02680	Dinitrophenylene	small molecule	experimental	
DB02681	2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium	small molecule	experimental	
DB02683	Inhibitor Bea428	small molecule	experimental	
DB02684	5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine	small molecule	experimental	
DB02685	3-Methylphenylalanine	small molecule	experimental	
DB02686	Undecyl-Beta-D-Maltopyranoside	small molecule	experimental	
DB02688	2,3-Didehydroalanine	small molecule	experimental	
DB02689	S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine	small molecule	experimental	
DB02690	NU1025	small molecule	experimental	
DB02691	Glycocholic acid	small molecule	experimental|investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Bile Acids and Salts|Cholagogues and Choleretics|Cholanes|Cholic Acids|Detergents|Gastrointestinal Agents|Glycine|Household Products|N-substituted Glycines|Peptides|Peptoids|Steroids|Surface-Active Agents
DB02693	(4S,5S)-1,2-dithiane-4,5-diol	small molecule	experimental	
DB02694	Pantoyl Adenylate	small molecule	experimental	
DB02695	O1-Pentyl-Mannose	small molecule	experimental	
DB02696	6-Aminohexyl-Uridine-C1,5'-Diphosphate	small molecule	experimental	
DB02697	Hydroxyaminovaline	small molecule	experimental	
DB02698	N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid	small molecule	experimental	
DB02699	4-Oxoretinol	small molecule	experimental	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Terpenes
DB02700	3-Deoxy-D-Glucosamine	small molecule	experimental	
DB02701	Nicotinamide	small molecule	approved|investigational	Alimentary Tract and Metabolism|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Nicotinic Acids|Physiological Phenomena|Pyridines|Vitamin B Complex|Vitamins
DB02702	XV638	small molecule	experimental	
DB02703	Fusidic Acid	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives for Systemic Use|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Cholestadienes|Cholestadienols|Cholestanes|Cholestenes|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Enzyme Inhibitors|Lipids|Medicated Dressings|Medicated Dressings With Antiinfectives|Membrane Lipids|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Other Miscellaneous Antibacterial Agents|Protein Synthesis Inhibitors|Sensory Organs|Steroid Antibacterials|Steroids|Sterols|UGT1A1 Substrates
DB02704	(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide	small molecule	experimental	
DB02705	6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine	small molecule	experimental	
DB02706	Mercaptocarboxylate Inhibitor	small molecule	experimental	
DB02707	Pentyl Trihydrogen Diphosphate	small molecule	experimental	
DB02709	Resveratrol	small molecule	approved|experimental|investigational	Analgesics|Analgesics, Non-Narcotic|Angiogenesis Inhibitors|Anti-Inflammatory Agents|Anticarcinogenic Agents|Antimutagenic Agents|Antineoplastic Agents, Phytogenic|Antioxidants|Antiplatelet agents|Benzene Derivatives|Benzylidene Compounds|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hematologic Agents|Peripheral Nervous System Agents|Phenols|Protective Agents|Ribonucleotide Reductases, antagonists & inhibitors|Sensory System Agents|Vasodilating Agents
DB02710	2,3,-Dihydroxybenzoylserine	small molecule	experimental	
DB02711	4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate	small molecule	experimental	
DB02712	Sorbinil	small molecule	experimental|investigational	Aldehyde Reductase, antagonists & inhibitors|Imidazoles
DB02713	Acetylamino-Acetic Acid	small molecule	experimental	
DB02714	3'-Uridinemonophosphate	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB02715	Compound 18	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Iodobenzoates
DB02716	7-Methyl-Guanosine-5'-Triphosphate	small molecule	experimental	
DB02717	Cellotetraose	small molecule	experimental	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Glucans|Macromolecular Substances|Monosaccharides|Polymers|Polysaccharides
DB02719	C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide	small molecule	experimental	
DB02720	Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide	small molecule	experimental	
DB02721	4-Iodopyrazole	small molecule	experimental	
DB02722	4-O-methyl-beta-D-glucuronic acid	small molecule	experimental	
DB02723	4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide	small molecule	experimental	
DB02724	Delta-2-Albomycin A1	small molecule	experimental	
DB02725	2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid	small molecule	experimental	
DB02726	2-Phosphoglycolic Acid	small molecule	experimental	
DB02727	N-Butyl-N'-Hydroxyguanidine	small molecule	experimental	Amidines
DB02728	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	small molecule	experimental	
DB02729	SD146	small molecule	experimental	
DB02730	4-Methylthio-Alpha-D-Mannose	small molecule	experimental	
DB02731	Ethylmercurithiosalicylic acid	small molecule	experimental	
DB02732	Nicotinamide Adenine Dinucleotide Acetone Adduct	small molecule	experimental	
DB02733	Purvalanol	small molecule	experimental	
DB02734	4-Deoxy-D-Mannuronic Acid	small molecule	experimental	
DB02735	2-Amino-3-Oxo-4-Sulfo-Butyric Acid	small molecule	experimental	
DB02736	Acetamide	small molecule	experimental	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB02738	Adenosine-5'-Pentaphosphate	small molecule	experimental	
DB02740	3-Indolebutyric Acid	small molecule	experimental	
DB02741	CD564	small molecule	experimental	
DB02742	Kifunensine	small molecule	experimental	Enzyme Inhibitors
DB02743	beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose	small molecule	experimental	Carbohydrates|Oligosaccharides|Polysaccharides
DB02744	RPR131247	small molecule	experimental	
DB02745	Uridine	small molecule	experimental|investigational	Analogs/Derivatives|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Analog|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB02746	Phthalic Acid	small molecule	experimental	Acids, Carbocyclic
DB02747	N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)Glycyl-L-Arginine-N-Phenylamide	small molecule	experimental	
DB02749	Pyromellitic Acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives
DB02750	S-(Methylmercury)-L-Cysteine	small molecule	experimental	
DB02751	Glycocyamine	small molecule	experimental	Affinity Labels|Amino Acids|Amino Acids, Peptides, and Proteins|Indicators and Reagents|Laboratory Chemicals
DB02752	Tosyl-D-Proline	small molecule	experimental	
DB02753	Selenoinosine	small molecule	experimental	
DB02754	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	small molecule	experimental	
DB02755	1-3 Sugar Ring of Pentamannosyl 6-Phosphate	small molecule	experimental	
DB02756	Pyroquilon	small molecule	experimental	Antifungal Agents
DB02757	Pyrazole	small molecule	experimental	Alcohol Dehydrogenase, antagonists & inhibitors|Enzyme Inhibitors
DB02758	Indolylpropionic Acid	small molecule	experimental	
DB02759	4-Methylumbelliferyl Chitobiose	small molecule	experimental	
DB02760	1,6-Di-O-Phosphono-D-Allitol	small molecule	experimental	
DB02761	S-Mercaptocysteine	small molecule	experimental	
DB02762	RU79072	small molecule	experimental	
DB02763	5-Mercapto-2-Nitro-Benzoic Acid	small molecule	experimental	
DB02765	R-9-(2-hydroxypropyl)adenine	small molecule	experimental	
DB02766	(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium	small molecule	experimental	
DB02767	3-Hydroxy-Myristic Acid	small molecule	experimental	
DB02768	Tert-Butyloxycarbonyl Group	small molecule	experimental	
DB02770	7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate	small molecule	experimental	
DB02772	Sucrose	small molecule	approved|experimental|investigational	Carbohydrates|Diet, Food, and Nutrition|Disaccharides|Flavoring Agents|Food|Food Additives|Food and Beverages|Oligosaccharides|Physiological Phenomena|Polysaccharides|Sweetening Agents
DB02773	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	small molecule	experimental	
DB02774	1,3-Propandiol	small molecule	experimental	
DB02776	1-Hexadecanosulfonic Acid	small molecule	experimental	
DB02777	Diundecyl Phosphatidyl Choline	small molecule	experimental	
DB02778	2,5-Anhydroglucitol-1,6-Biphosphate	small molecule	experimental	
DB02779	Dodecane-Trimethylamine	small molecule	experimental	
DB02780	Beta-3-Cysteine	small molecule	experimental	
DB02781	4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate	small molecule	experimental	
DB02783	4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate	small molecule	experimental	
DB02784	N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid	small molecule	experimental	
DB02785	N-[2(S)-Cyclopentyl-1(R)-Hydroxy-3(R)Methyl]-5-[(2(S)-Tertiary-Butylamino-Carbonyl)-4-(N1-(2)-(N-Methylpiperazinyl)-3-Chloro-Pyrazinyl-5-Carbonyl)-Piperazino]-4(S)-Hydroxy-2(R)-Phenylmethyl-Pentanamide	small molecule	experimental	
DB02786	2-Anhydro-3-Fluoro-Quinic Acid	small molecule	experimental	
DB02787	N-Acetylmannosaminitol	small molecule	experimental	
DB02788	(S)-acetoin	small molecule	experimental	
DB02789	Pregnenolone	small molecule	approved|experimental	Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenes|Progesterone Congeners|Steroids
DB02790	Phenyl-Uridine-5'-Diphosphate	small molecule	experimental	
DB02792	Deglucobalhimycin	small molecule	experimental	
DB02793	Isochorismic Acid	small molecule	experimental	Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Isomerism
DB02794	N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide	small molecule	experimental	
DB02795	P-Anisic Acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Ethers|Hydroxy Acids|Hydroxybenzoates|Phenols|Phenyl Ethers
DB02796	9-Deazainosine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB02797	3-Nitrophenylboronic Acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Boron Compounds
DB02798	Alpha-Methylene Adenosine Monophosphate	small molecule	experimental	
DB02799	N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide	small molecule	experimental	
DB02800	5-Hydroxymethylene-6-Hydrofolic Acid	small molecule	experimental	
DB02801	2,3 -Anhydro-Quinic Acid	small molecule	experimental	
DB02802	5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose	small molecule	experimental	
DB02803	3-Phenyl-1,2-Propandiol	small molecule	experimental	
DB02804	A-98881	small molecule	experimental	
DB02805	Uracil arabinose-3'-phosphate	small molecule	experimental	
DB02806	2-Methoxyethanol	small molecule	experimental	Alcohols|Glycols|Immunologic Factors|Immunosuppressive Agents|Noxae|Solvents|Teratogens|Toxic Actions
DB02807	3-deoxy-D-lyxo-hexonic acid	small molecule	experimental	
DB02808	Trifluorofurnesyl Diphosphate	small molecule	experimental	
DB02809	Brodimoprim-4,6-Dicarboxylate	small molecule	experimental	
DB02810	N-(2-Acetamido)Iminodiacetic Acid	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines
DB02811	Diethylphosphono Group	small molecule	experimental	
DB02812	(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide	small molecule	experimental	
DB02813	2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone	small molecule	experimental	
DB02814	3'-Deazo-Thiamin Diphosphate	small molecule	experimental	
DB02816	7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem	small molecule	experimental	
DB02817	5-Exo-Hydroxycamphor	small molecule	experimental	
DB02818	Iodo-Willardiine	small molecule	experimental	
DB02819	Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester	small molecule	experimental	
DB02820	1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct	small molecule	experimental	
DB02821	Canaline	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids
DB02822	Para-Bromobenzyl Alcohol	small molecule	experimental	Alcohols|Benzene Derivatives|Benzyl Compounds
DB02823	Phosphonoacetic Acid	small molecule	experimental	Acetates|Acids, Acyclic|Anti-Infective Agents|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Nucleic Acid Synthesis Inhibitors|Organophosphonates|Organophosphorus Compounds|Reverse Transcriptase Inhibitors
DB02824	N-Pyridoxyl-Glycine-5-Monophosphate	small molecule	experimental	
DB02825	Methylphosphonic Acid Ester Group	small molecule	experimental	
DB02827	7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	small molecule	experimental	
DB02828	5-Fluorolevulinic Acid	small molecule	experimental	Keto Acids
DB02829	4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid	small molecule	experimental	
DB02830	FR236913	small molecule	experimental	
DB02831	Dihydrogenphosphate	small molecule	experimental	
DB02832	Siroheme	small molecule	experimental	Biological Factors|Metalloporphyrins|Pigments, Biological|Porphyrins
DB02833	[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine	small molecule	experimental	
DB02834	IDD552	small molecule	experimental	Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Sulfur Compounds
DB02835	Alpha-D-Glucose 1,6-Bisphosphate	small molecule	experimental	
DB02836	Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate	small molecule	experimental	
DB02837	O4-Sulfonylgalactose	small molecule	experimental	
DB02838	3,4-Dihydro-2h-Pyrrolium-5-Carboxylate	small molecule	experimental	
DB02839	2,4-Dihydroxybenzoic Acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Phenols
DB02840	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	small molecule	experimental	
DB02841	[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid	small molecule	experimental	
DB02842	9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide	small molecule	experimental	
DB02843	alpha-D-glucose-1-phosphate	small molecule	experimental	Carbohydrates|Hexosephosphates|Sugar Phosphates
DB02844	S-Adenosyl-1,8-Diamino-3-Thiooctane	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB02845	Methylphosphinic Acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds
DB02846	L-thioproline	small molecule	experimental	
DB02847	(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol	small molecule	experimental	
DB02848	{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol	small molecule	experimental	
DB02849	N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate	small molecule	experimental	
DB02850	(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone	small molecule	experimental	
DB02851	Thiocamphor	small molecule	experimental	Bornanes|Ketones|Monoterpenes|Norbornanes|Terpenes
DB02852	Domoic Acid	small molecule	experimental	Central Nervous System Depressants|Marine Toxins|Neuromuscular Agents|Neurotoxins|Peripheral Nervous System Agents|Pyrrolidines
DB02853	D-Proline	small molecule	experimental	
DB02854	Aetiocholanolone	small molecule	experimental	
DB02855	N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline	small molecule	experimental	Amino Acids, Peptides, and Proteins|Cathepsin B, antagonists & inhibitors|Central Nervous System Agents|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|Neuroprotective Agents|Oligopeptides|Peptides|Protease Inhibitors|Protective Agents
DB02856	Methyl-Carbamic Acid Ethyl Ester	small molecule	experimental	
DB02857	Guanosine	small molecule	experimental|investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB02858	3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid	small molecule	experimental	
DB02859	Soraphen A	small molecule	experimental	Lactones|Polyketides
DB02860	Calyculin A	small molecule	experimental	Carcinogens|Cardiovascular Agents|Enzyme Inhibitors|Noxae|Phosphoprotein Phosphatases, antagonists & inhibitors|Toxic Actions|Vasoconstrictor Agents
DB02861	4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide	small molecule	experimental	
DB02862	Gluco-Phenylimidazole	small molecule	experimental	
DB02864	Biliverdin Ix Gamma Chromophore	small molecule	experimental	
DB02865	Glucosamine 4-Phosphate	small molecule	experimental	Amino Sugars|Carbohydrates|Hexosamines|Hexosephosphates|Sugar Phosphates
DB02866	Dansylamide	small molecule	experimental	Coloring Agents|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Naphthalenes|Sulfones|Sulfur Compounds
DB02867	D-Mannose 1-Phosphate	small molecule	experimental	
DB02868	3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine	small molecule	experimental	
DB02869	3-amino-5-phenylpentane	small molecule	experimental	
DB02870	N-Allyl-Aniline	small molecule	experimental	
DB02871	3-Butylthiolane 1-Oxide	small molecule	experimental	Alcohol Dehydrogenase, antagonists & inhibitors|Sulfur Compounds
DB02872	Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone	small molecule	experimental	
DB02873	1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One	small molecule	experimental	
DB02875	CRA_1802	small molecule	experimental	
DB02876	3-(4-Carbamoyl-1-Carboxy-2-Methylsulfonyl-Buta-1,3-Dienylamino)-Indolizine-2-Carboxylic Acid	small molecule	experimental	
DB02877	Arotinoid acid	small molecule	experimental	Acids, Carbocyclic|Alkenes|Benzene Derivatives|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB02878	3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid	small molecule	experimental	
DB02879	2,3-Di-O-Sulfo-Alpha-D-Glucopyranose	small molecule	experimental	
DB02880	N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide	small molecule	experimental	
DB02881	4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol	small molecule	experimental	
DB02882	Cyanocinnoline	small molecule	experimental	
DB02883	2',3'-Dideoxycytidine-5'-Monophosphate	small molecule	experimental	
DB02884	Beta-Cyclohexyl-Alanine	small molecule	experimental	
DB02885	4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine	small molecule	experimental	
DB02887	2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate	small molecule	experimental	
DB02888	FKB-001	small molecule	experimental	
DB02889	4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose	small molecule	experimental	
DB02890	6-Hydroxyuridine-5'-Phosphate	small molecule	experimental	
DB02891	Tricyclazole	small molecule	experimental|investigational	Sulfur Compounds
DB02892	L-2-Amino-6-Methylene-Pimelic Acid	small molecule	experimental	
DB02893	D-Methionine	small molecule	approved|experimental|investigational	
DB02894	Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester	small molecule	experimental	
DB02895	3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol	small molecule	experimental	
DB02896	Methylthioinosine	small molecule	experimental	Carbohydrates|Glycosides|Inosine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Sulfur Compounds|Thioinosine|Thionucleosides
DB02897	Acetylphosphate	small molecule	experimental	
DB02898	5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone	small molecule	experimental	
DB02899	N-Carboxymethionine	small molecule	experimental	
DB02900	alpha-D-mannose 6-phosphate	small molecule	experimental	
DB02901	Stanolone	small molecule	illicit|investigational	5-Androstanon (3) Derivatives|Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|P-glycoprotein/ABCB1 Substrates|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners
DB02902	3'-Phosphate-Adenosine-5'-Phosphate Sulfate	small molecule	experimental	
DB02903	BV3	small molecule	experimental	
DB02904	Beta-3-Serine	small molecule	experimental	
DB02905	Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester	small molecule	experimental	
DB02906	(2s,4s)-Alpha-Campholinic Acid	small molecule	experimental	
DB02907	2-Amino-Vinyl-Phosphate	small molecule	experimental	
DB02908	RU78783	small molecule	experimental	
DB02909	5-(2-Chlorophenyl)Furan-2-Carboxylic Acid	small molecule	experimental	
DB02910	Octanoyl-Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB02911	2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine	small molecule	experimental	
DB02912	Propanoyl-CoA	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB02914	(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene	small molecule	experimental	
DB02915	4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine	small molecule	experimental	
DB02916	[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate	small molecule	experimental	
DB02917	N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide	small molecule	experimental	
DB02918	Zardaverine	small molecule	experimental	Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Phosphodiesterase Inhibitors|Respiratory System Agents
DB02919	2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	small molecule	experimental	
DB02920	Zn(Ii)-(20-Oxo-Protoporphyrin Ix)	small molecule	experimental	
DB02921	(South)-Methanocarba-Thymidine	small molecule	experimental	
DB02922	Hexafluoroacetone Hydrate	small molecule	experimental	Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ketones
DB02923	Biphenyl-2,3-Diol	small molecule	experimental	
DB02924	(4R)-limonene 1Î±,2Î±-epoxide	small molecule	experimental	
DB02925	Piretanide	small molecule	approved	Amides|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|High-Ceiling Diuretics|Membrane Transport Modulators|Natriuretic Agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB02927	Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid	small molecule	experimental	
DB02928	3-Amino-6-Hydroxy-Tyrosine	small molecule	experimental	
DB02929	K201	small molecule	experimental|investigational	
DB02930	Adenosine 5'-[Î³-thio]triphosphate	small molecule	experimental	Adenine Nucleotides|Affinity Labels|Carbohydrates|Glycosides|Indicators and Reagents|Laboratory Chemicals|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB02931	Coa-S-Acetyl Tryptamine	small molecule	experimental	
DB02932	(R)-Bicalutamide	small molecule	experimental	
DB02933	5'-Deoxy-5'-(Methylthio)-Tubercidin	small molecule	experimental	
DB02934	9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine	small molecule	experimental	
DB02935	Diglyme	small molecule	experimental	Alcohols|Ethers|Glycols
DB02936	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	small molecule	experimental	
DB02937	Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate	small molecule	experimental	
DB02938	Heptanoic Acid	small molecule	experimental|investigational	
DB02940	(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid	small molecule	experimental	
DB02941	3-(1-Aminoethyl)Nonanedioic Acid	small molecule	experimental	
DB02942	Inositol 1,3-Bisphosphate	small molecule	experimental	Alcohols|Carbohydrates|Inositol|Sugar Alcohols|Sugar Phosphates
DB02943	N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine	small molecule	experimental	
DB02945	alpha-L-iduronic acid	small molecule	experimental	
DB02946	Carpropamide	small molecule	experimental	
DB02947	2-Fluoro-2'-Deoxyadenosine	small molecule	experimental	
DB02948	Fosmidomycin	small molecule	experimental|investigational	Organophosphonates|Organophosphorus Compounds
DB02949	2-Acetyl-Protoporphyrin Ix	small molecule	experimental	
DB02950	Hymenialdisine	small molecule	experimental	Interleukin-8, antagonists & inhibitors
DB02951	3-Hydroxypyruvic Acid	small molecule	experimental	Keto Acids
DB02952	Alpha-Aminoisobutyric Acid	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Fatty Acids|Fatty Acids, Volatile|Isobutyrates|Lipids
DB02953	2-Thiomethyl-3-Phenylpropanoic Acid	small molecule	experimental	
DB02954	(Carboxyhydroxyamino)Ethanoic Acid	small molecule	experimental	
DB02955	Ricinoleic Acid	small molecule	experimental	Biological Products|Castor Oil|Complex Mixtures|Fats|Fats, Unsaturated|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|Oils|Oleic Acids|Plant Oils|Plant Preparations
DB02956	Pentasulfide-Sulfur	small molecule	experimental	
DB02957	Orotidine-5'-Monophosphate	small molecule	experimental	
DB02958	Selenomethionine Selenoxide	small molecule	experimental	
DB02959	Oxitriptan	small molecule	approved|investigational|nutraceutical	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psychoanaleptics|Psychotropic Drugs|Tryptophan
DB02960	1-Carboxyethylaminomethyl-4-Aminomethylbenzene	small molecule	experimental	
DB02961	Rhamnose	small molecule	experimental	Carbohydrates|Deoxy Sugars|Hexoses|Monosaccharides
DB02962	Benzimidazole	small molecule	experimental|investigational	Anthelmintics|Anti-Infective Agents|Antiparasitic Agents
DB02963	(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine	small molecule	experimental	
DB02964	8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One	small molecule	experimental	
DB02965	Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine	small molecule	experimental	
DB02966	Fluoro-Willardiine	small molecule	experimental	
DB02967	N-Ethylmaleimide	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids|Enzyme Inhibitors|Imides|Indicators and Reagents|Laboratory Chemicals|Maleates|Maleimides|Sulfhydryl Reagents
DB02968	Penicillin G Acyl-Serine	small molecule	experimental	Agents causing hyperkalemia
DB02969	4-Methyl-5-Hydroxyethylthiazole	small molecule	experimental	Sulfur Compounds
DB02970	2-Propyl-Aniline	small molecule	experimental	
DB02971	2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid	small molecule	experimental	
DB02972	1-Benzyl-(R)-Propylamine	small molecule	experimental	
DB02973	4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide	small molecule	experimental	
DB02974	4-(4-Chlorophenyl)Imidazole	small molecule	experimental	
DB02975	GE-2270A	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Sulfur Compounds
DB02976	Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester	small molecule	experimental	
DB02977	PNU177836	small molecule	experimental	
DB02978	Beta-Hydroxyleucine	small molecule	experimental	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB02979	N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane	small molecule	experimental	
DB02980	Thymidine-5'-(Dithio)Phosphate	small molecule	experimental	
DB02981	Vitamin B6 Complexed with 2-Amino-Hexanoic Acid	small molecule	experimental	
DB02982	Bombykol	small molecule	experimental	Alcohols|Lipids
DB02983	Para-Mercury-Benzenesulfonic Acid	small molecule	experimental	
DB02984	4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline	small molecule	experimental	
DB02985	8-Iodo-Guanine	small molecule	experimental	
DB02986	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	small molecule	experimental	
DB02987	Cysteine-S-Acetamide	small molecule	experimental	
DB02988	Imino-Tryptophan	small molecule	experimental	
DB02989	CRA_10972	small molecule	experimental	
DB02990	C16-Fatty-Acyl-Substrate-Mimic	small molecule	experimental	
DB02991	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	small molecule	experimental	
DB02992	1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol	small molecule	experimental	
DB02993	8-Methyl-9-Oxoguanine	small molecule	experimental	
DB02994	Cacodylic acid	small molecule	experimental	Agrochemicals|Arsenicals|Herbicides|Organometallic Compounds|Pesticides|Toxic Actions
DB02995	Cyclohexylammonium Ion	small molecule	experimental	
DB02996	2-(Thiomethylene)-4-Methylpentanoic Acid	small molecule	experimental	
DB02998	Methyltrienolone	small molecule	experimental	Estranes|Estrenes|Steroids
DB02999	Quisqualate	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Excitatory Amino Acid Agents|Excitatory Amino Acid Agonists|Neurotransmitter Agents|Oxadiazoles|Oxazoles
DB03000	S-9-(2-hydroxypropyl)adenine	small molecule	experimental	
DB03001	Peridinin	small molecule	experimental	Alkenes|Biological Factors|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB03002	p-Iodophenol	small molecule	experimental	Benzene Derivatives|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated
DB03003	Glutathione Sulfonic Acid	small molecule	experimental	
DB03004	1-[(1s)-Carboxy-2-(Methylsulfinyl)Ethyl]-(3r)-[(5s)-5-Amino-5-Carboxypentanamido]-(4r)-Sulfanylazetidin-2-One	small molecule	experimental	
DB03005	3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium	small molecule	experimental	
DB03006	Arsanilic acid	small molecule	experimental|vet_approved	Adjuvants, Immunologic|Alkenes|Anti-Infective Agents|Arsenicals|Hydrocarbons, Acyclic|Immunologic Factors|Organometallic Compounds|Protective Agents|Radiation-Protective Agents|Tellurium
DB03007	9r,13r-Opda	small molecule	experimental	
DB03008	5-fluoro-beta-L-gulosyl fluoride	small molecule	experimental	Carbohydrates|Monosaccharides
DB03009	2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One	small molecule	experimental	
DB03010	Patupilone	small molecule	experimental|investigational	Anti-Bacterial Agents|Antimitotic Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Mitosis Modulators|Polyketides|Tubulin Modulators
DB03011	Adenosine-5'-(Dithio)Phosphate	small molecule	experimental	
DB03012	Phenylalanine-N-Sulfonamide	small molecule	experimental	
DB03013	Di(N-Acetyl-D-Glucosamine)	small molecule	experimental	
DB03015	6-Hydroxy-1,6-Dihydro Purine Nucleoside	small molecule	experimental	
DB03016	CRA_1801	small molecule	experimental	
DB03017	Lauric Acid	small molecule	approved|experimental	Fatty Acids|Lipids
DB03018	3,4-Dimethylaniline	small molecule	experimental	Amines
DB03019	4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine	small molecule	experimental	
DB03020	5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide	small molecule	experimental	
DB03021	Ulapualide A	small molecule	experimental	Ionophores
DB03022	3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	small molecule	experimental	
DB03023	1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine	small molecule	experimental	
DB03024	2-Methyl-3-(2-Aminothiazolo)Propanal	small molecule	experimental	
DB03025	(S)-oct-1-en-3-ol	small molecule	experimental	
DB03026	Phosphoglycolohydroxamic Acid	small molecule	experimental	
DB03028	1h-Benoximidazole-2-Carboxylic Acid	small molecule	experimental	
DB03030	4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole	small molecule	experimental	
DB03031	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide	small molecule	experimental	
DB03032	S-Octylglutathione	small molecule	experimental	Amino Acids, Peptides, and Proteins|Glutathione Transferase, antagonists & inhibitors|Oligopeptides|Peptides
DB03033	1-Methyloxy-4-Sulfone-Benzene	small molecule	experimental	
DB03034	D-Levofloxacin	small molecule	experimental	OCT2 Inhibitors
DB03035	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	small molecule	experimental	
DB03037	Oxidized Acetyl Dithranol	small molecule	experimental	
DB03038	LY341770	small molecule	experimental	
DB03039	4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide	small molecule	experimental	
DB03040	Nitrilotriacetic Acid	small molecule	experimental	Acetates|Acids, Acyclic|Chelating Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Sequestering Agents
DB03041	UDP-alpha-D-glucuronic acid	small molecule	experimental	Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Diphosphate Sugars|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides|Uridine Diphosphate|Uridine Diphosphate Sugars
DB03042	5-Phosphoarabinonic Acid	small molecule	experimental	
DB03043	(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid	small molecule	experimental	
DB03044	1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea	small molecule	experimental|investigational	
DB03045	Pantothenyl-Aminoethanol-Acetate Pivalic Acid	small molecule	experimental	
DB03046	7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide	small molecule	experimental	
DB03047	L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine	small molecule	experimental	
DB03048	6-Carboxymethyluracil	small molecule	experimental	
DB03049	S-Selanyl Cysteine	small molecule	experimental	
DB03051	Tetrahydrofuran-2-Carboxylic Acid	small molecule	experimental	
DB03052	Dazoxiben	small molecule	experimental	Enzyme Inhibitors|Thromboxane-A Synthase, antagonists & inhibitors
DB03053	1-Aminocyclopropylphosphonate	small molecule	experimental	
DB03054	Bromoform	small molecule	experimental	Carcinogens|Hydrocarbons, Halogenated|Noxae|Teratogens|Toxic Actions
DB03056	4-Piperidino-Piperidine	small molecule	experimental	
DB03057	Malonaldehyde	small molecule	experimental	Aldehydes
DB03058	2-Aminobenzyl alcohol	small molecule	experimental	Alcohols|Benzene Derivatives|Benzyl Compounds
DB03059	Acetoacetyl-CoA	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03060	Sri-9662	small molecule	experimental	
DB03061	(R)-N-(1-Methyl-Hexyl)-Formamide	small molecule	experimental	
DB03062	(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone	small molecule	experimental	Dietary Supplements|Supplements
DB03063	N-(1-Benzyl-3-{[3-(1,3-Dioxo-1,3-Dihydro-Isoindol-2-Yl)-Propionyl]-[2-(Hexahydro-Benzo[1,3]Dioxol-5-Yl)-Ethyl]-Amino}-2-Hydroxy-Propyl)-4-Benzyloxy-3,5-Dimethoxy-Benzamide	small molecule	experimental	
DB03064	3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline	small molecule	experimental	
DB03065	7-Nitroindazole-2-Carboxamidine	small molecule	experimental	
DB03066	D-Lactic acid	small molecule	experimental	Hydroxy Acids|Lactates
DB03067	4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	small molecule	experimental	
DB03068	Zebularine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB03069	Cytidine-5'-Diphospho-Beta-D-Xylose	small molecule	experimental	
DB03070	Selenazole-4-Carboxyamide-Adenine Dinucleotide	small molecule	experimental	
DB03071	4-Methylidene-5-One	small molecule	experimental	
DB03072	2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone	small molecule	experimental	
DB03073	3-Methoxybenzamide	small molecule	experimental	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors
DB03074	7-Deaza-7-Cyano-Guanine	small molecule	experimental	
DB03075	(Diphosphono)Aminophosphonic Acid	small molecule	experimental	
DB03076	AHA047	small molecule	experimental	
DB03077	3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione	small molecule	experimental	
DB03078	PASBN	small molecule	experimental	
DB03079	Alpha-Ribazole-5'-Phosphate Derivative	small molecule	experimental	
DB03081	Crc200 (Chiron-Behring)	small molecule	experimental	
DB03082	6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide	small molecule	experimental	
DB03083	IC261	small molecule	experimental	Benzene Derivatives|Phenols
DB03084	Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine	small molecule	experimental	
DB03085	Glycolic acid	small molecule	approved|investigational	Acetates|Acids, Acyclic|Dermatologicals|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Keratolytic Agents|Lipids
DB03086	N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide	small molecule	experimental	
DB03087	2-(Sec-Butyl)Thiazole	small molecule	experimental	
DB03088	Pidolic Acid	small molecule	approved|investigational	Acids, Acyclic|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Acidic|Amino Acids, Cyclic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Glutamates|Imines|Imino Acids|Mineral Supplements|Pyrrolidines|Pyrrolidinones
DB03090	Ethylaminobenzylmethylcarbonyl Group	small molecule	experimental	
DB03091	4-Amido-4-Carbamoyl-Butyric Acid	small molecule	experimental	
DB03092	5-Hydroxymethyl-Chonduritol	small molecule	experimental	
DB03093	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	small molecule	experimental	
DB03094	3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On	small molecule	experimental	
DB03095	Tetramethylammonium Ion	small molecule	experimental	
DB03096	N-Aminoethylmorpholine	small molecule	experimental	
DB03097	Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole	small molecule	experimental	
DB03098	[Methylseleno]Acetate	small molecule	experimental	
DB03099	5-Amino 6-Nitro Uracil	small molecule	experimental	
DB03100	6-Nitroindazole	small molecule	experimental	Nitric Oxide Synthase, antagonists & inhibitors|Pyrazoles
DB03101	Ribose-1-Phosphate	small molecule	experimental	
DB03102	2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid	small molecule	experimental	
DB03103	Thymidine-5'- Diphosphate	small molecule	experimental	
DB03104	RU82129	small molecule	experimental	
DB03105	5-Hydroxy Norvaline	small molecule	experimental	
DB03106	scyllo-inositol	small molecule	investigational	Alcohols|Carbohydrates|Stereoisomerism|Sugar Alcohols
DB03107	Beta-Alanine	small molecule	experimental	Alanine|Amino Acids|Amino Acids, Peptides, and Proteins
DB03108	4-phospho-D-erythronic acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids
DB03109	N-Acetyl-D-Allosamine	small molecule	experimental	
DB03110	2-Chlorophenol	small molecule	experimental	Benzene Derivatives|Chlorobenzenes|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Phenols
DB03111	Glucosamine 1-Phosphate	small molecule	experimental	Amino Sugars|Carbohydrates|Hexosamines|Hexosephosphates|Sugar Phosphates
DB03112	6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid	small molecule	experimental	
DB03113	3-Fluoro-2-(Phosphonooxy)Propanoic Acid	small molecule	experimental	
DB03114	PAS219	small molecule	experimental	
DB03115	5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide	small molecule	experimental	
DB03116	5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate	small molecule	experimental	
DB03117	2-Carboxypropyl-Coenzyme A	small molecule	experimental	
DB03118	1-(5-Chloroindol-3-Yl)-3-Hydroxy-3-(2h-Tetrazol-5-Yl)-Propenone	small molecule	experimental	
DB03120	Para-Toluene Sulfonate	small molecule	experimental	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB03121	(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid	small molecule	experimental	
DB03124	5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid	small molecule	experimental	
DB03125	2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium	small molecule	experimental	
DB03126	Mant-Adp	small molecule	experimental	Acids, Carbocyclic|Adenine Nucleotides|Aminobenzoates|Benzene Derivatives|Benzoates|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03127	Benzamidine	small molecule	experimental	Amidines|Enzyme Inhibitors|Serine Proteinase Inhibitors
DB03128	Acetylcholine	small molecule	approved|investigational	Amines|Antiglaucoma Preparations and Miotics|Biogenic Amines|Cardiovascular Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Miotics|Neurotransmitter Agents|Ophthalmologicals|Parasympathomimetics|Sensory Organs|Vasodilating Agents
DB03129	[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine	small molecule	experimental	
DB03130	S-P-Nitrobenzyloxycarbonylglutathione	small molecule	experimental	
DB03132	3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Alkanes|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Thiazoles|Triose-Phosphate Isomerase, antagonists & inhibitors
DB03133	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole	small molecule	experimental	
DB03134	2-Aminopimelic Acid	small molecule	experimental	
DB03135	[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid	small molecule	experimental	
DB03136	4-Iodobenzo[B]Thiophene-2-Carboxamidine	small molecule	experimental	
DB03137	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine	small molecule	experimental	
DB03138	Perchlorate	small molecule	experimental	Acids|Acids, Noncarboxylic|Chlorine Compounds
DB03139	6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid	small molecule	experimental	
DB03140	4-Carboxyphenylboronic Acid	small molecule	experimental	
DB03141	3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril	small molecule	experimental	
DB03142	Alpha-L-Arabinose	small molecule	experimental	
DB03143	Nonan-1-Ol	small molecule	experimental	
DB03144	N-Omega-Hydroxy-L-Arginine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB03145	4-Methyl-5-Hydroxyethylthiazole Phosphate	small molecule	experimental	
DB03146	2-deazo-6-thiophosphate guanosine-5'-monophosphate	small molecule	experimental	
DB03147	Flavin adenine dinucleotide	small molecule	approved	Adenine Nucleotides|Biological Factors|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Flavins|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pigments, Biological|Pteridines|Purine Nucleotides|Purines|Ribonucleotides|Vitamin B Complex|Vitamins
DB03148	Phosphomethylphosphonic Acid Adenosyl Ester	small molecule	experimental	
DB03150	2',3'-Dideoxythymidine-5'-Monophosphate	small molecule	experimental	
DB03151	(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion	small molecule	experimental	
DB03152	B-2-Octylglucoside	small molecule	experimental	
DB03153	3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol	small molecule	experimental	
DB03154	{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid	small molecule	experimental	
DB03155	1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione	small molecule	experimental	
DB03156	beta-D-glucuronic acid	small molecule	experimental	
DB03157	N,O-Didansyl-L-Tyrosine	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Naphthalenes|Sulfones|Sulfur Compounds|Thymidylate Synthase, antagonists & inhibitors
DB03158	D-Myo-Inositol-1,4-Bisphosphate	small molecule	experimental	
DB03159	CRA_8696	small molecule	experimental	
DB03160	N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate	small molecule	experimental	
DB03161	Thymidine-5'-Diphospho-Beta-D-Xylose	small molecule	experimental	
DB03162	4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid	small molecule	experimental	
DB03163	2-oxopropyl-CoM	small molecule	experimental	
DB03164	6-Amino-1-Methylpurine	small molecule	experimental	
DB03165	2-Dimethylamino-Ethyl-Diphosphate	small molecule	experimental	
DB03166	Acetic acid	small molecule	approved	Acetates|Acids, Acyclic|Anti-Infective Agents|Fatty Acids|Fatty Acids, Volatile|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Indicators and Reagents|Laboratory Chemicals|Lipids|Organic Acids|Otologicals|Sensory Organs
DB03167	Pentabromophenol	small molecule	experimental	Benzene Derivatives
DB03168	Nicotinamide Adenine Dinucleotide Cyclohexanone	small molecule	experimental	
DB03169	(S)-Hmg-Coa	small molecule	experimental	
DB03170	Dephospho Coenzyme A	small molecule	experimental	
DB03171	Indole-3-Propanol Phosphate	small molecule	experimental	
DB03172	Tubercidin	small molecule	experimental	Antibiotics, Antineoplastic|Antimetabolites|Antimetabolites, Antineoplastic|Carbohydrates|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Toxic Actions
DB03173	CRA_10433	small molecule	experimental	
DB03174	Phosphonoacetaldehyde	small molecule	experimental	Aldehydes
DB03175	Propyl alcohol	small molecule	approved|experimental	Alcohols|Antiseptics and Disinfectants|Dermatologicals|Propanols
DB03176	KB-141	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Ethers|Ligands|Phenols|Receptors, Thyroid Hormone, agonists
DB03177	5-methylbenzimidazole	small molecule	experimental	
DB03178	Guanosine-2',3'-Cyclophosphorothioate	small molecule	experimental	
DB03179	Sinapoyl Coenzyme A	small molecule	experimental	
DB03180	4,5-Dimethyl-1,2-Phenylenediamine	small molecule	experimental	Amines|Aniline Compounds|Diamines|Polyamines
DB03181	2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione	small molecule	experimental	
DB03182	Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex	small molecule	experimental	
DB03183	1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	small molecule	experimental	
DB03184	5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid	small molecule	experimental	
DB03185	1-Beta-Ribofuranosyl-1,3-Diazepinone	small molecule	experimental	
DB03186	U-Pi-a-Pi	small molecule	experimental	
DB03187	6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid	small molecule	experimental	
DB03189	Cu-Cyclam	small molecule	experimental	
DB03190	N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate	small molecule	experimental	
DB03191	3-Oxiran-2ylalanine	small molecule	experimental	
DB03192	3r-Hydroxydecanoyl-Coa	small molecule	experimental	
DB03193	Stearic acid	small molecule	approved|experimental	Fatty Acids|Lipids
DB03194	beta-L-methyl-fucose	small molecule	experimental	
DB03195	Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester	small molecule	experimental	
DB03196	4-Nitrophenyl-Ara	small molecule	experimental	
DB03197	6-Hydroxymethylpterin	small molecule	experimental	Biological Factors|Pigments, Biological|Pteridines
DB03198	Thio-Maltohexaose	small molecule	experimental	
DB03199	4-Methoxy-E-Rhodomycin T	small molecule	experimental	
DB03200	7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate	small molecule	experimental	
DB03201	D-Cysteine	small molecule	experimental	
DB03202	2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide	small molecule	experimental	
DB03203	Sphingosine	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Glycols|P-glycoprotein/ABCB1 Substrates
DB03204	5-(Aminomethyl)-2-Methylpyrimidin-4-Amine	small molecule	experimental	
DB03205	Pyrroloquinoline Quinone	small molecule	experimental	Coenzymes|Enzymes and Coenzymes|Quinolines|Quinolones
DB03206	Duvoglustat	small molecule	experimental|investigational	Alkaloids|Amino Sugars|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Hexosamines|Imines|Imino Pyranoses|Imino Sugars|Monosaccharides|Piperidines
DB03207	2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid	small molecule	experimental	
DB03208	Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose	small molecule	experimental	
DB03209	Oteracil	small molecule	approved	Triazines
DB03210	4-Aminohydrocinnamic Acid	small molecule	experimental	
DB03211	(3-Formyl-but-3-Enyl)-Phosphonic Acid	small molecule	experimental	
DB03212	4-Deoxyglucarate	small molecule	experimental	
DB03213	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone	small molecule	experimental	
DB03214	Vinylglycine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins
DB03215	(2s,5s)-5-Carboxymethylproline	small molecule	experimental	
DB03216	(1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine	small molecule	experimental	
DB03217	DPI59	small molecule	experimental	
DB03218	N-Acetyl-N'-Beta-D-Glucopyranosyl Urea	small molecule	experimental	Carbohydrates|Glycogen Phosphorylase, antagonists & inhibitors|Hexoses|Monosaccharides
DB03219	11-Deoxy-Beta-Rhodomycin	small molecule	experimental	
DB03220	FR233623	small molecule	experimental	
DB03221	AL7099A	small molecule	experimental	
DB03222	dATP	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03223	Diphthamide	small molecule	experimental	Amino Acids|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB03224	2-Formyl-Protoporphryn Ix	small molecule	experimental	
DB03225	D-Tryptophan	small molecule	experimental	
DB03226	Trifluoroethanol	small molecule	experimental	Alcohols
DB03227	Nicotinamide Mononucleotide	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Ribonucleotides
DB03228	5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide	small molecule	experimental	
DB03229	2-Oxo-4-Methylpentanoic Acid	small molecule	experimental	Caproates
DB03230	Adenosine-5'-Propylphosphate	small molecule	experimental	
DB03231	3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide	small molecule	experimental	
DB03232	2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol	small molecule	experimental	
DB03233	Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester	small molecule	experimental	
DB03234	(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone	small molecule	experimental	
DB03235	N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide	small molecule	experimental	
DB03236	(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid	small molecule	experimental	
DB03237	2,3-Dihydroxy-5-Oxo-Hexanedioate	small molecule	experimental	
DB03238	3,5-Difluoroaniline	small molecule	experimental	Amines
DB03239	3',5'-Dinitro-N-Acetyl-L-Thyronine	small molecule	experimental	
DB03240	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	small molecule	experimental	
DB03241	1-Amino-1-Carbonyl Pentane	small molecule	experimental	
DB03242	P-Aminophenyl-Alpha-D-Galactopyranoside	small molecule	experimental	
DB03243	4-Fluorobenzylamine	small molecule	experimental	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Fluorine Radioisotopes|Radioimmunodetection
DB03244	(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid	small molecule	experimental	
DB03245	S-4-Nitrobutyryl-Coa	small molecule	experimental	
DB03246	Beta-L-Arabinose	small molecule	experimental	
DB03247	Flavin mononucleotide	small molecule	approved|investigational	Biological Factors|Carbohydrates|Coenzymes|Diet, Food, and Nutrition|Enzymes and Coenzymes|Flavins|Food|Food and Beverages|Glycosides|Growth Substances|Micronutrients|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Physiological Phenomena|Pigments, Biological|Pteridines|Ribonucleotides|Vitamin B Complex|Vitamins
DB03248	2-(Phosphonooxy)Butanoic Acid	small molecule	experimental	
DB03249	2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate	small molecule	experimental	
DB03250	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole	small molecule	experimental	
DB03251	RWJ-51084	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Sulfur Compounds|Thiazoles
DB03252	D-Lysine	small molecule	experimental	
DB03253	(2s)-Pyrrolidin-2-Ylmethylamine	small molecule	experimental	
DB03254	4-Phenyl-1h-Imidazole	small molecule	experimental	
DB03255	Phenol	small molecule	approved|experimental	Anesthetics|Anesthetics, Local|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Antivaricose Therapy|Benzene Derivatives|Cardiovascular Agents|Dermatologicals|Disinfectants|Histamine Antagonists|Nervous System|Pharmaceutical Preparations|Pharmaceutical Solutions|Phenol and Derivatives|Phenols|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Throat Preparations|Vasoprotectives
DB03256	(6R)-Folinic acid	small molecule	experimental	Folic Acid and Derivatives|Vitamin B Complex|Vitamins
DB03257	5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid	small molecule	experimental	
DB03258	2'-Deoxycytidine 5'-triphosphate	small molecule	experimental	Carbohydrates|Cytosine Nucleotides|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides
DB03259	2',6'-Dichloro-Biphenyl-2,6-Diol	small molecule	experimental	
DB03260	1,6-Diaminohexane	small molecule	experimental	Amines|Polyamines
DB03262	Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	small molecule	experimental	
DB03263	Thiocellobiose	small molecule	experimental	Carbohydrates|Glycosides|Sulfur Compounds
DB03264	Dodecyl-Coa	small molecule	experimental	
DB03266	Glutaral	small molecule	experimental	Aldehydes|Anti-Infective Agents|Cross-Linking Reagents|Disinfectants|Fixatives|Indicators and Reagents|Laboratory Chemicals
DB03267	1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine	small molecule	experimental	
DB03268	RU82197	small molecule	experimental	
DB03269	4,6-Dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose	small molecule	experimental	
DB03270	2,6-Difluorobenzenesulfonamide	small molecule	experimental	
DB03272	4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol	small molecule	experimental	
DB03273	3'-Oxo-Adenosine	small molecule	experimental	
DB03274	2'-5'dideoxyuridine	small molecule	experimental	
DB03275	2-Amino-3-Mercapto-Propionamide	small molecule	experimental	
DB03276	4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid	small molecule	experimental	
DB03277	alpha-maltotriose	small molecule	experimental	
DB03278	D-Treitol	small molecule	experimental	
DB03279	Dodecyl-Alpha-D-Maltoside	small molecule	experimental	
DB03280	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	small molecule	experimental	
DB03281	2'-Deoxymaltose	small molecule	experimental	
DB03283	beta-L-fucose	small molecule	experimental	
DB03284	2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid	small molecule	experimental	
DB03285	2',4,4'-Trihydroxychalcone	small molecule	experimental	Aldehyde Reductase, antagonists & inhibitors|Benzopyrans|Chromones|Enzyme Inhibitors|Flavonoids|Ketones|Plants|Propiophenones|Pyrans
DB03286	C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide	small molecule	experimental	
DB03287	4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid	small molecule	experimental	
DB03288	5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide	small molecule	experimental	
DB03289	Thiarsa Dihydroxy Cysteine	small molecule	experimental	
DB03290	L-naphthyl-1-acetamido boronic acid alanine	small molecule	experimental	
DB03291	4-Deoxy-4-Amino-Beta-D-Glucose	small molecule	experimental	
DB03292	3-Phosphono-D-alanine	small molecule	experimental	
DB03293	9-Methyl Uric Acid	small molecule	experimental	
DB03294	1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide	small molecule	experimental	
DB03295	Glutathionylspermidine	small molecule	experimental	Amines|Amino Acids, Peptides, and Proteins|Biogenic Amines|Biogenic Polyamines|Diamines|Oligopeptides|Peptides|Polyamines|Putrescine
DB03296	Lactose Sialic Acid	small molecule	experimental	
DB03297	Benzylsulfinic Acid	small molecule	experimental	
DB03298	Phenylphosphate	small molecule	experimental	Organophosphorus Compounds
DB03299	N-Succinyl Phenylglycine	small molecule	experimental	
DB03300	Pterin Cytosine Dinucleotide	small molecule	experimental	
DB03301	2-Allyl-6-Methyl-Phenol	small molecule	experimental	
DB03302	4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One	small molecule	experimental	
DB03303	3-deoxy-D-arabino-hexonic acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids
DB03304	7-Deaza-7-Aminomethyl-Guanine	small molecule	experimental	
DB03305	N5-Iminoethyl-L-Ornithine	small molecule	experimental	
DB03306	RU78300	small molecule	experimental	
DB03307	4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide	small molecule	experimental	
DB03308	L-Leucyl-Hydroxylamine	small molecule	experimental	
DB03309	N-Cyclohexyltaurine	small molecule	experimental	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Buffers|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB03310	Glutathione disulfide	small molecule	approved|experimental|investigational	Amino Acids, Peptides, and Proteins|Glutathione|Oligopeptides|Peptides
DB03311	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide	small molecule	experimental	
DB03312	Brivudine	small molecule	experimental	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Direct Acting Antivirals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB03313	Cephalosporin C	small molecule	experimental	Agents that reduce seizure threshold|Amides|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Lactams|Sulfur Compounds|Thiazines
DB03314	Fluorotryptophane	small molecule	experimental	
DB03315	Guanosine 3'-monophosphate	small molecule	experimental	Carbohydrates|Glycosides|Guanine Nucleotides|Isomerism|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03316	1,4-Diethylene Dioxide	small molecule	experimental	
DB03317	Heme C	small molecule	experimental	Biological Factors|Metalloporphyrins|Pigments, Biological|Porphyrins
DB03318	6-Hydro-1-Methyladenosine-5'-Monophosphate	small molecule	experimental	
DB03319	(S)-ATPA	small molecule	experimental	
DB03320	3-Amino-Alanine	small molecule	experimental	
DB03321	4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid	small molecule	experimental	
DB03322	Dexpropranolol	small molecule	experimental	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Cardiovascular Agents|Naphthalenes|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols|Vasodilating Agents
DB03323	Maltose	small molecule	experimental|investigational	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Diet, Food, and Nutrition|Disaccharides|Flavoring Agents|Food|Food Additives|Food and Beverages|Glucans|Macromolecular Substances|Oligosaccharides|Physiological Phenomena|Polymers|Polysaccharides|Sweetening Agents
DB03325	Tyrosyladenylate	small molecule	experimental	
DB03326	deoxycytidylyl-3',5'-guanosine	small molecule	experimental	Carbohydrates|Cytosine Nucleotides|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Purine Nucleosides|Purines|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides
DB03327	{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid	small molecule	experimental	
DB03328	dioxothiomolybdenum(VI) ion	small molecule	experimental	
DB03329	2-Pyridinethiol	small molecule	experimental	
DB03330	S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione	small molecule	experimental	
DB03331	N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	small molecule	experimental	
DB03332	5,6-Cyclic-Tetrahydropteridine	small molecule	experimental	
DB03333	(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester	small molecule	experimental	
DB03335	1-Bromopropane-2-Ol	small molecule	experimental	
DB03336	BIA	small molecule	experimental	
DB03337	1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea	small molecule	experimental	
DB03338	Heptyl-Beta-D-Glucopyranoside	small molecule	experimental	
DB03339	3-Iodo-Benzyl Alcohol	small molecule	experimental	
DB03340	3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid	small molecule	experimental	
DB03341	Coa-S-Acetyl 5-Bromotryptamine	small molecule	experimental	
DB03342	4-(Acetylamino)-3-Guanidinobenzoic Acid	small molecule	experimental	
DB03343	Malate Like Intermediate	small molecule	experimental	
DB03344	Inositol-(1,3,4,5,6)-Pentakisphosphate	small molecule	experimental	
DB03345	Beta-Mercaptoethanol	small molecule	experimental	
DB03346	3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol	small molecule	experimental	
DB03347	Triethyl Phosphate	small molecule	experimental	Organophosphorus Compounds
DB03348	Huperzine B	small molecule	investigational	Drugs, Chinese Herbal
DB03349	8-Bromo-Adenosine-5'-Monophosphate	small molecule	experimental	
DB03350	Cobalt Hexammine Ion	small molecule	experimental	
DB03351	Sri-9439	small molecule	experimental	
DB03352	S-Arsonocysteine	small molecule	experimental	
DB03353	2-Iminobiotin	small molecule	experimental|investigational	Coenzymes|Enzymes and Coenzymes|Imidazoles
DB03354	2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole	small molecule	experimental	Carbohydrates|Glycogen Phosphorylase, antagonists & inhibitors|Glycosides|Oxazoles
DB03355	5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine	small molecule	experimental	
DB03357	(S)-Mandelic acid	small molecule	experimental	
DB03358	7n-Methyl-8-Hydroguanosine-5'-Triphosphate	small molecule	experimental	
DB03359	M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene	small molecule	experimental	
DB03360	N-Acetylproline	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids
DB03361	2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate	small molecule	experimental	
DB03362	N-Dimethyl-Lysine	small molecule	experimental	
DB03363	3-Acetylpyridine Adenine Dinucleotide	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03364	N-Carbamyl-D-Methionine	small molecule	experimental	
DB03365	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	small molecule	experimental	
DB03366	Imidazole	small molecule	experimental|investigational	Enzyme Inhibitors|Thromboxane-A Synthase, antagonists & inhibitors
DB03367	PF-00356231	small molecule	experimental	
DB03368	5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione	small molecule	experimental	
DB03369	9-Aminophenanthrene	small molecule	experimental	
DB03370	FR239087	small molecule	experimental	
DB03371	Modified Ribosylated Glutamyl Ester	small molecule	experimental	
DB03372	3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One	small molecule	experimental	
DB03373	ZK-806711	small molecule	experimental	
DB03374	3,5-Diiodotyrosine	small molecule	experimental	
DB03376	'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine	small molecule	experimental	
DB03378	4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One	small molecule	experimental	
DB03379	2-Carboxyethylphosphonic Acid	small molecule	experimental	
DB03380	L-Tyrosinamide	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins
DB03381	Hexadecanal	small molecule	experimental	
DB03382	S-oxy-L-cysteine	small molecule	experimental	
DB03383	5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide	small molecule	experimental	
DB03384	Fica	small molecule	experimental	
DB03385	4-Methylimidazole	small molecule	experimental	
DB03386	4-Fluorotryptophane	small molecule	experimental	
DB03387	N-Hydroxy-N-Isopropyloxamic Acid	small molecule	experimental	
DB03388	3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid	small molecule	experimental	
DB03389	alpha-D-Xylopyranose	small molecule	experimental	
DB03390	N-Propyl-Tartramic Acid	small molecule	experimental	
DB03391	Chromophore (Met-Tyr-Gly)	small molecule	experimental	
DB03392	(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester	small molecule	experimental	
DB03393	(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-	small molecule	experimental	
DB03395	Enalkiren	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Oligopeptides|Peptides|Protease Inhibitors|Renin-Inhibitors
DB03396	(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide	small molecule	experimental	
DB03397	Uridine-Diphosphate-N-Acetylglucosamine	small molecule	experimental	
DB03399	Ethyl Isocyanide	small molecule	experimental	
DB03400	3-(P-Tolyl)Propionic Acid	small molecule	experimental	
DB03401	1D-myo-inositol 1,4,5-trisphosphate	small molecule	experimental	Alcohols|Carbohydrates|Inositol|Inositol Phosphates|Sugar Alcohols|Sugar Phosphates
DB03402	1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate	small molecule	experimental	
DB03403	Cytidine-5'-Monophosphate	small molecule	experimental	Carbohydrates|Cytosine Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides
DB03404	Hemin	biotech	approved|investigational	Biological Factors|Heme|Metalloporphyrins|Pigments, Biological|Porphyrins
DB03405	N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide	small molecule	experimental	
DB03406	O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose	small molecule	experimental	
DB03407	4-Nitrocatechol	small molecule	experimental	Benzene Derivatives|Phenols
DB03408	gamma-Glutamylcysteine	small molecule	experimental	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB03409	Octahydroindole-2-Carboxylic Acid	small molecule	experimental	
DB03410	4-hydroxycoumarin	small molecule	experimental	Anticoagulants|Benzopyrans|Coumarins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Narrow Therapeutic Index Drugs|Pyrans|Vitamin K Antagonists
DB03411	2-Hydroxymethyl-Pyrrolidine-3,4-Diol	small molecule	experimental	
DB03412	6-hydroxy-L-norleucine	small molecule	experimental	
DB03413	Deoxyuridine-5'-Diphosphate	small molecule	experimental	
DB03414	5-Thio-a/B-D-Mannopyranosylamine	small molecule	experimental	
DB03415	3-Thiaoctanoyl-Coenzyme A	small molecule	experimental	
DB03416	Thiamine(1+) monophosphate	small molecule	experimental	
DB03417	1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid	small molecule	experimental	
DB03418	Diacetyldeuteroheme	small molecule	experimental	Biological Factors|Pigments, Biological|Porphyrins
DB03419	Uracil	small molecule	experimental|investigational	Fluorouracil and prodrugs|Pyrimidines|Pyrimidinones
DB03420	2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid	small molecule	experimental	
DB03421	2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione	small molecule	experimental	
DB03422	1,3-Thiazole-4-Carboxylic Acid	small molecule	experimental	
DB03423	S-Adenosyl-L-Homoselenocysteine	small molecule	experimental	
DB03424	Ubenimex	small molecule	experimental|investigational	Adjuvants, Immunologic|Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Aminopeptidases, antagonists & inhibitors|Anti-Bacterial Agents|Anti-HIV Agents|Anti-Infective Agents|Antibiotics, Antineoplastic|Enzyme Inhibitors|Immunologic Factors|Protease Inhibitors
DB03425	2s,4r-4-Methylglutamate	small molecule	experimental	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins
DB03426	Digalactosyl Diacyl Glycerol (Dgdg)	small molecule	experimental	
DB03427	Delta-(L-Alpha-Aminoadipoyl)-L-Cysteinyl-D-Vinylglycine	small molecule	experimental	
DB03428	SU9516	small molecule	experimental	
DB03429	Cardiolipin	small molecule	experimental	Antigens|Biological Factors|Carbohydrates|Epitopes|Glycerophosphates|Glycerophospholipids|Haptens|Lipids|Membrane Lipids|Phosphatidic Acids|Phosphatidylglycerols|Phospholipids|Sugar Phosphates
DB03430	(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile	small molecule	experimental	
DB03432	Beta-Amino Isobutyrate	small molecule	experimental	
DB03433	{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid	small molecule	experimental	
DB03434	3[N-Morpholino]Propane Sulfonic Acid	small molecule	experimental	
DB03435	Uridine-5'-Diphosphate	small molecule	experimental	
DB03436	Gallichrome	small molecule	experimental	Amines|Amino Acids, Peptides, and Proteins|Gallium|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Peptides|Peptides, Cyclic
DB03437	2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid	small molecule	experimental	
DB03438	Lysophosphatidylglycerol	small molecule	experimental	Carbohydrates|Glycerophosphates|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Phosphates
DB03439	4,6-dideoxy-4-amino-alpha-D-glucose	small molecule	experimental	
DB03440	N-Hexadecanoylglycine	small molecule	experimental	
DB03441	2-Benzyl-3-Iodopropanoic Acid	small molecule	experimental	
DB03442	2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid	small molecule	experimental	
DB03443	Bis(5-Amidino-Benzimidazolyl)Methanone Zinc	small molecule	experimental	
DB03444	(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime	small molecule	experimental	
DB03445	(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	small molecule	experimental	
DB03446	3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside	small molecule	experimental	
DB03447	Uridylyl-2'-5'-Phospho-Adenosine	small molecule	experimental	
DB03448	2'-Deoxyuridine 3'-Monophosphate	small molecule	experimental	
DB03449	N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine	small molecule	experimental	
DB03450	Cephalothin Group	small molecule	experimental	Nephrotoxic agents
DB03451	1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3	small molecule	experimental	
DB03452	3-Trimethylsilylsuccinic Acid	small molecule	experimental	
DB03453	(R)âN[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester	small molecule	experimental	
DB03454	3-methyl-benzene-1,2-diol	small molecule	experimental	
DB03455	(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid	small molecule	experimental	
DB03456	N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide	small molecule	experimental	
DB03458	N(4)-adenosyl-N(4)-methyl-2,4-diaminobutanoic acid	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids
DB03459	Sparfosic acid	small molecule	experimental	Acetates|Acids, Acyclic|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Excitatory Amino Acids|Fatty Acids|Fatty Acids, Volatile|Lipids|Noxae|Organophosphonates|Organophosphorus Compounds|Toxic Actions
DB03460	Violaxanthin	small molecule	experimental	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB03461	2'-Monophosphoadenosine 5'-Diphosphoribose	small molecule	experimental	
DB03462	Thymine	small molecule	experimental	Pyrimidines|Pyrimidinones|Uracil
DB03464	Formycin-5'-Monophosphate	small molecule	experimental	
DB03466	BMS184394	small molecule	experimental	
DB03467	Naringenin	small molecule	experimental	Anti-Ulcer Agents|BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|Estrogen Antagonists|Flavonoids|Gastrointestinal Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Pyrans
DB03468	1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide	small molecule	experimental	
DB03469	Heme D	small molecule	experimental	Biological Factors|Metalloporphyrins|Pigments, Biological|Porphyrins
DB03470	Trypanothione	small molecule	experimental	Amines|Amino Acids, Peptides, and Proteins|Biogenic Amines|Biogenic Polyamines|Diamines|Oligopeptides|Peptides|Polyamines|Putrescine|Trypanosoma
DB03471	6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid	small molecule	experimental	
DB03472	Cyclohexyl-Hexyl-Beta-D-Maltoside	small molecule	experimental	
DB03473	N5-Methylglutamine	small molecule	experimental	
DB03474	Reactive Red 1 Dye	small molecule	experimental	
DB03475	1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One	small molecule	experimental	
DB03476	Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine	small molecule	experimental	
DB03477	1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole	small molecule	experimental	
DB03478	2'-O-Acetyl Adenosine-5-Diphosphoribose	small molecule	experimental	
DB03479	8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione	small molecule	experimental	
DB03480	Brequinar Analog	small molecule	experimental	
DB03481	5,10-Dimethylene Tetrahydromethanopterin	small molecule	experimental	
DB03482	8-Demethyl-8-Dimethylamino-Flavin-Adenine-Dinucleotide	small molecule	experimental	
DB03483	4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid	small molecule	experimental	
DB03484	L-Alpha-Glycerophosphorylethanolamine	small molecule	experimental	
DB03485	Alpha-D-Fucose	small molecule	experimental	
DB03486	Phosphomethylphosphonic Acid Guanosyl Ester	small molecule	experimental	
DB03487	3-Aminosuccinimide	small molecule	experimental	
DB03488	Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose	small molecule	experimental	
DB03489	2-Keto-3-Deoxygluconate	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids
DB03490	3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole	small molecule	experimental	
DB03491	2'-Deoxyguanosine-5'-Diphosphate	small molecule	experimental	
DB03492	lambda-bis(2,2'-bipyridine)imidazole osmium (II)	small molecule	experimental	
DB03493	7-Methylguanosine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|RNA Caps
DB03495	4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose	small molecule	experimental	
DB03496	Alvocidib	small molecule	experimental|investigational	Antineoplastic Agents|BCRP/ABCG2 Substrates|Benzopyrans|Chromones|Cyclin-Dependent Kinases, antagonists & inhibitors|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Kinase Inhibitors|Pyrans|UGT1A1 Substrates
DB03497	O-Sulfo-L-Serine	small molecule	experimental	
DB03498	Mercaptomethyl Phosphonate	small molecule	experimental	
DB03499	Malate Ion	small molecule	experimental	
DB03500	Tricosanoic Acid	small molecule	experimental	Fatty Acids|Lipids
DB03501	Galactose-uridine-5'-diphosphate	small molecule	experimental	Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Diphosphate Sugars|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides|Uridine Diphosphate|Uridine Diphosphate Sugars
DB03502	(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate	small molecule	experimental	
DB03503	4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid	small molecule	experimental	
DB03504	9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine	small molecule	experimental	
DB03505	2,6-Diaminoquinazolin-4(3h)-One	small molecule	experimental	
DB03506	9-Deazaadenine	small molecule	experimental	
DB03507	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	small molecule	experimental	
DB03508	1-Ethoxy-2-(2-Methoxyethoxy)Ethane	small molecule	experimental	
DB03509	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	small molecule	experimental	Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors
DB03510	6-O-Phosphoryl Inosine Monophosphate	small molecule	experimental	
DB03511	alpha-D-galacturonic acid	small molecule	experimental	
DB03512	Uridine-2',3'-Vanadate	small molecule	experimental	
DB03513	(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid	small molecule	experimental	
DB03514	2-Methoxy-4-Vinyl-Phenol	small molecule	experimental	
DB03515	Equilenin	small molecule	experimental	17-Ketosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids
DB03516	Eniluracil	small molecule	investigational	Enzyme Inhibitors|Pyrimidines|Pyrimidinones
DB03517	[Methylthio]Acetate	small molecule	experimental	
DB03518	Mevalonic acid	small molecule	experimental	Hydroxy Acids
DB03520	6-Chloro-2-Fluoropurine	small molecule	experimental	
DB03522	Aspartic Acid-4-Carboxymethyl Ester	small molecule	experimental	
DB03523	Brequinar	small molecule	experimental	Antineoplastic Agents|Benzene Derivatives|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Oxidoreductases
DB03524	N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-(2-Thiophen-2-Yl-Acetylamino)-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide	small molecule	experimental	
DB03525	RU79073	small molecule	experimental	
DB03526	AL5927	small molecule	experimental	
DB03528	9-Beta-D-Xylofuranosyl-Adenine	small molecule	experimental	
DB03530	Acylated Ceftazidime	small molecule	experimental	
DB03531	Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone	small molecule	experimental	
DB03532	Phosphomethylphosphonic Acid Guanylate Ester	small molecule	experimental	
DB03533	Glycoluril	small molecule	experimental	Hydrocarbons, Acyclic
DB03534	3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide	small molecule	experimental	
DB03535	Z-Pro-Prolinal	small molecule	experimental	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB03536	Benzoyl-Arginine-Alanine-Methyl Ketone	small molecule	experimental	
DB03537	[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid	small molecule	experimental	
DB03539	2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose	small molecule	experimental	
DB03540	Norcamphor	small molecule	experimental	Monoterpenes|Terpenes
DB03541	10-Propargyl-5,8-Dideazafolic Acid	small molecule	experimental	
DB03542	L-Myo-Inositol-1-Phosphate	small molecule	experimental	
DB03543	1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate	small molecule	experimental	
DB03544	S-Phosphocysteine	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfhydryl Compounds|Sulfur Compounds
DB03546	N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid	small molecule	experimental	
DB03548	3-deoxy-Î±-D-manno-oct-2-ulopyranosonic acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids
DB03549	Biotinyl P-Nitroaniline	small molecule	experimental	
DB03550	Isopenicillin N	small molecule	experimental	Amides|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Lactams|Sulfur Compounds
DB03551	(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium	small molecule	experimental	
DB03552	3-Tyrosine	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Isomerism
DB03553	Glutaric Acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates
DB03554	5-Iodouracil	small molecule	experimental	Pyrimidines|Pyrimidinones
DB03555	CRA_11092	small molecule	experimental	
DB03556	2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400	small molecule	experimental	
DB03557	N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid	small molecule	experimental	
DB03558	Sp-876	small molecule	experimental	
DB03559	Cyclohexylformamide	small molecule	experimental	
DB03560	P-Hydroxybenzaldehyde	small molecule	experimental	Aldehydes
DB03562	Tetrahydrodeoxyuridine	small molecule	experimental	
DB03564	(4r)-2-Methylpentane-2,4-Diol	small molecule	experimental	
DB03565	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	small molecule	experimental	
DB03566	Spermidine	small molecule	experimental	Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Polyamines|Putrescine
DB03567	alpha-N-Acetyl-D-galactosamine	small molecule	experimental|investigational	
DB03568	Butyric Acid	small molecule	experimental|investigational	Acids, Acyclic|Butyrates|Fatty Acids|Fatty Acids, Volatile|Histamine Agents|Lipids|Neurotransmitter Agents
DB03569	4,5-Dehydro-L-Iduronic Acid	small molecule	experimental	
DB03570	Tris-Hydroxymethyl-Methyl-Ammonium	small molecule	experimental	
DB03571	3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide	small molecule	experimental	
DB03572	FR230513	small molecule	experimental	
DB03573	WRR-99	small molecule	experimental	
DB03574	Ferricrocin-Iron	small molecule	experimental	
DB03575	Phencyclidine	small molecule	illicit	Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Hallucinogens|Neurotransmitter Agents|NMDA Receptor Antagonists|Piperidines|Psychotropic Drugs
DB03576	N-Pyridoxyl-Threonine-5-Monophosphate	small molecule	experimental	
DB03577	Alpha-Benzyl-Aminobenzyl-Phosphonic Acid	small molecule	experimental	
DB03578	Pyruvamide	small molecule	experimental	Keto Acids
DB03581	Glucose-6-Phosphate	small molecule	experimental	Carbohydrates|Glucosephosphates|Hexosephosphates|Sugar Phosphates
DB03582	N~2~-Succinylornithine	small molecule	experimental	
DB03583	(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One	small molecule	experimental	
DB03584	4-Thio-beta-D-glucopyranose	small molecule	experimental	
DB03585	Oxyphenbutazone	small molecule	approved|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Butylpyrazolidines|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Ophthalmologicals|Other Nonsteroidal Antiimflammatory Agents|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory Organs|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB03586	(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate	small molecule	experimental	
DB03587	Pyruvaldehyde	small molecule	experimental	Aldehydes|Glyoxal
DB03588	Diphenylacetic Acid	small molecule	experimental	Acids, Carbocyclic|Phenylacetates
DB03589	Alpha-Ketomalonic Acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids
DB03590	2,6-Diaminopimelic Acid	small molecule	experimental	
DB03591	RU82209	small molecule	experimental	
DB03592	Pterin-6-Yl-Methyl-Monophosphate	small molecule	experimental	
DB03593	N7-Methyl-Guanosine-5'-Monophosphate	small molecule	experimental	
DB03594	1,2,4-Triazole	small molecule	experimental	
DB03595	CRA_9785	small molecule	experimental	
DB03596	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB03597	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	small molecule	experimental	
DB03598	Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]	small molecule	experimental	
DB03600	Capric acid	small molecule	experimental	Anti-Infective Agents|Antifungal Agents|Fatty Acids|Lipids
DB03601	5-deoxyflavanone	small molecule	experimental	
DB03602	S-Benzyl-Glutathione	small molecule	experimental	
DB03603	Glucaric acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids
DB03604	Tiratricol	small molecule	investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products|Thyronines
DB03605	(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid	small molecule	experimental	
DB03606	(S)-Rolipram	small molecule	experimental	
DB03607	[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron	small molecule	experimental	
DB03608	Diminazene	small molecule	experimental	Amidines|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Benzamidines|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals|Triazenes|Trypanocidal Agents
DB03609	3-Deoxyguanosine	small molecule	experimental	Carbohydrates|Deoxyribonucleosides|Glycosides|Guanosine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB03610	4-(trifluoromethyl)phenol	small molecule	experimental	Benzene Derivatives
DB03611	L-2-amino-4-methoxy-cis-but-3-enoic acid	small molecule	experimental	
DB03612	3-Hydroxybutyryl-Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03613	4-Hydroxyphenacyl Coenzyme A	small molecule	experimental	
DB03614	Methylcobalamin	small molecule	approved|experimental|investigational	Antianemic Preparations|Blood and Blood Forming Organs|Corrinoids|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins
DB03615	Ribostamycin	small molecule	approved|experimental	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycosides|Narrow Therapeutic Index Drugs|Neomycin|Nephrotoxic agents
DB03616	Kabiramide C	small molecule	experimental	
DB03617	Modified Acarbose Hexasaccharide	small molecule	experimental	
DB03618	2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactopyranosyl-Alpha-D-Glucopyranose	small molecule	experimental	
DB03619	Deoxycholic Acid	small molecule	approved	Bile Acids and Salts|BSEP/ABCB11 inducers|Cholagogues and Choleretics|Cholanes|Cholic Acids|Cytolytic Agent|Decreased Cell Membrane Integrity|Gastrointestinal Agents|Other Miscellaneous Therapeutic Agents|Steroids
DB03621	L-709,587	small molecule	experimental	
DB03622	2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione	small molecule	experimental	
DB03623	9-(4-Hydroxyphenyl)-2,7-Phenanthroline	small molecule	experimental	
DB03624	7-(Carboxyamino)-8-Amino-Nonanoic Acid	small molecule	experimental	
DB03626	5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione	small molecule	experimental	
DB03627	Adamantane	small molecule	experimental	Cycloparaffins
DB03628	ISO24	small molecule	experimental	
DB03629	Pyridoxal-5'-Phosphate-N-Oxide	small molecule	experimental	
DB03630	2-Iodobenzylthio Group	small molecule	experimental	
DB03631	3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine	small molecule	experimental	
DB03632	Argifin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Chitinase, antagonists & inhibitors|Peptides
DB03633	Lpc-Ether	small molecule	experimental	
DB03634	1,3-Di(N-Propyloxy-a-Mannopyranosyl)-Carbomyl 5-Methyazido-Benzene	small molecule	experimental	
DB03635	Ethanesulfonic Acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB03636	Glycinamid	small molecule	experimental	
DB03637	Guanidine-3-Propanol	small molecule	experimental	
DB03638	Cytidyl-2'-5'-Phospho-Guanosine	small molecule	experimental	
DB03639	1-Guanidinium-7-Aminoheptane	small molecule	experimental	
DB03640	Beta-Hydroxyaspartic Acid	small molecule	experimental	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids
DB03641	2'-deoxyuridine 5'-alpha,beta-imido-diphosphate	small molecule	experimental	
DB03642	Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide	small molecule	experimental	
DB03643	CRA_1144	small molecule	experimental	
DB03644	3-Hydroxyanthranilic Acid	small molecule	experimental	Acids, Carbocyclic|Aminobenzoates|Antioxidants|Benzene Derivatives|Benzoates|Free Radical Scavengers|Hydroxy Acids|Hydroxybenzoates|ortho-Aminobenzoates|Phenols|Protective Agents
DB03645	Phosphonoacetohydroxamic Acid	small molecule	experimental	
DB03646	2,3-di-O-phytanyl-sn-glycerol	small molecule	experimental	Alcohols|Carbohydrates|Ethers|Glycerol|Sugar Alcohols
DB03647	3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid	small molecule	experimental	
DB03648	2-{N'-[2-(5-Amino-1-Phenylcarbamoyl-Pentylcarbamoyl)-Hexyl]-Hydrazinomethyl}-Hexanoic Acid(5-Amino-1-Phenylcarbamoyl-Pentyl)-Amide	small molecule	experimental	
DB03649	[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate	small molecule	experimental	
DB03650	(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One	small molecule	experimental	
DB03651	Picric acid	small molecule	experimental	Benzene Derivatives|Enzyme Inhibitors|Indicators and Reagents|Laboratory Chemicals|Nitro Compounds|Nitrophenols|Phenols|Uncoupling Agents
DB03652	beta-D-Galactopyranuronic acid	small molecule	experimental	
DB03653	5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine	small molecule	experimental	
DB03654	S,S-Propylthiocysteine	small molecule	experimental	
DB03656	Tribenuron Methyl	small molecule	experimental	Acids|Acids, Noncarboxylic|Arylsulfonic Acids|Carbon Radioisotopes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB03657	1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose	small molecule	experimental	
DB03658	2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid	small molecule	experimental	
DB03659	Butylamine	small molecule	experimental	Amines
DB03660	4-Iodo-L-phenylalanine	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB03661	Cysteinesulfonic Acid	small molecule	experimental	
DB03662	Vitamin B6 Complexed with 2-Amino-Pentanoic Acid	small molecule	experimental	
DB03663	1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol	small molecule	experimental	
DB03664	UP5	small molecule	experimental	
DB03666	3'-Azido-3'-Deoxythymidine-5'-Monophosphate	small molecule	experimental	
DB03667	Acetic Acid Salicyloyl-Amino-Ester	small molecule	experimental	
DB03668	1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB03669	4-Fluorophenethyl Alcohol	small molecule	experimental	
DB03670	2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid	small molecule	experimental	
DB03671	4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One	small molecule	experimental	
DB03672	9-N-Phenylmethylamino-Tacrine	small molecule	experimental	
DB03673	Beta(2-Thienyl)Alanine	small molecule	experimental	
DB03675	2,3-Dihydroxy-Valerianic Acid	small molecule	experimental	
DB03676	Cystein-S-Yl Cacodylate	small molecule	experimental	
DB03677	N-Cyclohexyl-N'-Decylurea	small molecule	experimental	
DB03678	(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine	small molecule	experimental	
DB03679	2-Hydroxy-Tryptophan	small molecule	experimental	
DB03680	Tartronate	small molecule	experimental	
DB03682	Dibenzofuran-4,6-Dicarboxylic Acid	small molecule	experimental	Acids, Acyclic
DB03683	2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid	small molecule	experimental	
DB03685	Uridine monophosphate	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB03686	S-(P-Nitrobenzyl)Glutathione	small molecule	experimental	
DB03687	4-Diphosphocytidyl-2-C-Methyl-D-Erythritol	small molecule	experimental	
DB03688	3-Hydroxy-Propanoic Acid	small molecule	experimental	
DB03690	(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide	small molecule	experimental	
DB03691	WRR-112	small molecule	experimental	
DB03692	1-Hexadecanosulfonyl-O-L-Serine	small molecule	experimental	
DB03693	N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide	small molecule	experimental	
DB03694	N-Phenylthiourea	small molecule	experimental	
DB03695	Piritrexim	small molecule	investigational	Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists
DB03696	Lanosterol	small molecule	experimental	Cholestadienes|Cholestadienols|Cholestanes|Cholestenes|Lipids|Membrane Lipids|Steroids|Sterols|Terpenes|Triterpenes
DB03697	4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	small molecule	experimental	
DB03698	5-Mercaptoethanol-2-Decenoyl-Coenzyme A	small molecule	experimental	
DB03699	Succinyl-Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03700	D-Threonine	small molecule	experimental	
DB03701	Vanoxerine	small molecule	investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Uptake Inhibitors|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors
DB03702	2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid	small molecule	experimental	
DB03703	Cyclohexanol	small molecule	experimental	Alcohols|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|Lipids
DB03704	12-Hydroxydodecanoic Acid	small molecule	experimental	Fatty Acids|Lipids
DB03705	6-Methylamino-5-Nitroisocytosine	small molecule	experimental	
DB03706	1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane	small molecule	experimental	
DB03707	S-Ethyl-N-Phenyl-Isothiourea	small molecule	experimental	
DB03708	Adenosine 5'-phosphosulfate	small molecule	experimental|investigational	Adenine Nucleotides|Adenosine Monophosphate|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB03709	Bicine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins
DB03710	N5-(1-Imino-3-Butenyl)-L-Ornithine	small molecule	experimental	
DB03711	6-Hydroxy-6-Methyl-Heptan-3-One	small molecule	experimental	
DB03712	RU85053	small molecule	experimental	
DB03714	4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid	small molecule	experimental	
DB03716	5'-Fluoro-5'-Deoxyadenosine	small molecule	experimental	Adenosine|Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB03717	3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One	small molecule	experimental	
DB03718	6-Aza-Ump	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB03719	N-Ethyl-5'-Carboxamido Adenosine	small molecule	experimental	
DB03720	Z-Dehydrobutyrine	small molecule	experimental	
DB03721	N-acetyl-alpha-neuraminic acid	small molecule	experimental	
DB03722	3,4-Dihydro-5-Methyl-Isoquinolinone	small molecule	experimental	
DB03723	2'-Deoxy-Thymidine-Beta-L-Rhamnose	small molecule	experimental	
DB03724	(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol	small molecule	experimental	
DB03725	Phosphomethylphosphonic Acid-Guanylate Ester	small molecule	experimental	
DB03726	Purine Riboside-5'-Monophosphate	small molecule	experimental	
DB03727	Coproporphyrin I	small molecule	experimental	Biological Factors|Pigments, Biological|Porphyrins
DB03728	p-Chlorobenzoic acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates
DB03729	2-Amino-5-Hydroxy-Benzimidazole	small molecule	experimental	
DB03730	3,9-Dimethyladenine	small molecule	experimental	
DB03731	S-2-(Boronoethyl)-L-Cysteine	small molecule	experimental	
DB03732	Etheno-Nadp	small molecule	experimental	
DB03733	Ethylene Dichloride	small molecule	experimental	Alkanes|Ethane|Hydrocarbons, Acyclic|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated
DB03734	Xylarohydroxamate	small molecule	experimental	Acids, Acyclic|Amines|Carbohydrates|Hydroxy Acids|Hydroxylamines
DB03735	9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine	small molecule	experimental	
DB03736	2-Cyclopropylmethylenepropanal	small molecule	experimental	
DB03737	4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One	small molecule	experimental	
DB03738	Pantothenoylaminoethenethiol	small molecule	experimental	
DB03739	3-Hydroxyimino Quinic Acid	small molecule	experimental	
DB03740	N-acetyl-alpha-D-glucosamine	small molecule	experimental	
DB03741	2-Methylbutanoic Acid	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB03742	Compound 4-D	small molecule	experimental	
DB03744	Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate	small molecule	experimental	
DB03745	Arabinose-5-phosphate	small molecule	experimental	
DB03746	3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate	small molecule	experimental	
DB03747	3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol	small molecule	experimental	
DB03748	Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester	small molecule	experimental	
DB03749	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	small molecule	experimental	
DB03750	Isovaleric Acid	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates
DB03751	2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose	small molecule	experimental	
DB03752	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	small molecule	experimental	Sulfur Compounds
DB03753	Flurbiprofen Methyl Ester	small molecule	experimental	
DB03754	Tromethamine	small molecule	approved	Alcohols|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Buffers|Drug Delivery Systems|Excipients|Glycols|I.V. Solution Additives|i.v. Solutions|Laboratory Chemicals|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Propylene Glycols|Solutions Affecting the Electrolyte Balance|Tromethamine
DB03755	Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate	small molecule	experimental	
DB03756	Doconexent	small molecule	approved|investigational	Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Lipids|Oils|Physiological Phenomena
DB03757	(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine	small molecule	experimental	
DB03758	Radicicol	small molecule	experimental	Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Enzyme Inhibitors|Lactones|Polyketides|Tyrosine Kinase Inhibitors
DB03759	FG-9041	small molecule	experimental	Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neurotransmitter Agents
DB03760	Dihydrolipoic Acid	small molecule	experimental	Antioxidants|Coenzymes|Enzymes and Coenzymes|Fatty Acids|Lipids|Protective Agents|Sulfur Compounds|Thiophenes
DB03761	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	small molecule	experimental	Carbohydrates|Deoxyribonucleotides|Deoxyuracil Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB03763	5-Methyl-2'-Deoxypseudouridine	small molecule	experimental	
DB03764	4-Hydroperoxy-2-Methoxy-Phenol	small molecule	experimental	
DB03765	2'-cytidylic acid	small molecule	experimental	Carbohydrates|Cytosine Nucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides
DB03766	Propanoic acid	small molecule	approved|vet_approved	Acids, Acyclic|Anti-Infective Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Ophthalmologicals|Sensory Organs
DB03767	Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide	small molecule	experimental	
DB03768	N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3	small molecule	experimental	
DB03769	D-Eritadenine	small molecule	experimental	Purines
DB03770	N-Hydroxyguanidine	small molecule	experimental	
DB03771	Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine	small molecule	experimental	
DB03772	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol	small molecule	experimental	
DB03773	alpha-D-quinovopyranose	small molecule	experimental	Carbohydrates|Deoxy Sugars
DB03774	Glutamyl Group	small molecule	experimental	
DB03775	D-Dethiobiotin	small molecule	experimental	
DB03776	Lactaldehyde	small molecule	experimental	
DB03777	Rbt205 Inhibitor	small molecule	experimental	
DB03779	Glucosaminyl-(Alpha-6)-D-Myo-Inositol	small molecule	experimental	
DB03780	2-Aminoquinazolin-4(3h)-One	small molecule	experimental	
DB03781	2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid	small molecule	experimental	
DB03782	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	small molecule	experimental	
DB03783	Phenacetin	small molecule	withdrawn	Acetanilides|Amides|Analgesics|Analgesics, Non-Narcotic|Anilides|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Nervous System|Peripheral Nervous System Agents|Sensory System Agents
DB03784	Elaidoylamide	small molecule	experimental	
DB03785	(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid	small molecule	experimental	
DB03787	[5-hydroxy-6-methyl-4-({[(4E)-3-oxo-1,2-oxazolidin-4-ylidene]amino}methyl)pyridin-3-yl]methyl dihydrogen phosphate	small molecule	experimental	
DB03788	GC-24	small molecule	experimental	
DB03789	2,3-Dimethylimidazolium Ion	small molecule	experimental	
DB03790	S-Dioxymethionine	small molecule	experimental	
DB03791	(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid	small molecule	experimental	
DB03792	5-Amino-1h-Pyrimidine-2,4-Dione	small molecule	experimental	
DB03793	Benzoic Acid	small molecule	approved|investigational	Acids, Carbocyclic|Alimentary Tract and Metabolism|Ammonium Ion Binding Activity|Anti-Infective Agents|Antifungal Agents|Benzene Derivatives|Benzoates|Benzoic Acid|Diagnostic Agents|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Food Preservatives|Laxatives|Nitrogen Binding Agent|OAT3/SLC22A8 Inhibitors|Osmotic Laxative|Physiological Phenomena|Tests for Gastric Secretion|Urea Cycle Disorder Agents|Various Alimentary Tract and Metabolism Products
DB03794	Trifluoroalanine	small molecule	experimental	
DB03795	2-Dehydropantoate	small molecule	experimental	
DB03796	Palmitic Acid	small molecule	approved	Enzyme Inhibitors|Fatty Acids|Lipids|Palmitic Acids
DB03797	3-Aminomethyl-Pyridinium-Adenine-Dinucleotide	small molecule	experimental	
DB03798	2'-Deoxycytidine-5'-Monophosphate	small molecule	experimental	
DB03799	Trifluoromethionine	small molecule	experimental	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfur Compounds
DB03800	2'-deoxyuridylic acid	small molecule	experimental	Carbohydrates|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB03801	Lysine Nz-Carboxylic Acid	small molecule	experimental	
DB03802	1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	small molecule	experimental	
DB03803	Inhibitor Msa367	small molecule	experimental	
DB03804	5-Bromothienyldeoxyuridine	small molecule	experimental	
DB03807	1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	small molecule	experimental	
DB03808	Hexamidine	small molecule	experimental	Amidines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Biguanides and Amidines|Dermatologicals|Nasal Preparations|Ophthalmological and Otological Preparations|Ophthalmologicals|Sensory Organs|Throat Preparations
DB03809	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	small molecule	experimental	
DB03810	3-Methylglutamic acid	small molecule	experimental	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids|Glutamates
DB03811	Histidinol	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Imidazoles|Propanolamines|Propanols
DB03812	3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	small molecule	experimental	
DB03813	2-Decenoyl N-Acetyl Cysteamine	small molecule	experimental	
DB03814	2-(N-Morpholino)-Ethanesulfonic Acid	small molecule	experimental	
DB03815	Fucitol	small molecule	experimental	Alcohols|Carbohydrates
DB03816	Difluoromethionine	small molecule	experimental	
DB03817	2,4-Diaminobutyric Acid	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids
DB03818	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	small molecule	experimental	
DB03819	Salicylhydroxamic Acid	small molecule	experimental	Amides|Anti-Infective Agents|Antifungal Agents|Antiparasitic Agents|Antiprotozoals|Trypanocidal Agents
DB03820	(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate	small molecule	experimental	
DB03821	2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid	small molecule	experimental	
DB03822	Ethyl Dihydrogen Phosphate	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB03823	Epigallocatechin	small molecule	experimental|investigational	Benzopyrans|Chromans|Chromones|Flavonoids|Pyrans
DB03824	7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline	small molecule	experimental	
DB03825	Rhodamine 6G	small molecule	experimental	Antineoplastic Agents|Coloring Agents|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|P-glycoprotein/ABCB1 Substrates|Xanthenes
DB03826	5,6-Diaminouracil	small molecule	experimental	Pyrimidines|Pyrimidinones
DB03827	(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine	small molecule	experimental	
DB03828	RU78299	small molecule	experimental	
DB03829	Pseudouridine-5'-Monophosphate	small molecule	experimental	
DB03830	Phosphorylated Dihydropteroate	small molecule	experimental	
DB03831	[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate	small molecule	experimental	
DB03832	3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium	small molecule	experimental	
DB03833	2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole	small molecule	experimental	
DB03834	(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine	small molecule	experimental	
DB03835	N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide	small molecule	experimental	
DB03836	1,3,5-Trichloro-Benzene	small molecule	experimental	
DB03837	Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide	small molecule	experimental	
DB03839	D-Tyrosine	small molecule	experimental	
DB03840	Tetra(Imidazole)Diaquacopper (Ii)	small molecule	experimental	
DB03841	Y-700	small molecule	experimental	
DB03842	2-Chloro-6-Methyl-Aniline	small molecule	experimental	
DB03843	Formaldehyde	small molecule	approved|vet_approved	Aldehydes|Anti-Infective Agents|Anti-Infective Agents, Local|Biomedical and Dental Materials|Cell-mediated Immunity|Disinfectants|Fixatives|Increased Histamine Release|Macromolecular Substances|Standardized Chemical Allergen
DB03844	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB03845	P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate	small molecule	experimental	
DB03846	5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate	small molecule	experimental	
DB03847	Gamma-Carboxy-Glutamic Acid	small molecule	experimental	
DB03848	Benzenesulfinic acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Sulfur Acids|Sulfur Compounds
DB03849	Cilomilast	small molecule	investigational	Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors
DB03850	Jaspisamide A	small molecule	experimental	
DB03851	Carbazole Butanoic Acid	small molecule	experimental	
DB03852	Eucalyptol	small molecule	approved|nutraceutical	Alcohols|Anti-Infective Agents|Cough and Cold Preparations|Cyclohexanes|Cycloparaffins|Eucalyptus|Expectorants|Fatty Alcohols|Gutta-Percha|Hexanols|Lipids|Solvents|Terpenes
DB03853	Reactive Red 6 hapten	small molecule	experimental	
DB03854	Pentane-1,5-Diamine	small molecule	experimental	
DB03855	L-Threonohydroxamate 4-Phosphate	small molecule	experimental	
DB03856	L-Eflornithine	small molecule	experimental|investigational	
DB03857	1,4-dithio-beta-D-glucopyranose	small molecule	experimental	
DB03858	S-Acetonylcysteine	small molecule	experimental	
DB03859	1-Thio-Beta-D-Glucopyranose	small molecule	experimental	
DB03860	N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide	small molecule	experimental	
DB03861	(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium	small molecule	experimental	
DB03862	Tetrahydrooxazine	small molecule	experimental	
DB03863	2-O-methyl fucose	small molecule	experimental	
DB03864	Monothioglycerol	small molecule	experimental	Alcohols|Carbohydrates|Sugar Alcohols
DB03865	6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine	small molecule	experimental	
DB03866	Prostaglandin G2	small molecule	experimental	Anions|Autacoids|Biological Factors|Eicosanoids|Electrolytes|Fatty Acids|Fatty Acids, Unsaturated|Free Radicals|Inflammation Mediators|Ions|Lipids|Oxides|Oxygen Compounds|Peroxides|Prostaglandin Endoperoxides|Prostaglandins|Reactive Oxygen Species
DB03867	Meta-Nitro-Tyrosine	small molecule	experimental	
DB03868	3-Dehydroquinic Acid	small molecule	experimental	Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins|Hydroxy Acids
DB03869	5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine	small molecule	experimental	
DB03870	Ara-Alpha(1,3)-Xyl	small molecule	experimental	
DB03871	lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)	small molecule	experimental	
DB03872	2,3-Dideoxyfucose	small molecule	experimental	
DB03874	(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine	small molecule	experimental	
DB03876	Thieno[2,3-B]Pyridine-2-Carboxamidine	small molecule	experimental	
DB03877	AL4623	small molecule	experimental	
DB03878	N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide	small molecule	experimental	
DB03879	alpha-L-methyl-fucose	small molecule	experimental	
DB03880	Batimastat	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Enzyme Inhibitors|Metalloendopeptidases, antagonists & inhibitors|Sulfur Compounds
DB03881	MT-Immucillin-H	small molecule	experimental	Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Pyrimidines
DB03882	5-Alpha-Androstane-3-Beta,17beta-Diol	small molecule	experimental	
DB03883	Carboxyethyllumazine	small molecule	experimental	
DB03884	Phenylpyruvic acid	small molecule	experimental	Acids, Carbocyclic|Keto Acids|Pyruvates
DB03885	1-Menaphthyl Glutathione Conjugate	small molecule	experimental	
DB03886	Biopterin	small molecule	experimental	Biological Factors|Coenzymes|Enzymes and Coenzymes|Pigments, Biological|Pteridines|Pterins
DB03887	Alpha-Adenosine Monophosphate	small molecule	experimental	
DB03888	N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine	small molecule	experimental	
DB03889	S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione	small molecule	experimental	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB03890	N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide	small molecule	experimental	
DB03891	1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide	small molecule	experimental	
DB03892	5-N-Allyl-Arginine	small molecule	experimental	
DB03893	Thionicotinamide-Adenine-Dinucleotide	small molecule	experimental	
DB03894	N-Propargyl-1(S)-Aminoindan	small molecule	experimental	
DB03895	Malachite Green	small molecule	experimental	Agrochemicals|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Coloring Agents|Fungicides, Industrial|Pesticides|Toxic Actions
DB03896	Triphosphoric acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB03897	Hydroxyphenyl Propionic Acid	small molecule	experimental	
DB03898	3-Chloro-4-Hydroxyphenylglycine	small molecule	experimental	
DB03899	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	small molecule	experimental	
DB03900	2-Methyl-2-Propanol	small molecule	experimental	
DB03901	5-Oxo-Pyrrolidine-2-Carbaldehyde	small molecule	experimental	
DB03902	Oxalic Acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids|Indicators and Reagents|Laboratory Chemicals|OAT3/SLC22A8 Substrates|Oxalates|Reducing Agents
DB03903	Tmr	small molecule	experimental	
DB03904	Urea	small molecule	approved|investigational	Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbamide products|Dermatologicals|Diuretics, Osmotic|Emollients and Protectives|i.v. Solutions|Keratolytic Agents|Solutions Producing Osmotic Diuresis
DB03905	Succinamide-Coa	small molecule	experimental	
DB03906	2-Phenylheme	small molecule	experimental	
DB03907	N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide	small molecule	experimental	
DB03908	Inhibitor Bea322	small molecule	experimental	
DB03909	Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate	small molecule	experimental	
DB03910	S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea	small molecule	experimental	
DB03911	L-Xylopyranose	small molecule	experimental	
DB03912	4'-Phosphopantetheine	small molecule	experimental	Sulfhydryl Compounds|Sulfur Compounds
DB03913	Coenzyme F420	small molecule	experimental	Biological Factors|Coenzymes|Enzymes and Coenzymes|Flavins|Pigments, Biological|Pteridines
DB03914	[2-(1-amino-2-hydroxy-propyl)-4-(1H-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde	small molecule	experimental	
DB03915	2-Amino-3-Ketobutyric Acid	small molecule	experimental	
DB03916	4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine	small molecule	experimental	
DB03917	N-Ethyl Retinamide	small molecule	experimental	
DB03918	6S-5,6,7,8-Tetrahydrobiopterin	small molecule	experimental	
DB03919	Ethyl-Carbamic Acid Methyl Ester	small molecule	experimental	
DB03920	N-Methyl-Alpha-Beta-Dehydroalanine	small molecule	experimental	
DB03921	4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline	small molecule	experimental	
DB03923	Feruloyl Coenzyme A	small molecule	experimental	
DB03924	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	small molecule	experimental	
DB03925	Freselestat	small molecule	experimental|investigational	Leukocyte Elastase, antagonists & inhibitors|Oxazoles|Pyrimidines
DB03926	5-Alpha-Androstane-3-Beta,17-Alpha-Diol	small molecule	experimental	
DB03927	Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine	small molecule	experimental	
DB03928	Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol	small molecule	experimental	
DB03929	D-Serine	small molecule	approved|experimental	
DB03930	4-Methyl-Pyrroline-5-Carboxylic Acid	small molecule	experimental	
DB03931	Diguanosine-5'-Triphosphate	small molecule	experimental	
DB03932	LFA703	small molecule	experimental	
DB03933	C-1027 Aromatized Chromophore	small molecule	experimental	
DB03934	Protoporphyrin Ix Containing Zn	small molecule	experimental	
DB03935	1,4-Dideoxy-O2-Sulfo-Glucuronic Acid	small molecule	experimental	
DB03936	1-Deoxy-Ribofuranose-5'-Phosphate	small molecule	experimental	
DB03937	Erythose-4-Phosphate	small molecule	experimental	
DB03938	Deacetoxycephalosporin-C	small molecule	experimental	Agents that reduce seizure threshold
DB03939	4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One	small molecule	experimental	
DB03940	Oxamic Acid	small molecule	experimental	Acids, Aldehydic|Amino Acids|Amino Acids, Peptides, and Proteins|Glyoxylates
DB03941	Heptanyl-P-Phenol	small molecule	experimental	
DB03942	Carboxylic PRPP	small molecule	experimental	
DB03943	D-Asparagine	small molecule	experimental	
DB03944	5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One	small molecule	experimental	
DB03945	N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Choline|Ethanolamines|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB03946	3,4-Dihydroxybenzoic Acid	small molecule	experimental	Acids, Carbocyclic|Anticarcinogenic Agents|Antineoplastic Agents|Benzene Derivatives|Benzoates|Drugs, Chinese Herbal|Hydroxy Acids|Phenols|Protective Agents
DB03947	D-Xylulose	small molecule	experimental	
DB03948	6-Chloropurine Riboside, 5'-Monophosphate	small molecule	experimental	
DB03949	(2-Sulfanyl-3-Phenylpropanoyl)-Phe-Tyr	small molecule	experimental	
DB03950	(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide	small molecule	experimental	
DB03951	N-acetyl-D-glucosamine-6-phosphate	small molecule	experimental	
DB03952	9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine	small molecule	experimental	
DB03953	L-Thiocitrulline	small molecule	experimental	
DB03955	1-deoxymannojirimycin	small molecule	experimental	Alkaloids|Anti-Infective Agents|Carbohydrates|Enzyme Inhibitors|Imines|Imino Pyranoses|Imino Sugars|Monosaccharides|Piperidines
DB03956	Inositol 2,4,5-trisphosphate	small molecule	experimental	Alcohols|Carbohydrates|Inositol|Sugar Alcohols|Sugar Phosphates
DB03957	SP2456	small molecule	experimental	
DB03958	7-methyl-guanosine-5'-triphosphate-5'-guanosine	small molecule	experimental	
DB03959	N,O6-Disulfo-Glucosamine	small molecule	experimental	
DB03960	Cp-Coeleneterazine	small molecule	experimental	
DB03961	2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate	small molecule	experimental	
DB03962	Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate	small molecule	experimental	
DB03963	S-(Dimethylarsenic)Cysteine	small molecule	experimental	
DB03964	4-Hydroxy-Aconitate Ion	small molecule	experimental	
DB03966	Clorobiocin	small molecule	experimental	Aminocoumarins|Benzopyrans|Carbohydrates|Coumarins|Glycosides|Pyrans
DB03967	Dodecyl sulfate	small molecule	experimental	Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Dodecanol|Fatty Alcohols|Hydrocarbons, Acyclic|Lipids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents
DB03968	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	small molecule	experimental	
DB03970	(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid	small molecule	experimental	
DB03971	Acarbose Derived Hexasaccharide	small molecule	experimental	
DB03972	2-Amino-4h-1,3-Benzoxathiin-4-Ol	small molecule	experimental	
DB03973	3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate	small molecule	experimental	
DB03974	L-Homoarginine	small molecule	experimental	
DB03975	Mercuribenzoic Acid	small molecule	experimental	
DB03976	Phosphorylisopropane	small molecule	experimental	
DB03977	N-Trimethyllysine	small molecule	experimental	
DB03978	Tyrosinal	small molecule	experimental	
DB03979	1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol	small molecule	experimental	
DB03980	4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole	small molecule	experimental	
DB03981	1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid	small molecule	experimental	
DB03982	Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid	small molecule	experimental	
DB03983	(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)	small molecule	experimental	
DB03984	Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide	small molecule	experimental	
DB03985	R-azabisabolene	small molecule	experimental	
DB03986	6-Methyl-Formycin A	small molecule	experimental	
DB03987	2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine	small molecule	experimental	
DB03988	2,6-Diamino-Hexanoic Acid Amide	small molecule	experimental	
DB03989	D-Allopyranose	small molecule	experimental	
DB03990	4'-nitrophenyl-3i-thiolaminaritrioside	small molecule	experimental	
DB03991	2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid	small molecule	experimental	
DB03992	3-(Benzoylamino)-L-Alanine	small molecule	experimental	
DB03993	4-Methyl Valeric Acid	small molecule	experimental	
DB03994	Ethanolamine	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Ethanolamines|Sclerosing Activity|Sclerosing Solutions|Vascular Sclerosing Activity
DB03995	Betadex	small molecule	experimental	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cyclodextrins|Dextrins|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Glucans|Macromolecular Substances|Physiological Phenomena|Polymers|Polysaccharides|Sequestering Agents|Starch
DB03996	3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol	small molecule	experimental	
DB03997	L-histidinol phosphate	small molecule	experimental	
DB03998	[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde	small molecule	experimental	
DB03999	Butylphosphonate	small molecule	experimental	
DB04000	Bromo-Willardiine	small molecule	experimental	
DB04001	6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid	small molecule	experimental	
DB04002	4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide	small molecule	experimental	
DB04003	{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid	small molecule	experimental	
DB04004	2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One	small molecule	experimental	
DB04005	Uridine 5'-triphosphate	small molecule	experimental|investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleotides|Uracil Nucleotides
DB04006	[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone	small molecule	experimental	
DB04007	Bromo-WR99210	small molecule	experimental	
DB04008	Bis(5-Amidino-Benzimidazolyl)Methane Zinc	small molecule	experimental	
DB04009	Dimethyl Propionate Ester Heme	small molecule	experimental	
DB04010	2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide	small molecule	experimental	
DB04011	2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole	small molecule	experimental	
DB04012	(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine	small molecule	experimental	
DB04013	1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide	small molecule	experimental	
DB04014	Alsterpaullone	small molecule	experimental	CDC2 Protein Kinase|Cyclin B
DB04015	Methionine Phosphinate	small molecule	experimental	
DB04016	2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid	small molecule	experimental	
DB04017	Clorgiline	small molecule	experimental	Agents that produce hypertension|Amines|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors|Monoamine Oxidase Inhibitors|Propylamines|Psychotropic Drugs
DB04018	S-Isopropyl-Isothiourea	small molecule	experimental	
DB04020	4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol	small molecule	experimental	
DB04021	MF268	small molecule	experimental	
DB04022	Guanosine-5',3'-Tetraphosphate	small molecule	experimental	
DB04023	Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester	small molecule	experimental	
DB04024	N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine	small molecule	experimental	
DB04026	Pseudotropine	small molecule	experimental	Alkaloids|Aza Compounds|Azabicyclo Compounds
DB04027	D-Arginine	small molecule	experimental	
DB04028	Tyvelose	small molecule	experimental	Carbohydrates|Monosaccharides
DB04029	Phenylalanine Amide	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB04030	1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole	small molecule	experimental	
DB04031	Serine Vanadate	small molecule	experimental	
DB04032	Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide	small molecule	experimental	
DB04033	Z-Ala Prolinal	small molecule	experimental	
DB04034	Ribulose-5-Phosphate	small molecule	experimental	
DB04035	Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate	small molecule	experimental	
DB04036	Coenzyme a Persulfide	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB04037	N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine	small molecule	experimental	
DB04038	Ergosterol	small molecule	approved|experimental	Cholestanes|Cholestenes|Lipids|Membrane Lipids|Phytosterols|Steroids|Sterols
DB04039	3-Oxo-Pentadecanoic Acid	small molecule	experimental	
DB04040	N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide	small molecule	experimental	
DB04041	Nitrocefin Acyl-Serine	small molecule	experimental	
DB04042	2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol	small molecule	experimental	
DB04043	Carboxymycobactin T	small molecule	experimental	
DB04044	4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid	small molecule	experimental	
DB04045	Methylmalonyl-Coenzyme A	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB04046	Methyl beta-galactoside	small molecule	experimental	Carbohydrates|Galactosides|Glycosides|Methylglycosides
DB04047	[Pterin-6-Yl Methanyl]-Phosphonophosphate	small molecule	experimental	
DB04048	N-Carbamoyl-Alanine	small molecule	experimental	
DB04049	Coelenteramide	small molecule	experimental	Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids
DB04050	N-Propyl Isocyanide	small molecule	experimental	
DB04051	5-Phenylvaleric Acid	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates
DB04052	3,4-Dimethylphenol	small molecule	experimental	Benzene Derivatives
DB04053	Hypophosphite	small molecule	experimental	
DB04054	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	small molecule	experimental	
DB04055	2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium	small molecule	experimental	
DB04057	Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor	small molecule	experimental	
DB04058	D-[(Amino)Carbonyl]Phenylalanine	small molecule	experimental	
DB04059	8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide	small molecule	experimental	
DB04060	(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate	small molecule	experimental	
DB04061	Alpha-Amino-2-Indanacetic Acid	small molecule	experimental	
DB04062	Beta-D-Fucose	small molecule	experimental	
DB04063	2-Methylleucine	small molecule	experimental	
DB04064	Nogalaviketone	small molecule	experimental	
DB04065	N-Cyclopentyl-N-Cyclobutylformamide	small molecule	experimental	
DB04066	para-Coumaric Acid	small molecule	experimental	Acids, Carbocyclic|Adrenal Cortex Hormones|Anti-Infective Agents|Antioxidants|Cinnamates|Contraceptive Agents, Male|Free Radical Scavengers|Hormonal Contraceptives for Systemic Use|Protective Agents|Reproductive Control Agents
DB04067	4-Hydroxybenzyl Coenzyme A	small molecule	experimental	
DB04068	Fudp	small molecule	experimental	
DB04069	5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine	small molecule	experimental	
DB04070	6-Deoxyerythronolide B	small molecule	experimental	Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides
DB04071	Cpad	small molecule	experimental	
DB04072	Alpha-Methylisocitric Acid	small molecule	experimental	
DB04073	N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide	small molecule	experimental	
DB04074	alpha-Ketoisovalerate	small molecule	experimental	Pentanoic Acids|Valerates
DB04075	N-Acetyl-L-Glutamate	small molecule	experimental	
DB04076	Hypoxanthine	small molecule	experimental	Cytochrome P-450 CYP1A2 Substrates|Purines|Purinones|Xanthine derivatives
DB04079	Heptane-1,2,3-Triol	small molecule	experimental	Alcohols|Lipids
DB04080	RU78191	small molecule	experimental	
DB04081	(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide	small molecule	experimental	
DB04082	Decyloxy-Methanol	small molecule	experimental	
DB04083	N'-Pyridoxyl-Lysine-5'-Monophosphate	small molecule	experimental	
DB04084	2-deoxy-2-fluoro-Î±-D-mannose	small molecule	experimental	
DB04085	1-[Pyrrol-1-Yl-2,5-Dione-Methoxymethyl]-Pyrrole-2,5-Dione	small molecule	experimental	
DB04086	2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside	small molecule	experimental	
DB04087	Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate	small molecule	experimental	
DB04088	N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)	small molecule	experimental	
DB04089	AL5300	small molecule	experimental	
DB04090	RH-1	small molecule	experimental|investigational	
DB04092	Apstatin	small molecule	experimental	Amino Acids, Peptides, and Proteins
DB04093	Undecanal	small molecule	experimental	
DB04094	4-Hydroxy-2-Butanone	small molecule	experimental	Ketones
DB04095	9-Deazahypoxanthine	small molecule	experimental	Purines|Purinones
DB04096	5-Amino-5-Deoxy-Cellobiono-1,5-Lactam	small molecule	experimental	
DB04097	Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose	small molecule	experimental	
DB04098	Balanol	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cyclic AMP-Dependent Protein Kinases, antagonists & inhibitors|Hydroxy Acids|Phenols|Protein Kinase C, antagonists & inhibitors
DB04099	Deamido-Nad+	small molecule	experimental	
DB04100	(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)	small molecule	experimental	
DB04101	N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide	small molecule	experimental	
DB04102	2-Amino-Adenosine	small molecule	experimental	
DB04103	3-Methylcytosine	small molecule	experimental	Pyrimidines|Pyrimidinones
DB04104	3-Methyladenine	small molecule	experimental	Purines
DB04105	N-Heptylformamide	small molecule	experimental	
DB04106	Fotemustine	small molecule	experimental|investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosoureas|Urea
DB04107	[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester	small molecule	experimental	
DB04108	(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide	small molecule	experimental	
DB04109	[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine	small molecule	experimental	
DB04110	2-Nitro-P-Cresol	small molecule	experimental	Benzene Derivatives|Phenols
DB04111	Balhimycin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Glycopeptides|Peptides
DB04112	1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide	small molecule	experimental	
DB04113	N-Formylpiperidine	small molecule	experimental	Alcohol Dehydrogenase, antagonists & inhibitors
DB04114	3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine	small molecule	experimental	
DB04115	Berberine	small molecule	approved|investigational	Alkaloids|Benzylisoquinolines|Berberine Alkaloids|Isoquinolines
DB04116	Allolactose	small molecule	experimental	Carbohydrates|Disaccharides|Oligosaccharides|Polysaccharides
DB04117	4-(N,N-Dimethylamino)Cinnamoyl-Coa	small molecule	experimental	
DB04118	N-Coeleneterazine	small molecule	experimental	
DB04119	Hexatantalum Dodecabromide	small molecule	experimental	
DB04120	4-Methyl-1,2-Benzenediol	small molecule	experimental	
DB04121	Guanosine-3'-Monophosphate-5'-Diphosphate	small molecule	experimental	
DB04122	beta-D-glucose 6-phosphate	small molecule	experimental	
DB04123	(P-Iodophenylacetylamino)Methylphosphinic Acid	small molecule	experimental	
DB04124	Aurodox	small molecule	experimental	Alkenes|Anti-Bacterial Agents|Anti-Infective Agents|Hydrocarbons, Acyclic|Polyenes
DB04125	N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine	small molecule	experimental	
DB04126	N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane	small molecule	experimental	
DB04127	beta-D-arabinofuranose 5-phosphate	small molecule	experimental	
DB04128	5-Nitroso-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione	small molecule	experimental	
DB04129	Willardiine	small molecule	experimental	Acacia|Amino Acids|Amino Acids, Peptides, and Proteins|Pyrimidines|Pyrimidinones
DB04130	5-Methoxybenzimidazole	small molecule	experimental	
DB04131	10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione	small molecule	experimental	
DB04132	S-Hexylglutathione	small molecule	experimental	Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Lactoylglutathione Lyase, antagonists & inhibitors|Oligopeptides|Peptides
DB04133	Degraded Cephaloridine	small molecule	experimental	
DB04135	5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine	small molecule	experimental	
DB04136	Lysophosphotidylserine	small molecule	experimental	
DB04137	Guanosine-5'-Triphosphate	small molecule	experimental	
DB04138	2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide	small molecule	experimental	
DB04139	6-Hydroxypropylthymine	small molecule	experimental	
DB04140	1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide	small molecule	experimental	
DB04141	2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	small molecule	experimental	
DB04142	3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide	small molecule	experimental	
DB04143	Indole-3-Glycerol Phosphate	small molecule	experimental	Carbohydrates|Indicators and Reagents|Laboratory Chemicals|Lipids|Membrane Lipids|Phospholipids|Sugar Phosphates
DB04144	Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone	small molecule	experimental	
DB04145	Nicotinyl alcohol	small molecule	experimental	Cardiovascular Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Nicotinic Acid and Derivatives|Peripheral Vasodilators|Pyridines|Vasodilating Agents
DB04146	I-Coeleneterazine	small molecule	experimental	
DB04147	Lauryl Dimethylamine-N-Oxide	small molecule	experimental	
DB04149	(R)-Rolipram	small molecule	experimental	
DB04150	Threonine Derivative	small molecule	experimental	
DB04151	4-Methyl-Histidine	small molecule	experimental	
DB04152	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	small molecule	experimental	
DB04153	S-Hydroxymethyl Glutathione	small molecule	experimental	
DB04154	N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide	small molecule	experimental	
DB04155	2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose	small molecule	experimental	
DB04156	Aspartate Beryllium Trifluoride	small molecule	experimental	
DB04157	N-[(Aminooxy)Carbonyl]Aniline	small molecule	experimental	
DB04158	6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin	small molecule	experimental	
DB04159	Beta-Hydroxytryptophane	small molecule	experimental	
DB04160	Pyrophosphoric acid	small molecule	approved|experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates
DB04161	Propionamide	small molecule	experimental	
DB04162	5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione	small molecule	experimental	
DB04163	5-Phenylsulfanyl-2,4-Quinazolinediamine	small molecule	experimental	
DB04164	1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose	small molecule	experimental	
DB04165	Valpromide	small molecule	experimental	Acids, Acyclic|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acid Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System|Pentanoic Acids|Valerates
DB04166	Anthranilic acid	small molecule	experimental	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Central Nervous System Agents
DB04167	Aceglutamide	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins
DB04168	2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol	small molecule	experimental	
DB04169	3,5-Diaminophthalhydrazide	small molecule	experimental	
DB04170	4-bromo-3-hydroxy-3-methyl butyl diphosphate	small molecule	experimental	
DB04171	D-Isovaline	small molecule	experimental	
DB04172	[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine	small molecule	experimental	
DB04173	Fructose	small molecule	approved|experimental	Carbohydrates|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|General Nutrients|Hexoses|Ketoses|Monosaccharides|Physiological Phenomena|Sweetening Agents
DB04174	3'-1-Carboxy-1-Phosphonooxy-Ethoxy-Uridine-Diphosphate-N-Acetylglucosamine	small molecule	experimental	
DB04175	Mdl-29951	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB04176	Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester	small molecule	experimental	
DB04177	4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One	small molecule	experimental	
DB04178	Di-Stearoyl-3-Sn-Phosphatidylcholine	small molecule	experimental	
DB04179	Benzofuran	small molecule	experimental	
DB04180	4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide	small molecule	experimental	
DB04182	(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid	small molecule	experimental	
DB04183	Methylmalonic Acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids|Malonates
DB04185	Norvaline	small molecule	experimental	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB04186	N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea	small molecule	experimental	
DB04187	(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene	small molecule	experimental	
DB04188	MDL72527	small molecule	experimental	
DB04189	N2-(Carboxyethyl)-L-Arginine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB04190	Inhibitor Bea425	small molecule	experimental	
DB04191	Skf 107457	small molecule	experimental	Amino Acids, Peptides, and Proteins|Peptides
DB04193	L-Homoserine	small molecule	experimental	
DB04194	Chitotriose	small molecule	experimental	Carbohydrates|Chitin|Oligosaccharides|Polysaccharides
DB04195	Heptulose-2-Phosphate	small molecule	experimental	
DB04196	Pteroic Acid	small molecule	experimental	Biological Factors|Pigments, Biological|Pteridines
DB04197	Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine	small molecule	experimental	
DB04198	Formycin B	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB04199	1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate	small molecule	experimental	
DB04200	Matairesinol	small molecule	experimental	Benzene Derivatives|Benzyl Compounds|Plants
DB04201	Histidyl-Adenosine Monophosphate	small molecule	experimental	
DB04202	Isoformononetin	small molecule	experimental	
DB04203	3-Mercuri-4-Aminobenzenesulfonamide	small molecule	experimental	
DB04204	[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid	small molecule	experimental	
DB04205	Thymidine-3',5'-Diphosphate	small molecule	experimental	
DB04206	Nz2-Tryptophan	small molecule	experimental	
DB04207	N-(5-Amino-5-Carboxypentyl)Glutamic Acid	small molecule	experimental	
DB04208	3-(3,4-Dimethoxyphenyl)Propionic Acid	small molecule	experimental	
DB04209	Dequalinium	small molecule	approved|investigational	Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Miscellaneous Anti-infectives|Quinoline Derivatives|Quinolines|Quinolinium Compounds|Throat Preparations
DB04210	BV1	small molecule	experimental	
DB04211	(2R,3R,4R,5R,6R)-3-fluoro-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid	small molecule	experimental	
DB04212	2-Iminiopropanoate	small molecule	experimental	
DB04213	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	small molecule	experimental	
DB04214	4-Nitrophenyl Phosphate	small molecule	experimental	Benzene Derivatives|Chromogenic Compounds|Coloring Agents|Indicators and Reagents|Laboratory Chemicals|Nitro Compounds|Phenols
DB04215	CRA_9076	small molecule	experimental	
DB04216	Quercetin	small molecule	experimental|investigational	Antioxidants|BCRP/ABCG2 Inhibitors|Benzopyrans|Chromones|COMT Inhibitors|COMT Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Flavonoids|Flavonols|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protective Agents|Pyrans
DB04217	L-2-amino-3-butynoic acid	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids
DB04218	1-Deaza-Adenosine	small molecule	experimental	
DB04219	Trivanadate	small molecule	experimental	
DB04220	CGP 4832	small molecule	experimental	Amides|Lactams|Lactams, Macrocyclic
DB04221	Didecyldimethylammonium	small molecule	approved|experimental	Amines|Ammonium Compounds|Antiseptics and Disinfectants|Dermatologicals|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds
DB04222	Sparsomycin	small molecule	experimental	Antibiotics, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Protein Synthesis Inhibitors|Pyrimidines|Pyrimidinones
DB04223	Nitroarginine	small molecule	experimental|investigational	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Enzyme Inhibitors
DB04224	Oleic Acid	small molecule	approved|investigational|vet_approved	Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|Oleic Acids
DB04225	N-Methyldehydrobutyrine	small molecule	experimental	
DB04226	Dihydro-Acarbose	small molecule	experimental	
DB04227	9-Amino-2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid	small molecule	experimental	
DB04228	(2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid	small molecule	experimental	
DB04229	7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane	small molecule	experimental	
DB04230	Nitromethyldethia Coenzyme A	small molecule	experimental	
DB04231	Tetra(Imidazole)Diaquacopper (I)	small molecule	experimental	
DB04232	N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide	small molecule	experimental	
DB04233	(Hydroxyethyloxy)Tri(Ethyloxy)Octane	small molecule	experimental	
DB04234	N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide	small molecule	experimental	
DB04235	4-Amino Hexanoic Acid	small molecule	experimental	
DB04236	2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol	small molecule	experimental	
DB04237	Tris(Hydroxyethyl)Aminomethane	small molecule	experimental	
DB04238	N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid	small molecule	experimental	
DB04239	2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One	small molecule	experimental	
DB04240	(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose	small molecule	experimental	
DB04241	N-Pyridoxyl-2-Methylalanine-5-Phosphate	small molecule	experimental	
DB04242	P-Hydroxybenzoic Acid	small molecule	experimental	
DB04243	5-Methyluridine 5'-Monophosphate	small molecule	experimental	
DB04244	(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide	small molecule	experimental	
DB04246	CRA_23653	small molecule	experimental	
DB04248	beta-(1->4)-galactotriose	small molecule	experimental	
DB04249	Zinc Substituted Heme C	small molecule	experimental	Zinc Compounds
DB04250	Butyrylthiocholine	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Choline|Ethanolamines|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Sulfhydryl Compounds|Sulfur Compounds|Thiocholine|Trimethyl Ammonium Compounds
DB04252	N-Carbamoyl-L-Aspartate	small molecule	experimental	
DB04253	Tretazicar	small molecule	investigational	Antineoplastic Agents|Azirines|Prodrugs|Radiation-Sensitizing Agents
DB04254	8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine	small molecule	experimental	
DB04255	Inhibitor Bea388	small molecule	experimental	
DB04256	4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid	small molecule	experimental	
DB04257	Palmitoleic Acid	small molecule	experimental	Fatty Acids|Fatty Acids, Unsaturated|Lipids
DB04258	Seocalcitol	small molecule	experimental|investigational	Antineoplastic Agents|Cholestanes|Cholestenes|Immunologic Factors|Immunosuppressive Agents|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB04259	7n-Methyl-8-Hydroguanosine-5'-Monophosphate	small molecule	experimental	
DB04260	9-(5,5-Difluoro-5-Phosphonopentyl)Guanine	small molecule	experimental	
DB04261	Carbamic Acid	small molecule	experimental	Acids, Acyclic
DB04262	3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid	small molecule	experimental	
DB04263	Geneticin	small molecule	experimental	Agents that produce neuromuscular block (indirect)|Amebicides|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Coccidiostats|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents
DB04264	(10R)-10-Formyl-5,8,10-Trideazafolic Acid	small molecule	experimental	
DB04265	N-acetyl-beta-neuraminic acid	small molecule	experimental	
DB04266	5-(6-D-Ribitylamino-2,4-Dihydroxypyrimidin-5-Yl)-1-Pentyl-Phosphonic Acid	small molecule	experimental	
DB04267	Dipicolinic Acid	small molecule	experimental	Chelating Agents|Enzyme Inhibitors|Procollagen-Proline Dioxygenase, antagonists & inhibitors|Pyridines|Sequestering Agents
DB04268	Methylumbelliferyl Chitotriose	small molecule	experimental	
DB04269	Cyclotheonamide A	small molecule	experimental	Amino Acids, Peptides, and Proteins|Peptides|Thrombin, antagonists & inhibitors
DB04270	(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid	small molecule	experimental	
DB04271	3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	small molecule	experimental	
DB04272	Citric Acid	small molecule	approved|nutraceutical|vet_approved	Acid Preparations|Acidifying Activity|Acids, Acyclic|Alimentary Tract and Metabolism|Calcium Chelating Activity|Calcium Chelating Agents|Calculi Dissolution Agent|Chelating Agents|Citrates|Decreased Coagulation Factor Activity|Digestives, Incl. Enzymes|Hematologic Agents|Sequestering Agents|Tricarboxylic Acids|Urinary Acidifying Agents|Urinary Alkalinisers
DB04273	8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine	small molecule	experimental	
DB04274	5,4'-Dideoxyflavanone	small molecule	experimental	
DB04275	N-acetylserotonin	small molecule	experimental	Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Indoles|Inflammation Mediators|Tryptamines
DB04276	N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine	small molecule	experimental	
DB04277	Fructose -6-Phosphate	small molecule	experimental	
DB04278	2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide	small molecule	experimental	
DB04279	3-Isopropylmalic Acid	small molecule	experimental	
DB04280	((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate	small molecule	experimental	
DB04281	2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone	small molecule	experimental	
DB04282	2-deoxy-2-fluoro-Î±-D-glucose	small molecule	experimental	
DB04283	2-Bromo-6-Hydroxy-Purine	small molecule	experimental	
DB04284	L-proline betaine	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids
DB04285	{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid	small molecule	experimental	
DB04286	beta-D-Ribopyranose	small molecule	experimental	
DB04287	(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid	small molecule	experimental	
DB04288	2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine	small molecule	experimental	
DB04289	Genz-10850	small molecule	experimental	
DB04291	Oxfenicine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Carnitine O-Palmitoyltransferase, antagonists & inhibitors|Enzyme Inhibitors
DB04292	4-[(Isopropylamino)Methyl]Phenylalanine	small molecule	experimental	
DB04293	7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	small molecule	experimental	
DB04294	5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate	small molecule	experimental	
DB04295	N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea	small molecule	experimental	Carbohydrates|Glycogen Phosphorylase, antagonists & inhibitors|Hexoses|Monosaccharides
DB04296	5-Oxo-L-Norleucine	small molecule	experimental	
DB04297	7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide	small molecule	experimental	
DB04298	3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One	small molecule	experimental	
DB04299	Maleic Acid	small molecule	experimental	Acid Etching, Dental|Acids, Acyclic|Aldehyde Reductase, antagonists & inhibitors|Dicarboxylic Acids|Enzyme Inhibitors
DB04300	(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate	small molecule	experimental	
DB04301	Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate	small molecule	experimental	
DB04302	4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One	small molecule	experimental	
DB04303	4-O-methyl-alpha-D-glucuronic acid	small molecule	experimental	
DB04304	L-Gluconic Acid	small molecule	experimental	
DB04306	5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine	small molecule	experimental	
DB04307	5-Hydroxy-N-Propargyl-1(R)-Aminoindan	small molecule	experimental	
DB04308	D-4-hydroxyphenylglycine	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Carnitine O-Palmitoyltransferase, antagonists & inhibitors|Enzyme Inhibitors
DB04310	2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide	small molecule	experimental	
DB04311	4-Phenylbutylamine	small molecule	experimental	Amines
DB04312	2,3-Difluorobenzyl Alcohol	small molecule	experimental	
DB04313	(3S)-3-methyl-D-aspartic acid	small molecule	experimental|investigational	
DB04314	1-Methylcytosine	small molecule	experimental	Pyrimidines|Pyrimidinones
DB04315	Guanosine-5'-Diphosphate	small molecule	experimental	
DB04316	D-[(N-Hydroxyamino)Carbonyl]Phenylalanine	small molecule	experimental	
DB04317	3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid	small molecule	experimental	
DB04318	NÎ±-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide	small molecule	experimental	
DB04320	2-Bromo-2-Propene-1-Ol	small molecule	experimental	
DB04321	N-Hexylphosphonate Ethyl Ester	small molecule	experimental	
DB04322	LY249543	small molecule	experimental	
DB04323	2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid	small molecule	experimental	
DB04324	Ovalicin	small molecule	experimental	Terpenes
DB04325	Phenethylamine	small molecule	experimental	Amines|Central Nervous System Agents|Central Nervous System Depressants|Ethylamines|Psychotropic Drugs
DB04326	Dihydroxyacetone phosphate	small molecule	investigational	Carbohydrates|Sugar Phosphates
DB04327	Phosphatidylethanolamine	small molecule	experimental	Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Phosphates
DB04328	Shikimate-3-Phosphate	small molecule	experimental	Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydroxy Acids
DB04329	Isoquinoline	small molecule	experimental	
DB04330	Bilh 434	small molecule	experimental	
DB04331	Monastrol	small molecule	experimental	Kinesin, antagonists & inhibitors|Sulfur Compounds
DB04332	2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol	small molecule	experimental	
DB04333	Octamethylenediamine	small molecule	experimental	Amines|Polyamines
DB04334	6-hydroxydopa quinone	small molecule	experimental	Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Biogenic Amines|Biogenic Monoamines|Catecholamines|Coenzymes|Phenylalanine|Tyrosine
DB04335	Inosine	small molecule	approved|investigational	Carbohydrates|Dermatologicals|Genito Urinary System and Sex Hormones|Glycosides|Gynecological Antiinfectives and Antiseptics|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Ophthalmologicals|Purine Nucleosides|Purines|Ribonucleosides|Sensory Organs
DB04336	1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea	small molecule	experimental	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB04337	Methyl Isocyanide	small molecule	experimental	
DB04338	SB220025	small molecule	experimental	Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors
DB04339	Carbocisteine	small molecule	approved|investigational	Amino Acids|Amino Acids, Dicarboxylic|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anti-Infective Agents|Anti-Infective Agents, Local|Cough and Cold Preparations|Cysteine|Expectorants|Respiratory System Agents|Sulfhydryl Compounds|Sulfur Compounds
DB04340	2-[(Dioxidophosphoranyl)oxy]benzoate	small molecule	experimental	
DB04341	S-(3-Iodobenzyl)Glutathione	small molecule	experimental	
DB04342	7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid	small molecule	experimental	
DB04343	Glyoxylic acid	small molecule	experimental	Acids, Aldehydic
DB04345	7,8-dimethylalloxazine	small molecule	experimental	Biological Factors|Coenzymes|Enzymes and Coenzymes|Pigments, Biological|Pteridines
DB04346	(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran	small molecule	experimental	
DB04347	3-Dehydroshikimate	small molecule	experimental	Acids, Carbocyclic|Cyclohexanecarboxylic Acids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydroxy Acids
DB04348	Taurocholic Acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|BCRP/ABCG2 Inhibitors|Bile Acids and Salts|BSEP/ABCB11 inducers|BSEP/ABCB11 Substrates|Cholagogues and Choleretics|Cholanes|Cholic Acids|Detergents|Gastrointestinal Agents|Household Products|Hydrocarbons, Acyclic|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inducers|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Steroids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Surface-Active Agents|Taurine
DB04349	(S)-propane-1,2-diol	small molecule	experimental	
DB04350	Argadin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Peptides
DB04351	Aconitate Ion	small molecule	experimental	
DB04352	beta-D-Ribose-5-phosphate	small molecule	experimental	
DB04353	{(1s)-1-Benzyl-4-[3-Carbamoyl-1-(1-Carbamoyl-2-Phenyl-Ethylcarbamoyl)-(S)-Propylcarbamoyl]-2-Oxo-5-Phenyl-Pentyl}-Carbamic Acid Tert-Butyl Ester	small molecule	experimental	
DB04356	9-Deazaguanine	small molecule	experimental	Cytochrome P-450 CYP1A2 Substrates|Purines|Purinones|Xanthine derivatives
DB04357	Pteric Acid	small molecule	experimental	
DB04359	Vinylsulphonic Acid	small molecule	experimental	
DB04360	Benzo[B]Thiophene-2-Boronic Acid	small molecule	experimental	
DB04361	Methyldiazene	small molecule	experimental	
DB04362	Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid	small molecule	experimental	
DB04363	Mesobiliverdin Iv Alpha	small molecule	experimental	
DB04364	(R)-acetoin	small molecule	experimental	
DB04365	Arecoline	small molecule	experimental	Alkaloids|Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Acids|Pyridines
DB04366	3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate	small molecule	experimental	
DB04367	Debromohymenialdisine	small molecule	experimental	Protein Kinase C, antagonists & inhibitors
DB04368	Bb-3497	small molecule	experimental	Amines|Hydroxy Acids|Hydroxylamines
DB04369	1,3,2-Dioxaborolan-2-Ol	small molecule	experimental	
DB04370	S-sulphocysteine	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Sulfhydryl Compounds|Sulfur Compounds
DB04371	AL6528	small molecule	experimental	
DB04372	Di-Linoleoyl-3-Sn-Phosphatidylcholine	small molecule	experimental	
DB04373	4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide	small molecule	experimental	
DB04374	4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole	small molecule	experimental	
DB04376	13-Acetylphorbol	small molecule	experimental	
DB04377	Meglutol	small molecule	experimental	Acids, Acyclic|Anticholesteremic Agents|Antimetabolites|Dicarboxylic Acids|Enzyme Inhibitors|Glutarates|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|Toxic Actions
DB04378	3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide	small molecule	experimental	
DB04379	N-Methyl-N-(Methylbenzyl)Formamide	small molecule	experimental	
DB04380	Allantoate	small molecule	experimental	
DB04381	Crotonaldehyde	small molecule	experimental	
DB04382	2-Deoxy-Beta-D-Galactose	small molecule	experimental	
DB04383	L-Valinol	small molecule	experimental	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB04384	Fe-Mesopone	small molecule	experimental	
DB04385	3-Deazacytidine	small molecule	experimental	Carbohydrates|Cytidine Deaminase, antagonists & inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB04386	4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose	small molecule	experimental	
DB04387	1-Hydroxy-2-Amino-3-Cyclohexylpropane	small molecule	experimental	
DB04388	4-Carboxy-4-Aminobutanal	small molecule	experimental	
DB04389	Ado-P-Ch2-P-Ps-Ado	small molecule	experimental	
DB04391	Aeruginosin 98-B	small molecule	experimental	Amino Acids, Peptides, and Proteins|Peptides
DB04392	Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]	small molecule	experimental	
DB04393	Soneclosan	small molecule	experimental	
DB04394	3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide	small molecule	experimental	
DB04395	Phosphoaminophosphonic Acid-Adenylate Ester	small molecule	experimental	
DB04396	Thiodigalactoside	small molecule	experimental	Carbohydrates|Galactosides|Glycosides|Sulfur Compounds|Thioglycosides
DB04397	Alpha-D-Glucose-1-Phosphate-6-Vanadate	small molecule	experimental	
DB04398	Lactic Acid	small molecule	approved|vet_approved	Basic Ointments and Protectants|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxy Acids|Lactates|Laxatives|Miscellaneous Local Anti-infectives|Organic Acids|Osmotic Laxative
DB04400	L-erythro-7,8-dihydrobiopterin	small molecule	experimental	Biological Factors|Coenzymes|Enzymes and Coenzymes|Pigments, Biological|Pteridines|Pterins
DB04401	[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde	small molecule	experimental	
DB04404	Allosamizoline	small molecule	experimental	Amino Sugars|Carbohydrates|Chitinase|Hexosamines
DB04405	2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid	small molecule	experimental	
DB04406	3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid	small molecule	experimental	
DB04407	4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	small molecule	experimental	
DB04408	Ncs-Chromophore	small molecule	experimental	
DB04409	Naphthalene Trisulfonate	small molecule	experimental	
DB04410	3-Phenylpropylamine	small molecule	experimental	Amines
DB04411	Alpha-N-Dichloroacetyl-P-Aminophenylserinol	small molecule	experimental	
DB04414	Heptamolybdate	small molecule	experimental	
DB04415	3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl	small molecule	experimental	
DB04416	R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid	small molecule	experimental	
DB04417	P-Nitrophenol	small molecule	experimental	Benzene Derivatives|Nitro Compounds|Phenols
DB04418	Adenylosuccinic Acid	small molecule	experimental	Adenine Nucleotides|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Carbohydrates|Excitatory Amino Acids|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB04419	D-norleucine	small molecule	experimental	
DB04421	Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct	small molecule	experimental	
DB04422	2-Amino-4-Mercapto-Butyric Acid	small molecule	experimental	
DB04423	Coproporphyrin I Containing Co(Iii)	small molecule	experimental	
DB04424	RPR128515	small molecule	experimental	
DB04425	7,8-Dihydroneopterin	small molecule	experimental	Biological Factors|Biopterin|Coenzymes|Enzymes and Coenzymes|Pigments, Biological|Pteridines|Pterins
DB04426	Alpha-Methyl-N-Acetyl-D-Glucosamine	small molecule	experimental	
DB04427	3-[[N-[4-Methyl-Piperazinyl]Carbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid Benzyloxy-Amide	small molecule	experimental	
DB04429	4'-Hydroxyflavanone	small molecule	experimental	Benzopyrans|Chromones|Flavonoids|Pyrans
DB04430	3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile	small molecule	experimental	
DB04431	4-Epi-Vancosaminyl Derivative of Vancomycin	small molecule	experimental	
DB04432	ZK-805623	small molecule	experimental	
DB04433	N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine	small molecule	experimental	
DB04434	Naphthyridine Inhibitor	small molecule	experimental	
DB04436	3-Fluorotyrosine	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Central Nervous System Agents|Central Nervous System Stimulants|Spin Labels
DB04437	Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline	small molecule	experimental	
DB04438	BVDU-MP	small molecule	experimental	
DB04439	Modified Acarbose Pentasaccharide	small molecule	experimental	
DB04440	Nebularine	small molecule	experimental	Anti-Infective Agents|Antineoplastic Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines
DB04441	2-Fluoroadenosine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB04442	2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine	small molecule	experimental	
DB04444	Tetrafluoroaluminate Ion	small molecule	experimental	
DB04445	Mercuric iodide	small molecule	experimental	Anions|Antiseptics and Disinfectants|Dermatologicals|Electrolytes|Iodine Compounds|Ions|Mercurial Products
DB04446	Benzo[B]Thiophene-2-Carboxamidine	small molecule	experimental	
DB04447	1,4-Dithiothreitol	small molecule	experimental	
DB04448	2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene	small molecule	experimental	
DB04449	5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol	small molecule	experimental	
DB04450	Heptyl 1-Thiohexopyranoside	small molecule	experimental	
DB04451	4-Methylpiperazin-1-Yl Carbonyl Group	small molecule	experimental	
DB04452	Aminoquinuride	small molecule	experimental	
DB04453	4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose	small molecule	experimental	
DB04454	Alpha-Aminobutyric Acid	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids
DB04455	N,N,N-trimethylglycinium	small molecule	experimental|investigational	
DB04456	Arsenous acid	small molecule	experimental|investigational	Anions|Arsenicals|Electrolytes|Ions|Organometallic Compounds
DB04457	2'-Deoxyguanosine-5'-Monophosphate	small molecule	experimental	
DB04458	2,2-Dichloro-1-Methanesulfinyl-3-Methyl-Cyclopropanecarboxylic Acid [1-(4-Bromo-Phenyl)-Ethyl]-Amide	small molecule	experimental	
DB04459	3,4-Dichloroisocoumarin	small molecule	experimental	Benzopyrans|Enzyme Inhibitors|Pyrans|Serine Proteinase Inhibitors
DB04460	(C8-S)-Hydantocidin 5'-Phosphate	small molecule	experimental	
DB04461	Coproporphyrinogen III	small molecule	experimental	Biological Factors|Pigments, Biological|Porphyrinogens|Porphyrins
DB04462	Tetrabromo-2-Benzotriazole	small molecule	experimental	
DB04463	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	small molecule	experimental	
DB04464	N-Formylmethionine	small molecule	experimental	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Methionine|Sulfur Compounds
DB04465	Lactose	small molecule	approved|investigational	Carbohydrates|Diet, Food, and Nutrition|Disaccharides|Flavoring Agents|Food|Food Additives|Food and Beverages|Oligosaccharides|Physiological Phenomena|Polysaccharides|Sweetening Agents
DB04466	SR12813	small molecule	experimental	
DB04467	N-(5'-phosphopyridoxyl)-L-alanine	small molecule	experimental	
DB04468	Afimoxifene	small molecule	investigational	Androstanes|Androstenes|Androstenols|Antineoplastic Agents|Benzene Derivatives|Benzylidene Compounds|Estrogen Antagonists|Estrogen Receptor Modulators|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Receptors, Estrogen, agonists|Selective Estrogen Receptor Modulators|Steroids|Stilbenes
DB04469	1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester	small molecule	experimental	
DB04470	CRA_10656	small molecule	experimental	
DB04471	2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol	small molecule	experimental	
DB04472	(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol	small molecule	experimental	
DB04473	Alpha-L-Fucose	small molecule	experimental	
DB04474	1-Anilino-8-Naphthalene Sulfonate	small molecule	experimental	
DB04476	Trencam-3,2-Hopo	small molecule	experimental	
DB04477	N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine	small molecule	experimental	
DB04478	Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine	small molecule	experimental	
DB04479	4-Nitro-Inden-1-One	small molecule	experimental	
DB04480	3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole	small molecule	experimental	
DB04481	Meso-Erythritol	small molecule	experimental	
DB04482	Cmp-2-Keto-3-Deoxy-Octulosonic Acid	small molecule	experimental	
DB04483	2-deoxy-2-fluoro-Î²-D-mannose	small molecule	experimental	
DB04484	L-Phenylalaninol	small molecule	experimental	
DB04485	Deoxythymidine	small molecule	experimental|investigational	Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines
DB04486	(2s)-2,8-Diaminooctanoic Acid	small molecule	experimental	
DB04487	N-Methylleucine	small molecule	experimental	
DB04488	(6r,7r)-3-[(Acetyloxy)Methyl]-7-{[(6s)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Octane-2-Carboxylate	small molecule	experimental	
DB04489	Guanidinoethylmercaptosuccinic acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids
DB04490	3-(Mercaptomethylene)Pyridine	small molecule	experimental	
DB04491	Diisopropylphosphono Group	small molecule	experimental	
DB04492	2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose	small molecule	experimental	
DB04493	Fructose-6-Phosphate	small molecule	experimental	Carbohydrates|Hexosephosphates|Sugar Phosphates
DB04494	Dihydroxy(oxo)molybdenum(6+)	small molecule	experimental	
DB04495	RU81843	small molecule	experimental	Amides|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Azepines|Lactams|Phosphoamino Acids|Tyrosine
DB04496	4-Phospho-D-Erythronohydroxamic Acid	small molecule	experimental	Amines|Carbohydrates|Hydroxy Acids|Hydroxylamines
DB04497	2'-Monophosphoadenosine-5'-Diphosphoribose	small molecule	experimental	
DB04498	Aspartate Semialdehyde	small molecule	experimental	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids
DB04499	R-Styrene Oxide	small molecule	experimental	
DB04500	Acedoben	small molecule	experimental	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates
DB04501	Camphane	small molecule	experimental	Monoterpenes|Norbornanes|Terpenes
DB04502	WRR-204	small molecule	experimental	
DB04503	Sp-722	small molecule	experimental	
DB04504	(3s)-2,3,4,5-Tetrahydropyridin-3-Amine	small molecule	experimental	
DB04505	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	small molecule	experimental	
DB04506	Chlorophyll B	small molecule	experimental	Biological Factors|Metalloporphyrins|Pigments, Biological|Porphyrins
DB04508	Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside	small molecule	experimental	
DB04509	N-Methylnaloxonium	small molecule	experimental	
DB04510	3-phospho-D-glyceric acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids
DB04511	N-Succinyl Methionine	small molecule	experimental	
DB04512	2-Isobutyl-3-Methoxypyrazine	small molecule	experimental	Odors
DB04513	N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide	small molecule	experimental	Amides|Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors|Cardiovascular Agents|Enzyme Inhibitors|Sulfones|Sulfur Compounds|Vasodilating Agents
DB04514	Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester	small molecule	experimental	
DB04515	6-deoxy-2-O-methyl-alpha-L-galactopyranose	small molecule	experimental	
DB04516	2-Deoxy-Glucitol-6-Phosphate	small molecule	experimental	
DB04517	Dipyrromethane Cofactor	small molecule	experimental	Coenzymes
DB04518	3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol	small molecule	experimental	
DB04519	Caprylic acid	small molecule	investigational	Acids, Acyclic|Fatty Acids|Lipids|OAT3/SLC22A8 Inhibitors
DB04520	(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione	small molecule	experimental	
DB04521	GSHNA	small molecule	experimental	
DB04522	Dexfosfoserine	small molecule	experimental	
DB04523	Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate	small molecule	experimental	
DB04524	Malonyl-CoA	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzyme A|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB04525	2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid	small molecule	experimental	
DB04526	L-Glycero-D-Manno-Heptopyranose	small molecule	experimental	Carbohydrates|Monosaccharides
DB04527	Beta-Hydroxyasparagine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins
DB04528	2,4-Dinitrophenol	small molecule	experimental	Benzene Derivatives|Coloring Agents|Dinitrophenols|Enzyme Inhibitors|Nitro Compounds|Nitrophenols|Phenols|Uncoupling Agents
DB04529	Desvancosaminyl Vancomycin	small molecule	experimental	
DB04530	S,S-(2-Hydroxyethyl)Thiocysteine	small molecule	experimental	
DB04531	Benzylcysteine	small molecule	experimental	
DB04532	Indole	small molecule	experimental	
DB04533	2-Amino-P-Cresol	small molecule	experimental	Benzene Derivatives|Phenols
DB04534	5-Nitroindazole	small molecule	experimental	Pyrazoles
DB04537	L-Tryptophanamide	small molecule	experimental	
DB04538	threo-3-methyl-L-aspartic acid	small molecule	experimental	
DB04539	Glyphosate	small molecule	experimental	Agrochemicals|Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Enzyme Inhibitors|Herbicides|Pesticides|Toxic Actions|Uncoupling Agents
DB04540	Cholesterol	small molecule	approved|investigational	BCRP/ABCG2 Inducers|Cholestanes|Cholestenes|Lipids|Membrane Lipids|P-glycoprotein/ABCB1 Inhibitors|Steroids|Sterols
DB04541	(8ar)-Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione	small molecule	experimental	
DB04542	3'-Azido-3'-Deoxythymidine-5'-Diphosphate	small molecule	experimental	
DB04543	2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One	small molecule	experimental	
DB04544	1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide	small molecule	experimental	
DB04545	Afegostat	small molecule	experimental|investigational	Carbohydrates|Glycoside Hydrolases, antagonists & inhibitors|Imines|Imino Sugars|Monosaccharides|Piperidines
DB04546	3-Deaza-Adenosine	small molecule	experimental	
DB04547	Inhibitor Bea409	small molecule	experimental	
DB04548	4-Deoxy-D-Glucuronic Acid	small molecule	experimental	
DB04549	4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide	small molecule	experimental	
DB04551	beta-D-fructofuranose 1,6-bisphosphate	small molecule	experimental	
DB04552	Niflumic Acid	small molecule	experimental	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Nicotinic Acids|ortho-Aminobenzoates|Peripheral Nervous System Agents|Pyridines|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Topical Products for Joint and Muscular Pain|UGT1A9 Inhibitors
DB04553	2-Oxobutanoic Acid	small molecule	experimental	
DB04554	8-Bromoadenosine-5'-Diphosphate	small molecule	experimental	
DB04555	Cytidine-5'-Diphosphate	small molecule	experimental	
DB04556	3-[(1s)-1-(Dimethylamino)Ethyl]Phenol	small molecule	experimental	
DB04557	Arachidonic Acid	small molecule	experimental	Arachidonic Acids|Autacoids|Biological Factors|Cytochrome P-450 CYP2C9 Substrates|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids
DB04559	N-(Chlorophenyl)-N'-Hydroxyguanidine	small molecule	experimental	
DB04560	4,7-Dioxosebacic Acid	small molecule	experimental	Fatty Acids|Lipids|Porphobilinogen Synthase, antagonists & inhibitors
DB04561	4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid	small molecule	experimental	
DB04562	Tricarballylic Acid	small molecule	experimental	Acids, Acyclic
DB04563	CRA_9678	small molecule	experimental	
DB04564	Gluconolactone	small molecule	approved|experimental	Acids, Acyclic|Calculi Dissolution Agent|Carbohydrates|Hydroxy Acids|Irrigation|Sugar Acids
DB04565	4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid	small molecule	experimental	
DB04566	Inosinic Acid	small molecule	experimental	Carbohydrates|Glycosides|Inosine Nucleotides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB04567	Chromophore (Gly-Tyr-Gly)	small molecule	experimental	
DB04568	5-Aminoimidazole Ribonucleoside	small molecule	experimental	
DB04569	Formic Acid Benzyl Ester	small molecule	experimental	
DB04570	Latamoxef	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Amides|Anions|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Electrolytes|Gases|Hydrogen Sulfide|Ions|Lactams|Nephrotoxic agents|Sulfides|Sulfur Compounds|Third-Generation Cephalosporins
DB04571	Trioxsalen	small molecule	approved	Antipsoriatics|Antipsoriatics for Systemic Use|Antipsoriatics for Topical Use|Benzopyrans|Coumarins|Dermatologicals|Furocoumarins|Photosensitizing Agents|Psoralens for Systemic Use|Psoralens for Topical Use|Pyrans|Radiation-Sensitizing Agents
DB04572	Thiotepa	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alkylating Activity|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Aziridines|Azirines|Cholinesterase Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Electrolytes|Ethylene Imines|Immunologic Factors|Immunosuppressive Agents|Ions|Myeloablative Agonists|Myelosuppressive Agents|Noxae|Organophosphorus Compounds|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions|Triethylenephosphoramide
DB04573	Estriol	small molecule	approved|investigational|vet_approved	Estradiol Congeners|Estranes|Estrenes|Estrogens|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates|Sex Hormones and Modulators of the Genital System|Steroids
DB04574	Estrone sulfate	small molecule	approved	17-Ketosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estranes|Estrenes|Estrogens|Estrogens, Conjugated (USP)|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Ketosteroids|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Reproductive Control Agents|Steroids
DB04575	Quinestrol	small molecule	approved	Estradiol Congeners|Estrogenic Steroids, Alkylated|Estrogens|Ethinyl Estradiol|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnatrienes|Norsteroids|Steroids
DB04576	Fleroxacin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB04577	1-(1-phenylcyclopentyl)methylamine	small molecule	experimental	
DB04578	(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide	small molecule	experimental	
DB04579	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-	small molecule	experimental	
DB04580	1-Methyl-2-quinolone	small molecule	experimental	
DB04581	1-benzylimidazole	small molecule	experimental	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Neurotransmitter Agents
DB04582	IMAZAQUIN	small molecule	experimental	
DB04583	5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid	small molecule	experimental	
DB04584	Phenyldehydroalanine	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB04585	DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID	small molecule	experimental	
DB04586	2-bromophenol	small molecule	experimental	Benzene Derivatives
DB04587	2'-O-BUTYL-5-METHYLURIDINE	small molecule	experimental	
DB04588	N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	small molecule	experimental	
DB04590	(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID	small molecule	experimental	
DB04591	N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE	small molecule	experimental	
DB04592	3-Bromo-3-buten-1-ol	small molecule	experimental	
DB04593	3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID	small molecule	experimental	
DB04594	3-hydroxyglutaric acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids
DB04595	(E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID BENZYL ESTER	small molecule	experimental	
DB04596	4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-Î²-D-mannopyranosyl}-D-glucopyranuronic acid	small molecule	experimental	
DB04597	[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]	small molecule	experimental	
DB04598	2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID	small molecule	experimental	
DB04599	Aniracetam	small molecule	experimental	Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Nootropic Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs|Pyrrolidines
DB04600	4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE	small molecule	experimental	
DB04601	4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE	small molecule	experimental	
DB04602	PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE	small molecule	experimental	
DB04603	2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE	small molecule	experimental	
DB04604	5-iodotubercidin	small molecule	experimental	Adenosine Kinase, antagonists & inhibitors|Carbohydrates|Enzyme Inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB04605	5-Aminoisoquinoline	small molecule	experimental	
DB04606	2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)	small molecule	experimental	
DB04607	PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE	small molecule	experimental	
DB04608	9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE	small molecule	experimental	
DB04609	INHIBITOR Q8467 OF DUPONT MERCK	small molecule	experimental	
DB04610	7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin	small molecule	experimental	
DB04612	N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE	small molecule	experimental	
DB04613	(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER	small molecule	experimental	
DB04614	(R)-tacrine(10)-hupyridone	small molecule	experimental	
DB04615	(S)-tacrine(10)-hupyridone	small molecule	experimental	
DB04616	TACRINE(8)-4-AMINOQUINOLINE	small molecule	experimental	
DB04617	(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM	small molecule	experimental	
DB04618	4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE	small molecule	experimental	
DB04619	ACETOPHENONE	small molecule	experimental	Dermatologicals|Ketones|Photosensitizing Agents|Radiation-Sensitizing Agents
DB04620	Cycloleucine	small molecule	experimental	Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cycloparaffins|Cyclopentanes
DB04622	N-ACETYLHISTAMINE	small molecule	experimental	Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Ethylamines|Imidazoles|Inflammation Mediators
DB04623	2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE	small molecule	experimental	
DB04624	DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)	small molecule	experimental	
DB04626	Apramycin	small molecule	experimental|vet_approved	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Glycosides|Kanamycin|Narrow Therapeutic Index Drugs|Nephrotoxic agents
DB04627	Cyclouridine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB04628	Allosamidin	small molecule	experimental	Agrochemicals|Amino Sugars|Carbohydrates|Chitinase, antagonists & inhibitors|Enzyme Inhibitors|Glucosamine|Hexosamines|Insecticides|Oligosaccharides|Pesticides|Polysaccharides|Toxic Actions
DB04629	Aplyronine A	small molecule	experimental	Actins, antagonists & inhibitors|Lactones|Polyketides
DB04630	Aldosterone	small molecule	experimental|investigational	11-Hydroxycorticosteroids|Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Mineralocorticoids|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Substrates|Pregnanes|Pregnenediones|Pregnenes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB04631	Atpenin A5	small molecule	experimental	Pyridines
DB04632	4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE	small molecule	experimental	
DB04633	N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine	small molecule	experimental	
DB04634	N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE	small molecule	experimental	
DB04636	Glutamine t-butyl ester	small molecule	experimental	
DB04637	6-Bromo-1-hexanol	small molecule	experimental	
DB04638	2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE	small molecule	experimental	
DB04639	Biphenylalanine	small molecule	experimental	
DB04640	Naphthalene-2,6-disulfonic acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB04641	3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB04642	7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID	small molecule	experimental	
DB04643	4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID	small molecule	experimental	
DB04644	4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID	small molecule	experimental	
DB04645	5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID	small molecule	experimental	
DB04646	Dibromothymoquinone	small molecule	experimental	Benzoquinones|Quinones
DB04647	BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA	small molecule	experimental	
DB04648	S-propylamine-L-cysteine	small molecule	experimental	
DB04649	TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S	small molecule	experimental	
DB04650	5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID	small molecule	experimental	
DB04651	BIOTINOL-5-AMP	small molecule	experimental	
DB04652	Corticosterone	small molecule	experimental	11-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB04653	CBZ-LEU-LEU-TYR-CH2F	small molecule	experimental	
DB04654	4-PIPERIDIN-4-YLBUTANAL	small molecule	experimental	
DB04655	Metoprine	small molecule	experimental	Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists|Pyrimidines
DB04656	1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID	small molecule	experimental	
DB04657	Carboxin	small molecule	approved|experimental	Agrochemicals|Amides|Anilides|Fungicides, Industrial|Oxathiins|Pesticides|Toxic Actions
DB04658	(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL	small molecule	experimental	
DB04659	(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	small molecule	experimental	
DB04660	Choline alfoscerate	small molecule	experimental|investigational	Biological Products|Carbohydrates|Complex Mixtures|Glycerophosphates|Glycerophospholipids|Lecithins|Lipids|Membrane Lipids|Nervous System|Parasympathomimetics|Pharmaceutical Preparations|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Plant Extracts|Plant Preparations|Sugar Phosphates
DB04661	Cis-tetracosenoyl sulfatide	small molecule	experimental	
DB04662	OLOMOUCINE II	small molecule	experimental	Cyclin-Dependent Kinases, antagonists & inhibitors
DB04663	2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM	small molecule	experimental	
DB04664	Cyclohexyl-pentyl-maltoside	small molecule	experimental	Carbohydrates|Glycosides|Surface-Active Agents
DB04665	Coumarin	small molecule	experimental	Anticoagulants|Benzopyrans|Cytochrome P-450 CYP2C9 Substrates|Edema, drug therapy|Pyrans|Vitamin K Antagonists
DB04666	CHROMOPHORE (LYS-TYR-GLY)	small molecule	experimental	
DB04667	CHROMOPHORE (HIS-TYR-GLY)	small molecule	experimental	
DB04668	CHROMOPHORE (GLU-TYR-GLY)	small molecule	experimental	
DB04669	TRIAZOLOPYRIMIDINE	small molecule	experimental	
DB04671	L-CYSTEIN-S-1-(IMINOMETHYL)-L-ORNITHINE	small molecule	experimental	
DB04672	cyclic 3',5'-thymidine monophosphate	small molecule	experimental	Carbohydrates|Deoxyribonucleosides|Deoxyribonucleotides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines|Thymidine|Thymine Nucleotides
DB04673	4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE	small molecule	experimental	
DB04674	2-HYDROXY-3,5-DIIODOBENZOIC ACID	small molecule	experimental	
DB04676	Dansyllysine	small molecule	experimental	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Naphthalenes|Sulfones|Sulfur Compounds
DB04677	N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE	small molecule	experimental	
DB04678	H TYPE II TRISACCHARIDE	small molecule	experimental	
DB04679	H TYPE I TRISACCHARIDE	small molecule	experimental	
DB04680	GALACTOSE GREASE	small molecule	experimental	
DB04681	BETA-METHYLLACTOSIDE	small molecule	experimental	
DB04682	Octylphenoxy polyethoxyethanol	small molecule	experimental	Adrenal Cortex Hormones|Alcohols|Antifoaming Agents|Antispermatogenic Agents|Biomedical and Dental Materials|Contraceptive Agents, Female|Contraceptive Agents, Male|Detergents|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Hormonal Contraceptives for Systemic Use|Household Products|Macromolecular Substances|Noxae|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Reproductive Control Agents|Spermatocidal Agents|Surface-Active Agents|Toxic Actions
DB04683	(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE	small molecule	experimental	
DB04684	BIS(HEXAMETHYLENE)TRIAMINE	small molecule	experimental	
DB04685	1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE	small molecule	experimental	
DB04686	CHROMOPHORE (ASP-TYR-GLY)	small molecule	experimental	
DB04687	DIMETHYL THIOPHOSPHATE	small molecule	experimental	
DB04688	Methylecgonine	small molecule	experimental	Alkaloids|Analgesics|Aza Compounds|Azabicyclo Compounds|Central Nervous System Agents|Narcotics|Peripheral Nervous System Agents|Sensory System Agents|Tropanes
DB04689	2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	small molecule	experimental	
DB04690	Camptothecin	small molecule	experimental	Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|BCRP/ABCG2 Substrates|Enzyme Inhibitors|P-glycoprotein/ABCB1 Substrates|Topoisomerase I Inhibitors|Topoisomerase Inhibitors
DB04691	2'-O-[1-ETHYL-1H-IMIDAZOL)] THYMIDINE-5'-MONOPHOSPHATE	small molecule	experimental	
DB04692	Ethyl (2E)-4-({(2S)-2-[(N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl)amino]-2-phenylacetyl}amino)-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate	small molecule	experimental	
DB04693	(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE	small molecule	experimental	
DB04694	2,6-anhydro-3-deoxy-3-fluoronononic acid	small molecule	experimental	
DB04695	Farnesyl thiopyrophosphate	small molecule	experimental	Organophosphates|Organophosphorus Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes
DB04696	4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN	small molecule	experimental	
DB04697	TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE	small molecule	experimental	
DB04698	N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE	small molecule	experimental	
DB04699	gamma-butyrolactone	small molecule	experimental	Furans|Lactones|Solvents
DB04700	GLUTATHIONE SULFINATE	small molecule	experimental	
DB04701	S-METHYL-GLUTATHIONE	small molecule	experimental	
DB04702	S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE	small molecule	experimental	
DB04703	Hesperidin	small molecule	approved|investigational	Benzopyrans|Chromones|Flavanones|Flavonoids|Pyrans
DB04704	20-hydroxycholesterol	small molecule	experimental	Cholestanes|Cholestenes|Cholesterol|Lipids|Membrane Lipids|Steroids|Sterols
DB04705	(3BETA)-CHOLEST-5-ENE-3,25-DIOL	small molecule	experimental	
DB04706	(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL	small molecule	experimental	
DB04707	Hydroxyfasudil	small molecule	experimental	Amides|Isoquinolines|Piperazines|Sulfonamides|Sulfones|Sulfur Compounds
DB04708	(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE	small molecule	experimental	
DB04709	(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE	small molecule	experimental	
DB04710	(E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER	small molecule	experimental	
DB04711	Iodipamide	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB04712	ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE	small molecule	experimental	
DB04713	4-Iodo-D-phenylalanine	small molecule	experimental	
DB04714	ISOPENTENYL PYROPHOSPHATE	small molecule	experimental	Terpenes
DB04715	IMIDAZOPYRIDAZIN 1	small molecule	experimental	
DB04716	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE	small molecule	experimental	
DB04717	2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin	small molecule	experimental	
DB04718	(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-2-O-{2-[(piperidin-3-ylmethyl)amino]ethyl}-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside	small molecule	experimental	
DB04719	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	small molecule	experimental	
DB04720	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	small molecule	experimental	
DB04721	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	small molecule	experimental	
DB04722	2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE	small molecule	experimental	
DB04723	2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID	small molecule	experimental	
DB04724	(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE	small molecule	experimental	
DB04725	Licofelone	small molecule	investigational	Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors
DB04726	7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE	small molecule	experimental	
DB04727	N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA	small molecule	experimental	
DB04728	Lividomycin A	small molecule	experimental	
DB04729	Gentamicin C1a	small molecule	experimental	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Carbohydrates|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents
DB04731	1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE	small molecule	experimental	
DB04732	N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID	small molecule	experimental	
DB04733	1,6-DI-O-PHOSPHONO-D-MANNITOL	small molecule	experimental	
DB04734	Citraconic acid	small molecule	experimental	Acids, Acyclic|Dicarboxylic Acids
DB04735	MONOGALACTOSYL-DIACYLGLYCEROL	small molecule	experimental	
DB04736	2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE	small molecule	experimental	
DB04737	(S)-HYDROXY(PHENYL)ACETONITRILE	small molecule	experimental	
DB04738	Motuporin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Cytotoxins|Peptides
DB04739	4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE	small molecule	experimental	
DB04740	MOXALACTAM (HYDROLYZED)	small molecule	experimental	
DB04741	Myxothiazol	small molecule	experimental	Acids, Acyclic|Acrylates|Anti-Infective Agents|Antifungal Agents|Electron Transport Complex III|Sulfur Compounds
DB04742	(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid	small molecule	experimental	
DB04743	Nimesulide	small molecule	approved|investigational|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiarrhythmic agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiplatelet agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Sulfones|Sulfur Compounds|Topical Products for Joint and Muscular Pain
DB04744	Lawsone	small molecule	experimental	Anti-Infective Agents|Antifungal Agents|Coloring Agents|Cosmetics|Dermatologicals|Enzyme Inhibitors|Household Products|Naphthalenes|Oxidoreductases|Protective Agents|Quinones|Radiation-Protective Agents|Sunscreening Agents
DB04745	2-OXOQUINOLINE	small molecule	experimental	
DB04746	(10E,12Z)-octadeca-10,12-dienoic acid	small molecule	experimental	
DB04747	11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID	small molecule	experimental	
DB04748	OXIMINOARYLSULFONAMIDE	small molecule	experimental	
DB04749	2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE	small molecule	experimental	
DB04750	OREGON GREEN 488 CARBOXYLATE	small molecule	experimental	
DB04751	Purvalanol A	small molecule	experimental	CDC2 Protein Kinase, antagonists & inhibitors
DB04752	Phosphatidyl ethanol	small molecule	experimental	
DB04753	9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	small molecule	experimental	
DB04754	GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE	small molecule	experimental	
DB04755	PROPYL-1-PHOSPHATE	small molecule	experimental	
DB04756	2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid	small molecule	experimental	
DB04757	GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE	small molecule	experimental	
DB04758	2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE)	small molecule	experimental	
DB04759	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)	small molecule	experimental	
DB04760	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)	small molecule	experimental	
DB04761	PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]	small molecule	experimental	
DB04762	N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE	small molecule	experimental	
DB04763	1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM	small molecule	experimental	
DB04764	[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE	small molecule	experimental	
DB04765	N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE	small molecule	experimental	
DB04767	N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID	small molecule	experimental	
DB04768	Pyrithiamine Pyrophosphate	small molecule	experimental	
DB04769	5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE	small molecule	experimental	
DB04770	O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL	small molecule	experimental	
DB04771	1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE	small molecule	experimental	
DB04772	1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE	small molecule	experimental	
DB04773	METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE	small molecule	experimental	
DB04774	Reidispongiolide A	small molecule	experimental	Lactones|Polyketides
DB04775	Reidispongiolide C	small molecule	experimental	
DB04776	(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol	small molecule	experimental	Purines
DB04777	(R)-4-Nitrostyrene oxide	small molecule	experimental	
DB04778	SC45647	small molecule	experimental	Amidines|Sweetening Agents
DB04779	ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE	small molecule	experimental	
DB04780	Sulfatide	small molecule	experimental	
DB04781	5-hydroxyvaleric acid	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB04782	(S)-4-Nitrostyrene oxide	small molecule	experimental	
DB04783	Sphinxolide B	small molecule	experimental	
DB04784	(R)-1-phenylethanol	small molecule	experimental	
DB04785	Streptolydigin	small molecule	experimental	Carbohydrates|Glycosides
DB04786	Suramin	small molecule	investigational	Acids|Acids, Noncarboxylic|Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antinematodal Agents|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Naphthalenesulfonates|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Trypanocidal Agents
DB04787	Tanaproget	small molecule	investigational	Oxazines|Receptors, Progesterone, agonists|Sulfur Compounds
DB04788	Tagetitoxin	small molecule	experimental	Acids, Acyclic|Bacterial Toxins
DB04789	5-methyltetrahydrofolic acid	small molecule	investigational|nutraceutical	Folic Acid and Derivatives|Vitamin B Complex|Vitamins
DB04790	2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol	small molecule	experimental	
DB04791	2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL	small molecule	experimental	
DB04792	2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL	small molecule	experimental	
DB04793	1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol	small molecule	experimental	
DB04794	Bifonazole	small molecule	approved|investigational	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives
DB04795	Thenoyltrifluoroacetone	small molecule	experimental	Butanones|Chelating Agents|Ketones|Sequestering Agents|Sulfur Compounds|Thiophenes
DB04796	Inecalcitol	small molecule	experimental|investigational	Cholestanes|Cholestenes|Hydrocarbons, Acyclic|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB04797	Triazolopyridine	small molecule	experimental	
DB04798	THIO-ATPA	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Sulfur Compounds
DB04799	5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole	small molecule	experimental	Sulfur Compounds
DB04800	1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID	small molecule	experimental	
DB04801	cis-Vaccenic acid	small molecule	experimental	Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids
DB04802	D-ERITHRO-2,3-DIAMINO-BUTYRIC ACID	small molecule	experimental	
DB04803	Verdoheme	small molecule	experimental	Biological Factors|Metalloporphyrins|Pigments, Biological|Porphyrins
DB04804	L-threo-2,3-diamino-butyric acid	small molecule	experimental	
DB04805	Virginiamycin S1	small molecule	experimental	Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic|Streptogramins
DB04806	(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE	small molecule	experimental	
DB04807	4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE	small molecule	experimental	
DB04808	Neamine	small molecule	experimental	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Carbohydrates|Glycosides|Narrow Therapeutic Index Drugs|Neomycin|Nephrotoxic agents
DB04809	SALOPHEN-10-PROPIONATE IRON CHELATE	small molecule	experimental	
DB04810	Salophen-10-carboxylate iron chelate	small molecule	experimental	
DB04811	Salophen iron chelate	small molecule	experimental	
DB04812	Benoxaprofen	small molecule	withdrawn	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Dermatologicals|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Lipoxygenase Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents
DB04813	Bithionol	small molecule	withdrawn	Anthelmintics|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antitrematodals|Benzene Derivatives|Dermatologicals|Phenols|Preparations Containing Sulfur
DB04814	Bunamiodyl	small molecule	withdrawn	
DB04815	Clioquinol	small molecule	approved|vet_approved|withdrawn	Anti-Infective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antiseptics and Disinfectants|Cell-mediated Immunity|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxyquinoline Derivatives|Hydroxyquinolines|Increased Histamine Release|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Antifungals|Otologicals|Oxyquinoline|Quinoline Derivatives|Quinolines|Sensory Organs|Standardized Chemical Allergen
DB04816	Dantron	small molecule	approved|investigational|withdrawn	Alimentary Tract and Metabolism|Anthracenes|Contact Laxatives|Drugs for Constipation|Enemas|Gastrointestinal Agents|Laxatives|Mutagens|Noxae|Quinones|Toxic Actions
DB04817	Metamizole	small molecule	approved|investigational|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Aminopyrine|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antipyretics|Central Nervous System Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents
DB04818	Iproniazid	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hydrazines|Isonicotinic Acids|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Psychotropic Drugs|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB04819	Methapyrilene	small molecule	withdrawn	Amines|Aminopyridines|Anti-Allergic Agents|Antihistamines for Systemic Use|Central Nervous System Agents|Central Nervous System Depressants|Diamines|Ethylenediamines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Hypnotics and Sedatives|Neurotransmitter Agents|Polyamines|Pyridines|Substituted Ethylene Diamines
DB04820	Nialamide	small molecule	approved|withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Isonicotinic Acids|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Nervous System|Psychoanaleptics|Psychotropic Drugs|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB04821	Nomifensine	small molecule	withdrawn	Central Nervous System Depressants|Dopamine Agents|Dopamine Uptake Inhibitors|Isoquinolines|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychoanaleptics
DB04822	Oxeladin	small molecule	withdrawn	Acids, Carbocyclic|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Respiratory System Agents
DB04823	Oxyphenisatin	small molecule	investigational|withdrawn	Alimentary Tract and Metabolism|Contact Laxatives|Drugs for Constipation|Gastrointestinal Agents|Indoles|Laxatives
DB04824	Phenolphthalein	small molecule	approved|withdrawn	Alimentary Tract and Metabolism|Benzene Derivatives|Contact Laxatives|Drugs for Constipation|Indicators and Reagents|Laboratory Chemicals|Laxatives|Phenolphthaleins|Phenols
DB04825	Prenylamine	small molecule	withdrawn	Adrenergic Agents|Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Phenethylamines|QTc Prolonging Agents|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB04826	Thenalidine	small molecule	withdrawn	Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals
DB04827	Urethane	small molecule	approved|withdrawn	Acids, Acyclic|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Antineoplastic Agents|Carbamates|Carcinogens|Central Nervous System Agents|Central Nervous System Depressants|Noxae|Toxic Actions
DB04828	Zomepirac	small molecule	withdrawn	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Musculo-Skeletal System|Nephrotoxic agents|P-glycoprotein/ABCB1 Inhibitors|Peripheral Nervous System Agents|Sensory System Agents
DB04829	Lysergic acid diethylamide	small molecule	illicit|investigational|withdrawn	Agents that produce hypertension|Alkaloids|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ergolines|Ergot Alkaloids and Derivatives|Hallucinogens|Lysergic Acid|Neurotransmitter Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists
DB04830	Buformin	small molecule	investigational|withdrawn	Alimentary Tract and Metabolism|Amidines|Biguanides|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Guanidines|Oral Hypoglycemics
DB04831	Tienilic acid	small molecule	withdrawn	Acetates|Acids, Acyclic|Antigout Preparations|Antihypertensive Agents|Aryloxyacetic Acid Derivatives|Cardiovascular Agents|Diuretics|Fatty Acids|Fatty Acids, Volatile|Glycolates|High-Ceiling Diuretics|Hydroxy Acids|Lipids|Natriuretic Agents|Phenoxyacetates|Renal Agents|Sulfur Compounds|Thiophenes|Uricosuric Agents
DB04832	Zimelidine	small molecule	withdrawn	Brompheniramine|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Pheniramine|Psychoanaleptics|Pyridines|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB04833	Methaqualone	small molecule	illicit|withdrawn	Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Psycholeptics|Quinazolines|Quinazolinones
DB04834	Rapacuronium	small molecule	approved|withdrawn	Agents producing tachycardia|Androstanes|Androstanols|Anticholinergic Agents|Central Nervous System Depressants|Muscarinic Antagonists|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular-Blocking Agents (Nondepolarizing)|Peripheral Nervous System Agents|Steroids
DB04835	Maraviroc	small molecule	approved|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|CCR5 Co-receptor Antagonist|CCR5 Receptor Antagonists|Cycloparaffins|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Direct Acting Antivirals|HIV Fusion Inhibitors
DB04836	Amineptine	small molecule	illicit|withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Agents|Central Nervous System Depressants|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB04837	Clofedanol	small molecule	approved|withdrawn	Alcohols|Amines|Amino Alcohols|Antitussive Agents|Cough and Cold Preparations|Histamine Antagonists|Histamine H1 Antagonists|Propanols
DB04838	Cyclandelate	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hydroxy Acids|Mandelic Acids|Peripheral Vasodilators|Vasodilating Agents
DB04839	Cyproterone acetate	small molecule	approved|investigational	Adrenal Cortex Hormones|Antiandrogens|Antiandrogens and Estrogens|Antineoplastic Agents|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Oral|Cyproterone|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Other Miscellaneous Therapeutic Agents|Pregnadienes|Pregnanes|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|Steroids, Chlorinated
DB04840	Debrisoquin	small molecule	approved|investigational	Adrenergic Agents|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Autonomic Agents|Cardiovascular Agents|Catecholamines|Cytochrome P-450 CYP2D6 Substrates|Guanidine Derivatives|Isoquinolines|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Sympatholytics
DB04841	Flunarizine	small molecule	approved	Agents causing hyperkalemia|Antiarrhythmic agents|Anticonvulsants|Antimigraine Agents, Miscellaneous|Antivertigo Preparations|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Piperazine Derivatives|Piperazines|Vasodilating Agents
DB04842	Fluspirilene	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antipsychotic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diphenylbutylpiperidine Derivatives|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Imidazoles|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Piperidines|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Spiro Compounds|Tranquilizing Agents
DB04843	Mepenzolate	small molecule	approved	Acids, Carbocyclic|Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Diphenylacetic Acids|Drugs for Functional Gastrointestinal Disorders|Hydroxy Acids|Muscarinic Antagonists|Phenylacetates|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB04844	Tetrabenazine	small molecule	approved|investigational	Adrenergic Agents|Cytochrome P-450 CYP2D6 Substrates|Highest Risk QTc-Prolonging Agents|Membrane Transport Modulators|Miscellaneous Central Nervous System Agents|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|QTc Prolonging Agents|Quinolizines|Vesicular Monoamine Transporter 2 Inhibitor|Vesicular Monoamine Transporter 2 Inhibitors
DB04845	Ixabepilone	small molecule	approved|investigational	Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytotoxic Antibiotics and Related Substances|Immunosuppressive Agents|Lactones|Macrolides|Microtubule Inhibition|Microtubule Inhibitors|Myelosuppressive Agents|Polyketides|Tubulin Modulators
DB04846	Celiprolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Antagonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Autonomic Agents|Benzene Derivatives|Beta Blocking Agents, Selective|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenoxypropanolamines|Phenylurea Compounds|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents|Sympathomimetics|Urea|Vasodilating Agents
DB04847	Roxadustat	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors
DB04848	AZD0947	small molecule	investigational	
DB04849	Cediranib	small molecule	investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB04850	Posizolid	small molecule	investigational	OATP1B1/SLCO1B1 Inhibitors|Oxazoles
DB04851	Biricodar dicitrate	small molecule	investigational	P-glycoprotein/ABCB1 Inhibitors
DB04852	Implitapide	small molecule	investigational	
DB04853	Binodenoson	small molecule	investigational	Carbohydrates|Glycosides|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists|Purines|Ribonucleosides
DB04854	Febuxostat	small molecule	approved	Antigout Preparations|Musculo-Skeletal System|Preparations Inhibiting Uric Acid Production|Sulfur Compounds|Thiazoles|Xanthine Oxidase Inhibitors
DB04855	Dronedarone	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiarrhythmic agents|Antiarrhythmics, Class III|Benzofurans|Bradycardia-Causing Agents|Cardiac Therapy|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Inhibitors|QTc Prolonging Agents
DB04856	Dexloxiglumide	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates
DB04857	Brasofensine	small molecule	investigational	Amines|Hydroxylamines
DB04858	Tirapazamine	small molecule	investigational	Antineoplastic Agents|Radiation-Sensitizing Agents
DB04859	Zanapezil	small molecule	investigational	
DB04860	Isatoribine	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB04861	Nebivolol	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Benzopyrans|Beta Blocking Agents and Thiazides|Beta Blocking Agents, Selective|Beta Blocking Agents, Selective, and Thiazides|Beta-Blockers (Beta1 Selective)|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethanolamines|Hypotensive Agents|Neurotransmitter Agents|Pyrans|Vasodilating Agents
DB04862	Merimepodib	small molecule	investigational	Acids, Acyclic|Benzene Derivatives|IMP Dehydrogenase, antagonists & inhibitors|Urea
DB04863	Lefradafiban	small molecule	investigational	Antianginal Agents|Benzene Derivatives|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors|Vasodilating Agents
DB04864	Huperzine A	small molecule	approved|experimental	Central Nervous System Agents|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Terpenes
DB04865	Omacetaxine mepesuccinate	small molecule	approved|investigational	Alkaloids|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antineoplastic and Immunomodulating Agents|Apoptosis|Benzazepines|Growth Inhibitors|Growth Substances|Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DB04866	Halofuginone	small molecule	investigational|vet_approved	Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Synthesis Inhibitors|Quinazolines
DB04867	Lintitript	small molecule	investigational	Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Indoles|Sulfur Compounds
DB04868	Nilotinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors
DB04869	Olcegepant	small molecule	investigational	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides|Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors
DB04870	Oleoyl-estrone	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Anti-Obesity Agents|Central Nervous System Agents|Drug Carriers|Estradiol Congeners|Estranes|Estrenes|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Lipids|Steroids
DB04871	Lorcaserin	small molecule	approved	Alimentary Tract and Metabolism|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Depressants|Centrally Acting Antiobesity Products|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 2c Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin 5-HT2C Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists
DB04872	Osanetant	small molecule	investigational	Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Psychotropic Drugs|Tranquilizing Agents
DB04873	Piboserod	small molecule	investigational	
DB04874	Picoplatin	small molecule	investigational	Organometallic Compounds
DB04875	Pralnacasan	small molecule	investigational	
DB04876	Vildagliptin	small molecule	approved|investigational	Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cycloparaffins|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Glucagon-Like Peptide 1|Oral Hypoglycemics|Protease Inhibitors
DB04877	Voacamine	small molecule	experimental	Alkaloids|Indole Alkaloids|Indoles|P-glycoprotein/ABCB1 Inhibitors|Secologanin Tryptamine Alkaloids
DB04878	Voglibose	small molecule	investigational	Alcohols|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Carbohydrates|Cyclohexanes|Cycloparaffins|Drugs Used in Diabetes|Enzyme Inhibitors|Fatty Alcohols|Glycoside Hydrolase Inhibitors|Hexanols|Lipids|Oral Hypoglycemics|Sugar Alcohols
DB04879	Vatalanib	small molecule	investigational	Enzyme Inhibitors|Protein Kinase Inhibitors|Pyridazines|Tyrosine Kinase Inhibitors
DB04880	Enoximone	small molecule	approved|investigational	Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Imidazoles|Phosphodiesterase 3 Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Vasodilating Agents
DB04881	Elacridar	small molecule	investigational	BCRP/ABCG2 Inhibitors|Benzocycloheptenes|Drug Resistance, Multiple|Isoquinolines|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB04882	Edotecarin	small molecule	investigational	Indoles
DB04883	Darusentan	small molecule	investigational	Acids, Carbocyclic|Endothelin Receptor Antagonists
DB04884	Dapoxetine	small molecule	investigational	Amines|Benzene Derivatives|Benzyl Compounds|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hypoglycemia-Associated Agents|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Urologicals
DB04885	Cilansetron	small molecule	investigational	Alimentary Tract and Metabolism|Central Nervous System Depressants|Drugs for Functional Gastrointestinal Disorders|Indoles|Serotonin Agents|Serotonin Receptor Antagonists
DB04886	Calanolide A	small molecule	investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Benzopyrans|Calophyllum|Coumarins|Plant Extracts|Pyrans
DB04887	Brecanavir	small molecule	investigational	Acids, Acyclic|Dioxoles
DB04888	Bifeprunox	small molecule	investigational	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Neurotoxic agents
DB04889	Bicifadine	small molecule	investigational	Analgesics
DB04890	Bepotastine	small molecule	approved	Anti-Allergic Agents|Histamine Antagonists|Histamine H1 Antagonists|Mast Cell Stabilizers
DB04891	Becocalcidiol	small molecule	investigational	Cholestanes|Cholestenes|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB04892	Phenserine	small molecule	investigational	Acids, Acyclic|Alkaloids|Carbamates|Cholinesterase Inhibitors|Indole Alkaloids|Indoles|Phenylcarbamates|Stereoisomerism
DB04893	AZD3409	small molecule	investigational	
DB04894	Vapreotide	small molecule	experimental|investigational	Amino Acids, Peptides, and Proteins|Analgesics|Antineoplastic Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Peripheral Nervous System Agents|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Proteins|Sensory System Agents|Somatostatin and Analogues|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB04895	Pegaptanib	biotech	approved|investigational	Antineovascularisation Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Ocular Vascular Disorder Agents|Oligonucleotides|Ophthalmologicals|Pegylated agents|Polynucleotides|Sensory Organs|Vascular Endothelial Growth Factor A
DB04896	Milnacipran	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cycloparaffins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators
DB04897	Lucinactant	biotech	approved|investigational	Alcohols|Amino Acids, Peptides, and Proteins|Bradycardia-Causing Agents|Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Pharmaceutical Preparations|Phosphatidic Acids|Phospholipids|Pulmonary Surfactants|Sugar Phosphates
DB04898	Ximelagatran	small molecule	approved|investigational|withdrawn	Amines|Anticoagulants|Antithrombins|Azetines|Benzene Derivatives|Benzyl Compounds|Blood and Blood Forming Organs|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Proteinase Inhibitors
DB04899	Nesiritide	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Cardiac Therapy|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypotensive Agents|Natriuretic Agents|Natriuretic Peptides|Nerve Tissue Proteins|Peptide Hormones|Peptides|Proteins|Vasodilators Used in Cardiac Diseases
DB04900	Thymalfasin	biotech	investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Peptide Hormones|Peptides|Proteins|Thymus Hormones
DB04901	Galiximab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB04903	Pagoclone	small molecule	investigational	Central Nervous System Depressants|GABA Agents|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Receptors, GABA-A
DB04904	Amolimogene	biotech	investigational	Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides
DB04905	Tesmilifene	small molecule	investigational	Antiplatelet agents|Benzene Derivatives|Carbohydrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Ethers|Glycerophosphates|Glycerophospholipids|Hematologic Agents|Histamine Agents|Lipids|Membrane Lipids|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|Phenols|Phosphatidic Acids|Phospholipids|Sugar Phosphates
DB04907	EG009	biotech	investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzymes|Enzymes and Coenzymes|Genetic Therapy|Phosphotransferases|Phosphotransferases (Alcohol Group Acceptor)|Transferases
DB04908	Flibanserin	small molecule	approved|investigational	Agents that produce hypertension|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Miscellaneous Central Nervous System Agents|P-glycoprotein/ABCB1 Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists
DB04909	Sitamaquine	small molecule	investigational	Quinolines
DB04910	Oxibendazole	small molecule	investigational|vet_approved	Anthelmintics|Anti-Infective Agents|Antiparasitic Agents
DB04911	Oritavancin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2D6 Inducers (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 2D6 Inducers|Cytochrome P450 3A4 Inducers|Glycoconjugates|Glycopeptide Antibacterials|Lipoglycopeptide Antibacterial|Lipoglycopeptides|Peptides
DB04912	Stannsoporfin	small molecule	investigational	Biological Factors|Enzyme Inhibitors|Heme Oxygenase (Decyclizing), antagonists & inhibitors|Pigments, Biological|Porphyrins
DB04914	G17DT	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Products|Complex Mixtures|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunization|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Proteins|Vaccines
DB04915	Idronoxil	small molecule	investigational	Benzopyrans|Chromones|Flavonoids|Pyrans
DB04917	Renzapride	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT4 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists
DB04918	Ceftobiprole	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB04919	Alfimeprase	biotech	investigational	Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Metalloproteases|Peptide Hydrolases
DB04920	Clevidipine	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channel Blockers (Dihydropyridine)|Cardiovascular Agents|Cholinesterase substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB04921	Dirucotide	biotech	investigational	Amino Acids, Peptides, and Proteins|Membrane Proteins|Myelin Proteins|Nerve Tissue Proteins|Peptides|Proteins
DB04924	Itopride	small molecule	investigational	Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Benzene Derivatives|Benzoates|Drugs for Functional Gastrointestinal Disorders|Propulsives
DB04925	Desmoteplase	biotech	investigational	Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Peptide Hydrolases|Proteins|Recombinant Proteins|Serine Endopeptidases|Serine Proteases
DB04926	Neramexane	small molecule	investigational	Cycloparaffins
DB04927	NM100060	small molecule	investigational	
DB04928	XP12B	small molecule	investigational	
DB04929	DG031	small molecule	investigational	
DB04930	Permethrin	small molecule	approved|investigational	Agrochemicals|Antiparasitic Products, Insecticides and Repellents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Enzyme Inhibitors|Insecticides|Monoterpenes|Pesticides|Pyrethrines, Incl. Synthetic Compounds|Pyrethrins|Scabicides and Pediculicides|Terpenes|Toxic Actions
DB04931	Afamelanotide	small molecule	experimental|investigational	Amino Acids, Peptides, and Proteins|Dermatologicals|Emollients and Protectives|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Melanocortins|Melanocyte-Stimulating Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Systemic Use|Protein Precursors|Proteins
DB04932	Defibrotide	biotech	approved|investigational	Anticoagulants|Antiplatelet agents|Aptamers, Nucleotide|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosides|Hematologic Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB04933	Eritoran	small molecule	investigational	Antigens|Antigens, Bacterial|Bacterial Toxins|Biological Factors|Carbohydrates|Endotoxins|Glycoconjugates|Lipids|Lipopolysaccharides|Lipopolysaccharides, antagonists & inhibitors|Oligosaccharides|Polysaccharides|Polysaccharides, Bacterial|Toll-Like Receptor 4, antagonists & inhibitors|Toxins, Biological
DB04934	Rifalazil	small molecule	investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antituberculosis Agents|Lactams|Lactams, Macrocyclic|Leprostatic Agents
DB04936	Tagatose	small molecule	investigational	Carbohydrates|Chelating Agents|Iron Chelating Agents|Monosaccharides|Sequestering Agents
DB04938	Ospemifene	small molecule	approved|investigational	Benzene Derivatives|Benzylidene Compounds|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Estrogen Agonist/Antagonist|Genito Urinary System and Sex Hormones|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|Stilbenes
DB04941	Crofelemer	small molecule	approved	Antidiarrheals|Benzopyrans|Biomedical and Dental Materials|Biopolymers|Chromans|Chromones|Flavonoids|Macromolecular Substances|Polymers|Pyrans|Tannins
DB04942	Tamibarotene	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives|Naphthalenes
DB04943	LX201	small molecule	investigational	
DB04944	Acadesine	small molecule	investigational	Carbohydrates|Cardiac Therapy|Glycosides|Imidazoles|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides
DB04946	Iloperidone	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Psycholeptics|QTc Prolonging Agents|Schizophrenia|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB04947	Altropane	small molecule	investigational	Alkaloids|Aza Compounds|Azabicyclo Compounds|Iodine Radioisotopes|Tropanes
DB04948	Lofexidine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antihypertensive Agents|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Drugs Used in Addictive Disorders|Drugs Used in Opioid Dependence|Hypotensive Agents|Imidazoles|Imidazolines|MATE 1 Inhibitors|MATE inhibitors|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB04949	Pexelizumab	biotech	investigational	Amino Acid Sequence|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Biochemical Phenomena|Blood Proteins|Globulins|Immunoglobulin Fab Fragments|Immunoglobulin Fragments|Immunoglobulin Variable Region|Immunoglobulins|Immunoproteins|Information Science|Information Services|Molecular Sequence Data|Molecular Structure|Peptide Fragments|Peptides|Physicochemical Phenomena|Proteins|Serum Globulins
DB04950	Ranpirnase	biotech	investigational	Antineoplastic Agents|Egg Proteins|Enzyme Inhibitors|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Protein Synthesis Inhibitors|Rana pipiens
DB04951	Pirfenidone	small molecule	approved|investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antifibrotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Peripheral Nervous System Agents|Pyridines|Pyridones|Sensory System Agents
DB04952	Ramoplanin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Peptides|Peptides, Cyclic
DB04953	Ezogabine	small molecule	approved|investigational	Acids, Acyclic|Amines|Aniline Compounds|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Diamines|Membrane Transport Modulators|Nervous System|Polyamines|Potassium Channel Opener|Potassium Channel Openers|Potential QTc-Prolonging Agents|QTc Prolonging Agents|UGT1A1 Substrates|UGT1A9 Substrates
DB04954	Tecadenoson	small molecule	investigational	Carbohydrates|Glycosides|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists|Purines|Ribonucleosides
DB04955	Pumactant	small molecule	investigational	
DB04956	Afelimomab	biotech	investigational	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Proteins|Serum Globulins|Tumor Necrosis Factor Alpha (TNF-Î±) Inhibitors
DB04957	Azimilide	small molecule	investigational	Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiovascular Agents|Imidazoles|Imidazolidines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB04958	Epratuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB04959	HspE7	biotech	investigational	
DB04960	Tipifarnib	small molecule	investigational	Antineoplastic Agents|P-glycoprotein/ABCB1 Inhibitors|Quinolines
DB04961	Troxacitabine	small molecule	investigational	Anti-HIV Agents|Anti-Infective Agents|Antineoplastic Agents|Dioxoles|Pyrimidines|Pyrimidinones
DB04962	Bectumomab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB04963	rhGAD65	biotech	investigational	
DB04964	Oregovomab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|CA-125 Antigen|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB04967	Lucanthone	small molecule	investigational	Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Schistosomicides|Sulfur Compounds|Thioxanthenes|Xanthenes|Xanthones
DB04968	PH94B	small molecule	investigational	
DB04969	NV1020	biotech	investigational	
DB04970	Lesopitron	small molecule	investigational	
DB04971	Reglixane	small molecule	investigational	
DB04972	Canfosfamide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Cytotoxins|Oligopeptides|Peptides
DB04973	LErafAON	biotech	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides
DB04974	AP1903	small molecule	investigational	Cross-Linking Reagents
DB04975	Banoxantrone	small molecule	investigational	Anthracenes|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Quinones
DB04976	M40403	biotech	investigational	Elements|Metals|Metals, Heavy|Transition Elements
DB04977	Plitidepsin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic
DB04978	SP1049C	small molecule	investigational	Alcohols|Anthracyclines|Biomedical and Dental Materials|Carbohydrates|Daunorubicin|Ethylene Glycols|Glycols|Glycosides|Macromolecular Substances|Naphthacenes|Polyethylene Glycols|Polymers
DB04979	AVR118	biotech	investigational	
DB04980	Lemuteporfin	small molecule	investigational	Alcohols|Biological Factors|Glycols|Pigments, Biological
DB04981	CG7870	biotech	investigational	
DB04982	Talampanel	small molecule	investigational	Benzazepines|Receptors, AMPA, antagonists & inhibitors
DB04983	Denufosol	small molecule	investigational	Carbohydrates|Cytosine Nucleotides|Deoxyribonucleotides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides
DB04985	Tigapotide	biotech	investigational	Amino Acids, Peptides, and Proteins|Peptides|Proteins|Seminal Plasma Proteins
DB04986	ZYC300	biotech	investigational	
DB04987	P113D	biotech	investigational	
DB04988	IGN311	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB04989	Ty800	biotech	investigational	
DB04991	XL784	small molecule	investigational	
DB04992	AP5346	small molecule	investigational	Organometallic Compounds
DB04995	AT1022	small molecule	investigational	
DB04996	Satraplatin	small molecule	investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Organometallic Compounds|Platinum Compounds
DB04997	ATL1102	small molecule	investigational	
DB04998	AGRO100	small molecule	investigational	Aptamers, Nucleotide|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides
DB04999	MBO7133	small molecule	investigational	
DB05000	AeroLEF	biotech	investigational	
DB05001	PSN9301	small molecule	investigational	
DB05003	Imexon	small molecule	investigational	Ketones
DB05004	Peptide YY (3-36)	small molecule	investigational	Amino Acids, Peptides, and Proteins|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides
DB05005	CCX282	small molecule	investigational	
DB05006	Adecatumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antigens|Antigens, Surface|Biological Factors|Blood Proteins|Carbohydrates|Globulins|Glycoconjugates|Glycoproteins|Immunoglobulins|Immunoproteins|Membrane Glycoproteins|Membrane Proteins|Proteins|Serum Globulins
DB05009	Apadenoson	small molecule	investigational	Acids, Carbocyclic|Adenosine A2 Receptor Agonists|Carbohydrates|Cyclohexanes|Cycloparaffins|Glycosides|Hydrocarbons, Acyclic|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines
DB05010	SGS-742	small molecule	investigational	Central Nervous System Agents|GABA Agents|GABA Antagonists|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents
DB05011	EG004	small molecule	investigational	
DB05012	XEN2174	small molecule	investigational	Amino Acids, Peptides, and Proteins
DB05013	Ingenol Mebutate	small molecule	approved	Cell Death Inducer|Dermatologicals|Increased Cellular Death|Misc. Skin and Mucous Membrane Agents|Terpenes
DB05014	XL999	small molecule	investigational	
DB05015	Belinostat	small molecule	approved|investigational	Amides|Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein/ABCB1 Substrates|Sulfones|Sulfur Compounds|UGT1A1 Substrates
DB05016	Ataluren	small molecule	approved|investigational	Musculo-Skeletal System|OAT3/SLC22A8 Inhibitors|OATP1B3 inhibitors|Oxazoles
DB05017	YSIL6	small molecule	investigational	
DB05018	Migalastat	small molecule	approved|investigational	Alkaloids|Carbohydrates|Imines|Imino Pyranoses|Imino Sugars|Monosaccharides|Other Miscellaneous Therapeutic Agents|Piperidines|UGT1A1 Substrates
DB05019	LC16M8	biotech	investigational	
DB05020	ANA380	small molecule	investigational	
DB05021	EMZ702	small molecule	investigational	
DB05022	Amonafide	small molecule	investigational	Anti-Infective Agents|Antineoplastic Agents|Enzyme Inhibitors|Imides|Indicators and Reagents|Intercalating Agents|Isoquinolines|Laboratory Chemicals|Naphthalenes|Piperidines|Piperidones
DB05023	ATL1101	small molecule	investigational	
DB05024	CTA018	small molecule	investigational	
DB05025	Arimoclomol	small molecule	investigational	Amines
DB05027	DG041	small molecule	investigational	
DB05029	Lancovutide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Bacterial Proteins|Membrane Proteins|Peptides|Pore Forming Cytotoxic Proteins|Proteins
DB05032	REV131	small molecule	investigational	Amino Acids, Peptides, and Proteins|Proteins
DB05033	INCB7839	small molecule	investigational	
DB05034	Ularitide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Diuretics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Natriuretic Peptides|Peptide Hormones|Peptides|Peripheral Nervous System Agents|Respiratory System Agents
DB05035	Eprotirome	small molecule	investigational	Amides
DB05036	Grn163l	small molecule	investigational	
DB05037	AT7519	small molecule	investigational	Cyclin-Dependent Kinases, antagonists & inhibitors
DB05038	Anatibant	small molecule	investigational	Bradykinin Receptor Antagonists
DB05039	Indacaterol	small molecule	approved	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Indenes|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Selective Beta 2-adrenergic Agonists|UGT1A1 Substrates
DB05040	MVA3000	biotech	investigational	
DB05041	RP101	small molecule	investigational	
DB05042	SGS518	small molecule	investigational	
DB05043	GSK159797	small molecule	investigational	
DB05044	PSN357	small molecule	investigational	
DB05045	Obinepitide	small molecule	investigational	
DB05046	V1003	small molecule	investigational	
DB05047	CX717	small molecule	illicit|investigational	
DB05048	Cannabinor	small molecule	investigational	Terpenes
DB05049	DDP733	small molecule	investigational	
DB05050	ADL5859	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyrans|Receptors, Opioid, delta
DB05051	BZL101	small molecule	investigational	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Preparations|Scutellaria
DB05052	MF101	small molecule	investigational	
DB05053	MB-07803	small molecule	investigational	
DB05054	AN0128	small molecule	investigational	Boron Compounds
DB05055	RG2417	small molecule	investigational	
DB05056	EGS21	small molecule	investigational	
DB05057	Erdosteine	small molecule	investigational	Acetates|Acids, Acyclic|Cough and Cold Preparations|Expectorants|Fatty Acids|Fatty Acids, Volatile|Lipids|Respiratory System Agents|Sulfhydryl Compounds|Sulfur Compounds
DB05059	ILY101	small molecule	investigational	
DB05060	R1626	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides
DB05061	GFT14	small molecule	investigational	
DB05063	Mitoquinone	small molecule	investigational	Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones
DB05064	INCB13739	small molecule	investigational	11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors|Amides|Sulfones|Sulfur Compounds
DB05068	ATG002	small molecule	investigational	
DB05069	ATG003	small molecule	investigational	
DB05070	ADX10059	small molecule	investigational	
DB05071	ACE393	small molecule	investigational	
DB05072	AV608	small molecule	investigational	
DB05073	SRT501	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticarcinogenic Agents|Antimutagenic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antioxidants|Benzene Derivatives|Benzylidene Compounds|Central Nervous System Agents|Enzyme Inhibitors|Hematologic Agents|Peripheral Nervous System Agents|Phenols|Protective Agents|Ribonucleotide Reductases, antagonists & inhibitors|Sensory System Agents|Vasodilating Agents
DB05075	TG-100801	small molecule	investigational	Benzene Derivatives
DB05076	Fenretinide	small molecule	investigational	Alkenes|Anticarcinogenic Agents|Antineoplastic Agents|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Protective Agents|Retinoids|Terpenes
DB05077	SLV319	small molecule	investigational	Agents producing tachycardia|Amides|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Receptor, Cannabinoid, CB1, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB05078	AER001	small molecule	investigational	
DB05079	HY10275	small molecule	investigational	
DB05080	OBE101	small molecule	investigational	
DB05081	JB991	small molecule	investigational	
DB05082	ARX201	small molecule	investigational	
DB05084	Abaloparatide	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Analogs/Derivatives|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Intercellular Signaling Peptides and Proteins|Parathyroid Hormone-Related Protein|Parathyroid Hormones and Analogues|Peptide Hormones|Peptides|Proteins|Thyroid Products
DB05085	TM30339	small molecule	investigational	
DB05087	Ganaxolone	small molecule	investigational	Pregnanes|Steroids
DB05088	Tiomolibdate ion	small molecule	investigational	Adenosine Triphosphatases, antagonists & inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Chelating Agents|Elements|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Metals|Metals, Heavy|Sequestering Agents|Transition Elements
DB05089	VPM4001	biotech	investigational	
DB05090	FP0011	small molecule	investigational	
DB05091	M0002	small molecule	investigational	
DB05092	CDP323	small molecule	investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Integrin alpha4
DB05093	AX200	small molecule	investigational	
DB05095	Cimicoxib	small molecule	investigational	Agents causing hyperkalemia|Agents that produce hypertension|Amides|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sulfones|Sulfur Compounds
DB05096	LY2140023	small molecule	investigational	Amino Acids, Peptides, and Proteins
DB05097	Labetuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05098	Leptin	small molecule	investigational	Adipokines|Amino Acids, Peptides, and Proteins|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Intercellular Signaling Peptides and Proteins|Peptide Hormones|Peptides|Proteins
DB05099	Ancrod	biotech	approved|investigational	Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Bodily Secretions|Cardiovascular Agents|Complex Mixtures|Crotalid Venoms|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Fluids and Secretions|Hematologic Agents|Hydrolases|Peptide Hydrolases|Serine Endopeptidases|Serine Proteases|Snake Venoms|Toxins, Biological|Venombin A|Venoms|Viper Venoms
DB05100	Prinomastat	small molecule	investigational	Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors
DB05101	Matuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05102	Rupintrivir	small molecule	investigational	Pyrrolidines
DB05103	AN-9	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05104	Asimadoline	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05105	Pleconaril	small molecule	investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Common Cold, drug therapy|Direct Acting Antivirals|Oxazoles
DB05106	IR208	biotech	investigational	
DB05107	16-Bromoepiandrosterone	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstanols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB05108	EHT899	small molecule	investigational	
DB05109	Trabectedin	small molecule	approved|investigational	Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Immunosuppressive Agents|Isoquinolines|Myelosuppressive Agents|Noxae|Toxic Actions
DB05110	VIR201	biotech	investigational	
DB05111	Fontolizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05112	AP5280	small molecule	investigational	Acids, Acyclic|Acrylates|Amides|Drug Delivery Systems|Organometallic Compounds
DB05113	105AD7	small molecule	investigational	
DB05114	EHC18	small molecule	investigational	
DB05115	NN344	small molecule	investigational	Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Insulin|Pancreatic Hormones|Peptide Hormones|Peptides|Proinsulin|Protein Precursors|Proteins
DB05116	Thymectacin	small molecule	investigational	Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Nucleotides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB05117	IGN301	biotech	investigational	
DB05118	R1204	small molecule	investigational	
DB05119	Rilapladib	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Quinolines
DB05120	AT1391	small molecule	investigational	
DB05121	1D09C3	biotech	investigational	
DB05122	R1295	small molecule	investigational	
DB05123	Gemcabene	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05124	ARC183	small molecule	investigational	
DB05125	SC12267	small molecule	investigational	
DB05126	PYM50018	small molecule	investigational	
DB05127	ANA971	small molecule	investigational	
DB05128	Aminocandin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Echinocandin Antifungal|Lipids|Peptides
DB05129	Elsamitrucin	small molecule	investigational	Antibiotics, Antineoplastic|Antineoplastic Agents|Carbohydrates|Glycosides
DB05130	INCB3284	small molecule	investigational	Acids, Carbocyclic|Amides|Amino Acids|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Benzoates
DB05131	TTP889	small molecule	investigational	
DB05132	ND1251	small molecule	investigational	
DB05133	VP025	small molecule	investigational	
DB05134	Tanespimycin	small molecule	investigational	Amides|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Lactams|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Quinones
DB05135	Vibriolysin	small molecule	investigational	
DB05136	Bavituximab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05137	Lobeline	small molecule	investigational	Alkaloids|Autonomic Agents|Cholinergic Agents|Cholinergic Agonists|Ganglionic Stimulants|Neurotransmitter Agents|Nicotinic Agonists|Peripheral Nervous System Agents|Piperidines|Respiratory System Agents
DB05138	AdPEDF	biotech	investigational	
DB05139	CR002	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05140	RAV12	biotech	investigational	
DB05141	LY2181308	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB05142	ND7001	small molecule	investigational	
DB05143	OXI-4503	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Benzene Derivatives|Benzylidene Compounds|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates
DB05144	PEV3A	small molecule	investigational	
DB05145	TH0318	small molecule	investigational	
DB05146	XL820	small molecule	investigational	
DB05147	CYT997	small molecule	investigational	
DB05148	CG0070	small molecule	investigational	
DB05149	XL844	small molecule	investigational	
DB05150	CAD106	small molecule	investigational	
DB05151	TST10088	small molecule	investigational	
DB05152	NGX267	small molecule	investigational	Muscarinic Agonists|Sulfur Compounds
DB05154	Pretomanid	small molecule	approved|investigational	Antituberculosis Agents|Imidazoles|Nitro Compounds
DB05155	CR665	small molecule	investigational	Amino Acids, Peptides, and Proteins|Nerve Tissue Proteins|Neuropeptides|Peptides|Proteins
DB05156	SL017	small molecule	investigational	
DB05157	KC706	small molecule	investigational	
DB05158	PM02734	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic
DB05159	CCX915	small molecule	investigational	
DB05160	Topsalysin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Membrane Proteins|Proteins|Toxins, Biological
DB05161	Elafin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Peptides|Protease Inhibitors|Proteinase Inhibitory Proteins, Secretory|Proteins
DB05163	PV903	small molecule	investigational	
DB05164	CMLVAX100	biotech	investigational	
DB05165	LY2275796	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB05166	APD668	small molecule	investigational	
DB05167	PDPSC18	biotech	investigational	
DB05168	Vintafolide	small molecule	investigational	Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Indole Alkaloids|Indoles|Pigments, Biological|Pteridines|Pterins|Secologanin Tryptamine Alkaloids|Vinca Alkaloids
DB05169	AT9283	small molecule	investigational	Protein Kinase Inhibitors
DB05170	Benzimate	small molecule	investigational	
DB05171	E-2012	small molecule	investigational	Amyloid Precursor Protein Secretases
DB05172	AT3022	small molecule	investigational	
DB05173	PTC299	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Central Nervous System Agents|Enzyme Inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds
DB05174	CX501	small molecule	investigational	
DB05177	DG051	small molecule	investigational	
DB05178	DLO6001	small molecule	investigational	
DB05179	DLO6002	small molecule	investigational	
DB05180	LX6171	small molecule	investigational	
DB05181	BTA798	small molecule	investigational	
DB05182	AS1409	small molecule	investigational	
DB05183	MLN0415	small molecule	investigational	
DB05184	XL228	small molecule	investigational	
DB05185	TRO19622	small molecule	investigational	Cholestanes|Cholestenes|Steroids
DB05186	SQ-109	small molecule	investigational	Amines|Cycloparaffins|Diamines|Polyamines
DB05187	Elafibranor	small molecule	investigational	Acids, Acyclic|Benzopyrans|Chromones|Fatty Acids|Fatty Acids, Volatile|Flavonoids|Ketones|Lipids|PPAR alpha, agonists|PPAR delta, agonists|Propiophenones|Pyrans
DB05188	KD3010	small molecule	investigational	Amides|PPAR delta, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB05189	EPC2407	small molecule	investigational	Pyrans
DB05190	XL281	small molecule	investigational	
DB05191	Atl146e	small molecule	investigational	Acids, Carbocyclic|Adenosine A2 Receptor Agonists|Cyclohexanes|Cycloparaffins
DB05192	MB07811	small molecule	investigational	Organophosphorus Compounds
DB05194	KB002	small molecule	investigational	
DB05195	ADC4022	small molecule	investigational	
DB05196	ACR325	small molecule	investigational	
DB05197	Sofalcone	small molecule	investigational	Anti-Ulcer Agents|Benzopyrans|Chromones|Flavonoids|Gastrointestinal Agents|Ketones|Propiophenones|Pyrans
DB05198	CYC116	small molecule	investigational	Protein Kinase Inhibitors|Sulfur Compounds
DB05199	LX1031	small molecule	investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Tryptophan Hydroxylase, antagonists & inhibitors
DB05200	AT2220	small molecule	investigational	
DB05201	V24343	small molecule	investigational	
DB05202	Egaptivon pegol	biotech	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Pegylated agents|Polynucleotides
DB05203	SPP1148	small molecule	investigational	
DB05204	XL418	small molecule	investigational	
DB05205	CX157	small molecule	investigational	
DB05207	SD118	small molecule	investigational	
DB05209	SYM001	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulin Isotypes|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05210	SF1126	small molecule	investigational	Amino Acids, Peptides, and Proteins|Benzopyrans|Peptides|Pyrans
DB05211	PS386113	small molecule	investigational	
DB05212	HE3286	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Androstenols|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids
DB05214	KD7040	small molecule	investigational	
DB05217	GMX1777	small molecule	investigational	Amidines
DB05218	PN0621	biotech	investigational	
DB05219	Crisaborole	small molecule	approved|investigational	Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors
DB05220	Alisertib	small molecule	investigational	Protein Kinase Inhibitors
DB05222	KB001	biotech	investigational	
DB05223	Pracinostat	small molecule	investigational	Antineoplastic Agents|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB05224	REP8839	small molecule	investigational	Amines|Polyamines|Sulfur Compounds
DB05225	AM103	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05226	BTA9881	small molecule	investigational	
DB05227	APD791	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Neurotransmitter Agents|Oxazines|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB05228	RDEA806	small molecule	investigational	
DB05229	Beraprost	small molecule	investigational	Anticoagulants|Antiplatelet agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Cardiovascular Agents|Cryoprotective Agents|Cytochrome P-450 CYP2C8 Substrates|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Hematologic Agents|Inflammation Mediators|Lipids|Platelet Aggregation Inhibitors Excl. Heparin|Prostaglandins|Prostaglandins I|Vasodilating Agents
DB05230	AC3056	small molecule	investigational	
DB05232	Tetrodotoxin	small molecule	investigational	Anesthetics|Anesthetics, Local|Biological Factors|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Marine Toxins|Membrane Transport Modulators|Noxae|Peripheral Nervous System Agents|Poisons|Quinazolines|Sensory System Agents|Sodium Channel Blockers|Toxic Actions|Toxins, Biological
DB05233	AP1081	small molecule	investigational	
DB05234	LGD2941	small molecule	investigational	Quinolines
DB05235	NRP409	small molecule	investigational	
DB05236	ReN001	biotech	investigational	
DB05237	rhMBL	biotech	investigational	
DB05239	Cobimetinib	small molecule	approved|investigational	Antineoplastic Agents|Azetines|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Kinase Inhibitor|Kinase Inhibitors|MAP Kinase Kinase 1, antagonists & inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates
DB05241	XL765	small molecule	investigational	Amides|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB05242	eiRNA	biotech	investigational	
DB05243	XL019	small molecule	investigational	
DB05244	G4544	small molecule	investigational	
DB05245	Silver sulfadiazine	small molecule	approved|vet_approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Miscellaneous Local Anti-infectives|Sulfadiazine|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB05246	Methsuximide	small molecule	approved	Agents causing hyperkalemia|Anti-epileptic Agent|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 Enzyme Inhibitors|Decreased Central Nervous System Disorganized Electrical Activity|Imides|Nervous System|Potential QTc-Prolonging Agents|Pyrrolidines|Pyrrolidinones|QTc Prolonging Agents|Succinimide Derivatives
DB05249	FavId	small molecule	investigational	
DB05252	Fenoxaprop-ethyl	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05253	Proellex	small molecule	investigational	Norpregnanes|Norsteroids|Steroids
DB05254	Fibrinolysin	biotech	investigational	Anticoagulants|Blood and Blood Forming Organs|Cardiovascular Agents|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Peptide Hydrolases|Serine Endopeptidases|Serine Proteases
DB05255	Ronacaleret	small molecule	investigational	Acids, Carbocyclic|Indenes
DB05257	Neocartilage	biotech	investigational	
DB05258	Natural alpha interferon	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antiviral Agents|Biological Factors|Cytokines|Immunologic Factors|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon Type I|Interferons|Myelosuppressive Agents|Peptides|Proteins
DB05259	Glatiramer	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|Membrane Proteins|Peptides|Proteins|T-Lymphocytes, Helper-Inducer, immunology|Vesicular Transport Proteins
DB05260	Gallium nitrate	small molecule	approved|investigational	Antineoplastic Agents|Bone Resorption Inhibition|Calcium Resorption Inhibitor|Elements|Immunosuppressive Agents|Metals|Metals, Heavy
DB05262	Oxypurinol	small molecule	investigational	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Enzyme Inhibitors|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Pyrazoles|Pyrimidines|Terpenes|Xanthine Oxidase Inhibitors
DB05263	Caprospinol	small molecule	investigational	Acids, Acyclic|Cholestanes|Fatty Acids|Fatty Acids, Volatile|Lipids|Steroids
DB05264	NPI 32101	small molecule	investigational	
DB05265	Ecabet	small molecule	investigational	Anti-Infective Agents|Anti-Ulcer Agents|Anticarcinogenic Agents|Antineoplastic Agents|Diterpenes|Enzyme Inhibitors|Gastrointestinal Agents|Pepsin A, antagonists & inhibitors|Phenanthrenes|Protease Inhibitors|Protective Agents|Terpenes
DB05266	Ibudilast	small molecule	investigational	Anti-Asthmatic Agents|Antiplatelet agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Hematologic Agents|Leukotriene Antagonists|Peripheral Nervous System Agents|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Respiratory System Agents|Vasodilating Agents
DB05268	iCo-007	small molecule	investigational	
DB05271	Rotigotine	small molecule	approved	Agents that produce hypertension|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dopamine Agents|Dopamine Agonists|Hypotensive Agents|Naphthalenes|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sulfur Compounds
DB05273	Samarium (153Sm) lexidronam	small molecule	approved|investigational	Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Pain Palliation (Bone Seeking Agents)|Peripheral Nervous System Agents|Radioactive Therapeutic Agent|Radioisotopes|Radiopharmaceutical Activity|Samarium|Sensory System Agents|Therapeutic Radiopharmaceuticals|Various Pain Palliation Radiopharmaceuticals
DB05276	Hepatitis B Immune Globulin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Blood Proteins|Globulins|Human Immunoglobulin|Immunization, Passive|Immunoglobulins|Immunoproteins|Passively Acquired Immunity|Proteins|Serum|Serum Globulins|Virus Neutralization|Virus-specific Hyperimmune Globulins
DB05281	S-8184	small molecule	investigational	
DB05282	MCC	small molecule	investigational	
DB05284	CA4P	small molecule	investigational	
DB05285	SB-249553	small molecule	investigational	
DB05288	Anecortave acetate	small molecule	investigational	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Angiogenesis Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnadienes|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB05289	Tarenflurbil	small molecule	investigational	Acids, Acyclic|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Benzene Derivatives|Biphenyl Compounds|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Peripheral Nervous System Agents|Propionates|Sensory System Agents
DB05290	SPP 301	small molecule	investigational	
DB05292	IDM-1	small molecule	investigational	
DB05293	IDM-2	small molecule	investigational	
DB05294	Vandetanib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protein Kinase Inhibitors|QTc Prolonging Agents|Tyrosine Kinase Inhibitors
DB05295	Eldecalcitol	small molecule	investigational	Cholestanes|Cholestenes|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB05296	Motexafin lutetium	small molecule	investigational	Biological Factors|Dermatologicals|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents
DB05297	Paclitaxel docosahexaenoic acid	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes
DB05298	Tetomilast	small molecule	investigational	Sulfur Compounds
DB05299	keyhole limpet hemocyanin	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antigens|Biological Factors|Blood Proteins|Haptens|Hemeproteins|Immunologic Factors|Metalloproteins|Mollusca|Pigments, Biological|Proteins
DB05300	PTI-801	small molecule	investigational	
DB05301	LAX-101	small molecule	investigational	
DB05303	OMS-103HP	small molecule	investigational	Acids, Carbocyclic|Benzocycloheptenes|Dibenzocycloheptenes|Imidazoles|Pharmaceutical Preparations|Phenylpropionates
DB05304	WX-G250	small molecule	investigational	
DB05305	Cintredekin Besudotox	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Immunotoxins|Intercellular Signaling Peptides and Proteins|Interleukins|Peptides|Proteins|Toxins, Biological
DB05306	Alferminogene Tadenovec	biotech	investigational	Antianginal Agents|Vasodilating Agents
DB05307	CHF-1512	small molecule	investigational	
DB05308	ANX-510	small molecule	investigational	
DB05309	TP-508	small molecule	investigational	
DB05310	FP-1096	small molecule	investigational	
DB05311	Ecallantide	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Drugs Used in Hereditary Angioedema|Kallikrein Inhibitors|Kallikreins, antagonists & inhibitors|Plasma Kallikrein Inhibitor
DB05312	NVS antibody	small molecule	investigational	
DB05313	MP4	small molecule	investigational	
DB05315	MC-1	small molecule	investigational	
DB05316	Pimavanserin	small molecule	approved|investigational	Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB05317	TAK-475	small molecule	investigational	Azepines|Farnesyl-Diphosphate Farnesyltransferase, antagonists & inhibitors
DB05319	Oportuzumab monatox	biotech	investigational	Amino Acids, Peptides, and Proteins|Proteins|Recombinant Proteins
DB05320	ATG-Fresenius S	small molecule	investigational	
DB05321	PEG-uricase	biotech	investigational	Alcohols|Biomedical and Dental Materials|Enzymes|Enzymes and Coenzymes|Enzymes, Immobilized|Ethylene Glycols|Glycols|Macromolecular Substances|Oxidoreductases|Pegylated agents|Polymers
DB05322	INGN 201	biotech	investigational	Biological Products|Complex Mixtures|Gene Transfer Techniques|Genes, p53
DB05325	INGN 225	biotech	investigational	Biological Products|Complex Mixtures|Vaccines
DB05326	INKP-102	small molecule	investigational	
DB05327	Ranirestat	small molecule	investigational	Aldehyde Reductase, antagonists & inhibitors|Stereoisomerism
DB05328	VGV-1	small molecule	investigational	
DB05329	MDX-1379	biotech	investigational	
DB05330	ALTU-135	biotech	investigational	Carboxylic Ester Hydrolases|Enzymes|Enzymes and Coenzymes|Esterases|Glycoside Hydrolases|Hydrolases
DB05332	Romiplostim	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematinics|Hematopoietic Cell Growth Factors|Hemostatics|Increased Megakaryocyte Maturation|Increased Platelet Production|Intercellular Signaling Peptides and Proteins|Membrane Proteins|Peptides|Proteins|Receptors, Cell Surface|Receptors, Immunologic|Receptors, Thrombopoietin, agonists|Recombinant Proteins|Thrombopoietin Receptor Agonist|Thrombopoietin Receptor Agonists
DB05333	TC-5231	small molecule	investigational	
DB05336	Obiltoxaximab	biotech	approved	Amino Acids, Peptides, and Proteins|Anthrax Protective Antigen-directed Antibody|Anthrax Protective Antigen-directed Antibody Interactions|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05337	SOT-107	biotech	investigational	
DB05339	MN-305	small molecule	investigational	
DB05340	ATL-2502	small molecule	investigational	
DB05343	Arundic acid	small molecule	investigational	Acids, Acyclic|Fatty Acids|Lipids
DB05344	Ciliary neurotrophic factor	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Nerve Growth Factors|Nerve Tissue Proteins|Peptides|Proteins
DB05345	SO-101	small molecule	investigational	
DB05346	WL-1002	small molecule	investigational	
DB05350	AP-1034	small molecule	investigational	
DB05351	Dexlansoprazole	small molecule	approved|investigational	2-Pyridinylmethylsulfinylbenzimidazoles|Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Benzimidazoles|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Enzyme Inhibitors|Gastric Acid Lowering Agents|Gastrointestinal Agents|Proton Pump Inhibitors|Proton-pump Inhibitors|Pyridines|Sulfoxides|Sulfur Compounds
DB05352	Fx-1006A	small molecule	investigational	
DB05353	CMC 001	small molecule	investigational	
DB05361	SR-123781A	small molecule	investigational	
DB05362	SSR-126517E	small molecule	investigational	
DB05363	LIC-477	small molecule	investigational	
DB05364	ROX-888	small molecule	investigational	
DB05367	Actelion-1	small molecule	investigational	Amides|Endothelin A Receptor Antagonists|Endothelin B Receptor Antagonists|Endothelin Receptor Antagonists|Sulfones|Sulfur Compounds
DB05368	Ragweed pollen extract	biotech	approved|investigational	
DB05369	HZT-501	small molecule	investigational	
DB05370	NOVA-22007	small molecule	investigational	
DB05371	ACR-16	small molecule	investigational	
DB05372	CP-945598	small molecule	investigational	Agents producing tachycardia|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Receptor, Cannabinoid, CB1, antagonists & inhibitors
DB05374	Rindopepimut	small molecule	investigational	Biological Products|Complex Mixtures|Vaccines
DB05377	Chlorfenson	small molecule	investigational	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB05380	DOTMP HO-166	small molecule	investigational	
DB05381	Histamine	small molecule	approved|investigational	Adjuvants, Immunologic|Amines|Antineoplastic and Immunomodulating Agents|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diagnostic Agents|Ethylamines|Gastric Function|Histamine Agents|Histamine Agonists|Imidazoles|Inflammation Mediators|Neurotransmitter Agents|OCT2 Inhibitors|OCT2 Substrates|Other Diagnostics|Tests for Gastric Secretion
DB05382	Iodine	small molecule	approved|investigational	Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Halogens|Herbs and Natural Products|Iodine Products|Micronutrients|Minerals|Miscellaneous Local Anti-infectives|Physiological Phenomena|Trace Elements
DB05383	Pimagedine	small molecule	investigational	Amidines|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors|OCT2 Inhibitors
DB05384	Carbopol 974P	small molecule	approved|investigational	Adrenal Cortex Hormones|Biomedical and Dental Materials|Contraceptive Agents, Female|Dental Materials|Hormonal Contraceptives for Systemic Use|Macromolecular Substances|Plastics|Polymers|Resins, Synthetic|Spermatocidal Agents
DB05385	PRO 2000	small molecule	investigational	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Biomedical and Dental Materials|Macromolecular Substances|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB05386	recombinant human GM-CSF	biotech	investigational	Cholinesterase Inhibitors
DB05387	AE-941	small molecule	investigational	Cartilage|Complex Mixtures
DB05389	Tetrachlorodecaoxide	small molecule	approved|investigational	Anions|Electrolytes|Elements|Gases|Halogens|Ions|Oxygen Compounds|Protective Agents|Radiation-Protective Agents
DB05390	INS 316	small molecule	investigational	
DB05391	liposomal prostaglandin E1	small molecule	investigational	
DB05393	NOV-002	small molecule	investigational	Amino Acids, Peptides, and Proteins|Chlorine Compounds|Glutathione|Nitrogen Compounds|Oligopeptides|Peptides|Pharmaceutical Preparations
DB05394	Corticorelin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|Tests for Pituitary Function
DB05395	Amibegron	small molecule	investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Naphthalenes|Neurotransmitter Agents
DB05396	Albinterferon Alfa-2B	biotech	investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Interferon Type I|Interferons|Peptides|Proteins
DB05398	C31G	small molecule	investigational	Amines|Ammonium Compounds|Fatty Acids|Lipids|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB05399	Succinobucol	small molecule	investigational	Benzene Derivatives|Phenols
DB05400	QS-21	biotech	investigational	Adjuvants, Immunologic|Carbohydrates|Glycosides|Immunologic Factors
DB05402	ME-609	small molecule	investigational	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Guanine|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pharmaceutical Preparations|Pregnanes|Pregnenediones|Pregnenes|Purines|Purinones|Steroids
DB05403	CEP-1347	small molecule	investigational	Indoles
DB05404	AZD 3355	small molecule	investigational	Acids|Acids, Noncarboxylic|Amines|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Gastrointestinal Agents|Neurotransmitter Agents|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds
DB05405	XTL-001	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05406	GTI-2501	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB05407	TBC-3711	small molecule	investigational	Endothelin A Receptor Antagonists|Endothelin Receptor Antagonists|Sulfur Compounds
DB05408	Emricasan	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates
DB05409	NCX 701	small molecule	investigational	Acetanilides|Acids|Acids, Noncarboxylic|Amides|Anilides|Anions|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds
DB05410	NCX 1022	small molecule	investigational	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB05411	VB2-011	biotech	investigational	
DB05412	Talmapimod	small molecule	investigational	
DB05413	Tifuvirtide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antigens|Antigens, Viral|Biological Factors|env Gene Products, Human Immunodeficiency Virus|Gene Products, env|HIV Antigens|Human Immunodeficiency Virus Proteins|Membrane Fusion Proteins|Membrane Proteins|Peptides|Polyproteins|Proteins|Retroviridae Proteins|Viral Envelope Proteins|Viral Fusion Proteins|Viral Proteins|Viral Structural Proteins
DB05414	Pipendoxifene	small molecule	investigational	
DB05415	OSI-461	small molecule	investigational	Indenes|Phosphodiesterase Inhibitors
DB05416	Cardarine	small molecule	investigational	Sulfur Compounds
DB05417	GW 468816	small molecule	investigational	Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors
DB05418	GW 597599	small molecule	investigational	
DB05419	ADX-10061	small molecule	investigational	
DB05420	Gallium maltolate	small molecule	investigational	Gallium|Pyrans
DB05421	CP-122721	small molecule	investigational	
DB05422	OPC-14523	small molecule	investigational	Quinolines
DB05423	ORG-34517	small molecule	investigational	Dioxoles|Receptors, Glucocorticoid, antagonists & inhibitors
DB05424	Canertinib	small molecule	investigational	Acids, Acyclic|Anesthetics|Antineoplastic Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Oxazines|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents|Tyrosine Kinase Inhibitors
DB05426	talactoferrin alpha	small molecule	investigational	
DB05427	IDD-3	biotech	investigational	
DB05428	motexafin gadolinium	small molecule	investigational	Antineoplastic Agents|Biological Factors|Contrast Media|Dermatologicals|Diagnostic Uses of Chemicals|Gadolinium|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents
DB05429	CAT-213	biotech	investigational	
DB05430	VLTS-589	small molecule	investigational	
DB05431	MLN-977	small molecule	investigational	
DB05432	DAS-431 IV	small molecule	investigational	
DB05433	rGLP-1	small molecule	investigational	
DB05434	ABT-510	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB05437	RIGScan CR49	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05438	IDM-4	biotech	investigational	
DB05439	IDD-1	biotech	investigational	
DB05440	SRP 299	small molecule	investigational	Biological Products|Complex Mixtures|Vaccines
DB05441	AVAC	biotech	investigational	
DB05442	Etiprednol dicloacetate	small molecule	investigational	Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists
DB05443	ADL 10-0101	small molecule	investigational	
DB05444	Iroxanadine	small molecule	investigational	
DB05445	TA-NIC	biotech	investigational	Biological Products|Complex Mixtures|Nicotine
DB05446	LJP 1082	small molecule	investigational	Alcohols|Amino Acids, Peptides, and Proteins|Biomedical and Dental Materials|Carbohydrates|Ethylene Glycols|Glycoconjugates|Glycols|Macromolecular Substances|Polymers|Proteins
DB05447	AVI-4557	small molecule	investigational	
DB05448	PX-12	small molecule	investigational	
DB05449	FM-VP4	small molecule	investigational	
DB05450	PYM50028	small molecule	investigational	Cholestanes|Drugs, Chinese Herbal|Sapogenins|Saponins|Steroids
DB05451	P54	small molecule	investigational	
DB05452	PH-284	small molecule	investigational	
DB05454	Paliroden	small molecule	investigational	
DB05455	SR 121463	small molecule	investigational	
DB05456	ETC-588	small molecule	investigational	Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Phosphates
DB05457	OSI-7904L	small molecule	investigational	Acids, Acyclic|Dicarboxylic Acids
DB05458	Pozanicline	small molecule	investigational	
DB05459	Briakinumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin Inhibitors|Proteins|Serum Globulins
DB05460	Ezatiostat	small molecule	investigational	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB05461	OPC-28326	small molecule	investigational	Amines
DB05462	Chlorotoxin I-131	small molecule	investigational	
DB05463	ISS-1018	small molecule	investigational	
DB05464	NOX-700	small molecule	investigational	Acids, Acyclic|Carbamates|Sulfur Compounds
DB05465	Tandutinib	small molecule	investigational	Potential QTc-Prolonging Agents|QTc Prolonging Agents|Tyrosine Kinase Inhibitors
DB05466	R673	small molecule	investigational	
DB05467	R667	small molecule	investigational	
DB05468	R411	small molecule	investigational	
DB05469	R450	small molecule	investigational	
DB05470	VX-702	small molecule	investigational	Benzene Derivatives|Urea
DB05471	SGN-30	biotech	investigational	
DB05472	omega interferon	small molecule	investigational	Immunosuppressive Agents|Myelosuppressive Agents
DB05473	QR-334	small molecule	investigational	
DB05474	T487	small molecule	investigational	
DB05475	Golotimod	small molecule	investigational	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB05476	WX-UK1	small molecule	investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB05477	MUC1 Dendritic Cell Vaccine	biotech	investigational	
DB05478	Pradefovir Mesylate	small molecule	investigational	Purines
DB05479	CZEN 002	small molecule	investigational	
DB05480	PBI-1402	small molecule	investigational	
DB05481	Recombinant alpha 1-antitrypsin	small molecule	investigational	
DB05482	7-ethyl-10-hydroxycamptothecin	small molecule	investigational	Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Prodrugs|Radiation-Sensitizing Agents|Topoisomerase I Inhibitors|Topoisomerase Inhibitors
DB05483	PCL-016	small molecule	investigational	
DB05484	MDX-018	small molecule	investigational	
DB05485	ADH-1	biotech	investigational	
DB05487	Custirsen	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides, Antisense|Pyrans|Sulfur Compounds
DB05488	Technetium Tc-99m ciprofloxacin	small molecule	investigational	Anti-Bacterial Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|Organometallic Compounds|QTc Prolonging Agents|Quinolines|Quinolones
DB05489	ACA 125	small molecule	investigational	
DB05490	T131	small molecule	investigational	Amides|PPAR gamma, agonists|Sulfones|Sulfur Compounds
DB05491	ATN-161	small molecule	investigational	
DB05492	Epicept NP-1	small molecule	investigational	
DB05493	NX-1207	small molecule	investigational	
DB05494	Elacytarabine	small molecule	investigational	Arabinonucleosides|Carbohydrates|Cytidine|Fatty Acids|Glycosides|Lipids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB05495	PG-530742	small molecule	investigational	
DB05496	Otelixizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05498	KW-7158	small molecule	investigational	Sulfur Compounds
DB05499	TAK-428	small molecule	investigational	
DB05500	AVN-944	biotech	investigational	Acids, Acyclic|Benzene Derivatives|IMP Dehydrogenase, antagonists & inhibitors|Urea
DB05501	AMD-070	small molecule	investigational	Receptors, CXCR4, antagonists & inhibitors
DB05502	AG-858	biotech	investigational	
DB05505	NM-702	small molecule	investigational	
DB05506	ISIS 113715	small molecule	investigational	
DB05507	VX-765	small molecule	investigational	Acids, Carbocyclic|Amino Acids, Peptides, and Proteins|Aminobenzoates|Benzene Derivatives|Benzoates|Oligopeptides|Peptides
DB05509	LI-301	small molecule	investigational	
DB05511	Piclidenoson	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB05512	MM-093	biotech	investigational	
DB05513	Atiprimod	small molecule	investigational	
DB05514	Cobiprostone	small molecule	investigational	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids
DB05516	PI-0824	biotech	investigational	
DB05518	Managlinat dialanetil	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Fructose-Bisphosphatase, antagonists & inhibitors|Organophosphorus Compounds
DB05519	Budiodarone	small molecule	investigational	Benzofurans
DB05520	Mimopezil	small molecule	investigational	
DB05521	Telaprevir	small molecule	approved|withdrawn	Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 2B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Protease Inhibitors
DB05524	Pelitinib	small molecule	investigational	Amines|Quinolines|Receptor, Epidermal Growth Factor, antagonists & inhibitors
DB05525	EW-A-401	biotech	investigational	
DB05528	Mipomersen	small molecule	approved|investigational	Anticholesteremic Agents|Antisense Elements (Genetics)|Apolipoprotein B-100 Synthesis Inhibitor|Carbohydrates|Decreased Protein Synthesis|Diagnostic Uses of Chemicals|DNA|DNA, Antisense|Glycosides|Hypolipidemic Agents|Laboratory Chemicals|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Molecular Probes|Noxae|Nucleic Acid Probes|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligodeoxyribonucleotides, Antisense|Oligonucleotides|Oligonucleotides, Antisense|Polynucleotides|Toxic Actions
DB05530	CPG 10101	biotech	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides
DB05532	BMS-488043	small molecule	investigational	HIV Fusion Inhibitors
DB05533	QR-333	small molecule	investigational	
DB05540	Alanosine	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Chelating Agents|Sequestering Agents
DB05541	Brivaracetam	small molecule	approved|investigational	Anticonvulsants|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Epoxide Hydrolase Inhibitors|Miscellaneous Anticonvulsants|Nervous System|Pyrrolidines
DB05542	Naronapride	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT4 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB05549	INO-1001	small molecule	investigational	Poly(ADP-ribose) Polymerases, antagonists & inhibitors
DB05550	Iratumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05552	TG100-115	small molecule	investigational	Benzene Derivatives|Phosphatidylinositol 3-Kinases, antagonists & inhibitors
DB05553	Regrelor	small molecule	investigational	Adenine Nucleotides|Carbohydrates|Glycosides|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purines|Ribonucleotides
DB05555	Enokizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05560	Delcasertib	small molecule	investigational	Amino Acids, Peptides, and Proteins|Protein Kinase C-delta, antagonists & inhibitors
DB05562	Naluzotan	small molecule	investigational	Agents that produce hypertension|Amides|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sulfones|Sulfur Compounds
DB05565	PBT-1033	small molecule	investigational	
DB05575	Motesanib	small molecule	investigational	Nicotinic Acids|Pyridines|Tyrosine Kinase Inhibitors
DB05578	Ramucirumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins|Vascular Endothelial Growth Factor Receptor 2 Antagonist|VEGFR2 Inhibitors
DB05580	TRU-015	small molecule	investigational	
DB05585	Verubulin	small molecule	investigational	
DB05586	Facinicline	small molecule	investigational	Pyrazoles
DB05590	Bedoradrine	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05592	Blarcamesine	small molecule	investigational	
DB05594	Cantuzumab ravtansine	biotech	investigational	
DB05595	Farletuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05596	PRX-03140	small molecule	investigational	
DB05599	Fibroblast growth factor-1	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Fibroblast Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB05606	Beclanorsen	small molecule	investigational	
DB05607	PRX-08066	small molecule	investigational	Central Nervous System Depressants|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds
DB05608	MKC-1	small molecule	investigational	Protein Kinase Inhibitors
DB05611	Apilimod	small molecule	investigational	Oxazines
DB05616	4'-Methylene-5,8,10-trideazaaminopterin	small molecule	investigational	Biological Factors|Pigments, Biological|Pteridines|Pterins
DB05620	AVI-4065	small molecule	investigational	
DB05624	Teverelix	small molecule	investigational	Amino Acids, Peptides, and Proteins|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptides
DB05625	CTCE-9908	small molecule	investigational	Amino Acids, Peptides, and Proteins
DB05626	Retaspimycin	small molecule	investigational	Amides|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Lactams|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Quinones
DB05630	Sodium stibogluconate	small molecule	approved|investigational	Acids, Acyclic|Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antimony Compounds|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Carbohydrates|Gluconates|Hydroxy Acids|Organometallic Compounds|Schistosomicides|Sugar Acids
DB05631	ALT-2074	small molecule	investigational	Selenium Compounds
DB05633	Glypromate	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB05638	Asvasiran	biotech	investigational	
DB05642	DDP-225	small molecule	investigational	
DB05644	KP-1461	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides
DB05645	Larazotide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB05649	NTx-265	biotech	investigational	
DB05650	OT-551	small molecule	investigational	
DB05652	VTP-201227	small molecule	investigational	
DB05653	IRX-5183	small molecule	investigational	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB05656	Veltuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05659	faropenem medoxomil	small molecule	investigational	Amides|Aza Compounds|Azabicyclo Compounds|Lactams|Sulfur Compounds
DB05660	D-JNKI-1	small molecule	investigational	Amino Acids, Peptides, and Proteins|Neuroprotective Agents
DB05662	NP-50301	small molecule	investigational	
DB05667	Levoketoconazole	small molecule	investigational	
DB05668	Palifosfamide	small molecule	investigational	Acids|Acids, Noncarboxylic|Alkylating Drugs|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Cyclophosphamide|Electrolytes|Hydrocarbons, Halogenated|Ions|Mustard Compounds|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Oxazines|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions
DB05670	ATL-104	biotech	investigational	
DB05671	AC-100	biotech	investigational	
DB05675	EP-2104R	biotech	investigational	Amino Acids, Peptides, and Proteins|Contrast Media|Elements|Lanthanoid Series Elements|Metals|Metals, Rare Earth
DB05676	Apremilast	small molecule	approved|investigational	Acids, Carbocyclic|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic and Immunomodulating Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Disease-modifying Antirheumatic Agents|Imides|Immunosuppressive Agents|Isoindoles|Peripheral Nervous System Agents|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Selective Immunosuppressants|Sensory System Agents
DB05678	SLx-4090	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB05679	Ustekinumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents|Blood Proteins|Dermatologicals|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin Inhibitors|Interleukin-12 Antagonist|Interleukin-12 Antagonists|Interleukin-23 Antagonist|Interleukin-23 Antagonists|Miscellaneous Therapeutic Agents|Proteins|Serum Globulins
DB05680	Sotirimod	small molecule	investigational	
DB05683	Iodofiltic acid I-123	small molecule	investigational	Benzene Derivatives|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodine Radioisotopes|Lipids
DB05685	FX06	biotech	investigational	
DB05686	Sivifene	small molecule	investigational	Benzene Derivatives|Hydrazines
DB05687	BL-1020	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Antipsychotic Agents|Butyrates|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Neurotoxic agents|Phenothiazines|Sulfur Compounds
DB05688	CRx-119	small molecule	investigational	
DB05695	NPS-2143	small molecule	investigational	
DB05705	ALS-08	small molecule	investigational	
DB05706	13-deoxydoxorubicin	small molecule	investigational	
DB05708	GTS-21	small molecule	investigational	Benzene Derivatives|Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Agonists
DB05710	Gantacurium Chloride	small molecule	investigational	Anticholinergic Agents|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Nicotinic Antagonists
DB05712	AZD-9684	small molecule	investigational	
DB05713	LY-517717	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins
DB05714	Flovagatran	small molecule	investigational	Acids|Acids, Noncarboxylic|Amino Acids, Peptides, and Proteins|Boron Compounds|Oligopeptides|Peptides
DB05718	Maxy-G34	biotech	investigational	Alcohols|Amino Acids, Peptides, and Proteins|Biological Factors|Biomedical and Dental Materials|Carbohydrates|Colony-Stimulating Factors|Cytokines|Ethylene Glycols|Glycoconjugates|Glycols|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Macromolecular Substances|Peptides|Polymers|Proteins|Recombinant Proteins
DB05719	Elesclomol	small molecule	investigational	Amides|Sulfur Compounds
DB05722	CGC-11047	small molecule	investigational	Amines
DB05723	ALKS 29	small molecule	investigational	
DB05724	alpha-Conotoxin VC 1.1	small molecule	investigational	Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Marine Toxins|Mollusk Venoms|Toxins, Biological|Venoms
DB05730	PMI-001	small molecule	investigational	
DB05732	Strontium malonate	small molecule	investigational	
DB05735	Cefilavancin	small molecule	investigational	Amides|Amino Acids, Peptides, and Proteins|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Carbohydrates|Glycoconjugates|Lactams|Peptides|Sulfur Compounds|Thiazines
DB05736	MIV-701	small molecule	investigational	
DB05737	Varespladib methyl	small molecule	investigational	Acids, Acyclic|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Phospholipase A2 Inhibitors
DB05738	Vapitadine	small molecule	investigational	
DB05739	CYT006-AngQb	biotech	investigational	Amino Acids, Peptides, and Proteins|Angiotensin II|Peptides
DB05740	RPI-78M	small molecule	investigational	
DB05741	AGS-005	small molecule	investigational	
DB05742	AGS-004	small molecule	investigational	
DB05744	CRx-139	small molecule	investigational	
DB05746	PF-03187207	small molecule	investigational	
DB05747	R-851	small molecule	investigational	
DB05749	MPI-674	small molecule	investigational	
DB05750	AVE-1625	small molecule	investigational	
DB05751	RP01	small molecule	investigational	
DB05752	ALKS 27	small molecule	investigational	
DB05753	VSF-173	small molecule	investigational	
DB05754	IPH 1101	small molecule	investigational	
DB05755	BF-37	small molecule	investigational	
DB05756	PAC-113	small molecule	investigational	
DB05757	DNB-001	small molecule	investigational	
DB05758	CYT007-TNFQb	biotech	investigational	
DB05765	ATX-201	small molecule	investigational	
DB05766	ACP-104	small molecule	investigational	
DB05767	Andrographolide	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antiparasitic Agents|Antiplatelet agents|Antiprotozoals|Biological Products|Central Nervous System Agents|Colitis, Ulcerative, drug therapy|Complex Mixtures|Hematologic Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Plant Preparations|Sensory System Agents|Stereoisomerism|Terpenes
DB05768	Alkaline Phosphatase	small molecule	investigational	Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Phosphoric Monoester Hydrolases
DB05769	LCP-AtorFen	small molecule	investigational	
DB05771	LLL-3348	small molecule	investigational	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Preparations
DB05772	Rabeximod	small molecule	investigational	
DB05773	Trastuzumab emtansine	biotech	approved|investigational	Amides|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Antibodies|Antibodies, Monoclonal|Antimitotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Globulins|HER2 Receptor Antagonist|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Lactams|Lactams, Macrocyclic|Lactones|Mitosis Modulators|Myelosuppressive Agents|P-glycoprotein/ABCB1 Substrates|Polyketides|Proteins|Serum Globulins|Tubulin Modulators
DB05775	CRx-401	small molecule	investigational	
DB05776	IC41	biotech	investigational	
DB05777	Thrombomodulin Alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Glycoproteins|Membrane Glycoproteins|Membrane Proteins|Platelet Membrane Glycoproteins|Proteins|Receptors, Cell Surface|Receptors, G-Protein-Coupled|Receptors, Immunologic|Receptors, Peptide|Receptors, Proteinase-Activated|Receptors, Thrombin
DB05778	Col-118	small molecule	investigational	
DB05779	Oglufanide	small molecule	investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Angiogenesis Modulating Agents|Antidotes|Antineoplastic Agents|Cardiovascular Agents|Growth Inhibitors|Growth Substances|Immunologic Factors|Oligopeptides|Peptides|Protective Agents
DB05780	ATX-101	small molecule	investigational	
DB05785	LGD-1550	small molecule	investigational	
DB05786	Irofulven	small molecule	investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Noxae|Radiation-Sensitizing Agents|Terpenes|Toxic Actions
DB05787	LM-609	biotech	investigational	
DB05789	MX6	small molecule	investigational	
DB05790	SR 140333	small molecule	investigational	Stereoisomerism
DB05791	Perflubron	small molecule	investigational	Anti-Obesity Agents|Central Nervous System Agents|Contrast Media|Diagnostic Uses of Chemicals|Emulsions|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Magnetic Resonance Imaging Contrast Media|Radiation-Sensitizing Agents
DB05792	Arylacenamide	small molecule	investigational	Cycloparaffins|Receptors, sigma
DB05793	PRO-542	biotech	investigational	Amino Acids, Peptides, and Proteins|Antigens|Antigens, Surface|Biological Factors|Blood Proteins|Carbohydrates|Cell Adhesion Molecules|Globulins|Glycoconjugates|Glycoproteins|HIV Fusion Inhibitors|Immunoglobulin Constant Regions|Immunoglobulin Fc Fragments|Immunoglobulin Fragments|Immunoglobulins|Immunoproteins|Membrane Glycoproteins|Membrane Proteins|Peptide Fragments|Peptides|Proteins|Recombinant Fusion Proteins|Recombinant Proteins|Serum Globulins
DB05794	Serelaxin	biotech	investigational	Cardiac Therapy|Vasodilators Used in Cardiac Diseases
DB05795	YKP-10A	small molecule	investigational	
DB05796	Daglutril	small molecule	investigational	Neprilysin, antagonists & inhibitors
DB05797	TNX-901	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05798	GEM-231	biotech	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB05799	NOX-100	small molecule	investigational	
DB05800	Alethine	small molecule	investigational	Amines|Ethylamines|Mercaptoethylamines|Sulfhydryl Compounds|Sulfur Compounds
DB05801	GTI 2040	small molecule	investigational	
DB05803	ISIS 14803	small molecule	investigational	
DB05804	Prasterone sulfate	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Androstenols|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP3A7 Substrates|Dehydroepiandrosterone|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB05805	NS-2359	small molecule	investigational	Alkaloids|Aza Compounds|Azabicyclo Compounds|Neurotransmitter Uptake Inhibitors
DB05806	Cositecan	small molecule	investigational	Alkaloids
DB05807	HGTV-43	biotech	investigational	
DB05808	PI-88	small molecule	investigational	Carbohydrates|Polysaccharides
DB05809	TA-CIN	biotech	investigational	
DB05810	99mTc-glucarate	small molecule	investigational	
DB05811	HSV-2 theracine	biotech	investigational	
DB05812	Abiraterone	small molecule	approved	Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 17A1 Inhibitors|Cytochrome P450 2D6 Inhibitors|Endocrine Therapy|Enzyme Inhibitors|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors|Steroids
DB05814	GPI-1485	small molecule	investigational	Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Polyketides
DB05815	GnRH pharmaccine	biotech	investigational	
DB05817	Laromustine	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB05818	SGN-15	biotech	investigational	
DB05819	NBI-6024	biotech	investigational	Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pancreatic Hormones|Peptide Hormones|Peptides|Proinsulin|Protein Precursors|Proteins
DB05820	DP-b99	small molecule	investigational	Acetates|Acids, Acyclic|Amines|Diamines|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Lipids|Polyamines
DB05821	DP-VPA	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Pentanoic Acids|Valerates
DB05824	CNS-5161	small molecule	investigational	
DB05825	NCX 1015	small molecule	investigational	Pregnadienes|Pregnadienetriols|Pregnanes|Steroids
DB05826	Prolease-r-hFSH	small molecule	investigational	
DB05827	G207	biotech	investigational	
DB05828	LU-31130	small molecule	investigational	
DB05829	Parathyroid hormone	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Calcium Homeostasis|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Parathyroid Hormones and Analogues|Peptide Hormones|Peptides|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB05830	Trestolone	small molecule	investigational	Adrenal Cortex Hormones|Contraceptive Agents, Male|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Steroids|Testosterone Congeners
DB05831	ING-1	small molecule	investigational	
DB05832	PPI-1019	small molecule	investigational	
DB05833	lymphotoxin beta receptor	small molecule	investigational	Amino Acids, Peptides, and Proteins|Membrane Proteins|Proteins|Receptors, Cell Surface|Receptors, Cytokine|Receptors, Immunologic|Receptors, Tumor Necrosis Factor
DB05834	OC-1012	small molecule	investigational	
DB05835	NS-3728	small molecule	investigational	
DB05836	AG-702	biotech	investigational	
DB05837	OSI-7836	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides
DB05838	OPC-51803	small molecule	investigational	Receptors, Vasopressin, agonists
DB05839	BG-777	small molecule	investigational	
DB05840	AGI-1096	small molecule	investigational	Acids, Acyclic|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids
DB05841	AI-128	small molecule	investigational	
DB05842	AI-850	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes
DB05843	trans NV-04	small molecule	investigational	
DB05845	NV-07a	small molecule	investigational	
DB05846	Mito-4509	small molecule	investigational	
DB05848	humanized SMART Anti-IL-12 Antibody	biotech	investigational	
DB05849	NCX 950	small molecule	investigational	
DB05851	Biomed 101	small molecule	investigational	
DB05852	cryopreserved human liver cells	biotech	investigational	
DB05854	CLX-0921	small molecule	investigational	Sulfur Compounds
DB05855	Rivanicline	small molecule	investigational	Alkaloids|Pyridines|Solanaceous Alkaloids
DB05856	CPD 923	small molecule	investigational	
DB05857	Q-Derp1	biotech	investigational	
DB05858	BI-K0376	biotech	investigational	
DB05859	PI-166	small molecule	investigational	
DB05860	PEG-Infergen	small molecule	investigational	Pegylated agents
DB05861	Tasquinimod	small molecule	investigational	
DB05863	TRX1	biotech	investigational	
DB05864	PPI-2458	small molecule	investigational	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Ethers|Ethers, Cyclic
DB05865	VIT-100	small molecule	investigational	
DB05866	ETC-1001	small molecule	investigational	
DB05867	99mTc-14 F7 Mab	biotech	investigational	
DB05868	Ciluprevir	small molecule	investigational	Acids, Acyclic|Sulfur Compounds
DB05869	Ethyl pyruvate	small molecule	investigational	Keto Acids
DB05870	anti-alpha5Beta1-integrin antibody	biotech	investigational	
DB05871	UC-781	small molecule	investigational	Amides
DB05873	AVI-4020	small molecule	investigational	
DB05874	AEOL 10150	small molecule	investigational	Antioxidants|Biological Factors|Pigments, Biological|Porphyrins
DB05875	substance P	biotech	investigational	Amino Acids, Peptides, and Proteins|Autacoids|Biological Factors|Cholinesterase substrates|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Neurotransmitter Agents|Oligopeptides|Peptides|Proteins|Tachykinins
DB05876	PDE4	small molecule	investigational	
DB05879	AME-527	biotech	investigational	
DB05880	MBT-0312	small molecule	investigational	
DB05881	EHT 0202	small molecule	investigational	
DB05882	CHF 4227	small molecule	investigational	Pyrans
DB05883	ABX-PTH	biotech	investigational	
DB05884	HCV-086	small molecule	investigational	
DB05885	Seletracetam	small molecule	investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Pyrrolidines|Vasodilating Agents
DB05886	NV-18	small molecule	investigational	
DB05887	TAFA-93	small molecule	investigational	
DB05888	MEM 1414	small molecule	investigational	
DB05889	Inotuzumab ozogamicin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Blood Proteins|CD22-directed Antibody Interactions|CD22-directed Immunoconjugate|Decreased DNA Integrity|Globulins|Immunoglobulins|Immunoproteins|Increased Cellular Death|P-glycoprotein/ABCB1 Substrates|Proteins|Serum Globulins
DB05890	VEGF-AS	small molecule	investigational	
DB05892	RI 624	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Receptor, Nerve Growth Factor, antagonists & inhibitors|Serum Globulins
DB05894	GT 389-255	small molecule	investigational	
DB05895	HGS-TR2J	biotech	investigational	
DB05896	Sirna-027	small molecule	investigational	
DB05897	rhIGFBP-3	small molecule	investigational	
DB05898	CERE-110	small molecule	investigational	
DB05899	IT-101	small molecule	investigational	Alkaloids|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Dextrins|Glucans|Macromolecular Substances|Polymers|Polysaccharides|Starch
DB05903	KOS-1584	small molecule	investigational	Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides
DB05904	BLX-883	small molecule	investigational	
DB05905	TD-2749	small molecule	investigational	
DB05906	CCR5 mAb	biotech	investigational	
DB05911	RUS 3108	small molecule	investigational	
DB05912	REN-850	small molecule	investigational	
DB05913	OSI-930	small molecule	investigational	Sulfur Compounds
DB05914	Mesenchymal Stem Cells	biotech	investigational	
DB05915	MYO-029	biotech	investigational	Amino Acids, Peptides, and Proteins|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB05916	CT-011	biotech	investigational	
DB05918	LS11	small molecule	investigational	
DB05919	DDP-200	small molecule	investigational	
DB05920	RTA 744	small molecule	investigational	
DB05924	NLX-P101	small molecule	investigational	
DB05928	Dovitinib	small molecule	investigational	BCRP/ABCG2 Inducers|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|Quinolines|Tyrosine Kinase Inhibitors|UGT1A3 Inhibitors
DB05929	GPI-0100	small molecule	investigational	Carbohydrates|Glycosides
DB05930	SB-559448	small molecule	investigational	
DB05931	Pegdinetanib	small molecule	investigational	Amino Acids, Peptides, and Proteins|Blood Proteins|Carbohydrates|Extracellular Matrix Proteins|Globulins|Glycoconjugates|Glycoproteins|Membrane Glycoproteins|Membrane Proteins|Peptides|Proteins|Scleroproteins|Serum Globulins|Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
DB05932	Denibulin	small molecule	investigational	
DB05934	CTCE-0214	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Biological Factors|Chemokines|Chemokines, CXC|Chemotactic Factors|Cytokines|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB05936	CVT-6883	small molecule	investigational	Adenosine A2 Receptor Antagonists
DB05938	Edonerpic	small molecule	investigational	Acids, Acyclic|Dicarboxylic Acids|Sulfur Compounds
DB05939	MK-0354	small molecule	investigational	
DB05941	Leronlimab	biotech	investigational	Amino Acids, Peptides, and Proteins|Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antibodies|Antibodies, Monoclonal|Antibodies, Viral|Antiviral Agents|Blood Proteins|Deltaretrovirus Antibodies|Globulins|HIV Fusion Inhibitors|Immunoglobulins|Immunoproteins|Proteins|Receptors, CCR5|Serum Globulins|Viral Fusion Protein Inhibitors
DB05943	Resatorvid	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB05944	Varlitinib	small molecule	investigational	Sulfur Compounds
DB05945	MDX-1303	small molecule	investigational	
DB05950	Contulakin-G	small molecule	investigational	
DB05956	EVT-101	small molecule	investigational	
DB05959	ENMD-1198	small molecule	investigational	Estranes|Steroids
DB05961	PPL-100	small molecule	investigational	
DB05964	Amitifadine	small molecule	investigational	Stereoisomerism
DB05966	TAS-108	small molecule	investigational	
DB05967	ANZ-100	small molecule	investigational	
DB05968	PR-104	small molecule	investigational	Hydrocarbons, Halogenated|Mustard Compounds
DB05969	SNS-032	small molecule	investigational	Sulfur Compounds
DB05971	Archexin	small molecule	investigational	
DB05973	Inosine 5'-sulfate	small molecule	investigational	
DB05974	Transcrocetinate	small molecule	investigational	Alkenes|Anticarcinogenic Agents|Antineoplastic Agents|Antioxidants|Biological Factors|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Protective Agents|Terpenes
DB05983	Bardoxolone methyl	small molecule	investigational	Pentacyclic Triterpenes|Sapogenins|Steroids|Terpenes|Triterpenes
DB05984	RAF-265	small molecule	investigational	
DB05990	Obeticholic acid	small molecule	approved	Alimentary Tract and Metabolism|Bile Acid Preparations|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|Cholanes|Cholic Acids|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Deoxycholic Acid|Farnesoid X Receptor Agonist|Farnesoid X Receptor Agonists|Miscellaneous GI Drugs|Steroids
DB05992	Plinabulin	small molecule	investigational	Piperazines
DB05993	PRX-07034	small molecule	investigational	
DB05996	Glembatumumab vedotin	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06005	Adomiparin	small molecule	investigational	
DB06011	AMG-222	small molecule	investigational	Agents causing angioedema|Benzocycloheptenes|Blood Glucose Lowering Agents|DPP-IV Inhibitors
DB06013	Aldoxorubicin	small molecule	investigational	Anthracyclines|Antineoplastic Agents|Carbohydrates|Cardiotoxic antineoplastic agents|Daunorubicin|Glycosides|Hydrazines|Naphthacenes
DB06014	Eteplirsen	biotech	approved|investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides, Antisense|Polynucleotides
DB06016	Cariprazine	small molecule	approved|investigational	Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotoxic agents|Psycholeptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists
DB06021	AV-412	small molecule	investigational	Receptor, Epidermal Growth Factor, antagonists & inhibitors|Receptor, ErbB-2, antagonists & inhibitors
DB06039	PA-1050040	small molecule	investigational	
DB06040	Filanesib	small molecule	investigational	Sulfur Compounds|Thiazoles
DB06042	ZEN-012	small molecule	investigational	
DB06043	Olaratumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06049	IPH 2101	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06058	XTL-6865	small molecule	investigational	
DB06061	AZD-8330	small molecule	investigational	
DB06063	CAM-2029	small molecule	investigational	
DB06064	KAI-1455	small molecule	investigational	
DB06069	XMT-1001	small molecule	investigational	Acetals|Alkaloids|Biomedical and Dental Materials|Macromolecular Substances
DB06070	SNX-5422	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyrazoles
DB06071	DTS-201	small molecule	investigational	
DB06073	CTS-21166	small molecule	investigational	
DB06075	Linsitinib	small molecule	investigational	
DB06077	Lumateperone	small molecule	investigational	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Neurotoxic agents
DB06080	ABT-869	small molecule	investigational	Benzene Derivatives|Pyrazoles|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors|Urea
DB06081	Caplacizumab	small molecule	investigational	Amino Acid Sequence|Amino Acids, Peptides, and Proteins|Biochemical Phenomena|Blood Proteins|Globulins|Immunoglobulin Fab Fragments|Immunoglobulin Fragments|Immunoglobulin Variable Region|Immunoglobulins|Immunoproteins|Information Science|Information Services|Molecular Sequence Data|Molecular Structure|Peptide Fragments|Peptides|Physicochemical Phenomena|Proteins|Serum Globulins|von Willebrand Factor, antagonists & inhibitors
DB06082	PX-478	small molecule	investigational	Acids, Carbocyclic|Hydrocarbons, Halogenated
DB06083	Tapinarof	small molecule	investigational	Benzene Derivatives|Benzylidene Compounds|Phenols
DB06087	Friulimicin B	small molecule	investigational	Amino Acids, Peptides, and Proteins
DB06089	ICA-105665	small molecule	investigational	
DB06090	Bradanicline	small molecule	investigational	Receptors, Nicotinic
DB06091	Evofosfamide	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Hydrocarbons, Halogenated|Imidazoles|Ions|Mustard Compounds|Nitro Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB06093	ABT-560	small molecule	investigational	
DB06094	Apatorsen	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB06096	NXN-188	small molecule	investigational	
DB06097	GSK-923295	small molecule	investigational	
DB06098	PRLX 93936	small molecule	investigational	
DB06101	IMC-1C11	biotech	investigational	Amino Acids, Peptides, and Proteins|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06103	VX-148	small molecule	investigational	Benzene Derivatives|Urea
DB06106	AIT-034	small molecule	investigational	
DB06111	AB192	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors|Imines|Imino Acids|Organophosphorus Compounds
DB06112	3,4-Methylenedioxy-N-isopropylamphetamine	small molecule	investigational	
DB06116	Eldelumab	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Chemokine CXCL10|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06117	1alpha,24S-Dihydroxyvitamin D2	small molecule	investigational	
DB06119	Cenobamate	small molecule	investigational	
DB06124	L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal	small molecule	investigational	
DB06127	Bisegliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors
DB06129	SVV-001	small molecule	investigational	
DB06130	FAV-201	biotech	investigational	
DB06133	Dimethylcurcumin	small molecule	investigational	
DB06134	SNS-314	small molecule	investigational	Benzene Derivatives|Protein Kinase Inhibitors|Sulfur Compounds|Urea
DB06137	KX-01	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB06138	IRL-1620	small molecule	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB06140	SUVN-502	small molecule	investigational	
DB06144	Sertindole	small molecule	approved|investigational|withdrawn	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Indole Derivatives|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB06145	Spiramycin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Coccidiostats|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Glycosides|Lactones|Leucomycins|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides
DB06147	Sulfathiazole	small molecule	approved|vet_approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Short-Acting Sulfonamides|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds|Thiazoles
DB06148	Mianserin	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents, Second-Generation|Antidepressive Agents, Tetracyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dibenzazepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB06149	Teicoplanin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Peptides
DB06150	Sulfadimethoxine	small molecule	approved|vet_approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Long-Acting Sulfonamides|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB06151	Acetylcysteine	small molecule	approved|investigational	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anti-Infective Agents|Antidote for Acetaminophen Overdose|Antidotes|Antioxidants|Cough and Cold Preparations|Cysteine|Decreased Respiratory Secretion Viscosity|Expectorants|Free Radical Scavengers|Increased Glutathione Concentration|OATP1B1/SLCO1B1 Inhibitors|Ophthalmologicals|Protective Agents|Reduction Activity|Respiratory System Agents|Sensory Organs|Sulfhydryl Compounds|Sulfur Compounds
DB06152	Nylidrin	small molecule	approved	2-Amino-1-Phenylethanol Derivatives|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Genito Urinary System and Sex Hormones|Miscellaneous Vasodilatating Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Peripheral Vasodilators|Phenethylamines|Phenylpropanolamine|Propanolamines|Propanols|Reproductive Control Agents|Sympathomimetics|Sympathomimetics, Labour Repressants|Tocolytic Agents|Vasodilating Agents
DB06153	Pizotifen	small molecule	approved	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anticholinergic Agents|Antimigraine Agents, Miscellaneous|Antimigraine Preparations|Central Nervous System Agents|Central Nervous System Depressants|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Peripheral Nervous System Agents|Psychotropic Drugs|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiophenes
DB06154	Pentaerythritol tetranitrate	small molecule	approved	Alcohols|Antianginal Agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Fibrin Modulating Agents|Glycols|Hematologic Agents|Organic Nitrates|Polysaccharides|Propylene Glycols|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB06155	Rimonabant	small molecule	approved|investigational	Agents producing tachycardia|Alimentary Tract and Metabolism|Antiobesity Preparations, Excl. Diet Products|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors
DB06156	Tesofensine	small molecule	investigational	Biogenic Monoamines, antagonists & inhibitors
DB06157	Istaroxime	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstanols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors|Steroids
DB06159	Rubitecan	small molecule	investigational	Alkaloids|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors
DB06160	Garenoxacin	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB06161	Opebacan	small molecule	investigational	
DB06162	Lumiliximab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06163	Plevitrexed	small molecule	investigational	Antineoplastic Agents
DB06166	Fosdevirine	small molecule	investigational	Acids|Acids, Noncarboxylic|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds
DB06168	Canakinumab	biotech	approved|investigational	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin Inhibitors|Interleukin-1beta, antagonists & inhibitors|Proteins|Serum Globulins
DB06169	Indibulin	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB06171	Paclitaxel trevatide	biotech	investigational	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes
DB06174	Noscapine	small molecule	approved|investigational	Alkaloids|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Isoquinolines|Opiate Alkaloids|Opium Alkaloids and Derivatives|Respiratory System Agents
DB06176	Romidepsin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Highest Risk QTc-Prolonging Agents|Histone Deacetylase Inhibitors|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic|QTc Prolonging Agents
DB06177	Glufosfamide	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Carbohydrates|Cyclophosphamide|Electrolytes|Hexoses|Hydrocarbons, Halogenated|Ions|Monosaccharides|Mustard Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Oxazines|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB06178	Talotrexin	small molecule	investigational	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Biological Factors|Pigments, Biological|Pteridines
DB06179	Darinaparsin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Oligopeptides|Organometallic Compounds|Peptides
DB06181	IMO-2055	small molecule	investigational	Antineoplastic Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides|Toll-Like Receptor 9, agonists
DB06182	Talabostat	small molecule	investigational	Acids|Acids, Noncarboxylic|Amino Acids, Peptides, and Proteins|Boron Compounds|Dipeptidyl-Peptidases and Tripeptidyl-Peptidases, antagonists & inhibitors|Oligopeptides|Peptides
DB06184	AEG35156	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB06185	Forodesine	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Purines|Pyrimidines
DB06186	Ipilimumab	biotech	approved	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|CTLA-4-directed Antibody Interactions|CTLA-4-directed Blocking Antibody|Globulins|Immunoglobulin G|Immunoglobulins|Immunoproteins|Increased T Lymphocyte Activation|Proteins|Serum Globulins
DB06187	Valtorcitabine	small molecule	investigational	
DB06188	Ispinesib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB06190	Solabegron	small molecule	investigational	Acids, Carbocyclic|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Benzene Derivatives|Neurotransmitter Agents
DB06191	Zosuquidar	small molecule	investigational	Benzocycloheptenes|Drug Resistance, Multiple|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB06192	Nimotuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06193	Pixantrone	small molecule	approved|investigational	Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB06194	Elocalcitol	small molecule	investigational	Cholestanes|Cholestenes|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB06195	Seliciclib	small molecule	investigational	Antineoplastic Agents|Cyclin-Dependent Kinases, antagonists & inhibitors|Enzyme Inhibitors|Protein Kinase Inhibitors
DB06196	Icatibant	small molecule	approved|investigational	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Autacoids|Biological Factors|Blood and Blood Forming Organs|Bradykinin B2 Receptor Antagonists|Bradykinin Receptor Antagonists|Central Nervous System Agents|Complement Inactivating Agents|Drugs Used in Hereditary Angioedema|Immunologic Factors|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Peripheral Nervous System Agents|Proteins|Sensory System Agents
DB06197	Bimosiamose	small molecule	investigational	Alkanes|Benzene Derivatives|Carbohydrates|Hexoses|Hydrocarbons, Acyclic|Monosaccharides
DB06198	Alovudine	small molecule	investigational	Anti-Infective Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Fluorine Radioisotopes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides
DB06199	Atrasentan	small molecule	investigational	Endothelin Receptor Antagonists|OATP1B1/SLCO1B1 Substrates
DB06200	Tedisamil	small molecule	investigational	Antiarrhythmic agents|Antiarrhythmics, Class III|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Cycloparaffins|Moderate Risk QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents
DB06201	Rufinamide	small molecule	approved	Anticonvulsants|Carboxamide Derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Miscellaneous Anticonvulsants|Nervous System
DB06202	Lasofoxifene	small molecule	approved|investigational	Genito Urinary System and Sex Hormones|Naphthalenes|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System
DB06203	Alogliptin	small molecule	approved	Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretins|Oral Hypoglycemics|Pyrimidines|Pyrimidinones
DB06204	Tapentadol	small molecule	approved	Analgesics|Benzene Derivatives|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Narcotics|Nervous System|Opiate Agonists|Opioid Agonist|Opioids|Receptors, Opioid, mu, agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|UGT1A9 Substrates
DB06205	Hyaluronidase (Human Recombinant)	biotech	approved|investigational	Glycoside Hydrolases
DB06206	Sugammadex	small molecule	approved	Antidotes|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cyclodextrins|Dextrins|Glucans|Macromolecular Substances|Polymers|Polysaccharides|Starch
DB06207	Silodosin	small molecule	approved	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Benign Prostatic Hypertrophy|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Selective Alfa-1-adrenergic Blocking Agents|Urological Agents|Urologicals
DB06209	Prasugrel	small molecule	approved	Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Platelet Aggregation|Hematologic Agents|P2Y12 Platelet Inhibitor|Piperazines|Platelet Aggregation Inhibitors Excl. Heparin|Purinergic P2Y Receptor Antagonists|Sulfur Compounds|Thiophenes
DB06210	Eltrombopag	small molecule	approved	Acids, Carbocyclic|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Blood and Blood Forming Organs|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hematinics|Hemostatics|Increased Megakaryocyte Maturation|Increased Platelet Production|OATP1B1/SLCO1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Thrombopoietin Receptor Agonist|Thrombopoietin Receptor Agonists|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A3 Inhibitors|UGT1A4 Inhibitors|UGT1A6 Inhibitors|UGT1A9 Inhibitors|UGT2B15 Inhibitors|UGT2B7 Inhibitors
DB06211	Doripenem	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Carbapenems|Lactams|OAT3/SLC22A8 Substrates|Penem Antibacterial|Sulfur Compounds
DB06212	Tolvaptan	small molecule	approved	Agents causing hyperkalemia|Antidiuretic Hormone Receptor Antagonists|Cardiovascular Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diuretics|Hyponatremia|Natriuretic Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Vasopressin V2 Receptor Antagonist|Vasopressin V2 Receptor Antagonists
DB06213	Regadenoson	small molecule	approved|investigational	Adenosine A2 Receptor Agonists|Cardiac Therapy|Neurotransmitter Agents|Purinergic Agents|Purinergic Agonists|Purinergic P1 Receptor Agonists
DB06215	Ferumoxytol	small molecule	approved|investigational	Ferric Compounds|Ferrous Compounds|Hematinics|Hematologic Agents|Iron Compounds|Magnetic Resonance Contrast Activity|Minerals|Organometallic Compounds|Paramagnetic Contrast Agent|Parenteral Iron Replacement|Parenteral Nutrition Solutions|Pharmaceutical Preparations|Pharmaceutical Solutions|Solutions
DB06216	Asenapine	small molecule	approved	Acid Reducers|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diazepines, Oxazepines, Thiazepines and Oxepines|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Highest Risk QTc-Prolonging Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H2 Antagonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tranquilizing Agents
DB06217	Vernakalant	small molecule	approved|investigational	Antiarrhythmic agents|Antiarrhythmics, Class III|Benzene Derivatives|Cardiac Therapy|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Ethers|Methyl Ethers|Phenols|Phenyl Ethers|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB06218	Lacosamide	small molecule	approved	Acetates|Acids, Acyclic|Alkanes|Amides|Anti-epileptic Agent|Anticonvulsants|Bradycardia-Causing Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Decreased Central Nervous System Disorganized Electrical Activity|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Acyclic|Lipids|Miscellaneous Anticonvulsants|Nervous System
DB06219	Dalbavancin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycoconjugates|Glycopeptide Antibacterials|Glycopeptides|Lipoglycopeptide Antibacterial|Lipoglycopeptides|Peptides
DB06224	Alicaforsen	small molecule	investigational	Carbohydrates|Gastrointestinal Agents|Glycosides|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides
DB06226	Nelipepimut-S	biotech	investigational	
DB06228	Rivaroxaban	small molecule	approved	Anticoagulants|Antithrombins|BCRP/ABCG2 Substrates|Blood and Blood Forming Organs|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Morpholines|Oxazines|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Serine Proteinase Inhibitors|Sulfur Compounds|Thiophenes
DB06229	Ocaperidone	small molecule	investigational	Pyrimidines
DB06230	Nalmefene	small molecule	approved|investigational|withdrawn	Alkaloids|Antipruritics|Appetite Depressants|Central Nervous System Agents|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Morphinans|Naloxone|Nervous System|Neuroprotective Agents|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents
DB06231	Caldaret	small molecule	investigational	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB06233	Ridaforolimus	small molecule	investigational	Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides|Protein Kinase Inhibitors
DB06234	Maribavir	small molecule	investigational	Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Carbohydrates|Direct Acting Antivirals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides
DB06235	Vadimezan	small molecule	investigational	Antineoplastic Agents|Cytochrome P-450 CYP1A2 Substrates|Xanthenes
DB06236	Elvucitabine	small molecule	investigational	Carbohydrates|Cytidine|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Glycosides|HIV Reverse Transcriptase|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB06237	Avanafil	small molecule	approved	Cyclic Nucleotide Phosphodiesterases, Type 5|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs Used in Erectile Dysfunction|Genito Urinary System and Sex Hormones|Phosphodiesterase 5 Inhibitors|Urologicals|Vasodilating Agents
DB06240	Tariquidar	small molecule	investigational	Drug Resistance, Multiple|P-glycoprotein/ABCB1 Inhibitors
DB06241	Clenoliximab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antigens, CD4|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06243	Eflornithine	small molecule	approved|withdrawn	Agents Against Leishmaniasis and Trypanosomiasis|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Decarboxylase Inhibitor|Decarboxylase Inhibitors|Dermatologicals|Enzyme Inhibitors|Misc. Skin and Mucous Membrane Agents|Ornithine|Ornithine Decarboxylase Inhibitors|Trypanocidal Agents
DB06244	Trafermin	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB06245	Lanoteplase	biotech	investigational	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Biological Factors|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB06246	Exisulind	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticarcinogenic Agents|Antineoplastic Agents|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Indenes|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents
DB06247	CX516	small molecule	investigational	Receptors, AMPA
DB06248	Amelubant	small molecule	investigational	Acids, Acyclic|Receptors, Leukotriene B4, antagonists & inhibitors
DB06249	Arzoxifene	small molecule	approved|investigational	Sulfur Compounds
DB06250	Fluasterone	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB06251	Dersalazine	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols|Platelet Activating Factor, antagonists & inhibitors|Salicylates
DB06253	Thioctic acid tromethamine	small molecule	investigational	
DB06255	Incadronic acid	small molecule	experimental	Bisphosphonates|Bone Density Conservation Agents|Organophosphonates|Organophosphorus Compounds
DB06257	HE-2200	small molecule	investigational	Androstanes|Androstenes|Steroids
DB06258	Bimoclomol	small molecule	investigational	
DB06260	Aviptadil	small molecule	experimental	Amino Acids, Peptides, and Proteins|Erectile Dysfunction|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Imidazoles|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pharmaceutical Preparations|Proteins
DB06261	Hexaminolevulinate	small molecule	approved	Amino Acids|Amino Acids, Peptides, and Proteins|Carbon Radioisotopes|Keto Acids|Levulinic Acids|Other Diagnostics|Photosensitizing Agents
DB06262	Droxidopa	small molecule	approved|investigational	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Alcohols|Anti-Dyskinesia Agents|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Catecholamines|Central Nervous System Agents|Epinephrine|Ethanolamines|Increased Blood Pressure|Norepinephrine
DB06263	Amrubicin	small molecule	investigational	Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Glycosides|Naphthacenes
DB06264	Tolperisone	small molecule	investigational	Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Ketones|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents|Propiophenones|Pyridines|Topical Products for Joint and Muscular Pain
DB06266	Lonidamine	small molecule	investigational	Adrenal Cortex Hormones|Anti-Infective Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiparasitic Agents|Antiprotozoals|Antispermatogenic Agents|Contraceptive Agents, Male|Hormonal Contraceptives for Systemic Use|Noxae|Pyrazoles|Radiation-Sensitizing Agents|Reproductive Control Agents|Toxic Actions|Trypanocidal Agents
DB06267	Udenafil	small molecule	investigational	Amides|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Drugs Used in Erectile Dysfunction|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Sulfones|Sulfur Compounds|Urologicals|Vasodilating Agents
DB06268	Sitaxentan	small molecule	approved|investigational|withdrawn	Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Endothelin Receptor Antagonists|Sulfur Compounds
DB06270	MAHDL01	small molecule	investigational	
DB06271	Sulodexide	biotech	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Heparin and similars|Heparin Group|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Polysaccharides|Toxic Actions
DB06272	Maxacalcitol	small molecule	investigational	Anticarcinogenic Agents|Antineoplastic Agents|Cholestanes|Cholestenes|Dermatologicals|Lipids|Membrane Lipids|Protective Agents|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB06273	Tocilizumab	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Disease-modifying Antirheumatic Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin 6 Receptor Antagonists|Interleukin Inhibitors|Interleukin-6 Receptor Antagonist|Proteins|Serum Globulins
DB06274	Alvimopan	small molecule	approved|investigational	Alimentary Tract and Metabolism|Drugs for Constipation|Gastrointestinal Agents|Opioid Antagonists|Peripheral Opioid Receptor Antagonists|Receptors, Opioid, mu, antagonists & inhibitors
DB06276	Tanomastat	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives|Matrix Metalloproteinases
DB06280	Senicapoc	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids
DB06281	Torcetrapib	small molecule	investigational	Anticholesteremic Agents|Blood Pressure|Cholesterol Ester Transfer Proteins|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions
DB06282	Levocetirizine	small molecule	approved	Antihistamines for Systemic Use|Central Nervous System Depressants|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Hydroxyzine|Neurotransmitter Agents|Piperazine Derivatives|Piperazines|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB06283	Ziconotide	small molecule	approved	Agents causing hyperkalemia|Analgesics|Analgesics, Non-Narcotic|Antiarrhythmic agents|Biological Factors|Bodily Secretions|Bradycardia-Causing Agents|Calcium Channel Blockers|Calcium Channels, N-Type|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Complex Mixtures|Conotoxins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Fluids and Secretions|Marine Toxins|Membrane Transport Modulators|Mollusk Venoms|N-Calcium Channel Receptor Antagonists|Nervous System|Neuroprotective Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Sensory System Agents|Toxins, Biological|Vasodilating Agents|Venoms
DB06285	Teriparatide	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Bone Density Conservation Agents|Calcium Homeostasis|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Parathyroid Hormones and Analogues|Peptide Hormones|Peptides|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB06287	Temsirolimus	small molecule	approved	Agents causing angioedema|Anti-Bacterial Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Kinase Inhibitor|Lactones|Macrolides|Myelosuppressive Agents|Narrow Therapeutic Index Drugs|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Polyketides|Protein Kinase Inhibitors
DB06288	Amisulpride	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents
DB06290	Simeprevir	small molecule	approved	Amides|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|HCV NS3/4A Protease Inhibitors|HCV Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB06292	Dapagliflozin	small molecule	approved	Alimentary Tract and Metabolism|Benzene Derivatives|Blood Glucose Lowering Agents|Carbohydrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Drugs Used in Diabetes|Glycosides|Hypotensive Agents|Oral Hypoglycemics|P-glycoprotein/ABCB1 Substrates|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|Sodium-Glucose Transport Proteins, antagonists & inhibitors|Sodium-Glucose Transporter 2 Inhibitors|UGT1A9 Substrates
DB06293	Pegnivacogin	small molecule	investigational	Carbohydrates|Factor IXa, antagonists & inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Pegylated agents|Polynucleotides
DB06295	Pramiconazole	small molecule	investigational	
DB06297	LX-2931	small molecule	investigational	Amines|Hydroxylamines
DB06299	Hydronidone	small molecule	investigational	
DB06302	Glesatinib	small molecule	investigational	Tyrosine Kinase Inhibitors
DB06303	Otilimab	biotech	investigational	
DB06305	Sonepcizumab	biotech	investigational	
DB06306	Onalespib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|HSP90 Heat-Shock Proteins, antagonists & inhibitors
DB06307	Apoptone	small molecule	investigational	Androstanes|Steroids
DB06309	Refametinib	small molecule	investigational	Amides|Amines|Aniline Compounds|Sulfones|Sulfur Compounds
DB06310	Motavizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antiinfectives for Systemic Use|Blood Proteins|Globulins|Immune Sera and Immunoglobulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins|Specific Immunoglobulins
DB06311	Darapladib	small molecule	investigational	Amines|Enzyme Inhibitors|Hydroxylamines|Phospholipase A2 Inhibitors|Pyrimidines
DB06313	BNC105	small molecule	investigational	Benzene Derivatives|Ethers|Methyl Ethers|Phenols|Phenyl Ethers
DB06314	SGX-523	small molecule	investigational	
DB06317	Elotuzumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins|SLAMF7-directed Antibody Interactions|SLAMF7-directed Immunostimulatory Antibody
DB06321	R-348	small molecule	investigational	
DB06323	AZX-100	biotech	investigational	Amino Acids, Peptides, and Proteins|Heat-Shock Proteins|Molecular Chaperones|Proteins
DB06325	Pegpleranib	small molecule	investigational	Pegylated agents
DB06326	Latiglutenase	biotech	investigational	Celiac Disease, drug therapy|Enzymes|Enzymes and Coenzymes|Hydrolases
DB06328	Methoxyamine	small molecule	investigational	Amines
DB06331	4-O-Demethylpenclomedine	small molecule	investigational	Pyridines
DB06333	Trodusquemine	biotech	investigational	Amines|Biogenic Amines|Biogenic Polyamines|Diamines|Polyamines|Putrescine|Spermidine|Steroids
DB06334	Tucidinostat	small molecule	investigational	Acids, Carbocyclic|Amides|Amines|Antineoplastic Agents|Benzene Derivatives|Benzoates|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents
DB06335	Saxagliptin	small molecule	approved	Agents causing angioedema|Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Incretins|OAT3/SLC22A8 Substrates|Oligopeptides|Oral Hypoglycemics|Peptides|Protease Inhibitors
DB06336	Elsiglutide	small molecule	investigational	
DB06342	Coltuximab ravtansine	biotech	investigational	Amides|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Antibodies|Antibodies, Monoclonal|Blood Proteins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Globulins|Immunoglobulins|Immunoproteins|Immunotoxins|Lactams|Lactams, Macrocyclic|Lactones|Macrolides|Polyketides|Proteins|Serum Globulins
DB06343	Teprotumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06345	AR-9281	small molecule	investigational	Cycloparaffins|Epoxide Hydrolases, antagonists & inhibitors
DB06346	Fiboflapon	small molecule	investigational	Acids, Acyclic|Asthma, drug therapy|Fatty Acids|Fatty Acids, Volatile|Lipids|Valerates
DB06347	Cenisertib	small molecule	investigational	Monoterpenes|Terpenes
DB06350	Elinogrel	small molecule	investigational	Amides|Quinazolines|Sulfones|Sulfur Compounds
DB06354	Tezampanel	small molecule	investigational	Receptors, AMPA, antagonists & inhibitors
DB06358	Iclaprim	small molecule	investigational	Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Enzyme Inhibitors|Folic Acid Antagonists|Trimethoprim and Derivatives
DB06360	Lucatumumab	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Multiple Myeloma, drug therapy|Proteins|Serum Globulins
DB06361	rsPSMA Vaccine	biotech	approved|investigational	
DB06362	Becatecarin	small molecule	investigational	Carbohydrates|Glycosides|Indoles
DB06364	XR5944	small molecule	investigational	
DB06365	Sapacitabine	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidines|Pyrimidinones
DB06366	Pertuzumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Breast Neoplasms|Globulins|HER2 Receptor Antagonist|HER2/Neu/cerbB2 Antagonists|Immunoglobulins|Immunoproteins|Proteins|Receptor, ErbB-2, antagonists & inhibitors|Serum Globulins
DB06367	Relacatib	small molecule	investigational	Sulfur Compounds
DB06368	Alamifovir	small molecule	investigational	
DB06370	Indisulam	small molecule	investigational	Amides|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Sulfones|Sulfur Compounds
DB06371	Siplizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06372	Rilonacept	biotech	approved|investigational	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Interleukin Inhibitors|Interleukin-1 Receptor Accessory Protein|Proteins|Receptors, Interleukin-1 Type I|Recombinant Proteins
DB06374	Elacestrant	small molecule	investigational	
DB06376	CHGN111	small molecule	investigational	
DB06379	Calcitonin gene-related peptide	biotech	investigational	Amino Acids, Peptides, and Proteins|Cardiovascular Agents|Nerve Tissue Proteins|Neuropeptides|Peptides|Proteins|Vasodilating Agents
DB06393	Xaliproden	small molecule	investigational	Nervous System
DB06395	Abafungin	small molecule	investigational	Antifungal Agents|Azole Antifungals|Sulfur Compounds
DB06397	Nicaraven	small molecule	investigational	Antioxidants|Nicotinic Acids|Protective Agents|Pyridines
DB06399	Atacicept	biotech	investigational	Amino Acids, Peptides, and Proteins|Proteins|Recombinant Proteins
DB06400	Vitespen	small molecule	investigational	
DB06401	Bazedoxifene	small molecule	approved|investigational	Bone Density Conservation Agents|Estrogen Agonist/Antagonist|Estrogen Receptor Modulators|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Selective Estrogen Receptor Modulators|Sex Hormones and Modulators of the Genital System|UGT1A1 Substrates
DB06402	Telavancin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycopeptide Antibacterials|Glycopeptides|Glycosides|Lipoglycopeptide Antibacterial|Lipoglycopeptides|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB06403	Ambrisentan	small molecule	approved|investigational	Acids, Carbocyclic|Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Endothelin Receptor Antagonists|Hypertension, Pulmonary|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|UGT1A9 Substrates|Vasodilating Agents
DB06404	Human C1-esterase inhibitor	biotech	approved	Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Proteins|C1 inhibitors|Carbohydrates|Complement C1 Inactivator Proteins|Complement Inactivating Agents|Complement Inactivator Proteins|Complement System Proteins|Decreased Vascular Permeability|Drugs Used in Hereditary Angioedema|Glycoconjugates|Glycoproteins|Immunologic Factors|Immunoproteins|Kallikrein Inhibitors|Peptides|Protease Inhibitors|Proteins|Serpins
DB06405	Eprodisate	small molecule	investigational	Acids|Acids, Noncarboxylic|Alkanes|Hydrocarbons, Acyclic|Sulfur Acids|Sulfur Compounds
DB06406	Idraparinux	small molecule	investigational	Anticoagulants|Antithrombins|Carbohydrates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Polysaccharides|Protease Inhibitors|Serine Proteinase Inhibitors
DB06408	Taribavirin	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine-Nucleoside Phosphorylase, antagonists & inhibitors|Ribonucleosides
DB06410	Doxercalciferol	small molecule	approved	Anti-Parathyroid Agents|Bone Density Conservation Agents|Calcium Homeostasis|Cholestanes|Cholestenes|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Lipids|Membrane Lipids|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Sterols|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB06412	Oxymetholone	small molecule	approved|illicit	Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB06413	Armodafinil	small molecule	approved|investigational	Benzene Derivatives|Central Nervous System Agents|Central Nervous System Stimulants|Centrally Acting Sympathomimetics|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Wakefulness-Promoting Agents
DB06414	Etravirine	small molecule	approved	Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Non-Nucleoside Analog|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|P-glycoprotein/ABCB1 Inducers|Reverse Transcriptase Inhibitors
DB06415	Calfactant	small molecule	approved	Alveolar Surface Tension Reduction|Bradycardia-Causing Agents|Complex Mixtures|Pulmonary Surfactants|Respiratory System Agents|Surface-Active Agents|Surfactant Activity
DB06419	Cethromycin	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Erythromycin|Lactones|Macrolides|Polyketides|Protein Synthesis Inhibitors|RNA, Ribosomal, 23S
DB06420	Annamycin	small molecule	investigational	Anthracyclines|Antibiotics, Antineoplastic|Antineoplastic Agents|Carbohydrates|Daunorubicin|Glycosides|Naphthacenes|P-glycoprotein/ABCB1 Inhibitors
DB06421	Declopramide	small molecule	investigational	Acids, Carbocyclic|Amides|Aminobenzoates|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|para-Aminobenzoates
DB06422	Ticalopride	small molecule	investigational	Acids, Carbocyclic|Amides|Aminobenzoates|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Chlorobenzoates|para-Aminobenzoates|Piperidines
DB06429	Talnetant	small molecule	investigational	Receptors, Neurokinin-3, antagonists & inhibitors
DB06431	Evernimicin	small molecule	investigational	Carbohydrates|Glycosides
DB06433	Tezacitabine	small molecule	investigational	Antineoplastic Agents|Carbohydrates|Cytidine|Deoxyribonucleosides|Enzyme Inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Radiation-Sensitizing Agents|Ribonucleoside Diphosphate Reductase, antagonists & inhibitors|Ribonucleosides
DB06434	Repifermin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Fibroblast Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB06435	Tarazepide	small molecule	investigational	Benzazepines
DB06436	Semaxanib	small molecule	investigational	Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Enzyme Inhibitors|Growth Inhibitors|Growth Substances|Protein Kinase Inhibitors
DB06437	Tifacogin	small molecule	investigational	Amino Acids, Peptides, and Proteins
DB06439	Tyloxapol	small molecule	approved|investigational	Alcohols|Biomedical and Dental Materials|Cough and Cold Preparations|Detergents|Ethylene Glycols|Expectorants|Glycols|Household Products|Macromolecular Substances|Polymers|Surface-Active Agents
DB06440	Ravuconazole	small molecule	investigational	Antifungal Agents|Azole Antifungals|Sulfur Compounds
DB06441	Cangrelor	small molecule	approved	Adenine Nucleotides|Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Carbohydrates|Decreased Platelet Aggregation|Glycosides|Hematologic Agents|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|P2Y12 Platelet Inhibitor|Platelet Aggregation Inhibitors Excl. Heparin|Purine Nucleotides|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Purines|Ribonucleotides
DB06442	Avasimibe	small molecule	investigational	Acids|Acids, Acyclic|Acids, Noncarboxylic|Arteriosclerosis|Chemically-Induced Disorders|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Acids|Sulfur Compounds
DB06444	Dexanabinol	small molecule	investigational	Antiemetics|Autonomic Agents|Cannabinoids and similars|Cardiovascular Agents|Central Nervous System Agents|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Gastrointestinal Agents|Neuroprotective Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Terpenes
DB06445	Diethylnorspermine	small molecule	investigational	Amines|Antihypertensive Agents|Antineoplastic Agents|Biogenic Amines|Biogenic Polyamines|Cardiovascular Agents|Diamines|Polyamines|Putrescine|Spermidine
DB06446	Dotarizine	small molecule	investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Benzene Derivatives|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Membrane Transport Modulators|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Antagonists|Vasodilating Agents
DB06447	E5531	small molecule	investigational	Antigens|Antigens, Bacterial|Bacterial Toxins|Biological Factors|Carbohydrates|Endotoxins|Glycoconjugates|Lipids|Lipopolysaccharides|Polysaccharides|Polysaccharides, Bacterial|Toxins, Biological
DB06448	Lonafarnib	small molecule	investigational	P-glycoprotein/ABCB1 Inhibitors
DB06449	Ilodecakin	small molecule	investigational	
DB06451	Aprinocarsen	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides|Protein Kinase C, antagonists & inhibitors|Sulfur Compounds
DB06453	Mirostipen	small molecule	investigational	
DB06454	Sarizotan	small molecule	investigational	
DB06455	Meclinertant	small molecule	investigational	Receptors, Neurotensin, antagonists & inhibitors
DB06457	Tecastemizole	small molecule	investigational	
DB06458	Remacemide	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Neuroprotective Agents|Protective Agents
DB06460	Enrasentan	small molecule	investigational	Endothelin Receptor Antagonists|Indenes
DB06461	Squalamine	small molecule	investigational	Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Anti-Bacterial Agents|Anti-Infective Agents|Anticarcinogenic Agents|Antineoplastic Agents|Cholestanes|Growth Inhibitors|Growth Substances|Hydroxy Acids|Protective Agents|Steroids
DB06465	FK-960	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB06467	Apolizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06468	Cariporide	small molecule	investigational	Amidines|Antiarrhythmic agents|Cardiovascular Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds
DB06469	Lestaurtinib	small molecule	investigational	Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Indoles|Tyrosine Kinase Inhibitors
DB06470	Clomethiazole	small molecule	investigational	Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|GABA Agents|GABA Modulators|Hypnotics and Sedatives|Nervous System|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Psycholeptics|Sulfur Compounds|Thiazoles
DB06471	Naxifylline	small molecule	investigational	Adenosine A1 Receptor Antagonists|Alkaloids|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones
DB06472	Fradafiban	small molecule	investigational	Benzene Derivatives|Platelet Glycoprotein GPIIb-IIIa Complex, antagonists & inhibitors
DB06475	Ruplizumab	biotech	investigational	
DB06477	Sumanirole	small molecule	investigational	
DB06478	Porfiromycin	small molecule	investigational	Antibiotics, Antineoplastic|Antineoplastic Agents|Azirines|Indolequinones|Indoles|Mitomycins|Quinones
DB06479	Propentofylline	small molecule	investigational	Alkaloids|Anti-Ulcer Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Nervous System|Neuroprotective Agents|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Purines|Purinones|Xanthine derivatives
DB06480	Prucalopride	small molecule	approved	Alimentary Tract and Metabolism|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Constipation|Laxatives|Miscellaneous GI Drugs|P-glycoprotein/ABCB1 Substrates
DB06481	Manitimus	small molecule	investigational	Hydrocarbons, Acyclic
DB06482	ALGRX 1207	small molecule	investigational	
DB06485	Ropidoxuridine	small molecule	investigational	
DB06486	Enzastaurin	small molecule	investigational	
DB06489	Liatermin	small molecule	investigational	
DB06492	Mirococept	biotech	investigational	
DB06493	Velafermin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB06494	Sufugolix	small molecule	investigational	
DB06495	Onercept	biotech	investigational	Amino Acids, Peptides, and Proteins|Antigens|Antigens, CD|Antigens, Differentiation|Antigens, Surface|Biological Factors|Biomarkers|Membrane Proteins|Polyethylene Glycols|Proteins|Receptors, Cell Surface|Receptors, Cytokine|Receptors, Death Domain|Receptors, Immunologic|Receptors, Tumor Necrosis Factor|Recombinant Proteins
DB06497	Aplaviroc	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives|HIV Fusion Inhibitors
DB06499	Furaprofen	small molecule	investigational	
DB06504	S-8510	small molecule	investigational	Benzazepines
DB06506	Repinotan	small molecule	investigational	Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Pyrans|Serotonin Agents|Serotonin Receptor Agonists|Sulfur Compounds
DB06508	GW-559090	small molecule	investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB06510	Muraglitazar	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Phenoxybenzamine|PPAR alpha, agonists|PPAR gamma, agonists|UGT1A1 Substrates
DB06512	Deramciclane	small molecule	investigational	Anti-Anxiety Agents|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Monoterpenes|Neurotransmitter Agents|Norbornanes|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Terpenes|Tranquilizing Agents
DB06515	Resiniferatoxin	small molecule	investigational	Neurotoxins|Terpenes|TRPV Cation Channels
DB06518	R-1487	small molecule	investigational	Mitogen-Activated Protein Kinase 14, antagonists & inhibitors|Pyridines
DB06519	Edaglitazone	small molecule	investigational	
DB06521	Ertiprotafib	small molecule	investigational	Acids, Carbocyclic|Sulfur Compounds
DB06523	Levovirin	small molecule	investigational	
DB06525	Ganstigmine	small molecule	investigational	Acids, Acyclic|Carbamates
DB06527	Tramiprosate	small molecule	investigational	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anticonvulsants|Carbohydrates|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Agonists|Hydrocarbons, Acyclic|Neurotransmitter Agents|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB06529	Ocinaplon	small molecule	investigational	Central Nervous System Depressants|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives
DB06530	Resiquimod	small molecule	investigational	
DB06532	Pafuramidine	small molecule	investigational	Amidines|Pneumocystis jirovecii|Pneumonia, Pneumocystis
DB06533	Ragaglitazar	small molecule	investigational	Acids, Carbocyclic
DB06534	Thrombopoietin	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB06535	Etilevodopa	small molecule	investigational	Amines|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Parkinson Drugs|Biogenic Amines|Biogenic Monoamines|Catecholamines|Dihydroxyphenylalanine|Dopa and Dopa Derivatives|Dopamine Agents|Nervous System|Phenylalanine|Tyrosine
DB06536	Tesaglitazar	small molecule	investigational	Acids|Acids, Carbocyclic|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB06538	Robalzotan	small molecule	investigational	Pyrans
DB06543	Astaxanthin	small molecule	investigational	Alkenes|Anticoagulants|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Fibrinolytic Agents|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB06545	Gavilimomab	biotech	investigational	
DB06548	Minodronic acid	small molecule	investigational	Organophosphonates|Organophosphorus Compounds
DB06549	Labradimil	small molecule	investigational	Amino Acids, Peptides, and Proteins|Autacoids|Biological Factors|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins
DB06550	Bivatuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06554	Gaboxadol	small molecule	investigational	Analgesics|Anesthetics|Anticonvulsants|Appetite Depressants|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Agonists|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents
DB06555	Siramesine	small molecule	investigational	
DB06556	Edifoligide	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB06557	Lerdelimumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06558	Tezosentan	small molecule	investigational	Cardiovascular Agents|Receptors, Endothelin|Vasodilating Agents
DB06559	Lanimostim	small molecule	investigational	
DB06560	Pascolizumab	biotech	investigational	
DB06562	Emfilermin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB06568	alpha-Hydroxy glycineamide	small molecule	investigational	
DB06569	P-57AS3	small molecule	investigational	
DB06573	Rebimastat	small molecule	investigational	Matrix Metalloproteinases
DB06575	Valomaciclovir	small molecule	investigational	Herpes Zoster|Purines|Purinones|Varicellovirus|Xanthine derivatives
DB06576	Baminercept	biotech	investigational	Amino Acids, Peptides, and Proteins|Proteins|Recombinant Proteins
DB06578	Tonabersat	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyrans
DB06579	Adipiplon	small molecule	investigational	Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Agonists|Neurotransmitter Agents|Psychotropic Drugs|Receptors, GABA-A|Tranquilizing Agents
DB06580	Celgosivir	small molecule	investigational	
DB06581	Bevirimat	small molecule	investigational	Acids, Acyclic|Anti-HIV Agents|Dicarboxylic Acids|Terpenes
DB06582	Dextofisopam	small molecule	investigational	Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|Psychotropic Drugs|Stereoisomerism
DB06585	Fipamezole	small molecule	investigational	Indenes
DB06586	Cetilistat	small molecule	investigational	Oxazines
DB06587	Mitemcinal	small molecule	investigational	Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides
DB06588	Triphendiol	small molecule	investigational	Benzopyrans|Chromones|Flavonoids|Pyrans
DB06589	Pazopanib	small molecule	approved	Amides|Angiogenesis Inhibitors|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors|Sulfones|Sulfur Compounds|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors
DB06590	Ceftaroline fosamil	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Methicillin Resistance|Nephrotoxic agents|Staphylococcal Infections|Sulfur Compounds|Thiazines
DB06594	Agomelatine	small molecule	approved|investigational	Acetates|Acids, Acyclic|Amides|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Melatonin, agonists|Nervous System|Psychoanaleptics|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB06595	Midostaurin	small molecule	approved|investigational	Alkaloids|Antineoplastic Agents|Carbazoles|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A7 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Indole Alkaloids|Indoles|Kinase Inhibitor|Protein Kinase C, antagonists & inhibitors|Protein Kinase Inhibitors|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB06597	Estradiol sulfamate	small molecule	investigational	Amides|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Steryl-Sulfatase, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB06598	Brostallicin	small molecule	investigational	Amidines
DB06599	Lexatumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Receptors, TNF-Related Apoptosis-Inducing Ligand|Serum Globulins
DB06600	Nemonoxacin	small molecule	investigational	Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines
DB06602	Reslizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Drugs for Obstructive Airway Diseases|Globulins|Immunoglobulins|Immunoproteins|Interleukin Antagonists|Interleukin-5 Antagonist|Interleukin-5 Antagonists|Proteins|Serum Globulins
DB06603	Panobinostat	small molecule	approved|investigational	Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Immunosuppressive Agents|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents
DB06604	Ilepatril	small molecule	investigational	Prodrugs
DB06605	Apixaban	small molecule	approved	Anticoagulants|Antithrombins|BCRP/ABCG2 Substrates|Blood and Blood Forming Organs|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|P-glycoprotein/ABCB1 Substrates|Pyridines|Serine Proteinase Inhibitors
DB06606	Teplizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06607	Catumaxomab	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06608	Tafenoquine	small molecule	approved|investigational	Aminoquinolines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Cytochrome P-450 CYP2D6 Substrates|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OCT2 Inhibitors|Quinolines
DB06609	Odiparcil	small molecule	investigational	Carbohydrates
DB06610	Omiganan	small molecule	investigational	
DB06611	Pegsunercept	biotech	investigational	Alcohols|Amino Acids, Peptides, and Proteins|Antigens|Antigens, CD|Antigens, Differentiation|Antigens, Surface|Biological Factors|Biomarkers|Biomedical and Dental Materials|Ethylene Glycols|Glycols|Macromolecular Substances|Membrane Proteins|Pegylated agents|Polymers|Proteins|Receptors, Cell Surface|Receptors, Cytokine|Receptors, Death Domain|Receptors, Immunologic|Receptors, Tumor Necrosis Factor|Recombinant Proteins
DB06612	Mepolizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin Inhibitors|Interleukin-5 Antagonist|Interleukin-5 Antagonists|Proteins|Serum Globulins
DB06614	Peramivir	small molecule	approved|investigational	Amidines|Anti-Infective Agents|Antiviral Agents|Cycloparaffins|Enzyme Inhibitors|Neuraminidase Inhibitors|Neuraminidase, antagonists & inhibitors
DB06616	Bosutinib	small molecule	approved	Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB06618	Cutamesine	small molecule	investigational	Carbon Radioisotopes|Central Nervous System Agents|Nootropic Agents|Receptors, sigma, agonists
DB06619	Amdoxovir	small molecule	investigational	Carbohydrates|Dioxoles|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines
DB06620	Aplindore	small molecule	investigational	
DB06622	7-beta-Hydroxyepiandrosterone	small molecule	investigational	
DB06623	Flupirtine	small molecule	investigational	Amines|Analgesics|Central Nervous System Agents|Nervous System|Peripheral Nervous System Agents|Pyridines|Sensory System Agents
DB06624	Taranabant	small molecule	investigational	
DB06625	Vipadenant	small molecule	investigational	Adenosine A2 Receptor Antagonists|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists
DB06626	Axitinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Enzyme Inhibitors|Kinase Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Pyrazoles|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Substrates
DB06629	Zibotentan	small molecule	investigational	
DB06630	Anacetrapib	small molecule	investigational	Anticholesteremic Agents|Cholesterol Ester Transfer Proteins, antagonists & inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Oxazoles|Toxic Actions
DB06634	Casopitant	small molecule	investigational	Alimentary Tract and Metabolism|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents
DB06635	Otamixaban	small molecule	investigational	Anticoagulants|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Proteinase Inhibitors
DB06636	Isavuconazonium	small molecule	approved|investigational	Antifungal Agents|Azole Antifungals|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB06637	Dalfampridine	small molecule	approved	Amines|Aminopyridines|Cardiovascular Agents|Membrane Transport Modulators|Nervous System|OCT2 Substrates|Other Miscellaneous Therapeutic Agents|Potassium Channel Antagonists|Potassium Channel Blockers|Pyridines
DB06638	Quarfloxin	small molecule	investigational	Oxazines|Quinolines
DB06640	Fispemifene	small molecule	investigational	Benzene Derivatives|Benzylidene Compounds|Stilbenes
DB06641	Perifosine	small molecule	investigational	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Choline|Ethanolamines|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB06642	Bevasiranib	biotech	investigational	Antisense Elements (Genetics)|Diagnostic Uses of Chemicals|Laboratory Chemicals|Molecular Probes|Nucleic Acid Probes|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|RNA|RNA, Antisense|RNA, Small Untranslated|RNA, Untranslated
DB06643	Denosumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Blood Proteins|Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Musculo-Skeletal System|Proteins|RANK Ligand Blocking Activity|RANK Ligand Inhibitor|Serum Globulins
DB06645	Anamorelin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides
DB06647	Volociximab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06649	Priralfinamide	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Lipids
DB06650	Ofatumumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antigens, CD20|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD20-directed Antibody Interactions|CD20-directed Cytolytic Antibody|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB06652	Vicriviroc	small molecule	investigational	Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates
DB06654	Safinamide	small molecule	approved|investigational	Agents that produce hypertension|Agents that reduce seizure threshold|Amines|Amino Acids|Amino Acids, Peptides, and Proteins|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Benzyl Compounds|Breast Cancer Resistance Protein Inhibitors|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Monoamine Oxidase B Inhibitors|Monoamine Oxidase Inhibitors|Monoamine Oxidase-B Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB06655	Liraglutide	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Gastrointestinal Hormones|GLP-1 Agonists|Glucagon-Like Peptide 1|Glucagon-like Peptide-1 (GLP-1) Agonists|Glucagon-Like Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypoglycemia-Associated Agents|Incretin Mimetics|Incretins|Insulins and Analogues|Insulins and Analogues for Injection, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins
DB06656	TAS-106	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB06657	Valrocemide	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins
DB06659	Rostaporfin	small molecule	investigational	Biological Factors|Dermatologicals|Photosensitizing Agents|Pigments, Biological|Radiation-Sensitizing Agents
DB06660	Saredutant	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Receptors, Neurokinin-2, antagonists & inhibitors
DB06662	Abetimus	biotech	investigational	Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycosides|Immunosuppressive Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides|Selective Immunosuppressants
DB06663	Pasireotide	small molecule	approved	Amino Acids, Peptides, and Proteins|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents|Somatostatin Agonists|Somatostatin and Analogues|Somatostatin Receptor Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB06666	Lixivaptan	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB06669	Arverapamil	small molecule	investigational	
DB06670	Odanacatib	small molecule	investigational	Benzene Derivatives|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|P-glycoprotein/ABCB1 Substrates
DB06673	Almorexant	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB06674	Golimumab	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|Disease-modifying Antirheumatic Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Proteins|Serum Globulins|Tumor Necrosis Factor Alpha (TNF-Î±) Inhibitors|Tumor Necrosis Factor Blocker|Tumor Necrosis Factor Receptor Blocking Activity
DB06677	Clazosentan	small molecule	investigational	Amides|Dioxins|Receptor, Endothelin A|Sulfones|Sulfur Compounds|Vasospasm, Intracranial
DB06678	Esmirtazapine	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antidepressive Agents, Tetracyclic|Carbon Radioisotopes|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Dibenzazepines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Psychotropic Drugs
DB06679	Amediplase	small molecule	investigational	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrinolytic Agents|Hydrolases|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB06680	Asoprisnil	small molecule	investigational	Amines|Estranes|Hydroxylamines|Steroids
DB06681	Belatacept	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD80-directed Antibody Interactions|CD86-directed Antibody Interactions|Globulins|Immunoconjugates|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Proteins|Selective Immunosuppressants|Selective T Cell Costimulation Blocker|Serum Globulins|T Lymphocyte Costimulation Activity Blockade
DB06682	Naproxcinod	small molecule	investigational	Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Cardiovascular Agents|Musculo-Skeletal System|Naphthaleneacetic Acids|Naphthalenes|Nitric Oxide Donors|Propionates
DB06683	Clevudine	small molecule	investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Arabinonucleosides|Carbohydrates|Direct Acting Antivirals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB06684	Vilazodone	small molecule	approved	Agents that produce hypertension|Benzofurans|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Indoles|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Piperazines|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists
DB06685	Laquinimod	small molecule	investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Nervous System|Quinolines
DB06688	Sipuleucel-T	biotech	approved|investigational	Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|Autologous Cellular Immunotherapy|Cancer Vaccines|Cell-mediated Immunity|Cells, Cultured, Autologous|Complex Mixtures|Intercellular Adhesion Molecule-1|Peripheral Blood Mononuclear Cells
DB06689	Ethanolamine oleate	small molecule	approved	Antivaricose Therapy|Cardiovascular Agents|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids|Pharmaceutical Preparations|Pharmaceutical Solutions|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Vasoprotectives
DB06690	Nitrous oxide	small molecule	approved|vet_approved	Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Anions|Central Nervous System Agents|Central Nervous System Depressants|Electrolytes|Gases|Ions|Methemoglobinemia Associated Agents|Nervous System|Nitrogen Compounds|Nitrogen Oxides|Oxides|Oxygen Compounds|Peripheral Nervous System Agents|Sensory System Agents
DB06691	Mepyramine	small molecule	approved|vet_approved	Amines|Aminopyridines|Anti-Allergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Sleep Aids, Pharmaceutical|Substituted Ethylene Diamines
DB06692	Aprotinin	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Antifibrinolytic Agents|Blood and Blood Forming Organs|Cholinesterase Inhibitors|Coagulants|Decreased Fibrinolysis|Enzyme Inhibitors|Hematologic Agents|Hemostatics|Proteinase Inhibitors|Proteins|Serine Proteinase Inhibitors|Trypsin Inhibitors
DB06693	Mevastatin	small molecule	experimental	Anti-Infective Agents|Anticholesteremic Agents|Antifungal Agents|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Naphthalenes|Noxae|Toxic Actions
DB06694	Xylometazoline	small molecule	approved|investigational	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antiarrhythmic agents|Antihistamine Drugs|Calcium Channel Blockers|Cardiovascular Agents|Decongestants and Antiallergics|Membrane Transport Modulators|Nasal Decongestants|Nasal Preparations|Ophthalmologicals|Pyridines|Respiratory System Agents|Sensory Organs|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents|Vasodilating Agents
DB06695	Dabigatran etexilate	small molecule	approved	Anticoagulants|Antithrombins|Benzimidazoles|Blood and Blood Forming Organs|Enzyme Inhibitors|Hematologic Agents|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Pyridines|Serine Proteinase Inhibitors|UGT1A9 Substrates
DB06696	Arbekacin	small molecule	experimental|investigational	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Glycosides|Kanamycin|Narrow Therapeutic Index Drugs|Nephrotoxic agents
DB06697	Artemether	small molecule	approved	Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Artemisia|Artemisinin and Derivatives, Plain|Coccidiostats|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Electrolytes|Free Radicals|Highest Risk QTc-Prolonging Agents|Ions|Oxides|Oxygen Compounds|Peroxides|QTc Prolonging Agents|Reactive Oxygen Species|Schistosomicides|Sesquiterpenes|Terpenes
DB06698	Betahistine	small molecule	approved|investigational	Antivertigo Preparations|Cardiovascular Agents|Histamine Agents|Histamine Agonists|Histamine Antagonists|Miscellaneous Central Nervous System Agents|Miscellaneous Therapeutic Agents|Nervous System|Neurotransmitter Agents|Pyridines|Vasodilating Agents
DB06699	Degarelix	small molecule	approved	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin-releasing Hormone Antagonists|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Hormone Antagonists and Related Agents|Peptides|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB06700	Desvenlafaxine	small molecule	approved|investigational	Agents producing tachycardia|Agents that reduce seizure threshold|Alcohols|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cyclohexanes|Cyclohexanols|Cycloparaffins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Fatty Alcohols|Hexanols|Hypoglycemia-Associated Agents|Lipids|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|Phenols|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators
DB06701	Dexmethylphenidate	small molecule	approved|investigational	Acids, Carbocyclic|Agents that produce hypertension|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Central Nervous System Stimulation|Centrally Acting Sympathomimetics|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Dopamine Agents|Dopamine Uptake Inhibitors|Membrane Transport Modulators|Methylphenidate|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Phenylacetates|Piperidines|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB06702	Fesoterodine	small molecule	approved	Agents producing tachycardia|Anticholinergic Agents|Benzene Derivatives|Cholinergic Agents|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Muscarinic Antagonists|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Urological Agents|Urologicals
DB06703	Gadobutrol	small molecule	approved	Contrast Media|Diagnostic Uses of Chemicals|Gadolinium|Gadolinium-based Contrast Agent|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Other Diagnostics|Paramagnetic Contrast Media
DB06704	Iobenguane	small molecule	approved|investigational	Amidines|Antineoplastic Agents|Benzene Derivatives|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Enzyme Inhibitors|Guanidines|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Indicators and Reagents|Iodine (131I) Compounds|Iodobenzenes|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Therapeutic Radiopharmaceuticals|Tumour Detection
DB06705	Gadofosveset trisodium	small molecule	approved	Contrast Media|Diagnostic Uses of Chemicals|Elements|Gadolinium-based Contrast Agent|Lanthanoid Series Elements|Magnetic Resonance Angiography|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Metals|Metals, Rare Earth|Paramagnetic Contrast Agent|Paramagnetic Contrast Media
DB06706	Isometheptene	small molecule	approved	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alimentary Tract and Metabolism|Amines|Drugs for Functional Gastrointestinal Disorders|Methemoglobinemia Associated Agents
DB06707	Levonordefrin	small molecule	approved	Adrenergic Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Cardiovascular Agents|Catecholamines|Epinephrine|Ethanolamines|Norepinephrine|Vasoconstrictor Agents
DB06708	Lumefantrine	small molecule	approved	Alcohols|Amines|Amino Alcohols|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB06709	Methacholine	small molecule	approved|investigational	Amines|Ammonium Compounds|Autonomic Agents|Bronchoconstrictor Agents|Cholinergic Agents|Cholinergic Agonists|Cholinergic Receptor Agonist|Methacholine Compounds|Miotics|Muscarinic Agonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Other Diagnostics|Parasympathomimetics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Respiratory System Agents|Trimethyl Ammonium Compounds
DB06710	Methyltestosterone	small molecule	approved	3-Oxoandrosten (4) Derivatives|Anabolic Agents|Androgens|Androgens and Estrogens|Androstanes|Androstenes|Androstenols|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners
DB06711	Naphazoline	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Cardiovascular Agents|Decongestants and Antiallergics|Imidazoles|Nasal Decongestants|Nasal Preparations|Neurotransmitter Agents|Ophthalmologicals|Respiratory System Agents|Sensory Organs|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents
DB06712	Nilvadipine	small molecule	investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB06713	Norelgestromin	small molecule	approved|investigational	Adrenal Cortex Hormones|Amines|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hydroxylamines|Norgestrel|Norpregnanes|Norpregnenes|Norsteroids|Pharmaceutical Preparations|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB06714	Propylhexedrine	small molecule	approved	Amines
DB06715	Potassium Iodide	small molecule	approved	Anions|Antidotes|Cough and Cold Preparations|Electrolytes|Expectorants|Iodides|Iodine Compounds|Ions|Laxatives|Minerals|Ophthalmologicals|Osmotic Laxative|Potassium Compounds|Potassium Salt|Sensory Organs|Thyroid Products
DB06716	Fospropofol	small molecule	approved|illicit|investigational	Agents that reduce seizure threshold|Anesthetics|Anesthetics, General|Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Phenols
DB06717	Fosaprepitant	small molecule	approved	Antiemetics|Autonomic Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Miscellaneous Antiemetics|Neurokinin 1 Antagonists|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Oxazines|Peripheral Nervous System Agents|Substance P/Neurokinin-1 Receptor Antagonist
DB06718	Stanozolol	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Androstan Derivatives|Androstanes|Androstanols|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB06719	Buserelin	biotech	approved|investigational	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Fertility Agents|Fertility Agents, Female|Gonadotropin-releasing hormone agonist|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Miscellaneous Therapeutic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents|Reproductive Control Agents
DB06720	Velaglucerase alfa	biotech	approved|investigational	Alimentary Tract and Metabolism|Enzymes|Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
DB06721	Gimatecan	small molecule	investigational	Alkaloids|OATP1B1/SLCO1B1 Substrates
DB06723	Aluminum hydroxide	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Anions|Antacids|Antacids and Adsorbents|Carbon Compounds, Inorganic|Carbonic Acid|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxides|Immunologic Factors|Ions|Miscellaneous Local Anti-infectives
DB06724	Calcium Carbonate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Alkalies|Anions|Antacids|Antacids and Adsorbents|Blood Coagulation Factors|Calcium Compounds|Calcium Salts|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Ions|Mineral Supplements|Minerals|Phosphate Binder|Replacement Preparations
DB06725	Lornoxicam	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Oxicams|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines
DB06726	Bufuralol	small molecule	experimental|investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents
DB06727	Sparteine	small molecule	experimental	Alkaloids|Antiarrhythmic agents|Antiarrhythmics, Class I|Antiarrhythmics, Class Ia|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Quinolizidines|Quinolizines|Reproductive Control Agents
DB06728	Aniline	small molecule	experimental	Amines|Carcinogens|Cytochrome P-450 CYP2E1 Substrates|Noxae|Toxic Actions
DB06729	Sulfaphenazole	small molecule	approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intermediate-Acting Sulfonamides|Long-Acting Sulfonamides|Ophthalmologicals|Pyrazoles|Sensory Organs|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB06730	Gestodene	small molecule	investigational	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB06731	Seproxetine	small molecule	investigational	Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Selective Serotonin Reuptake Inhibitors|Serotonin Agents|Serotonin Modulators
DB06732	beta-Naphthoflavone	small molecule	experimental	Benzoflavones|Benzopyrans|Chromones|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 Enzyme Inducers|Enzyme Inhibitors|Flavonoids|Pyrans
DB06733	Bafilomycin A1	small molecule	experimental	Anti-Infective Agents|Antifungal Agents|Enzyme Inhibitors|Lactones|P-glycoprotein/ABCB1 Inhibitors|Polyketides|Proton-Translocating ATPases, antagonists & inhibitors
DB06734	Bafilomycin B1	small molecule	experimental	Lactones|P-glycoprotein/ABCB1 Inhibitors|Polyketides
DB06735	Enclomiphene	small molecule	investigational	Benzene Derivatives|Benzylidene Compounds|Clomiphene|Cytochrome P-450 CYP2D6 Substrates|Estrogen Antagonists|Estrogen Receptor Modulators|Fertility Agents|Fertility Agents, Female|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Selective Estrogen Receptor Modulators|Stilbenes
DB06736	Aceclofenac	small molecule	approved|investigational	Acetic Acid Derivatives and Related Substances|Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Phenylacetates|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB06737	Zaltoprofen	small molecule	experimental	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Nephrotoxic agents|Peripheral Nervous System Agents|Pyrans|Sensory System Agents|Sulfur Compounds
DB06738	Ketobemidone	small molecule	experimental	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Isonipecotic Acids|Narcotics|Nervous System|Neurotransmitter Agents|Opioids|Peripheral Nervous System Agents|Phenylpiperidine Derivatives|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|UGT1A9 Substrates
DB06739	Seratrodast	small molecule	experimental	Analgesics|Analgesics, Non-Narcotic|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Central Nervous System Agents|Cytochrome P-450 CYP2A6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Fatty Acids|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipids|Peripheral Nervous System Agents|Prostaglandin Antagonists|Quinones|Respiratory System Agents|Sensory System Agents|UGT1A9 Substrates
DB06740	BW-A 58C	small molecule	experimental	Naphthalenes|Quinones
DB06741	Gavestinel	small molecule	investigational	Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Glycine Agents|Neurotransmitter Agents|UGT1A1 Substrates|UGT1A9 Substrates
DB06742	Ambroxol	small molecule	investigational	Amines|Aniline Compounds|Bromhexine|Cough and Cold Preparations|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Expectorants|Respiratory System Agents
DB06743	Ginkgolide A	small molecule	nutraceutical	Diterpenes|Terpenes
DB06744	ginkgolide-B	small molecule	nutraceutical	
DB06745	ginkgolide-C	small molecule	nutraceutical	Diterpenes|Terpenes
DB06746	ginkgolide-J	small molecule	nutraceutical	Diterpenes|Terpenes
DB06747	ginkgolide-M	small molecule	nutraceutical	
DB06748	Ginsenoside C	small molecule	nutraceutical	Antineoplastic Agents|Carbohydrates|Glycosides|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Panax|Saponins|Terpenes|Toxic Actions|Triterpenes
DB06749	ginsenoside Rb1	small molecule	nutraceutical	Carbohydrates|Glycosides|OATP1B3 inhibitors|Panax|Saponins|Terpenes|Triterpenes
DB06750	Ginsenoside Rg1	small molecule	nutraceutical	Carbohydrates|Central Nervous System Agents|Drugs, Chinese Herbal|Glycosides|Panax|Saponins|Terpenes|Triterpenes
DB06751	Drotaverine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Alkaloids|Analgesics|Autonomic Agents|Benzylisoquinolines|Cardiovascular Agents|Central Nervous System Agents|Drugs for Functional Gastrointestinal Disorders|Isoquinolines|Opiate Alkaloids|Papaverine and Derivatives|Parasympatholytics|Peripheral Nervous System Agents|Sensory System Agents|Vasodilating Agents
DB06752	Chymopapain	biotech	approved|withdrawn	Cysteine Endopeptidases|Cysteine Proteases|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Musculo-Skeletal System|Peptide Hydrolases
DB06754	Danaparoid	small molecule	approved|withdrawn	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Chondroitin|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosaminoglycans|Hematologic Agents|Heparin and similars|Heparinoids|Polysaccharides
DB06755	Beta carotene	small molecule	approved|nutraceutical	Alimentary Tract and Metabolism|Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Dermatologicals|Diet, Food, and Nutrition|Emollients and Protectives|Food|Food and Beverages|Growth Substances|Hydrocarbons, Acyclic|Micronutrients|Physiological Phenomena|Pigments, Biological|Polyenes|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Systemic Use|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)
DB06756	Glycine betaine	small molecule	approved|nutraceutical	Acid Preparations|Alimentary Tract and Metabolism|Amines|Amino Acids and Derivatives|Ammonium Compounds|Cholinesterase Inhibitors|Digestives, Incl. Enzymes|Gastrointestinal Agents|Hypolipidemic Agents|Lipid Regulating Agents|Lipotropic Agents|Methylating Activity|Methylating Agent|Nitrogen Compounds|Noxae|Onium Compounds|Other Miscellaneous Therapeutic Agents|Quaternary Ammonium Compounds|Toxic Actions|Trimethyl Ammonium Compounds
DB06757	Manganese	small molecule	approved|nutraceutical	Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Diet, Food, and Nutrition|Electrolytes|Elements|Food|Food and Beverages|Growth Substances|Hydrochloric Acid|Ions|Magnetic Resonance Contrast Activity|Metals|Metals, Heavy|Micronutrients|Minerals|Paramagnetic Contrast Agent|Physiological Phenomena|Replacement Preparations|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Trace Elements|Transition Elements
DB06759	Fomivirsen	biotech	approved|investigational|withdrawn	Anti-Infective Agents|Antisense Elements (Genetics)|Antiviral Agents|Carbohydrates|Diagnostic Uses of Chemicals|Glycosides|Laboratory Chemicals|Molecular Probes|Nucleic Acid Probes|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Oligonucleotides, Antisense|Ophthalmologicals|Polynucleotides|Sensory Organs|Sulfur Compounds
DB06760	Sacrosidase	biotech	approved	Alimentary Tract and Metabolism|Enzymes|Enzymes and Coenzymes|Glycoside Hydrolases|Hydrolases|Sucrose-specific Enzyme
DB06761	Beractant	biotech	approved	Alveolar Surface Tension Reduction|Bradycardia-Causing Agents|Complex Mixtures|Pulmonary Surfactants|Respiratory System Agents|Surface-Active Agents|Surfactant Activity
DB06762	Pinacidil	small molecule	approved	Amidines|Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Guanidine Derivatives|Guanidines|Membrane Transport Modulators|Vasodilating Agents
DB06763	Saralasin	small molecule	investigational	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Angiotensin II|Angiotensin Receptor Antagonists|Angiotensins|Autacoids|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins
DB06764	Tetryzoline	small molecule	approved	Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Cardiovascular Agents|Decongestants and Antiallergics|Nasal Decongestants|Nasal Preparations|Ophthalmic Solutions|Ophthalmologicals|Peripheral Nervous System Agents|Pharmaceutical Preparations|Pharmaceutical Solutions|Respiratory System Agents|Sensory Organs|Solutions|Sympathomimetics|Sympathomimetics Used as Decongestants|Sympathomimetics, Plain|Vasoconstrictor Agents
DB06766	Alcaftadine	small molecule	approved	Decongestants and Antiallergics|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Ophthalmologicals|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sensory Organs
DB06767	Ammonium chloride	small molecule	approved|investigational|vet_approved	Acidifiers|Acidifying Agents|Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Ammonium Compounds|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorides|Chlorine Compounds|Electrolyte Solutions|Electrolytes|Genito Urinary System and Sex Hormones|Hydrochloric Acid|I.V. Solution Additives|Ions|Nitrogen Compounds|Urinary Acidifying Agents|Urologicals
DB06768	Ammonium lactate	small molecule	approved	alpha-Hydroxy Acid|Hydroxy Acids|Lactates
DB06769	Bendamustine	small molecule	approved|investigational	Acids, Acyclic|Alkylating Activity|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Benzimidazoles|Butyrates|Cytochrome P-450 CYP1A2 Substrates|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Halogenated|Immunosuppressive Agents|Lipids|Mustard Compounds|Myelosuppressive Agents|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Toxic Actions
DB06770	Benzyl alcohol	small molecule	approved	Alcohols|Anesthetics|Anesthetics, Local|Antiparasitic Products, Insecticides and Repellents|Benzene Derivatives|Benzyl Alcohols|Benzyl Compounds|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|P-glycoprotein/ABCB1 Inhibitors|Pediculicides|Peripheral Nervous System Agents|Sensory System Agents
DB06771	Besifloxacin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|Ophthalmologicals|QTc Prolonging Agents|Quinolines|Quinolone Antimicrobial|Quinolones|Sensory Organs|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB06772	Cabazitaxel	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Diterpenes|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Myelosuppressive Agents|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Taxane Derivatives|Taxoids|Terpenes
DB06773	Human calcitonin	biotech	approved|investigational	Bone Density Conservation Agents|Calcitonin Preparations|Calcium Homeostasis|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB06774	Capsaicin	small molecule	approved	Alkaloids|Alkenes|Alkynes|Amides|Anesthetics|Anesthetics, Local|Antipruritics|Basic Lotions and Liniments|Benzene Derivatives|Capsaicin and Similar Agents|Catechols|Cholinesterase Inhibitors|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Lipids|Musculo-Skeletal System|Nervous System|Peripheral Nervous System Agents|Phenols|Polyunsaturated Alkamides|Sensory System Agents|Solanaceous Alkaloids|Topical Products for Joint and Muscular Pain
DB06775	Carglumic acid	small molecule	approved	Alimentary Tract and Metabolism|Amino Acids|Amino Acids and Derivatives|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Ammonia Detoxicants|Carbamoyl Phosphate Synthetase 1 Activator|Carbamoyl Phosphate Synthetase 1 Activators
DB06776	Sodium cellulose phosphate	small molecule	approved	Biomedical and Dental Materials|Biopolymers|Calcium Binder|Calcium Chelating Activity|Carbohydrates|Cation Exchange Resins|Drugs for Treatment of Hypercalcemia|Glucans|Macromolecular Substances|Polymers|Polysaccharides
DB06777	Chenodeoxycholic acid	small molecule	approved	Alimentary Tract and Metabolism|Bile Acid Preparations|Bile Acids and Salts|Bile and Liver Therapy|Bile Therapy|Cholanes|Cholic Acids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Deoxycholic Acid|Gastrointestinal Agents|Steroids
DB06778	Cupric sulfate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Antidotes|Autonomic Agents|Central Nervous System Agents|Copper-containing Intrauterine Device|Electrolytes|Emetics|Gastrointestinal Agents|Ions|Laxatives|Osmotic Laxative|Peripheral Nervous System Agents|Protective Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB06779	Dalteparin	small molecule	approved	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB06780	Desoxycorticosterone acetate	small molecule	approved	Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Desoxycorticosterone|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Mineralocorticoids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB06781	Difluprednate	small molecule	approved	Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB06782	Dimercaprol	small molecule	approved	Antidotes|Chelating Agents|Heavy Metal Antagonists|Metal Chelating Activity|Metal Chelator|Sequestering Agents|Sulfhydryl Compounds|Sulfur Compounds
DB06783	Prussian blue	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Antidotes|Chelating Activity|Coloring Agents|Cyanides|Decorporation Agent|Electrolytes|Ferrous Compounds|Hydrogen Cyanide|Ion Exchange Activity|Ions|Iron Compounds|Nitrogen Compounds|Organometallic Compounds|Protective Agents
DB06784	Gallium citrate Ga 67	small molecule	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB06785	Ganirelix	small molecule	approved	Amino Acids, Peptides, and Proteins|Anti-Gonadotropin-Releasing Hormones|Decreased GnRH Secretion|Gonadotropin Releasing Hormone Receptor Antagonists|Gonadotropin-releasing Hormone Antagonists|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB06786	Halcinonide	small molecule	approved|investigational|withdrawn	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Very Potent (Group IV)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB06787	Hexocyclium	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB06788	Histrelin	small molecule	approved	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents
DB06789	Hydroxyprogesterone caproate	small molecule	approved|investigational	Adrenal Cortex Hormones|Antineoplastic Agents|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Corpus Luteum Hormones|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Delayed-Action Preparations|Estrogen Antagonists|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Pregnanes|Pregnenediones|Pregnenes|Progesterone|Progesterone Congeners|Progestin Contraceptives|Progestins|Steroids
DB06791	Lanreotide	small molecule	approved	Acromegaly|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypoglycemia-Associated Agents|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Other Miscellaneous Therapeutic Agents|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Proteins|Somatostatin and Analogues|Somatostatin Receptor Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB06792	Lanthanum carbonate	small molecule	approved	Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Elements|Kidney Failure, Chronic|Lanthanoid Series Elements|Metals|Metals, Rare Earth|Phosphate Binder|Phosphate-removing Agents
DB06793	Levopropoxyphene	small molecule	withdrawn	Acids, Acyclic|Agents that reduce seizure threshold|Fatty Acids|Fatty Acids, Volatile|Lipids|Propionates
DB06794	Lodoxamide	small molecule	approved	Acids, Aldehydic|Alcohols|Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Allergic Agents|Antioxidants|Decongestants and Antiallergics|Decreased Histamine Release|Glycols|Glyoxylates|Histamine Agents|Mast Cell Stabilizers|Neurotransmitter Agents|Ophthalmologicals|Propylene Glycols|Sensory Organs
DB06795	Mafenide	small molecule	approved|vet_approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Methemoglobinemia Associated Agents|Methylated Sulfonamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB06796	Mangafodipir	small molecule	approved|investigational|withdrawn	Acetates|Acids, Acyclic|Amines|Coenzymes|Contrast Media|Diagnostic Uses of Chemicals|Diamines|Enzymes and Coenzymes|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|Manganese|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Picolines|Polyamines|Pyridines|Pyridoxal
DB06797	Mebutamate	small molecule	approved	Anti-Anxiety Agents|Carbamates|Central Nervous System Depressants|Nervous System|Psycholeptics
DB06799	Methenamine	small molecule	approved|vet_approved	Acids, Carbocyclic|Adamantane|Amides|Amines|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Benzoates|Cycloparaffins|Hydroxy Acids|Keto Acids|Polyamines|Renal Agents|Urinary Acidifying Agents
DB06800	Methylnaltrexone	small molecule	approved	Alimentary Tract and Metabolism|Alkaloids|Amines|Ammonium Compounds|Central Nervous System Agents|Drugs for Constipation|Miscellaneous GI Drugs|Morphinans|Naloxone|Nitrogen Compounds|Onium Compounds|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Peripheral Opioid Receptor Antagonists|Phenanthrenes|Sensory System Agents
DB06801	Monoctanoin	small molecule	experimental	Acids, Acyclic|Fatty Acids|Lipids|Solvents
DB06802	Nepafenac	small molecule	approved|investigational	Acetamides|Acetates|Acids, Acyclic|Acids, Carbocyclic|Agents causing hyperkalemia|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Central Nervous System Agents|Cyclooxygenase Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Nephrotoxic agents|Nonsteroidal Anti-inflammatory Compounds|Ophthalmologicals|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory Organs|Sensory System Agents
DB06803	Niclosamide	small molecule	approved|investigational|vet_approved	Agrochemicals|Amides|Anilides|Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Anticestodals|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|Molluscacides|Pesticides|Salicylamides|Salicylanilides|Salicylic Acid Derivatives|Toxic Actions
DB06804	Nonoxynol-9	small molecule	approved|withdrawn	Adrenal Cortex Hormones|Alcohols|Antispermatogenic Agents|Biomedical and Dental Materials|Contraceptive Agents, Female|Contraceptive Agents, Male|Ethylene Glycols|Glycols|Hormonal Contraceptives for Systemic Use|Macromolecular Substances|Noxae|Polyethylene Glycols|Polymers|Reproductive Control Agents|Spermatocidal Agents|Surface-Active Agents|Toxic Actions
DB06807	Phenyl aminosalicylate	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols|Salicylates
DB06809	Plerixafor	small molecule	approved	Adjuvants, Immunologic|Anti-HIV Agents|Anti-Infective Agents|Antineoplastic and Immunomodulating Agents|Hematinics|Hematopoietic Stem Cell Mobilizer|HIV Fusion Inhibitors|Increased Hematopoietic Stem Cell Mobilization|Receptors, CXCR4, antagonists & inhibitors
DB06810	Plicamycin	small molecule	approved|investigational|withdrawn	Anthracyclines|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Coloring Agents|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Fluorescent Dyes|Glycosides|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Naphthacenes|Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors
DB06811	Polidocanol	small molecule	approved	Alcohols|Antivaricose Therapy|Biomedical and Dental Materials|Cardiovascular Agents|Detergents|Ethylene Glycols|Glycols|Household Products|Macromolecular Substances|Pegylated agents|Pharmaceutical Preparations|Pharmaceutical Solutions|Polymers|Sclerosing Activity|Sclerosing Agents for Local Injection|Sclerosing Solutions|Solutions|Surface-Active Agents|Tissue Adhesives|Vascular Sclerosing Activity|Vasoprotectives
DB06812	Povidone-iodine	small molecule	approved	Alkenes|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents (Vaginal)|Antiseptics and Disinfectants|Biomedical and Dental Materials|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydrocarbons, Acyclic|Iodine Compounds|Iodine Products|Iodophors|Irrigating Solutions|Macromolecular Substances|Medicated Dressings|Medicated Dressings With Antiinfectives|Medicated Shampoos|Miscellaneous Local Anti-infectives|Ophthalmologicals|Plastics|Polyenes|Polymers|Polyvinyls|Povidone|Pyrrolidines|Pyrrolidinones|Sensory Organs|Throat Preparations|Vinyl Compounds
DB06813	Pralatrexate	small molecule	approved|investigational	Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Folic Acid Analogues|Folic Acid Antagonists|Immunosuppressive Agents|Pigments, Biological|Pteridines|Pterins
DB06814	Protokylol	small molecule	approved|vet_approved	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Catecholamines|Dioxoles|Epinephrine|Ethanolamines
DB06815	Pyrithione	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Dermatologicals|Gallium Radioisotopes|Indium Radioisotopes|Keratolytic Agents|Miscellaneous Local Anti-infectives|Radiopharmaceuticals|Sulfur Compounds
DB06816	Pyrvinium	small molecule	approved	Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Quinolines|Quinolinium Compounds
DB06817	Raltegravir	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Enzyme Inhibitors|HIV Integrase Inhibitors|Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|Integrase Inhibitors|Pyrrolidines|Pyrrolidinones|UGT1A1 Substrates
DB06819	Phenylbutyric acid	small molecule	approved|investigational	Acids, Carbocyclic|Alimentary Tract and Metabolism|Ammonium Ion Binding Activity|Antineoplastic Agents|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Nitrogen Binding Agent|Urea Cycle Disorder Agents|Various Alimentary Tract and Metabolism Products
DB06820	Sulconazole	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives
DB06821	Sulfameter	small molecule	approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Leprostatic Agents|Long-Acting Sulfonamides|Renal Agents|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB06822	Tinzaparin	small molecule	approved	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Fibrinolytic Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB06823	Tiopronin	small molecule	approved|investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Cough and Cold Preparations|Cystine Disulfide Reduction|Expectorants|Glycine|N-substituted Glycines|Peptides|Peptoids|Reducing and Complexing Thiol|Sulfur Compounds
DB06824	Triethylenetetramine	small molecule	approved|investigational	Amines|Chelating Agents|Diamines|Ethylenediamines|Metal Chelating Activity|Metal Chelator|Polyamines|Sequestering Agents
DB06825	Triptorelin	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Gonadotropin Releasing Hormone Receptor Agonist|Gonadotropin Releasing Hormone Receptor Agonists|Gonadotropin-releasing hormone agonist|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Hypothalamic Hormones|Luteolytic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Potential QTc-Prolonging Agents|Proteins|QTc Prolonging Agents|Reproductive Control Agents
DB06826	Unoprostone	small molecule	approved|investigational	Antiglaucoma Preparations and Miotics|Antihypertensive Agents|Autacoids|Biological Factors|Cardiovascular Agents|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Ophthalmologicals|Prostaglandins|Prostaglandins F|Prostaglandins, Synthetic|Sensory Organs
DB06827	Viomycin	small molecule	approved	Agents that produce neuromuscular block (indirect)|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antituberculosis Agents|Enzyme Inhibitors|Peptides|Peptides, Cyclic|Protein Synthesis Inhibitors
DB06828	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	small molecule	experimental	
DB06829	4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB06830	(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	small molecule	experimental	
DB06831	2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE	small molecule	experimental	
DB06832	2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL	small molecule	experimental	
DB06833	1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE	small molecule	experimental	
DB06834	N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide	small molecule	experimental	
DB06835	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	small molecule	experimental	
DB06836	N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide	small molecule	experimental	
DB06837	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	small molecule	experimental	
DB06838	methyl L-phenylalaninate	small molecule	experimental	
DB06839	N-(ethoxycarbonyl)-L-leucine	small molecule	experimental	
DB06840	diethyl [(1R)-1,5-diaminopentyl]boronate	small molecule	experimental	
DB06841	D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide	small molecule	experimental	
DB06842	(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one	small molecule	experimental	
DB06843	2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE	small molecule	experimental	
DB06844	4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE	small molecule	experimental	
DB06845	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide	small molecule	experimental	
DB06847	5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	small molecule	experimental	
DB06848	1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine	small molecule	experimental	
DB06849	1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine	small molecule	experimental	
DB06850	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide	small molecule	experimental	
DB06851	N-(pyridin-3-ylmethyl)aniline	small molecule	experimental	
DB06852	4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB06853	N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	small molecule	experimental	
DB06855	6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine	small molecule	experimental	
DB06856	6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE	small molecule	experimental	
DB06857	N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE	small molecule	experimental	
DB06858	N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	small molecule	experimental	
DB06859	N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE	small molecule	experimental	
DB06860	2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	small molecule	experimental	
DB06861	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	small molecule	experimental	
DB06862	2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID	small molecule	experimental	
DB06864	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	small molecule	experimental	
DB06865	6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	small molecule	experimental	
DB06866	6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID	small molecule	experimental	
DB06867	3,6,9,12,15,18-HEXAOXAICOSANE	small molecule	experimental	
DB06868	N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide	small molecule	experimental	
DB06869	1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE	small molecule	experimental	
DB06870	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	small molecule	experimental	
DB06871	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	small molecule	experimental	
DB06872	1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE	small molecule	experimental	
DB06873	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE	small molecule	experimental	
DB06874	(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL	small molecule	experimental	
DB06875	3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE	small molecule	experimental	Estrogen Receptor beta, agonists|Naphthalenes
DB06876	N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE	small molecule	experimental	
DB06877	N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	small molecule	experimental	
DB06878	1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide	small molecule	experimental	
DB06879	5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE	small molecule	experimental	
DB06880	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	small molecule	experimental	
DB06881	(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE	small molecule	experimental	
DB06882	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea	small molecule	experimental	
DB06883	1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea	small molecule	experimental	
DB06884	4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE	small molecule	experimental	
DB06885	3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid	small molecule	experimental	
DB06886	N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL	small molecule	experimental	
DB06887	[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid	small molecule	experimental	
DB06888	(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE	small molecule	experimental	
DB06889	3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one	small molecule	experimental	
DB06890	(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE	small molecule	experimental	
DB06891	5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE	small molecule	experimental	
DB06892	(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide	small molecule	experimental	
DB06893	1-DECANE-SULFONIC-ACID	small molecule	experimental	
DB06894	1-DODECANOL	small molecule	experimental	Alcohols|Fatty Alcohols|Lipids
DB06896	1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide	small molecule	experimental	
DB06897	3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol	small molecule	experimental	
DB06898	4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol	small molecule	experimental	
DB06899	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE	small molecule	experimental	
DB06900	1-[4-(hydroxymethyl)phenyl]guanidine	small molecule	experimental	
DB06901	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	small molecule	experimental	
DB06902	4-(1-methyl-1-phenylethyl)phenol	small molecule	experimental	
DB06903	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	small molecule	experimental	
DB06904	(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE	small molecule	experimental	
DB06905	(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid	small molecule	experimental	
DB06906	2-AMINO-4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER	small molecule	experimental	
DB06907	2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID	small molecule	experimental	
DB06908	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	small molecule	experimental	
DB06909	1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide	small molecule	experimental	
DB06910	[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE	small molecule	experimental	
DB06911	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	small molecule	experimental	
DB06912	UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE	small molecule	experimental	
DB06913	(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE	small molecule	experimental	
DB06914	1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE	small molecule	experimental	
DB06915	naphthalene-1,2,4,5,7-pentol	small molecule	experimental	
DB06916	N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE	small molecule	experimental	
DB06917	(4-fluorophenyl)(pyridin-4-yl)methanone	small molecule	experimental	
DB06918	2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE	small molecule	experimental	
DB06919	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	small molecule	experimental	
DB06920	Eribaxaban	small molecule	experimental	
DB06921	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID	small molecule	experimental	
DB06922	2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	small molecule	experimental	
DB06923	2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE	small molecule	experimental	
DB06924	(2R)-2-benzyl-3-nitropropanoic acid	small molecule	experimental	
DB06925	3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	small molecule	experimental	
DB06926	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	small molecule	experimental	
DB06927	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	small molecule	experimental	
DB06928	(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID	small molecule	experimental	
DB06929	1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	small molecule	experimental	
DB06930	N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide	small molecule	experimental	
DB06931	(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)	small molecule	experimental	
DB06932	10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine	small molecule	experimental	
DB06933	N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide	small molecule	experimental	
DB06934	(1R)-3-chloro-1-phenylpropan-1-ol	small molecule	experimental	
DB06935	2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID	small molecule	experimental	
DB06936	N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide	small molecule	experimental	
DB06937	4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL	small molecule	experimental	
DB06938	4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide	small molecule	experimental	
DB06939	N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE	small molecule	experimental	
DB06940	N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide	small molecule	experimental	
DB06941	(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide	small molecule	experimental	
DB06942	N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide	small molecule	experimental	
DB06943	(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol	small molecule	experimental	
DB06944	N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide	small molecule	experimental	
DB06945	N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide	small molecule	experimental	
DB06946	(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid	small molecule	experimental	
DB06947	1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide	small molecule	experimental	
DB06948	2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE	small molecule	experimental	
DB06949	N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide	small molecule	experimental	
DB06950	4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	small molecule	experimental	
DB06951	(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid	small molecule	experimental	
DB06952	(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB06953	2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE	small molecule	experimental	
DB06954	2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate	small molecule	experimental	
DB06955	3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid	small molecule	experimental	
DB06956	N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	small molecule	experimental	
DB06957	4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	small molecule	experimental	
DB06958	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE	small molecule	experimental	
DB06959	(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine	small molecule	experimental	
DB06960	N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide	small molecule	experimental	
DB06961	5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide	small molecule	experimental	
DB06962	(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone	small molecule	experimental	
DB06963	3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide	small molecule	experimental	
DB06964	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE	small molecule	experimental	
DB06965	Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester	small molecule	experimental	
DB06966	Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester	small molecule	experimental	
DB06967	6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE	small molecule	experimental	
DB06968	1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)	small molecule	experimental	
DB06969	2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide	small molecule	experimental	
DB06970	2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE	small molecule	experimental	
DB06971	N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA	small molecule	experimental	
DB06972	7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile	small molecule	experimental	
DB06973	4,4'-PROPANE-2,2-DIYLDIPHENOL	small molecule	experimental	
DB06974	5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one	small molecule	experimental	
DB06976	1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA	small molecule	experimental	
DB06977	(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine	small molecule	experimental	
DB06978	N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide	small molecule	experimental	
DB06979	5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid	small molecule	experimental	
DB06980	(2S)-2-(1H-indol-3-yl)hexanoic acid	small molecule	experimental	
DB06981	(2S)-2-(1H-indol-3-yl)pentanoic acid	small molecule	experimental	
DB06982	(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid	small molecule	experimental	
DB06983	(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol	small molecule	experimental	
DB06984	(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL	small molecule	experimental	
DB06985	2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid	small molecule	experimental	
DB06986	2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	small molecule	experimental	
DB06987	(R)-Atenolol	small molecule	experimental	
DB06988	2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE	small molecule	experimental	
DB06989	{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID	small molecule	experimental	
DB06990	4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID	small molecule	experimental	
DB06991	N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide	small molecule	experimental	
DB06992	(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone	small molecule	experimental	
DB06993	(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine	small molecule	experimental	
DB06994	(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine	small molecule	experimental	
DB06995	N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide	small molecule	experimental	
DB06996	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	small molecule	experimental	
DB06997	2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide	small molecule	experimental	
DB06998	[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid	small molecule	experimental	
DB06999	N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide	small molecule	experimental	
DB07000	N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide	small molecule	experimental	
DB07001	(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine	small molecule	experimental	
DB07002	4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile	small molecule	experimental	
DB07003	(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine	small molecule	experimental	
DB07004	2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide	small molecule	experimental	
DB07005	D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide	small molecule	experimental	
DB07006	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	small molecule	experimental	
DB07007	(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine	small molecule	experimental	
DB07008	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE	small molecule	experimental	
DB07009	2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL	small molecule	experimental	
DB07010	N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE	small molecule	experimental	
DB07011	(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE	small molecule	experimental	
DB07012	6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE	small molecule	experimental	
DB07013	TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE	small molecule	experimental	
DB07014	2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole	small molecule	experimental	
DB07015	(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine	small molecule	experimental	
DB07016	(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline	small molecule	experimental	
DB07017	(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one	small molecule	experimental	
DB07018	5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE	small molecule	experimental	
DB07019	N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE	small molecule	experimental	
DB07020	N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide	small molecule	experimental	
DB07021	(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine	small molecule	experimental	
DB07022	3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate	small molecule	experimental	
DB07023	(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE	small molecule	experimental	
DB07024	2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE	small molecule	experimental	
DB07025	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07026	(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE	small molecule	experimental	
DB07027	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	small molecule	experimental	
DB07028	(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID	small molecule	experimental	
DB07029	4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE	small molecule	experimental	
DB07030	(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID	small molecule	experimental	
DB07031	3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid	small molecule	experimental	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB07032	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	small molecule	experimental	
DB07033	5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE	small molecule	experimental	
DB07034	2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID	small molecule	experimental	
DB07035	(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE	small molecule	experimental	
DB07036	(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	small molecule	experimental	
DB07037	(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL	small molecule	experimental	
DB07038	2-(cyclohexylamino)benzoic acid	small molecule	experimental	
DB07039	(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide	small molecule	experimental	
DB07040	2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide	small molecule	experimental	
DB07041	N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide	small molecule	experimental	
DB07042	7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide	small molecule	experimental	
DB07043	7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide	small molecule	experimental	
DB07044	3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	small molecule	experimental	
DB07045	(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol	small molecule	experimental	
DB07046	2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide	small molecule	experimental	
DB07047	2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID	small molecule	experimental	
DB07048	N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide	small molecule	experimental	
DB07049	(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine	small molecule	experimental	
DB07050	5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide	small molecule	experimental	
DB07051	3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER	small molecule	experimental	
DB07052	5'-S-ethyl-5'-thioadenosine	small molecule	experimental	
DB07053	2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	small molecule	experimental	
DB07054	(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL	small molecule	experimental	
DB07055	2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione	small molecule	experimental	
DB07056	2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide	small molecule	experimental	
DB07057	(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid	small molecule	experimental	
DB07058	5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione	small molecule	experimental	
DB07059	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE	small molecule	experimental	
DB07060	3-(INDOL-3-YL) LACTATE	small molecule	experimental	
DB07061	1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL	small molecule	experimental	
DB07062	N-{3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide	small molecule	experimental	
DB07063	{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID	small molecule	experimental	
DB07064	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	small molecule	experimental	
DB07065	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB07066	2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	small molecule	experimental	
DB07067	(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE	small molecule	experimental	
DB07068	(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID	small molecule	experimental	
DB07069	3-Hydroxyhippuric acid	small molecule	experimental	Acids, Carbocyclic|Amides|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Keto Acids
DB07070	(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid	small molecule	experimental	
DB07071	(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE	small molecule	experimental	
DB07072	(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE	small molecule	experimental	
DB07073	5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one	small molecule	experimental	
DB07074	6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER	small molecule	experimental	
DB07075	3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE	small molecule	experimental	
DB07076	6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE	small molecule	experimental	
DB07077	(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE	small molecule	experimental	
DB07078	(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE	small molecule	experimental	
DB07079	3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol	small molecule	experimental	
DB07080	N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE	small molecule	experimental	Amides|Hydrocarbons, Halogenated|Sulfones|Sulfur Compounds
DB07081	(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE	small molecule	experimental	
DB07082	1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL	small molecule	experimental	
DB07083	beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	small molecule	experimental	
DB07084	N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide	small molecule	experimental	
DB07085	2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID	small molecule	experimental	
DB07086	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	small molecule	experimental	
DB07087	4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	small molecule	experimental	
DB07088	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide	small molecule	experimental	
DB07089	N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide	small molecule	experimental	
DB07090	(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	small molecule	experimental	
DB07091	(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide	small molecule	experimental	
DB07092	(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE	small molecule	experimental	
DB07093	{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID	small molecule	experimental	
DB07094	1-(2,2'-bithiophen-5-yl)methanamine	small molecule	experimental	
DB07095	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide	small molecule	experimental	
DB07096	6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE	small molecule	experimental	
DB07097	4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	small molecule	experimental	
DB07098	4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide	small molecule	experimental	
DB07099	N-[4-(benzyloxy)phenyl]glycinamide	small molecule	experimental	
DB07100	4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	small molecule	experimental	
DB07101	PD-0325901	small molecule	investigational	Acids, Carbocyclic|Amides|Amines|Aniline Compounds|Benzene Derivatives|Benzoates
DB07102	(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid	small molecule	experimental	
DB07103	2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE	small molecule	experimental	
DB07104	4-amino-N-[4-(benzyloxy)phenyl]butanamide	small molecule	experimental	
DB07105	2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE	small molecule	experimental	
DB07106	4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE	small molecule	experimental	
DB07107	(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE	small molecule	experimental	
DB07108	4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID	small molecule	experimental	
DB07109	(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid	small molecule	experimental	
DB07110	4-(4-FLUOROBENZYL)PIPERIDINE	small molecule	experimental	
DB07111	(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid	small molecule	experimental	
DB07112	N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE	small molecule	experimental	
DB07113	(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE	small molecule	experimental	
DB07114	4-[(METHYLSULFONYL)AMINO]BENZOIC ACID	small molecule	experimental	
DB07115	N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide	small molecule	experimental	
DB07116	1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE	small molecule	experimental	
DB07117	5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE	small molecule	experimental	
DB07118	Hymecromone	small molecule	experimental|investigational	Alimentary Tract and Metabolism|Benzopyrans|Bile and Liver Therapy|Bile Therapy|Coumarins|Indicators and Reagents|Laboratory Chemicals|Narrow Therapeutic Index Drugs|Pyrans|Umbelliferones
DB07119	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	small molecule	experimental	
DB07120	N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE	small molecule	experimental	
DB07121	4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	small molecule	experimental	
DB07122	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	small molecule	experimental	
DB07123	N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE	small molecule	experimental	
DB07124	(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	small molecule	experimental	
DB07125	4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid	small molecule	experimental	
DB07126	O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE	small molecule	experimental	
DB07127	{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID	small molecule	experimental	
DB07128	N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE	small molecule	experimental	
DB07129	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	small molecule	experimental	
DB07130	4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07131	(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide	small molecule	experimental	
DB07132	1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA	small molecule	experimental	
DB07133	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	small molecule	experimental	
DB07134	5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	small molecule	experimental	
DB07135	(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE	small molecule	experimental	
DB07136	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID	small molecule	experimental	
DB07137	(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE	small molecule	experimental	
DB07138	Neflamapimod	small molecule	investigational	
DB07139	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	small molecule	experimental	
DB07140	5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	small molecule	experimental	
DB07141	5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	small molecule	experimental	
DB07142	5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	small molecule	experimental	
DB07143	D-phenylalanyl-N-benzyl-L-prolinamide	small molecule	experimental	
DB07144	5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine	small molecule	experimental	
DB07145	(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE	small molecule	experimental	
DB07146	2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE	small molecule	experimental	
DB07147	methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate	small molecule	experimental	
DB07148	(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one	small molecule	experimental	
DB07149	(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one	small molecule	experimental	
DB07150	4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME	small molecule	experimental	
DB07151	4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one	small molecule	experimental	
DB07152	N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide	small molecule	experimental	
DB07153	6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine	small molecule	experimental	
DB07154	(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE	small molecule	experimental	
DB07155	(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE	small molecule	experimental	
DB07156	(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione	small molecule	experimental	
DB07157	(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE	small molecule	experimental	
DB07158	5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE	small molecule	experimental	
DB07159	Tamatinib	small molecule	experimental|investigational	
DB07160	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE	small molecule	experimental	
DB07161	5-phenyl-1H-indazol-3-amine	small molecule	experimental	
DB07162	4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide	small molecule	experimental	
DB07163	5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE	small molecule	experimental	
DB07164	N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine	small molecule	experimental	
DB07165	N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE	small molecule	experimental	
DB07167	5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE	small molecule	experimental	
DB07168	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile	small molecule	experimental	
DB07169	5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE	small molecule	experimental	
DB07170	5'-FLUORO-2',5'-DIDEOXYADENOSINE	small molecule	experimental	
DB07171	5-(2-hydroxyethyl)nonane-1,9-diol	small molecule	experimental	
DB07172	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	small molecule	experimental	
DB07173	7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE	small molecule	experimental	
DB07174	6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE	small molecule	experimental	
DB07175	N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide	small molecule	experimental	
DB07176	5-aminonaphthalene-1-sulfonic acid	small molecule	experimental	
DB07177	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	small molecule	experimental	
DB07178	5-PENTYL-2-PHENOXYPHENOL	small molecule	experimental	
DB07179	3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide	small molecule	experimental	
DB07180	5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide	small molecule	experimental	
DB07181	4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide	small molecule	experimental	
DB07182	(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID	small molecule	experimental	
DB07183	N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide	small molecule	experimental	
DB07184	6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione	small molecule	experimental	
DB07185	2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID	small molecule	experimental	
DB07186	4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE	small molecule	experimental	
DB07187	6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE	small molecule	experimental	
DB07188	(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE	small molecule	experimental	
DB07189	(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid	small molecule	experimental	
DB07190	3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide	small molecule	experimental	
DB07192	(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	small molecule	experimental	
DB07193	(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine	small molecule	experimental	
DB07194	2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide	small molecule	experimental	
DB07195	4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	small molecule	experimental	
DB07196	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	small molecule	experimental	
DB07197	4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07198	5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE	small molecule	experimental	
DB07199	(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID	small molecule	experimental	
DB07200	(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID	small molecule	experimental	
DB07201	(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid	small molecule	experimental	
DB07202	6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07203	6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE	small molecule	experimental	
DB07204	(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE	small molecule	experimental	
DB07205	N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	small molecule	experimental	
DB07206	6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE	small molecule	experimental	
DB07207	2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE	small molecule	experimental	
DB07208	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	small molecule	experimental	
DB07209	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	small molecule	experimental	
DB07210	3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB07211	(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE	small molecule	experimental	
DB07212	N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE	small molecule	experimental	
DB07213	(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL	small molecule	experimental	
DB07215	2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID	small molecule	experimental	
DB07216	(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE	small molecule	experimental	
DB07217	N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide	small molecule	experimental	
DB07218	6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE	small molecule	experimental	
DB07219	BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	small molecule	experimental	
DB07220	N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE	small molecule	experimental	
DB07221	(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM	small molecule	experimental	
DB07222	(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE	small molecule	experimental	
DB07223	METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE	small molecule	experimental	
DB07224	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE	small molecule	experimental	
DB07225	N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE	small molecule	experimental	
DB07226	N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE	small molecule	experimental	
DB07227	4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE	small molecule	experimental	
DB07228	1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA	small molecule	experimental	
DB07229	3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE	small molecule	experimental	
DB07230	3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE	small molecule	experimental	
DB07231	N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE	small molecule	experimental	
DB07232	Veliparib	small molecule	investigational	Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors
DB07233	N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan	small molecule	experimental	
DB07234	3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	small molecule	experimental	
DB07235	N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE	small molecule	experimental	
DB07236	3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL	small molecule	experimental	
DB07237	{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone	small molecule	experimental	
DB07238	Nesbuvir	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB07239	7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile	small molecule	experimental	
DB07240	3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid	small molecule	experimental	
DB07241	7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole	small molecule	experimental	
DB07242	(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	small molecule	experimental	
DB07243	(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE	small molecule	experimental	
DB07244	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	small molecule	experimental	
DB07245	6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE	small molecule	experimental	
DB07246	(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE	small molecule	experimental	
DB07247	[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA	small molecule	experimental	
DB07248	7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE	small molecule	experimental	
DB07249	N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine	small molecule	experimental	
DB07250	N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE	small molecule	experimental	
DB07251	N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE	small molecule	experimental	
DB07252	3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide	small molecule	experimental	
DB07253	N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine	small molecule	experimental	
DB07254	N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE	small molecule	experimental	
DB07255	N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE	small molecule	experimental	
DB07256	3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE	small molecule	experimental	
DB07257	4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione	small molecule	experimental	
DB07258	(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol	small molecule	experimental	
DB07259	1-(4-thiophen-2-ylphenyl)methanamine	small molecule	experimental	
DB07260	N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline	small molecule	experimental	
DB07261	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE	small molecule	experimental	
DB07262	1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE	small molecule	experimental	
DB07263	[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid	small molecule	experimental	
DB07264	(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE	small molecule	experimental	
DB07265	3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID	small molecule	experimental	
DB07266	8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one	small molecule	experimental	
DB07267	2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine	small molecule	experimental	
DB07268	2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE	small molecule	experimental	
DB07269	(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID	small molecule	experimental	
DB07270	N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE	small molecule	experimental	
DB07271	4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one	small molecule	experimental	
DB07272	N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE	small molecule	experimental	
DB07273	1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE	small molecule	experimental	
DB07274	N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide	small molecule	experimental	
DB07275	3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one	small molecule	experimental	
DB07276	5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE	small molecule	experimental	
DB07277	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE	small molecule	experimental	
DB07278	2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE	small molecule	experimental	
DB07279	N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE	small molecule	experimental	
DB07280	5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE	small molecule	experimental	
DB07281	N~3~-BENZYLPYRIDINE-2,3-DIAMINE	small molecule	experimental	
DB07282	3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid	small molecule	experimental	
DB07283	9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid	small molecule	experimental	
DB07284	N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE	small molecule	experimental	
DB07285	(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID	small molecule	experimental	
DB07286	BMS-564929	small molecule	experimental	
DB07287	2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL	small molecule	experimental	
DB07288	N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide	small molecule	experimental	
DB07289	5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07290	(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE	small molecule	experimental	
DB07291	5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile	small molecule	experimental	
DB07292	4-(2-amino-1,3-thiazol-4-yl)phenol	small molecule	experimental	
DB07293	benzyl (2-oxopropyl)carbamate	small molecule	experimental	
DB07294	3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid	small molecule	experimental	
DB07295	2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID	small molecule	experimental	
DB07296	(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE	small molecule	experimental	
DB07297	5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE	small molecule	experimental	
DB07298	3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07299	4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE	small molecule	experimental	
DB07300	2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine	small molecule	experimental	
DB07301	9H-CARBAZOLE	small molecule	experimental	Carcinogens|Indoles|Noxae|Toxic Actions
DB07302	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	small molecule	experimental	
DB07303	N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE	small molecule	experimental	
DB07304	5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID	small molecule	experimental	
DB07305	5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID	small molecule	experimental	
DB07306	ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	small molecule	experimental	
DB07307	N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide	small molecule	experimental	
DB07308	5-(2-CHLOROBENZYL)-2-FUROIC ACID	small molecule	experimental	
DB07309	5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID	small molecule	experimental	
DB07310	(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one	small molecule	experimental	
DB07311	18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE	small molecule	experimental	
DB07312	2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE	small molecule	experimental	
DB07313	5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID	small molecule	experimental	
DB07314	1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA	small molecule	experimental	
DB07315	5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide	small molecule	experimental	
DB07316	N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	small molecule	experimental	
DB07317	(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one	small molecule	experimental	
DB07318	N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE	small molecule	experimental	
DB07319	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	small molecule	experimental	
DB07320	4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID	small molecule	experimental	
DB07321	2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE	small molecule	experimental	
DB07322	2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	small molecule	experimental	
DB07323	2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID	small molecule	experimental	
DB07324	3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE	small molecule	experimental	
DB07325	N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	small molecule	experimental	
DB07326	6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide	small molecule	experimental	
DB07327	(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE	small molecule	experimental	
DB07328	METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE	small molecule	experimental	
DB07329	1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID	small molecule	experimental	
DB07330	trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium	small molecule	experimental	
DB07331	2-(4-NITROPHENYL)ACETIC ACID	small molecule	experimental	
DB07332	ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE	small molecule	experimental	
DB07333	N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE	small molecule	experimental	
DB07334	N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE	small molecule	experimental	
DB07335	3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL	small molecule	experimental	
DB07336	4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL	small molecule	experimental	
DB07337	4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE	small molecule	experimental	
DB07338	Acifluorfen	small molecule	experimental	Acids, Carbocyclic|Agrochemicals|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Herbicides|Pesticides|Toxic Actions
DB07339	(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione	small molecule	experimental	
DB07340	N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine	small molecule	experimental	
DB07341	octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside	small molecule	experimental	
DB07342	1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone	small molecule	experimental	Cycloparaffins|Heme Oxygenase-1, antagonists & inhibitors
DB07343	4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE	small molecule	experimental	
DB07344	3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL	small molecule	experimental	
DB07345	4-(2-aminoethyl)-2-cyclohexylphenol	small molecule	experimental	
DB07346	4-(2-aminoethyl)-2-ethylphenol	small molecule	experimental	
DB07347	4-(2-Aminoethyl)Benzenesulfonyl Fluoride	small molecule	experimental	Enzyme Inhibitors|Serine Proteinase Inhibitors|Sulfur Compounds|Trypsin Inhibitors
DB07348	Brefeldin A	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Lactones|Macrolides|P-glycoprotein/ABCB1 Inhibitors|Polyketides|Protein Synthesis Inhibitors
DB07349	(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE	small molecule	experimental	
DB07350	(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide	small molecule	experimental	
DB07351	O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE	small molecule	experimental	
DB07352	Apigenin	small molecule	experimental	Benzopyrans|Chromones|Flavones|Flavonoids|Pyrans
DB07353	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	small molecule	experimental	
DB07354	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	small molecule	experimental	
DB07355	3-(heptyloxy)benzoic acid	small molecule	experimental	
DB07356	(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE	small molecule	experimental	
DB07357	4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	small molecule	experimental	
DB07358	2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide	small molecule	experimental	
DB07359	3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide	small molecule	experimental	
DB07360	1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea	small molecule	experimental	
DB07362	1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea	small molecule	experimental	
DB07363	THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)	small molecule	experimental	
DB07364	6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE	small molecule	experimental	
DB07365	NAPHTHALEN-2-YL-3-ALANINE	small molecule	experimental	
DB07366	2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER	small molecule	experimental	
DB07367	(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol	small molecule	experimental	
DB07368	4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE	small molecule	experimental	
DB07369	N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide	small molecule	experimental	
DB07370	(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol	small molecule	experimental	
DB07371	3-(10-methyl-9-anthryl)propanoic acid	small molecule	experimental	
DB07373	ANDROSTA-1,4-DIENE-3,17-DIONE	small molecule	experimental	Androstanes|Androstenes|Steroids
DB07374	Anisomycin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Protein Synthesis Inhibitors|Pyrrolidines
DB07375	5-BETA-ANDROSTANE-3,17-DIONE	small molecule	experimental	
DB07376	5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)	small molecule	experimental	
DB07377	N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE	small molecule	experimental	
DB07378	4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL	small molecule	experimental	
DB07379	(2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol	small molecule	experimental	
DB07380	1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	small molecule	experimental	
DB07381	S-Atrolactic Acid	small molecule	experimental	
DB07382	N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine	small molecule	experimental	
DB07383	N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE	small molecule	experimental	
DB07384	1-ACETYL-2-CARBOXYPIPERIDINE	small molecule	experimental	
DB07385	3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE	small molecule	experimental	
DB07387	3-(BUTYLSULPHONYL)-PROPANOIC ACID	small molecule	experimental	
DB07388	ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE	small molecule	experimental	
DB07389	N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE	small molecule	experimental	
DB07390	2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE	small molecule	experimental	
DB07391	(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE	small molecule	experimental	
DB07392	2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE	small molecule	experimental	
DB07393	2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE	small molecule	experimental	
DB07394	AUROVERTIN B	small molecule	experimental	Pyrans
DB07395	4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid	small molecule	experimental	
DB07396	1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid	small molecule	experimental	
DB07397	(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide	small molecule	experimental	
DB07398	2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	small molecule	experimental	
DB07400	1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE	small molecule	experimental	
DB07401	METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE	small molecule	experimental	
DB07402	Azapropazone	small molecule	withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Renal Agents|Sensory System Agents|Triazines|Uricosuric Agents
DB07403	4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE	small molecule	experimental	
DB07404	(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID	small molecule	experimental	
DB07405	1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE	small molecule	experimental	
DB07406	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	small molecule	experimental	
DB07407	5-(2-METHOXYPHENYL)-2-FUROIC ACID	small molecule	experimental	
DB07408	5-(2-NITROPHENYL)-2-FUROIC ACID	small molecule	experimental	
DB07409	(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID	small molecule	experimental	
DB07410	[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID	small molecule	experimental	
DB07411	PHENYLALANINE BORONIC ACID	small molecule	experimental	
DB07412	1-biphenyl-2-ylmethanamine	small molecule	experimental	
DB07413	5'-S-[2-(decylamino)ethyl]-5'-thioadenosine	small molecule	experimental	
DB07414	(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one	small molecule	experimental	
DB07415	4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine	small molecule	experimental	
DB07416	(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE	small molecule	experimental	
DB07418	bis(4-nitrophenyl) hydrogen phosphate	small molecule	experimental	
DB07419	S-23	small molecule	experimental	Amides|Isoquinolines
DB07420	(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid	small molecule	experimental	
DB07421	4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile	small molecule	experimental	
DB07422	(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide	small molecule	experimental	
DB07423	(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide	small molecule	experimental	
DB07424	tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate	small molecule	experimental	
DB07425	Sobetirome	small molecule	investigational	Acids, Acyclic|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids
DB07426	[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)	small molecule	experimental	
DB07427	2-[(2-methoxy-5-methylphenoxy)methyl]pyridine	small molecule	experimental	
DB07428	4-[(5-methoxy-2-methylphenoxy)methyl]pyridine	small molecule	experimental	
DB07429	2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid	small molecule	experimental	
DB07430	(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	small molecule	experimental	
DB07431	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	small molecule	experimental	
DB07432	[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate	small molecule	experimental	
DB07433	(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE	small molecule	experimental	
DB07434	HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE	small molecule	experimental	
DB07435	1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE	small molecule	experimental	
DB07436	N-(1-PHENYL-PROPYL)-FORMAMIDE	small molecule	experimental	
DB07437	1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE	small molecule	experimental	
DB07439	1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE	small molecule	experimental	
DB07440	4-TERT-BUTYLBENZENESULFONIC ACID	small molecule	experimental	
DB07441	3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID	small molecule	experimental	
DB07443	(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide	small molecule	experimental	
DB07444	6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	small molecule	experimental	
DB07445	N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE	small molecule	experimental	
DB07446	N-(biphenyl-4-ylsulfonyl)-D-leucine	small molecule	experimental	
DB07447	5beta-dihydrotestosterone	small molecule	experimental	
DB07448	(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid	small molecule	experimental	
DB07449	N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE	small molecule	experimental	
DB07450	(R)-minalrestat	small molecule	experimental	
DB07451	1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA	small molecule	experimental	
DB07452	2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	small molecule	experimental	
DB07453	2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE	small molecule	experimental	
DB07454	(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	small molecule	experimental	
DB07455	N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide	small molecule	experimental	
DB07456	3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione	small molecule	experimental	
DB07457	3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE	small molecule	experimental	
DB07458	3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione	small molecule	experimental	
DB07459	4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE	small molecule	experimental	
DB07460	2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE	small molecule	experimental	
DB07461	3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	small molecule	experimental	
DB07462	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	small molecule	experimental	
DB07463	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol	small molecule	experimental	
DB07464	1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID	small molecule	experimental	
DB07465	(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile	small molecule	experimental	
DB07466	(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID	small molecule	experimental	
DB07467	4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide	small molecule	experimental	
DB07468	(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	small molecule	experimental	
DB07469	(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	small molecule	experimental	
DB07470	(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one	small molecule	experimental	
DB07471	5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE	small molecule	experimental	
DB07472	(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE	small molecule	experimental	
DB07473	(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER	small molecule	experimental	
DB07474	3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE	small molecule	experimental	
DB07476	N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE	small molecule	experimental	
DB07477	Felbinac	small molecule	experimental	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB07478	1,1'-BIPHENYL-3,4-DIOL	small molecule	experimental	
DB07479	(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL	small molecule	experimental	
DB07480	4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN	small molecule	experimental	
DB07481	tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate	small molecule	experimental	
DB07482	(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE	small molecule	experimental	
DB07483	1,1'-BIPHENYL-2-SULFINIC ACID	small molecule	experimental	
DB07484	(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid	small molecule	experimental	
DB07485	4,4'-cyclohexane-1,1-diyldiphenol	small molecule	experimental	
DB07486	3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline	small molecule	experimental	
DB07487	(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE	small molecule	experimental	
DB07488	{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE	small molecule	experimental	
DB07489	4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium	small molecule	experimental	
DB07490	2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL	small molecule	experimental	
DB07491	5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid	small molecule	experimental	
DB07492	Bromamphenicol	small molecule	experimental	Alcohols|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols
DB07493	(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE	small molecule	experimental	
DB07494	(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE	small molecule	experimental	
DB07495	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE	small molecule	experimental	
DB07496	1,3-DIPHENYLUREA	small molecule	experimental	
DB07497	5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL	small molecule	experimental	
DB07498	4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID	small molecule	experimental	
DB07499	N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide	small molecule	experimental	
DB07500	(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one	small molecule	experimental	
DB07501	(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	small molecule	experimental	
DB07502	4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol	small molecule	experimental	
DB07503	(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE	small molecule	experimental	
DB07504	(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol	small molecule	experimental	
DB07505	N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide	small molecule	experimental	
DB07506	L-BENZYLSUCCINIC ACID	small molecule	experimental	
DB07507	2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione	small molecule	experimental	
DB07508	4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE	small molecule	experimental	
DB07509	difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron	small molecule	experimental	
DB07510	3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid	small molecule	experimental	
DB07511	4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile	small molecule	experimental	
DB07512	7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE	small molecule	experimental	
DB07513	7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE	small molecule	experimental	
DB07514	3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one	small molecule	experimental	
DB07515	1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL	small molecule	experimental	
DB07516	(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	small molecule	experimental	
DB07517	3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC	small molecule	experimental	
DB07518	(2R)-2-ETHYL-1-HEXANESULFONIC ACID	small molecule	experimental	
DB07519	(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	small molecule	experimental	
DB07520	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	small molecule	experimental	
DB07521	6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL	small molecule	experimental	
DB07522	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE	small molecule	experimental	
DB07524	N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine	small molecule	experimental	
DB07525	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	small molecule	experimental	
DB07526	N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE	small molecule	experimental	
DB07527	N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE	small molecule	experimental	
DB07528	3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one	small molecule	experimental	
DB07529	2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE	small molecule	experimental	
DB07530	(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol	small molecule	experimental	
DB07531	4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	small molecule	experimental	
DB07532	N-hexanoyl-L-homoserine	small molecule	experimental	
DB07533	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE	small molecule	experimental	
DB07534	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE	small molecule	experimental	
DB07535	2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one	small molecule	experimental	
DB07536	N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide	small molecule	experimental	
DB07537	N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide	small molecule	experimental	
DB07538	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE	small molecule	experimental	
DB07539	4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID	small molecule	experimental	
DB07540	4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE	small molecule	experimental	
DB07541	4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid	small molecule	experimental	
DB07542	5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID	small molecule	experimental	
DB07543	(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol	small molecule	experimental	
DB07544	N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE	small molecule	experimental	
DB07545	N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE	small molecule	experimental	
DB07546	[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid	small molecule	experimental	
DB07547	5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07548	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE	small molecule	experimental	
DB07549	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE	small molecule	experimental	
DB07550	2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE	small molecule	experimental	
DB07551	(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile	small molecule	experimental	
DB07552	(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile	small molecule	experimental	
DB07553	9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE	small molecule	experimental	
DB07555	Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium	small molecule	experimental	
DB07556	N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE	small molecule	experimental	
DB07557	(5BETA)-PREGNANE-3,20-DIONE	small molecule	experimental	
DB07558	acetylleucyl-leucyl-norleucinal	small molecule	experimental	Amino Acids, Peptides, and Proteins|Calpain, antagonists & inhibitors|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|NF-kappa B, antagonists & inhibitors|Oligopeptides|Peptides|Protease Inhibitors
DB07559	(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide	small molecule	experimental	
DB07560	N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide	small molecule	experimental	
DB07561	(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide	small molecule	experimental	
DB07562	N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE	small molecule	experimental	
DB07563	1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine	small molecule	experimental	
DB07564	6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	small molecule	experimental	
DB07565	Chloramphenicol succinate	small molecule	approved	Alcohols|Anti-Bacterial Agents|Anti-Infective Agents|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols
DB07567	(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL	small molecule	experimental	
DB07568	(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE	small molecule	experimental	
DB07569	CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE	small molecule	experimental	
DB07570	3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID	small molecule	experimental	
DB07571	N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE	small molecule	experimental	
DB07572	3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate	small molecule	experimental	
DB07573	(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol	small molecule	experimental	
DB07574	2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE	small molecule	experimental	
DB07575	2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE	small molecule	experimental	
DB07577	6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE	small molecule	experimental	
DB07578	3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE	small molecule	experimental	
DB07579	BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE	small molecule	experimental	
DB07580	BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE	small molecule	experimental	
DB07581	5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID	small molecule	experimental	
DB07582	N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE	small molecule	experimental	
DB07583	(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE	small molecule	experimental	
DB07584	N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine	small molecule	experimental	
DB07585	5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine	small molecule	experimental	
DB07586	5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE	small molecule	experimental	
DB07587	N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE	small molecule	experimental	
DB07588	3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID	small molecule	experimental	
DB07589	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE	small molecule	experimental	
DB07590	S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE	small molecule	experimental	
DB07591	N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE	small molecule	experimental	
DB07592	(2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate	small molecule	experimental	
DB07593	1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE	small molecule	experimental	
DB07594	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	small molecule	experimental	
DB07595	(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE	small molecule	experimental	
DB07596	(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate	small molecule	experimental	
DB07597	CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	small molecule	experimental	
DB07598	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	small molecule	experimental	
DB07599	[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID	small molecule	experimental	
DB07601	4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol	small molecule	experimental	
DB07602	S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE	small molecule	experimental	
DB07603	N-hexanoyl-L-homocysteine	small molecule	experimental	
DB07604	(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE	small molecule	experimental	
DB07605	2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE	small molecule	experimental	
DB07606	6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE	small molecule	experimental	
DB07607	4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE	small molecule	experimental	
DB07608	N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide	small molecule	experimental	
DB07609	N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	small molecule	experimental	
DB07610	NAPHTHALENE-1,2-DIOL	small molecule	experimental	
DB07611	DECANE-1-THIOL	small molecule	experimental	
DB07612	6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE	small molecule	experimental	
DB07613	3-phenyl-5-(1H-pyrazol-3-yl)isoxazole	small molecule	experimental	
DB07614	PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE	small molecule	experimental	
DB07615	Tranilast	small molecule	investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Anti-Allergic Agents|Anti-Inflammatory Agents|Antiarrhythmic agents|Antiplatelet agents|Benzene Derivatives|Benzoates|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|Histamine Agents|Membrane Transport Modulators|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents
DB07616	4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid	small molecule	experimental	
DB07617	N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	small molecule	experimental	
DB07618	2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE	small molecule	experimental	
DB07619	N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide	small molecule	experimental	
DB07620	2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE	small molecule	experimental	
DB07621	(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE	small molecule	experimental	
DB07622	1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA	small molecule	experimental	
DB07623	4,4'-DIPYRIDYL DISULFIDE	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfhydryl Reagents|Sulfides|Sulfur Compounds
DB07624	1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide	small molecule	experimental	
DB07625	4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide	small molecule	experimental	
DB07626	4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	small molecule	experimental	
DB07627	(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE	small molecule	experimental	
DB07628	6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one	small molecule	experimental	
DB07629	N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	small molecule	experimental	
DB07630	N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE	small molecule	experimental	
DB07631	N-DODECYL-N,N-DIMETHYLGLYCINATE	small molecule	experimental	
DB07632	5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide	small molecule	experimental	
DB07633	octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside	small molecule	experimental	
DB07634	(2,6-DIMETHYL-PHENOXY)-ACETIC ACID	small molecule	experimental	
DB07635	bis(4-hydroxyphenyl)methanone	small molecule	experimental	
DB07636	5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE	small molecule	experimental	
DB07637	Dibromotyrosine	small molecule	experimental	Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB07638	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	small molecule	experimental	
DB07639	3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER	small molecule	experimental	
DB07640	2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione	small molecule	experimental	
DB07641	Decyl(dimethyl)phosphine oxide	small molecule	experimental	Organophosphorus Compounds|Phosphorus Compounds
DB07642	5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine	small molecule	experimental	
DB07643	5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine	small molecule	experimental	
DB07644	5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine	small molecule	experimental	
DB07645	SEBACIC ACID	small molecule	experimental	Acids, Acyclic|Fatty Acids|Lipids
DB07646	UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE	small molecule	experimental	
DB07647	(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL	small molecule	experimental	
DB07648	(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL	small molecule	experimental	
DB07649	(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol	small molecule	experimental	
DB07650	DECYL FORMATE	small molecule	experimental	
DB07651	N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE	small molecule	experimental	
DB07652	1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE	small molecule	experimental	
DB07653	N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE	small molecule	experimental	
DB07654	(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC	small molecule	experimental	
DB07655	3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE	small molecule	experimental	
DB07657	PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER	small molecule	experimental	
DB07658	AC-(D)PHE-PRO-BOROLYS-OH	small molecule	experimental	
DB07659	AC-(D)PHE-PRO-BOROHOMOLYS-OH	small molecule	experimental	
DB07660	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	small molecule	experimental	
DB07661	1,6-DIHYDROXY NAPHTHALENE	small molecule	experimental	
DB07662	N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE	small molecule	experimental	
DB07663	2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID	small molecule	experimental	
DB07664	5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	small molecule	experimental	
DB07665	N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide	small molecule	experimental	
DB07666	(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE	small molecule	experimental	
DB07667	2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	small molecule	experimental	
DB07668	3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID	small molecule	experimental	
DB07669	2,3-DIMETHYL-1,4-NAPHTHOQUINONE	small molecule	experimental	Naphthalenes|Quinones
DB07670	4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE	small molecule	experimental	
DB07671	2-[1-METHYLHEXYL]-4,6-DINITROPHENOL	small molecule	experimental	
DB07672	TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE	small molecule	experimental	
DB07673	DEAMINO-METHYL-PHENYLALANINE	small molecule	experimental	
DB07674	O,O-DIETHYL HYDROGEN THIOPHOSPHATE	small molecule	experimental	
DB07675	(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID	small molecule	experimental	
DB07676	3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one	small molecule	experimental	
DB07677	2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one	small molecule	experimental	
DB07678	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	small molecule	experimental	
DB07679	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	small molecule	experimental	
DB07680	[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID	small molecule	experimental	
DB07681	DODECANESULFONATE ION	small molecule	experimental	
DB07683	N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine	small molecule	experimental	
DB07684	5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID	small molecule	experimental	
DB07685	4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	small molecule	experimental	
DB07686	4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	small molecule	experimental	
DB07687	4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE	small molecule	experimental	
DB07688	4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE	small molecule	experimental	
DB07689	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	small molecule	experimental	
DB07691	2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid	small molecule	experimental	
DB07692	1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	small molecule	experimental	
DB07693	N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide	small molecule	experimental	
DB07694	2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide	small molecule	experimental	
DB07695	N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide	small molecule	experimental	
DB07696	methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate	small molecule	experimental	
DB07697	1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine	small molecule	experimental	
DB07698	3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine	small molecule	experimental	
DB07700	3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN	small molecule	experimental	
DB07701	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	small molecule	experimental	
DB07702	17alpha-Estriol	small molecule	experimental	
DB07703	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	small molecule	experimental	
DB07704	6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE	small molecule	experimental	
DB07705	1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE	small molecule	experimental	
DB07706	2-Hydroxyestradiol	small molecule	experimental	COMT Substrates|Estradiol Congeners|Estranes|Estrenes|Estrogens, Catechol|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB07707	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	small molecule	experimental	
DB07708	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	small molecule	experimental	
DB07710	PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE	small molecule	experimental	
DB07711	(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol	small molecule	experimental	
DB07712	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	small molecule	experimental	
DB07713	(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid	small molecule	experimental	
DB07714	6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID	small molecule	experimental	
DB07715	Emodin	small molecule	investigational	Anthracenes|Anthraquinones|Biological Products|Cascara|Complex Mixtures|Enzyme Inhibitors|Gastrointestinal Agents|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Protein Kinase Inhibitors|Quinones
DB07716	(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL	small molecule	experimental	
DB07717	(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE	small molecule	experimental	
DB07718	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	small molecule	experimental	
DB07719	[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid	small molecule	experimental	
DB07720	Epibatidine	small molecule	experimental	Analgesics|Analgesics, Non-Narcotic|Central Nervous System Agents|Cholinergic Agents|Cholinergic Agonists|Neurotransmitter Agents|Nicotinic Agonists|Peripheral Nervous System Agents|Sensory System Agents
DB07721	DIETHYL 4-METHOXYPHENYL PHOSPHATE	small molecule	experimental	
DB07722	3-(4-NITRO-PHENOXY)-PROPAN-1-OL	small molecule	experimental	
DB07723	3-(5-methoxy-1H-indol-3-yl)propanoic acid	small molecule	experimental	
DB07724	Indeglitazar	small molecule	experimental	
DB07726	2-tert-butylbenzene-1,4-diol	small molecule	experimental	
DB07728	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	small molecule	experimental	
DB07729	3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide	small molecule	experimental	
DB07730	5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE	small molecule	experimental	
DB07731	4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL	small molecule	experimental	
DB07732	2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE	small molecule	experimental	
DB07733	1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE	small molecule	experimental	
DB07734	N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide	small molecule	experimental	
DB07735	N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	small molecule	experimental	
DB07736	(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide	small molecule	experimental	
DB07737	(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide	small molecule	experimental	
DB07738	N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide	small molecule	experimental	
DB07739	(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE	small molecule	experimental	
DB07740	(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid	small molecule	experimental	
DB07741	4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE	small molecule	experimental	
DB07742	N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE	small molecule	experimental	
DB07743	S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE	small molecule	experimental	
DB07744	Z-Val-Ala-Asp fluoromethyl ketone	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Caspase Inhibitors|Central Nervous System Agents|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|Neuroprotective Agents|Protease Inhibitors|Protective Agents
DB07745	2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE	small molecule	experimental	
DB07746	3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID	small molecule	experimental	
DB07747	(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	small molecule	experimental	
DB07748	2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE	small molecule	experimental	
DB07749	2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE	small molecule	experimental	
DB07750	(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	small molecule	experimental	
DB07751	(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	small molecule	experimental	
DB07753	3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID	small molecule	experimental	
DB07754	N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid	small molecule	experimental	
DB07755	(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	small molecule	experimental	
DB07756	1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL	small molecule	experimental	
DB07757	(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one	small molecule	experimental	
DB07758	5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID	small molecule	experimental	
DB07759	5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID	small molecule	experimental	
DB07760	3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid	small molecule	experimental	
DB07761	(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol	small molecule	experimental	
DB07762	4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID	small molecule	experimental	
DB07763	(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE	small molecule	experimental	
DB07764	FLUORESCIN	small molecule	experimental	
DB07765	METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE	small molecule	experimental	
DB07766	(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}	small molecule	experimental	
DB07767	Ferulic acid	small molecule	experimental	Acids, Carbocyclic|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticoagulants|Antihypertensive Agents|Antioxidants|Cardiovascular Agents|Central Nervous System Agents|Cholagogues and Choleretics|Cinnamates|Free Radical Scavengers|Gastrointestinal Agents|Hematologic Agents|Indicators and Reagents|Laboratory Chemicals|Peripheral Nervous System Agents|Plants|Protective Agents|Sensory System Agents
DB07768	Epitestosterone	small molecule	experimental	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB07769	S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	small molecule	experimental	
DB07770	5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07771	[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID	small molecule	experimental	
DB07772	(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid	small molecule	experimental	
DB07773	5-FLUOROINDOLE PROPANOL PHOSPHATE	small molecule	experimental	
DB07775	3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE	small molecule	experimental	
DB07776	Flavone	small molecule	approved|experimental	Benzopyrans|Chromones|Flavones|Flavonoids|Pyrans
DB07778	FAMOXADONE	small molecule	experimental	Acids, Acyclic|Acrylates|Electron Transport Complex III, antagonists & inhibitors
DB07779	N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE	small molecule	experimental	
DB07780	Farnesyl diphosphate	small molecule	experimental	Organophosphates|Organophosphorus Compounds|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes
DB07781	N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA	small molecule	experimental	
DB07782	4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE	small molecule	experimental	
DB07783	1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	small molecule	experimental	
DB07784	[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID	small molecule	experimental	
DB07785	1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE	small molecule	experimental	
DB07786	1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE	small molecule	experimental	
DB07787	5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE	small molecule	experimental	
DB07788	(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE	small molecule	experimental	
DB07789	1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea	small molecule	experimental	
DB07790	N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE	small molecule	experimental	
DB07791	4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE	small molecule	experimental	
DB07792	(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	small molecule	experimental	
DB07793	(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE	small molecule	experimental	
DB07794	5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE	small molecule	experimental	
DB07795	Fisetin	small molecule	experimental	Benzopyrans|Chromones|Pyrans
DB07796	(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE	small molecule	experimental	
DB07797	N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA	small molecule	experimental	
DB07798	(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	small molecule	experimental	
DB07800	N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE	small molecule	experimental	
DB07801	N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide	small molecule	experimental	
DB07802	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	small molecule	experimental	
DB07803	2-phenyl-1H-imidazole-4-carboxylic acid	small molecule	experimental	
DB07804	5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE	small molecule	experimental	
DB07805	3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE	small molecule	experimental	
DB07806	(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	small molecule	experimental	
DB07807	(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL	small molecule	experimental	
DB07808	(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid	small molecule	experimental	
DB07809	4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE	small molecule	experimental	
DB07810	3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE	small molecule	experimental	
DB07811	N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide	small molecule	experimental	
DB07812	N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide	small molecule	experimental	
DB07813	GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE	small molecule	experimental	
DB07814	Gibberellic acid	small molecule	experimental	Diterpenes|Diterpenes, Kaurane|Growth Substances|Plant Growth Regulators|Terpenes
DB07815	GIBBERELLIN A4	small molecule	experimental	Diterpenes|Diterpenes, Kaurane|Terpenes
DB07816	N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID	small molecule	experimental	
DB07817	1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea	small molecule	experimental	
DB07818	(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE	small molecule	experimental	
DB07819	(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE	small molecule	experimental	
DB07820	6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL	small molecule	experimental	
DB07821	(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate	small molecule	experimental	
DB07823	(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid	small molecule	experimental	
DB07824	4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one	small molecule	experimental	
DB07825	(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid	small molecule	experimental	
DB07826	2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide	small molecule	experimental	
DB07827	4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID	small molecule	experimental	
DB07829	4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE	small molecule	experimental	
DB07830	(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE	small molecule	experimental	
DB07831	2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE	small molecule	experimental	
DB07832	4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde	small molecule	experimental	
DB07833	N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide	small molecule	experimental	
DB07834	N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide	small molecule	experimental	
DB07835	N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide	small molecule	experimental	
DB07836	1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL	small molecule	experimental	
DB07837	[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid	small molecule	experimental	
DB07838	(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE	small molecule	experimental	
DB07839	N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE	small molecule	experimental	
DB07840	(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol	small molecule	experimental	
DB07841	Geranylgeranyl diphosphate	small molecule	experimental	Organophosphates|Organophosphorus Compounds|Phosphate salts|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Terpenes
DB07842	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	small molecule	experimental	
DB07843	5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	small molecule	experimental	
DB07844	6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE	small molecule	experimental	
DB07845	2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide	small molecule	experimental	
DB07846	1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE	small molecule	experimental	
DB07847	6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE	small molecule	experimental	
DB07848	5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide	small molecule	experimental	
DB07849	S-NONYL-CYSTEINE	small molecule	experimental	
DB07850	(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid	small molecule	experimental	
DB07851	(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE	small molecule	experimental	
DB07852	1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID	small molecule	experimental	
DB07853	[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE	small molecule	experimental	
DB07854	N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	small molecule	experimental	
DB07855	(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE	small molecule	experimental	
DB07856	6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE	small molecule	experimental	
DB07857	(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine	small molecule	experimental	
DB07858	(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine	small molecule	experimental	
DB07859	4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE	small molecule	experimental	
DB07860	(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE	small molecule	experimental	
DB07861	(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide	small molecule	experimental	
DB07862	7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE	small molecule	experimental	
DB07863	2-chloro-5-nitro-N-phenylbenzamide	small molecule	experimental	
DB07864	4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07865	3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one	small molecule	experimental	
DB07866	(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one	small molecule	experimental	
DB07867	6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07868	6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07869	6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07870	(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID	small molecule	experimental	
DB07871	6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB07872	5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide	small molecule	experimental	
DB07873	Lauryl alcohol diphosphonic acid	small molecule	experimental	
DB07874	(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one	small molecule	experimental	
DB07875	5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide	small molecule	experimental	
DB07876	(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE	small molecule	experimental	
DB07877	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	small molecule	experimental	
DB07878	N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE	small molecule	experimental	
DB07879	N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide	small molecule	experimental	
DB07880	2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID	small molecule	experimental	
DB07881	N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE	small molecule	experimental	
DB07882	4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID	small molecule	experimental	
DB07883	(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE	small molecule	experimental	
DB07884	ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE	small molecule	experimental	
DB07885	Talviraline	small molecule	investigational	Acquired Immunodeficiency Syndrome
DB07887	(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE	small molecule	experimental	
DB07888	3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER	small molecule	experimental	
DB07889	(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol	small molecule	experimental	
DB07890	4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID	small molecule	experimental	
DB07891	4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid	small molecule	experimental	
DB07892	1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE	small molecule	experimental	
DB07893	PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE	small molecule	experimental	
DB07894	4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID	small molecule	experimental	
DB07895	ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID	small molecule	experimental	Alcohols|Fatty Alcohols|Lipids|Organophosphorus Compounds|Sesquiterpenes|Terpenes
DB07896	(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid	small molecule	experimental	
DB07897	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	small molecule	experimental	
DB07898	2-(BUTYRYLOXY)-1-{[(TETRAHYDROXYPHOSPHORANYL)OXY]METHYL}ETHYL BUTYRATE	small molecule	experimental	
DB07899	(2S) N-acetyl-L-alanyl-Î±L-phenylalanyl-chloroethylketone	small molecule	experimental	
DB07900	3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE	small molecule	experimental	
DB07901	5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE	small molecule	experimental	
DB07902	TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE	small molecule	experimental	
DB07903	3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE	small molecule	experimental	
DB07905	(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione	small molecule	experimental	
DB07906	[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL	small molecule	experimental	
DB07907	(2S)-2-HYDROXYOCTANOIC ACID	small molecule	experimental	
DB07908	7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN	small molecule	experimental	
DB07909	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	small molecule	experimental	
DB07910	(2S)-2-amino-3-phenylpropane-1,1-diol	small molecule	experimental	
DB07911	(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE	small molecule	experimental	
DB07912	2-OXOHEPTYLPHOSPHONIC ACID	small molecule	experimental	
DB07913	HOMOPHENYLALANINYLMETHANE	small molecule	experimental	
DB07914	2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	small molecule	experimental	Fatty Acids|Lipids
DB07915	(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid	small molecule	experimental	
DB07916	3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID	small molecule	experimental	
DB07917	4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE	small molecule	experimental	
DB07918	2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE	small molecule	experimental	
DB07919	7-METHOXY-1-METHYL-9H-BETA-CARBOLINE	small molecule	experimental	
DB07920	N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide	small molecule	experimental	
DB07921	2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide	small molecule	experimental	
DB07922	N-oxo-2-(phenylsulfonylamino)ethanamide	small molecule	experimental	
DB07923	octyl alpha-L-altropyranoside	small molecule	experimental	
DB07924	octyl beta-D-galactopyranoside	small molecule	experimental	Carbohydrates|Glycosides
DB07925	4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID	small molecule	experimental	
DB07926	N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE	small molecule	experimental	
DB07927	3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid	small molecule	experimental	
DB07928	N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE	small molecule	experimental	
DB07929	N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE	small molecule	experimental	
DB07930	(3R)-3-HYDROXYDODECANOIC ACID	small molecule	experimental	
DB07931	Hexestrol	small molecule	withdrawn	Antineoplastic Agents|Antineoplastic Agents, Hormonal|Benzene Derivatives|Benzylidene Compounds|Diethylstilbestrol|Estrogens|Estrogens, Non-Steroidal|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Stilbenes
DB07932	dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate	small molecule	experimental	
DB07933	Erteberel	small molecule	experimental|investigational	Pyrans
DB07934	[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE	small molecule	experimental	
DB07935	5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile	small molecule	experimental	
DB07936	N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine	small molecule	experimental	
DB07937	2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine	small molecule	experimental	
DB07938	5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine	small molecule	experimental	
DB07939	N-(3-MERCAPTOPROPANOYL)-D-ALANINE	small molecule	experimental	
DB07940	9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE	small molecule	experimental	
DB07941	PH-797804	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors|Pyridines
DB07942	2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine	small molecule	experimental	
DB07943	2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol	small molecule	experimental	
DB07944	N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE	small molecule	experimental	
DB07945	5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid	small molecule	experimental	
DB07946	N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide	small molecule	experimental	
DB07947	ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE	small molecule	experimental	
DB07949	({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID	small molecule	experimental	
DB07950	Indoleacetic acid	small molecule	experimental	Growth Substances|Indoles|Plant Growth Regulators
DB07951	N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID	small molecule	experimental	
DB07952	N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID	small molecule	experimental	
DB07953	N-[1H-INDOL-3-YL-ACETYL]VALINE ACID	small molecule	experimental	
DB07954	3-isobutyl-1-methyl-7H-xanthine	small molecule	experimental	Alkaloids|Enzyme Inhibitors|Phosphodiesterase Inhibitors|Purines|Purinones|Xanthine derivatives
DB07955	(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE	small molecule	experimental	
DB07956	[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER	small molecule	experimental	
DB07957	METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE	small molecule	experimental	
DB07958	(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID	small molecule	experimental	
DB07959	3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE	small molecule	experimental	
DB07960	5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID	small molecule	experimental	
DB07961	1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA	small molecule	experimental	
DB07962	METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE	small molecule	experimental	
DB07963	N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE	small molecule	experimental	
DB07964	(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE	small molecule	experimental	
DB07965	6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile	small molecule	experimental	
DB07966	[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile	small molecule	experimental	
DB07967	9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE	small molecule	experimental	
DB07968	N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA	small molecule	experimental	
DB07969	3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol	small molecule	experimental	
DB07970	5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide	small molecule	experimental	
DB07971	5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE	small molecule	experimental	
DB07972	1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE	small molecule	experimental	
DB07973	N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE	small molecule	experimental	
DB07974	1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE	small molecule	experimental	
DB07975	2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID	small molecule	experimental	
DB07976	3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07977	3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB07978	2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID	small molecule	experimental	
DB07979	(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID	small molecule	experimental	
DB07981	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide	small molecule	experimental	
DB07982	2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol	small molecule	experimental	
DB07983	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	small molecule	experimental	
DB07984	2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide	small molecule	experimental	
DB07985	+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE	small molecule	experimental	
DB07986	[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID	small molecule	experimental	
DB07987	[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER	small molecule	experimental	
DB07988	2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE	small molecule	experimental	
DB07989	2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER	small molecule	experimental	
DB07990	(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE	small molecule	experimental	
DB07991	N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE	small molecule	experimental	
DB07992	3-SULFOOXY-1H-INDOLE	small molecule	experimental	
DB07993	N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE	small molecule	experimental	
DB07994	N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE	small molecule	experimental	
DB07995	N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE	small molecule	experimental	
DB07996	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	small molecule	experimental	Amides|Enzyme Inhibitors|Isoquinolines|Piperazines|Sulfonamides|Sulfones|Sulfur Compounds
DB07997	N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE	small molecule	experimental	
DB07999	{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID	small molecule	experimental	
DB08000	2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE	small molecule	experimental	
DB08001	5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID	small molecule	experimental	
DB08003	ISOTHIAZOLIDINONE ANALOG	small molecule	experimental	
DB08004	(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol	small molecule	experimental	
DB08005	4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide	small molecule	experimental	
DB08006	N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08007	(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID	small molecule	experimental	
DB08008	5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08009	5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE	small molecule	experimental	
DB08010	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime	small molecule	experimental	
DB08011	(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime	small molecule	experimental	
DB08012	(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE	small molecule	experimental	
DB08013	(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE	small molecule	experimental	
DB08014	(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE	small molecule	experimental	
DB08015	(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime	small molecule	experimental	
DB08016	4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE	small molecule	experimental	
DB08017	3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE	small molecule	experimental	
DB08018	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	small molecule	experimental	
DB08019	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	small molecule	experimental	
DB08020	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	small molecule	experimental	
DB08021	5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide	small molecule	experimental	
DB08022	(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile	small molecule	experimental	
DB08023	N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine	small molecule	experimental	
DB08024	1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE	small molecule	experimental	
DB08025	N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE	small molecule	experimental	
DB08026	2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide	small molecule	experimental	
DB08027	1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea	small molecule	experimental	
DB08028	BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE	small molecule	experimental	
DB08029	N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide	small molecule	experimental	
DB08030	3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide	small molecule	experimental	
DB08031	N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE	small molecule	experimental	
DB08032	N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	small molecule	experimental	
DB08033	(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE	small molecule	experimental	
DB08034	(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE	small molecule	experimental	
DB08035	1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE	small molecule	experimental	
DB08036	6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one	small molecule	experimental	
DB08037	(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide	small molecule	experimental	
DB08038	L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide	small molecule	experimental	
DB08039	(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE	small molecule	experimental	
DB08040	N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine	small molecule	experimental	
DB08041	3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID	small molecule	experimental	
DB08042	N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine	small molecule	experimental	
DB08043	1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA	small molecule	experimental	
DB08044	ABT-341	small molecule	experimental	Benzene Derivatives|Enzyme Inhibitors
DB08045	4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL	small molecule	experimental	
DB08046	2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide	small molecule	experimental	
DB08047	4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol	small molecule	experimental	
DB08048	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	small molecule	experimental	
DB08049	7,8-dihydroxy-4-phenyl-2H-chromen-2-one	small molecule	experimental	
DB08050	5-phenyl-2-keto-valeric acid	small molecule	experimental	
DB08051	(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE	small molecule	experimental	
DB08052	1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	small molecule	experimental	
DB08053	1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	small molecule	experimental	
DB08054	1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	small molecule	experimental	
DB08055	N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	small molecule	experimental	
DB08056	N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine	small molecule	experimental	
DB08057	N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine	small molecule	experimental	
DB08058	4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one	small molecule	experimental	
DB08059	Wortmannin	small molecule	experimental	Androstanes|Androstenes|Anti-Infective Agents|Antifungal Agents|Central Nervous System Depressants|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Immunosuppressive Agents|Insulin Antagonists|Mycotoxins|Neurotransmitter Agents|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Phosphodiesterase Inhibitors|Protein Kinase Inhibitors|Radiation-Sensitizing Agents|Serotonin Agents|Serotonin Receptor Antagonists|Steroids
DB08060	4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID	small molecule	experimental	
DB08061	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	small molecule	experimental	
DB08062	3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE	small molecule	experimental	
DB08063	1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE	small molecule	experimental	
DB08064	N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA	small molecule	experimental	
DB08065	2-(1H-pyrazol-3-yl)-1H-benzimidazole	small molecule	experimental	
DB08066	N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE	small molecule	experimental	
DB08067	4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM	small molecule	experimental	
DB08068	N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-	small molecule	experimental	
DB08069	4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE	small molecule	experimental	
DB08070	2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE	small molecule	experimental	
DB08071	(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine	small molecule	experimental	
DB08072	4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE	small molecule	experimental	
DB08073	(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE	small molecule	experimental	
DB08074	3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine	small molecule	experimental	
DB08075	4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine	small molecule	experimental	
DB08076	4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine	small molecule	experimental	
DB08077	2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID	small molecule	experimental	
DB08078	{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid	small molecule	experimental	
DB08079	AMG-208	small molecule	investigational	
DB08080	LATRUNCULIN B	small molecule	experimental	Marine Toxins|Porifera|Sulfur Compounds|Thiazoles
DB08081	3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE	small molecule	experimental	
DB08082	N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE	small molecule	experimental	
DB08083	2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide	small molecule	experimental	
DB08084	IDD594	small molecule	experimental	Acids, Acyclic|Aldehyde Reductase, antagonists & inhibitors|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds
DB08085	1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE	small molecule	experimental	
DB08086	N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine	small molecule	experimental	
DB08087	4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE	small molecule	experimental	
DB08088	2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile	small molecule	experimental	
DB08089	LGD-2226	small molecule	experimental	Quinolines
DB08090	(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol	small molecule	experimental	
DB08091	3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE	small molecule	experimental	
DB08092	3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide	small molecule	experimental	
DB08093	3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE	small molecule	experimental	
DB08094	(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE	small molecule	experimental	
DB08095	3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA	small molecule	experimental	
DB08096	8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM	small molecule	experimental	
DB08097	2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE	small molecule	experimental	
DB08098	{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid	small molecule	experimental	
DB08099	6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine	small molecule	experimental	
DB08100	2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol	small molecule	experimental	
DB08101	2,6-dibromo-4-[(E)-2-phenylethenyl]phenol	small molecule	experimental	
DB08102	3,5-dibromobiphenyl-4-ol	small molecule	experimental	
DB08103	2,6-dibromo-4-phenoxyphenol	small molecule	experimental	
DB08104	N-(3,5-dibromo-4-hydroxyphenyl)benzamide	small molecule	experimental	
DB08105	N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid	small molecule	experimental	
DB08106	N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid	small molecule	experimental	
DB08107	N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID	small molecule	experimental	
DB08108	N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	small molecule	experimental	
DB08109	(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID	small molecule	experimental	
DB08110	(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID	small molecule	experimental	
DB08111	4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol	small molecule	experimental	
DB08112	N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID	small molecule	experimental	
DB08113	3-pyridin-4-yl-1H-indazole	small molecule	experimental	
DB08114	5-benzyl-1,3-thiazol-2-amine	small molecule	experimental	
DB08115	2-aminoethyl naphthalen-1-ylacetate	small molecule	experimental	
DB08116	(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine	small molecule	experimental	
DB08118	2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide	small molecule	experimental	
DB08119	1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)	small molecule	experimental	
DB08120	6,8-DIMERCAPTO-OCTANOIC ACID AMIDE	small molecule	experimental	
DB08121	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	small molecule	experimental	
DB08122	N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	small molecule	experimental	
DB08123	N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE	small molecule	experimental	
DB08124	3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE	small molecule	experimental	
DB08125	4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE	small molecule	experimental	
DB08126	3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	small molecule	experimental	
DB08127	1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene	small molecule	experimental	
DB08128	(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine	small molecule	experimental	
DB08129	(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol	small molecule	experimental	
DB08130	N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine	small molecule	experimental	
DB08131	2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID	small molecule	experimental	
DB08132	5-hydroxynaphthalene-1-sulfonamide	small molecule	experimental	
DB08133	N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide	small molecule	experimental	
DB08134	4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide	small molecule	experimental	
DB08135	N-phenyl-1H-pyrazole-3-carboxamide	small molecule	experimental	
DB08136	4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	small molecule	experimental	
DB08137	(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide	small molecule	experimental	
DB08138	{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide	small molecule	experimental	
DB08139	5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile	small molecule	experimental	
DB08140	5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE	small molecule	experimental	
DB08141	4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide	small molecule	experimental	
DB08142	4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide	small molecule	experimental	Cyclin-Dependent Kinases, antagonists & inhibitors
DB08143	5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE	small molecule	experimental	
DB08144	6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine	small molecule	experimental	
DB08145	6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE	small molecule	experimental	
DB08146	7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine	small molecule	experimental	
DB08147	4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid	small molecule	experimental	
DB08148	1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	small molecule	experimental	
DB08149	1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine	small molecule	experimental	
DB08150	4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium	small molecule	experimental	
DB08151	(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol	small molecule	experimental	
DB08152	{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate	small molecule	experimental	
DB08153	(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE	small molecule	experimental	
DB08154	3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile	small molecule	experimental	
DB08155	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	small molecule	experimental	
DB08156	3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID	small molecule	experimental	
DB08157	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	small molecule	experimental	
DB08158	2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE	small molecule	experimental	
DB08159	4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE	small molecule	experimental	
DB08160	(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL	small molecule	experimental	
DB08161	(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID	small molecule	experimental	
DB08162	Fasudil	small molecule	investigational	Amides|Antiarrhythmic agents|Calcium Channel Blockers|Cardiovascular Agents|Enzyme Inhibitors|Isoquinolines|Membrane Transport Modulators|Peripheral Vasodilators|Piperazines|Protein Kinase Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Vasodilating Agents
DB08163	5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine	small molecule	experimental	
DB08164	(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE	small molecule	experimental	
DB08165	indane-5-sulfonamide	small molecule	experimental	
DB08166	(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile	small molecule	experimental	
DB08167	Methylthioninium	small molecule	experimental|investigational	Oxidation-Reduction Activity|Oxidation-Reduction Agent|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB08168	7-AMINO-4-METHYL-CHROMEN-2-ONE	small molecule	experimental	
DB08169	(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide	small molecule	experimental	
DB08170	(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE	small molecule	experimental	
DB08171	11-MERCAPTOUNDECANOIC ACID	small molecule	experimental	Lipids|Sulfur Compounds
DB08172	(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide	small molecule	experimental	
DB08173	5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE	small molecule	experimental	
DB08174	5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE	small molecule	experimental	
DB08175	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	small molecule	experimental	
DB08176	(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE	small molecule	experimental	
DB08177	(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID	small molecule	experimental	
DB08178	4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	small molecule	experimental	
DB08179	methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate	small molecule	experimental	
DB08180	2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE	small molecule	experimental	
DB08181	2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	small molecule	experimental	
DB08182	4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine	small molecule	experimental	
DB08184	2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE	small molecule	experimental	
DB08185	2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE	small molecule	experimental	
DB08186	(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE	small molecule	experimental	
DB08187	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	small molecule	experimental	
DB08188	Emivirine	small molecule	investigational	Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Pyrimidines|Pyrimidinones|Reverse Transcriptase Inhibitors
DB08190	N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide	small molecule	experimental	
DB08191	4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid	small molecule	experimental	
DB08192	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	small molecule	experimental	
DB08193	2-(3-NITROPHENYL)ACETIC ACID	small molecule	experimental	
DB08194	4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine	small molecule	experimental	
DB08195	(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE	small molecule	experimental	
DB08196	2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	small molecule	experimental	
DB08197	(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime	small molecule	experimental	
DB08198	[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE	small molecule	experimental	
DB08199	N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE	small molecule	experimental	
DB08200	(1R)-menthyl hexyl phosphonate group	small molecule	experimental	
DB08201	(1S)-menthyl hexyl phosphonate group	small molecule	experimental	
DB08202	4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE	small molecule	experimental	
DB08203	7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE	small molecule	experimental	
DB08204	3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE	small molecule	experimental	
DB08205	4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL	small molecule	experimental	
DB08206	4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL	small molecule	experimental	
DB08207	2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE	small molecule	experimental	
DB08208	2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE	small molecule	experimental	
DB08209	2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID	small molecule	experimental	
DB08210	2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE	small molecule	experimental	
DB08211	5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide	small molecule	experimental	
DB08212	1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA	small molecule	experimental	
DB08213	1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE	small molecule	experimental	
DB08214	4-(1H-IMIDAZOL-1-YL)PHENOL	small molecule	experimental	
DB08215	2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE	small molecule	experimental	
DB08216	2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID	small molecule	experimental	
DB08217	S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate	small molecule	experimental	
DB08218	HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM	small molecule	experimental	
DB08219	4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE	small molecule	experimental	
DB08220	(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid	small molecule	experimental	
DB08221	N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE	small molecule	experimental	
DB08222	METHOXYUNDECYLPHOSPHINIC ACID	small molecule	experimental	
DB08223	N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE	small molecule	experimental	
DB08224	(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL	small molecule	experimental	
DB08226	Myxopyronin B	small molecule	experimental	DNA-Directed RNA Polymerases, antagonists & inhibitors
DB08227	1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE	small molecule	experimental	
DB08228	5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one	small molecule	experimental	
DB08229	[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID	small molecule	experimental	
DB08230	5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE	small molecule	experimental	
DB08231	Myristic acid	small molecule	experimental	Fatty Acids|Lipids|Myristic Acids
DB08232	[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid	small molecule	experimental	
DB08233	6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE	small molecule	experimental	
DB08234	5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine	small molecule	experimental	
DB08235	N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide	small molecule	experimental	
DB08236	(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one	small molecule	experimental	
DB08237	2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)	small molecule	experimental	
DB08238	5-AMINO-NAPHTALENE-2-MONOSULFONATE	small molecule	experimental	
DB08239	(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	small molecule	experimental	
DB08240	N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE	small molecule	experimental	
DB08241	4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE	small molecule	experimental	
DB08242	N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide	small molecule	experimental	
DB08244	(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE	small molecule	experimental	
DB08245	1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE	small molecule	experimental	
DB08246	(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE	small molecule	experimental	
DB08247	6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE	small molecule	experimental	
DB08248	3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE	small molecule	experimental	
DB08249	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	small molecule	experimental	
DB08250	(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE	small molecule	experimental	
DB08251	4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID	small molecule	experimental	
DB08252	2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID	small molecule	experimental	
DB08253	NAM NAPTHYLAMINOALANINE	small molecule	experimental	
DB08254	2-NAPHTHALENESULFONIC ACID	small molecule	experimental	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Naphthalenes|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB08255	(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL	small molecule	experimental	
DB08256	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	small molecule	experimental	
DB08257	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	small molecule	experimental	
DB08258	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	small molecule	experimental	
DB08259	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	small molecule	experimental	
DB08260	(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide	small molecule	experimental	
DB08261	2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester	small molecule	experimental	
DB08262	2,6-dicarboxynaphthalene	small molecule	experimental	
DB08263	N-(carboxycarbonyl)-D-phenylalanine	small molecule	experimental	
DB08264	(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene	small molecule	experimental	
DB08265	2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL	small molecule	experimental	
DB08266	Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate	small molecule	experimental	
DB08267	6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	small molecule	experimental	
DB08268	6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE	small molecule	experimental	
DB08270	N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE	small molecule	experimental	
DB08271	N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID	small molecule	experimental	
DB08272	(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID	small molecule	experimental	
DB08273	4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION	small molecule	experimental	
DB08274	6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE	small molecule	experimental	
DB08275	N-DODECANOYL-L-TYROSINE	small molecule	experimental	
DB08276	trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-)	small molecule	experimental	
DB08277	2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE	small molecule	experimental	
DB08278	1-(2-CYCLOPROPYLETHYL)-3-(1,1-DIOXIDO-2H-1,2,4-BENZOTHIADIAZIN-3-YL)-6-FLUORO-4-HYDROXYQUINOLIN-2(1H)-ONE	small molecule	experimental	
DB08279	3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB08280	(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE	small molecule	experimental	
DB08281	O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate	small molecule	experimental	
DB08282	O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate	small molecule	experimental	
DB08283	(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL	small molecule	experimental	
DB08284	O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate	small molecule	experimental	
DB08285	(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol	small molecule	experimental	
DB08286	NAPHTHYLOXYACETIC ACID	small molecule	experimental	
DB08287	(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide	small molecule	experimental	
DB08288	CYCLOHEXYL-NORSTATINE	small molecule	experimental	
DB08289	N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE	small molecule	experimental	
DB08291	N-(3-AMINOPROPYL)-2-NITROBENZENAMINE	small molecule	experimental	
DB08292	(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	small molecule	experimental	
DB08293	(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE	small molecule	experimental	
DB08294	2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID	small molecule	experimental	
DB08295	4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION	small molecule	experimental	
DB08296	5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID	small molecule	experimental	
DB08297	ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE	small molecule	experimental	
DB08299	4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid	small molecule	experimental	
DB08300	1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine	small molecule	experimental	
DB08301	N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE	small molecule	experimental	
DB08302	3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid	small molecule	experimental	
DB08303	(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide	small molecule	experimental	
DB08304	(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	small molecule	experimental	
DB08305	(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	small molecule	experimental	
DB08306	3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid	small molecule	experimental	
DB08307	2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE	small molecule	experimental	
DB08308	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	small molecule	experimental	
DB08309	3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL	small molecule	experimental	
DB08310	N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide	small molecule	experimental	
DB08312	6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE	small molecule	experimental	
DB08313	nocodazole	small molecule	experimental	Antimitotic Agents|Antineoplastic Agents|Benzimidazoles|Mitosis Modulators|Tubulin Modulators
DB08314	(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE	small molecule	experimental	
DB08315	2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE	small molecule	experimental	
DB08316	4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one	small molecule	experimental	
DB08317	5-methyl-6-phenylquinazoline-2,4-diamine	small molecule	experimental	
DB08318	6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine	small molecule	experimental	
DB08319	2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID	small molecule	experimental	
DB08320	DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE	small molecule	experimental	
DB08321	(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol	small molecule	experimental	
DB08322	2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID	small molecule	experimental	
DB08323	3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE	small molecule	experimental	
DB08324	N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE	small molecule	experimental	
DB08325	2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE	small molecule	experimental	
DB08326	2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE	small molecule	experimental	
DB08327	2-(3,6-DIHYDROXYPHENYL)ACETIC ACID	small molecule	experimental	
DB08328	PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID	small molecule	experimental	
DB08329	Sulthiame	small molecule	experimental	Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Sulfur Compounds
DB08330	METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE	small molecule	experimental	
DB08331	N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine	small molecule	experimental	
DB08332	9-(2-carboxyethyl)-10-methylanthracene endoperoxide	small molecule	experimental	
DB08333	4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	small molecule	experimental	
DB08334	3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	small molecule	experimental	
DB08335	4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME	small molecule	experimental	
DB08336	2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate	small molecule	experimental	
DB08337	2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate	small molecule	experimental	
DB08338	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	small molecule	experimental	
DB08339	6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE	small molecule	experimental	
DB08340	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	small molecule	experimental	
DB08341	4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	small molecule	experimental	
DB08342	S-PALMITOYL-L-CYSTEINE	small molecule	experimental	
DB08344	4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide	small molecule	experimental	
DB08345	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	small molecule	experimental	
DB08346	(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE	small molecule	experimental	
DB08347	4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile	small molecule	experimental	
DB08348	N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE	small molecule	experimental	
DB08349	N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide	small molecule	experimental	
DB08350	5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE	small molecule	experimental	
DB08351	N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide	small molecule	experimental	
DB08352	6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine	small molecule	experimental	
DB08353	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	small molecule	experimental	
DB08354	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	small molecule	experimental	
DB08355	1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid	small molecule	experimental	
DB08356	4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol	small molecule	experimental	
DB08357	1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE	small molecule	experimental	
DB08358	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	small molecule	experimental	
DB08359	2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE	small molecule	experimental	
DB08360	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	small molecule	experimental	
DB08361	2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide	small molecule	experimental	
DB08362	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	small molecule	experimental	
DB08363	1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine	small molecule	experimental	
DB08364	1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE	small molecule	experimental	
DB08365	8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide	small molecule	experimental	
DB08366	3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid	small molecule	experimental	
DB08367	(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE	small molecule	experimental	
DB08368	OCTANE-1,3,5,7-TETRACARBOXYLIC ACID	small molecule	experimental	
DB08369	1-(biphenyl-4-ylmethyl)-1H-imidazole	small molecule	experimental	
DB08370	S-(4-BROMOBENZYL)CYSTEINE	small molecule	experimental	
DB08371	PARA-(BENZOYL)-PHENYLALANINE	small molecule	experimental	
DB08372	1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA	small molecule	experimental	
DB08373	4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL	small molecule	experimental	
DB08374	Phenylalanylmethylchloride	small molecule	experimental	
DB08375	PCNOTAXIME Group	small molecule	experimental	
DB08376	(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate	small molecule	experimental	
DB08377	N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine	small molecule	experimental	
DB08378	4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID	small molecule	experimental	
DB08379	6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one	small molecule	experimental	
DB08382	Gosogliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|Diabetes Mellitus, Type 2, drug therapy|DPP-IV Inhibitors
DB08383	4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole	small molecule	experimental	
DB08384	2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline	small molecule	experimental	
DB08385	4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid	small molecule	experimental	
DB08386	2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline	small molecule	experimental	
DB08387	2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline	small molecule	experimental	
DB08388	5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE	small molecule	experimental	
DB08389	6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	small molecule	experimental	
DB08390	(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE	small molecule	experimental	
DB08391	6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE	small molecule	experimental	
DB08392	2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL	small molecule	experimental	
DB08393	2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL	small molecule	experimental	
DB08394	PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE	small molecule	experimental	
DB08395	2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE	small molecule	experimental	
DB08396	4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID	small molecule	experimental	
DB08397	6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB08398	2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine	small molecule	investigational	Carcinogens|Mutagens|Noxae|Toxic Actions
DB08399	PICEATANNOL	small molecule	experimental	Benzene Derivatives|Benzylidene Compounds|Tyrosine Kinase Inhibitors
DB08400	4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid	small molecule	experimental	
DB08401	(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID	small molecule	experimental	
DB08402	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	small molecule	experimental	
DB08403	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	small molecule	experimental	
DB08404	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE	small molecule	experimental	
DB08405	S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE	small molecule	experimental	
DB08406	[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE	small molecule	experimental	
DB08407	PLATENSIMYCIN	small molecule	experimental	3-Oxoacyl-(Acyl-Carrier-Protein) Synthase|Acids, Carbocyclic|Amides|Anti-Infective Agents|Benzene Derivatives|Benzoates|Cycloparaffins
DB08408	(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate	small molecule	experimental	
DB08409	4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE	small molecule	experimental	
DB08410	PARA-NITROBENZYL GLUTARYL GLYCINIC ACID	small molecule	experimental	
DB08411	N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine	small molecule	experimental	
DB08412	6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID	small molecule	experimental	
DB08413	METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER	small molecule	experimental	
DB08414	6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE	small molecule	experimental	
DB08416	(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE	small molecule	experimental	
DB08418	(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate	small molecule	experimental	
DB08419	(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE	small molecule	experimental	
DB08420	1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID	small molecule	experimental	
DB08421	PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE	small molecule	experimental	
DB08422	[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE	small molecule	experimental	
DB08423	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE	small molecule	experimental	
DB08424	[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE	small molecule	experimental	
DB08426	THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE	small molecule	experimental	
DB08427	PREPHENIC ACID	small molecule	experimental	Acids, Carbocyclic|Cyclohexanes|Cycloparaffins
DB08428	3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL	small molecule	experimental	
DB08429	N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide	small molecule	experimental	
DB08430	PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE	small molecule	experimental	
DB08431	[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID	small molecule	experimental	
DB08432	THYMIDINE-5'-THIOPHOSPHATE	small molecule	experimental	
DB08433	phenyl ethenesulfonate	small molecule	experimental	
DB08434	2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID	small molecule	experimental	
DB08435	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	small molecule	experimental	
DB08436	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	small molecule	experimental	
DB08437	Puromycin	small molecule	experimental	Acids, Carbocyclic|Adenosine|Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antimetabolites|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Cinnamates|Enzyme Inhibitors|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Protein Synthesis Inhibitors|Purine Nucleosides|Purines|Ribonucleosides|Toxic Actions|Trypanocidal Agents
DB08438	(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID	small molecule	experimental	
DB08439	Parecoxib	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|COX-2 Inhibitors|Cyclooxygenase Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sensory System Agents
DB08440	N-1,10-phenanthrolin-5-ylacetamide	small molecule	experimental	
DB08441	6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE	small molecule	experimental	
DB08442	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	small molecule	experimental	
DB08443	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	small molecule	experimental	
DB08444	3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile	small molecule	experimental	
DB08445	(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE	small molecule	experimental	
DB08446	3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile	small molecule	experimental	
DB08447	3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL	small molecule	experimental	
DB08448	(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol	small molecule	experimental	
DB08449	2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid	small molecule	experimental	
DB08450	N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine	small molecule	experimental	
DB08451	N-(QUINOLIN-8-YL)METHANESULFONAMIDE	small molecule	experimental	
DB08453	2-NONYL-4-HYDROXYQUINOLINE N-OXIDE	small molecule	experimental	
DB08454	N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE	small molecule	experimental	
DB08455	Ro 12-7310	small molecule	experimental	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Retinoids|Terpenes
DB08456	S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate	small molecule	experimental	
DB08457	4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE	small molecule	experimental	
DB08458	(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE	small molecule	experimental	
DB08459	3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile	small molecule	experimental	
DB08460	3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile	small molecule	experimental	
DB08461	3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL	small molecule	experimental	
DB08462	N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE	small molecule	experimental	
DB08463	(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol	small molecule	experimental	
DB08464	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	small molecule	experimental	
DB08465	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	small molecule	experimental	
DB08466	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	small molecule	experimental	
DB08467	6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID	small molecule	experimental	
DB08469	tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate	small molecule	experimental	
DB08470	3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole	small molecule	experimental	
DB08471	1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine	small molecule	experimental	
DB08472	(R)-Fluoxetine	small molecule	experimental	
DB08473	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	small molecule	experimental	
DB08474	3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN	small molecule	experimental	
DB08475	[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate	small molecule	experimental	
DB08476	3-AMINO-AZACYCLOTRIDECAN-2-ONE	small molecule	experimental	
DB08478	N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide	small molecule	experimental	
DB08479	N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide	small molecule	experimental	
DB08480	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	small molecule	experimental	
DB08481	4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE	small molecule	experimental	
DB08482	[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER	small molecule	experimental	
DB08484	4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE	small molecule	experimental	
DB08485	(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID	small molecule	experimental	
DB08486	Efaproxiral	small molecule	investigational	Acids, Acyclic|Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antisickling Agents|Fatty Acids|Fatty Acids, Volatile|Hematologic Agents|Lipids|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy
DB08487	3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE	small molecule	experimental	
DB08488	4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE	small molecule	experimental	
DB08489	N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE	small molecule	experimental	
DB08490	CTS-1027	small molecule	experimental|investigational	Amines|Hydroxy Acids|Hydroxylamines
DB08491	N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE	small molecule	experimental	
DB08492	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	small molecule	experimental	
DB08493	5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID	small molecule	experimental	
DB08494	S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate	small molecule	experimental	
DB08495	4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE	small molecule	experimental	
DB08496	(R)-warfarin	small molecule	experimental	Anticoagulants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Vitamin K Antagonists
DB08497	(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	small molecule	experimental	
DB08498	(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate	small molecule	experimental	
DB08499	N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide	small molecule	experimental	
DB08500	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	small molecule	experimental	
DB08501	DIETHYL PROPANE-1,3-DIYLBISCARBAMATE	small molecule	experimental	
DB08502	Capravirine	small molecule	investigational	Anti-HIV Agents
DB08503	(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol	small molecule	experimental	
DB08504	6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM	small molecule	experimental	
DB08505	methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate	small molecule	experimental	
DB08506	N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine	small molecule	experimental	
DB08507	N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID	small molecule	experimental	
DB08508	N-BENZOYL-D-ALANINE	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins
DB08509	1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE	small molecule	experimental	
DB08510	5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE	small molecule	experimental	
DB08511	6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	small molecule	experimental	
DB08512	6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	small molecule	experimental	
DB08513	[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID	small molecule	experimental	
DB08514	6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one	small molecule	experimental	
DB08515	(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE	small molecule	experimental	
DB08516	(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]	small molecule	experimental	
DB08517	(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one	small molecule	experimental	
DB08519	N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine	small molecule	experimental	
DB08520	(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE	small molecule	experimental	
DB08521	4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE	small molecule	experimental	
DB08522	4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE	small molecule	experimental	
DB08523	[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL	small molecule	experimental	
DB08524	2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE	small molecule	experimental	
DB08525	HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE	small molecule	experimental	
DB08526	CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE	small molecule	experimental	
DB08527	1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE	small molecule	experimental	
DB08528	2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE	small molecule	experimental	
DB08529	(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)	small molecule	experimental	
DB08530	7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE	small molecule	experimental	
DB08531	5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08532	6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	small molecule	experimental	
DB08533	3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine	small molecule	experimental	
DB08534	5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08535	3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08536	3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine	small molecule	experimental	
DB08537	3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine	small molecule	experimental	
DB08538	N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08539	3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine	small molecule	experimental	
DB08540	2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER	small molecule	experimental	
DB08541	[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid	small molecule	experimental	
DB08542	3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione	small molecule	experimental	
DB08543	1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE	small molecule	experimental	
DB08544	(S)-Fluoxetine	small molecule	experimental	
DB08545	(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE	small molecule	experimental	
DB08546	4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE	small molecule	experimental	
DB08547	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	small molecule	experimental	
DB08548	[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate	small molecule	experimental	
DB08549	(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER	small molecule	experimental	
DB08550	7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline	small molecule	experimental	Central Nervous System Depressants|Enzyme Inhibitors|Isoquinolines|Monoamine Oxidase Inhibitors|Phenylethanolamine N-Methyltransferase, antagonists & inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB08551	3-{(R)-(Dihydroxyboryl)[(2-thienylacetyl)amino]methyl}benzoic acid	small molecule	experimental	
DB08552	(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid	small molecule	experimental	
DB08553	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime	small molecule	experimental	
DB08554	N-(3-carboxypropanoyl)-L-norvaline	small molecule	experimental	
DB08555	1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline	small molecule	experimental	
DB08556	5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID	small molecule	experimental	
DB08557	2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide	small molecule	experimental	
DB08558	2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL	small molecule	experimental	
DB08559	N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide	small molecule	experimental	
DB08560	3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE	small molecule	experimental	
DB08561	BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE	small molecule	experimental	
DB08562	4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID	small molecule	experimental	
DB08564	(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide	small molecule	experimental	
DB08565	L-1-naphthyl-2-acetamido-ethane boronic acid	small molecule	experimental	
DB08566	D-1-naphthyl-2-acetamido-ethane boronic acid	small molecule	experimental	
DB08568	(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE	small molecule	experimental	
DB08569	3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE	small molecule	experimental	
DB08570	4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Neuraminidase, antagonists & inhibitors
DB08571	4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID	small molecule	experimental	
DB08572	4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE	small molecule	experimental	
DB08573	3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID	small molecule	experimental	
DB08574	(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE	small molecule	experimental	
DB08575	2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM	small molecule	experimental	
DB08576	1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE	small molecule	experimental	
DB08577	3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE	small molecule	experimental	
DB08578	4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid	small molecule	experimental	
DB08579	4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline	small molecule	experimental	
DB08580	4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline	small molecule	experimental	
DB08581	4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid	small molecule	experimental	
DB08582	N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide	small molecule	experimental	
DB08583	2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide	small molecule	experimental	
DB08584	6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline	small molecule	experimental	
DB08585	S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate	small molecule	experimental	
DB08586	S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate	small molecule	experimental	
DB08587	SINAPINATE	small molecule	experimental	
DB08588	2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE	small molecule	experimental	
DB08589	SYRINGATE	small molecule	experimental	
DB08590	1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE	small molecule	experimental	
DB08591	5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE	small molecule	experimental	
DB08593	1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE	small molecule	experimental	
DB08594	TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE	small molecule	experimental	
DB08595	4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL	small molecule	experimental	
DB08596	5'-deoxy-5'-piperidin-1-ylthymidine	small molecule	experimental	
DB08597	6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine	small molecule	experimental	
DB08598	4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE	small molecule	experimental	
DB08599	N-[(4-methoxyphenyl)sulfonyl]-D-alanine	small molecule	experimental	
DB08600	5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE	small molecule	experimental	
DB08601	tributylstannanyl	small molecule	experimental	
DB08602	3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one	small molecule	experimental	
DB08603	N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide	small molecule	experimental	
DB08604	Triclosan	small molecule	approved|investigational	Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzene Derivatives|Dermatologicals|Ethers|Fatty Acid Synthesis Inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Local Anti-infectives|Noxae|Phenol and Derivatives|Phenols|Phenyl Ethers|Toxic Actions
DB08605	6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL	small molecule	experimental	
DB08606	(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL	small molecule	experimental	
DB08607	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	small molecule	experimental	
DB08608	4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE	small molecule	experimental	
DB08609	(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide	small molecule	experimental	
DB08610	N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE	small molecule	experimental	
DB08611	2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL	small molecule	experimental	
DB08612	1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE	small molecule	experimental	
DB08613	2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL	small molecule	experimental	
DB08614	3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE	small molecule	experimental	
DB08615	2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM	small molecule	experimental	
DB08617	4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE	small molecule	experimental	
DB08618	3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER	small molecule	experimental	
DB08619	Testosterone succinate	small molecule	experimental	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB08620	{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide	small molecule	experimental	
DB08621	Thiamphenicol	small molecule	experimental|investigational	Alcohols|Amphenicols|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Chloramphenicol|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols
DB08622	4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL	small molecule	experimental	
DB08623	2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID	small molecule	experimental	
DB08624	BENZOTHIAZOLE	small molecule	experimental	Sulfur Compounds|Thiazoles
DB08626	Thiorphan	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Enzyme Inhibitors|Glycine|N-substituted Glycines|Peptides|Peptoids|Protease Inhibitors|Sulfur Compounds
DB08627	(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE	small molecule	experimental	
DB08628	(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE	small molecule	experimental	
DB08629	N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE	small molecule	experimental	
DB08631	N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE	small molecule	experimental	
DB08632	1,3,5-BENZENETRICARBOXYLIC ACID	small molecule	experimental	Acids, Acyclic
DB08633	TNP-470	small molecule	investigational	Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antibiotics, Antineoplastic|Antineoplastic Agents|Cycloparaffins|Growth Inhibitors|Growth Substances|Terpenes
DB08634	6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL	small molecule	experimental	
DB08635	N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID	small molecule	experimental	
DB08636	2-Hydroxybenzalpyruvate	small molecule	experimental	Acids, Carbocyclic
DB08637	4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID	small molecule	experimental	
DB08638	2-AMINO-3-(1-HYDROPEROXY-1H-INDOL-3-YL)PROPAN-1-OL	small molecule	experimental	
DB08639	Dapivirine	small molecule	investigational	HIV Reverse Transcriptase
DB08640	(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID	small molecule	experimental	
DB08641	(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID	small molecule	experimental	
DB08642	(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine	small molecule	experimental	
DB08643	2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER	small molecule	experimental	
DB08644	{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER	small molecule	experimental	
DB08645	6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE	small molecule	experimental	
DB08646	TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL	small molecule	experimental	
DB08647	TRAZEOLIDE	small molecule	experimental	
DB08648	(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid	small molecule	experimental	
DB08649	(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL	small molecule	experimental	
DB08651	3'-THIO-THYMIDINE-5'-PHOSPHATE	small molecule	experimental	
DB08652	2-(1H-INDOL-3-YL)ACETAMIDE	small molecule	experimental	
DB08653	2-(1H-INDOL-3-YL)ETHANAMINE	small molecule	experimental	
DB08654	TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL	small molecule	experimental	
DB08655	9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE	small molecule	experimental	
DB08656	5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide	small molecule	experimental	
DB08657	2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID	small molecule	experimental	Sulfur Compounds
DB08658	ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE	small molecule	experimental	
DB08659	2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide	small molecule	experimental	
DB08660	1,2,5,8-tetrahydroxyanthracene-9,10-dione	small molecule	experimental	
DB08661	1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione	small molecule	experimental	
DB08662	3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE	small molecule	experimental	
DB08663	4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE	small molecule	experimental	
DB08664	({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER	small molecule	experimental	
DB08665	6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE	small molecule	experimental	
DB08666	5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine	small molecule	experimental	
DB08667	4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine	small molecule	experimental	
DB08668	3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid	small molecule	experimental	
DB08669	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	small molecule	experimental	
DB08670	METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE	small molecule	experimental	
DB08671	5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE	small molecule	experimental	
DB08672	4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE	small molecule	experimental	
DB08673	4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE	small molecule	experimental	
DB08674	(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE	small molecule	experimental	
DB08675	(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid	small molecule	experimental	
DB08676	(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE	small molecule	experimental	
DB08677	N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE	small molecule	experimental	
DB08678	(4-ETHYLPHENYL)SULFAMIC ACID	small molecule	experimental	
DB08680	N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid	small molecule	experimental	
DB08681	1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE	small molecule	experimental	
DB08682	1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE	small molecule	experimental	
DB08683	REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE	small molecule	experimental	
DB08684	O-Decyl Hydrogen Thiocarbonate	small molecule	experimental	
DB08685	1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine	small molecule	experimental	
DB08686	5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE	small molecule	experimental	
DB08687	FG-2216	small molecule	investigational	
DB08688	undecan-2-one	small molecule	experimental	
DB08689	UBIQUINONE-1	small molecule	experimental	
DB08690	UBIQUINONE-2	small molecule	experimental	Antidotes|Benzoquinones|Coenzymes|Enzymes and Coenzymes|Protective Agents|Quinones
DB08691	ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate	small molecule	experimental	
DB08692	D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid	small molecule	experimental	
DB08693	L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid	small molecule	experimental	
DB08694	9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol	small molecule	experimental	
DB08695	3-(4-nitrophenyl)-1H-pyrazole	small molecule	experimental	
DB08697	4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide	small molecule	experimental	
DB08698	1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL	small molecule	experimental	
DB08699	1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine	small molecule	experimental	
DB08701	2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE	small molecule	experimental	
DB08702	2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID	small molecule	experimental	
DB08703	12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one	small molecule	experimental	
DB08704	[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate	small molecule	experimental	
DB08705	6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE	small molecule	experimental	
DB08706	(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID	small molecule	experimental	
DB08707	4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine	small molecule	experimental	
DB08708	N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine	small molecule	experimental	
DB08709	2,3-diphenyl-1H-indole-7-carboxylic acid	small molecule	experimental	
DB08710	(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE	small molecule	experimental	
DB08711	Methyl vanillate	small molecule	experimental	
DB08712	11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID	small molecule	experimental	
DB08713	2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL	small molecule	experimental	
DB08714	2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL	small molecule	experimental	
DB08715	2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL	small molecule	experimental	
DB08717	[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid	small molecule	experimental	
DB08718	4-(3-ethylthiophen-2-yl)benzene-1,2-diol	small molecule	experimental	
DB08719	5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE	small molecule	experimental	
DB08720	5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole	small molecule	experimental	
DB08721	5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole	small molecule	experimental	
DB08722	5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole	small molecule	experimental	
DB08723	5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE	small molecule	experimental	
DB08724	5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole	small molecule	experimental	
DB08725	(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole	small molecule	experimental	
DB08726	5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole	small molecule	experimental	
DB08727	3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole	small molecule	experimental	
DB08728	5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole	small molecule	experimental	
DB08729	5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide	small molecule	experimental	
DB08730	3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE	small molecule	experimental	
DB08731	2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid	small molecule	experimental	
DB08732	NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE	small molecule	experimental	
DB08733	(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE	small molecule	experimental	
DB08734	6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE	small molecule	experimental	
DB08735	R,S-Warfarin alcohol	small molecule	experimental	
DB08736	S,R-Warfarin alcohol	small molecule	experimental	
DB08737	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL	small molecule	experimental	
DB08738	1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one	small molecule	experimental	
DB08739	2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione	small molecule	experimental	
DB08740	CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE	small molecule	experimental	
DB08741	5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine	small molecule	experimental	
DB08742	1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)	small molecule	experimental	
DB08743	2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE	small molecule	experimental	
DB08744	6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one	small molecule	experimental	
DB08745	4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE	small molecule	experimental	
DB08746	1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE	small molecule	experimental	
DB08747	(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one	small molecule	experimental	
DB08748	4-(DIMETHYLAMINO)BENZOIC ACID	small molecule	experimental	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates
DB08749	3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE	small molecule	experimental	
DB08750	1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE	small molecule	experimental	
DB08751	N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE	small molecule	experimental	
DB08752	N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	small molecule	experimental	
DB08753	4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE	small molecule	experimental	
DB08754	(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE	small molecule	experimental	
DB08755	N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide	small molecule	experimental	
DB08756	(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE	small molecule	experimental	
DB08757	5-(2-chlorophenyl)furan-2-carbohydrazide	small molecule	experimental	
DB08758	IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE	small molecule	experimental	
DB08759	[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID	small molecule	experimental	
DB08760	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	small molecule	experimental	
DB08761	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	small molecule	experimental	
DB08762	O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID	small molecule	experimental	
DB08763	[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE	small molecule	experimental	
DB08765	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	small molecule	experimental	
DB08766	Zofenoprilat	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids|Proline
DB08767	2-(4-METHOXYPHENYL)ACETAMIDE	small molecule	experimental	
DB08768	N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE	small molecule	experimental	
DB08770	4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol	small molecule	experimental	
DB08771	(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one	small molecule	experimental	
DB08772	3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID	small molecule	experimental	
DB08773	RALOXIFENE CORE	small molecule	experimental	
DB08774	1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine	small molecule	experimental	
DB08775	NÎ±-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide	small molecule	experimental	
DB08776	N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE	small molecule	experimental	
DB08777	5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE	small molecule	experimental	
DB08778	[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone	small molecule	experimental	
DB08779	2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol	small molecule	experimental	
DB08780	6-MORPHOLIN-4-YL-9H-PURINE	small molecule	experimental	
DB08781	1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE	small molecule	experimental	
DB08782	4-(2-AMINOETHYL)BENZENESULFONAMIDE	small molecule	experimental	Amides|Sulfones|Sulfur Compounds
DB08783	(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid	small molecule	experimental	
DB08784	2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID	small molecule	experimental	
DB08785	4-METHYL-2H-CHROMEN-2-ONE	small molecule	experimental	
DB08786	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	small molecule	experimental	
DB08787	4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine	small molecule	experimental	
DB08788	3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE	small molecule	experimental	
DB08789	2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	small molecule	experimental	
DB08790	1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID	small molecule	experimental	
DB08791	1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE	small molecule	experimental	
DB08792	Diloxanide	small molecule	experimental	Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Dichloroacetamide Derivatives
DB08794	Ethyl biscoumacetate	small molecule	withdrawn	4-Hydroxycoumarins|Anticoagulants|Benzopyrans|Blood and Blood Forming Organs|Coumarins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|Narrow Therapeutic Index Drugs|Pyrans|Vitamin K Antagonists
DB08795	Azidocillin	small molecule	experimental	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Lactams|Penicillins|Sulfur Compounds
DB08796	Pipazethate	small molecule	experimental	Amides|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Respiratory System Agents|Sulfones|Sulfur Compounds
DB08797	Salicylamide	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cyclooxygenase Inhibitors|Ligands|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Salicylic Acid and Derivatives|Sensory System Agents
DB08798	Sulfamoxole	small molecule	experimental	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Intermediate-Acting Sulfonamides|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB08799	Antazoline	small molecule	approved	Anti-Allergic Agents|Antiallergic Agents, Excl. Corticosteroids|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Imidazoles|Moderate Risk QTc-Prolonging Agents|Nasal Preparations|Neurotransmitter Agents|QTc Prolonging Agents
DB08800	Chloropyramine	small molecule	experimental	Amines|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Diamines|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Polyamines|Substituted Ethylene Diamines
DB08801	Dimetindene	small molecule	approved|investigational	Agents producing tachycardia|Anti-Allergic Agents|Anticholinergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Indenes|Muscarinic Antagonists|Neurotransmitter Agents|Pyridines|Substituted Alkylamines
DB08802	Isothipendyl	small molecule	experimental	Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Neurotransmitter Agents|Phenothiazine Derivatives|Sulfur Compounds
DB08803	Tymazoline	small molecule	experimental	Nasal Preparations|Sympathomimetics, Plain
DB08804	Nandrolone decanoate	small molecule	approved|illicit	Anabolic Agents|Androgens|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|HIV Wasting Syndrome|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nandrolone|Steroids|Testosterone Congeners
DB08805	Metiamide	small molecule	experimental	Acid Reducers|Anti-Ulcer Agents|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents|Sulfur Compounds|Thiourea|Urea
DB08806	Roxatidine acetate	small molecule	experimental	Acid Reducers|Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents
DB08807	Bopindolol	small molecule	experimental	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols
DB08808	Bupranolol	small molecule	experimental	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Potential QTc-Prolonging Agents|Propanolamines|Propanols|QTc Prolonging Agents
DB08809	Dichloroacetic Acid	small molecule	approved|investigational	Acetates|Acids, Acyclic|Chloroacetates|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Lipids
DB08810	Cinitapride	small molecule	investigational	Acids, Carbocyclic|Agents that produce hypertension|Amides|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists
DB08811	Tofisopam	small molecule	experimental	Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Nervous System|Psycholeptics|Psychotropic Drugs|Stereoisomerism
DB08813	Nadroparin	small molecule	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB08814	Triflusal	small molecule	approved|investigational	Acids, Carbocyclic|Anticoagulants|Antiplatelet agents|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Hematologic Agents|Hydroxy Acids|Hydroxybenzoates|Phenols|Platelet Aggregation Inhibitors Excl. Heparin
DB08815	Lurasidone	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Hyperglycemia-Associated Agents|Indole Derivatives|Isoindoles|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiazoles|Tranquilizing Agents
DB08816	Ticagrelor	small molecule	approved	Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Carbohydrates|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Cytochrome P450 3A5 Inhibitors|Decreased Platelet Aggregation|Glycosides|Neurotransmitter Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|P2Y12 Platelet Inhibitor|Phenylalanine Hydroxylase Activators|Platelet Aggregation Inhibitors Excl. Heparin|Purine Nucleosides|Purinergic Agents|Purinergic Antagonists|Purinergic P2 Receptor Antagonists|Purinergic P2Y Receptor Antagonists|Purines|Ribonucleosides
DB08818	Hyaluronic acid	small molecule	approved|vet_approved	Adjuvants, Immunologic|Carbohydrates|Cicatrizants|Dermatologicals|Glycosaminoglycans|Immunologic Factors|Lubricants|Musculo-Skeletal System|Nasal Preparations|Ophthalmologicals|Polysaccharides|Preparations for Treatment of Wounds and Ulcers|Protective Agents|Sensory Organs|Surgical Aids|Viscoelastic Substances|Viscosupplements
DB08819	Tafluprost	small molecule	approved	Antiglaucoma Preparations and Miotics|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Increased Prostaglandin Activity|Inflammation Mediators|Lipids|Ophthalmics|Ophthalmologicals|Prostaglandin Receptor Agonists|Prostaglandins|Prostaglandins, Synthetic|Sensory Organs
DB08820	Ivacaftor	small molecule	approved	Amines|Aniline Compounds|Benzene Derivatives|Chloride Channel Activation Potentiators|Cystic Fibrosis Transmembrane Conductance Regulator|Cystic Fibrosis Transmembrane Conductance Regulator Potentiators|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A Inhibitors|Cytochrome P450 3A4 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Phenols|Quinolines
DB08822	Azilsartan medoxomil	small molecule	approved|investigational	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 1 Receptor Blockers|Angiotensin Receptor Antagonists|Decreased Blood Pressure|Hypotensive Agents|Oxazoles
DB08823	Spinosad	small molecule	approved|investigational|vet_approved	Agrochemicals|Insecticides|Lactones|Pediculicides|Pesticides|Pharmaceutical Preparations|Polyketides|Toxic Actions
DB08824	Ioflupane I-123	small molecule	approved	Alkaloids|Aza Compounds|Azabicyclo Compounds|Carbon Radioisotopes|Central Nervous System|Diagnostic Radiopharmaceuticals|Fluorine Radioisotopes|Iodine (123I) Compounds|Iodine Radioisotopes|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Tropanes
DB08826	Deferiprone	small molecule	approved	Chelating Agents|Heavy Metal Antagonists|Iron Chelating Activity|Iron Chelating Agents|Pyridines|Sequestering Agents|UGT1A6 substrate
DB08827	Lomitapide	small molecule	approved|investigational	CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P450 3A4 Inhibitors|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Microsomal Triglyceride Transfer Protein Inhibitor|Microsomal Triglyceride Transfer Protein Inhibitors|Miscellaneous Antilipemic Agents|P-glycoprotein/ABCB1 Inhibitors
DB08828	Vismodegib	small molecule	approved|investigational	Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hedgehog Pathway Inhibitor|P-glycoprotein/ABCB1 Substrates|Smoothened Receptor Antagonists
DB08830	Dehydroascorbic Acid	small molecule	experimental	Acids, Acyclic|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Lactones|Micronutrients|Physiological Phenomena|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins
DB08831	2-deoxyglucose	small molecule	experimental|investigational	Anti-Infective Agents|Antimetabolites|Carbohydrates|Deoxy Sugars|Noxae|Toxic Actions
DB08834	Tauroursodeoxycholic acid	small molecule	experimental|investigational	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anti-Infective Agents|Bile Acids and Salts|Chenodeoxycholic Acid|Cholagogues and Choleretics|Cholanes|Cholic Acids|Deoxycholic Acid|Gastrointestinal Agents|Hydrocarbons, Acyclic|Isomerism|Steroids|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Taurine|Taurocholic Acid|Taurodeoxycholic Acid
DB08835	Spaglumic Acid	small molecule	experimental	Antiallergic Agents, Excl. Corticosteroids|Decongestants and Antiallergics|Mast Cell Stabilizers|Nasal Preparations|Ophthalmologicals|Sensory Organs
DB08836	Temocapril	small molecule	experimental|investigational	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Azepines|Cardiovascular Agents|Enzyme Inhibitors|OATP1B1/SLCO1B1 Substrates|Protease Inhibitors|Sulfur Compounds|Thiepins
DB08837	Tetraethylammonium	small molecule	experimental|investigational	Amines|Ammonium Compounds|Cardiovascular Agents|Ganglion Blockers|MATE 1 Substrates|MATE 2 Substrates|MATE substrates|Membrane Transport Modulators|Nitrogen Compounds|OCT2 Substrates|Onium Compounds|Potassium Channel Blockers|Quaternary Ammonium Compounds|Tetraethylammonium Compounds
DB08838	Agmatine	small molecule	experimental|investigational	Agents causing hyperkalemia|Amidines|Antiarrhythmic agents|Anticholinergic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Guanidines|Nicotinic Antagonists|NMDA Receptor Antagonists|OCT2 Substrates|Vasodilating Agents
DB08839	Serotonin	small molecule	investigational|nutraceutical	Amines|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Bodily Secretions|Central Nervous System Depressants|Complex Mixtures|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fluids and Secretions|Hydrolases|Indoles|Inflammation Mediators|Neurotransmitter Agents|Peptide Hydrolases|Serine Proteases|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Snake Venoms|Toxins, Biological|Tryptamines|Venoms|Viper Venoms
DB08841	Tyramine	small molecule	investigational|nutraceutical	Adrenergic Agents|Agents producing tachycardia|Agents that produce hypertension|Amines|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Peripheral Nervous System Agents|Sympathomimetics
DB08842	Acetylcarnitine	small molecule	approved|investigational	Amines|Ammonium Compounds|Central Nervous System Agents|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Nervous System|Nitrogen Compounds|Nootropic Agents|Onium Compounds|Physiological Phenomena|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB08843	GS 0573	small molecule	investigational	Anti-Infective Agents|Antineoplastic Agents|Immunologic Factors|Purines
DB08844	Uric Acid	small molecule	experimental|investigational	Alkaloids|Antioxidants|Protective Agents|Purines|Purinones|Xanthine derivatives
DB08845	Oxogluric acid	small molecule	experimental|investigational|nutraceutical	Acids, Acyclic|Dicarboxylic Acids|Glutarates|Keto Acids
DB08846	Ellagic Acid	small molecule	investigational	Benzopyrans|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|OAT3/SLC22A8 Substrates|Pyrans
DB08847	Hydroxyproline	small molecule	approved|experimental	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Imines|Imino Acids|Proline
DB08848	Guvacine	small molecule	experimental	Pyridines
DB08855	Leukotriene C4	small molecule	experimental|investigational	Arachidonic Acids|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Leukotrienes|Lipids|SRS-A
DB08856	DADLE	small molecule	experimental	Amino Acids, Peptides, and Proteins|Enkephalin, Leucine|Enkephalins|Nerve Tissue Proteins|Neuropeptides|Opioid Peptides|Peptides|Proteins
DB08860	Pitavastatin	small molecule	approved	Anticholesteremic Agents|BCRP/ABCG2 Substrates|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Enzyme Inhibitors|Hydroxymethylglutaryl-CoA Reductase Inhibitors|Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Noxae|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Toxic Actions
DB08861	DPDPE	small molecule	experimental	Amino Acids, Peptides, and Proteins|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Enkephalins|Narcotics|Nerve Tissue Proteins|Neuropeptides|Neurotransmitter Agents|Opioid Peptides|Opioids|Peptides|Peripheral Nervous System Agents|Proteins|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB08862	Cholecystokinin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Cholagogues and Choleretics|Diagnostic Agents|Gastrointestinal Agents|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Peptides|Tests for Pancreatic Function
DB08864	Rilpivirine	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|Enzyme Inhibitors|Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor|Nitriles|Non-Nucleoside Analog|Non-Nucleoside Reverse Transcriptase Inhibitors|Nonnucleoside Reverse Transcriptase Inhibitors|Nucleic Acid Synthesis Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyrimidines|QTc Prolonging Agents|Reverse Transcriptase Inhibitors
DB08865	Crizotinib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Enzyme Inhibitors|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|OCT2 Inhibitors|Organic Cation Transporter 1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB08867	Ulipristal	small molecule	approved	Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Postcoital|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norsteroids|Progesterone Agonist/Antagonist|Progesterone Receptor Modulators|Selective Progesterone Receptor Modulators|Sex Hormones and Modulators of the Genital System|Steroids
DB08868	Fingolimod	small molecule	approved|investigational	Alcohols|Amines|Amino Alcohols|Antineoplastic and Immunomodulating Agents|Bradycardia-Causing Agents|Glycols|Immunologic Factors|Immunosuppressive Agents|Potential QTc-Prolonging Agents|Propylene Glycols|QTc Prolonging Agents|Selective Immunosuppressants|Sphingosine|Sphingosine 1-phosphate Receptor Modulator|Sphingosine 1-Phosphate Receptor Modulators
DB08869	Tesamorelin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Growth Hormone Releasing Factor Analog|Growth Hormone-Releasing Hormone|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Increased GHRH Activity|Lipodystrophy|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone-Releasing Hormones|Proteins|Somatotropin Agonists|Somatropin and Somatropin Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB08870	Brentuximab vedotin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD30-directed Antibody Interactions|CD30-directed Immunoconjugate|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Microtubule Inhibition|Proteins|Serum Globulins
DB08871	Eribulin	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Microtubule Inhibition|Microtubule Inhibitors|Myelosuppressive Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB08872	Gabapentin enacarbil	small molecule	approved|investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Anti-epileptic Agent|Butyrates|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids
DB08873	Boceprevir	small molecule	approved|withdrawn	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A5 Inhibitors|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|Imines|Imino Acids|NS3/4A Protease Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protease Inhibitors
DB08874	Fidaxomicin	small molecule	approved	Alimentary Tract and Metabolism|Anti-Bacterial Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Carbohydrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Glycosides|Intestinal Antiinfectives|Macrolide Antibacterial|Macrolides|Other Macrolides|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates
DB08875	Cabozantinib	small molecule	approved|investigational	Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Kinase Inhibitor|Protein Kinase Inhibitors|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors|Tyrosine Kinase Inhibitors
DB08876	Taliglucerase alfa	biotech	approved|investigational	Alimentary Tract and Metabolism|Enzyme Replacement Therapy|Enzymes|Enzymes and Coenzymes|Gaucher Disease|Glucosidases|Glycoside Hydrolases|Hydrolases|Hydrolytic Lysosomal Glucocerebroside-specific Enzyme|Recombinant Proteins
DB08877	Ruxolitinib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Immunosuppressive Agents|Janus Kinases, antagonists & inhibitors|Kinase Inhibitor|Myelosuppressive Agents|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB08878	Aminopterin	small molecule	investigational|withdrawn	Biological Factors|Enzyme Inhibitors|Folic Acid Antagonists|Pigments, Biological|Pteridines|Pterins
DB08879	Belimumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|B Lymphocyte Stimulator-directed Antibody Interactions|B Lymphocyte Stimulator-specific Inhibitor|Blood Proteins|Decreased B Lymphocyte Activation|Globulins|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Proteins|Selective Immunosuppressants|Serum Globulins
DB08880	Teriflunomide	small molecule	approved	Acids, Acyclic|Amines|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Benzene Derivatives|Butyrates|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dihydroorotate Dehydrogenase Inhibitors|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Immunologic Factors|Immunomodulatory Agents|Immunosuppressive Agents|Lipids|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|Peripheral Nervous System Agents|Pyrimidine Synthesis Inhibitor|Selective Immunosuppressants|Sensory System Agents|Toluene
DB08881	Vemurafenib	small molecule	approved	Amides|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inhibitors|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Sulfones|Sulfur Compounds|Tyrosine Kinase Inhibitors
DB08882	Linagliptin	small molecule	approved	Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|DPP-IV Inhibitors|Drugs Used in Diabetes|Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretins|Oral Hypoglycemics|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Purines|Quinazolines
DB08883	Perampanel	small molecule	approved	AMPA Receptor Antagonists|Anticonvulsants|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Miscellaneous Anticonvulsants|Nervous System|Noncompetitive AMPA Glutamate Receptor Antagonist|Pyridines|Receptors, AMPA, antagonists & inhibitors
DB08884	Gadoxetic acid	small molecule	approved	Acetates|Acids, Acyclic|Amines|Contrast Media|Diagnostic Uses of Chemicals|Fatty Acids|Fatty Acids, Volatile|Gadolinium-based Contrast Agent|Lipids|Magnetic Resonance Contrast Activity|Magnetic Resonance Imaging Contrast Media|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Organometallic Compounds|Other Diagnostics|Paramagnetic Contrast Agent|Paramagnetic Contrast Media|Pentetic Acid|Polyamines
DB08885	Aflibercept	biotech	approved	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antineovascularisation Agents|EENT Drugs, Miscellaneous|Enzymes|Enzymes and Coenzymes|Membrane Proteins|Ocular Vascular Disorder Agents|Ophthalmics|Ophthalmologicals|Phosphotransferases|Phosphotransferases (Alcohol Group Acceptor)|Protein Kinases|Protein-Tyrosine Kinases|Proteins|Receptor Protein-Tyrosine Kinases|Receptors, Cell Surface|Receptors, Growth Factor|Receptors, Peptide|Recombinant Proteins|Sensory Organs|Transferases|Vascular Endothelial Growth Factor Inhibitor|Vascular Endothelial Growth Factor Inhibitors
DB08886	Asparaginase Erwinia chrysanthemi	biotech	approved|investigational	Antineoplastic Agents|Asparaginase|Asparagine-specific Enzyme
DB08887	Icosapent ethyl	small molecule	approved|investigational|nutraceutical	Antiplatelet agents|Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Hematologic Agents|Hypolipidemic Agents|Inflammation Mediators|Lipids|Oils|Physiological Phenomena
DB08888	Ocriplasmin	biotech	approved	Amino Acids, Peptides, and Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Ophthalmics|Ophthalmologicals|Peptide Hydrolases|Peptides|Sensory Organs|Serine Endopeptidases|Serine Proteases
DB08889	Carfilzomib	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Myelosuppressive Agents|P-glycoprotein/ABCB1 Substrates|Peptides|Proteasome Inhibitors
DB08890	Linaclotide	small molecule	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Drugs for Constipation|Guanylate Cyclase Activators|Guanylate Cyclase-C Agonist|Laxatives|Miscellaneous GI Drugs
DB08891	Arbaclofen	small molecule	investigational	
DB08892	Arbaclofen Placarbil	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|GABA Agents|GABA Agonists|GABA-B Receptor Agonists|gamma-Aminobutyric Acid|Lipids|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Neuromuscular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents
DB08893	Mirabegron	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amides|Anilides|Cholinesterase substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Beta 3-adrenergic Agonists|Sulfur Compounds|Urological Agents|Urologicals
DB08894	Peginesatide	biotech	approved|investigational	Alcohols|Amino Acids, Peptides, and Proteins|Antianemic Preparations|Biomedical and Dental Materials|Blood and Blood Forming Organs|Erythropoiesis-Stimulating Agents|Ethylene Glycols|Glycols|Increased Erythroid Cell Production|Macromolecular Substances|Pegylated agents|Polymers
DB08895	Tofacitinib	small molecule	approved|investigational	Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Bradycardia-Causing Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Disease-modifying Antirheumatic Agents|Enzyme Inhibitors|Immunosuppressive Agents|Janus Kinase 3, antagonists & inhibitors|Janus Kinase Inhibitor|Janus Kinase Inhibitors|Myelosuppressive Agents|Protein Kinase Inhibitors|Selective Immunosuppressants
DB08896	Regorafenib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|Benzene Derivatives|Bradycardia-Causing Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Inhibitors|UGT1A9 Substrates|Urea
DB08897	Aclidinium	small molecule	approved	Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Alkaloids|Anticholinergic Agents|Antimuscarinics Antispasmodics|Aza Compounds|Azabicyclo Compounds|Cholinesterase substrates|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists
DB08898	Glucarpidase	biotech	approved|investigational	Carboxypeptidases|Detoxifying Agents for Antineoplastic Treatment|Enzymes|Enzymes and Coenzymes|Exopeptidases|Hydrolases|Peptide Hydrolases
DB08899	Enzalutamide	small molecule	approved	Androgen Receptor Antagonists|Androgen Receptor Inhibitor|Antiandrogens|Antiandrogens, non-steroidal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2D6 Inducers (moderate)|Cytochrome P-450 CYP2D6 Inducers (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 3A4 Inducers|Endocrine Therapy|Hormone Antagonists and Related Agents|Hydantoins|Imidazoles|Imidazolidines|P-glycoprotein/ABCB1 Inhibitors
DB08900	Teduglutide	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Analogs/Derivatives|Gastrointestinal Agents|Gastrointestinal Hormones|GLP-2 Analog|Glucagon-Like Peptide 2|Glucagon-like Peptide-2 (GLP-2) Agonists|Glucagon-Like Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Miscellaneous GI Drugs|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins|Various Alimentary Tract and Metabolism Products
DB08901	Ponatinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB08902	Raxibacumab	biotech	approved	Amino Acids, Peptides, and Proteins|Anthrax Protective Antigen-directed Antibody|Anthrax Protective Antigen-directed Antibody Interactions|Antibodies|Antiinfectives for Systemic Use|Blood Proteins|Globulins|Immune Sera and Immunoglobulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins|Specific Immunoglobulins
DB08903	Bedaquiline	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diarylquinoline Antimycobacterial|Drugs for Treatment of Tuberculosis|Moderate Risk QTc-Prolonging Agents|Mycobacterium tuberculosis|QTc Prolonging Agents|Quinolines
DB08904	Certolizumab pegol	biotech	approved	Agents reducing cytokine levels|Alcohols|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic and Immunomodulating Agents|Biologics for Rheumatoid Arthritis Treatment|Biomedical and Dental Materials|Blood Proteins|Disease-modifying Antirheumatic Agents|Ethylene Glycols|Globulins|Glycols|Immunoglobulin Fab Fragments|Immunoglobulin Fragments|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Macromolecular Substances|Miscellaneous GI Drugs|Pegylated agents|Peptide Fragments|Peptides|Polyethylene Glycols|Polymers|Proteins|Serum Globulins|Tumor Necrosis Factor Alpha (TNF-Î±) Inhibitors|Tumor Necrosis Factor Blocker|Tumor Necrosis Factor Receptor Blocking Activity
DB08905	Formestane	small molecule	approved|investigational|withdrawn	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Gonadal Hormones|Gonadal Steroid Hormones|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroid Synthesis Inhibitors|Steroids|Testosterone Congeners
DB08906	Fluticasone furoate	small molecule	approved	Adrenal Cortex Hormones|Adrenergics, Inhalants|Agents to Treat Airway Disease|Androstanes|Androstenes|Corticosteroids|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Obstructive Airway Diseases|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Steroids
DB08907	Canagliflozin	small molecule	approved	Agents causing hyperkalemia|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Carbohydrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diuretics|Drugs Used in Diabetes|Glucosides|Glycosides|Hypotensive Agents|Oral Hypoglycemics|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|Sodium-Glucose Transporter 2 Inhibitors|Sulfur Compounds|Thiophenes|UGT1A9 Substrates
DB08908	Dimethyl fumarate	small molecule	approved|investigational	Acids, Acyclic|Dermatologicals|Dicarboxylic Acids|Fumarates|Immunologic Factors|Immunosuppressive Agents|Miscellaneous Central Nervous System Agents|Nervous System|Radiation-Sensitizing Agents
DB08909	Glycerol phenylbutyrate	small molecule	approved	Acids, Carbocyclic|Alcohols|Alimentary Tract and Metabolism|Carbohydrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Nitrogen Binding Agent|Sugar Alcohols|Urea Cycle Disorder Agents|Various Alimentary Tract and Metabolism Products
DB08910	Pomalidomide	small molecule	approved	Acids, Carbocyclic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Growth Inhibitors|Growth Substances|Imides|Immunologic Factors|Immunosuppressive Agents|Isoindoles|Myelosuppressive Agents|P-glycoprotein/ABCB1 Substrates|Phthalic Acids|Phthalimides|Piperidines|Piperidones|Thalidomide Analog
DB08911	Trametinib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Kinase Inhibitor|MAP Kinase Kinase 1, antagonists & inhibitors|MAP Kinase Kinase 2, antagonists & inhibitors|Protein Kinase Inhibitors|Pyridines|Pyrimidines
DB08912	Dabrafenib	small molecule	approved|investigational	Amines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (strong)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 3A4 Inducers|Enzyme Inhibitors|Hydroxylamines|Hyperglycemia-Associated Agents|Kinase Inhibitor|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporter 1 Inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Protein Kinase Inhibitors|Proto-Oncogene Proteins B-raf, antagonists & inhibitors|QTc Prolonging Agents
DB08913	Radium Ra 223 Dichloride	small molecule	approved|investigational	Antineoplastic Agents|Elements|Elements, Radioactive|Isotopes|Metals|Metals, Alkaline Earth|Metals, Heavy|Radioactive alpha-Particle Emitting Therapeutic Agent
DB08915	Aleglitazar	small molecule	investigational	Sulfur Compounds
DB08916	Afatinib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Kinase Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB08917	Ferric Carboxymaltose	small molecule	approved	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Disaccharides|Glucans|Iron Compounds|Macromolecular Substances|Oligosaccharides|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Polymers|Polysaccharides
DB08918	Levomilnacipran	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cycloparaffins|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Miscellaneous Antidepressants|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Norepinephrine Uptake Inhibitors|P-glycoprotein/ABCB1 Substrates|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin and Noradrenaline Reuptake Inhibitors|Serotonin Modulators
DB08921	(4R)-limonene	small molecule	investigational	Anticarcinogenic Agents|Carcinogens|Cyclohexanes|Cycloparaffins|Solvents
DB08922	Perospirone	small molecule	experimental	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotoxic agents|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents
DB08924	Amfecloral	small molecule	experimental	
DB08925	Adrafinil	small molecule	withdrawn	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Hydroxy Acids|Hydroxylamines|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics
DB08926	Acediasulfone	small molecule	experimental	Sulfur Compounds
DB08927	Amperozide	small molecule	experimental	Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB08928	Arsthinol	small molecule	experimental	Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals|Organometallic Compounds
DB08930	Dolutegravir	small molecule	approved	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Direct Acting Antivirals|Enzyme Inhibitors|HIV Integrase Inhibitors|Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|Integrase Inhibitors|Miscellaneous Antiretrovirals*|Multidrug and Toxin Extrusion Transporter 1 Inhibitors|OAT3/SLC22A8 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates
DB08931	Riociguat	small molecule	approved	Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Guanylate Cyclase|Guanylate Cyclase Stimulators|Hypotensive Agents|Soluble Guanylate Cyclase Stimulator|Vasodilating Agents
DB08932	Macitentan	small molecule	approved	Amides|Antihypertensive Agents|Antihypertensives for Pulmonary Arterial Hypertension|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Endothelin A Receptor Antagonists|Endothelin B Receptor Antagonists|Endothelin Receptor Antagonists|Sulfones|Sulfur Compounds|Vasodilating Agents
DB08933	Luliconazole	small molecule	approved	Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inhibitors|Dermatologicals|Imidazole and Triazole Derivatives
DB08934	Sofosbuvir	small molecule	approved	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Carbohydrates|Direct Acting Antivirals|Glycosides|Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor|Nucleic Acids, Nucleotides, and Nucleosides|Nucleoside Analog|Nucleosides|Nucleotides|P-glycoprotein/ABCB1 Substrates|Pyrimidine Nucleosides|Pyrimidine Nucleotides|Pyrimidines|Ribonucleosides|Ribonucleotides|RNA Replicase Inhibitors|Uracil Nucleotides|Uridine Monophosphate
DB08935	Obinutuzumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|CD20-directed Antibody Interactions|CD20-directed Cytolytic Antibody|Globulins|Hypotensive Agents|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Myelosuppressive Agents|Proteins|Serum Globulins
DB08936	Chlorcyclizine	small molecule	approved	Antihistamines for Systemic Use|Histamine Antagonists|Histamine H1 Antagonists|Piperazine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB08937	TAS-102	small molecule	investigational	Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pharmaceutical Preparations|Pyrimidine Nucleosides|Pyrimidines|Pyrimidinones|Thymidine
DB08938	Magaldrate	small molecule	approved|withdrawn	Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Anions|Antacids|Antacids With Antiflatulents|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxides|Ions|Magnesium Compounds
DB08939	Letosteine	small molecule	experimental	Cough and Cold Preparations|Expectorants|Respiratory System Agents|Sulfur Compounds|Thiazoles
DB08940	Kebuzone	small molecule	experimental	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Butylpyrazolidines|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents
DB08941	Isoxsuprine	small molecule	approved|withdrawn	2-Amino-1-Phenylethanol Derivatives|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiovascular Agents|Ethylamines|Hypotensive Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Peripheral Vasodilators|Phenethylamines|Propanolamines|Propanols|Reproductive Control Agents|Sympathomimetics|Tocolytic Agents|Vasodilating Agents
DB08942	Isoxicam	small molecule	withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines
DB08943	Isoconazole	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole and Triazole Derivatives|Imidazole Derivatives|Imidazoles|Ointments
DB08944	Isoaminile	small molecule	approved|withdrawn	Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Nitriles|Respiratory System Agents
DB08945	Iotroxic acid	small molecule	experimental|withdrawn	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB08946	Iopanoic acid	small molecule	approved|withdrawn	Benzene Derivatives|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB08947	Iopamidol	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB08948	Iodamide	small molecule	withdrawn	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB08949	Inositol nicotinate	small molecule	approved|withdrawn	Cardiovascular Agents|Nicotinic Acid and Derivatives|Other Nutritional Agents|Peripheral Vasodilators|Pyridines|Vasodilating Agents|Vitamin B Complex|Vitamins
DB08950	Indoramin	small molecule	withdrawn	Acids, Carbocyclic|Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amides|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Cardiovascular Agents|Hypotensive Agents|Indoles|Neurotransmitter Agents|Piperidines
DB08951	Indoprofen	small molecule	withdrawn	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Isoindoles|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Phenylpropionates|Propionates|Sensory System Agents
DB08952	Indenolol	small molecule	withdrawn	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Propanols|QTc Prolonging Agents|Vasodilating Agents
DB08953	Indalpine	small molecule	investigational|withdrawn	Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB08954	Ifenprodil	small molecule	approved|investigational|withdrawn	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Anti-Parkinson Drugs|Anticonvulsants|Cardiovascular Agents|Central Nervous System Depressants|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neurotransmitter Agents|NMDA Receptor Antagonists|Peripheral Vasodilators|Receptors, N-Methyl-D-Aspartate|Vasodilating Agents
DB08955	Ibuproxam	small molecule	withdrawn	Acetamides|Acetates|Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Hydroxylamines|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents
DB08956	Hydroxydione	small molecule	investigational|withdrawn	Pregnanes|Steroids
DB08957	Hexoprenaline	small molecule	experimental|withdrawn	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Amines|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethylamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenethylamines|Reproductive Control Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists|Tocolytic Agents
DB08958	Hexetidine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Anti-Infective Agents|Anti-Infective Agents, Local|Antifungal Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Pyrimidines|Stomatological Preparations
DB08960	Hexamethonium	small molecule	experimental	Amines|Ammonium Compounds|Anticholinergic Agents|Antihypertensive Agents|Autonomic Agents|Bis-Trimethylammonium Compounds|Cardiovascular Agents|Central Nervous System Depressants|Cholinergic Agents|Ganglion Blockers|Hexamethonium Compounds|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Neurotransmitter Agents|Nicotinic Antagonists|Nitrogen Compounds|Onium Compounds|Peripheral Nervous System Agents|Quaternary Ammonium Compounds
DB08961	Azosemide	small molecule	investigational	Amides|Amines|Aniline Compounds|Cardiovascular Agents|Diuretics|Natriuretic Agents|Sodium Potassium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds
DB08962	Glibornuride	small molecule	investigational|withdrawn	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C9 Substrates|Drugs Used in Diabetes|Oral Hypoglycemics|Sulfones|Sulfonylureas|Sulfur Compounds|Urea
DB08964	Gemeprost	small molecule	approved|withdrawn	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins E|Prostaglandins E, Synthetic|Reproductive Control Agents|Uterotonic agents
DB08965	Fusafungine	small molecule	approved|withdrawn	Anti-Bacterial Agents|Throat Preparations
DB08966	Fursultiamine	small molecule	approved	Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins
DB08967	Dimetotiazine	small molecule	approved	Analgesics|Antimigraine Preparations|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Nervous System|Neurotransmitter Agents|Sulfur Compounds
DB08968	Fominoben	small molecule	experimental|withdrawn	Antitussive Agents|Central Nervous System Agents|Oxazines|Respiratory System Agents
DB08969	Flurothyl	small molecule	withdrawn	Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|Ethers|Ethyl Ethers
DB08970	Fluprednidene	small molecule	experimental	Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents
DB08971	Fluocortolone	small molecule	approved|withdrawn	Adrenal Cortex Hormones|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use, Plain|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Ophthalmologicals|Pregnadienediols|Pregnadienes|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoprotectives
DB08972	Flumequine	small molecule	withdrawn	Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Renal Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB08973	Fluclorolone acetonide	small molecule	approved|withdrawn	Pregnadienes|Pregnanes|Steroids
DB08974	Flubendazole	small molecule	experimental|withdrawn	Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Benzimidazole Derivatives|Benzimidazoles|Carbamates
DB08975	Florantyrone	small molecule	withdrawn	
DB08976	Floctafenine	small molecule	approved|withdrawn	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Benzene Derivatives|Benzoates|Central Nervous System Agents|Miscellaneous Analgesics and Antipyretics|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Sensory System Agents
DB08978	Fentonium	small molecule	withdrawn	Alimentary Tract and Metabolism|Alkaloids|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Solanaceous Alkaloids|Tropanes
DB08979	Fenspiride	small molecule	experimental	Anti-Asthmatic Agents|Asthma|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Peripheral Nervous System Agents|Respiratory System Agents
DB08980	Fendiline	small molecule	withdrawn	Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Non-Selective Calcium Channel Blockers|Phenethylamines|Phenylalkylamine Derivatives|QTc Prolonging Agents|Vasodilating Agents
DB08981	Fenbufen	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents
DB08982	Etozoline	small molecule	experimental	
DB08983	Etofibrate	small molecule	experimental	Acids, Acyclic|Anticholesteremic Agents|Benzene Derivatives|Butyrates|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Phenols|Phenyl Ethers|Toxic Actions
DB08984	Etofenamate	small molecule	experimental	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Benzene Derivatives|Benzoates|Central Nervous System Agents|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|ortho-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB08985	Etilefrine	small molecule	withdrawn	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Phenylephrine|Protective Agents|Sympathomimetics|Vasoconstrictor Agents
DB08986	Etifoxine	small molecule	investigational|withdrawn	Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB08987	Etidocaine	small molecule	approved	Acetanilides|Amides|Anesthetics|Anesthetics, Local|Anilides|Central Nervous System Agents|Nervous System|Peripheral Nervous System Agents|Sensory System Agents
DB08988	Ethoheptazine	small molecule	approved|withdrawn	
DB08989	Etamivan	small molecule	withdrawn	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Respiratory System Agents
DB08990	Eprazinone	small molecule	experimental|withdrawn	Cough and Cold Preparations|Expectorants|Ketones|Respiratory System Agents
DB08991	Epirizole	small molecule	experimental	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Pyrazoles|Pyrimidines|Sensory System Agents
DB08992	Eperisone	small molecule	investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ketones|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Vasodilating Agents
DB08993	Enviomycin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibiotics, Antitubercular|Antituberculosis Agents|Peptides|Peptides, Cyclic|Viomycin
DB08994	Ditazole	small molecule	experimental|withdrawn	Anticoagulants|Blood and Blood Forming Organs|Platelet Aggregation Inhibitors Excl. Heparin
DB08995	Diosmin	small molecule	approved|investigational	Benzopyrans|Capillary Stabilizing Agents|Chromones|Flavones|Flavonoids|Pyrans|Vasoprotectives
DB08996	Dimetacrine	small molecule	experimental|withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB08997	Dexetimide	small molecule	withdrawn	Agents producing tachycardia|Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Anticholinergic Agents|Autonomic Agents|Central Nervous System Agents|Cholinergic Agents|Muscarinic Antagonists|Nervous System|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Piperidines|Piperidones|Tertiary Amines
DB08998	Demexiptiline	small molecule	experimental	Benzocycloheptenes
DB08999	Cyclopentamine	small molecule	withdrawn	Cycloparaffins|Ganglion Blockers|Nasal Preparations|Sympathomimetics, Plain
DB09000	Cyamemazine	small molecule	experimental	Anti-Anxiety Agents|Antipsychotic Agents|Central Nervous System Depressants|Nervous System|Neurotoxic agents|Phenothiazines|Phenothiazines With Aliphatic Side-Chain|Photosensitizing Agents|Psycholeptics|Sulfur Compounds
DB09001	Barbexaclone	small molecule	experimental	Anticonvulsants|Barbiturates|Barbiturates and Derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Nervous System|Pyrimidines|Pyrimidinones
DB09002	Cloperastine	small molecule	experimental	Cough and Cold Preparations
DB09003	Clocapramine	small molecule	experimental	
DB09004	Clobutinol	small molecule	withdrawn	Alcohols|Amines|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Respiratory System Agents
DB09005	Batroxobin	biotech	experimental	Biological Factors|Blood and Blood Forming Organs|Bodily Secretions|Cardiovascular Agents|Coagulants|Complex Mixtures|Crotalid Venoms|Endopeptidases|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fluids and Secretions|Hematologic Agents|Hemostatics|Hydrolases|Peptide Hydrolases|Serine Endopeptidases|Serine Proteases|Snake Venoms|Toxins, Biological|Venombin A|Venoms|Viper Venoms
DB09006	Clinofibrate	small molecule	experimental	Acetates|Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Glycolates|Hydroxy Acids|Lipids
DB09007	Chlorphenoxamine	small molecule	withdrawn	Agents producing tachycardia|Amines|Aminoalkyl Ethers|Anticholinergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Cholinergic Agents|Dermatologicals|Histamine Agents|Histamine Antagonists|Muscarinic Antagonists|Neurotransmitter Agents
DB09008	Cefaloridine	small molecule	experimental|withdrawn	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|Sulfur Compounds|Thiazines
DB09009	Articaine	small molecule	approved	Amide Local Anesthetic|Amides|Anesthetics|Anesthetics, Local|Central Nervous System Agents|Hyperglycemia-Associated Agents|Local Anesthesia|Nervous System|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiophenes
DB09010	Carmofur	small molecule	withdrawn	Antimetabolites|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Fluoropyrimidines|Pyrimidine Analogues|Pyrimidines|Pyrimidinones|Uracil
DB09011	Beclamide	small molecule	experimental	Acids, Acyclic|Anticonvulsants|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System
DB09012	Carbazochrome	small molecule	experimental|withdrawn	Biological Factors|Blood and Blood Forming Organs|Coagulants|Hematologic Agents|Hemostatics|Indoles|Pigments, Biological
DB09013	Befunolol	small molecule	experimental	Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-Agonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiglaucoma Preparations and Miotics|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Ophthalmologicals|Propanols|Sensory Organs
DB09014	Captodiame	small molecule	experimental	Anti-Anxiety Agents|Central Nervous System Depressants|Diphenylmethane Derivatives|Nervous System|Psycholeptics|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB09015	Canrenoic acid	small molecule	approved|withdrawn	Agents causing hyperkalemia|Cardiovascular Agents|Diuretics|Diuretics, Potassium Sparing|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Potassium-Sparing Agents|Pregnadienes|Pregnanes|Steroids
DB09016	Butriptyline	small molecule	approved	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Depressants|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB09017	Brotizolam	small molecule	investigational|withdrawn	Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB09018	Bromopride	small molecule	investigational	Acids, Carbocyclic|Alimentary Tract and Metabolism|Amides|Aminobenzoates|Antiemetics|Autonomic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Chlorobenzoates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Drugs for Functional Gastrointestinal Disorders|Ethers|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Neurotransmitter Agents|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Propulsives
DB09019	Bromhexine	small molecule	approved	Amines|Aniline Compounds|Cough and Cold Preparations|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Expectorants|Respiratory System Agents
DB09020	Bisacodyl	small molecule	approved	Alimentary Tract and Metabolism|Benzene Derivatives|Contact Laxatives|Cresols|Drugs for Constipation|Enemas|Gastrointestinal Agents|Increased Large Intestinal Motility|Laxatives|Phenols|Stimulation Large Intestine Fluid/Electrolyte Secretion
DB09021	Benzoctamine	small molecule	experimental	Anti-Anxiety Agents|Central Nervous System Depressants|Dibenzo-Bicyclo-Octadiene Derivatives|Nervous System|Psycholeptics
DB09022	Benfluorex	small molecule	investigational|withdrawn	Alimentary Tract and Metabolism|Amines|Anti-Obesity Agents|Appetite Depressants|Blood Glucose Lowering Agents|Central Nervous System Agents|Drugs Used in Diabetes|Ethylamines|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Oral Hypoglycemics|Phenethylamines|Toxic Actions
DB09023	Benactyzine	small molecule	withdrawn	Acids, Carbocyclic|Agents producing tachycardia|Anticholinergic Agents|Autonomic Agents|Benzilates|Central Nervous System Agents|Central Nervous System Depressants|Cholinergic Agents|Diphenylacetic Acids|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Psychotropic Drugs
DB09026	Aliskiren	small molecule	approved|investigational	Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Antihypertensive Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dicarboxylic Acids|Hypotensive Agents|Renin-Inhibitors
DB09027	Ledipasvir	small molecule	approved	Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Breast Cancer Resistance Protein Inhibitors|Direct Acting Antivirals|Hepatitis C Virus NS5A Inhibitor|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates
DB09028	Cytisine	small molecule	experimental	Nicotine, antagonists & inhibitors
DB09029	Secukinumab	biotech	approved	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin Inhibitors|Interleukin-17, antagonists & inhibitors|Interleukin-17A Antagonist|Interleukin-17A Antagonists|Misc. Skin and Mucous Membrane Agents|Proteins|Psoriasis, drug therapy|Serum Globulins
DB09030	Vorapaxar	small molecule	approved	Anticoagulants|Antiplatelet agents|Blood and Blood Forming Organs|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|P-glycoprotein/ABCB1 Inhibitors|Platelet Aggregation Inhibitors Excl. Heparin|Protease-activated Receptor-1 Antagonist|Protease-activated Receptor-1 Antagonists|Receptor, PAR-1, antagonists & inhibitors|Receptors, Thrombin, antagonists & inhibitors
DB09031	Miltefosine	small molecule	approved|investigational	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Anti-Infective Agents|Antifungal Agents|Antileishmanial|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Antiparasitic Agents|Antiprotozoals|Choline|Ethanolamines|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Trimethyl Ammonium Compounds
DB09033	Vedolizumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Blood Proteins|Gastrointestinal Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Integrin Receptor Antagonist|Integrin Receptor Antagonists|Proteins|Selective Immunosuppressants|Serum Globulins
DB09034	Suvorexant	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P450 3A Inhibitors|Neurotransmitter Agents|Orexin Receptor Antagonists|P-glycoprotein/ABCB1 Inhibitors|Sleep Aids, Pharmaceutical
DB09035	Nivolumab	biotech	approved	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulin G|Immunoglobulins|Immunoproteins|Programmed Death Receptor-1 Blocking Antibody|Programmed Death Receptor-1-directed Antibody Interactions|Proteins|Serum Globulins
DB09036	Siltuximab	biotech	approved|investigational	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin Inhibitors|Interleukin-6 Antagonist|Interleukin-6 Antagonists|Proteins|Serum Globulins
DB09037	Pembrolizumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Programmed Death Receptor-1 Blocking Antibody|Programmed Death Receptor-1-directed Antibody Interactions|Proteins|Serum Globulins
DB09038	Empagliflozin	small molecule	approved	Alimentary Tract and Metabolism|Benzene Derivatives|Blood Glucose Lowering Agents|Carbohydrates|Diuretics|Drugs Used in Diabetes|Glycosides|Hypotensive Agents|Oral Hypoglycemics|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|Sodium-Glucose Transporter 2 Inhibitors
DB09039	Eliglustat	small molecule	approved	Alimentary Tract and Metabolism|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Gaucher Disease|Glucosylceramide Synthase Inhibitor|Glucosylceramide Synthase Inhibitors|Highest Risk QTc-Prolonging Agents|Other Miscellaneous Therapeutic Agents|P-glycoprotein/ABCB1 Inhibitors|QTc Prolonging Agents|Various Alimentary Tract and Metabolism Products
DB09040	Efinaconazole	small molecule	approved	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Azole Antifungals|Dermatologicals|Imidazole and Triazole Derivatives
DB09041	Tavaborole	small molecule	approved|investigational	Anti-Infective Agents|Antifungal Agents|Oxaborole Antifungal|Protein Synthesis Inhibitors
DB09042	Tedizolid phosphate	small molecule	approved	Agents that produce hypertension|Anti-Bacterial Agents|Anti-Infective Agents|Central Nervous System Depressants|Immunosuppressive Agents|Myelosuppressive Agents|Organophosphorus Compounds|Oxazolidinone Antibacterial|Oxazolidinones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB09043	Albiglutide	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Gastrointestinal Hormones|GLP-1 Agonists|Glucagon-like Peptide-1 (GLP-1) Agonists|Glucagon-Like Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretins|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins|Recombinant Proteins
DB09045	Dulaglutide	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Blood Proteins|Drugs Used in Diabetes|Gastrointestinal Hormones|Globulins|GLP-1 Agonists|Glucagon-like Peptide-1 (GLP-1) Agonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunoglobulin Constant Regions|Immunoglobulin Fragments|Immunoglobulins|Immunoproteins|Incretin Mimetics|Pancreatic Hormones|Peptide Fragments|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins|Recombinant Proteins|Serum Globulins
DB09046	Metreleptin	biotech	approved	Adipokines|Amino Acids, Peptides, and Proteins|Analogs/Derivatives|Biological Factors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Intercellular Signaling Peptides and Proteins|Leptin|Leptin Analog|Obesity, drug therapy|Peptide Hormones|Peptides|Proteins
DB09047	Finafloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents, Urinary|Quinolines|Quinolone Antimicrobial|Quinolones
DB09048	Netupitant	small molecule	approved|investigational	Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|Neurokinin 1 Antagonists|P-glycoprotein/ABCB1 Inhibitors|Substance P/Neurokinin-1 Receptor Antagonist
DB09049	Naloxegol	small molecule	approved	Alcohols|Alimentary Tract and Metabolism|Alkaloids|Biomedical and Dental Materials|Central Nervous System Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Drugs for Constipation|Ethylene Glycols|Glycols|Macromolecular Substances|Miscellaneous GI Drugs|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Peripheral Opioid Receptor Antagonists|Phenanthrenes|Polymers|Sensory System Agents
DB09050	Ceftolozane	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Sulfur Compounds|Thiazines
DB09051	Elosulfase alfa	biotech	approved|investigational	Alimentary Tract and Metabolism|Carbon-Oxygen Lyases|Chondroitinases and Chondroitin Lyases|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme|Lyases|Polysaccharide-Lyases|Recombinant Proteins|Sulfatases
DB09052	Blinatumomab	biotech	approved|investigational	Amides|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bispecific CD19-directed CD3-directed T Cell Engager|Blood Proteins|CD19-directed Antibody Interactions|CD3 Receptor Agonists|CD3-directed Antibody Interactions|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Monoterpenes|Myelosuppressive Agents|Norbornanes|Proteins|Serum Globulins|Sulfones|Sulfur Compounds|Terpenes
DB09053	Ibrutinib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Immunosuppressive Agents|Kinase Inhibitor|Myelosuppressive Agents|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB09054	Idelalisib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Kinase Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Quinazolines
DB09055	Acipimox	small molecule	approved|investigational	Hypolipidemic Agents|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Nicotinic Acid and Derivatives|Noxae|Toxic Actions
DB09056	Amorolfine	small molecule	approved|investigational	Anti-Infective Agents|Antifungal Agents|Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Oxazines
DB09057	Anthrax immune globulin human	biotech	approved	Immunoglobulins|Serum Globulins|Vaccines
DB09059	Atosiban	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Posterior|Reproductive Control Agents|Tocolytic Agents
DB09060	Avibactam	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Aza Compounds|beta-Lactamase Inhibitors|Enzyme Inhibitors|OAT3/SLC22A8 Substrates
DB09061	Cannabidiol	small molecule	approved|investigational	Agents producing tachycardia|Agents that produce hypertension|BCRP/ABCG2 Inhibitors|Cannabinoids and similars|Central Nervous System Depressants|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Terpenes
DB09062	Cefminox	small molecule	experimental	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB09063	Ceritinib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Bradycardia-Causing Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C9 Inhibitors|Cytochrome P450 3A Inhibitors|Enzyme Inhibitors|Hyperglycemia-Associated Agents|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptor Protein-Tyrosine Kinases, antagonists & inhibitors|Sulfur Compounds|Tyrosine Kinase Inhibitors
DB09064	Ciprofibrate	small molecule	approved|investigational	Acids, Acyclic|Benzene Derivatives|Butyrates|Carcinogens|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Peroxisome Proliferators|Phenols|Phenyl Ethers|Toxic Actions
DB09065	Cobicistat	small molecule	approved	Acids, Acyclic|Anti-HIV Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Carbamates|Chemically-Induced Disorders|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Cytochrome P450 3A Inhibitors|Enzyme Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Other Miscellaneous Therapeutic Agents|P-glycoprotein/ABCB1 Inhibitors|Sulfur Compounds|Thiazoles
DB09066	Corifollitropin alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Follicle Stimulating Hormone|Genito Urinary System and Sex Hormones|Gonadotropins|Gonadotropins, Pituitary|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Recombinant Proteins|Sex Hormones and Modulators of the Genital System
DB09067	Corticorelin ovine triflutate	small molecule	approved	Amino Acids, Peptides, and Proteins|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|Tests for Pituitary Function
DB09068	Vortioxetine	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Agents that produce hypertension|Anions|Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Electrolytes|Gases|Hydrogen Sulfide|Ions|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT1 Receptor Antagonists|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Sulfur Compounds|Tranquilizing Agents
DB09069	Trimetazidine	small molecule	approved|investigational	Cardiac Therapy|Cardiovascular Agents|Piperazines|Vasodilating Agents
DB09070	Tibolone	small molecule	approved|investigational	Anabolic Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Cardiovascular Agents|Estrogen Receptor Modulators|Estrogens|Genito Urinary System and Sex Hormones|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norsteroids|Sex Hormones and Modulators of the Genital System|Steroids
DB09071	Tasimelteon	small molecule	approved|investigational	Central Nervous System Depressants|Cycloparaffins|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics and Sedatives|Melatonin Receptor Agonists|Nervous System|Psycholeptics|Receptors, Melatonin, agonists
DB09072	Sodium oxybate	small molecule	approved	Acids, Acyclic|Adjuvants, Anesthesia|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Butyrates|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Hydroxybutyrates|Lipids|Miscellaneous Central Nervous System Agents|Nervous System
DB09073	Palbociclib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cyclin-Dependent Kinases, antagonists & inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|Kinase Inhibitor|Kinase Inhibitors|Myelosuppressive Agents|Protein Kinase Inhibitors
DB09074	Olaparib	small molecule	approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Immunosuppressive Agents|Myelosuppressive Agents|Poly(ADP-ribose) Polymerase Inhibitors|Pyridazines
DB09075	Edoxaban	small molecule	approved	Anticoagulants|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Serine Proteinase Inhibitors|Sulfur Compounds
DB09076	Umeclidinium	small molecule	approved	Adrenergics, Inhalants|Agents producing tachycardia|Agents to Treat Airway Disease|Anticholinergic Agents|Antimuscarinics Antispasmodics|Cytochrome P-450 CYP2D6 Substrates|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|P-glycoprotein/ABCB1 Substrates|Pulmonary Disease, Chronic Obstructive, drug therapy
DB09077	Dinutuximab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Glycolipid Disialoganglioside-directed Antibody|Glycolipid Disialoganglioside-directed Antibody Interactions|Hypotensive Agents|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Myelosuppressive Agents|Proteins|Serum Globulins
DB09078	Lenvatinib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Kinase Inhibitor|Moderate Risk QTc-Prolonging Agents|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|QTc Prolonging Agents|Receptor Tyrosine Kinase Inhibitors|Tyrosine Kinase Inhibitors|Urea
DB09079	Nintedanib	small molecule	approved	Antifibrotic Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Kinase Inhibitor|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB09080	Olodaterol	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Drugs for Obstructive Airway Diseases|Neurotransmitter Agents|Oxazines|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB09081	Idebenone	small molecule	approved|investigational	Antioxidants|Benzoquinones|Coenzymes|Enzymes and Coenzymes|Nervous System|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Quinones
DB09082	Vilanterol	small molecule	approved	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Benzene Derivatives|Benzyl Compounds|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Obstructive Airway Diseases|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Immunosuppressive Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB09083	Ivabradine	small molecule	approved	Bradycardia-Causing Agents|Cardiac Therapy|Cardiovascular Agents|Cyclic Nucleotide-Gated Cation Channels, antagonists & inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Highest Risk QTc-Prolonging Agents|Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists|Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker|Miscellaneous Cardiac Drugs|QTc Prolonging Agents
DB09084	Benzydamine	small molecule	approved	Agents causing hyperkalemia|Agents that produce hypertension|Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antiinflammatory Products for Vaginal Administration|Genito Urinary System and Sex Hormones|Indazoles|Mouthwashes and Gargles|Musculo-Skeletal System|Nephrotoxic agents|Pyrazoles|Stomatological Preparations|Topical Products for Joint and Muscular Pain
DB09085	Tetracaine	small molecule	approved|vet_approved	Acids, Carbocyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Aminobenzoates|Anesthetics|Anesthetics for Topical Use|Anesthetics, General|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Benzene Derivatives|Benzoates|Central Nervous System Agents|Dental Agents|Dermatologicals|Ester Local Anesthetic|Esters of Aminobenzoic Acid|Local Anesthesia|Nervous System|Ophthalmologicals|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory Organs|Sensory System Agents|Vasoprotectives
DB09086	Eugenol	small molecule	approved	Acids, Carbocyclic|Anti-Infective Agents|Caffeic Acids|Cell-mediated Immunity|Cinnamates|Increased Histamine Release|Solvents|Standardized Chemical Allergen
DB09087	Potassium alum	small molecule	approved	Acids|Acids, Noncarboxylic|Aluminium Compounds|Anions|Electrolytes|Elements|Ions|Metals|Metals, Alkali|Metals, Light|Potassium Salt|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB09088	Amylocaine	small molecule	approved|withdrawn	Acids, Carbocyclic|Benzene Derivatives
DB09089	Trimebutine	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents producing tachycardia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Benzene Derivatives|Benzoates|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Functional Gastrointestinal Disorders|Ethers|Gastrointestinal Agents|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Potential QTc-Prolonging Agents|Prokinetic Agents|QTc Prolonging Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group
DB09090	Pinaverium	small molecule	approved	Agents causing hyperkalemia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Functional Gastrointestinal Disorders|Membrane Transport Modulators|Miscellaneous GI Drugs|Oxazines|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents
DB09091	Tixocortol	small molecule	approved|withdrawn	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Alimentary Tract and Metabolism|Anti-Allergic Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Cell-mediated Immunity|Corticosteroids|Corticosteroids Acting Locally|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Increased Histamine Release|Intestinal Antiinflammatory Agents|Nasal Preparations|Pregnanes|Pregnenediones|Pregnenes|Standardized Chemical Allergen|Steroids
DB09092	Xanthinol	small molecule	approved|withdrawn	Alkaloids|Cardiovascular Agents|Nicotinic Acids|Peripheral Vasodilators|Purine Derivatives|Purines|Purinones|Pyridines|Vasodilating Agents
DB09093	Chlortetracycline	small molecule	approved|investigational|vet_approved	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antibiotics for Topical Use|Antiinfectives and Antiseptics for Local Oral Treatment|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiprotozoals|Dermatologicals|Enzyme Inhibitors|Naphthacenes|Ophthalmologicals|Protein Synthesis Inhibitors|Sensory Organs|Stomatological Preparations|Tetracyclines
DB09094	Podophyllin	small molecule	approved	Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Biological Products|Caustics|Complex Mixtures|Dermatologicals|Keratolytic Agents|Misc. Skin and Mucous Membrane Agents|Noxae|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Toxic Actions
DB09095	Difluocortolone	small molecule	approved|investigational|withdrawn	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Fluocortolone|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated
DB09096	Benzoyl peroxide	small molecule	approved	Acids, Carbocyclic|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Benzene Derivatives|Benzoates|Dermatologicals|Keratolytic Agents|Nitrogen Binding Agent|Peroxides
DB09097	Quinagolide	small molecule	approved|investigational	Dopamine Agents|Dopamine Agonists|Dopamine D2 Receptor Agonists|Genito Urinary System and Sex Hormones|Miscellaneous Therapeutic Agents|Neurotransmitter Agents|Prolactine Inhibitors|Quinolines
DB09098	Somatrem	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Anterior Pituitary Lobe Hormones and Analogues|Growth Hormone|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Anterior|Somatropin and Somatropin Agonists|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB09099	Somatostatin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|P-glycoprotein/ABCB1 Substrates|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormone Release Inhibiting Hormones|Proteins|Somatostatin and Analogues|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB09100	Thyroid, porcine	biotech	approved	Thyroid Products
DB09101	Elvitegravir	small molecule	approved	Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C9 Inducers|Direct Acting Antivirals|HIV Integrase|HIV Integrase Inhibitors|Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor|Quinolines|UGT1A1 Substrates
DB09102	Daclatasvir	small molecule	approved|investigational	Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Direct Acting Antivirals|HCV Replication Complex Inhibitors|Hepatitis C Virus NS5A Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB09103	Ancestim	biotech	approved|investigational|withdrawn	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Colony-Stimulating Factors|Cytokines|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB09104	Magnesium hydroxide	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Alkalies|Anions|Antacids|Antacids and Adsorbents|Basic Ointments and Protectants|Calculi Dissolution Agent|Drugs for Acid Related Disorders|Electrolytes|Emollients Demulcents and Protectants|Gastric Acid Lowering Agents|Gastrointestinal Agents|Genito Urinary System and Sex Hormones|Hydroxides|Ions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Magnesium Salts|Osmotic Laxative|Urologicals
DB09105	Asfotase Alfa	biotech	approved|investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Enzyme Replacement Therapy|Enzymes|Enzymes and Coenzymes|Esterases|Globulins|Hydrolases|Hypophosphatasia, drug therapy|Immunoglobulin Isotypes|Immunoglobulins|Immunoproteins|Phosphoric Monoester Hydrolases|Proteins|Recombinant Proteins|Serum Globulins|Tissue-nonspecific Alkaline Phosphatase
DB09106	Hydroxyethyl Starch	small molecule	approved	Biomedical and Dental Materials|Biomimetic Materials|Biopolymers|Blood and Blood Forming Organs|Blood and Related Products|Blood Substitutes|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions|Carbohydrates|Glucans|Hematologic Agents|Increased Intravascular Volume|Macromolecular Substances|Osmotic Activity|Plasma Substitutes|Polymers|Polysaccharides|Replacement Preparations|Starch
DB09107	Methoxy polyethylene glycol-epoetin beta	biotech	approved	Alcohols|Amino Acids, Peptides, and Proteins|Antianemic Preparations|Biological Factors|Biomedical and Dental Materials|Blood and Blood Forming Organs|Carbohydrates|Colony-Stimulating Factors|Cytokines|Erythropoiesis-Stimulating Agents|Ethylene Glycols|Glycoconjugates|Glycols|Glycoproteins|Hematinics|Hematopoietic Cell Growth Factors|Increased Erythroid Cell Production|Intercellular Signaling Peptides and Proteins|Macromolecular Substances|Pegylated agents|Peptides|Polymers|Proteins
DB09108	Simoctocog Alfa	biotech	approved	
DB09109	Turoctocog alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Hemostatics|Proteins|Recombinant Proteins
DB09110	Coenzyme M	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Cough and Cold Preparations|Cytoprotective Agent|Detoxifying Agents for Antineoplastic Treatment|Expectorants|Hydrocarbons, Acyclic|Protective Agents|Sulfhydryl Compounds|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB09111	Pentastarch	small molecule	approved|investigational	Biomedical and Dental Materials|Biomimetic Materials|Biopolymers|Blood Substitutes|Carbohydrates|Glucans|Hematologic Agents|Increased Intravascular Volume|Macromolecular Substances|Osmotic Activity|Plasma Substitutes|Polymers|Polysaccharides|Starch
DB09112	Nitrous acid	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Anions|Antidotes|Diet, Food, and Nutrition|Electrolytes|Food|Food Additives|Food and Beverages|Food Preservatives|Hypotensive Agents|Indicators and Reagents|Ions|Laboratory Chemicals|Nitrites|Nitrogen Compounds|Nitrous Acid|Physiological Phenomena|Sodium Compounds
DB09113	Poractant alfa	biotech	approved	Alveolar Surface Tension Reduction|Bradycardia-Causing Agents|Complex Mixtures|Lipids|Membrane Lipids|Pulmonary Surfactants|Respiratory System Agents|Surface-Active Agents|Surfactant Activity
DB09114	Colfosceril palmitate	small molecule	approved|investigational|withdrawn	Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Lung Surfactants|Membrane Lipids|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Pulmonary Surfactants|Sugar Phosphates
DB09115	Diiodohydroxyquinoline	small molecule	approved	Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxyquinolines|Oxyquinoline|Quinoline Derivatives|Quinolines
DB09116	Calcium carbimide	small molecule	approved|withdrawn	Acids|Acids, Noncarboxylic|Anions|Carbodiimides|Cyanides|Drugs Used in Addictive Disorders|Drugs Used in Alcohol Dependence|Electrolytes|Hydrogen Cyanide|Imines|Ions|Nervous System|Nitrogen Compounds
DB09117	Paraldehyde	small molecule	approved|investigational	Acetaldehyde|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB09118	Stiripentol	small molecule	approved	Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (strong)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Miscellaneous Anticonvulsants|Nervous System
DB09119	Eslicarbazepine acetate	small molecule	approved	Anticonvulsants|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Nervous System|Sodium Channel Blockers|UGT1A1 Substrates|Voltage-Gated Sodium Channel Blockers
DB09120	Zucapsaicin	small molecule	approved|investigational	Alkaloids|Alkenes|Alkynes|Amides|Benzene Derivatives|Capsaicin and Similar Agents|Catechols|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Lipids|Musculo-Skeletal System|Other Nonsteroidal Antiimflammatory Agents|Phenols|Polyunsaturated Alkamides|Solanaceous Alkaloids|Topical Products for Joint and Muscular Pain
DB09121	Aurothioglucose	small molecule	approved|withdrawn	Antiinflammatory and Antirheumatic Products|Gold Preparations|Musculo-Skeletal System|Organogold Compounds|Organometallic Compounds|Specific Antirheumatic Agents
DB09122	Peginterferon beta-1a	biotech	approved	Adjuvants, Immunologic|Alcohols|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Biomedical and Dental Materials|Cytokines|Ethylene Glycols|Glycols|Immunosuppressive Agents|Intercellular Signaling Peptides and Proteins|Interferon Type I|Interferons|Macromolecular Substances|Myelosuppressive Agents|Pegylated agents|Peptides|Polymers|Proteins
DB09123	Dienogest	small molecule	approved	Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptive Agents, Male|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estranes|Estrenes|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormone Antagonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Pregnadien Derivatives|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners
DB09124	Medrogestone	small molecule	approved	Adrenal Cortex Hormones|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progestins|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids
DB09125	Potassium Citrate	small molecule	approved|investigational|vet_approved	Acids, Acyclic|Agents causing hyperkalemia|Alimentary Tract and Metabolism|Alkalinizing Activity|Anticoagulants|Calculi Dissolution Agent|Cardiovascular Agents|Citrates|Citric Acid|Citric Acid Derivatives|Diuretics|Expectorants|Metabolic Alkalinizer|Mineral Supplements|Natriuretic Agents|Potassium|Potassium Salt|Replacement Preparations|Respiratory System Agents|Tricarboxylic Acids|Urinary Alkalinisers
DB09126	Chorionic Gonadotropin (Human)	biotech	approved|vet_approved	Amino Acids, Peptides, and Proteins|Genito Urinary System and Sex Hormones|Gonadotropins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Placental Hormones|Pregnancy Proteins|Proteins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System
DB09128	Brexpiprazole	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Agonists|Dopamine D2 Receptor Agonists|Hyperglycemia-Associated Agents|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Quinolines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Agonists|Serotonin Receptor Antagonists|Sulfur Compounds
DB09129	Chromic chloride	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Antioxidants|Chlorine Compounds|Electrolytes|Hydrochloric Acid|Ions|Minerals|Protective Agents|Replacement Preparations
DB09130	Copper	small molecule	approved|investigational	Copper-containing Intrauterine Device|Decreased Embryonic Implantation|Decreased Sperm Motility|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Inhibit Ovum Fertilization|Metals|Metals, Heavy|Micronutrients|Minerals|Physiological Phenomena|Replacement Preparations|Trace Elements|Transition Elements
DB09131	Cupric Chloride	small molecule	approved|investigational	Elements|Metals|Metals, Heavy|Transition Elements
DB09132	Gadoteric acid	small molecule	approved	Alcohols|Amino Sugars|Carbohydrates|Chelating Agents|Contrast Media|Diagnostic Uses of Chemicals|Gadolinium|Gadolinium-based Contrast Agent|Hexosamines|Magnetic Resonance Imaging Contrast Media|Paramagnetic Contrast Media|Roentgenography|Sequestering Agents|Sorbitol|Sugar Alcohols
DB09133	Iothalamic acid	small molecule	approved	Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Contrast Media|Diagnostic Uses of Chemicals|Hexosamines|Iodobenzoates|Iothalamic Acid|Meglumine|Radiographic Contrast Agent|Roentgenography|Sorbitol|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB09134	Ioversol	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB09135	Ioxilan	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB09136	Isosulfan blue	small molecule	approved	Amines|Aniline Compounds|Coloring Agents
DB09137	Technetium Tc-99m mebrofenin	small molecule	approved	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Hepatic and Reticulo Endothelial System|Imines|Indicators and Reagents|Laboratory Chemicals|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Organometallic Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds
DB09138	Technetium Tc-99m medronate	small molecule	approved	Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Organophosphonates|Organophosphorus Compounds|Organotechnetium Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Skeleton|Technetium (99Mtc) Compounds
DB09139	Technetium Tc-99m oxidronate	small molecule	approved	Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Skeleton|Technetium (99Mtc) Compounds
DB09140	Oxygen	small molecule	approved|vet_approved	Chalcogens|Elements|Gases|Medical Gases|Miscellaneous Therapeutic Agents|Other Miscellaneous Therapeutic Agents
DB09141	Protamine sulfate	biotech	approved	Amino Acids, Peptides, and Proteins|Antiheparin Agents|Coagulants|Hematologic Agents|Heparin Antagonists|Heparin Reversal Agent|Nuclear Proteins|Nucleoproteins|Proteins
DB09142	Sincalide	small molecule	approved	Amino Acids, Peptides, and Proteins|Cholecystokinin|Cholecystokinin Analog|Diagnostic Agents|Gallbladder Function|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B3 substrates|Peptides|Tests for Bile Duct Patency
DB09143	Sonidegib	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hedgehog Pathway Inhibitor|Smoothened Receptor Antagonists
DB09144	Uridine triacetate	small molecule	approved|investigational	Acids, Acyclic|Carbohydrates|Fatty Acids|Fatty Acids, Volatile|Glycosides|Lipids|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Analog|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB09145	Water	small molecule	approved	Alkalies|Anions|Diluents|EENT Drugs, Miscellaneous|Electrolytes|Hydroxides|Ions|Irrigating Solutions|Other Miscellaneous Therapeutic Agents|Oxides|Oxygen Compounds
DB09146	Iron saccharate	small molecule	approved	Acids, Acyclic|Anemia, Iron-Deficiency|Antianemic Preparations|Blood and Blood Forming Organs|Carbohydrates|Disaccharides|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Hematinics|Hematologic Agents|Hydroxy Acids|Iron Compounds|Iron Preparations|Iron Trivalent, Oral Preparations|Oligosaccharides|Organometallic Compounds|Parenteral Iron Replacement|Pharmaceutical Preparations|Phosphate Binder|Phosphate-removing Agents|Polysaccharides|Sugar Acids
DB09147	Ferric pyrophosphate	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Elements|Ions|Iron Compounds|Metals|Metals, Heavy|Parenteral Iron Replacement|Phosphate Binder|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates|Transition Elements
DB09148	Florbetaben (18F)	small molecule	approved	Amines|Benzene Derivatives|Benzylidene Compounds|Central Nervous System|Diagnostic Radiopharmaceuticals|Fluorine Radioisotopes|Positron Emitting Activity|Radioactive Diagnostic Agent
DB09149	Florbetapir (18F)	small molecule	approved|investigational	Alcohols|Amines|Central Nervous System|Diagnostic Radiopharmaceuticals|Fluorine Radioisotopes|Glycols|Positron Emitting Activity|Radioactive Diagnostic Agent
DB09151	Flutemetamol (18F)	small molecule	approved|investigational	Central Nervous System|Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09152	Nitrogen	small molecule	approved|vet_approved	Elements|Gases|Medical Gases|Miscellaneous Therapeutic Agents|Other Miscellaneous Therapeutic Agents
DB09153	Sodium Chloride	small molecule	approved|vet_approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorides|Chlorine Compounds|Diluents|EENT Drugs, Miscellaneous|Electrolyte Solutions|Electrolytes|Hydrochloric Acid|I.V. Solution Additives|Ions|Irrigating Solutions|Mineral Supplements|Other Miscellaneous Therapeutic Agents|Replacement Preparations|Respiratory Agents, Miscellaneous|Salt Solutions|Sodium|Sodium Compounds
DB09154	Sodium Citrate	small molecule	approved|investigational	Acids, Acyclic|Antacids and Adsorbents|Anticoagulants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Buffers|Calculi Dissolution Agent|Citric Acid Derivatives|Irrigating Solutions|Laboratory Chemicals|Laxatives|Miscellaneous Anticoagulants|Miscellaneous GI Drugs|Osmotic Laxative|Salt Solutions|Tricarboxylic Acids|Urinary Alkalinisers
DB09155	Helium	small molecule	approved|investigational|vet_approved	Elements|Gases|Medical Gases|Miscellaneous Therapeutic Agents|Noble Gases|Other Miscellaneous Therapeutic Agents
DB09156	Iopromide	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodinated Contrast Agents|Iodobenzoates|Radiographic Contrast Agent|Roentgenography|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB09157	Carbon dioxide	small molecule	approved|investigational|vet_approved	Anions|Carbon Compounds, Inorganic|Electrolytes|Gases|Ions|Medical Gases|Miscellaneous Therapeutic Agents|Other Diagnostics|Other Miscellaneous Therapeutic Agents|Oxides|Oxygen Compounds|Radiographic Contrast Agent|X-Ray Contrast Activity
DB09158	Trypan blue free acid	small molecule	approved	Acids|Acids, Noncarboxylic|Arylsulfonates|Arylsulfonic Acids|Azo Compounds|Coloring Agents|Diagnostic Dye|Naphthalenes|Naphthalenesulfonates|Ocular Disorders|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB09160	Technetium Tc-99m tetrofosmin	small molecule	approved	Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Technetium (99Mtc) Compounds
DB09161	Technetium Tc-99m sestamibi	small molecule	approved|investigational	Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Nitriles|Organometallic Compounds|Organotechnetium Compounds|P-glycoprotein/ABCB1 Substrates|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds
DB09163	Technetium Tc-99m exametazime	small molecule	approved	Amines|Central Nervous System|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Hydroxylamines|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Organotechnetium Compounds|Oximes|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds
DB09164	Technetium Tc-99m disofenin	small molecule	approved	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Hepatic and Reticulo Endothelial System|Imines|Imino Acids|Indicators and Reagents|Laboratory Chemicals|Organometallic Compounds|Organotechnetium Compounds|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium (99Mtc) Compounds
DB09165	Technetium Tc-99m pyrophosphate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Diphosphates|Electrolytes|Indicators and Reagents|Ions|Laboratory Chemicals|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Polyphosphates|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Skeleton|Technetium (99Mtc) Compounds|Technetium Compounds
DB09166	Etizolam	small molecule	experimental	Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB09167	Dosulepin	small molecule	approved	Adrenergic Agents|Adrenergic Uptake Inhibitors|Agents producing tachycardia|Agents that produce hypertension|Agents that reduce seizure threshold|Anticholinergic Agents|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dibenzothiepins|Histamine Antagonists|Histamine H1 Antagonists|Membrane Transport Modulators|Muscarinic Antagonists|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|Potential QTc-Prolonging Agents|Psychoanaleptics|Psychotropic Drugs|QTc Prolonging Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Sulfur Compounds|Thiepins
DB09168	4-Phenylfentanyl	small molecule	illicit	
DB09169	3-Allylfentanyl	small molecule	illicit	Piperidines
DB09170	Î²-Hydroxythiofentanyl	small molecule	illicit	
DB09171	Î²-Methylfentanyl	small molecule	illicit	
DB09172	Brifentanil	small molecule	illicit	Piperidines
DB09173	Butyrfentanyl	small molecule	illicit	
DB09174	Lofentanil	small molecule	illicit	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09175	Mirfentanil	small molecule	experimental	Piperidines
DB09177	p-Fluorofentanyl	small molecule	illicit	
DB09178	Phenaridine	small molecule	illicit	Amines|Aminopyridines|Pyridines
DB09179	R-30490	small molecule	experimental	Piperidines
DB09180	Thienylfentanyl	small molecule	illicit	
DB09181	Trefentanil	small molecule	experimental	
DB09182	Benzylfentanyl	small molecule	illicit	Piperidines
DB09183	Dasabuvir	small molecule	approved	Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Direct Acting Antivirals|Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor|P-glycoprotein/ABCB1 Substrates|Pyrimidines|Pyrimidinones|RNA Replicase Inhibitors|Sulfones|Sulfur Compounds|UGT1A1 Inhibitors
DB09184	Edivoxetine	small molecule	investigational	Adrenergic Uptake Inhibitors|Alcohols|Central Nervous System Depressants|Oxazines
DB09185	Viloxazine	small molecule	approved|investigational|withdrawn	Adrenergic Agents|Adrenergic Uptake Inhibitors|Antidepressive Agents, Second-Generation|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Morpholines|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Oxazines|Psychoanaleptics|Psychotropic Drugs
DB09186	Nisoxetine	small molecule	experimental	Adrenergic Uptake Inhibitors|Amines|Central Nervous System Depressants|Norepinephrine, antagonists & inhibitors|Propylamines
DB09187	Lortalamine	small molecule	experimental	Adrenergic Uptake Inhibitors|Central Nervous System Depressants|Pyrans
DB09188	Amedalin	small molecule	experimental	
DB09189	Daledalin	small molecule	experimental	
DB09190	Talopram	small molecule	experimental	Adrenergic Uptake Inhibitors|Amines|Carbon Radioisotopes|Central Nervous System Depressants
DB09191	Talsupram	small molecule	experimental	Sulfur Compounds
DB09192	Tandamine	small molecule	experimental	
DB09193	CP-39,332	small molecule	experimental	
DB09194	Etoperidone	small molecule	withdrawn	Central Nervous System Depressants|Combined Inhibitors of Serotonin/Norepinephrine Reuptake|Nervous System|Piperazines|Psychoanaleptics|Pyridines|Pyridones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists
DB09195	Lorpiprazole	small molecule	approved	Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates
DB09196	Lubazodone	small molecule	experimental	Oxazines
DB09197	Mepiprazole	small molecule	experimental	
DB09198	Lobeglitazone	small molecule	experimental	Blood Glucose Lowering Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|OATP1B1/SLCO1B1 Inhibitors|PPAR alpha, agonists|PPAR gamma, agonists|Sulfur Compounds|Thiazoles|Thiazolidinediones
DB09199	Netoglitazone	small molecule	experimental	Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones
DB09200	Rivoglitazone	small molecule	experimental|investigational	Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones
DB09201	Ciglitazone	small molecule	experimental	Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones
DB09202	Cirazoline	small molecule	experimental	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Cardiovascular Agents|Nasal Decongestants|Neurotransmitter Agents|Respiratory System Agents|Vasoconstrictor Agents
DB09203	Synephrine	small molecule	experimental	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Adrenergic and Dopaminergic Agents|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Decongestants and Antiallergics|Ethanolamines|Nasal Decongestants|Neurotransmitter Agents|Ophthalmologicals|Peripheral Nervous System Agents|Respiratory System Agents|Sensory Organs|Sympathomimetics|Sympathomimetics Used as Decongestants|Tyramine|Vasoconstrictor Agents
DB09204	Arotinolol	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Hypotensive Agents|Neurotransmitter Agents|Propanols
DB09205	Moxisylyte	small molecule	approved|investigational	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Amines|Autonomic Agents|Cardiovascular Agents|Cholinesterase substrates|Dimethylamines|Drugs Used in Erectile Dysfunction|Genito Urinary System and Sex Hormones|Methylamines|Miotics|Neurotransmitter Agents|Peripheral Nervous System Agents|Peripheral Vasodilators|Sympatholytics|Urologicals|Vasodilating Agents
DB09206	Trimazosin	small molecule	experimental	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Cardiovascular Agents|Neurotransmitter Agents|Vasodilating Agents
DB09207	AS-8112	small molecule	experimental	Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotransmitter Agents
DB09208	Pegloticase	biotech	approved|investigational	Alcohols|Antigout Preparations|Biomedical and Dental Materials|Enzymes|Enzymes and Coenzymes|Enzymes, Immobilized|Ethylene Glycols|Glycols|Macromolecular Substances|Musculo-Skeletal System|Oxidoreductases|Pegylated agents|Polymers|Uric Acid-specific Enzyme
DB09209	Pholcodine	small molecule	approved|illicit	Alkaloids|Analgesics|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Morphinans|Morphine Derivatives|Opiate Alkaloids|Opium Alkaloids and Derivatives|Oxazines|Peripheral Nervous System Agents|Phenanthrenes|Respiratory System Agents|Sensory System Agents
DB09210	Piracetam	small molecule	approved|investigational	Acetamides|Acetates|Acids, Acyclic|Amides|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System|Neuroprotective Agents|Nootropic Agents|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Pyrrolidines|Pyrrolidinones
DB09211	Limaprost	small molecule	investigational	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins E
DB09212	Loxoprofen	small molecule	investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents
DB09213	Dexibuprofen	small molecule	approved|investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Musculo-Skeletal System|Nephrotoxic agents|Phenylpropionates|Propionates
DB09214	Dexketoprofen	small molecule	approved|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Musculo-Skeletal System|Nephrotoxic agents|Propionates|Topical Products for Joint and Muscular Pain
DB09215	Droxicam	small molecule	withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Oxicams|Peripheral Nervous System Agents|Sensory System Agents
DB09216	Tolfenamic Acid	small molecule	approved|investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Aminobenzoates|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiarrhythmic agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Benzoates|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Fenamates|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Membrane Transport Modulators|Migraine Disorders, drug therapy|Musculo-Skeletal System|Nephrotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Prostaglandin Antagonists|Sensory System Agents
DB09217	Firocoxib	small molecule	experimental|vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Furans|Lactones|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)|Sulfur Compounds
DB09218	Clonixin	small molecule	experimental	Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Nephrotoxic agents|Nicotinic Acids|Peripheral Nervous System Agents|Pyridines|Sensory System Agents
DB09219	Bisoxatin	small molecule	approved	Alimentary Tract and Metabolism|Contact Laxatives|Drugs for Constipation|Laxatives
DB09220	Nicorandil	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Anions|Antiarrhythmic agents|Antihypertensive Agents|Cardiac Therapy|Cardiovascular Agents|Diet, Food, and Nutrition|Electrolytes|Food|Food and Beverages|Growth Substances|Ions|Micronutrients|Nicotinic Acids|Nitrates|Nitric Acid|Nitrogen Compounds|Physiological Phenomena|Pyridines|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB09221	Polaprezinc	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Dipeptides|Gastrointestinal Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins|Zinc Compounds
DB09222	Fibrinogen Human	biotech	approved	Acute-Phase Proteins|Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Fibrinogen|Hemostatics|Increased Coagulation Activity|Protein Precursors|Proteins
DB09223	Blonanserin	small molecule	investigational	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotoxic agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB09224	Melperone	small molecule	investigational	Antiarrhythmic agents|Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Butyrophenone Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Ketones|Moderate Risk QTc-Prolonging Agents|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|QTc Prolonging Agents|Tranquilizing Agents
DB09225	Zotepine	small molecule	approved|investigational|withdrawn	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Nervous System|Neurotoxic agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds|Thiepins|Tranquilizing Agents
DB09226	RP-5063	small molecule	investigational	Antipsychotic Agents|Antipsychotic Agents (Second Generation [Atypical])|Central Nervous System Depressants|Neurotoxic agents
DB09227	Barnidipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Hypotensive Agents|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB09228	Conestat alfa	biotech	approved|investigational	Blood and Blood Forming Organs|C1 inhibitors|Drugs Used in Hereditary Angioedema|Protease Inhibitors
DB09229	Aranidipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Vasodilating Agents
DB09230	Azelnidipine	small molecule	investigational	Acids, Acyclic|Agents causing hyperkalemia|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Antiarrhythmic agents|Azetidines|Azetines|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Imines|Imino Acids|Pyridines|Vasodilating Agents
DB09231	Benidipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Dihydropyridines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB09232	Cilnidipine	small molecule	investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dihydropyridine Derivatives|Hypotensive Agents|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB09233	Cronidipine	small molecule	experimental	
DB09234	Darodipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dihydropyridines|Membrane Transport Modulators|Pyridines|Vasodilating Agents
DB09235	Efonidipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Benzene Derivatives|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Diuretics|Hypotensive Agents|Membrane Transport Modulators|Natriuretic Agents|Nitro Compounds|Phenols|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Vasodilating Agents
DB09236	Lacidipine	small molecule	approved|investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dihydropyridine Derivatives|Hypotensive Agents|Membrane Transport Modulators|Mutagens|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB09237	Levamlodipine	small molecule	experimental	Nicotinic Acids|Pyridines
DB09238	Manidipine	small molecule	approved|investigational	ACE Inhibitors and Calcium Channel Blockers|Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dihydropyridine Derivatives|Membrane Transport Modulators|Pyridines|Selective Calcium Channel Blockers With Mainly Vascular Effects|Vasodilating Agents
DB09239	Niguldipine	small molecule	experimental	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antiarrhythmic agents|Antihypertensive Agents|Antineoplastic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents|Vasodilating Agents
DB09240	Niludipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dihydropyridines|Membrane Transport Modulators|Pyridines|Vasodilating Agents
DB09241	Methylene blue	small molecule	approved|investigational	Agents that produce hypertension|Agents that reduce seizure threshold|Antidotes|Antipsychotic Agents|Central Nervous System Depressants|Diagnostic Agents|Enzyme Inhibitors|Gastric Function|Miscellaneous Therapeutic Agents|Monoamine Oxidase Inhibitors|Neurotoxic agents|Oxidation-Reduction Agent|Phenothiazines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sulfur Compounds|Tests for Gastric Secretion
DB09242	Moxonidine	small molecule	approved|investigational	Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Cardiovascular Agents|Hypotensive Agents|Imidazoline Receptor Agonists|Sympatholytics
DB09243	Hydracarbazine	small molecule	experimental	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09244	Pirlindole	small molecule	experimental	Agents that produce hypertension|Agents that reduce seizure threshold|Antineoplastic Agents|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Indoles|Monoamine Oxidase Inhibitors|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB09245	Toloxatone	small molecule	experimental	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Monoamine Oxidase A Inhibitors|Monoamine Oxidase Inhibitors|Nervous System|Oxazoles|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09246	Benmoxin	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09247	Iproclozide	small molecule	withdrawn	Acetates|Acids, Acyclic|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Hydroxy Acids|Lipids|Nervous System|Psychoanaleptics
DB09248	Mebanazine	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09249	Octamoxin	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09250	Pheniprazine	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09251	Phenoxypropazine	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09252	Pivhydrazine	small molecule	withdrawn	Acids, Acyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09253	Safrazine	small molecule	withdrawn	Agents that produce hypertension|Agents that reduce seizure threshold|Central Nervous System Depressants|Monoamine Oxidase Inhibitors|Monoamine Oxidase Inhibitors, Non-Selective|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09254	Caroxazone	small molecule	withdrawn	Acetamides|Acetates|Acids, Acyclic|Agents that produce hypertension|Agents that reduce seizure threshold|Amides|Benzene Derivatives|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09255	Dextran	small molecule	approved|investigational|vet_approved	Anticoagulants|Biomedical and Dental Materials|Biomimetic Materials|Biopolymers|Blood and Blood Forming Organs|Blood and Related Products|Blood Substitutes|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions|Carbohydrates|Dextrans|Glucans|Hematologic Agents|Increased Intravascular Volume|Macromolecular Substances|Osmotic Activity|Plasma Substitutes|Polymers|Polysaccharides
DB09256	Tegafur	small molecule	approved|investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Fluoropyrimidines|Fluorouracil and prodrugs|Noxae|Pyrimidine Analogues|Pyrimidines|Pyrimidinones|Toxic Actions|Uracil
DB09257	Gimeracil	small molecule	approved	
DB09258	Bemiparin	small molecule	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Glycosaminoglycans|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB09259	Reviparin	small molecule	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Cardiovascular Agents|Fibrin Modulating Agents|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB09260	Parnaparin	small molecule	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Blood and Blood Forming Organs|Carbohydrates|Glycosaminoglycans|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB09261	Certoparin	small molecule	approved|investigational	Agents causing hyperkalemia|Anticoagulants|Carbohydrates|Glycosaminoglycans|Hematologic Agents|Heparin (Low Molecular Weight)|Heparin and similars|Polysaccharides
DB09262	Imidafenacin	small molecule	investigational	Agents producing tachycardia|Anticholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Muscarinic Antagonists
DB09263	Patiromer	small molecule	approved|investigational	Biomedical and Dental Materials|Macromolecular Substances|Potassium Binder|Potassium Ion Binding Activity
DB09264	Idarucizumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antidotes|Antihemorrhagic Agents, Miscellaneous|Blood Proteins|Globulins|Humanized Monoclonal Antibody Fragment|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB09265	Lixisenatide	small molecule	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|GLP-1 Agonists|Glucagon-like Peptide-1 (GLP-1) Agonists|Incretin Mimetics
DB09266	Technetium Tc-99m tilmanocept	small molecule	approved|investigational	Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Technetium (99Mtc) Compounds|Tumour Detection
DB09267	Strontium ranelate	small molecule	approved|withdrawn	Bone Density Conservation Agents|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Musculo-Skeletal System|Strontium|Sulfur Compounds
DB09268	Picosulfuric acid	small molecule	approved	Acids, Acyclic|Alimentary Tract and Metabolism|Contact Laxatives|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Pyridines|Tricarboxylic Acids
DB09269	Phenylacetic acid	small molecule	approved	Acids, Carbocyclic|Ammonium Ion Binding Activity|Antineoplastic Agents|Laxatives|Nitrogen Binding Agent|Noxae|Osmotic Laxative|Toxic Actions|Urea Cycle Disorder Agents
DB09270	Ubidecarenone	small molecule	approved|investigational|nutraceutical	Benzoquinones|Cardiac Therapy|Coenzymes|Diet, Food, and Nutrition|Electron Transport Chain Complex Proteins|Enzymes and Coenzymes|Food|Food and Beverages|Growth Substances|Hypoglycemia-Associated Agents|Micronutrients|Other Nutritional Agents|P-glycoprotein/ABCB1 Substrates|Physiological Phenomena|Quinones|Vitamins
DB09271	Cimetropium	small molecule	experimental|investigational	Alimentary Tract and Metabolism|Alkaloids|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Tropanes
DB09272	Eluxadoline	small molecule	approved|investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Gastrointestinal Agents|Miscellaneous GI Drugs|Mixed Agonist / Antagonist Opioids|OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|Opioid Antagonists|Opioid mu-Receptor Agonists|Opioids|Receptors, Opioid, delta, antagonists & inhibitors|Receptors, Opioid, mu, agonists|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09273	Doxofylline	small molecule	experimental	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Anti-Asthmatic Agents|Antitussive Agents|Autonomic Agents|Bronchodilator Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Drugs for Obstructive Airway Diseases|Enzyme Inhibitors|Peripheral Nervous System Agents|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Purines|Purinones|Respiratory System Agents|Vasodilating Agents|Xanthine derivatives
DB09274	Artesunate	small molecule	approved|investigational	Acids, Acyclic|Amebicides|Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Artemisia|Artemisinin and Derivatives, Plain|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dicarboxylic Acids|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sesquiterpenes|Terpenes
DB09275	Bismuth subcitrate potassium	small molecule	approved|investigational	Bismuth containing drugs|Neurotoxic agents
DB09276	Sodium aurothiomalate	small molecule	approved|investigational	Acids, Acyclic|Antiinflammatory and Antirheumatic Products|Dicarboxylic Acids|Gold Compounds|Gold Preparations|Hydroxy Acids|Malates|Musculo-Skeletal System|Organogold Compounds|Organometallic Compounds|Specific Antirheumatic Agents|Sulfhydryl Compounds|Sulfur Compounds|Thiomalates|UGT1A1 Inhibitors
DB09277	Choline C 11	small molecule	approved|investigational	
DB09278	Activated charcoal	small molecule	approved	Adsorption|Alimentary Tract and Metabolism|Anions|Antacids and Adsorbents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Antifoaming Agents|Carbon|Charcoal Preparations|Electrolytes|Elements|Intestinal Adsorbents|Ions|Microspheres|Oxygen Compounds|Protective Agents
DB09279	Fimasartan	small molecule	investigational	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin II Antagonists, Plain|Angiotensin Receptor Antagonists|Benzene Derivatives|Hypotensive Agents
DB09280	Lumacaftor	small molecule	approved	Amines|Cystic Fibrosis Transmembrane Conductance Regulator|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inducers|Cytochrome P450 3A Inducers|Dioxoles|P-glycoprotein inducers|P-glycoprotein/ABCB1 Inducers|P-glycoprotein/ABCB1 Inhibitors|Pyridines
DB09281	Magnesium Trisilicate	small molecule	approved	Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Anions|Antacids|Calculi Dissolution Agent|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Ions|Laxatives|Magnesium Compounds|Minerals|Osmotic Laxative|Oxides|Oxygen Compounds|Silicates|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB09282	Molsidomine	small molecule	approved|investigational	Cardiac Therapy|Cardiovascular Agents|Morpholines|Nitric Oxide Donors|Oxadiazoles|Oxazines|Oxazoles|Sydnones|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB09283	Trapidil	small molecule	experimental	Antiplatelet agents|Cardiac Therapy|Cardiovascular Agents|Enzyme Inhibitors|Hematologic Agents|Phosphodiesterase Inhibitors|Pyrimidines|Triazoles|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB09284	Imolamine	small molecule	investigational	Cardiac Therapy|Cardiovascular Agents|Oxazoles|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB09285	Morniflumate	small molecule	experimental	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aminobenzoates|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Benzene Derivatives|Benzoates|Fenamates|Musculo-Skeletal System|Nephrotoxic agents|Nicotinic Acids|ortho-Aminobenzoates|Pyridines
DB09286	Pipamperone	small molecule	investigational	Antipsychotic Agents|Butyrophenone Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Hypotensive Agents|Ketones|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB09287	Polyethylene glycol	small molecule	approved|vet_approved	Alcohols|Alimentary Tract and Metabolism|Biomedical and Dental Materials|Drugs for Constipation|Electrolytes|Ethylene Glycols|Gastrointestinal Agents|Glycols|Laxatives|Macromolecular Substances|Osmotic Activity|Osmotic Laxative|P-glycoprotein/ABCB1 Inhibitors|Pegylated agents|Polymers|Solvents|Stimulation Large Intestine Fluid/Electrolyte Secretion|Surface-Active Agents
DB09288	Propacetamol	small molecule	experimental	Acetanilides|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anilides|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Cholinesterase substrates|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP2E1 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Prodrugs|Sensory System Agents|UGT1A1 Substrates|UGT1A6 substrate|UGT1A9 Substrates
DB09289	Tianeptine	small molecule	investigational	Agents that produce hypertension|Agents that reduce seizure threshold|Analgesics|Antidepressive Agents, Tricyclic|Azepines|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Sulfur Compounds|Thiepins
DB09290	Ramosetron	small molecule	investigational	Antiemetics|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP1A2 Substrates|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin Agents|Serotonin Receptor Antagonists
DB09291	Rolapitant	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2D6 Inhibitors|Neurokinin 1 Antagonists|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|P-glycoprotein/ABCB1 Inhibitors|Substance P/Neurokinin-1 Receptor Antagonist
DB09292	Sacubitril	small molecule	approved	Acids, Acyclic|Agents causing angioedema|Amino Acids|Amino Acids, Peptides, and Proteins|Butyrates|Fatty Acids|Fatty Acids, Volatile|Hypotensive Agents|Lipids|Neprilysin Inhibitor|Neprilysin, antagonists & inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors
DB09293	Iodide I-131	small molecule	approved|investigational	Diagnostic Radiopharmaceuticals|Iodine (131I) Compounds|Radioactive Therapeutic Agent|Radiopharmaceutical Activity|Therapeutic Radiopharmaceuticals|Thyroid Diagnostic Radiopharmaceuticals
DB09295	Talniflumate	small molecule	experimental	Agents causing hyperkalemia|Agents that produce hypertension|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)
DB09296	Ombitasvir	small molecule	approved|investigational	Acids, Acyclic|Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Direct Acting Antivirals|Hepatitis C Virus NS5A Inhibitor|P-glycoprotein/ABCB1 Substrates|UGT1A1 Inhibitors
DB09297	Paritaprevir	small molecule	approved|investigational	Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|BCRP/ABCG2 Inhibitors|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Direct Acting Antivirals|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|UGT1A1 Inhibitors
DB09298	Silibinin A	small molecule	experimental|investigational	OAT3/SLC22A8 Substrates|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|UGT1A1 Inhibitors
DB09299	Tenofovir alafenamide	small molecule	approved	Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleoside and Nucleotide Reverse Transcriptase Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Purines|Tenofovir and prodrugs
DB09300	Butylscopolamine	small molecule	approved|investigational|vet_approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Amines|Ammonium Compounds|Anticholinergic Agents|Antimuscarinics Antispasmodics|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Cholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|Quaternary Ammonium Compounds|Scopolamine Derivatives|Tropanes
DB09301	Chondroitin sulfate	small molecule	approved|investigational|nutraceutical	Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Carbohydrates|Chondroitin|Glycosaminoglycans|Musculo-Skeletal System|Polysaccharides
DB09302	Alirocumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Hypercholesterolemia, drug therapy|Immunoglobulins|Immunoproteins|PCSK9 Inhibitor|Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors|Proteins|Serum Globulins
DB09303	Evolocumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Lipid Modifying Agents|Lipid Modifying Agents, Plain|PCSK9 Inhibitor|Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors|Proteins|Serum Globulins
DB09304	Setiptiline	small molecule	experimental	Antidepressive Agents, Tetracyclic|Dibenzazepines
DB09305	Aptazapine	small molecule	experimental	Antidepressive Agents, Tetracyclic|Benzazepines
DB09306	Metralindole	small molecule	experimental	Indoles|Pyridines
DB09307	Oxaprotiline	small molecule	experimental	Agents that produce hypertension|Agents that reduce seizure threshold|Anthracenes|Antidepressive Agents, Tetracyclic|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Narrow Therapeutic Index Drugs|Neurotoxic agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB09308	Solithromycin	small molecule	investigational	Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ketolides|Lactones|Macrolides|Polyketides
DB09309	Kitasamycin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Leucomycins|Macrolides|Polyketides
DB09310	Coagulation Factor XIII A-Subunit (Recombinant)	biotech	approved	Blood and Blood Forming Organs|Blood Coagulation Factors|Hemostatics
DB09311	Polycarbophil	small molecule	experimental	Antidiarrheals|Biomedical and Dental Materials|Bulk-Forming Laxatives|Dental Materials|Drug Carriers|Gastrointestinal Agents|Laxatives|Macromolecular Substances|Plastics|Polymers|Resins, Synthetic
DB09312	Antilymphocyte immunoglobulin (horse)	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibody-Surface Protein Interactions|Antineoplastic and Immunomodulating Agents|Biological Products|Blood|Blood Proteins|Body Fluids|Complex Mixtures|Fluids and Secretions|Globulins|Hemic and Immune Systems|Immune Sera|Immunoglobulin G|Immunoglobulins|Immunologic Factors|Immunoproteins|Immunosuppressive Agents|Increased T Lymphocyte Destruction|Lymphocyte Function Alteration|Miscellaneous Therapeutic Agents|Proteins|Selective Immunosuppressants|Serum|Serum Globulins
DB09313	Ioxaglic acid	small molecule	approved|investigational	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Radiographic Contrast Agent|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB09314	Technetium Tc-99m pertechnetate	small molecule	approved|investigational	Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Technetium Compounds|Thyroid Diagnostic Radiopharmaceuticals
DB09315	Xenon-133	small molecule	approved	Diagnostic Radiopharmaceuticals|Inhalation Diagnostic Agent|Radiopharmaceutical Activity
DB09316	Thallous Chloride	small molecule	approved	Elements|Metals|Metals, Heavy|Radioactive Diagnostic Agent
DB09317	Synthetic Conjugated Estrogens, A	small molecule	approved	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists
DB09318	Synthetic Conjugated Estrogens, B	small molecule	approved	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists
DB09319	Carindacillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB09320	Procaine benzylpenicillin	small molecule	approved|vet_approved	Acids, Carbocyclic|Amides|Aminobenzoates|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Benzene Derivatives|Benzoates|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Lactams|para-Aminobenzoates|Penicillin G|Penicillins|Sulfur Compounds
DB09321	Zinc oxide	small molecule	approved	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anions|Basic Ointments and Protectants|Basic Powders and Demulcents|Copper Absorption Inhibitor|Cosmetics|Dermatologicals|Electrolytes|Household Products|Ions|Oxides|Oxygen Compounds|Protective Agents|Radiation-Protective Agents|Sunscreen Agents|Sunscreening Agents|Vasoprotectives|Zinc Compounds
DB09322	Zinc sulfate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Anions|Astringents|Copper Absorption Inhibitor|Dermatologicals|Electrolytes|Ions|Mineral Supplements|Minerals|Misc. Skin and Mucous Membrane Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|Vasoprotectives|Zinc Compounds
DB09324	Sulbactam	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactamase Inhibitors|beta-Lactams|Enzyme Inhibitors|Lactams|Sulfur Compounds
DB09325	Sodium fluoride	small molecule	approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Biomedical and Dental Materials|Caries Prophylactic Agents|Cariostatic Agents|Dental Agents|Electrolytes|Fluorides|Fluorine Compounds|Hydrofluoric Acid|Ions|Laxatives|Mineral Supplements|Miscellaneous Therapeutic Agents|Mouthwashes and Gargles|Osmotic Laxative|Protective Agents|Sodium Compounds|Stomatological Preparations
DB09326	Ammonia N-13	small molecule	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09327	Tegafur-uracil	small molecule	approved|investigational	Cytochrome P-450 CYP2A6 Substrates
DB09328	Vayarin	small molecule	approved|investigational	Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors
DB09329	Antihemophilic Factor (Recombinant), PEGylated	biotech	approved|investigational	Alcohols|Amino Acids, Peptides, and Proteins|Biological Factors|Biomedical and Dental Materials|Blood Coagulation Factors|Blood Proteins|Ethylene Glycols|Glycols|Hemostatics|Macromolecular Substances|Pegylated agents|Polymers|Proteins|Recombinant Proteins
DB09330	Osimertinib	small molecule	approved	Acids, Acyclic|Acrylates|Amides|Amines|Antineoplastic Agents|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 1A2 Inducers|Cytochrome P450 3A Inhibitors|Cytochrome P450 3A4 Inducers|Enzyme Inhibitors|Kinase Inhibitor|Kinase Inhibitors|P-glycoprotein/ABCB1 Substrates|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB09331	Daratumumab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Blood Proteins|CD38-directed Antibody Interactions|CD38-directed Cytolytic Antibody|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB09332	Kappadione	small molecule	approved	
DB09333	Iopodic acid	small molecule	approved|investigational|withdrawn	Benzene Derivatives|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB09334	Seractide acetate	biotech	approved	
DB09335	Alatrofloxacin	small molecule	approved|withdrawn	Anti-Infective Agents|Antineoplastic Agents|Enzyme Inhibitors|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB09336	Technetium Tc-99m nofetumomab merpentan	small molecule	approved|withdrawn	
DB09337	Medical air	small molecule	approved|vet_approved	Medical Gases|Other Miscellaneous Therapeutic Agents
DB09338	Mersalyl	small molecule	experimental	Alkylmercury Compounds|Diuretics|Enzyme Inhibitors|Low-Ceiling Diuretics, Excl. Thiazides|Mercurial Diuretics|Organomercury Compounds|Organometallic Compounds
DB09339	Indium In-111 imciromab pentetate	biotech	withdrawn	Diagnostic Radiopharmaceuticals
DB09340	Tyropanoic acid	small molecule	approved	Benzene Derivatives|Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Iodobenzenes|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB09341	Dextrose, unspecified form	small molecule	approved|vet_approved	Antivaricose Therapy|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Caloric Agents|Carbohydrates|Cardiac Function|Diabetes Mellitus|Diagnostic Agents|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|General Nutrients|Hemodialysis Solution|Hexoses|Irrigating Solutions|Miscellaneous Therapeutic Agents|Monosaccharides|Physiological Phenomena|Sclerosing Agents for Local Injection|Sweetening Agents|Tests for Diabetes|Vasoprotectives
DB09342	Propoxycaine	small molecule	approved	Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethers|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|para-Aminobenzoates|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Sensory System Agents
DB09343	Tipiracil	small molecule	approved|investigational	MATE 1 Substrates|MATE substrates|OCT2 Substrates|Thymidine Phosphorylase Inhibitor
DB09344	Invert sugar	small molecule	experimental	Antivaricose Therapy|Biomedical and Dental Materials|Carbohydrates|Cariogenic Agents|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Hexoses|Ketoses|Monosaccharides|Physiological Phenomena|Sclerosing Agents for Local Injection|Sweetening Agents|Vasoprotectives
DB09345	Pramocaine	small molecule	approved	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anesthetics|Anesthetics for Topical Use|Anesthetics, Local|Antipruritics and Local Anesthetics|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Central Nervous System Agents|Dermatologicals|Oxazines|Peripheral Nervous System Agents|Sensory System Agents|Vasoprotectives
DB09346	Metrizoic acid	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Radiographic Contrast Agent|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Activity|X-Ray Contrast Media, Iodinated
DB09347	Acetrizoic acid	small molecule	withdrawn	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|meta-Aminobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB09348	Propiolactone	small molecule	approved|withdrawn	Anti-Infective Agents|Disinfectants|Lactones
DB09349	Gastric intrinsic factor	biotech	approved|experimental	Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Glycoproteins|Mucoproteins|Proteins
DB09350	Piperonyl butoxide	small molecule	approved|vet_approved	Agrochemicals|Benzodioxoles|Dioxoles|Pesticide Synergists|Pesticides|Toxic Actions
DB09351	Levobetaxolol	small molecule	approved|investigational	Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates
DB09352	Hydroxyamphetamine	small molecule	approved	Adrenergic Agonists|Amines|Amphetamines|Autonomic Agents|Ethylamines|Mydriatics|Peripheral Nervous System Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB09353	Octasulfur	small molecule	approved	Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Chalcogens|Dermatologicals|Elements|Keratolytic Agents|Preparations Containing Sulfur
DB09355	Sulfabenzamide	small molecule	approved	Amides|Sulfones|Sulfur Compounds
DB09357	Dexpanthenol	small molecule	approved	Alanine|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|beta-Alanine|Cicatrizants|Dermatologicals|Imides|Ophthalmologicals|Preparations for Treatment of Wounds and Ulcers|Sensory Organs|Vitamin B Complex|Vitamins|Wound Healing
DB09363	Rauwolfia serpentina root	small molecule	investigational	Alkaloids|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Indole Alkaloids|Indoles|Secologanin Tryptamine Alkaloids
DB09364	Procaine merethoxylline	small molecule	approved	
DB09366	Propyliodone	small molecule	approved	Contrast Media|Diagnostic Uses of Chemicals|Iodopyridones|Non-Watersoluble X-Ray Contrast Media|Pyridines|Pyridones|X-Ray Contrast Media, Iodinated
DB09369	Polyestradiol phosphate	small molecule	approved	Antineoplastic and Immunomodulating Agents|Endocrine Therapy|Estradiol Congeners|Estranes|Estrenes|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB09371	Norethynodrel	small molecule	approved	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB09372	Tannic acid	small molecule	approved	Biomedical and Dental Materials|Biopolymers|Macromolecular Substances|Polymers
DB09373	Trolamine polypeptide oleate condensate	small molecule	approved|vet_approved	
DB09374	Indocyanine green acid form	small molecule	approved|investigational	BSEP/ABCB11 Substrates|Cardiac Function|Coloring Agents|Diagnostic Dye|Indoles|Liver Function
DB09375	Chymotrypsin	small molecule	approved|vet_approved	Blood and Blood Forming Organs|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Ophthalmologicals|Peptide Hydrolases|Sensory Organs|Serine Endopeptidases|Serine Proteases|Surgical Aids
DB09376	Lapyrium	small molecule	approved	Pyridines
DB09378	Fluprednisolone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB09379	Sutilain	biotech	approved|withdrawn	Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Peptide Hydrolases|Serine Endopeptidases|Serine Proteases
DB09381	Estrogens, esterified	small molecule	approved	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estrogens
DB09383	Meprednisone	small molecule	approved|investigational	Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB09389	Norgestrel	small molecule	approved	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Contraceptives, Postcoital|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB09393	Amino acids	small molecule	investigational	Amino Acid Hypertonic Solution|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|i.v. Solutions|Solutions for Parenteral Nutrition
DB09394	Phosphoric acid	small molecule	approved	Acid Etching, Dental|Acids|Acids, Noncarboxylic|Biomedical and Dental Materials|Dental Materials|Phosphorus Acids|Phosphorus Compounds
DB09395	Sodium acetate	small molecule	approved|investigational	Acetates|Acetic Acid|Acids, Acyclic|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Electrolyte Solutions|Fatty Acids|Fatty Acids, Volatile|I.V. Solution Additives|Lipids|Replacement Preparations
DB09397	Technetium Tc-99m sulfur colloid	small molecule	approved|investigational	Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Hepatic and Reticulo Endothelial System|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Sulfur Compounds|Technetium (99Mtc), Particles and Colloids|Technetium Compounds
DB09398	Fluoride ion F-18	small molecule	approved	Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Tumour Detection
DB09401	Isosorbide	small molecule	approved|investigational	Adrenal Cortex Hormones|Alcohols|Antianginal Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antispermatogenic Agents|Carbohydrates|Cardiovascular Agents|Contraceptive Agents, Male|Diuretics|Diuretics, Osmotic|Hormonal Contraceptives for Systemic Use|Natriuretic Agents|Noxae|Organic Nitrates|Reproductive Control Agents|Sesquiterpenes|Sorbitol|Spermatocidal Agents|Sugar Alcohols|Terpenes|Toxic Actions|Vasodilating Agents
DB09403	Iocetamic acid	small molecule	approved	Benzene Derivatives|Contrast Media|Hydrocarbons, Halogenated|Hydrocarbons, Iodinated|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB09407	Magnesium chloride	small molecule	approved	Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anions|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Calculi Dissolution Agent|Chlorides|Chlorine Compounds|Electrolyte Solutions|Electrolytes|Hemodialysis Solution|Hydrochloric Acid|I.V. Solution Additives|Ions|Magnesium Compounds|Mineral Supplements|Minerals
DB09409	Magnesium acetate tetrahydrate	small molecule	approved	Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Laxatives|Osmotic Laxative
DB09413	Monopotassium phosphate	small molecule	approved|investigational|vet_approved	Acids|Acids, Noncarboxylic|Anions|Biomedical and Dental Materials|Buffers|Cariostatic Agents|Dental Materials|Electrolytes|Ions|Laboratory Chemicals|Laxatives|Osmotic Laxative|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Potassium Salt|Protective Agents|Replacement Preparations
DB09414	Dipotassium phosphate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Biomedical and Dental Materials|Buffers|Cariostatic Agents|Dental Materials|Electrolytes|Ions|Laboratory Chemicals|Laxatives|Osmotic Laxative|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Potassium Salt|Protective Agents
DB09418	Potassium perchlorate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Chlorine Compounds|Perchlorates|Potassium Salt|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Thyroid Products
DB09419	Xylose	small molecule	approved	Carbohydrates|Monosaccharides|Pentoses
DB09420	Iodide I-123	small molecule	approved	Diagnostic Radiopharmaceuticals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Thyroid Diagnostic Radiopharmaceuticals
DB09421	Protirelin	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Diagnostic Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins|Tests for Thyreoidea Function|Thyroid Products
DB09422	Soybean oil	small molecule	approved	Biological Products|Caloric Agents|Complex Mixtures|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Food|Food and Beverages|Lipid Emulsion|Lipids|Oils|Physiological Phenomena|Plant Oils|Plant Preparations
DB09425	Indium In-111 pentetate	small molecule	approved	Central Nervous System|Diagnostic Radiopharmaceuticals|Lead Chelator|Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09429	Albumin iodinated I-125 serum	biotech	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09430	Albumin iodinated I-131 serum	biotech	approved	Radiopharmaceutical Activity
DB09443	Krypton Kr 81m	small molecule	approved	Diagnostic Radiopharmaceuticals
DB09446	Safflower oil	biotech	approved|investigational	Biological Products|Complex Mixtures|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Food|Food and Beverages|Lipids|Oils|Physiological Phenomena|Plant Oils|Plant Preparations
DB09449	Sodium phosphate, monobasic	small molecule	approved	Acids|Acids, Noncarboxylic|Agents that reduce seizure threshold|Anions|Electrolytes|Ions|Laxatives|Osmotic Laxative|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Potassium Salt
DB09456	Insulin Beef	biotech	approved	Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Insulins and Analogues|Insulins and Analogues for Injection, Fast-Acting|Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting|Insulins and Analogues for Injection, Intermediate-Acting|Insulins and Analogues for Injection, Long-Acting
DB09459	L-tartaric acid	small molecule	approved	Acids, Acyclic|Carbohydrates|Chelating Agents|Dicarboxylic Acids|Hydroxy Acids|Sugar Acids|Urinary Alkalinisers
DB09460	Sodium carbonate	small molecule	approved	Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Ions
DB09462	Glycerin	small molecule	approved|investigational	Alcohols|Alimentary Tract and Metabolism|Basic Ointments and Protectants|Carbohydrates|Cell-mediated Immunity|Cryoprotective Agents|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 Enzyme Inducers|Drugs for Constipation|Enemas|Increased Histamine Release|Increased IgG Production|Irrigating Solutions|Laxatives|Non-Standardized Chemical Allergen|Osmotic Laxative|Other Cold and Cough Preparations|Other Diagnostics|P-glycoprotein/ABCB1 Inhibitors|Protective Agents|Solvents|Sugar Alcohols
DB09472	Sodium sulfate	small molecule	approved|vet_approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Drugs for Constipation|Electrolytes|Gastrointestinal Agents|Ions|Laxatives|Mineral Supplements|Osmotic Laxative|Sodium|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB09473	Indium In-111 oxyquinoline	small molecule	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09477	Enalaprilat	small molecule	approved	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Decreased Blood Pressure|Dipeptides|Enalapril|Enzyme Inhibitors|Hypotensive Agents|Oligopeptides|Peptides|Protease Inhibitors
DB09479	Rubidium Rb-82	small molecule	approved|investigational	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09481	Magnesium carbonate	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Antacids|Calculi Dissolution Agent|Drugs for Acid Related Disorders|Drugs for Constipation|Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Elements|Gastric Acid Lowering Agents|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Metals|Metals, Alkaline Earth|Metals, Light|Osmotic Laxative
DB09483	Potassium lactate	small molecule	approved	Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Electrolyte Solutions|I.V. Solution Additives|Laxatives|Osmotic Laxative|Potassium Salt
DB09484	Sodium fluorophosphate	small molecule	approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Biomedical and Dental Materials|Caries Prophylactic Agents|Cariostatic Agents|Dental Agents|Electrolytes|Fluorides|Fluorine Compounds|Hydrofluoric Acid|Ions|Laxatives|Mineral Supplements|Osmotic Laxative|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Protective Agents|Stomatological Preparations|Toothpastes
DB09487	Iotrolan	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB09488	Acrivastine	small molecule	approved	Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Neurotransmitter Agents|Potential QTc-Prolonging Agents|Pyridines|QTc Prolonging Agents
DB09490	Indium In-111 chloride	small molecule	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09493	Technetium Tc-99m red blood cells	biotech	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09494	Cetyl alcohol	small molecule	approved	Alcohols|Lipids
DB09495	Avobenzone	small molecule	approved|investigational	Cosmetics|Dermatologicals|Household Products|Ketones|Protective Agents|Radiation-Protective Agents|Sunscreening Agents
DB09496	Octinoxate	small molecule	approved|investigational	Acids, Carbocyclic|Cosmetics|Dermatologicals|Emollients and Protectives|Household Products|Protective Agents|Protectives Against UV-Radiation|Protectives Against UV-Radiation for Topical Use|Radiation-Protective Agents|Sunscreen Agents|Sunscreening Agents
DB09498	Strontium chloride Sr-89	small molecule	approved|investigational	Elements|Metals|Metals, Alkaline Earth|Metals, Heavy|Pain Palliation (Bone Seeking Agents)|Radioactive Therapeutic Agent|Strontium Radioisotopes|Therapeutic Radiopharmaceuticals|Various Pain Palliation Radiopharmaceuticals
DB09499	Thiosulfuric acid	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Antidotes|Antioxidants|Antituberculosis Agents|Chelating Agents|Electrolytes|Ions|Minerals|Protective Agents|Sequestering Agents|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB09502	Fludeoxyglucose F-18	small molecule	approved|investigational	Carbohydrates|Deoxy Sugars|Deoxyglucose|Diagnostic Radiopharmaceuticals|Diagnostic Uses of Chemicals|Indicators and Reagents|Laboratory Chemicals|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Radiopharmaceuticals|Tumour Detection
DB09510	Urea C-13	small molecule	approved	Helicobacter pylori Diagnostic
DB09511	Talc	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Antiperspirants|Cosmetics|Electrolytes|Household Products|Ions|Magnesium Compounds|Minerals|Oxides|Oxygen Compounds|Silicates|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB09512	Simethicone	small molecule	approved	Antifoaming Agents|Biomedical and Dental Materials|Dermatologicals|Dimethylpolysiloxanes|Emollients|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds|Silicones|Siloxanes|Surface-Active Agents
DB09513	Urea C-14	small molecule	approved	
DB09516	Mequinol	small molecule	approved	Antineoplastic Agents|Antioxidants|Benzene Derivatives|Depigmenting Activity|Dermatologicals|Ethers|Lentigo|Melanin Synthesis Inhibitors|Methyl Ethers|Phenols|Phenyl Ethers|Protective Agents|Skin Lightening Agent
DB09517	Sodium ferric gluconate complex	small molecule	approved	Iron Preparations|Parenteral Iron Replacement|Phosphate Binder
DB09526	Hydroquinone	small molecule	approved|investigational	Antioxidants|Benzene Derivatives|Depigmenting Activity|Depigmenting Agents|Dermatologicals|Melanin Synthesis Inhibitor|Melanin Synthesis Inhibitors|Mutagens|Noxae|Phenols|Protective Agents|Radiation-Protective Agents|Toxic Actions
DB09527	Secretin porcine	biotech	approved	Amino Acids, Peptides, and Proteins|Gastrointestinal Agents|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Proteins
DB09532	Secretin human	biotech	approved	Amino Acids, Peptides, and Proteins|Diagnostic Agents|Gastrointestinal Agents|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Proteins|Tests for Pancreatic Function
DB09534	Ecamsule	small molecule	approved	Acids|Acids, Noncarboxylic|Cosmetics|Dermatologicals|Household Products|Monoterpenes|Norbornanes|Protective Agents|Radiation-Protective Agents|Sulfur Acids|Sulfur Compounds|Sunscreening Agents|Terpenes
DB09535	Octocrylene	small molecule	approved|investigational	Acids, Acyclic|Sunscreen Agents|Sunscreening Agents
DB09536	Titanium dioxide	small molecule	approved	Astringents and Deodorants|Biocompatible Materials|Biomedical and Dental Materials|Coloring Agents|Cosmetics|Dermatologicals|Elements|Household Products|Metals|Metals, Light|Photosensitizing Agents|Protective Agents|Radiation-Protective Agents|Radiation-Sensitizing Agents|Sunscreen Agents|Sunscreening Agents|Transition Elements|Water Pollutants, Chemical
DB09537	Iodine povacrylex	small molecule	approved	
DB09539	Omega-3-acid ethyl esters	small molecule	approved|investigational	Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Inflammation Mediators|Lipids|Nootropic Agents|Oils|Pharmaceutical Preparations|Physiological Phenomena
DB09543	Methyl salicylate	small molecule	approved|vet_approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Betula|Biological Products|Complex Mixtures|Fixatives|Gaultheria|Hydroxy Acids|Hydroxybenzoates|Lipids|Oils|Pharmaceutical Preparations|Phenols|Plant Preparations|Salicylates
DB09546	Iobenguane sulfate I-123	small molecule	approved|investigational	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09551	Desoxyribonuclease	small molecule	approved	Blood and Blood Forming Organs|Enzymes
DB09552	Thonzonium	small molecule	approved	Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds
DB09555	Dexchlorpheniramine maleate	small molecule	approved	Agents that reduce seizure threshold|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|OCT2 Inhibitors|Pheniramine|Pyridines|QTc Prolonging Agents|Stereoisomerism
DB09559	Necitumumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Epidermal Growth Factor Receptor Antagonist|Globulins|HER1 Antagonists|Immunoglobulins|Immunoproteins|Proteins|Receptor, Epidermal Growth Factor, antagonists & inhibitors|Serum Globulins
DB09561	Sodium glycerophosphate	small molecule	approved	Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Carbohydrates|Electrolyte Solutions|I.V. Solution Additives|Laxatives|Lipids|Membrane Lipids|Osmotic Laxative|Phosphate salts|Phospholipids|Sugar Phosphates
DB09563	Choline C-11	small molecule	approved	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB09564	Insulin Degludec	biotech	approved	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Drugs Used in Diabetes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Insulin|Insulin Analog|Insulins and Analogues|Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting|Insulins and Analogues for Injection, Long-Acting|Pancreatic Hormones|Peptide Hormones|Peptides
DB09567	Olive oil	small molecule	approved	Biological Products|Complex Mixtures|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Food|Food and Beverages|Lipid Emulsion|Lipids|Oils|Physiological Phenomena|Plant Oils|Plant Preparations
DB09568	Omega-3-carboxylic acids	small molecule	approved|investigational	Fatty Acids, Omega-3
DB09570	Ixazomib	small molecule	approved|investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Protease Inhibitors|Proteasome Inhibitors
DB09571	Levmetamfetamine	small molecule	approved	
DB09877	Corynebacterium diphtheriae	biotech	approved|investigational	
DB10061	Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine	biotech	approved	
DB10062	Rabies virus inactivated antigen, B	biotech	approved	Actively Acquired Immunity|Antiinfectives for Systemic Use|Immune Sera|Immune Sera and Immunoglobulins|Inactivated Rabies Virus Vaccine|Rabies Vaccines|Vaccines
DB10076	Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen	biotech	approved|investigational	Actively Acquired Immunity|Inactivated Haemophilus Influenzae B Vaccine
DB10276	Rotavirus Vaccine	biotech	approved	Actively Acquired Immunity|Antiinfectives for Systemic Use|Live Attenuated Rotavirus Vaccine|Live Rotavirus Vaccine|Rota Virus Diarrhea Vaccines|Vaccines|Viral Vaccines
DB10283	Rabies virus inactivated antigen, A	biotech	approved|investigational	Actively Acquired Immunity|Antiinfectives for Systemic Use|Biological Products|Complex Mixtures|Immune Sera|Immune Sera and Immunoglobulins|Inactivated Rabies Virus Vaccine|Rabies Vaccines|Vaccines|Viral Vaccines
DB10284	Neisseria meningitidis serogroup b recombinant lp2086 a05 protein variant antigen	biotech	approved	
DB10285	Neisseria meningitidis serogroup b recombinant lp2086 b01 protein variant antigen	biotech	approved	
DB10286	Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved|investigational	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10287	Streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10288	Streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10289	Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10290	Streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10291	Streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10292	Streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10293	Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10294	Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10295	Streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10296	Streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10297	Streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10298	Streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10299	Human papillomavirus type 6 L1 capsid protein antigen	biotech	approved	Actively Acquired Immunity|Inactivated Human Papillomavirus Vaccine
DB10300	Human papillomavirus type 11 L1 capsid protein antigen	biotech	approved	Actively Acquired Immunity|Inactivated Human Papillomavirus Vaccine
DB10301	Human papillomavirus type 16 L1 capsid protein antigen	biotech	approved	Actively Acquired Immunity|Inactivated Human Papillomavirus Vaccine
DB10302	Human papillomavirus type 18 L1 capsid protein antigen	biotech	approved	Actively Acquired Immunity|Inactivated Human Papillomavirus Vaccine
DB10310	Human papillomavirus type 31 L1 capsid protein antigen	biotech	approved	
DB10311	Human papillomavirus type 33 L1 capsid protein antigen	biotech	approved	
DB10312	Human papillomavirus type 45 L1 capsid protein antigen	biotech	approved	
DB10313	Human papillomavirus type 52 L1 capsid protein antigen	biotech	approved	
DB10314	Human papillomavirus type 58 L1 capsid protein antigen	biotech	approved	
DB10315	Measles virus strain enders' attenuated edmonston live antigen	biotech	approved|investigational	Actively Acquired Immunity|Live Attenuated Measles Virus Vaccine
DB10316	Mumps virus strain b level jeryl lynn live antigen	biotech	approved	Actively Acquired Immunity|Live Mumps Virus Vaccine
DB10317	Rubella virus vaccine	biotech	approved|investigational	Actively Acquired Immunity|Antiinfectives for Systemic Use|Live Attenuated Rubella Virus Vaccine|Live vaccines|Rubella Vaccines|Vaccines|Viral Vaccines
DB10318	Varicella Zoster Vaccine (Live/Attenuated)	biotech	approved	Actively Acquired Immunity|Antiinfectives for Systemic Use|Biological Products|Complex Mixtures|Herpesvirus Vaccines|Live Attenuated Herpes Zoster Virus Vaccine|Live Attenuated Varicella Zoster Virus Vaccine|Live vaccines|Vaccines|Varicella Zoster Vaccines|Viral Vaccines
DB10319	Streptococcus pneumoniae type 1 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10320	Streptococcus pneumoniae type 2 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10321	Streptococcus pneumoniae type 3 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10322	Streptococcus pneumoniae type 4 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10323	Streptococcus pneumoniae type 5 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10324	Streptococcus pneumoniae type 6b capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10325	Streptococcus pneumoniae type 7f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10326	Streptococcus pneumoniae type 8 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10327	Streptococcus pneumoniae type 9n capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10328	Streptococcus pneumoniae type 9v capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10329	Streptococcus pneumoniae type 10a capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10330	Streptococcus pneumoniae type 11a capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10331	Streptococcus pneumoniae type 12f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10332	Streptococcus pneumoniae type 14 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10333	Streptococcus pneumoniae type 15b capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10334	Streptococcus pneumoniae type 17f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10335	Streptococcus pneumoniae type 18c capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10336	Streptococcus pneumoniae type 19f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10337	Streptococcus pneumoniae type 19a capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10338	Streptococcus pneumoniae type 20 capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10339	Streptococcus pneumoniae type 22f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10340	Streptococcus pneumoniae type 23f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10341	Streptococcus pneumoniae type 33f capsular polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Pneumococcal Vaccine
DB10342	Haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen	biotech	approved|investigational	Actively Acquired Immunity|Inactivated Haemophilus Influenzae B Vaccine
DB10343	Bacillus calmette-guerin substrain tice live antigen	biotech	approved	Actively Acquired Immunity|Increased Immunologically Active Molecule Activity|Increased Macrophage Proliferation|Live Attenuated Bacillus Calmette-Guerin Immunotherapy|Live Attenuated Bacillus Calmette-Guerin Vaccine|Live vaccines|Vaccines
DB10344	Ginger	biotech	approved	Cell-mediated Immunity|Herbs and Natural Products|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10345	House dust	biotech	approved	Cell-mediated Immunity|Complex Mixtures|Increased Histamine Release|Increased IgG Production|Non-Standardized House Dust Allergenic Extract|Particulate Matter
DB10346	Acacia longifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10348	Fraxinus americana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10349	Paspalum notatum pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10350	Fagus grandifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10351	Cynodon dactylon pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10352	Betula lenta pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10353	Poa annua pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10354	Acer negundo pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10355	Bromus inermis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10356	Xanthium strumarium pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10357	Zea mays pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10359	Rumex acetosella pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10360	Rumex crispus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10361	Ulmus americana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10362	Ulmus pumila pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10363	Corylus americana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10364	Carya ovata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10365	Sorghum halepense pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10366	Poa pratensis pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10368	Chenopodium album pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10369	Acer saccharum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10370	Festuca pratensis pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10371	Prosopis juliflora pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10372	Artemisia vulgaris pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10373	Morus rubra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10374	Quercus agrifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10375	Quercus virginiana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10376	Quercus alba pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10377	Avena sativa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10378	Olea europaea pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10379	Dactylis glomerata pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10381	Amaranthus retroflexus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10382	Plantago lanceolata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10383	Populus alba pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10384	Ambrosia acanthicarpa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10385	Ambrosia artemisiifolia pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10386	Ambrosia trifida pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10387	Ambrosia psilostachya pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10388	Salsola kali pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10389	Lolium perenne pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10390	Artemisia tridentata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10391	Atriplex wrightii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10392	Platanus occidentalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10393	Platanus racemosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10394	Phleum pratense pollen	biotech	approved|investigational	Allergenic Extracts|Biological Products|Cell-mediated Immunity|Complex Mixtures|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10395	Holcus lanatus pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10396	Juglans nigra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10397	Juglans californica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10398	Salix nigra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10399	Felis catus skin	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Animal Skin Allergenic Extract
DB10400	Dermatophagoides farinae	biotech	approved	Allergenic Extracts|Allergens|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Allergenic Extract
DB10401	Dermatophagoides pteronyssinus	biotech	approved	Allergenic Extracts|Allergens|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Allergenic Extract
DB10403	Agrostis gigantea pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract|Standardized Pollen Allergenic Extract
DB10404	Anthoxanthum odoratum pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Standardized Pollen Allergenic Extract
DB10406	Bos taurus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10408	Cotton seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB10411	Ceiba pentandra fiber	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Fiber Allergenic Extract
DB10412	Mus musculus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10413	Orris	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB10415	Rabbit	biotech	approved|investigational	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB10416	Cavia porcellus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10417	Periplaneta americana	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10418	Blatella germanica	biotech	approved	Allergens|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Insect Proteins|Non-Standardized Insect Allergenic Extract
DB10419	Solenopsis invicta	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Venom Allergenic Extract
DB10420	Gallus gallus feather	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Feather Allergenic Extract
DB10421	Anas platyrhynchos feather	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Feather Allergenic Extract
DB10422	Anser anser feather	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Feather Allergenic Extract
DB10423	Acremonium strictum	biotech	approved	
DB10424	Alternaria alternata	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10425	Aspergillus fumigatus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Fungal Allergenic Extract
DB10426	Aspergillus niger var. niger	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10427	Aureobasidium pullulans var. pullutans	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10428	Botrytis cinerea	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10429	Candida albicans	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10430	Chaetomium globosum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10431	Cladosporium cladosporioides	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10432	Cladosporium sphaerospermum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10433	Cochliobolus sativus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10434	Epicoccum nigrum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10435	Fusarium oxysporum vasinfectum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10436	Helminthosporium solani	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10437	Mucor plumbeus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10438	Neurospora intermedia	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10439	Penicillium chrysogenum var. chrysogenum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10440	Phoma exigua var. exigua	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10441	Rhizopus arrhizus var. arrhizus	biotech	approved	Allergens|Cell-mediated Immunity|Fungal Proteins|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10442	Rhodotorula rubra	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10443	Ustilago maydis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10444	Ustilago tritici	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10445	Stemphylium solani	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10446	Trichophyton mentagrophytes	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10447	Saccharomyces cerevisiae	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Food Allergenic Extract|Non-Standardized Fungal Allergenic Extract
DB10449	Aspergillus repens	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10450	Aspergillus terreus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10451	Acacia	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB10452	Ailanthus altissima pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10453	Alnus incana subsp. rugosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10454	Medicago sativa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10455	Fraxinus velutina pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10456	Populus tremuloides pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10457	Morella cerifera pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10458	Betula nigra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10459	Amaranthus palmeri pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10460	Juniperus ashei pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10461	Juniperus virginiana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10462	Xanthium strumarium var. canadense pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10463	Populus deltoides pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10464	Populus fremontii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10465	Populus deltoides subsp. monilifera pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10466	Cupressus arizonica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10467	Taxodium distichum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10468	Eupatorium capillifolium pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10469	Ulmus crassifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10470	Eucalyptus globulus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10471	Solidago canadensis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10472	Celtis occidentalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10473	Juniperus californica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10474	Robinia pseudoacacia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10475	Acer rubrum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10478	Melaleuca quinquenervia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10479	Chenopodium ambrosioides pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10480	Morus alba pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10481	Quercus rubra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10482	Syagrus romanzoffiana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10483	Schinus molle pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10484	Amaranthus spinosus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10485	Casuarina equisetifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10486	Pinus strobus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10487	Pinus echinata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10488	Ligustrum vulgare pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10489	Elymus repens pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10490	Ambrosia tenuifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10491	Ambrosia bidentata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10493	Artemisia frigida pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10494	Distichlis spicata pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10495	Liquidambar styraciflua pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10496	Juglans regia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10498	Triticum aestivum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10499	Felis catus hair	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Animal Hair Allergenic Extract
DB10500	Almond	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10501	Apple	biotech	approved	Allergens|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10502	Apricot	biotech	approved	Allergens|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10503	Asparagus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10504	Avocado	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10505	Banana	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10506	Barley	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10508	String bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10509	Beef	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB10510	Brazil nut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10511	Broccoli	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10512	Buckwheat	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10513	Cabbage	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10514	Cantaloupe	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10515	Carrot	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10516	Casein	biotech	approved	Amino Acids, Peptides, and Proteins|Beverages|Bodily Secretions|Cell-mediated Immunity|Dairy Products|Diet, Food, and Nutrition|Dietary Proteins|Fluids and Secretions|Food|Food and Beverages|Increased Histamine Release|Milk components|Milk Proteins|Non-Standardized Food Allergenic Extract|Phosphoproteins|Physiological Phenomena|Proteins|Sequestering Agents
DB10517	Celery	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10518	Cherry	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10519	Chicken	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Poultry Proteins
DB10520	Cinnamon	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10523	Coconut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10525	Coffee bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10526	Red king crab	biotech	approved	
DB10527	Cucumber	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10528	Egg white	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10529	Egg	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10530	Egg yolk	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10531	Flounder	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10532	Garlic	biotech	approved|nutraceutical	Cell-mediated Immunity|Herbs and Natural Products|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10533	Grape	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10534	Grapefruit	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10535	Karaya gum	biotech	approved	Biological Products|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cell-mediated Immunity|Complex Mixtures|Equipment and Supplies|Increased Histamine Release|Increased IgG Production|Macromolecular Substances|Non-Standardized Food Allergenic Extract|Plant Exudates|Plant Gums|Polymers|Polysaccharides|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives
DB10536	Honeydew melon	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10537	Lamb	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB10538	Lemon	biotech	approved|investigational	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10539	Lettuce	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10540	Lima bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10541	Lobster	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Shellfish Proteins
DB10542	Goat milk	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10543	Cow milk	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10544	Cultivated mushroom	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10545	Mustard seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10546	Oat	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10547	Black olive	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10548	Onion	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10549	Orange	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10550	Oyster	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Shellfish Proteins
DB10551	Pea	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10552	Peach	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10553	Peanut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10554	Pear	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10555	Pecan	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10556	Green bell pepper	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10557	Black pepper	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10558	Pineapple	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10559	Pistachio	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10560	Plum	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10561	Pork	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB10562	Potato	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10563	Rice	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10564	Rye	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10566	Sesame seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10567	Shrimp	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Shellfish Proteins
DB10568	Soybean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10569	Spinach	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10570	Squash	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10571	Strawberry	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10572	Corn	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10573	Tomato	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10574	Tuna	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10575	Turkey	biotech	approved|investigational	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Poultry Proteins
DB10576	Vanilla	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10577	English walnut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10578	Watermelon	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10579	Wheat	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10580	Tea leaf	biotech	approved|investigational	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10581	Khuskia oryzae	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10582	Artemisia annua pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10583	Clostridium tetani toxoid antigen (formaldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Antiinfectives for Systemic Use|Bacterial Vaccines|Biological Products|Complex Mixtures|Inactivated Clostridium Tetani Vaccine|Tetanus Vaccines|Toxoids|Vaccines
DB10603	Meriones unguiculatus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10604	Capra hircus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10605	Mesocricetus auratus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10606	Sus scrofa skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10607	Oryctolagus cuniculus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10608	Rattus norvegicus skin	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Skin Allergenic Extract
DB10609	Bombyx mori fiber	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10610	Duck	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Poultry Proteins
DB10611	Allergenic extract- beef liver	biotech	approved	
DB10612	Veal	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB10613	Bluefish	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10614	Common carp	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10615	Haddock	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10616	Pacific halibut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10617	Herring	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10618	Mackerel	biotech	approved	
DB10619	Northern pike	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10620	Red snapper	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10621	Atlantic salmon	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10622	European pilchard	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10623	Scallop	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Shellfish Proteins
DB10624	Smelt	biotech	approved	
DB10625	Swordfish	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10626	Trout	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10627	White fish	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10628	Blackberry	biotech	approved	
DB10629	Blueberry	biotech	approved	
DB10630	Sour cherry	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10631	Cranberry	biotech	approved|investigational	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10632	Date	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10633	Fig	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10634	Wine grape	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10635	Lime (citrus)	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10636	Raspberry	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10637	Tangerine	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10638	Artichoke	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10639	Kidney bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10640	Beet	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10641	Kiwi fruit	biotech	approved	
DB10642	Brussels sprout	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10643	Cauliflower	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10644	Eggplant	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10645	Lentil	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10646	Green olive	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10647	Parsley	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10648	Sweet potato	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10650	Raphanus sativus	biotech	approved	
DB10651	Rhubarb	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10652	Turnip	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10653	Cashew	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10654	Hazelnut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10655	Macadamia nut	biotech	approved	
DB10656	Nectarine	biotech	approved	
DB10657	Mango	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10658	Papaya	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Herbs and Natural Products|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10659	Leek	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10660	Okra	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10661	Parsnip	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10662	Chickpea	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10663	Black-eyed pea	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10664	Watercress	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10666	Arabica coffee bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10667	Tragacanth	biotech	approved	Biological Products|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cell-mediated Immunity|Complex Mixtures|Drug Delivery Systems|Excipients|Increased Histamine Release|Increased IgG Production|Macromolecular Substances|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Plant Exudates|Plant Gums|Polymers|Polysaccharides
DB10669	Allspice	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10670	Laurus nobilis	biotech	approved	
DB10671	Caraway seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10672	Clove	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10673	Dill	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10674	Horseradish	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10675	Licorice	biotech	approved	
DB10676	Nutmeg	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB10677	Oregano	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10678	Paprika	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10679	White pepper	biotech	approved	
DB10681	Poppy seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10683	Spearmint	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10685	Wheat bran	biotech	approved	
DB10686	American chestnut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Nut Proteins|Plant Proteins
DB10687	Hops	biotech	approved	Cell-mediated Immunity|Herbs and Natural Products|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10688	Musca domestica	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10690	Ctenocephalides canis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10691	Aedes taeniorhynchus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10693	Ctenocephalides felis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10694	Aspergillus flavus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Fungal Allergenic Extract
DB10695	Eurotium herbariorum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10696	Trichothecium roseum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10697	Curvularia inaequalis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10698	Fusarium compactum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10699	Geotrichum candidum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10700	Phoma glomerata	biotech	approved	
DB10701	Rhodotorula mucilaginosa	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10702	Stemphylium sarciniforme	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10703	Trichoderma harzianum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10704	Ustilago avenae	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10706	Puccinia graminis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10707	Cotton	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Fiber Allergenic Extract
DB10708	Flax seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10710	Tobacco leaf	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB10711	Corcorus capsularis fiber	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Fiber Allergenic Extract
DB10712	Agave sisalana fiber	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Fiber Allergenic Extract
DB10713	Poa compressa pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10714	Phalaris arundinacea pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10715	Bouteloua gracilis pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10716	Urochloa mutica pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10717	Secale cereale pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10718	Leymus condensatus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10719	Pascopyrum smithii pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10720	Acacia baileyana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10721	Alnus rubra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10722	Alnus rhombifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10723	Fraxinus latifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10724	Betula populifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10725	Tamarix gallica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10727	Juniperus monosperma pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10728	Juniperus pinchotii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10729	Juniperus scopulorum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10730	Juniperus osteosperma pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10731	Juniperus occidentalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10732	Tilia americana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10733	Mangifera indica pollen	biotech	approved	
DB10734	Acer macrophyllum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10735	Acer saccharinum pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10736	Broussonetia papyrifera pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10737	Quercus velutina pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10738	Quercus macrocarpa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10739	Quercus kelloggii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10740	Quercus gambelii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10741	Quercus lobata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10742	Quercus nigra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10743	Citrus sinensis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10744	Pinus taeda pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10745	Pinus palustris pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10746	Pinus ponderosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10747	Pinus elliottii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10748	Pinus virginiana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10749	Pinus monticola pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10750	Populus nigra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10751	Elaeagnus angustifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10752	Salix lasiolepis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10753	Salix discolor pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10754	Populus balsamifera subsp. trichocarpa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10755	Taraxacum officinale pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10756	Atriplex polycarpa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10757	Baccharis halimifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10758	Hymenoclea salsola pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10759	Allenrolfea occidentalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10760	Atriplex lentiformis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10761	Artemisia douglasiana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10762	Artemisia ludoviciana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10763	Urtica dioica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10764	Iva axillaris pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10765	Ambrosia deltoidea pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10766	Sarcobatus vermiculatus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10767	Atriplex canescens pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10768	Artemisia absinthium pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10769	Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Inactivated Japanese Encephalitis Virus Vaccine|Vaccines
DB10770	Foreskin fibroblast (neonatal)	biotech	approved	Allogeneic Cultured Cell Scaffold|Cells, Cultured, Allogeneic|Fibroblasts|Tissue Scaffolds
DB10771	Bovine type I collagen	biotech	approved	Allogeneic Cultured Cell Scaffold
DB10772	Foreskin keratinocyte (neonatal)	biotech	approved	Allogeneic Cultured Cell Scaffold|Cells, Cultured, Allogeneic|Keratinocytes|Tissue Scaffolds
DB10788	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Inactivated Bordetella Pertussis Vaccine
DB10789	Bordetella pertussis pertactin antigen	biotech	approved	Amino Acids, Peptides, and Proteins|Bacterial Proteins|Bacterial Toxins|Biological Factors|Bordetella bronchiseptica|Bordetella pertussis|Membrane Proteins|Proteins|Toxins, Biological|Virulence Factors
DB10790	Bordetella pertussis fimbriae 2/3 antigen	biotech	approved	Actively Acquired Immunity|Inactivated Bordetella Pertussis Vaccine
DB10791	Influenza A virus A/california/7/2009 x-179a (H1N1) antigen (formaldehyde inactivated)	biotech	approved|investigational	
DB10792	Influenza A virus A/switzerland/9715293/2013 nib-88 (H3N2) antigen (formaldehyde inactivated)	biotech	approved|investigational	
DB10793	Influenza B virus B/phuket/3073/2013 antigen (formaldehyde inactivated)	biotech	approved|investigational	
DB10795	Poliovirus type 1 antigen (formaldehyde inactivated)	biotech	approved|investigational	Actively Acquired Immunity|Inactivated Poliovirus Vaccine
DB10796	Poliovirus type 2 antigen (formaldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Inactivated Poliovirus Vaccine
DB10797	Poliovirus type 3 antigen (formaldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Inactivated Poliovirus Vaccine
DB10798	Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen	biotech	approved|investigational	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB10799	Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB10800	Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB10801	Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB10802	Influenza a virus a/california/7/2009(h1n1)-like antigen (formaldehyde inactivated)	biotech	approved	
DB10803	Salmonella typhi ty2 vi polysaccharide antigen	biotech	approved	Actively Acquired Immunity|Inactivated Salmonella Typhi Vaccine|Vaccines
DB10804	Bacillus calmette-guerin substrain connaught live antigen	biotech	approved|investigational	Live Attenuated Bacillus Calmette-Guerin Vaccine|Live vaccines|Vaccines
DB10805	Yellow Fever Vaccine	biotech	approved|investigational	Actively Acquired Immunity|Antiinfectives for Systemic Use|Biological Products|Complex Mixtures|Live Attenuated Yellow Fever Virus Vaccine|Live vaccines|Vaccines|Viral Vaccines|Yellow Fever Vaccines
DB10807	Candida tropicalis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10808	Mucor racemosus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10809	Penicillium camemberti	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10810	Penicillium expansum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10811	Penicillium italicum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10812	Penicillium roqueforti	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10813	Phoma destructiva	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10814	Rhizopus stolonifer	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10815	Fraxinus pennsylvanica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10816	Atriplex confertifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10817	Passalora fulva	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10818	Cochliobolus spicifer	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10819	Myrothecium verrucaria	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10820	Hypomyces perniciosus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10821	Neurospora crassa	biotech	approved	
DB10822	Paecilomyces variotii	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10823	Microascus brevicaulis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10824	Colletotrichum coccodes	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10825	Pleospora herbarum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10826	Streptomyces griseus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Bacterial Allergenic Extract
DB10827	Trichoderma viride	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10828	Trichophyton schoenleinii	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10829	Basil	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10830	Mung bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10831	Betula papyrifera pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10832	Betula occidentalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10833	Betula alleghaniensis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10834	Ustilago cynodontis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10835	Ustilago nuda hordei	biotech	approved	Allergens|Cell-mediated Immunity|Fungal Proteins|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10836	Bromus secalinus pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10837	Beta vulgaris pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10838	Chenopodium botrys pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10839	Mycocladus corymbiferus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10840	Acrothecium robustum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10841	Humicola grisea	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10842	Microsporum audouinii	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10843	Microsporum canis	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10844	Apiospora montagnei	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Fungal Allergenic Extract
DB10845	Phycomyces blakesleeanus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10846	Sporotrichum pruinosum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10847	Stachybotrys chartarum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10848	Syncephalastrum racemosum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10849	Tetracoccosporium paxianum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10850	Verticillium albo-atrum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10851	White catfish	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10852	Carob	biotech	approved	Antidiarrheals|Biological Products|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cell-mediated Immunity|Complex Mixtures|Gastrointestinal Agents|Increased Histamine Release|Macromolecular Substances|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Exudates|Polymers|Polysaccharides
DB10853	Sweet cherry	biotech	approved	
DB10856	Bos taurus hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10857	Serinus canaria feather	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Feather Allergenic Extract
DB10858	Melilotus albus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10859	Melilotus officinalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10860	Typha latifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10861	Atlantic cod	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10862	Red currant	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10864	Cumin	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10865	Cladosporium herbarum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10866	Acheta domesticus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Allergenic Extract
DB10867	Canis lupus familiaris hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10868	Odocoileus virginianus hair	biotech	approved	
DB10869	Grain mill dust	biotech	approved	
DB10870	Epidermophyton floccosum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10871	Ambrosia dumosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10872	Ambrosia confertiflora pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10873	Sporisorium cruentum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10874	Goose	biotech	approved	
DB10875	Concord grape	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fruit Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10876	Capra hircus hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10877	Cavia porcellus hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10879	Arrhenatherum elatius pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10880	Equus caballus hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10881	Sus scrofa hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10882	Carya cordiformis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10883	Carya glabra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10884	Millet seed	biotech	approved	
DB10885	Mustard greens	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10887	Quercus palustris pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10888	Quercus stellata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10889	Quercus garryana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10890	Red bell pepper	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10891	Perch	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10892	Pumpkin	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10893	Melopsittacus undulatus feather	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Feather Allergenic Extract
DB10894	Pinus contorta pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10895	Pinus sylvestris pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10896	Pinus rigida pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10897	Chili pepper	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10898	Oryctolagus cuniculus hair	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Hair Allergenic Extract
DB10899	Sequoia sempervirens pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10900	Rumex obtusifolius pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10901	Rumex altissimus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10902	Rumex salicifolius var. mexicanus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10903	Sitotroga cerealella	biotech	approved	
DB10904	English sole	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10905	Safflower	biotech	approved	
DB10906	Sugarcane	biotech	approved	
DB10907	Sunflower seed	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10908	Platanus hybrida pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10909	Artemisia californica pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10910	Helianthus annuus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10911	Carpinus caroliniana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10912	Picea pungens pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10913	Starch, tapioca	biotech	approved	
DB10914	Larix occidentalis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10915	Trichophyton rubrum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10916	Salix lucida ssp. lasiandra pollen	biotech	approved	
DB10918	Venison	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB10919	Black walnut	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Nut Proteins
DB10921	Artemisia dracunculus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10922	Pinus banksiana pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10923	Pinus resinosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10924	Pinus nigra pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10925	Pinus thunbergii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10926	Carya tomentosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10927	Iva annua pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10928	Bassia scoparia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10929	Cyclachaena xanthifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10933	Cochliobolus lunatus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10934	Haematonectria haematococca	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10935	Chrysonilia sitophila	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10936	Pleospora betae	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10937	Puccinia striiformis var. striiformis	biotech	approved	
DB10941	Bassia hyssopifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10942	Brassica rapa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10943	Callistemon citrinus pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10945	Dicoria canescens pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10946	Krascheninnikovia lanata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10947	Ambrosia ambrosioides pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10948	Ambrosia chamissonis pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Pollen Allergenic Extract
DB10949	Koeleria macrantha pollen	biotech	approved	Allergenic Extracts|Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10950	Phoenix dactylifera pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10952	Quercus dumosa pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10953	Suaeda moquinii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10954	Tilia cordata pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10955	Apis mellifera venom	biotech	approved	Allergenic Extracts|Bee and Wasp Venom|Miscellaneous Therapeutic Agents
DB10956	Vespula maculifrons venom protein	biotech	approved	Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Venom Allergenic Extract
DB10957	Dolichovespula arenaria venom protein	biotech	approved	Allergenic Extracts|Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Miscellaneous Therapeutic Agents|Standardized Insect Venom Allergenic Extract
DB10958	Dolichovespula maculata venom protein	biotech	approved	Allergenic Extracts|Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Miscellaneous Therapeutic Agents|Standardized Insect Venom Allergenic Extract
DB10959	Polistes fuscatus venom protein	biotech	approved	Allergenic Extracts|Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Venom Allergenic Extract
DB10961	Hordeum vulgare pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10962	Agrostis stolonifera pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10963	Phalaris minor pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10964	Lolium perenne subsp. multiflorum pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10965	Sorghum bicolor subsp. bicolor pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10966	Sorghum bicolor subsp. drummondii pollen	biotech	approved	Cell-mediated Immunity|Grass Pollen Allergen Extracts|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10967	Amphiachyris dracunculoides pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10968	Iva angustifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10969	Neurospora sitophila	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10970	Trichophyton tonsurans	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB10975	Tanacetum cinerariifolium flower	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB10976	Largemouth bass	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10977	Cocoa	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10979	Blue crab	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Shellfish Proteins
DB10980	Barley malt	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB10981	Radish	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB10982	Sage	biotech	approved	Agents that reduce seizure threshold|Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10983	Thyme	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Food Allergenic Extract
DB10984	Peppermint	biotech	approved	Cell-mediated Immunity|Herbs and Natural Products|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB10986	Pseudotsuga menziesii pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10988	Maclura pomifera pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB10989	Hepatitis A Vaccine	biotech	approved	Actively Acquired Immunity|Biological Products|Complex Mixtures|Inactivated Hepatitis A Virus Vaccine|Vaccines|Viral Hepatitis Vaccines|Viral Vaccines
DB10990	Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen	biotech	approved|investigational	Actively Acquired Immunity|Haemophilus Vaccines|Inactivated Haemophilus Influenzae B Vaccine|Vaccines, Inactivated
DB10991	Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Inactivated Bordetella Pertussis Vaccine
DB10994	Human papillomavirus type 16 L1 capsid protein residues 2-471 antigen	biotech	approved|investigational	
DB10997	Autologous cultured chondrocytes	biotech	approved|investigational	Autologous Cultured Cell|Cells, Cultured, Autologous|Chondrocytes
DB10998	Influenza A virus A/brisbane/10/2010 (H1N1) antigen (mdck cell derived, propiolactone inactivated)	biotech	approved|investigational	
DB11003	Anthrax vaccine	biotech	approved	Actively Acquired Immunity|Anthrax Vaccines|Live Attenuated Bacillus Anthracis Vaccine|Live vaccines|Vaccines|Vaccines, Attenuated
DB11005	Ulmus parvifolia pollen	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Pollen Allergenic Extract
DB11007	Cytisus scoparius flowering top	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB11009	Quahog, unspecified	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Shellfish Proteins
DB11010	Cod, unspecified	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB11014	Salmon, unspecified	biotech	approved	Allergens|Cell-mediated Immunity|Dietary Proteins|Fish Proteins, Dietary|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB11018	Canis lupus familiaris dander	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Dander|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Dander Allergenic Extract
DB11021	Equus caballus dander	biotech	approved	Allergens|Cell-mediated Immunity|Cells, Epidermal|Dander|Increased Histamine Release|Increased IgG Production|Non-Standardized Animal Dander Allergenic Extract
DB11022	Aspergillus nidulans	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB11025	Dendryphiella vinosa	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB11026	Solenopsis richteri	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Venom Allergenic Extract
DB11027	Polistes annularis venom protein	biotech	approved	Bee and Wasp Venom
DB11028	Polistes exclamans venom protein	biotech	approved	Bee and Wasp Venom
DB11029	Polistes metricus venom protein	biotech	approved	Bee and Wasp Venom
DB11030	Vespula germanica venom protein	biotech	approved	Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Venom Allergenic Extract
DB11031	Vespula pensylvanica venom protein	biotech	approved	Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Venom Allergenic Extract
DB11032	Vespula squamosa venom protein	biotech	approved	Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Standardized Insect Venom Allergenic Extract
DB11033	Vespula vulgaris venom protein	biotech	approved	Allergenic Extracts|Bee and Wasp Venom|Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Miscellaneous Therapeutic Agents|Standardized Insect Venom Allergenic Extract
DB11034	Influenza A virus A/bolivia/559/2013 (H1N1) live (attenuated) antigen	biotech	approved|investigational	
DB11048	Influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB11050	Typhoid Vaccine Live Ty21a	biotech	approved	Actively Acquired Immunity|Inactivated Salmonella Typhi Vaccine|Live Attenuated Salmonella Typhi Vaccine|Live vaccines|Vaccines
DB11051	Azficel-T	biotech	approved|investigational	Autologous Cultured Cell|Cells, Cultured, Autologous|Fibroblasts
DB11054	Human cord blood hematopoietic progenitor cell	biotech	approved	Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy|Cells, Allogeneic|Hematopoietic Stem Cells
DB11056	Stannous chloride	small molecule	approved	
DB11057	Mineral oil	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Basic Ointments and Protectants|Dermatologicals|Drugs for Constipation|Emollients|Laxatives|Petrolatum|Softener and Emollient Laxatives|Softeners, Emollients
DB11058	Petrolatum	small molecule	approved|investigational	Basic Ointments and Protectants|Dermatologicals|Emollients|Ointment Bases|Pharmaceutic Aids|Pharmaceutical Preparations
DB11059	Carboxymethylcellulose	small molecule	approved|investigational	Anorexigenic Agents & Respiratory and CNS Stimulants|Artificial Tears|Biomedical and Dental Materials|Biopolymers|Bulk-Forming Laxatives|Carbohydrates|Cellulose|EENT Drugs, Miscellaneous|Gastrointestinal Agents|Glucans|Laxatives|Macromolecular Substances|Methylcellulose|Polymers|Polysaccharides
DB11060	Polyvinyl alcohol	small molecule	approved	Alcohols|Alkenes|Artificial Tears|Biomedical and Dental Materials|EENT Drugs, Miscellaneous|Hydrocarbons, Acyclic|Macromolecular Substances|Plastics|Polyenes|Polymers|Polyvinyls|Vinyl Compounds
DB11061	Povidone	small molecule	approved	Alkenes|Artificial Tears|Biomedical and Dental Materials|Biomimetic Materials|Blood Substitutes|Hematologic Agents|Hydrocarbons, Acyclic|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Plasma Substitutes|Plastics|Polyenes|Polymers|Polyvinyls|Pyrrolidines|Pyrrolidinones|Vinyl Compounds
DB11062	Octisalate	small molecule	approved|investigational	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols|Sunscreening Agents
DB11063	Polysorbate 80	small molecule	approved	Alcohols|Artificial Tears|Biomedical and Dental Materials|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents
DB11064	Homosalate	small molecule	approved|investigational	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols|Sunscreening Agents
DB11065	Pancrelipase amylase	biotech	approved	Amylases|Enzymes|Enzymes and Coenzymes|Glycoside Hydrolases|Hydrolases
DB11066	Pancrelipase protease	biotech	approved	
DB11068	Selenic acid	small molecule	approved	Alimentary Tract and Metabolism|Antioxidants|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Mineral Supplements|Physiological Phenomena|Protective Agents|Selenium|Selenium Compounds|Trace Elements
DB11071	Phenyl salicylate	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Genito Urinary System and Sex Hormones|Hydroxy Acids|Hydroxybenzoates|Phenols|Urologicals
DB11072	Hydrogen fluoride	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Dental Agents|Fluorine Compounds
DB11073	Cetylpyridinium	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Dermatologicals|Detergents|Household Products|Irrigating Solutions|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Anti-infectives|Mouthwashes and Gargles|Pyridines|Pyridinium Compounds|Quaternary Ammonium Compounds|Surface-Active Agents|Throat Preparations
DB11074	Dimethicone	small molecule	approved	Antifoaming Agents|Basic Ointments and Protectants|Biomedical and Dental Materials|Macromolecular Substances|Misc. Skin and Mucous Membrane Agents|Organosilicon Compounds|Polymers|Scabicides and Pediculicides|Silicon Compounds|Silicones|Siloxanes|Skin Barrier Activity
DB11075	Hypromellose	small molecule	approved	Artificial Tears|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Cellulose|EENT Drugs, Miscellaneous|Glucans|Macromolecular Substances|Ophthalmologicals|Other Diagnostics|Polymers|Polysaccharides|Sensory Organs|Surgical Aids|Viscoelastic Substances
DB11077	Polyethylene glycol 400	small molecule	approved	Alcohols|Biomedical and Dental Materials|EENT Drugs, Miscellaneous|Ethylene Glycols|Glycols|Macromolecular Substances|Pegylated agents|Polymers
DB11079	Trolamine salicylate	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Phenols|Salicylates|Sunscreening Agents
DB11080	Silver nitrate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Electrolytes|Ions|Nitrates|Nitric Acid|Nitrogen Compounds|Silver Compounds
DB11081	Aluminum chloride	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Astringents|Astringents and Deodorants|Chlorine Compounds|Dental Agents|Dermatologicals|Electrolytes|Hydrochloric Acid|Ions
DB11082	Coal tar	small molecule	approved	Complex Mixtures|Dermatologicals|Keratolytic Agents|Keratoplastic Agents|Tars
DB11085	Resorcinol	small molecule	approved	Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Infective Agents|Benzene Derivatives|Dermatologicals|Ophthalmologicals|Phenols|Root Canal Filling Materials|Sensory Organs
DB11086	Cocoa butter	small molecule	approved	Antipruritics and Local Anesthetics|Diet, Food, and Nutrition|Fats|Food|Food and Beverages|Lipids|Physiological Phenomena
DB11087	Pyrethrum extract	small molecule	approved	Agrochemicals|Insecticides|Monoterpenes|Pesticides|Terpenes|Toxic Actions
DB11088	Shark liver oil	biotech	approved	
DB11089	Docusate	small molecule	approved	Acids, Acyclic|Alimentary Tract and Metabolism|Dicarboxylic Acids|Drugs for Constipation|Enemas|Laxatives|Osmotic Laxative|Softener and Emollient Laxatives|Softeners, Emollients|Succinates|Surface-Active Agents
DB11090	Potassium nitrate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Explosive Agents|Ions|Laxatives|Nitric Acid|Nitrogen Compounds|Osmotic Laxative|Potassium Salt
DB11091	Hydrogen peroxide	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antifibrinolytic Agents|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Dermatologicals|Electrolytes|Free Radicals|Ions|Noxae|Otologicals|Oxidants|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sensory Organs|Stomatological Preparations|Toxic Actions
DB11092	Stannous fluoride	small molecule	approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Biomedical and Dental Materials|Caries Prophylactic Agents|Cariostatic Agents|Electrolytes|Fluorides|Fluorine Compounds|Hydrofluoric Acid|Ions|Protective Agents|Stomatological Preparations|Tin Compounds
DB11093	Calcium Citrate	small molecule	approved|investigational	Acids, Acyclic|Alimentary Tract and Metabolism|Blood Coagulation Factors|Calcium Compounds|Calcium Salts|Citrates|Citric Acid|Diet, Food, and Nutrition|Food|Food Additives|Food and Beverages|Mineral Supplements|Phosphate Binder|Physiological Phenomena|Tricarboxylic Acids
DB11094	Vitamin D	small molecule	approved|nutraceutical|vet_approved	Bone Density Conservation Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Secosteroids|Steroids|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB11095	Desirudin	biotech	approved	Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombin Proteins|Antithrombins|Blood and Blood Forming Organs|Cardiovascular Agents|Fibrin Modulating Agents|Hematologic Agents|Peptides|Proteins|Serpins|Thrombin Inhibitors
DB11096	Meradimate	small molecule	approved	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates
DB11097	Plantago seed	biotech	approved|investigational	Biological Products|Bulk-Forming Laxatives|Complex Mixtures|Gastrointestinal Agents|Herbs and Natural Products|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB11098	Potassium bicarbonate	small molecule	approved	Acids|Acids, Noncarboxylic|Agents causing hyperkalemia|Alimentary Tract and Metabolism|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Electrolytes|Ions|Mineral Supplements|Potassium|Potassium Salt
DB11100	Allantoin	small molecule	approved	Basic Ointments and Protectants|Dermatologicals|Herbs and Natural Products|Hydantoins|Imidazoles|Imidazolidines|Urea
DB11102	N-acetyltyrosine	small molecule	approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins
DB11104	Sulfur hexafluoride	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Contrast Media|Electrolytes|Fluorides|Fluorine Compounds|Gases|Hydrofluoric Acid|Ions|Other Diagnostics|Sulfur Compounds|Ultrasound Contrast Activity|Ultrasound Contrast Media
DB11105	Benzalkonium	small molecule	approved|investigational	Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzylammonium Compounds|Dermatologicals|Detergents|Household Products|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical|Quaternary Ammonium Compounds|Surface-Active Agents|Throat Preparations
DB11107	Potassium bitartrate	small molecule	experimental	Potassium Salt|Radiographic Contrast Agent
DB11108	Aluminum sesquichlorohydrate	small molecule	approved	Acids|Acids, Noncarboxylic|Alkalies|Aluminium Compounds|Anions|Chlorine Compounds|Electrolytes|Hydrochloric Acid|Hydroxides|Ions
DB11109	Chlorine	small molecule	approved	Elements|Gases|Halogens|Noxae|Poisons|Toxic Actions
DB11110	Magnesium citrate	small molecule	approved	Acids, Acyclic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Calculi Dissolution Agent|Citrates|Drugs for Constipation|Gastrointestinal Agents|Irrigating Solutions|Laxatives|Laxatives, magnesium containing|Magnesium Compounds|Mineral Supplements|Osmotic Laxative|Salt Solutions|Tricarboxylic Acids
DB11111	Witch hazel	biotech	nutraceutical	
DB11112	Lanolin	small molecule	approved	Basic Ointments and Protectants|Cosmetics|Household Products|Lipids|Waxes
DB11113	Castor oil	small molecule	approved|investigational|nutraceutical|vet_approved	Alimentary Tract and Metabolism|Biological Products|Complex Mixtures|Contact Laxatives|Drugs for Constipation|Fats|Fats, Unsaturated|Gastrointestinal Agents|Laxatives|Lipids|Oils|Plant Oils|Plant Preparations
DB11114	Eucalyptus oil	small molecule	approved	Other Cold and Cough Preparations
DB11115	Ensulizole	small molecule	approved	Acids|Acids, Noncarboxylic|Sulfur Acids|Sulfur Compounds|Sunscreen Agents
DB11116	Aluminum zirconium trichlorohydrex gly	small molecule	approved|experimental	
DB11117	Undecylenic acid	small molecule	approved|investigational	Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Lipids
DB11118	Ammonia	small molecule	approved	Gases|Nitrogen Compounds
DB11119	Sodium iodide	small molecule	approved	Anions|Electrolytes|Iodides|Iodine Compounds|Ions|Laxatives|Osmotic Laxative|Replacement Preparations|Sodium Compounds|Thyroid Diagnostic Radiopharmaceuticals
DB11120	Turpentine	small molecule	approved|experimental	Biological Products|Biomedical and Dental Materials|Biopolymers|Complex Mixtures|Irritants|Lipids|Macromolecular Substances|Noxae|Oils|Oils, Volatile|Plant Exudates|Polymers|Resins, Plant|Solvents|Toxic Actions
DB11121	Chloroxylenol	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Agents|Antiplatyhelmintic Agents|Antiseptics and Disinfectants|Benzene Derivatives|Chlorobenzenes|Dermatologicals|Disinfectants|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Miscellaneous Local Anti-infectives|Phenol and Derivatives|Phenols|Schistosomicides
DB11123	Hypochlorite	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Antiseptics and Disinfectants|Chlorine Compounds|Dermatologicals|Disinfectants|Electrolytes|Free Radicals|Hypochlorous Acid|Ions|Miscellaneous Local Anti-infectives|Noxae|Oxidants|Oxides|Oxygen Compounds|Reactive Oxygen Species|Sodium Compounds|Toxic Actions
DB11124	Racepinephrine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-1 Receptor Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alpha-and Beta-adrenergic Agonists|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Cardiovascular Agents|Catecholamines|Epinephrine|Ethanolamines|Mydriatics|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Sympathomimetics|Vasoconstrictor Agents
DB11125	Benzethonium	small molecule	approved	Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzylammonium Compounds|Dermatologicals|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Throat Preparations
DB11126	Calcium gluconate	small molecule	approved|vet_approved	Acids, Acyclic|Alimentary Tract and Metabolism|Blood Coagulation Factors|Calcium Salts|Carbohydrates|Dermatologicals|Gluconates|Hydroxy Acids|Mineral Supplements|Minerals|Phosphate Binder|Replacement Preparations|Sugar Acids
DB11127	Selenious acid	small molecule	approved|investigational	Alimentary Tract and Metabolism|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Mineral Supplements|Minerals|Physiological Phenomena|Replacement Preparations|Selenious Acid|Selenium|Selenium Compounds|Sodium Compounds|Trace Elements
DB11128	Ammonium molybdate	small molecule	approved	Coloring Agents|Elements|Metals|Metals, Heavy|Transition Elements
DB11129	Carbamide peroxide	small molecule	approved	Anions|Bleaching Agents|Electrolytes|Free Radicals|Ions|Noxae|Oxidants|Oxides|Oxygen Compounds|Reactive Oxygen Species|Tooth Bleaching Agents|Toxic Actions
DB11130	Opium	small molecule	approved|illicit	Alimentary Tract and Metabolism|Analgesics|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Antitussive Agents|Biological Products|Central Nervous System Agents|Central Nervous System Depressants|Complex Mixtures|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Gastrointestinal Agents|Narcotics|Natural Opium Alkaloids|Nervous System|Opiate Agonists|Opioids|Peripheral Nervous System Agents|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB11131	Capsicum oleoresin	biotech	approved	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Preparations
DB11132	Silicon dioxide	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Colloids|Complex Mixtures|Dental Casting Investment|Electrolytes|Hygroscopic Agents|Investigative Techniques|Ions|Minerals|Oxides|Oxygen Compounds|Pharmaceutical Preparations|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB11133	Omega-3 fatty acids	small molecule	approved|nutraceutical	Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Lipids|Membrane Lipids|Oils|Physiological Phenomena
DB11134	Cupric oxide	small molecule	approved	Copper-containing Intrauterine Device|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Trace Elements|Transition Elements
DB11135	Selenium	small molecule	approved|investigational|vet_approved	Alimentary Tract and Metabolism|Antioxidants|Chalcogens|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Micronutrients|Mineral Supplements|Minerals|Physiological Phenomena|Protective Agents|Selenium|Trace Elements
DB11136	Chromium	small molecule	approved	Cell-mediated Immunity|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Increased Histamine Release|Metals|Metals, Heavy|Micronutrients|Minerals|Physiological Phenomena|Standardized Chemical Allergen|Trace Elements|Transition Elements
DB11137	Molybdenum	small molecule	approved	Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Trace Elements|Transition Elements
DB11140	Chromium Cr-51	small molecule	approved	
DB11141	Manganese gluconate	small molecule	approved	Acids, Acyclic|Carbohydrates|Hydroxy Acids|Paramagnetic Contrast Agent|Sugar Acids
DB11142	Selenomethionine	small molecule	approved|investigational	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Methionine|Organoselenium Compounds|Sulfur Compounds
DB11143	Cresol	small molecule	approved	Benzene Derivatives|Phenols|Standardized Chemical Allergen
DB11145	Oxyquinoline	small molecule	approved|vet_approved	Alimentary Tract and Metabolism|Anti-Infective Agents, Local|Antiinfectives and Antiseptics for Local Oral Treatment|Antiseptics and Disinfectants|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hydroxyquinolines|Quinoline Derivatives|Quinolines|Stomatological Preparations|Throat Preparations
DB11147	Aluminum zirconium pentachlorohydrate	small molecule	approved	
DB11148	Butamben	small molecule	approved|withdrawn	Acids, Carbocyclic|Aminobenzoates|Anesthetics|Anesthetics, Local|Benzene Derivatives|Benzoates|Central Nervous System Agents|Cholinesterase substrates|para-Aminobenzoates|Peripheral Nervous System Agents|Sensory System Agents
DB11149	Aluminum zirconium tetrachlorohydrex gly	small molecule	approved	
DB11150	Barium sulfate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Barium Compounds|Barium Sulfate Containing X-Ray Contrast Media|Contrast Media|Diagnostic Uses of Chemicals|Electrolytes|Ions|Radiographic Contrast Agent|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids|X-Ray Contrast Activity|X-Ray Contrast Media, Non-Iodinated
DB11151	Sodium hydroxide	small molecule	approved	Alkalies|Anions|Caustics|Electrolytes|Hydroxides|Ions|Noxae|Sodium Compounds|Toxic Actions
DB11152	Trichloroacetate	small molecule	approved	Acetates|Acids, Acyclic|Caustics|Chloroacetates|Fatty Acids|Fatty Acids, Volatile|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Lipids|Noxae|Toxic Actions
DB11153	Potassium hydroxide	small molecule	approved	Alkalies|Anions|Electrolytes|Indicators and Reagents|Ions|Laboratory Chemicals|Laxatives|Osmotic Laxative|Potassium Salt
DB11154	Zinc citrate	small molecule	approved	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anticoagulants|Calculi Dissolution Agent|Copper Absorption Inhibitor|Vasoprotectives|Zinc Compounds
DB11155	Triclocarban	small molecule	approved	Amides|Anilides|Anti-Infective Agents|Anti-Infective Agents, Local|Benzene Derivatives|Environmental Pollutants|Miscellaneous Local Anti-infectives|Phenylurea Compounds|Toxic Actions|Urea|Water Pollutants|Water Pollutants, Chemical
DB11156	Pyrantel	small molecule	approved|vet_approved	Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Central Nervous System Depressants|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Depolarizing Agents|Peripheral Nervous System Agents|Pyrantel|Pyrimidines|Sulfur Compounds|Tetrahydropyrimidine Derivatives|Thiophenes
DB11157	Anthralin	small molecule	approved	Anthracenes|Antipsoriatics|Antipsoriatics for Topical Use|Antracen Derivatives|Dermatologicals
DB11158	Pectin	small molecule	approved|investigational|vet_approved	Alimentary Tract and Metabolism|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Biological Products|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Complex Mixtures|Gastrointestinal Agents|Intestinal Adsorbents|Macromolecular Substances|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Polymers|Polysaccharides
DB11159	Sodium sulfide	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Saccharomyces cerevisiae|Sulfur Compounds
DB11160	Phenyltoloxamine	small molecule	approved	Benzene Derivatives
DB11161	Polyethylene glycol 300	small molecule	approved	Alcohols|Biomedical and Dental Materials|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers
DB11164	Bicisate	small molecule	approved|investigational	
DB11165	Rosin	small molecule	approved	Biological Products|Biomedical and Dental Materials|Biopolymers|Cell-mediated Immunity|Complex Mixtures|Increased Histamine Release|Macromolecular Substances|Pinus|Plant Exudates|Polymers|Standardized Chemical Allergen|Tars
DB11166	Antithrombin Alfa	biotech	approved|investigational	Anticoagulants|Decreased Coagulation Factor Activity|Factor Xa Inhibitors|Recombinant Antithrombin|Thrombin Inhibitors
DB11168	Calcium threonate	small molecule	approved	Acids, Acyclic|Blood Coagulation Factors|Fatty Acids|Fatty Acids, Volatile|Lipids
DB11169	Ferrous asparto glycinate	small molecule	approved	
DB11171	Ferric sulfate	small molecule	approved	Hematinics|Iron Compounds|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder
DB11172	Sesame oil	small molecule	approved|investigational|nutraceutical	Biological Products|Complex Mixtures|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Food|Food and Beverages|Lipids|Oils|Physiological Phenomena|Plant Oils|Plant Preparations
DB11174	2-(l-menthoxy)ethanol	small molecule	experimental	
DB11175	Zinc picolinate	small molecule	approved|investigational	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Copper Absorption Inhibitor|Iron Chelating Agents|Pyridines|Sequestering Agents|Vasoprotectives|Zinc Compounds
DB11176	Zeaxanthin	small molecule	approved|investigational	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes|Xanthophylls
DB11178	Polysorbate 20	small molecule	approved	Alcohols|Biomedical and Dental Materials|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents
DB11179	Exametazime	small molecule	approved	Ketones
DB11180	Tetrofosmin	small molecule	approved	
DB11181	Homatropine	small molecule	approved	Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Muscarinic Agonists|Muscarinic Antagonists|Mydriatics and Cycloplegics|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|Sensory Organs
DB11182	Rose bengal free acid	small molecule	approved|investigational	Colouring Agents|Diagnostic Agents|Ophthalmologicals|Other Diagnostics|Sensory Organs
DB11183	Light green SF yellowish	small molecule	approved|experimental	Acids|Acids, Noncarboxylic|Amines|Ammonium Compounds|Arylsulfonates|Arylsulfonic Acids|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB11184	Oftasceine	small molecule	approved	
DB11185	Sulisobenzone	small molecule	approved	Benzene Derivatives|Benzhydryl Compounds|Ketones|Sunscreening Agents
DB11186	Pentoxyverine	small molecule	approved|investigational	Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Cycloparaffins|Respiratory System Agents
DB11189	Magnesium glycinate	small molecule	approved	Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Laxatives|Osmotic Laxative
DB11190	Pantethine	small molecule	approved|investigational	Alimentary Tract and Metabolism|Sulfhydryl Compounds|Sulfur Compounds|Vitamin B Complex|Vitamins
DB11191	Cobamamide	small molecule	approved	Antianemic Preparations|Blood and Blood Forming Organs|Coenzymes|Corrinoids|Enzymes and Coenzymes|Vitamin B Complex|VITAMIN B12 AND FOLIC ACID|Vitamins
DB11193	Papain	small molecule	approved	Cysteine Endopeptidases|Cysteine Proteases|Endopeptidases|Enzymes|Enzymes and Coenzymes|Gastrointestinal Agents|Hydrolases|Peptide Hydrolases
DB11195	Xylitol	small molecule	experimental|investigational	Alcohols|Carbohydrates|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Physiological Phenomena|Sugar Alcohols|Sweetening Agents
DB11197	Ferrous cysteine glycinate	small molecule	approved	
DB11198	Peppermint oil	small molecule	approved|investigational	Antiemetics|Antifoaming Agents|Autonomic Agents|Biological Products|Central Nervous System Agents|Complex Mixtures|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Gastrointestinal Agents|Herbs and Natural Products|Lipids|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Oils|Oils, Volatile|Parasympatholytics|Peripheral Nervous System Agents|Plant Preparations
DB11199	Sage oil	small molecule	approved|nutraceutical	Agents that reduce seizure threshold|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB11200	Aluminum zirconium octachlorohydrex gly	small molecule	approved	
DB11201	Menthyl salicylate	small molecule	approved	
DB11202	N-alkyl ethylbenzyl dimethyl ammonium (C12-C14)	small molecule	approved	
DB11203	Boron	small molecule	approved	Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metalloids|Micronutrients|Physiological Phenomena|Trace Elements
DB11204	Panthenol	small molecule	approved	
DB11205	Alcloxa	small molecule	approved	
DB11206	Bemotrizinol	small molecule	approved	Benzene Derivatives|Sunscreening Agents
DB11207	Amiloxate	small molecule	approved	Acids, Carbocyclic
DB11208	Aluminum chlorohydrex propylene glycol	small molecule	approved	
DB11209	Iron protein succinylate	small molecule	approved|investigational	Acids, Acyclic|Amino Acids, Peptides, and Proteins|Anemia, Hypochromic, drug therapy|Beverages|Bodily Secretions|Dairy Products|Dicarboxylic Acids|Diet, Food, and Nutrition|Dietary Proteins|Ferric Compounds|Fluids and Secretions|Food|Food and Beverages|Hematinics|Hematologic Agents|Iron|Milk components|Physiological Phenomena|Proteins
DB11210	Ferrous bisglycinate	small molecule	approved	Amino Acids|Amino Acids, Peptides, and Proteins|Iron Compounds|Organometallic Compounds
DB11217	Arbutin	small molecule	approved	Carbohydrates|Glucosides|Glycosides
DB11218	Tea tree oil	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Biological Products|Complex Mixtures|Lipids|Miscellaneous Local Anti-infectives|Oils|Oils, Volatile|Plant Oils|Plant Preparations
DB11219	Enzacamene	small molecule	approved	Bornanes|Ketones|Monoterpenes|Norbornanes|Sunscreen Agents|Sunscreening Agents|Terpenes
DB11220	Octacosanol	small molecule	nutraceutical	Alcohols|Lipids
DB11221	Dioxybenzone	small molecule	approved	Benzene Derivatives|Benzhydryl Compounds|Ketones|Sunscreening Agents
DB11222	Benzoin resin	biotech	approved	Angiosperms|Biological Products|Complex Mixtures|Embryophyta|Eukaryota|Miscellaneous Local Anti-infectives|Pharmaceutical Preparations|Plant Preparations|Plants|Streptophyta|Styracaceae|Viridiplantae
DB11223	Tolu balsam	small molecule	experimental	Biological Products|Biomedical and Dental Materials|Biopolymers|Complex Mixtures|Macromolecular Substances|Plant Exudates|Polymers|Resins, Plant|Standardized Chemical Allergen
DB11225	Peg-100 stearate	small molecule	approved	Pegylated agents
DB11226	Ethylhexyl methoxycrylene	small molecule	approved|experimental	
DB11228	Methylcellulose	small molecule	approved	Alimentary Tract and Metabolism|Biomedical and Dental Materials|Biopolymers|Bulk-Forming Laxatives|Carbohydrates|Cellulose|Drugs for Constipation|EENT Drugs, Miscellaneous|Glucans|Laxatives|Macromolecular Substances|Polymers|Polysaccharides
DB11229	Padimate A	small molecule	experimental|withdrawn	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates
DB11230	Magnesium Aluminum Silicate	small molecule	approved	Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Anions|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Pharmaceutic Aids|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB11231	Lycopene	small molecule	approved|investigational	Alkenes|Anticarcinogenic Agents|Antineoplastic Agents|Antioxidants|Biological Factors|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Protective Agents|Radiation-Protective Agents|Terpenes
DB11233	Silver citrate	small molecule	experimental	
DB11234	Poliglusam	small molecule	approved	Anticholesteremic Agents|Biocompatible Materials|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Chelating Agents|Chitin|Coagulants|Hematologic Agents|Hemostatics|Hypolipidemic Agents|Lipid Regulating Agents|Macromolecular Substances|Noxae|Polymers|Polysaccharides|Sequestering Agents|Toxic Actions
DB11235	Thonzylamine	small molecule	approved	Agents producing tachycardia|Antiallergic Agents, Excl. Corticosteroids|Anticholinergic Agents|Antihistamines for Systemic Use|Antihistamines for Topical Use|Antipruritics, Incl. Antihistamines, Anesthetics, Etc.|Dermatologicals|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Muscarinic Antagonists|Nasal Preparations|Neurotransmitter Agents|Substituted Ethylene Diamines
DB11237	Trypsin	small molecule	approved|vet_approved	Blood and Blood Forming Organs|Dermatologicals|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Musculo-Skeletal System|Peptide Hydrolases|Preparations for Treatment of Wounds and Ulcers|Serine Endopeptidases|Serine Proteases
DB11238	Borage oil	small molecule	approved|investigational	Agents that reduce seizure threshold|Biological Products|Complex Mixtures|Dietary Fats, Unsaturated|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Linolenic Acids|Lipids|Oils|Plant Preparations
DB11239	Aluminum sulfate	small molecule	approved	Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Aluminium Compounds|Anions|Electrolytes|Immunologic Factors|Ions|Laxatives|Osmotic Laxative|Sulfates|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB11242	Gelatin	small molecule	approved|vet_approved	Amino Acids, Peptides, and Proteins|Proteins|Scleroproteins
DB11243	Ethyl macadamiate	small molecule	approved	
DB11244	Cyclomethicone 5	small molecule	approved	
DB11246	Copper gluconate	small molecule	approved|investigational	Acids, Acyclic|Carbohydrates|Copper-containing Intrauterine Device|Hydroxy Acids|Sugar Acids
DB11247	Sambucus nigra flowering top	biotech	experimental	
DB11248	Zinc gluconate	small molecule	approved|vet_approved	Acids, Acyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Carbohydrates|Copper Absorption Inhibitor|Hydroxy Acids|Mineral Supplements|Sugar Acids|Vasoprotectives|Zinc Compounds
DB11250	Glyceryl monostearate	small molecule	experimental	Lipids
DB11251	Tocopherol	small molecule	approved|investigational	Alimentary Tract and Metabolism|Antioxidants|Benzopyrans|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB11252	Poloxamer 407	small molecule	approved|investigational	Alcohols|Biomedical and Dental Materials|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents
DB11253	Xanthan gum	small molecule	approved	Antigens|Antigens, Bacterial|Biological Factors|Carbohydrates|Diet, Food, and Nutrition|Drug Carriers|Food|Food Additives|Food and Beverages|Physiological Phenomena|Polysaccharides
DB11254	Hexylresorcinol	small molecule	approved	Anthelmintics|Anti-Infective Agents|Anti-Infective Agents, Local|Antiparasitic Agents|Benzene Derivatives|Miscellaneous Anti-infectives|Phenols|Resorcinols|Throat Preparations
DB11255	Chromium picolinate	small molecule	approved	Iron Chelating Agents|Pyridines|Sequestering Agents|Standardized Chemical Allergen
DB11256	Levomefolic acid	small molecule	approved|investigational	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Folic Acid and Derivatives|Vitamin B Complex|Vitamins
DB11257	Fluoride ion	small molecule	approved	
DB11259	Diosmetin	small molecule	experimental	Benzopyrans|Chromones|Pyrans
DB11260	Diacetyl benzoyl lathyrol	small molecule	approved	
DB11261	Atractylodes japonica root	small molecule	approved	
DB11262	Bisoctrizole	small molecule	approved	
DB11263	Polydatin	small molecule	approved	Benzene Derivatives|Benzylidene Compounds|Carbohydrates|Drugs, Chinese Herbal|Glycosides
DB11264	Calcium glycerophosphate	small molecule	approved	Carbohydrates|Lipids|Membrane Lipids|Phospholipids|Sugar Phosphates
DB11265	Curcuma xanthorrhiza oil	biotech	nutraceutical	
DB11266	Sea salt	small molecule	approved	
DB11267	Triethoxycaprylylsilane	small molecule	experimental	Naphthalenes|Organosilicon Compounds|Quinones|Silicon Compounds
DB11268	Protocatechualdehyde	small molecule	approved	Aldehydes|Anticoagulants|Benzene Derivatives|Hematologic Agents|Phenols
DB11269	Diethylamino hydroxybenzoyl hexyl benzoate	small molecule	approved	Amines|Aniline Compounds|Benzene Derivatives|Benzhydryl Compounds|Ketones|Phenols
DB11270	Atractylodes japonica root oil	small molecule	approved	
DB11271	Polysilicone-15	small molecule	approved	
DB11272	Methyl undecenoyl leucinate	small molecule	approved	
DB11273	Dihydroergocornine	small molecule	approved	Agents that produce hypertension|Alkaloids|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Neurotransmitter Agents
DB11274	Dihydro-alpha-ergocryptine	small molecule	approved	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates
DB11275	Epicriptine	small molecule	approved	Alkaloids
DB11276	Pine needle oil (pinus mugo)	small molecule	approved|experimental	
DB11277	Aluminum zirconium pentachlorohydrex gly	small molecule	approved	
DB11278	DL-Methylephedrine	small molecule	approved	Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension
DB11279	Brilliant green cation	small molecule	approved|vet_approved	Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Coloring Agents|Nitrogen Compounds|Onium Compounds
DB11282	Diethyltoluamide	small molecule	approved	Acids, Carbocyclic|Agrochemicals|Amides|Antiparasitic Products, Insecticides and Repellents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insect Repellents|Insecticides and Repellents|Pesticides|Protective Agents|Toxic Actions
DB11283	DL-dimyristoylphosphatidylcholine	small molecule	approved	Carbohydrates|Glycerophosphates|Glycerophospholipids|Indicators and Reagents|Laboratory Chemicals|Lipids|Membrane Lipids|Phosphatidic Acids|Phosphatidylcholines|Phospholipids|Sugar Phosphates
DB11284	DL-dimyristoylphosphatidylglycerol	small molecule	approved	Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Phosphates
DB11286	Colloidal oatmeal	biotech	approved|nutraceutical	Allergens|Cell-mediated Immunity|Dietary Proteins|Grain Proteins|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract|Plant Proteins
DB11288	Borneol	small molecule	experimental	Monoterpenes|Norbornanes|Perfume|Terpenes
DB11293	Rice bran oil	small molecule	approved	Anticholesteremic Agents|Biological Products|Complex Mixtures|Dietary Fats, Unsaturated|Hypolipidemic Agents|Lipid Regulating Agents|Lipids|Noxae|Oils|Plant Preparations|Toxic Actions
DB11294	Coccidioides immitis spherule	biotech	approved	Cell-mediated Immunity|Skin Test Antigen
DB11295	Trichophyton verrucosum	small molecule	approved	
DB11296	Prezatide	small molecule	experimental	Amino Acids, Peptides, and Proteins|Growth Substances|Peptides
DB11298	Thioredoxin	small molecule	approved	Amino Acids, Peptides, and Proteins|Proteins
DB11299	Vanillyl butyl ether	small molecule	approved	
DB11300	Thrombin	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Coagulants|Endopeptidases|Enzyme Precursors|Enzymes|Enzymes and Coenzymes|Hematologic Agents|Hemostatics|Hydrolases|Increased Coagulation Factor Activity|Local Hemostatics|Peptide Hydrolases|Proteins|Serine Endopeptidases|Serine Proteases
DB11301	Curcuma aromatica root oil	small molecule	approved	
DB11302	Hydrogenated soybean oil	small molecule	approved	
DB11304	Phenoxyethanol	small molecule	approved	Alcohols|Anesthetics|Anti-Infective Agents|Anti-Infective Agents, Local|Central Nervous System Agents|Glycols
DB11305	Quaternium-18	small molecule	experimental	
DB11311	Prothrombin	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Enzyme Precursors|Enzymes and Coenzymes|Increased Coagulation Activity|Proteins
DB11312	Protein C	biotech	approved	Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factor Inhibitors|Blood Proteins|Carbohydrates|Cardiovascular Agents|Decreased Coagulation Factor Activity|Enzyme Precursors|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Glycoconjugates|Glycoproteins|Hematologic Agents|Proteins
DB11315	Methscopolamine	small molecule	approved	Agents producing tachycardia|Alimentary Tract and Metabolism|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds|Belladonna and Derivatives, Plain|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Mydriatics and Cycloplegics|Ophthalmologicals|Parasympatholytics|Peripheral Nervous System Agents|Scopolamine Derivatives|Sensory Organs|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Tropanes
DB11318	1,2-Docosahexanoyl-sn-glycero-3-phosphoserine	small molecule	experimental	
DB11321	Cod liver oil	small molecule	nutraceutical|vet_approved	Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Fats|Fats, Unsaturated|Fish Oils|Food|Food and Beverages|Growth Substances|Lipids|Micronutrients|Oils|Physiological Phenomena
DB11323	Glycol salicylate	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Hydroxy Acids|Hydroxybenzoates|Phenols
DB11324	Nonivamide	small molecule	investigational	Acids, Carbocyclic|Alkaloids|Alkenes|Alkynes|Amides|Benzene Derivatives|Benzoates|Catechols|Ethers|Fatty Acids|Fatty Acids, Monounsaturated|Fatty Acids, Unsaturated|Hydrocarbons, Acyclic|Hydroxy Acids|Hydroxybenzoate Ethers|Hydroxybenzoates|Lipids|Nitric Oxide Synthase, antagonists & inhibitors|Peripheral Nervous System Agents|Phenols|Phenyl Ethers|Polyunsaturated Alkamides|Sensory System Agents|Solanaceous Alkaloids
DB11326	Boric acid	small molecule	approved	Acids|Acids, Noncarboxylic|Agrochemicals|Anti-Infective Agents|Boron Compounds|Insecticides|Otologicals|Pesticides|Sensory Organs|Toxic Actions
DB11327	Dipyrithione	small molecule	approved	
DB11328	Tetradecyl hydrogen sulfate (ester)	small molecule	approved	
DB11329	C11-12 isoparaffin	small molecule	approved	
DB11330	Factor IX Complex (Human)	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Proteins
DB11331	1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))	small molecule	approved	
DB11332	Sinapultide	small molecule	approved	Amino Acids, Peptides, and Proteins|Pulmonary Surfactants
DB11333	Poloxamer 188	small molecule	approved|investigational	Alcohols|Biomedical and Dental Materials|Drug Delivery Systems|Ethylene Glycols|Excipients|Glycols|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polyethylene Glycols|Polymers|Surface-Active Agents
DB11336	Kinetin	small molecule	approved	Cytokinins|Growth Substances|Plant Growth Regulators|Purines
DB11337	Zeatin	small molecule	experimental	Cytokinins|Growth Substances|Plant Growth Regulators|Purines
DB11338	Clove oil	biotech	approved|nutraceutical	Biological Products|Complex Mixtures|Lipids|Oils|Plant Oils|Plant Preparations
DB11340	Ubiquinol	small molecule	approved|investigational	Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones
DB11341	Ichthammol	small molecule	approved	Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds
DB11342	Aluminum oxide	small molecule	approved	Aluminium Compounds|Anions|Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Dermatologicals|Electrolytes|Ions|Oxides|Oxygen Compounds
DB11343	Silanol	small molecule	approved	Organosilicon Compounds|Silicon Compounds
DB11344	(+)-menthol	small molecule	experimental	
DB11345	(S)-camphor	small molecule	experimental	
DB11346	Rubidium	small molecule	approved|investigational	Elements|Metals|Metals, Alkali|Metals, Heavy
DB11348	Calcium Phosphate	small molecule	approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Biocompatible Materials|Biomedical and Dental Materials|Blood Coagulation Factors|Calcium Compounds|Calcium Salts|Ceramics|Electrolytes|Ions|Mineral Supplements|Phosphate Binder|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB11349	Cetyl ethylhexanoate	small molecule	approved	
DB11350	Cocamidopropyl betaine	small molecule	approved	Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds|Quaternary Ammonium Compounds|Surface-Active Agents|Trimethyl Ammonium Compounds
DB11352	Ascorbyl phosphate	small molecule	approved	Vitamin C and analogues|Vitamins
DB11355	Propolis wax	small molecule	approved	
DB11356	Polyquaternium-10 (400 cps at 2%)	small molecule	approved	
DB11357	Linseed oil	small molecule	approved|investigational	Biological Products|Complex Mixtures|Fats|Fats, Unsaturated|Lipids|Oils|Plant Oils|Plant Preparations
DB11358	Evening primrose oil	small molecule	investigational|nutraceutical	Agents that reduce seizure threshold|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Biological Products|Central Nervous System Agents|Complex Mixtures|Dermatologicals|Dietary Fats, Unsaturated|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Hypolipidemic Agents|Linolenic Acids|Lipid Regulating Agents|Lipids|Noxae|Oenothera biennis|Oils|Peripheral Nervous System Agents|Plant Preparations|Sensory System Agents|Toxic Actions
DB11359	Guaiacol	small molecule	approved	Benzene Derivatives|Catechols|Ethers|Methyl Ethers|Phenols|Phenyl Ethers
DB11360	Lactobacillus plantarum	small molecule	approved|investigational	
DB11361	Betula pendula tar oil	small molecule	nutraceutical	
DB11362	Selexipag	small molecule	approved	Acetates|Acids, Acyclic|Amides|Antihypertensive Agents|Blood and Blood Forming Organs|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates|Platelet Aggregation Inhibitors Excl. Heparin|Prodrugs|Prostacyclin Receptor Agonist|Prostacyclin Receptor Agonists|Receptors, Prostaglandin, agonists|Vasodilating Agents
DB11363	Alectinib	small molecule	approved|investigational	Antineoplastic Agents|BCRP/ABCG2 Inhibitors|Indoles|Kinase Inhibitor|Kinase Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Protein Kinase Inhibitors|Tyrosine Kinase Inhibitors
DB11364	Pidotimod	small molecule	experimental	Acids, Acyclic|Adjuvants, Immunologic|Amino Acids|Amino Acids, Acidic|Amino Acids, Cyclic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Glutamates|Imines|Imino Acids|Immunologic Factors|Pyrrolidines|Pyrrolidinones|Sulfur Compounds|Thiazoles
DB11365	Sennosides	small molecule	approved	Alimentary Tract and Metabolism|Anthracenes|Anthraquinones|Biological Products|Complex Mixtures|Contact Laxatives|Drugs for Constipation|Gastrointestinal Agents|Herbs and Natural Products|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations|Quinones
DB11366	Roquinimex	small molecule	investigational	Adjuvants, Immunologic|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Growth Inhibitors|Growth Substances|Immunologic Factors|Quinolines
DB11367	Cefroxadine	small molecule	withdrawn	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalexin|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB11368	Chlorophetanol	small molecule	experimental	Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals
DB11371	Alfaxalone	small molecule	vet_approved	Anesthetics|Anesthetics, General|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Pregnanes|Steroids
DB11372	Altrenogest	small molecule	vet_approved	Adrenal Cortex Hormones|Estranes|Estrenes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Progesterone Congeners|Progestins|Steroids
DB11376	Azaperone	small molecule	investigational|vet_approved	Antipsychotic Agents|Antipsychotic Agents (First Generation [Typical])|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Hypnotics and Sedatives|Ketones|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents
DB11386	Chlorobutanol	small molecule	approved|investigational|vet_approved	Alcohols|Alimentary Tract and Metabolism|Antiemetics and Antinauseants|Butanols|Chlorohydrins|Fatty Alcohols|Lipids|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical
DB11390	Coumaphos	small molecule	vet_approved	Agrochemicals|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Benzopyrans|Cholinergic Agents|Cholinesterase Inhibitors|Coumarins|Enzyme Inhibitors|Insecticides|Narrow Therapeutic Index Drugs|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|Pyrans|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions|Umbelliferones
DB11395	Deracoxib	small molecule	vet_approved	Amides|Sulfones|Sulfur Compounds
DB11397	Dichlorvos	small molecule	vet_approved	Agrochemicals|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphates|Organophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Toxic Actions
DB11398	Diclazuril	small molecule	investigational|vet_approved	Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Coccidiostats
DB11403	Emodepside	small molecule	investigational|vet_approved	Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic
DB11408	Famphur	small molecule	vet_approved	Agrochemicals|Insecticides|Organophosphates|Organophosphorus Compounds|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions
DB11411	Fenprostalene	small molecule	vet_approved	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins, Synthetic|Reproductive Control Agents
DB11421	Imidacloprid	small molecule	vet_approved	Agrochemicals|Cholinergic Agents|Insecticides|Neurotransmitter Agents|Pesticides|Toxic Actions
DB11427	Maropitant	small molecule	vet_approved	Benzene Derivatives
DB11429	Mibolerone	small molecule	vet_approved	Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB11431	Moxidectin	small molecule	investigational|vet_approved	Agrochemicals|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|BCRP/ABCG2 Substrates|Insecticides|Lactones|P-glycoprotein/ABCB1 Substrates|Pesticides|Polyketides|Toxic Actions
DB11437	Nitarsone	small molecule	vet_approved	Organometallic Compounds
DB11440	Norgestomet	small molecule	vet_approved	Pregnanes|Pregnenes|Progesterone Congeners|Steroids
DB11446	Oxfendazole	small molecule	investigational|vet_approved	Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Benzimidazoles|Carbamates|Sulfur Compounds
DB11448	Phosmet	small molecule	vet_approved	Acids, Carbocyclic|Agrochemicals|Imides|Insecticides|Isoindoles|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Phthalic Acids|Phthalimides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions
DB11450	Pimobendan	small molecule	vet_approved	Cardiotonic Agents|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Enzyme Inhibitors|Phosphodiesterase Inhibitors|Protective Agents|Vasodilating Agents
DB11451	Poloxalene	small molecule	investigational|vet_approved	Alcohols|Anti-Infective Agents|Biomedical and Dental Materials|Disinfectants|Ethylene Glycols|Gastrointestinal Agents|Glycols|Macromolecular Substances|Polyethylene Glycols|Polymers|Surface-Active Agents
DB11454	Prostalene	small molecule	vet_approved	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins F, Synthetic|Prostaglandins, Synthetic
DB11455	Robenacoxib	small molecule	experimental|vet_approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amines|Aniline Compounds|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Nephrotoxic agents|Selective Cyclooxygenase 2 Inhibitors (NSAIDs)
DB11457	Rotenone	small molecule	vet_approved	Agrochemicals|Benzopyrans|Chromones|Enzyme Inhibitors|Flavonoids|Insecticides|Isoflavones|Pesticides|Pyrans|Toxic Actions|Uncoupling Agents
DB11458	Roxarsone	small molecule	vet_approved	Anti-Bacterial Agents|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Arsenicals|Coccidiostats|Organometallic Compounds
DB11460	Squalene	small molecule	vet_approved	Alkenes|Hydrocarbons, Acyclic|Polyenes|Terpenes|Triterpenes
DB11461	Sulfachlorpyridazine	small molecule	vet_approved	Amides|Amines|Aniline Compounds|Anti-Infective Agents|Anti-Infective Agents, Urinary|Renal Agents|Sulfanilamides|Sulfonamides|Sulfones|Sulfur Compounds
DB11466	Tepoxalin	small molecule	vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Immunologic Factors|Immunosuppressive Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents
DB11468	Tiamulin	small molecule	vet_approved	Anti-Bacterial Agents|Anti-Infective Agents|Terpenes
DB11471	Tilmicosin	small molecule	investigational|vet_approved	Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides
DB11473	Metrifonate	small molecule	vet_approved	Agrochemicals|Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antitrematodals|Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Insecticides|Neurotransmitter Agents|Organophosphonates|Organophosphorous Compounds|Organophosphorus Compounds|Pesticides|Toxic Actions
DB11475	Tylosin	small molecule	vet_approved	Anti-Bacterial Agents|Anti-Infective Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides
DB11477	Xylazine	small molecule	vet_approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-2 Receptor Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Neuromuscular Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Thiazines
DB11479	Zilpaterol	small molecule	vet_approved	Organosilicon Compounds|Receptors, Adrenergic, beta
DB11481	Atipamezole	small molecule	investigational|vet_approved	Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Neurotransmitter Agents
DB11482	Balsam of Peru	small molecule	nutraceutical|vet_approved	Biological Products|Biomedical and Dental Materials|Biopolymers|Cell-mediated Immunity|Complex Mixtures|Increased Histamine Release|Macromolecular Substances|Plant Exudates|Polymers|Resins, Plant|Standardized Chemical Allergen
DB11487	Dexamethasone isonicotinate	small molecule	vet_approved	Adrenal Cortex Hormones|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Dexamethasone|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB11490	Nalorphine	small molecule	experimental|vet_approved	Alkaloids|Antidotes|Central Nervous System Agents|Morphinans|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Semi-synthetic Opioids|Sensory System Agents
DB11491	Sarafloxacin	small molecule	vet_approved|withdrawn	Anti-Bacterial Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones
DB11495	(S)-methoprene	small molecule	vet_approved	
DB11510	Deslorelin	small molecule	investigational|vet_approved	Adrenal Cortex Hormones|Alcohol Dehydrogenase, antagonists & inhibitors|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Gonadotropin-releasing hormone agonist|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins
DB11512	Dihydrostreptomycin	small molecule	investigational|vet_approved	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Ophthalmologicals|Sensory Organs|Streptomycin
DB11518	Flunixin	small molecule	vet_approved	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antipyretics|Central Nervous System Agents|Nephrotoxic agents|Nicotinic Acids|Peripheral Nervous System Agents|Pyridines|Sensory System Agents|Veterinary Drugs
DB11521	Imidocarb	small molecule	vet_approved	Amides|Anilides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Benzene Derivatives|Carbanilides|Phenylurea Compounds|Urea
DB11522	Isoflupredone	small molecule	vet_approved	Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB11526	Masitinib	small molecule	investigational|vet_approved	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Protein Kinase Inhibitors|Sulfur Compounds
DB11529	Melengestrol	small molecule	vet_approved	Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Pregnadienes|Pregnanes|Steroids
DB11551	Trenbolone	small molecule	vet_approved	Anabolic Agents|Estranes|Estrenes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB11558	Toluene	small molecule	vet_approved	Benzene Derivatives|Solvents
DB11560	Lesinurad	small molecule	approved|investigational	Acetates|Acids, Acyclic|Antigout Preparations|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P450 3A Inducers|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Preparations Increasing Uric Acid Excretion|Renal Agents|Sulfhydryl Compounds|Sulfur Compounds|Urate Transporter 1 Inhibitor|Urate Transporter 1 Inhibitors|Uricosuric Agents
DB11561	Aminacrine	small molecule	experimental	Acridine Derivatives|Acridines|Aminoacridines|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Coloring Agents|Dermatologicals|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Mutagens|Noxae|Toxic Actions
DB11562	Bicuculline	small molecule	experimental	Alkaloids|Benzylisoquinolines|Central Nervous System Agents|Central Nervous System Stimulants|Convulsants|GABA Agents|GABA Antagonists|GABA-A Receptor Antagonists|Isoquinolines|Neurotransmitter Agents
DB11563	Sebelipase alfa	biotech	approved|investigational	Alimentary Tract and Metabolism|Carboxylic Ester Hydrolases|Cholesterol Ester Storage Disease, drug therapy|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme|Hydrolytic Lysosomal Triacylglycerol-specific Enzyme|Wolman Disease, drug therapy
DB11567	Insulin peglispro	biotech	investigational	Alcohols|Amino Acids, Peptides, and Proteins|Biomedical and Dental Materials|Blood Glucose Lowering Agents|Ethylene Glycols|Glycols|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Insulin|Macromolecular Substances|Pancreatic Hormones|Pegylated agents|Peptide Hormones|Peptides|Polymers
DB11568	Insulin tregopil	biotech	investigational	
DB11569	Ixekizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Interleukin-17A Antagonist|Interleukin-17A Antagonists|Misc. Skin and Mucous Membrane Agents|Proteins|Serum Globulins
DB11570	Padimate O	small molecule	approved	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Cosmetics|Dermatologicals|Household Products|Protective Agents|Radiation-Protective Agents|Sunscreen Agents|Sunscreening Agents
DB11571	Human Thrombin	biotech	approved	Blood Coagulation Factors|Increased Coagulation Factor Activity
DB11572	Thrombin Alfa	biotech	approved	Blood Coagulation Factors|Hemostatics|Increased Coagulation Factor Activity
DB11573	Aluminum chlorohydrate	small molecule	approved	Astringents and Deodorants|Dermatologicals|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Medicated Dressings|Medicated Dressings With Antiinfectives|Musculo-Skeletal System
DB11574	Elbasvir	small molecule	approved	Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hepatitis C Virus NS5A Inhibitor|P-glycoprotein/ABCB1 Substrates
DB11575	Grazoprevir	small molecule	approved	Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P450 3A Inhibitors|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates
DB11577	Indigotindisulfonic Acid	small molecule	approved	Coloring Agents|Diagnostic Agents|Indoles|Tests for Renal Function and Ureteral Injuries
DB11578	Hard fat	small molecule	approved	Pharmaceutical Vehicles|Suppositories
DB11579	Light Mineral Oil	small molecule	approved	Basic Ointments and Protectants
DB11580	Ravulizumab	biotech	investigational	
DB11581	Venetoclax	small molecule	approved|investigational	Amides|Antineoplastic Agents|BCL-2 Inhibitor|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Increased Cellular Death|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Sulfones|Sulfur Compounds
DB11582	Thiocolchicoside	small molecule	experimental	Alkaloids|Central Nervous System Depressants|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System
DB11583	Cetalkonium	small molecule	approved	Alcohols|Amines|Ammonium Compounds|Anti-Infective Agents|Anti-Infective Agents, Local|Lipids|Nitrogen Compounds|Onium Compounds|Surface-Active Agents
DB11584	Pipradrol	small molecule	approved	Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics
DB11585	Drometrizole trisiloxane	small molecule	approved	Biomedical and Dental Materials|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds
DB11586	Asunaprevir	small molecule	approved|investigational|withdrawn	Amides|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Cytochrome P-450 CYP2A6 Substrates|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Direct Acting Antivirals|HCV Protease Inhibitors|HIV Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Substrates|Protease Inhibitors|Sulfones|Sulfur Compounds
DB11587	Etafedrine	small molecule	approved	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Ethylamines|Phenethylamines|Propanolamines|Propanols
DB11588	Carbon monoxide	small molecule	approved|investigational	Anions|Carbon Compounds, Inorganic|Electrolytes|Gases|Gasotransmitters|Ions|Neurotransmitter Agents|Noxae|Oxides|Oxygen Compounds|Toxic Actions
DB11589	Neon	small molecule	approved|investigational	Elements|Gases|Noble Gases
DB11590	Thimerosal	small molecule	approved	Alkylmercury Compounds|Antiseptics and Disinfectants|Cell-mediated Immunity|Dermatologicals|Ethylmercury Compounds|Increased Histamine Release|Mercurial Products|Organomercury Compounds|Organometallic Compounds|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB11591	Bilastine	small molecule	approved|investigational	Antihistamines for Systemic Use|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB11592	Nitrocefin	small molecule	experimental	Amides|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Indicators and Reagents|Laboratory Chemicals|Lactams|Sulfur Compounds|Thiazines
DB11593	Isatoic anhydride	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|beta-Lactamase Inhibitors|Enzyme Inhibitors
DB11594	Domiphen	small molecule	approved|experimental	Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Antiinfectives and Antiseptics for Local Oral Treatment|Miscellaneous Anti-infectives|Miscellaneous Local Anti-infectives|Nitrogen Compounds|Onium Compounds|Stomatological Preparations
DB11595	Atezolizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Programmed Death Receptor-1 Blocking Antibody|Programmed Death Receptor-1-directed Antibody Interactions|Proteins|Serum Globulins
DB11596	Levoleucovorin	small molecule	approved|investigational	Antidotes|Biological Factors|Coenzymes|Detoxifying Agents for Antineoplastic Treatment|Diet, Food, and Nutrition|Enzymes and Coenzymes|Folic Acid|Folic Acid Analogues|Folic Acid and Derivatives|Food|Food and Beverages|Growth Substances|Leucovorin|Micronutrients|Physiological Phenomena|Pigments, Biological|Protective Agents|Pteridines|Pterins|Tetrahydrofolates|Vitamin B Complex|Vitamins
DB11597	Human Rho(D) immune globulin	biotech	approved|investigational	Endogenous Antigen Neutralization|Human Immunoglobulin G|Passively Acquired Immunity|Serum
DB11598	Antithrombin III human	biotech	approved	Alpha-Globulins|Amino Acids, Peptides, and Proteins|Anticoagulants|Antithrombin Proteins|Antithrombins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factor Inhibitors|Blood Proteins|Carbohydrates|Enzyme Inhibitors|Globulins|Glycosaminoglycans|Hematologic Agents|Oligosaccharides|Peptides|Polysaccharides|Proteins|Serine Proteinase Inhibitors|Serpins|Serum Globulins
DB11599	Starch, corn	small molecule	approved|nutraceutical	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Glucans|Macromolecular Substances|Polymers|Polysaccharides
DB11600	Beeswax	biotech	approved	Bees|Lipids
DB11601	Tuberculin Purified Protein Derivative	biotech	approved	Antigens|Antigens, Bacterial|Antihistamine Drugs|Biological Factors|Cell-mediated Immunity|Indicators and Reagents|Laboratory Chemicals|Skin Test Antigen|Tuberculosis|Tuberculosis Skin Test
DB11602	Hydroxyethyl cellulose	small molecule	approved	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Glucans|Macromolecular Substances|Ophthalmic Solutions|Polymers|Polysaccharides|Saliva, Artificial
DB11603	Human rabies virus immune globulin	biotech	approved	Rabies Vaccines|Serum|Vaccines
DB11604	Tetanus Immune Globulin	biotech	approved	Antiinfectives for Systemic Use|Immune Sera and Immunoglobulins|Immunoglobulins|Serum|Serum Globulins|Specific Immunoglobulins
DB11605	Myrrh	small molecule	approved	
DB11606	Susoctocog alfa	biotech	approved|investigational	Blood and Blood Forming Organs|Blood Coagulation Factors|Hemostatics
DB11607	Efmoroctocog alfa	biotech	approved|investigational	Hemostatics
DB11608	Eftrenonacog alfa	biotech	approved|investigational	Hemostatics
DB11609	Normethadone	small molecule	approved|illicit	Analgesics|Antitussive Agents|Central Nervous System Agents|Central Nervous System Depressants|Cough and Cold Preparations|Ketones|Narcotics|Opioids|Opium Alkaloids and Derivatives|Peripheral Nervous System Agents|Respiratory System Agents|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB11610	Oxilofrine	small molecule	approved	Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Ethanolamines|Ethylamines|Phenethylamines|Propanolamines|Propanols|Tyramine
DB11611	Lifitegrast	small molecule	approved	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Anti-inflammatory Agents, Miscellaneous|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lymphocyte Function-Associated Antigen-1|Lymphocyte Function-Associated Antigen-1 Antagonist|Lymphocyte Function-Associated Antigen-1 Antagonists|Sulfur Compounds
DB11613	Velpatasvir	small molecule	approved|investigational	Acids, Acyclic|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hepatitis C Virus NS5A Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|Organic Anion Transporting Polypeptide 2B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates
DB11614	Rupatadine	small molecule	approved	Antihistamines for Systemic Use|Benzocycloheptenes|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dibenzocycloheptenes|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Piperidines|Platelet Activating Factor, antagonists & inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB11616	Pirarubicin	small molecule	investigational	Anthracyclines|Anthracyclines and Related Substances|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Daunorubicin|Glycosides|Immunosuppressive Agents|Naphthacenes
DB11617	Aclarubicin	small molecule	investigational	Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Enzyme Inhibitors|Glycosides|Naphthacenes|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB11618	Zorubicin	small molecule	experimental	Anthracyclines|Anthracyclines and Related Substances|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Cytotoxic Antibiotics and Related Substances|Glycosides|Naphthacenes
DB11619	Gestrinone	small molecule	approved	Adrenal Cortex Hormones|Antigonadotropins and Similar Agents|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norgestrienone|Norpregnanes|Norpregnatrienes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB11620	Neridronic Acid	small molecule	experimental|investigational	Organophosphonates|Organophosphorus Compounds
DB11621	Human Varicella-Zoster Immune Globulin	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Biological Products|Blood|Blood Proteins|Body Fluids|Complex Mixtures|Fluids and Secretions|Globulins|Hemic and Immune Systems|Herpesvirus 3, Human|Immunization, Passive|Immunoglobulins|Immunoproteins|Proteins|Serum|Serum Globulins
DB11622	Dehydrocholic acid	small molecule	approved|investigational	Bile Acids and Salts|Cholagogues and Choleretics|Cholanes|Cholic Acids|Gastrointestinal Agents|Steroids
DB11623	Candoxatrilat	small molecule	experimental	Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Enzyme Inhibitors|Neprilysin, antagonists & inhibitors
DB11624	Epoetin delta	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB11625	Perflenapent	small molecule	investigational|withdrawn	Contrast Media|Diagnostic Uses of Chemicals|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ultrasound Contrast Media
DB11626	Tasonermin	biotech	approved	Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents
DB11627	Hepatitis B Vaccine (Recombinant)	biotech	approved|withdrawn	Actively Acquired Immunity|Antigens|Antigens, Viral|Biological Factors|Biological Products|Complex Mixtures|Hepatitis Antigens|Hepatitis B Antigens|Inactivated Hepatitis B Virus Vaccine|Vaccines|Viral Hepatitis Vaccines|Viral Vaccines
DB11628	Depreotide	small molecule	withdrawn	Amino Acids, Peptides, and Proteins|Peptides
DB11629	Laropiprant	small molecule	approved|investigational|withdrawn	
DB11630	Temoporfin	small molecule	approved|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Dermatologicals|Photosensitizing Agents|Pigments, Biological|Porphyrins|Radiation-Sensitizing Agents|Sensitizers Used in Photodynamic/radiation Therapy
DB11631	Eptotermin Alfa	biotech	approved|investigational|withdrawn	Amino Acids, Peptides, and Proteins|Biological Factors|Bone Morphogenetic Proteins|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Intercellular Signaling Peptides and Proteins|Musculo-Skeletal System|Peptides|Proteins|TGF-beta Superfamily Proteins
DB11632	Opicapone	small molecule	approved|investigational	Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|COMT Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Oxazoles
DB11633	Isavuconazole	small molecule	approved|investigational	Antifungal Agents|Antiinfectives for Systemic Use|Antimycotics for Systemic Use|Azole Antifungals|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inducers (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (moderate)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A4 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Triazole Derivatives|UGT1A9 Inhibitors
DB11634	Colestilan chloride	small molecule	approved|investigational|withdrawn	Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Steroids
DB11635	Tocofersolan	small molecule	approved	Alcohols|Alimentary Tract and Metabolism|Benzopyrans|Biomedical and Dental Materials|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drug Carriers|Ethylene Glycols|Glycols|Macromolecular Substances|Polymers|Pyrans|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB11636	Nomegestrol	small molecule	approved	Adrenal Cortex Hormones|Antineoplastic Agents, Hormonal|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Pregnadien Derivatives|Pregnadienes|Pregnanes|Progesterone Congeners|Progestins|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids
DB11637	Delamanid	small molecule	approved|investigational	Antiinfectives for Systemic Use|Antimycobacterials|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Treatment of Tuberculosis|Imidazoles|Moderate Risk QTc-Prolonging Agents|Nitro Compounds|QTc Prolonging Agents
DB11638	Artenimol	small molecule	experimental|investigational	Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Artemisia|Artemisinin and Derivatives, Plain|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sesquiterpenes|Terpenes|UGT1A9 Substrates
DB11639	Dibotermin alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Bone Morphogenetic Proteins|Drugs Affecting Bone Structure and Mineralization|Drugs for Treatment of Bone Diseases|Intercellular Signaling Peptides and Proteins|Musculo-Skeletal System|Peptides|Proteins|TGF-beta Superfamily Proteins
DB11640	Amifampridine	small molecule	approved|investigational	Amines|Aminopyridines|Cardiovascular Agents|Iodine Radioisotopes|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Nervous System|Potassium Channel Blockers|Potassium Channels|Pyridines|QTc Prolonging Agents
DB11641	Vinflunine	small molecule	approved|investigational	Alkaloids|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Indole Alkaloids|Indoles|P-glycoprotein/ABCB1 Substrates|Secologanin Tryptamine Alkaloids|Vinca Alkaloids
DB11642	Pitolisant	small molecule	approved|investigational	Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Histamine Antagonists|Moderate Risk QTc-Prolonging Agents|Nervous System|P-glycoprotein/ABCB1 Inhibitors|QTc Prolonging Agents|Receptors, Histamine H3
DB11643	Recombinant Cholera Toxin B Subunit	biotech	approved	Adjuvants, Immunologic|ADP Ribose Transferases|Bacterial Toxins|Biological Factors|Enterotoxins|Enzymes|Enzymes and Coenzymes|Glycosyltransferases|Immunologic Factors|Noxae|Pentosyltransferases|Poisons|Toxic Actions|Toxins, Biological|Transferases
DB11644	Tafamidis	small molecule	approved|investigational	Nervous System
DB11645	PF-4191834	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfur Compounds
DB11646	Conatumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11647	Incyclinide	small molecule	investigational	
DB11648	Afuresertib	small molecule	investigational	Amines|Polyamines|Sulfur Compounds
DB11649	Lersivirine	small molecule	investigational	RNA-Directed DNA Polymerase
DB11650	HT-0712	small molecule	investigational	Piperidines
DB11651	Dactolisib	small molecule	investigational	
DB11652	Tucatinib	small molecule	investigational	
DB11653	Bremelanotide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Melanocortins|Melanocyte-Stimulating Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Receptor, Melanocortin, Type 3, agonists|Receptor, Melanocortin, Type 4, agonists
DB11654	T-2000	small molecule	investigational	
DB11655	Evacetrapib	small molecule	investigational	Anticholesteremic Agents|Benzazepines|Cholesterol Ester Transfer Proteins, antagonists & inhibitors|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Toxic Actions
DB11656	Rebamipide	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Antioxidants|Enzyme Inhibitors|Gastrointestinal Agents|Protective Agents|Quinolines
DB11657	Tabalumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|B-Cell Activating Factor, antagonists & inhibitors|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11658	QAV-680	small molecule	investigational	
DB11659	Indium	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Elements|Indium Radioisotopes|Ions|Metals|Metals, Heavy|Nitric Acid|Nitrogen Compounds
DB11660	Latanoprostene Bunod	small molecule	approved|investigational	Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins, Synthetic
DB11661	Eptacog alfa pegol (activated)	biotech	investigational	Pegylated agents
DB11662	Rabusertib	small molecule	investigational	Antineoplastic Agents|Benzene Derivatives|Protein Kinase Inhibitors|Urea
DB11663	Pictilisib	small molecule	investigational	Amides|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Pyrazoles|Sulfones|Sulfur Compounds
DB11664	Psilocybine	small molecule	investigational	Alkaloids|Amines|Biogenic Amines|Biogenic Monoamines|Central Nervous System Agents|Central Nervous System Depressants|Hallucinogens|Indole Alkaloids|Indoles|Psychotropic Drugs|Tryptamines
DB11665	BMS-690514	small molecule	investigational	Carbon Radioisotopes
DB11666	Buparlisib	small molecule	investigational	Amines|Oxazines|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Pyridines
DB11667	2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine	small molecule	investigational	Arabinonucleosides|Carbohydrates|Cytidine|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB11668	Rusalatide acetate	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Peptide Hydrolases|Peptides|Proteins|Serine Endopeptidases|Serine Proteases|Wound Healing
DB11669	Ortataxel	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes
DB11670	SP-8203	small molecule	investigational	Quinazolines
DB11671	AZD-4877	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyrimidines
DB11672	Curcumin	small molecule	approved|experimental|investigational	Alkanes|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antineoplastic Agents|Benzene Derivatives|Catechols|Central Nervous System Agents|Coloring Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Diarylheptanoids|Enzyme Inhibitors|Heptanes|Hydrocarbons, Acyclic|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Phenols|Sensory System Agents
DB11673	Pyridoxamine	small molecule	investigational	Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Picolines|Pyridines|Vitamin B Complex|Vitamins
DB11674	Equol	small molecule	investigational	Benzopyrans|Chromones|Estrogens|Estrogens, Non-Steroidal|Flavonoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Isoflavones|Phytoestrogens|Pyrans
DB11675	Mosapride	small molecule	investigational	Acids, Carbocyclic|Amides|Anti-Ulcer Agents|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Gastrointestinal Agents|Neurotransmitter Agents|Oxazines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists
DB11676	Galidesivir	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purines
DB11677	Triheptanoin	small molecule	investigational	Glycerides|Lipids
DB11678	Treosulfan	small molecule	investigational	Acids|Acids, Noncarboxylic|Alcohols|Alkanes|Alkanesulfonates|Alkanesulfonic Acids|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Butylene Glycols|Glycols|Hydrocarbons, Acyclic|Mesylates|Noxae|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Toxic Actions
DB11679	Fruquintinib	small molecule	investigational	
DB11680	Ficlatuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11681	Tofimilast	small molecule	investigational	
DB11682	Daprodustat	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Pyrimidines|Pyrimidinones
DB11683	PF-06282999	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Pyrimidines
DB11684	APR-246	small molecule	investigational	
DB11685	Figitumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11686	Iferanserin	small molecule	investigational	Acids, Carbocyclic|Central Nervous System Depressants|Serotonin Agents|Serotonin Receptor Antagonists
DB11687	E-6201	small molecule	investigational	
DB11688	2-chloroethyl-3-sarcosinamide-1-nitrosourea	small molecule	investigational	Antineoplastic Agents|Nitroso Compounds|Nitrosourea Compounds|Urea
DB11689	Selumetinib	small molecule	investigational	Tyrosine Kinase Inhibitors
DB11690	Vonapanitase	biotech	investigational	Amino Acids, Peptides, and Proteins|Cholesterol|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Peptide Hydrolases|Proteins|Recombinant Proteins|Serine Endopeptidases|Serine Proteases
DB11691	Naldemedine	small molecule	approved|investigational	Opioid Antagonists
DB11692	Pavinetant	small molecule	investigational	Amides|Quinolines|Receptors, Neurokinin-3, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB11693	Voclosporin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Calcineurin Inhibitors|Cyclosporins|Immunosuppressive Agents|Peptides|Peptides, Cyclic
DB11694	Ilorasertib	small molecule	investigational	Amines|Benzene Derivatives|Pyridines|Urea
DB11695	Carnosine	small molecule	investigational	Amino Acids, Peptides, and Proteins|Dipeptides|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins
DB11696	Racecadotril	small molecule	investigational	Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antidiarrheals|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Enzyme Inhibitors|Gastrointestinal Agents|Glycine|N-substituted Glycines|Neprilysin, antagonists & inhibitors|Peptides|Peptoids|Protease Inhibitors|Sulfur Compounds
DB11697	Pacritinib	small molecule	investigational	fms-Like Tyrosine Kinase 3, antagonists & inhibitors|Janus Kinase 2, antagonists & inhibitors|Tyrosine Kinase Inhibitors
DB11698	Ipragliflozin	small molecule	investigational	Carbohydrates|Glycosides|Sulfur Compounds
DB11699	Tropisetron	small molecule	approved|investigational	Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Antiarrhythmic agents|Antiemetics|Antiemetics and Antinauseants|Autonomic Agents|Central Nervous System Agents|Central Nervous System Depressants|Gastrointestinal Agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Serotonin 5-HT3 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists
DB11700	Setmelanotide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Obesity Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Melanocortins|Melanocyte-Stimulating Hormones|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Anterior|Pro-Opiomelanocortin|Protein Precursors|Proteins|Receptor, Melanocortin, Type 4, agonists
DB11701	Amenamevir	small molecule	investigational	Oxazoles
DB11702	Antineoplaston A10	small molecule	investigational	Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Piperidines
DB11703	Acalabrutinib	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Kinase Inhibitor|Tyrosine Kinase Inhibitors
DB11704	Adomeglivant	small molecule	investigational	Benzene Derivatives
DB11705	Iomeprol	small molecule	approved|investigational	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB11706	Raxatrigine	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Ethers|Imines|Imino Acids|Phenols
DB11707	Olaptesed Pegol	small molecule	investigational	Pegylated agents
DB11708	Peficitinib	small molecule	investigational	Cycloparaffins|Nicotinic Acids|Pyridines
DB11709	Acetyl hexapeptide-8	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB11710	Trigonellamide	small molecule	investigational	
DB11711	Navarixin	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Cycloparaffins|Receptors, Interleukin-8A, antagonists & inhibitors|Receptors, Interleukin-8B, antagonists & inhibitors
DB11712	Tezacaftor	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates
DB11713	Ruzasvir	small molecule	investigational	
DB11714	Durvalumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker|Programmed Death Ligand-1-directed Antibody Interactions|Proteins|Serum Globulins
DB11715	Bapineuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11716	Misonidazole	small molecule	investigational	Anti-Infective Agents|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Imidazoles|Nitro Compounds|Nitroimidazoles|Radiation-Sensitizing Agents
DB11717	Epacadostat	small molecule	investigational	
DB11718	Encorafenib	small molecule	approved|investigational	Acids, Acyclic|Amides|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Sulfones|Sulfur Compounds
DB11719	UK-390957	small molecule	investigational	
DB11720	Angiotensin 1-7	small molecule	investigational	
DB11721	Mitoglitazone	small molecule	investigational	Sulfur Compounds|Thiazoles
DB11723	Dutogliptin	small molecule	investigational	Acids|Acids, Noncarboxylic|Agents causing angioedema|Blood Glucose Lowering Agents|Boron Compounds|DPP-IV Inhibitors
DB11724	Bombesin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Amphibian Venoms|Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Neurotransmitter Agents|Peptide Hormones|Peptides|Proteins|Toxins, Biological|Venoms
DB11725	Latrepirdine	small molecule	investigational	Alzheimer Disease
DB11726	Encenicline	small molecule	investigational	Nicotinic Agonists|Sulfur Compounds
DB11727	Endostar	biotech	investigational	
DB11729	GSK-2330672	small molecule	investigational	Amines|Azepines|Sulfur Compounds|Thiepins
DB11730	Ribociclib	small molecule	approved|investigational	Amines|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 3A Inhibitors|Highest Risk QTc-Prolonging Agents|Kinase Inhibitor|Kinase Inhibitors|Pyridines|QTc Prolonging Agents
DB11731	Depatuxizumab mafodotin	small molecule	investigational	Antibodies, Monoclonal|Immunoglobulins|Serum Globulins
DB11732	Lasmiditan	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Central Nervous System Depressants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists
DB11734	Fedovapagon	small molecule	investigational	
DB11735	Galactose	small molecule	approved|investigational	Carbohydrates|Contrast Media|Diagnostic Agents|Hexoses|Monosaccharides|Tests for Liver Functional Capacity|Ultrasound Contrast Media
DB11736	PF-00489791	small molecule	investigational	
DB11737	Icotinib	small molecule	experimental|investigational	Crown Compounds|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inducers|Cytochrome P-450 CYP3A5 Inducers (moderate)|Cytochrome P-450 CYP3A5 Inducers (weak)|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Ethers|Ethers, Cyclic|Tyrosine Kinase Inhibitors
DB11738	Rilmenidine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic alpha-Agonists|Agents producing tachycardia|Agents that produce hypertension|Antiadrenergic Agents, Centrally Acting|Antihypertensive Agents|Cardiovascular Agents|Imidazoline Receptor Agonists|Neurotransmitter Agents
DB11739	Vonoprazan	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB11740	MK-1775	small molecule	investigational	
DB11741	Famitinib	small molecule	investigational	Receptor Protein-Tyrosine Kinases, antagonists & inhibitors
DB11742	Ebastine	small molecule	approved|investigational	Antihistamines for Systemic Use|CYP3A Substrates (Sensitive)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Ketones|Neurotransmitter Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB11743	Ipatasertib	small molecule	investigational	Proto-Oncogene Proteins c-akt, antagonists & inhibitors
DB11744	Epetraborole	small molecule	investigational	Anti-Bacterial Agents|Leucine-tRNA Ligase, antagonists & inhibitors
DB11745	Otenabant	small molecule	investigational	
DB11746	Onartuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11747	Barasertib	small molecule	investigational	Organophosphorus Compounds|Protein Kinase Inhibitors
DB11748	Benfotiamine	small molecule	approved|experimental	Adjuvants, Immunologic|Alimentary Tract and Metabolism|Immunologic Factors|Pyrimidines|Sequestering Agents|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins
DB11749	(R)-Praziquantel	small molecule	investigational	
DB11750	Clobetasol	small molecule	approved|experimental|investigational	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Betamethasone|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Very Potent (Group IV)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB11751	Cabotegravir	small molecule	investigational	Anti-HIV Agents|OAT3/SLC22A8 Inhibitors|Pyridines
DB11752	Bryostatin 1	small molecule	investigational	Adjuvants, Immunologic|Anti-Bacterial Agents|Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Activation|Immunologic Factors|Lactones|Macrolides|Mitogens|Polyketides
DB11753	Rifamycin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inducers|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Drugs for Treatment of Tuberculosis|Lactams|Lactams, Macrocyclic|MATE 1 Inhibitors|MATE inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Ophthalmologicals|Otologicals|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Rifamycins|Sensory Organs
DB11754	Lirilumab	biotech	investigational	
DB11755	Tetrahydrocannabivarin	small molecule	investigational	Agents that produce hypertension|Central Nervous System Depressants|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB11756	Solanezumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11757	Istradefylline	small molecule	investigational	Adenosine A2 Receptor Antagonists|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists
DB11758	Cenicriviroc	small molecule	investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|CCR5 Receptor Antagonists|Receptors, CCR2, antagonists & inhibitors
DB11759	Pevonedistat	small molecule	investigational	Cycloparaffins
DB11760	Talazoparib	small molecule	approved|investigational	Antineoplastic Agents|BCRP/ABCG2 Substrates|Enzyme Inhibitors|P-glycoprotein/ABCB1 Substrates|Poly(ADP-ribose) Polymerase Inhibitors|Pyridazines
DB11761	Tenapanor	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB11762	Marizomib	small molecule	investigational	
DB11763	Momelotinib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB11764	Spebrutinib	small molecule	investigational	Acids, Acyclic|Acrylates|Amides|Protein Kinase Inhibitors
DB11765	PF-04991532	small molecule	investigational	Nicotinic Acids|Pyridines
DB11766	AZD-1305	small molecule	investigational	Acids, Acyclic|Aza Compounds
DB11767	Sarilumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Biologics for Rheumatoid Arthritis Treatment|Blood Proteins|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Disease-modifying Antirheumatic Agents|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin 6 Receptor Antagonists|Interleukin-6 Receptor Antagonist|Proteins|Serum Globulins
DB11768	Zytron	small molecule	approved|investigational	Amines|Organophosphorus Compounds|Sulfur Compounds
DB11769	Funapide	small molecule	investigational	
DB11770	Talinolol	small molecule	investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|P-glycoprotein/ABCB1 Substrates|Potential QTc-Prolonging Agents|Propanols|QTc Prolonging Agents
DB11771	Tremelimumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11772	Pilaralisib	small molecule	investigational	Amides|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB11773	BMS-903452	small molecule	investigational	Pyridines|Sulfur Compounds
DB11774	Pazufloxacin	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Antituberculosis Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB11775	PF-03758309	small molecule	investigational	p21-Activated Kinases, antagonists & inhibitors
DB11776	Brodalumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Immunosuppressive Agents|Interleukin 17 Receptor A Antagonists|Interleukin Inhibitors|Interleukin-17 Receptor A Antagonist|Misc. Skin and Mucous Membrane Agents|Proteins|Serum Globulins
DB11777	Cenderitide	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides|Toxins, Biological|Venoms
DB11778	Danusertib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Protein Kinase Inhibitors
DB11779	Danoprevir	small molecule	investigational	Amides|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Sulfones|Sulfur Compounds
DB11780	Allicin	small molecule	investigational	Acids|Acids, Noncarboxylic|Anti-Infective Agents|Antioxidants|Blood Glucose Lowering Agents|Free Radical Scavengers|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Protective Agents|Sulfur Acids|Sulfur Compounds|Toxic Actions
DB11781	Tosedostat	small molecule	investigational	Amines|Amino Acids|Amino Acids, Peptides, and Proteins|Hydroxy Acids|Hydroxylamines
DB11782	Birinapant	small molecule	investigational	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides
DB11783	Imidapril	small molecule	investigational	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Hypotensive Agents|Imidazoles|Protease Inhibitors
DB11784	NRX-1074	small molecule	investigational	
DB11785	Anisodamine	small molecule	investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Ulcer Agents|Antiarrhythmic agents|Antioxidants|Autonomic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP2D6 Substrates|Drugs, Chinese Herbal|Free Radical Scavengers|Gastrointestinal Agents|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Protective Agents|QTc Prolonging Agents|Sensory System Agents|Vasodilating Agents
DB11786	Pefcalcitol	small molecule	investigational	
DB11787	Ralimetinib	small molecule	investigational	Mitogen-Activated Protein Kinase 14, antagonists & inhibitors
DB11788	Neuropeptide Y	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Nerve Tissue Proteins|Neuropeptides|Peptides|Proteins
DB11789	Hyodeoxycholic Acid	small molecule	investigational	Bile Acids and Salts|Cholanes|Cholic Acids|Steroids
DB11790	Radafaxine	small molecule	investigational	Ketones|Propiophenones
DB11791	Capmatinib	small molecule	approved|investigational	
DB11792	Mirodenafil	small molecule	investigational	Amides|Enzyme Inhibitors|Phosphodiesterase 5 Inhibitors|Phosphodiesterase Inhibitors|Pyrimidines|Sulfones|Sulfur Compounds|Vasodilating Agents
DB11793	Niraparib	small molecule	approved|investigational	Antineoplastic Agents|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors|Pyrazoles
DB11794	Berzosertib	small molecule	investigational	
DB11795	GSK-2636771	small molecule	investigational	
DB11796	Fostemsavir	small molecule	investigational	Organophosphorus Compounds
DB11797	Aceneuramic acid	small molecule	investigational	
DB11798	Tanzisertib	small molecule	investigational	Alcohols|Carbon Radioisotopes|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors|Lipids
DB11799	Bictegravir	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|MATE 1 Inhibitors|MATE inhibitors|UGT1A1 Substrates
DB11800	Tivozanib	small molecule	investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Benzene Derivatives|Protein Kinase Inhibitors|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors|Urea
DB11801	Rapastinel	small molecule	investigational	
DB11803	Sirukumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11804	AZD-5672	small molecule	investigational	Acetamides|Acetates|Acids, Acyclic|Amides|Anti-HIV Agents|Anti-Infective Agents|Benzene Derivatives|CCR5 Receptor Antagonists|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfones|Sulfur Compounds
DB11805	Saracatinib	small molecule	investigational	Antineoplastic Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Enzyme Inhibitors|Tyrosine Kinase Inhibitors
DB11806	VTP-194204	small molecule	investigational	Fatty Acids|Ligands|Lipids|Naphthalenes
DB11807	Dexmecamylamine	small molecule	investigational	
DB11808	Faldaprevir	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals|Peptides|Protease Inhibitors|Sulfur Compounds
DB11809	Artefenomel	small molecule	investigational	Anions|Cycloparaffins|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Reactive Oxygen Species
DB11810	Etarfolatide	small molecule	investigational	
DB11811	Arhalofenate	small molecule	investigational	Acetates|Acids, Acyclic|Acids, Carbocyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB11812	Talaporfin	small molecule	investigational	Antineoplastic Agents|Biological Factors|Dermatologicals|Photosensitizing Agents|Pigments, Biological|Radiation-Sensitizing Agents
DB11813	Mipsagargin	small molecule	investigational	
DB11814	PF-03882845	small molecule	investigational	Pyrazoles
DB11815	Tilarginine	small molecule	approved|investigational	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Enzyme Inhibitors|Nitric Oxide Synthase, antagonists & inhibitors
DB11816	Omecamtiv Mecarbil	small molecule	investigational	
DB11817	Baricitinib	small molecule	approved|investigational	Amides|Azetines|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|MATE 2 Inhibitors|MATE 2 Substrates|MATE inhibitors|MATE substrates|OAT3/SLC22A8 Inhibitors|OAT3/SLC22A8 Substrates|OATP1B3 inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Sulfones|Sulfur Compounds
DB11818	Retosiban	small molecule	investigational	
DB11819	ASP-4058	small molecule	investigational	Oxazoles
DB11820	Nifurtimox	small molecule	investigational	Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Furans|Nitro Compounds|Nitrofuran Derivatives|Nitrofurans|Sulfur Compounds|Thiazines|Trypanocidal Agents
DB11821	Danegaptide	small molecule	investigational	Acids, Acyclic|Acids, Carbocyclic|Amides|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Benzoates|Imines|Imino Acids
DB11822	TMC-647055	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB11823	Esketamine	small molecule	approved|investigational	Agents producing tachycardia|Anesthetics|Anesthetics, General|Nervous System
DB11824	Tofogliflozin	small molecule	investigational	Benzene Derivatives|Carbohydrates|Glycosides
DB11825	Mirogabalin	small molecule	investigational	
DB11826	Lampalizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Blood Proteins|Globulins|Immunoglobulin Fragments|Immunoglobulins|Immunoproteins|Peptide Fragments|Peptides|Proteins|Serum Globulins
DB11827	Ertugliflozin	small molecule	approved|investigational	BCRP/ABCG2 Substrates|Diuretics|P-glycoprotein/ABCB1 Substrates|Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors|UGT1A1 Inhibitors|UGT1A9 Substrates
DB11828	Neratinib	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Kinase Inhibitor|Kinase Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Tyrosine Kinase Inhibitors
DB11829	Ruboxistaurin	small molecule	investigational	Acids, Acyclic|Dicarboxylic Acids|Enzyme Inhibitors|Imides|Maleates|Protein Kinase C, antagonists & inhibitors
DB11830	Mocetinostat	small molecule	investigational	Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB11831	Dinitrochlorobenzene	small molecule	investigational	Antigens|Benzene Derivatives|Biological Factors|Chlorobenzenes|Dinitrobenzenes|Epitopes|Haptens|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Indicators and Reagents|Irritants|Laboratory Chemicals|Nitro Compounds|Nitrobenzenes|Noxae|Toxic Actions
DB11832	Crenolanib	small molecule	investigational	Antineoplastic Agents|Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors|Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors|Tyrosine Kinase Inhibitors
DB11833	Basimglurant	small molecule	investigational	
DB11834	Guselkumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Interleukin-23 Antagonist|Interleukin-23 Antagonists|Misc. Skin and Mucous Membrane Agents|Proteins|Serum Globulins
DB11835	Indium In-111 pentetreotide	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Diagnostic Radiopharmaceuticals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Indium (111In) Compounds|Indium Radioisotopes|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary Hormone Release Inhibiting Hormones|Proteins|Radioactive Diagnostic Agent|Radiopharmaceutical Activity|Tumour Detection
DB11836	Sapanisertib	small molecule	investigational	
DB11837	Osilodrostat	small molecule	investigational	Cytochrome P-450 CYP11B2, antagonists & inhibitors
DB11838	Revamilast	small molecule	investigational	
DB11839	PZ-128	small molecule	investigational	
DB11840	Dalotuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11841	Entinostat	small molecule	investigational	Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB11842	Angiotensin II	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Angiotensin II|Angiotensins|Autacoids|Biological Factors|Cardiovascular Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Inflammation Mediators|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Proteins|Vasoconstriction|Vasoconstrictor Agents
DB11843	PF-04958242	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB11844	Pritelivir	small molecule	investigational	Antiviral Agents|Sulfur Compounds
DB11845	Lucitanib	small molecule	investigational	
DB11846	Creatinine	small molecule	investigational	Imidazoles
DB11847	Cadazolid	small molecule	investigational	Oxazoles
DB11848	Mannose 6-phosphate	small molecule	investigational	
DB11849	Emibetuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11850	Ublituximab	biotech	investigational	
DB11851	Bafetinib	small molecule	investigational	Protein Kinase Inhibitors
DB11852	Tegobuvir	small molecule	investigational	
DB11853	Relugolix	small molecule	investigational	Benzene Derivatives|Pyrimidines|Receptors, LHRH, antagonists & inhibitors|Urea
DB11854	Astodrimer	biotech	investigational	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Biomedical and Dental Materials|Drug Carriers|Drug Delivery Systems|Investigative Techniques|Lysine|Macromolecular Substances|Nanoparticles|Nanostructures|Peptides|Pharmaceutical Preparations|Polymers
DB11855	Revefenacin	small molecule	approved|investigational	Amides|Anticholinergic Agents|BCRP/ABCG2 Substrates|Benzene Derivatives|Bronchodilator Agents|Cytochrome P-450 CYP2D6 Substrates|Muscarinic Antagonists|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|P-glycoprotein/ABCB1 Substrates
DB11856	Ligelizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11857	Seribantumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11858	Leukotriene D4	small molecule	investigational	Arachidonic Acids|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Leukotrienes|Lipids|SRS-A
DB11859	Allopregnanolone	small molecule	investigational	Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Pregnanes|Steroids
DB11860	Aramchol	small molecule	investigational	Bile Acids and Salts|Cholanes|Steroids
DB11861	Litronesib	small molecule	investigational	Amides|Sulfones|Sulfur Compounds|Thiazoles
DB11862	Landogrozumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11863	Alvelestat	small molecule	investigational	Leukocyte Elastase, antagonists & inhibitors|Pyridines|Sulfur Compounds
DB11864	Preladenant	small molecule	investigational	
DB11865	Brivanib alaninate	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins
DB11866	Romosozumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11867	JNJ-39393406	small molecule	investigational	
DB11868	Etiracetam	small molecule	investigational	Acetamides|Acetates|Acids, Acyclic|Amides|Anticonvulsants|Central Nervous System Agents|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nootropic Agents|Pyrrolidines|Pyrrolidinones
DB11869	Valspodar	small molecule	investigational	Amino Acids, Peptides, and Proteins|Drug Resistance, Multiple|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic
DB11870	RG-4733	small molecule	investigational	Amyloid Precursor Protein Secretases, antagonists & inhibitors
DB11871	PF-00610355	small molecule	investigational	Acetamides|Acetates|Acids, Acyclic|Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfones|Sulfur Compounds
DB11872	ZD-6126	small molecule	investigational	
DB11873	Verinurad	small molecule	investigational	
DB11874	Crocin	small molecule	investigational	Alkenes|Biological Factors|Condiments|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Pigments, Biological|Polyenes|Terpenes
DB11875	3,3'-diindolylmethane	small molecule	investigational	Anticarcinogenic Agents|Antineoplastic Agents|Protective Agents
DB11876	Alanyl Glutamine	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|I.V. Solution Additives|Oligopeptides|Peptides
DB11877	Basmisanil	small molecule	investigational	
DB11878	Filibuvir	small molecule	investigational	Pyrans|RNA Replicase, antagonists & inhibitors
DB11879	Dusquetide	small molecule	investigational	
DB11880	Acridine Carboxamide	small molecule	investigational	Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB11881	AUY922	small molecule	investigational	Benzene Derivatives|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Phenols
DB11882	BPC-157	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Ulcer Agents|Gastrointestinal Agents|Peptides
DB11883	SB-705498	small molecule	investigational	TRPV Cation Channels, antagonists & inhibitors
DB11884	Vadastuximab Talirine	biotech	investigational	
DB11885	Anlotinib	small molecule	investigational	
DB11886	Infigratinib	small molecule	investigational	Antineoplastic Agents|Benzene Derivatives|Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors|Urea
DB11888	Laninamivir octanoate	small molecule	investigational	Acids, Acyclic|Amidines|Amino Sugars|Carbohydrates|Guanidines|Hydroxy Acids|Neuraminic Acids|Neuraminidase, antagonists & inhibitors|Pyrans|Sialic Acids|Sugar Acids
DB11889	Lanicemine	small molecule	investigational	Amines|Central Nervous System Depressants|Ethylamines|Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors
DB11890	Cilengitide	small molecule	investigational	Biological Factors|Bodily Secretions|Complex Mixtures|Fluids and Secretions|Toxins, Biological|Venoms
DB11891	CUDC-907	small molecule	investigational	Antineoplastic Agents|Histone Deacetylase Inhibitors|Oxazines|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB11892	Prulifloxacin	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB11893	Avagacestat	small molecule	investigational	Amides|Amyloid Precursor Protein Secretases, antagonists & inhibitors|Oxazoles|Sulfones|Sulfur Compounds
DB11894	Efatutazone	small molecule	investigational	Antineoplastic Agents|PPAR gamma, antagonists & inhibitors|Sulfur Compounds|Thiazoles
DB11895	Lenomorelin	biotech	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Peptide Hormones|Peptides
DB11896	Gedatolisib	small molecule	investigational	Oxazines
DB11898	2,4-thiazolidinedione	small molecule	investigational	Blood Glucose Lowering Agents|Ligands|Sulfur Compounds|Thiazoles
DB11899	MK-8776	small molecule	investigational	
DB11900	OC-459	small molecule	investigational	Indoles
DB11901	Apalutamide	small molecule	approved|investigational	BCRP/ABCG2 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (strong)|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inducers (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|MATE 2 Inhibitors|MATE inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inducers|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inducers
DB11902	Gisadenafil	small molecule	investigational	Amides|Cyclic Nucleotide Phosphodiesterases, Type 5|Pyrimidines|Sulfones|Sulfur Compounds
DB11903	GW842166	small molecule	investigational	Agents producing tachycardia|Cannabinoid Receptor Agonists|Cannabinoids and similars|Receptor, Cannabinoid, CB2, agonists
DB11904	Flumatinib	small molecule	investigational	Acids, Carbocyclic|Amides|Amines|Benzene Derivatives|Benzoates|Protein Kinase Inhibitors|Pyridines|Tyrosine Kinase Inhibitors
DB11905	Sutezolid	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Oxazoles|Tuberculosis, Pulmonary, drug therapy
DB11906	Acyline	small molecule	investigational	Amino Acids, Peptides, and Proteins|Gonadotropin-Releasing Hormone, antagonists & inhibitors|Peptides
DB11907	Rociletinib	small molecule	investigational	Acids, Acyclic|Acrylates|Amides
DB11909	Varespladib	small molecule	investigational	Acids, Acyclic|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Phospholipase A2 Inhibitors|Phospholipases A, antagonists & inhibitors
DB11910	MK-0249	small molecule	investigational	Quinazolines
DB11911	Galunisertib	small molecule	investigational	
DB11912	Lanopepden	small molecule	investigational	Amines|Anti-Bacterial Agents|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines
DB11913	LY-2090314	small molecule	investigational	Acids, Acyclic|Dicarboxylic Acids|Glycogen Synthase Kinase 3, antagonists & inhibitors|Imides|Maleates
DB11914	Lebrikizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11915	Valbenazine	small molecule	approved|investigational	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Quinolizines|Vesicular Monoamine Transporter 2 Inhibitor|Vesicular Monoamine Transporter 2 Inhibitors
DB11916	Indium In-111	small molecule	investigational	
DB11917	Vatiquinone	small molecule	investigational	Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones
DB11918	Guadecitabine	small molecule	investigational	Aza Compounds|Carbohydrates|Cytidine|Glycosides|Immunologic Factors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB11919	6-O-benzylguanine	small molecule	investigational	Antineoplastic Agents|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Purines|Purinones|Xanthine derivatives
DB11920	Lesogaberan	small molecule	investigational	Acids|Acids, Noncarboxylic|Amines|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Gastrointestinal Agents|Neurotransmitter Agents|Organophosphorus Compounds|Phosphorus Acids|Phosphorus Compounds
DB11921	Deflazacort	small molecule	approved|investigational	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Glucocorticoids|Hyperglycemia-Associated Agents|Immunologic Factors|Immunosuppressive Agents|Pregnanes|Pregnenes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB11922	Danirixin	small molecule	investigational	Sulfur Compounds
DB11923	Decoglurant	small molecule	investigational	
DB11924	Safingol	small molecule	investigational	Alcohols|Amines|Amino Alcohols|Enzyme Inhibitors|Glycols|Protein Kinase C, antagonists & inhibitors
DB11925	Vistusertib	small molecule	investigational	Oxazines|Protein Kinase Inhibitors
DB11926	Tesidolumab	biotech	investigational	
DB11927	Lodenafil Carbonate	small molecule	investigational	Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Ions
DB11928	Vosoritide	biotech	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Peptides|Peptide Hormones|Peptides
DB11929	Vaniprevir	small molecule	investigational	
DB11930	Varlilumab	biotech	investigational	
DB11932	Abametapir	small molecule	investigational	
DB11933	Riboprine	small molecule	investigational	
DB11934	Epelsiban	small molecule	investigational	Oxazines|Piperazines
DB11935	Flomoxef	small molecule	investigational	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Nephrotoxic agents|Second-Generation Cephalosporins|Sulfur Compounds|Thiazines
DB11936	Bempedoic acid	small molecule	investigational	Acids, Acyclic|Anti-Obesity Agents|Blood Glucose Lowering Agents|Hypolipidemic Agents|Lipids
DB11937	Kynurenic Acid	small molecule	investigational	Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Hydroxyquinolines|Neurotransmitter Agents|Quinolines|Xanthurenates
DB11938	Difelikefalin	small molecule	investigational	
DB11939	Henagliflozin	small molecule	investigational	
DB11940	Triapine	small molecule	investigational	Semicarbazides|Semicarbazones|Sulfur Compounds
DB11941	Tasisulam	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Sulfones|Sulfur Compounds
DB11942	Selinexor	small molecule	investigational	
DB11943	Delafloxacin	small molecule	approved|investigational	Anti-Bacterial Agents|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP2E1 Inducers (weak)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 Enzyme Inducers|Fluoroquinolone Antibacterial|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|UGT1A1 Substrates
DB11944	Ingavirin	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB11945	Avelumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Programmed Death Ligand-1 Antagonists|Programmed Death Ligand-1 Blocker|Programmed Death Ligand-1-directed Antibody Interactions|Proteins|Serum Globulins
DB11946	AZD-1981	small molecule	investigational	
DB11947	Pridopidine	small molecule	investigational	
DB11948	Lapachone	small molecule	investigational	Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Naphthalenes|Nucleic Acid Synthesis Inhibitors|Quinones|Radiation-Sensitizing Agents|Reverse Transcriptase Inhibitors
DB11949	Vestipitant	small molecule	investigational	Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents
DB11950	Teneligliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors|Sulfur Compounds|Thiazoles
DB11951	Lemborexant	small molecule	investigational	
DB11952	Duvelisib	small molecule	approved|investigational	BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|P-glycoprotein/ABCB1 Substrates|Phosphatidylinositol 3-Kinases, antagonists & inhibitors
DB11953	PF-04447943	small molecule	investigational	Phosphodiesterase Inhibitors|Pyrimidines
DB11954	Lomibuvir	small molecule	investigational	Alcohols|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|Lipids|Sulfur Compounds
DB11955	Avotermin	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Peptides|Proteins|TGF-beta Superfamily Proteins|Transforming Growth Factor beta
DB11956	Delanzomib	small molecule	investigational	Acids|Acids, Noncarboxylic|Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Boron Compounds|Enzyme Inhibitors|Protease Inhibitors|Proteasome Inhibitors
DB11957	Idalopirdine	small molecule	investigational	Amines|Benzene Derivatives|Benzyl Compounds|Central Nervous System Depressants|Serotonin Agents|Serotonin Receptor Antagonists
DB11958	Brivanib	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins
DB11959	Crenezumab	biotech	investigational	Alzheimer Disease, drug therapy|Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11960	Carboxyamidotriazole	small molecule	investigational	Agents causing hyperkalemia|Antiarrhythmic agents|Antineoplastic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Membrane Transport Modulators
DB11961	AZD-1236	small molecule	investigational	
DB11962	GSK-1059615	small molecule	investigational	
DB11963	Dacomitinib	small molecule	approved|investigational	Antineoplastic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (strong)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Quinazolines|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors
DB11964	Ilaprazole	small molecule	investigational	Benzimidazoles|Pyridines|Sulfoxides|Sulfur Compounds
DB11965	SJG-136	small molecule	investigational	Benzazepines
DB11966	BMS-986094	small molecule	investigational	Carbohydrates|Glycosides|Guanine Nucleotides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB11967	Binimetinib	small molecule	approved|investigational	Cytochrome P-450 CYP1A2 Substrates|MAP Kinase Kinase 1, antagonists & inhibitors|MAP Kinase Kinase 2, antagonists & inhibitors|UGT1A1 Substrates
DB11968	MK-7145	small molecule	investigational	
DB11969	Uprosertib	small molecule	investigational	Amines|Polyamines
DB11970	Burixafor	small molecule	investigational	
DB11971	Vilaprisan	small molecule	investigational	
DB11972	Rilotumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11973	Tesevatinib	small molecule	investigational	Aza Compounds|Receptor, EphB4, antagonists & inhibitors|Receptor, Epidermal Growth Factor, antagonists & inhibitors|Receptor, ErbB-2, antagonists & inhibitors|Tyrosine Kinase Inhibitors|Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
DB11974	PF-04691502	small molecule	investigational	Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Pyridines
DB11975	TAK-448	small molecule	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Neoplasm Proteins|Nerve Tissue Proteins|Neuropeptides|Peptides|Proteins|Tumor Suppressor Proteins
DB11976	Anifrolumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB11977	Golvatinib	small molecule	investigational	Amines|Pyridines|Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
DB11978	Glasdegib	small molecule	approved|investigational	Benzene Derivatives|Urea
DB11979	Elagolix	small molecule	approved|investigational	Antigonadotropins and Similar Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2D6 Substrates|Hydrocarbons, Halogenated|OATP1B1/SLCO1B1 Substrates|P-glycoprotein/ABCB1 Substrates|UGT1A1 Substrates
DB11980	Carbon Black	small molecule	investigational	Complex Mixtures|Particulate Matter|Smoke
DB11981	Elamipretide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB11982	GDC-0623	small molecule	investigational	
DB11983	Placulumab	biotech	investigational	
DB11984	Letaxaban	small molecule	investigational	Anticoagulants|Antithrombins|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Pyrimidines|Serine Proteinase Inhibitors|Sulfur Compounds
DB11985	Dapaconazole	small molecule	investigational	
DB11986	Entrectinib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyrazoles|Tyrosine Kinase Inhibitors
DB11987	GSK-2018682	small molecule	investigational	
DB11988	Ocrelizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Blood Proteins|CD20-directed Antibody Interactions|CD20-directed Cytolytic Antibody|Globulins|Immunoglobulins|Immunomodulatory Agents|Immunoproteins|Immunosuppressive Agents|Proteins|Serum Globulins
DB11989	Benznidazole	small molecule	approved|investigational	Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Imidazoles|Immunologic Factors|Mutagens|Nitro Compounds|Nitroimidazole Derivatives|Noxae|Toxic Actions|Trypanocidal Agents
DB11990	MK-0812	small molecule	investigational	
DB11991	Oprozomib	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB11992	Omarigliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors
DB11993	PF-03463275	small molecule	investigational	Aza Compounds|Glycine Plasma Membrane Transport Proteins, antagonists & inhibitors
DB11994	Diacerein	small molecule	approved|investigational	Anthracenes|Anti-Inflammatory Agents|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Musculo-Skeletal System|Quinones
DB11995	Avatrombopag	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C8 Inducers (weak)|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2C9 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|OAT3/SLC22A8 Inhibitors|P-glycoprotein/ABCB1 Substrates|Receptors, Thrombopoietin, agonists|Sulfur Compounds
DB11996	Thymopentin	small molecule	investigational	Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunologic Factors|Thymopoietins|Thymus Hormones
DB11997	Interleukin-7	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Interleukins|Peptides|Proteins
DB11998	Sorivudine	small molecule	investigational	Anti-Infective Agents|Antiviral Agents|Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB11999	Vosaroxin	small molecule	investigational	Sulfur Compounds
DB12000	Apabetalone	small molecule	investigational	
DB12001	Abemaciclib	small molecule	approved|investigational	Amines|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Kinase Inhibitor|Kinase Inhibitors|MATE 1 Inhibitors|MATE 1 Substrates|MATE 2 Inhibitors|MATE inhibitors|MATE substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Pyridines
DB12002	AZD-4818	small molecule	investigational	
DB12003	Thymosin beta-4	biotech	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Microfilament Proteins|Peptide Hormones|Peptides|Proteins|Thymus Hormones
DB12004	Briciclib	small molecule	investigational	
DB12005	Nirogacestat	small molecule	investigational	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Amyloid Precursor Protein Secretases, antagonists & inhibitors|Naphthalenes
DB12006	BMS-906024	small molecule	investigational	Benzazepines
DB12007	Isoflavone	small molecule	experimental	
DB12008	Prexasertib	small molecule	investigational	
DB12009	GW-406381	small molecule	investigational	
DB12010	Fostamatinib	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Phosphodiesterase 5 Inhibitors|Tyrosine Kinase Inhibitors|UGT1A1 Inhibitors|UGT1A9 Substrates|Vasodilating Agents
DB12011	Fevipiprant	small molecule	investigational	Indoles
DB12012	PF-04457845	small molecule	investigational	
DB12013	Axelopran	small molecule	investigational	Acids, Carbocyclic|Alkaloids|Amides|Aza Compounds|Azabicyclo Compounds|Benzene Derivatives|Benzoates|Opioid Antagonists
DB12014	Ozoralizumab	biotech	investigational	
DB12015	Alpelisib	small molecule	investigational	Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Sulfur Compounds
DB12016	Ponesimod	small molecule	investigational	Receptors, Lysosphingolipid, antagonists & inhibitors|Sulfur Compounds
DB12017	Ozagrel	small molecule	investigational	Acids, Acyclic|Acrylates|Cardiovascular Agents|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Histamine Agents|Neurotransmitter Agents|Thromboxane-A Synthase, antagonists & inhibitors
DB12018	Ulocuplumab	biotech	investigational	
DB12019	Tesetaxel	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes
DB12020	Tecovirimat	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Antiviral Agents|Benzene Derivatives|Benzoates
DB12021	Dinaciclib	small molecule	investigational	Cyclin-Dependent Kinases, antagonists & inhibitors|Pyridines
DB12022	Evatanepag	small molecule	investigational	
DB12023	Benralizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Interleukin 5 Receptor alpha-directed Antibody Interactions|Interleukin-5 Receptor alpha-directed Cytolytic Antibody|Proteins|Respiratory Agents, Miscellaneous|Serum Globulins
DB12024	PF-04418948	small molecule	investigational	Azetines|Receptors, Prostaglandin E, EP2 Subtype
DB12025	Triptolide	small molecule	investigational	Adrenal Cortex Hormones|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antispermatogenic Agents|Contraceptive Agents, Male|Ethers|Ethers, Cyclic|Hormonal Contraceptives for Systemic Use|Immunologic Factors|Immunosuppressive Agents|Noxae|Reproductive Control Agents|Terpenes|Toxic Actions|Tripterygium
DB12026	Voxilaprevir	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates
DB12027	Serdemetan	small molecule	investigational	Amines|Biogenic Amines|Biogenic Monoamines|Indoles|Radiation-Sensitizing Agents
DB12028	Broxuridine	small molecule	investigational	Anti-Infective Agents|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Carbohydrates|Deoxyribonucleosides|Deoxyuridine|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Radiation-Sensitizing Agents|Ribonucleosides|Toxic Actions|Uridine
DB12029	Chlorogenic Acid	small molecule	investigational	Acids, Carbocyclic|Cinnamates|Cyclohexanecarboxylic Acids|Cyclohexanes|Cycloparaffins
DB12030	Fluorescein lisicol	small molecule	investigational	Spiro Compounds|Xanthenes
DB12031	Ammonio methacrylate copolymer type A	small molecule	investigational	
DB12032	Atagabalin	small molecule	investigational	Acids, Acyclic|Cycloparaffins|Fatty Acids|Fatty Acids, Volatile|Lipids
DB12034	Gantenerumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12035	Sarecycline	small molecule	approved|investigational	Anti-Acne Preparations|Anti-Acne Preparations for Systemic Use|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|P-glycoprotein/ABCB1 Inhibitors|Tetracyclines
DB12036	Naquotinib	small molecule	investigational	
DB12037	Vedroprevir	small molecule	investigational	Antiviral Agents
DB12038	Ulinastatin	biotech	investigational	Amino Acids, Peptides, and Proteins|Carbohydrates|Enzyme Inhibitors|Glycoconjugates|Protease Inhibitors|Proteins|Serine Proteinase Inhibitors|Trypsin Inhibitors
DB12039	Epicatechin	small molecule	investigational	Benzopyrans|Chromans|Chromones|Flavonoids|Pyrans
DB12040	2-octyl cyanoacrylate	small molecule	investigational	Acids, Acyclic|Acrylates|Biomedical and Dental Materials|Equipment and Supplies|Macromolecular Substances|Nitriles|Polymers|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives
DB12041	Mapracorat	small molecule	investigational	Alcohols|Fatty Alcohols|Lipids|Receptors, Glucocorticoid, agonists
DB12042	Ibodutant	small molecule	investigational	Amino Acids, Peptides, and Proteins|Oligopeptides|Peptides|Receptors, Neurokinin-2, antagonists & inhibitors|Sulfur Compounds
DB12043	Sepetaprost	small molecule	investigational	Ethers|Ethers, Cyclic
DB12044	MK-0893	small molecule	investigational	Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Receptors, Glucagon, antagonists & inhibitors
DB12045	Mericitabine	small molecule	investigational	Carbohydrates|Cytidine|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12046	Atopaxar	small molecule	investigational	Receptors, Thrombin, antagonists & inhibitors
DB12047	Ganetespib	small molecule	investigational	HSP90 Heat-Shock Proteins, antagonists & inhibitors
DB12048	Savolitinib	small molecule	investigational	Tyrosine Kinase Inhibitors
DB12049	Dasolampanel etibutil	small molecule	investigational	
DB12050	LY-3039478	small molecule	investigational	
DB12051	Setrobuvir	small molecule	investigational	Amides|Quinolines|Sulfonamides|Sulfones|Sulfur Compounds
DB12052	Icariin	small molecule	investigational	Benzopyrans|Chromones|Drugs, Chinese Herbal|Pyrans
DB12053	Visilizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antigens, CD3|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12054	BQ-123	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antihypertensive Agents|Cardiovascular Agents|Endothelin Receptor Antagonists|Peptides
DB12055	MK-0767	small molecule	investigational	Sulfur Compounds
DB12056	Trebananib	biotech	investigational	Amino Acids, Peptides, and Proteins|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Growth Inhibitors|Growth Substances|Proteins|Recombinant Proteins
DB12057	ORM-12741	small molecule	investigational	Adrenergic alpha-2 Receptor Antagonists|Quinolizines
DB12058	Recoflavone	small molecule	investigational	Benzopyrans|Chromones|Pyrans
DB12059	JNJ-40411813	small molecule	investigational	Pyridines
DB12060	RRx-001	small molecule	investigational	Azetines|Carbon Radioisotopes
DB12061	Pardoprunox	small molecule	investigational	
DB12062	Volasertib	small molecule	investigational	
DB12063	CERC-301	small molecule	investigational	Receptors, N-Methyl-D-Aspartate, antagonists & inhibitors
DB12064	BMS-777607	small molecule	investigational	Amines|Pyridines
DB12065	Radalbuvir	small molecule	investigational	Sulfur Compounds
DB12066	Orteronel	small molecule	investigational	
DB12067	BMS-394136	small molecule	investigational	
DB12068	T-900607	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12069	Sovaprevir	small molecule	investigational	
DB12070	Letermovir	small molecule	approved|investigational	Acids, Acyclic|Antiviral Agents|BCRP/ABCG2 Inhibitors|BSEP/ABCB11 Inhibitors|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Inducers|Cytochrome P-450 CYP2C19 Inducers (moderate)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Cytochrome P450 2C19 Inducers|Cytochrome P450 2C9 Inducers|Cytochrome P450 3A Inhibitors|Cytomegalovirus DNA Terminase Complex Inhibitor|DNA Terminase Complex Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|UGT1A1 Substrates
DB12071	Vabicaserin	small molecule	investigational	Central Nervous System Depressants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin 5-HT2C Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB12072	Orantinib	small molecule	investigational	Acids, Acyclic|Enzyme Inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Protein Kinase Inhibitors
DB12073	Albaconazole	small molecule	investigational	Antifungal Agents|Azole Antifungals|Stereoisomerism|Triazoles
DB12074	Censavudine	small molecule	investigational	Anti-HIV Agents|Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Reverse Transcriptase Inhibitors
DB12075	Nagrestipen	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Chemokines|Chemotactic Factors|Cytokines|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB12076	Surotomycin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Lipids|Peptides
DB12077	Urelumab	biotech	investigational	
DB12078	Enobosarm	small molecule	investigational	
DB12079	Gefarnate	small molecule	investigational	Alimentary Tract and Metabolism|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Fatty Acids|Fatty Acids, Unsaturated|Gastrointestinal Agents|Lipids|Terpenes
DB12080	Ritobegron	small molecule	investigational	Acids, Acyclic|Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-3 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Ethylamines|Fatty Acids|Fatty Acids, Volatile|Lipids|Neurotransmitter Agents|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB12081	Anecortave	small molecule	investigational	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Angiogenesis Inhibitors|Angiogenesis Modulating Agents|Antineoplastic Agents|Antineovascularisation Agents|Growth Inhibitors|Growth Substances|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Ocular Vascular Disorder Agents|Ophthalmologicals|Pregnanes|Pregnenediones|Pregnenes|Sensory Organs|Steroids
DB12082	Vesnarinone	small molecule	investigational	Adjuvants, Immunologic|Anti-Infective Agents|Antineoplastic Agents|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Immunologic Factors|Phosphodiesterase Inhibitors|Protective Agents
DB12083	Mafosfamide	small molecule	investigational	Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Anions|Antineoplastic Agents|Electrolytes|Hydrocarbons, Halogenated|Immunologic Factors|Ions|Mustard Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB12084	ADP-597	small molecule	investigational	
DB12085	LCL-161	small molecule	investigational	Antineoplastic Agents|Proto-Oncogene Proteins c-bcl-2, antagonists & inhibitors|Sulfur Compounds
DB12086	Oxitropium	small molecule	investigational	Agents producing tachycardia|Alkaloids|Anticholinergic Agents|Autonomic Agents|Aza Compounds|Azabicyclo Compounds|Drugs for Obstructive Airway Diseases|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Tropanes
DB12087	Vanillyl alcohol	small molecule	investigational	Alcohols|Benzene Derivatives|Benzyl Compounds
DB12088	TT-232	small molecule	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary Hormone Release Inhibiting Hormones|Proteins
DB12089	Lorvotuzumab mertansine	biotech	investigational	Amides|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Antibodies|Blood Proteins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Globulins|Immunoglobulins|Immunoproteins|Lactams|Lactams, Macrocyclic|Lactones|Macrolides|Polyketides|Proteins|Serum Globulins
DB12090	Patritumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12091	Gadolinium	small molecule	approved|investigational	Anti-Inflammatory Agents|Contrast Media|Diagnostic Uses of Chemicals|Elements|Lanthanoid Series Elements|Metals|Metals, Rare Earth
DB12092	Naftopidil	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antiarrhythmic agents|Antihypertensive Agents|Antiplatelet agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|Membrane Transport Modulators|Neurotransmitter Agents|Vasodilating Agents
DB12093	Tetrahydropalmatine	small molecule	investigational	Adrenergic Agents|Agents causing hyperkalemia|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Antiarrhythmic agents|Antihypertensive Agents|Antipsychotic Agents|Benzylisoquinolines|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Isoquinolines|Membrane Transport Modulators|Neurotoxic agents|Neurotransmitter Agents|Peripheral Nervous System Agents|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Sensory System Agents|Tranquilizing Agents|Vasodilating Agents
DB12094	Semapimod	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Central Nervous System Agents|Hydrazines|Immunologic Factors|Peripheral Nervous System Agents|Sensory System Agents
DB12095	Telotristat ethyl	small molecule	approved|investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Tryptophan Hydroxylase Inhibitor
DB12096	PF-05175157	small molecule	investigational	
DB12097	Mannitol busulfan	small molecule	approved|investigational	Agents causing hyperkalemia
DB12098	L-Baclofen	small molecule	investigational	
DB12099	UK-396,082	small molecule	investigational	Amino Acids, Peptides, and Proteins
DB12100	Abediterol	small molecule	investigational	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Quinolines
DB12101	CC-220	small molecule	investigational	
DB12102	Fulranumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12104	Tarextumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12105	Imagabalin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Anxiety Agents|Central Nervous System Depressants
DB12106	PF-06305591	small molecule	investigational	
DB12107	Vaborbactam	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|beta-Lactamase Inhibitors|Boron Compounds
DB12108	Taselisib	small molecule	investigational	Antineoplastic Agents|Azepines|Phosphatidylinositol 3-Kinases, antagonists & inhibitors
DB12109	CPI-613	small molecule	investigational	Acids|Acids, Acyclic|Acids, Noncarboxylic|Anions|Electrolytes|Fatty Acids|Gases|Hydrogen Sulfide|Ions|Lipids|Sulfur Compounds
DB12110	m-Chlorophenylpiperazine	small molecule	investigational	Central Nervous System Depressants|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB12111	MK-212	small molecule	investigational	Central Nervous System Agents|Central Nervous System Depressants|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists
DB12112	Zuretinol acetate	small molecule	investigational	Adjuvants, Immunologic|Alkenes|Anticarcinogenic Agents|Antineoplastic Agents|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Immunologic Factors|Pigments, Biological|Polyenes|Protective Agents|Retinoids|Terpenes
DB12113	CE-224535	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Purinergic P2X Receptor Agonists|Pyrimidines|Pyrimidinones
DB12114	Poziotinib	small molecule	investigational	
DB12115	AZD-9164	small molecule	investigational	Receptor, Muscarinic M3, antagonists & inhibitors
DB12116	Epigallocatechin gallate	small molecule	investigational	Anticarcinogenic Agents|Antimutagenic Agents|Antineoplastic Agents|Antioxidants|Benzopyrans|Central Nervous System Agents|Chromans|Chromones|Flavonoids|Neuroprotective Agents|Protective Agents|Pyrans|Radiation-Protective Agents|Urokinase-Type Plasminogen Activator, antagonists & inhibitors
DB12117	Mitometh	small molecule	investigational	Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated
DB12118	Sotatercept	biotech	investigational	Amino Acids, Peptides, and Proteins|Immunoglobulin G|Immunoglobulins|Proteins|Recombinant Proteins|Serum Globulins
DB12119	Gevokizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12120	Avoralstat	small molecule	investigational	
DB12121	Entospletinib	small molecule	investigational	Pyrazoles
DB12122	Figopitant	small molecule	investigational	Acetamides|Acetates|Acids, Acyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids
DB12123	Cinepazide	small molecule	investigational	Peripheral Vasodilators
DB12124	Namitecan	small molecule	investigational	Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic
DB12125	Dianicline	small molecule	investigational	
DB12126	Bradykinin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Autacoids|Biological Factors|Cardiovascular Agents|Inflammation Mediators|Intercellular Signaling Peptides and Proteins|Kinins|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptides|Proteins|Vasodilating Agents
DB12127	Sultamicillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Sulfur Compounds
DB12128	Ulimorelin	small molecule	investigational	
DB12129	Tideglusib	small molecule	investigational|withdrawn	Glycogen Synthase Kinase 3, antagonists & inhibitors|Sulfur Compounds|Thiazoles
DB12130	Lorlatinib	small molecule	approved|investigational	Amides|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 Enzyme Inducers|Lactams
DB12131	Vinpocetine	small molecule	investigational	Agents causing hyperkalemia|Alkaloids|Antiarrhythmic agents|Anticonvulsants|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Enzyme Inhibitors|Indole Alkaloids|Indoles|Nervous System|Neuroprotective Agents|Nootropic Agents|Phosphodiesterase Inhibitors|Protective Agents|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Secologanin Tryptamine Alkaloids|Vasodilating Agents
DB12132	Vanutide cridificar	biotech	investigational	Amino Acids, Peptides, and Proteins|Proteins|Recombinant Proteins
DB12133	BLXA4	small molecule	investigational	
DB12134	Gepotidacin	small molecule	investigational	
DB12135	Elubrixin	small molecule	investigational	Amides|Benzene Derivatives|Receptors, Interleukin-8B, antagonists & inhibitors|Sulfones|Sulfur Compounds|Urea
DB12136	Solnatide	biotech	investigational	
DB12137	GSK-256066	small molecule	investigational	Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors|Quinolines|Sulfur Compounds
DB12138	PF-03715455	small molecule	investigational	Aza Compounds|p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors|Urea
DB12139	Alisporivir	small molecule	investigational	Amino Acids, Peptides, and Proteins|Cyclosporin Derivatives|Peptides|Peptides, Cyclic
DB12140	Dilmapimod	small molecule	investigational	p38 Mitogen-Activated Protein Kinases, antagonists & inhibitors|Pyridines
DB12141	Gilteritinib	small molecule	approved|investigational	Amines|Antineoplastic Agents|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|MATE 1 Inhibitors|MATE inhibitors|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents|Tyrosine Kinase Inhibitors
DB12142	Duligotuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antineoplastic Agents|Blood Proteins|Globulins|Immunoglobulin Isotypes|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12143	Rezatomidine	small molecule	investigational	
DB12144	BMS-275183	small molecule	investigational	
DB12145	AZD-0328	small molecule	investigational	Receptors, Nicotinic
DB12146	Rigosertib	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Sulfur Compounds
DB12147	Erdafitinib	small molecule	investigational	
DB12148	Menatetrenone	small molecule	investigational	Coagulants|Diterpenes|Hematologic Agents|Hemostatics|Naphthalenes|Naphthoquinones|Phytol|Quinones|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble)
DB12149	S-3304	small molecule	investigational	Enzyme Inhibitors|Matrix Metalloproteinase Inhibitors|Protease Inhibitors|Sulfur Compounds
DB12150	Pelubiprofen	small molecule	investigational	Acids, Carbocyclic
DB12151	Brincidofovir	small molecule	investigational	Nephrotoxic agents|Organophosphorus Compounds|Pyrimidines|Pyrimidinones
DB12152	Simtuzumab	biotech	investigational	
DB12153	Citicoline	small molecule	approved|experimental	Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Carbohydrates|Central Nervous System Agents|Choline|Cytidine Diphosphate|Cytosine Nucleotides|Ethanolamines|Glycosides|Nervous System|Nitrogen Compounds|Nootropic Agents|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Onium Compounds|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Pyrimidine Nucleotides|Pyrimidines|Quaternary Ammonium Compounds|Ribonucleotides|Trimethyl Ammonium Compounds
DB12154	Itacitinib	small molecule	investigational	Azetines|Pyridines
DB12155	Napabucasin	small molecule	investigational	
DB12156	Cordycepin	small molecule	investigational	Adenosine|Anti-Infective Agents|Antifungal Agents|Antineoplastic Agents|Carbohydrates|Deoxyribonucleosides|Glycosides|Mutagens|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides|Toxic Actions
DB12157	Fasinumab	biotech	investigational	
DB12158	Filorexant	small molecule	investigational	
DB12159	Dupilumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Anti-Asthmatic Agents|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Interleukin 4 Receptor alpha Antagonists|Interleukin-4 Receptor alpha Antagonist|Misc. Skin and Mucous Membrane Agents|Proteins|Serum Globulins
DB12160	Bucillamine	small molecule	investigational	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antiinflammatory and Antirheumatic Products|Antioxidants|Central Nervous System Agents|Musculo-Skeletal System|Penicillamine and Similar Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents|Specific Antirheumatic Agents|Sulfhydryl Compounds|Sulfur Compounds
DB12161	Deutetrabenazine	small molecule	approved|investigational	Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Highest Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolizines
DB12162	HX-1171	small molecule	investigational	
DB12163	Sarpogrelate	small molecule	investigational	Acids, Acyclic|Antiplatelet agents|Cardiovascular Agents|Central Nervous System Depressants|Dicarboxylic Acids|Fibrin Modulating Agents|Hematologic Agents|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Antagonists
DB12165	Presatovir	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12167	LY-3023414	small molecule	investigational	
DB12168	MK-0557	small molecule	investigational	Cycloparaffins
DB12169	Tralokinumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Asthma, drug therapy|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Interleukin-13|Proteins|Serum Globulins
DB12170	Veledimex	small molecule	investigational	
DB12171	ATU-027	biotech	investigational	
DB12172	Nimorazole	small molecule	investigational	Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antitrichomonal Agents|Imidazoles|Nitro Compounds|Nitroimidazole Derivatives|Nitroimidazoles
DB12173	Diphencyprone	small molecule	investigational	Cycloparaffins
DB12174	CUDC-101	small molecule	investigational	Amines|Antineoplastic Agents|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB12176	Tricaprylin	small molecule	investigational	Acids, Acyclic|Alzheimer Disease, drug therapy|Drug Delivery Systems|Excipients|Fatty Acids|Glycerides|Lipids|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles
DB12177	Eplivanserin	small molecule	investigational	Benzene Derivatives|Cardiovascular Agents|Central Nervous System Depressants|Fibrin Modulating Agents|Hematologic Agents|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Antagonists
DB12178	Telinavir	small molecule	investigational	
DB12179	Secoisolariciresinol	small molecule	investigational	Alcohols|Benzene Derivatives|Benzyl Compounds|Estrogens, Non-Steroidal|Glycols|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens
DB12180	Apitolisib	small molecule	investigational	Phosphatidylinositol 3-Kinase, antagonists & inhibitors
DB12181	Dalcetrapib	small molecule	investigational	Anticholesteremic Agents|Hypolipidemic Agents|Lipid Regulating Agents|Noxae|Sulfur Compounds|Toxic Actions
DB12182	Binetrakin	biotech	investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Biological Factors|Cytokines|Immunologic Factors|Intercellular Signaling Peptides and Proteins|Interleukins|Peptides|Proteins
DB12183	Sapitinib	small molecule	investigational	
DB12184	Gepirone	small molecule	investigational	Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Neurotransmitter Agents|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tranquilizing Agents
DB12185	Exatecan	small molecule	investigational	Alkaloids|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors
DB12186	SRT-2104	small molecule	investigational	Enzyme Activators
DB12187	Abacavir hydroxyacetate	small molecule	investigational	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DB12188	Zicronapine	small molecule	investigational	
DB12189	Etrolizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12190	Faropenem	small molecule	investigational	Amides|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Lactams|Sulfur Compounds
DB12191	Obatoclax	small molecule	investigational	
DB12192	Emeramide	small molecule	investigational	
DB12193	Ajulemic acid	small molecule	investigational	Agents producing tachycardia|Cannabinoids and similars|Terpenes
DB12194	Atamestane	small molecule	investigational	17-Ketosteroids|Adrenal Cortex Hormones|Androstanes|Androstenes|Enzyme Inhibitors|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Ketosteroids|Steroids|Testosterone Congeners
DB12195	VP-14637	small molecule	investigational	Benzene Derivatives
DB12196	CP-866087	small molecule	investigational	
DB12197	Auriclosene	small molecule	investigational	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Hydrocarbons, Acyclic|Sulfonic Acids|Sulfur Acids|Sulfur Compounds
DB12198	Fosdagrocorat	small molecule	investigational	
DB12199	TRV-120027	small molecule	investigational	
DB12200	Tivantinib	small molecule	investigational	Proto-Oncogene Proteins c-met, antagonists & inhibitors|Pyrrolidines
DB12201	PF-03654746	small molecule	investigational	Cycloparaffins|Histamine H3 Antagonists
DB12202	Zalutumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12203	Tozadenant	small molecule	investigational	Sulfur Compounds|Thiazoles
DB12204	Terbogrel	small molecule	investigational	
DB12205	Ganitumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12206	N-6022	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12207	Verdinexor	small molecule	investigational	Acids, Acyclic|Acrylates|Amides
DB12208	Iron isomaltoside 1000	small molecule	approved|investigational	Carbohydrates|Iron Compounds|Oligosaccharides|Organometallic Compounds|Polysaccharides
DB12209	Tirasemtiv	small molecule	investigational	
DB12210	AZD-6280	small molecule	investigational	Receptors, Opioid, delta, agonists
DB12211	PSI-697	small molecule	investigational	P-Selectin|Quinolines
DB12212	Landiolol	small molecule	investigational	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antiarrhythmic agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Oxazines
DB12213	Etaracizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12214	Luseogliflozin	small molecule	investigational	Alcohols|Carbohydrates|Sugar Alcohols
DB12216	Bergapten	small molecule	investigational	Antipsoriatics|Antipsoriatics for Systemic Use|Benzopyrans|Coumarins|Dermatitis, Phototoxic|Dermatologicals|Dermotoxins|Furocoumarins|Photosensitizing Agents|Psoralens for Systemic Use|Pyrans|Radiation-Sensitizing Agents
DB12218	AZD-5363	small molecule	investigational	Proto-Oncogene Proteins c-akt, antagonists & inhibitors
DB12219	GSK-424887	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids
DB12220	ORG-25935	small molecule	investigational	Naphthalenes
DB12221	Canrenone	small molecule	investigational	Agents causing hyperkalemia|Cardiovascular Agents|Diuretics|Diuretics, Potassium Sparing|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Mineralocorticoid Receptor Antagonists|Natriuretic Agents|Potassium-Sparing Agents|Pregnadienes|Pregnanes|Steroids
DB12222	Lurtotecan	small molecule	investigational	Alkaloids|Antineoplastic Agents
DB12223	Squaric Acid Dibutyl Ester	small molecule	investigational	Adjuvants, Immunologic|Allergens|Cycloparaffins|Immunologic Factors
DB12224	Oxothiazolidinecarboxylic acid	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Acidic|Amino Acids, Cyclic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Glutamates|Imines|Imino Acids|Pyrrolidines|Pyrrolidinones|Sulfur Compounds|Thiazoles
DB12225	Beclabuvir	small molecule	investigational	Antiviral Agents
DB12226	Terameprocol	small molecule	investigational	Benzene Derivatives|Benzyl Compounds|Catechols|Lignans|Phenols
DB12227	Tetulomab tetraxetan Lu-177	small molecule	investigational	
DB12228	Telcagepant	small molecule	investigational	
DB12229	Cerlapirdine	small molecule	investigational	Central Nervous System Depressants|Pyrazoles|Serotonin Agents|Serotonin Receptor Antagonists|Sulfur Compounds
DB12230	Bunazosin	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Neurotransmitter Agents
DB12231	Temefos	small molecule	investigational	Agrochemicals|Insecticides|Organophosphates|Organophosphorus Compounds|Organothiophosphates|Organothiophosphorus Compounds|Pesticides|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sulfur Compounds|Toxic Actions
DB12232	KRN-7000	small molecule	investigational	Adjuvants, Immunologic|Amides|Antineoplastic Agents|Carbohydrates|Ceramides|Cerebrosides|Glycoconjugates|Glycolipids|Glycosphingolipids|Immunologic Factors|Lipids|Membrane Lipids|Neutral Glycosphingolipids|Sphingolipids
DB12233	Iguratimod	small molecule	investigational	Amides|Benzopyrans|Pyrans|Sulfones|Sulfur Compounds
DB12234	BMS-214662	small molecule	investigational	Benzazepines
DB12235	Estetrol	small molecule	investigational	Estradiol Congeners|Estranes|Estrenes|Estriol|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB12236	Bexagliflozin	small molecule	investigational	
DB12237	GW-274150	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Nitric Oxide Synthase, antagonists & inhibitors|Sulfur Compounds
DB12238	MK-0777	small molecule	investigational	
DB12239	Balicatib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12240	Polatuzumab Vedotin	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12241	TAK-733	small molecule	investigational	Pyridines|Pyrimidines
DB12242	AZD-7762	small molecule	investigational	Sulfur Compounds
DB12243	Edaravone	small molecule	approved|investigational	Antioxidants|Free Radical Scavengers|OAT3/SLC22A8 Substrates|Protective Agents|Pyrazoles|Pyrazolones
DB12244	CP-601927	small molecule	investigational	
DB12245	Triclabendazole	small molecule	investigational	Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antitrematodals
DB12246	Inclacumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12247	AZD-4547	small molecule	investigational	
DB12248	Tulobuterol	small molecule	investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Alcohols|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB12249	Stem bromelain	biotech	approved|investigational	Cysteine Endopeptidases|Cysteine Proteases|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Peptide Hydrolases
DB12250	Cixutumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Radiation-Sensitizing Agents|Receptor, IGF Type 1|Serum Globulins
DB12251	Moxaverine	small molecule	investigational	Alimentary Tract and Metabolism|Alkaloids|Autonomic Agents|Benzylisoquinolines|Drugs for Functional Gastrointestinal Disorders|Isoquinolines|Opiate Alkaloids|Papaverine and Derivatives|Parasympatholytics|Peripheral Nervous System Agents
DB12252	PG-701	small molecule	investigational	
DB12253	GDC-0810	small molecule	investigational	Acids, Carbocyclic|Pyrazoles
DB12254	ABT-751	small molecule	investigational	Amides|Amines|Aniline Compounds|Benzene Derivatives|Phenols|Sulfones|Sulfur Compounds
DB12255	Vadadustat	small molecule	investigational	
DB12256	Bamosiran	biotech	investigational	
DB12257	Platinum	small molecule	investigational	Antineoplastic Agents|Chlorine Compounds|Cross-Linking Reagents|Elements|Indicators and Reagents|Laboratory Chemicals|Metals|Metals, Heavy|Nitrogen Compounds|Platinum Compounds|Radiation-Sensitizing Agents|Transition Elements
DB12258	Abicipar Pegol	biotech	investigational	Pegylated agents
DB12259	CG-200745	small molecule	investigational	Amines|Antineoplastic Agents|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines
DB12260	Radiprodil	small molecule	investigational	
DB12261	Ascrinvacumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12262	CRS-3123	small molecule	investigational	Methionine-tRNA Ligase, antagonists & inhibitors|Pyrans|Sulfur Compounds
DB12263	Begacestat	small molecule	investigational	Amides|Amyloid Precursor Protein Secretases|Sulfones|Sulfur Compounds
DB12264	Atevirdine	small molecule	investigational	Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Reverse Transcriptase Inhibitors
DB12265	Fexinidazole	small molecule	investigational	Imidazoles|Nitro Compounds
DB12266	Epofolate	small molecule	investigational	Anti-Bacterial Agents|Antineoplastic Agents|Biological Factors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Pigments, Biological|Polyketides|Pteridines|Pterins
DB12267	Brigatinib	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P450 3A Inducers|Kinase Inhibitor|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Tyrosine Kinase Inhibitors
DB12268	Carmegliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|Dipeptidyl Peptidase 4|DPP-IV Inhibitors
DB12269	PF-06273340	small molecule	investigational	
DB12270	Losmapimod	small molecule	investigational	Cycloparaffins|p38 Mitogen-Activated Protein Kinases|Protein Kinase Inhibitors
DB12271	ORE-1001	small molecule	investigational	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB12272	Vidupiprant	small molecule	investigational	Acids, Carbocyclic|Amides|Sulfones|Sulfur Compounds
DB12273	Ecopipam	small molecule	investigational	Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents
DB12274	Aducanumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12275	Seviteronel	small molecule	investigational	
DB12276	Apomine	small molecule	investigational	Organophosphonates|Organophosphorus Compounds
DB12277	Polihexanide	small molecule	approved|investigational	Amidines|Anti-Infective Agents|Antiseptics and Disinfectants|Biguanides and Amidines|Dermatologicals|Disinfectants|Guanidines
DB12278	Propiverine	small molecule	approved|investigational	Acids, Carbocyclic|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents producing tachycardia|Agents that produce hypertension|Anticholinergic Agents|Autonomic Agents|Cholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diphenylacetic Acids|Drugs for Urinary Frequency and Incontinence|Genito Urinary System and Sex Hormones|Hydroxy Acids|Muscarinic Antagonists|Neurotransmitter Agents|Parasympatholytics|Peripheral Nervous System Agents|Phenylacetates|Urological Agents|Urologicals
DB12279	OBP-801	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Histone Deacetylase Inhibitors|Peptides
DB12280	AZD-5423	small molecule	investigational	Acetates|Acids, Acyclic|Amides|Anti-Asthmatic Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Pyrazoles|Receptors, Glucocorticoid, agonists
DB12281	Luspatercept	biotech	investigational	
DB12282	Defactinib	small molecule	investigational	Focal Adhesion Kinase 1, antagonists & inhibitors
DB12283	Balapiravir	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides
DB12284	LY-2608204	small molecule	investigational	
DB12285	Verubecestat	small molecule	investigational	
DB12286	Simendan	small molecule	investigational	Antiarrhythmic agents|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Hydrazines|Moderate Risk QTc-Prolonging Agents|Phosphodiesterase Inhibitors|Protective Agents|QTc Prolonging Agents|Vasodilating Agents
DB12287	Talsaclidine	small molecule	investigational	
DB12288	Piromelatine	small molecule	investigational	
DB12289	Darexaban	small molecule	investigational	Acids, Carbocyclic|Amides|Anticoagulants|Antithrombins|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Factor Xa Inhibitors|Hematologic Agents|Protease Inhibitors|Serine Proteinase Inhibitors
DB12290	Puerarin	small molecule	investigational	Benzopyrans|Cardiovascular Agents|Chromones|Flavonoids|Pyrans|Vasodilating Agents
DB12291	Tacedinaline	small molecule	investigational	
DB12292	Barusiban	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides|Receptors, Oxytocin, antagonists & inhibitors
DB12293	Nefopam	small molecule	approved|investigational	Analgesics|Analgesics, Non-Narcotic|Azocines|Central Nervous System Agents|Nervous System|Oxazocines|Peripheral Nervous System Agents|Sensory System Agents
DB12294	Anrukinzumab	biotech	investigational	
DB12295	Evodenoson	small molecule	investigational	
DB12296	GS-5745	biotech	investigational	
DB12297	GLPG-0187	small molecule	investigational	
DB12298	5-(hydroxymethyl)-2-furaldehyde	small molecule	investigational	
DB12299	Bavisant	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Histamine H3 Antagonists
DB12300	P-nitrobiphenyl	small molecule	approved|experimental|investigational	
DB12301	Doravirine	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Pyridines
DB12302	CP-724714	small molecule	investigational	Receptor, ErbB-2, antagonists & inhibitors
DB12303	Motolimod	small molecule	investigational	Toll-Like Receptor 8, agonists
DB12304	Entolimod	biotech	investigational	Amino Acids, Peptides, and Proteins
DB12305	Dasotraline	small molecule	investigational	Amines|Cycloparaffins|Naphthalenes
DB12306	Cipargamin	small molecule	investigational	
DB12307	Foretinib	small molecule	investigational	Amides|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors|Tyrosine Kinase Inhibitors
DB12308	Eltanolone	small molecule	investigational	Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Pregnanes|Steroids
DB12309	GI-181771X	small molecule	investigational	Benzazepines|Receptor, Cholecystokinin A, agonists
DB12310	Trehalose	small molecule	investigational	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Disaccharides|Glucans|Macromolecular Substances|Oligosaccharides|Polymers|Polysaccharides
DB12311	CP1-1189	small molecule	investigational	Alkanes|Hydrocarbons, Acyclic
DB12312	ORG-25435	small molecule	investigational	Benzene Derivatives
DB12313	Dopexamine	small molecule	approved|investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic and Dopaminergic Agents|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Amines|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|Dopamine Agents|Dopamine Agonists|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Vasodilating Agents
DB12314	Chlorproguanil	small molecule	investigational	Amidines|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiprotozoals|Biguanides|Guanidines
DB12316	9CUAB30	small molecule	investigational	Fatty Acids|Lipids
DB12317	Vanucizumab	biotech	investigational	
DB12318	BMS-599626	small molecule	investigational	Acids, Acyclic|Receptor, Epidermal Growth Factor, antagonists & inhibitors
DB12319	Benzbromarone	small molecule	investigational|withdrawn	Antigout Preparations|Benzofurans|BSEP/ABCB11 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Musculo-Skeletal System|OATP1B1/SLCO1B1 Inhibitors|Preparations Increasing Uric Acid Excretion|Renal Agents|Uricosuric Agents
DB12320	Palovarotene	small molecule	investigational	Benzene Derivatives|Benzylidene Compounds
DB12321	Ifetroban	small molecule	investigational	Antiplatelet agents|Hematologic Agents
DB12322	GW-870086	small molecule	investigational	
DB12323	Radotinib	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Tyrosine Kinase Inhibitors
DB12325	Idasanutlin	small molecule	investigational	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Proto-Oncogene Proteins c-mdm2, antagonists & inhibitors
DB12326	Antroquinonol	small molecule	investigational	Benzoquinones|Coenzymes|Enzymes and Coenzymes|Quinones
DB12327	Salvinorin A	small molecule	investigational	Diterpenes|Salvia|Terpenes
DB12328	Cantharidin	small molecule	approved|investigational	Benzofurans|Enzyme Inhibitors|Irritants|Noxae|Toxic Actions
DB12329	Eravacycline	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Naphthacenes
DB12330	Blisibimod	biotech	investigational	Amino Acids, Peptides, and Proteins|B-Cell Activating Factor|Immunologic Factors|Proteins|Recombinant Proteins
DB12331	Labetuzumab govitecan	biotech	investigational	
DB12332	Rucaparib	small molecule	approved|investigational	Antineoplastic Agents|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inducers|Cytochrome P-450 CYP1A2 Inducers (moderate)|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (weak)|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (weak)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Poly(ADP-ribose) Polymerase Inhibitors|UGT1A1 Inhibitors
DB12333	SPK-843	small molecule	investigational	Alkenes|Hydrocarbons, Acyclic
DB12334	Milataxel	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Taxoids|Terpenes
DB12335	Tanezumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Receptor, Nerve Growth Factor, antagonists & inhibitors|Serum Globulins
DB12336	GDC-0917	small molecule	investigational	
DB12337	N-acetylsulfanilyl chloride	small molecule	investigational	
DB12338	Carisbamate	small molecule	investigational	Acids, Acyclic|Anticonvulsants|Central Nervous System Depressants|Nervous System
DB12339	Radezolid	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Oxazoles
DB12340	Navitoclax	small molecule	investigational	Amides|Amines|Antineoplastic Agents|Sulfones|Sulfur Compounds
DB12341	LY-2456302	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12342	Ensituximab	biotech	investigational	
DB12343	Temocillin	small molecule	approved|investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB12344	Fezakinumab	biotech	investigational	
DB12345	MBX-2982	small molecule	investigational	Sulfur Compounds
DB12346	Vatelizumab	biotech	investigational	
DB12347	CG-400549	small molecule	investigational	Sulfur Compounds
DB12348	5-amino-1,3,4-thiadiazole-2-thiol	small molecule	investigational	Sulfur Compounds|Thiazoles
DB12349	Dulanermin	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Peptides|Proteins|Recombinant Proteins|Tumor Necrosis Factors
DB12350	Rostafuroxin	small molecule	investigational	Androstanes|Steroids
DB12351	Siagoside	small molecule	investigational	Acidic Glycosphingolipids|Carbohydrates|Gangliosides|Glycoconjugates|Glycolipids|Glycosphingolipids|Lipids|Membrane Lipids|Sphingolipids
DB12352	Bizelesin	small molecule	investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Cross-Linking Reagents|Indicators and Reagents|Laboratory Chemicals|Noxae|Toxic Actions
DB12353	Ulodesine	small molecule	investigational	Carbohydrates|Imines|Imino Sugars|Monosaccharides|Pyrimidines|Pyrrolidines
DB12354	Imrecoxib	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Hydrogen Sulfide|Ions|Sulfur Compounds
DB12355	Netazepide	small molecule	investigational	Benzazepines|Benzene Derivatives|Receptors, Cholecystokinin, antagonists & inhibitors|Urea
DB12356	Fletikumab	biotech	investigational	
DB12357	BMS-863233	small molecule	investigational	
DB12358	Enbucrilate	small molecule	investigational	Acids, Acyclic|Acrylates|Biomedical and Dental Materials|Cyanoacrylates|Equipment and Supplies|Macromolecular Substances|Nitriles|Polymers|Surgical Equipment|Surgical Fixation Devices|Tissue Adhesives
DB12359	BIIB021	small molecule	investigational	HSP90 Heat-Shock Proteins, antagonists & inhibitors|Purines
DB12360	PF-03654764	small molecule	investigational	Cycloparaffins|Histamine H3 Antagonists
DB12361	Piclozotan	small molecule	investigational	Agents that produce hypertension|Azepines|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin 5-HT1 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB12362	Diaminopropanol tetraacetic acid	small molecule	approved|investigational	
DB12363	Dusigitumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12364	Betrixaban	small molecule	approved|investigational	Acids, Carbocyclic|Amides|Anticoagulants|Benzene Derivatives|Benzoates|Factor Xa Inhibitors|P-glycoprotein/ABCB1 Substrates
DB12365	Perzinfotel	small molecule	investigational	Aza Compounds|Organophosphorus Compounds
DB12366	Vestronidase alfa	biotech	approved|investigational	Lysosomal beta Glucuronidase
DB12367	Selurampanel	small molecule	investigational	Quinazolines
DB12368	AZD-3839	small molecule	investigational	
DB12369	Sotrastaurin	small molecule	investigational	
DB12370	Ipamorelin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB12371	Siponimod	small molecule	investigational	Azetines|Benzene Derivatives
DB12373	Isunakinra	biotech	investigational	Amino Acids, Peptides, and Proteins
DB12374	Velmanase alfa	biotech	investigational	
DB12375	Oglemilast	small molecule	investigational	
DB12376	Ricolinostat	small molecule	investigational	Amines|Antineoplastic Agents|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB12377	Relebactam	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Aza Compounds|beta-Lactamase Inhibitors|Enzyme Inhibitors
DB12378	Apricoxib	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12379	Indirubin	small molecule	investigational	Antibiotics, Antineoplastic|Antineoplastic Agents|Coloring Agents|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Protein Kinase Inhibitors
DB12380	GDC-0152	small molecule	investigational	Cycloparaffins
DB12381	Merestinib	small molecule	investigational	Antineoplastic Agents|Nicotinic Acids|Protein Kinase Inhibitors|Pyrazoles|Pyridines
DB12382	R-306465	small molecule	investigational	Amines|Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Sulfur Compounds
DB12383	Cytochlor	small molecule	investigational	
DB12384	AR-67	small molecule	investigational	Alkaloids
DB12385	10-hydroxycamptothecin	small molecule	investigational	Alkaloids|Antineoplastic Agents|Antineoplastic Agents, Phytogenic
DB12386	Bacillus calmette-guerin substrain danish 1331 live antigen	biotech	investigational	Live Attenuated Bacillus Calmette-Guerin Vaccine|Live vaccines|Vaccines
DB12387	OSI-027	small molecule	investigational	
DB12388	Evocalcet	small molecule	investigational	
DB12389	Zamicastat	small molecule	investigational	
DB12390	MBX-8025	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|PPAR delta, agonists
DB12391	Sagopilone	small molecule	investigational	Anti-Bacterial Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Polyketides|Sulfur Compounds|Thiazoles
DB12392	Resminostat	small molecule	investigational	Amides|Amines|Hydroxy Acids|Hydroxylamines|Sulfones|Sulfur Compounds
DB12393	Fanapanel	small molecule	investigational	Organophosphorus Compounds
DB12394	Eleclazine	small molecule	investigational	
DB12395	Esreboxetine	small molecule	investigational	Adrenergic Uptake Inhibitors|Central Nervous System Depressants|Oxazines
DB12396	Fresolimumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12397	DSM-265	small molecule	investigational	
DB12398	Naproxen etemesil	small molecule	investigational	
DB12399	Polmacoxib	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12400	Voxtalisib	small molecule	investigational	Amides|Phosphatidylinositol 3-Kinase, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB12401	Bromperidol	small molecule	approved|investigational	Antipsychotic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Ketones|Nervous System|Neurotoxic agents|P-glycoprotein/ABCB1 Substrates|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB12402	Pumosetrag	small molecule	investigational	
DB12403	Samarium	small molecule	investigational	Elements|Lanthanoid Series Elements|Metals|Metals, Rare Earth
DB12404	Remimazolam	small molecule	investigational	Benzazepines
DB12405	Triciribine	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides
DB12406	Lisofylline	small molecule	investigational	Adjuvants, Immunologic|Alkaloids|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Immunologic Factors|Peripheral Nervous System Agents|Purines|Purinones|Radiation-Sensitizing Agents|Sensory System Agents|Theobromine|Xanthine derivatives
DB12407	Iobitridol	small molecule	approved|investigational	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Triiodobenzoic Acids|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB12408	PF-03635659	small molecule	investigational	Acids, Carbocyclic|Azetines|Phenylacetates|Receptor, Muscarinic M3, antagonists & inhibitors
DB12409	Vatreptacog alfa	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Factor VII|Hydrolases|Peptide Hydrolases|Proteins|Serine Endopeptidases|Serine Proteases
DB12410	Sabarubicin	small molecule	investigational	Anthracyclines|Carbohydrates|Daunorubicin|Glycosides|Naphthacenes|Oligosaccharides|Polysaccharides
DB12411	R-428	small molecule	investigational	
DB12412	Gemigliptin	small molecule	investigational	Agents causing angioedema|Alimentary Tract and Metabolism|Blood Glucose Lowering Agents|Diabetes Mellitus, Type 2, drug therapy|DPP-IV Inhibitors|Drugs Used in Diabetes|Oral Hypoglycemics|Piperidines
DB12413	Indusatumab vedotin	biotech	investigational	
DB12414	Usistapide	small molecule	investigational	
DB12415	Galeterone	small molecule	investigational	Androstanes|Androstenes|Prostatic Neoplasms, drug therapy|Steroids
DB12416	VTP-27999	small molecule	investigational	Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Renin-Inhibitors
DB12417	Anagliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|DPP-IV Inhibitors
DB12418	Saccharin	small molecule	investigational	Benzothiazoles|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Physiological Phenomena|Sulfur Compounds|Sweetening Agents|Thiazoles
DB12419	HSD-016	small molecule	investigational	Alcohols
DB12420	Diazepinomicin	small molecule	investigational	Terpenes
DB12421	Somavaratan	biotech	investigational	
DB12422	Sulforaphane	small molecule	investigational	Anticarcinogenic Agents|Antineoplastic Agents|Isocyanates|Protective Agents|Sulfur Compounds
DB12423	Fozivudine Tidoxil	small molecule	investigational	Carbohydrates|Deoxyribonucleosides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Thymidine
DB12424	MK-3207	small molecule	investigational	Receptors, Calcitonin Gene-Related Peptide, antagonists & inhibitors
DB12425	Liothyronine I-131	small molecule	investigational	
DB12426	Bitopertin	small molecule	investigational	Sulfur Compounds
DB12427	Orvepitant	small molecule	investigational	Central Nervous System Depressants
DB12428	PAC-14028	small molecule	investigational	Acids, Acyclic|Acrylates|Amides|TRPV Cation Channels, antagonists & inhibitors
DB12429	CI-1040	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Calcium-Calmodulin-Dependent Protein Kinases
DB12430	BC-3781	small molecule	investigational	Acetates|Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfhydryl Compounds|Sulfur Compounds|Terpenes
DB12431	Muplestim	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Interleukins|Peptides|Proteins
DB12432	CC-401	small molecule	investigational	JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors|Pyrazoles
DB12433	SCH-900271	small molecule	investigational	
DB12434	Steviolbioside	small molecule	approved|investigational	Diterpenes|Stevia|Sweetening Agents|Terpenes
DB12435	Tipelukast	small molecule	investigational	
DB12436	Vofopitant	small molecule	investigational	Antiemetics|Autonomic Agents|Central Nervous System Agents|Gastrointestinal Agents|Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents|Peripheral Nervous System Agents
DB12438	Filociclovir	small molecule	investigational	
DB12439	Ioforminol	small molecule	investigational	Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Formates|Iodine Radioisotopes|Iodobenzoates
DB12440	Verdiperstat	small molecule	investigational	Pyrimidines
DB12441	Tavilermide	small molecule	investigational	
DB12442	Alvespimycin	small molecule	investigational	Amides|HSP90 Heat-Shock Proteins|Lactams|Quinones
DB12443	Sonedenoson	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB12444	Theanine	small molecule	investigational	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins
DB12445	Nitroaspirin	small molecule	investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiplatelet agents|Benzene Derivatives|Benzoates|Cardiovascular Agents|Central Nervous System Agents|Cysteine Proteinase Inhibitors|Enzyme Inhibitors|Fibrin Modulating Agents|Hematologic Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Peripheral Nervous System Agents|Phenols|Salicylates|Sensory System Agents
DB12446	Derenofylline	small molecule	investigational	
DB12447	Nadifloxacin	small molecule	investigational	Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Treatment of Acne|Antineoplastic Agents|Dermatologicals|Enzyme Inhibitors|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB12448	Lifibrol	small molecule	investigational	Acids, Carbocyclic|Alcohols|Benzene Derivatives|Benzoates|Fatty Alcohols|Hydroxy Acids|Lipids|Phenols
DB12449	Tempol	small molecule	investigational	Antioxidants|Central Nervous System Agents|Drug Synergism|Enzyme Inhibitors|Free Radicals|Neuroprotective Agents|Protective Agents|Protein Synthesis Inhibitors|Radiation-Protective Agents|Spin Labels
DB12450	Propyl Gallate	small molecule	investigational	Acids, Carbocyclic|Antioxidants|Benzene Derivatives|Benzoates|Gallic Acid|Hydroxy Acids|Hydroxybenzoates|Phenols|Protective Agents
DB12451	SCY-635	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides|Peptides, Cyclic
DB12452	Caprylic alcohol	small molecule	investigational	Alcohols|Fatty Alcohols|Lipids|Octanols|Solvents
DB12453	Chlorine Dioxide	small molecule	investigational	Anions|Anti-Infective Agents|Dental Disinfectants|Disinfectants|Electrolytes|Ions|Oxygen Compounds
DB12454	Zalypsis	small molecule	investigational	Alkaloids|Isoquinolines
DB12455	Omadacycline	small molecule	approved|investigational	Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Naphthacenes|P-glycoprotein/ABCB1 Substrates|Tetracyclines
DB12456	Bococizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12457	Rimegepant	small molecule	investigational	
DB12458	Muscimol	small molecule	investigational	Biological Factors|GABA Agents|GABA Agonists|GABA-A Receptor Agonists|Mycotoxins|Neurotransmitter Agents|Oxazoles|Toxins, Biological
DB12459	Belotecan	small molecule	investigational	Alkaloids|Antineoplastic Agents|Enzyme Inhibitors|Topoisomerase I Inhibitors|Topoisomerase Inhibitors
DB12460	Conbercept	biotech	investigational	Amino Acids, Peptides, and Proteins|Proteins|Recombinant Proteins
DB12461	GLPG-0492	small molecule	investigational	Androgens|Imidazoles|Imidazolidines
DB12462	Ralinepag	small molecule	investigational	
DB12463	Semagacestat	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Amyloid Precursor Protein Secretases, antagonists & inhibitors
DB12464	Bevenopran	small molecule	investigational	
DB12465	Ketanserin	small molecule	investigational	Antihypertensive Agents|Antiplatelet agents|Cardiovascular Agents|Central Nervous System Depressants|Hematologic Agents|Neurotransmitter Agents|Piperidines|Quinazolines|Quinazolinones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Antagonists
DB12466	Favipiravir	small molecule	investigational	
DB12467	TU-100	small molecule	investigational	DNA Topoisomerases, Type I|DNA Topoisomerases, Type II|Naphthalenes|Quinones|Topoisomerase Inhibitors
DB12468	Pf-04531083	small molecule	investigational	
DB12470	Dexelvucitabine	small molecule	investigational	Carbohydrates|Cytidine|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Glycosides|HIV Reverse Transcriptase|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12471	MK-3118	small molecule	investigational	Carbohydrates|Terpenes
DB12472	Levodropropizine	small molecule	investigational	Alcohols|Antitussive Agents|Central Nervous System Agents|Cough and Cold Preparations|Glycols|Respiratory System Agents
DB12473	Taurolidine	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Alkanes|Alkanesulfonic Acids|Anti-Infective Agents|Anti-Infective Agents, Local|Antineoplastic Agents|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Hydrocarbons, Acyclic|Irrigating Solutions|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Thiazines
DB12474	Lynestrenol	small molecule	approved|investigational	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estren Derivatives|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestin Contraceptives|Progestins|Progestogens and Estrogens, Sequential Preparations|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB12475	Biphenyl dimethyl dicarboxylate	small molecule	investigational	
DB12476	CPG-52852	small molecule	investigational	
DB12477	Perfluoro tert-butylcyclohexane	small molecule	investigational	
DB12478	Piribedil	small molecule	investigational	Anti-Dyskinesia Agents|Anti-Parkinson Agents (Dopamine Agonist)|Anti-Parkinson Drugs|Central Nervous System Agents|Dopamine Agents|Dopamine Agonists|Nervous System|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists|Piperazines
DB12479	Zabofloxacin	small molecule	investigational	Quinolines|Quinolones
DB12480	Betulinic Acid	small molecule	investigational	Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-HIV Agents|Anti-Infective Agents|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Retroviral Agents|Antimalarials|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antiparasitic Agents|Antiprotozoals|Antiviral Agents|Central Nervous System Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Peripheral Nervous System Agents|Prostaglandin Antagonists|Sensory System Agents|Terpenes
DB12481	Barium	small molecule	investigational	Elements|Metals|Metals, Alkaline Earth|Metals, Heavy
DB12482	Acotiamide	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Sulfur Compounds
DB12483	Copanlisib	small molecule	approved|investigational	BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Kinase Inhibitor|Kinase Inhibitors|MATE 2 Inhibitors|MATE inhibitors|P-glycoprotein/ABCB1 Substrates
DB12484	Tetrahydrouridine	small molecule	investigational	Antimetabolites|Carbohydrates|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions|Uridine
DB12485	Pimonidazole	small molecule	investigational	Imidazoles|Nitro Compounds|Radiation-Sensitizing Agents
DB12486	Elobixibat	small molecule	investigational	Amino Acids, Peptides, and Proteins|Azepines|Oligopeptides|Peptides|Sulfur Compounds|Thiepins
DB12487	Promestriene	small molecule	investigational	Estradiol Congeners|Estranes|Estrenes|Estrogens|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natural and Semisynthetic Estrogens, Plain|Sex Hormones and Modulators of the Genital System|Steroids
DB12489	Mirvetuximab Soravtansine	small molecule	investigational	Amides|Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Antibodies|Antibodies, Monoclonal|Blood Proteins|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Globulins|Immunoglobulins|Immunoproteins|Lactams|Lactams, Macrocyclic|Lactones|Macrolides|Polyketides|Proteins|Serum Globulins
DB12490	Forigerimod	biotech	investigational	Amino Acids, Peptides, and Proteins|Peptides|Ribonucleoprotein, U1 Small Nuclear
DB12491	Fasiglifam	small molecule	investigational	Sulfur Compounds
DB12492	Piritramide	small molecule	approved|investigational	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Diphenylpropylamine Derivatives|Isonipecotic Acids|Narcotics|Nervous System|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB12493	PD-217014	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Fatty Acids|Fatty Acids, Volatile|Ligands|Lipids
DB12494	SGI-1776	small molecule	investigational	
DB12495	Selepressin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormones|Pituitary Hormones, Posterior|Proteins|Receptors, Vasopressin, agonists|Vasopressin and Analogues|Vasopressins
DB12497	Alagebrium	small molecule	investigational	Sulfur Compounds
DB12498	Mogamulizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12499	Clascoterone	small molecule	investigational	17-Hydroxycorticosteroids|Acids, Acyclic|Adrenal Cortex Hormones|Fatty Acids|Fatty Acids, Volatile|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Lipids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB12500	Fedratinib	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12501	ABT-384	small molecule	investigational	11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors|Cycloparaffins
DB12504	JNJ-40346527	small molecule	investigational	
DB12505	E-7820	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12506	Fenamole	small molecule	investigational	
DB12507	Atecegatran metoxil	small molecule	investigational	Azetines
DB12508	E7107	small molecule	investigational	
DB12509	Imeglimin	small molecule	investigational	
DB12510	Ozone	small molecule	investigational	Chalcogens|Elements|Gases|Noxae|Oxidants|Oxidants, Photochemical|Oxygen|Toxic Actions
DB12511	Imiglitazar	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB12512	Verucerfont	small molecule	investigational	Aza Compounds|Oxazoles|Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors
DB12513	Omaveloxolone	small molecule	investigational	Terpenes
DB12514	Iofolastat I-123	small molecule	investigational	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins
DB12515	9-aminocamptothecin	small molecule	investigational	Alkaloids|Antineoplastic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates
DB12517	PF-00446687	small molecule	investigational	Receptor, Melanocortin, Type 4, agonists
DB12518	Raclopride	small molecule	investigational	Acids, Carbocyclic|Amides|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Chlorobenzoates|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotoxic agents|Neurotransmitter Agents|Psychotropic Drugs|Tranquilizing Agents
DB12519	Sarcosine	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Glycine|N-substituted Glycines|Peptides|Peptoids
DB12520	Plozalizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12521	Methyl pyrrolidone	small molecule	investigational	Noxae|Polymers|Pyrrolidines|Teratogens|Toxic Actions
DB12522	Toreforant	small molecule	investigational	
DB12523	Mizolastine	small molecule	investigational	Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Histamine H1 Antagonists, Non-Sedating|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|QTc Prolonging Agents
DB12524	BI-671800	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12525	Molgramostim	biotech	investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB12526	Batefenterol	small molecule	investigational	
DB12527	Sofinicline	small molecule	investigational	Aza Compounds
DB12528	Glyceryl Trierucate	small molecule	investigational	
DB12529	Nitrite	small molecule	approved|investigational	
DB12530	Inebilizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12531	Lobucavir	small molecule	investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Cytochrome P-450 CYP1A2 Substrates|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Purines|Purinones|Reverse Transcriptase Inhibitors|Xanthine derivatives
DB12532	Oxetacaine	small molecule	approved|investigational	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anesthetics|Anesthetics, Local|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Vasoprotectives
DB12533	Cevipabulin	small molecule	investigational	
DB12534	Mavrilimumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12535	AC-430	small molecule	investigational	
DB12536	N-acetylmannosamine	small molecule	investigational	Amino Sugars|Carbohydrates
DB12537	Benzodiazepine	small molecule	approved|investigational	Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates
DB12538	Nepadutant	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Peptides|Peripheral Nervous System Agents|Receptors, Tachykinin, antagonists & inhibitors|Respiratory System Agents
DB12539	Oltipraz	small molecule	investigational	Anthelmintics|Anti-Infective Agents|Anticarcinogenic Agents|Antineoplastic Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Enzyme Inhibitors|Nucleic Acid Synthesis Inhibitors|Protective Agents|Reverse Transcriptase Inhibitors|Schistosomicides
DB12540	Lecozotan	small molecule	investigational	Dioxins
DB12541	SAR-405838	small molecule	investigational	
DB12542	GSK-356278	small molecule	investigational	Oxazoles|Sulfur Compounds
DB12543	Samidorphan	small molecule	investigational	Alkaloids|Central Nervous System Agents|Morphinans|Naloxone|Opiate Alkaloids|Opioid Antagonists|Peripheral Nervous System Agents|Phenanthrenes|Sensory System Agents
DB12545	Indobufen	small molecule	investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiplatelet agents|Blood and Blood Forming Organs|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Hematologic Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Platelet Aggregation Inhibitors Excl. Heparin|Sensory System Agents
DB12547	LY-2886721	small molecule	investigational	Pyridines
DB12548	Sparsentan	small molecule	investigational	
DB12549	Pyrazoloacridine	small molecule	investigational	Antineoplastic Agents|Indicators and Reagents|Intercalating Agents|Laboratory Chemicals
DB12550	Taladegib	small molecule	investigational	Pyridazines
DB12551	Idazoxan	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-2 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Dioxanes|Dioxins|Imidazoles|Neurotransmitter Agents
DB12553	Fluocinolone	small molecule	investigational	Adrenal Cortex Hormones|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated
DB12554	Mebeverine	small molecule	approved|investigational	Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Anticholinergic Agents|Autonomic Agents|Central Nervous System Agents|Drugs for Functional Gastrointestinal Disorders|Ethylamines|Muscarinic Antagonists|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Anticholinergics, Esters With Tertiary Amino Group
DB12555	Nelotanserin	small molecule	investigational	Benzene Derivatives|Urea
DB12556	MK-5108	small molecule	investigational	Acids, Carbocyclic|Cyclohexanes|Cycloparaffins|Protein Kinase Inhibitors|Sulfur Compounds
DB12557	FK-614	small molecule	investigational	
DB12558	AEE-788	small molecule	investigational	Receptor, Epidermal Growth Factor, antagonists & inhibitors|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors
DB12559	EC-17	small molecule	investigational	
DB12560	Blosozumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12561	WNT-974	small molecule	investigational	
DB12562	Setipiprant	small molecule	investigational	
DB12563	MK-0686	small molecule	investigational	Acetates|Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Fatty Acids|Fatty Acids, Volatile|Lipids
DB12564	Gemcitabine elaidate	small molecule	investigational	Carbohydrates|Cytidine|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12565	Abexinostat	small molecule	investigational	Amines|Antineoplastic Agents|Enzyme Inhibitors|Histone Deacetylase Inhibitors|Hydroxy Acids|Hydroxylamines|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents
DB12566	Decernotinib	small molecule	investigational	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins
DB12567	Camicinal	small molecule	investigational	
DB12568	Tecemotide	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Products|Carbohydrates|Complex Mixtures|Glycoconjugates|Glycoproteins|Membrane Proteins|Proteins|Vaccines
DB12569	Tonapofylline	small molecule	investigational	Alkaloids|Purines|Purinones|Receptor, Adenosine A1
DB12570	CC-223	small molecule	investigational	
DB12571	Rimacalib	small molecule	investigational	
DB12572	Pexacerfont	small molecule	investigational	
DB12573	LY-2452473	small molecule	investigational	Acids, Acyclic
DB12574	LY-295501	small molecule	investigational	Benzene Derivatives|Urea
DB12575	Ronopterin	small molecule	investigational	Biological Factors|Coenzymes|Enzymes and Coenzymes|Nitric Oxide Synthase, antagonists & inhibitors|Pigments, Biological|Pteridines|Pterins
DB12576	AZD-3043	small molecule	investigational	Acids, Carbocyclic|Central Nervous System Depressants|Hypnotics and Sedatives
DB12577	Fosbretabulin	small molecule	investigational	Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzylidene Compounds
DB12578	Lexaptepid Pegol	small molecule	investigational	Pegylated agents
DB12579	JNJ-37822681	small molecule	investigational	Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Neurotransmitter Agents
DB12580	Tradipitant	small molecule	investigational	
DB12581	Ozarelix	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB12582	Piperine	small molecule	investigational	Alkenes|Alkynes|Amides|Chemically-Induced Disorders|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Dioxoles|Enzyme Inhibitors|Hydrocarbons, Acyclic|Piper nigrum|UDPglucose 4-Epimerase, antagonists & inhibitors
DB12583	Maltodextrin	small molecule	investigational	Carbohydrates|Maltose
DB12584	Bimagrumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12585	Ondelopran	small molecule	investigational	Amines|Benzene Derivatives|Benzyl Compounds|Nicotinic Acids|Opioid Antagonists|Pyridines
DB12586	Anhydrovinblastine	small molecule	investigational	
DB12587	Razupenem	small molecule	investigational	Amides|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Lactams|Sulfur Compounds
DB12588	AZD-1480	small molecule	investigational	Janus Kinase 2, antagonists & inhibitors
DB12589	Dacetuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12590	Indiplon	small molecule	investigational	Benzazepines|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Hypnotics (Nonbenzodiazepine)|Hypnotics and Sedatives|Neurotransmitter Agents|Sulfur Compounds
DB12591	BMS-911543	small molecule	investigational	Janus Kinase 2, antagonists & inhibitors
DB12592	EC-18	small molecule	investigational	
DB12593	Apaziquone	small molecule	investigational	Antineoplastic Agents|Azirines|Indoles|Quinones
DB12594	AZD-9056	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Cycloparaffins
DB12595	Na-1	biotech	investigational	
DB12596	Combretastatin	small molecule	investigational	Antimitotic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzyl Compounds|Benzylidene Compounds|Combretum|Mitosis Modulators|Stilbenes|Tubulin Modulators
DB12597	ABL-001	small molecule	investigational	
DB12598	Nafamostat	small molecule	investigational	Amidines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anticoagulants|Central Nervous System Agents|Complement Inactivating Agents|Enzyme Inhibitors|Fibrinolysin, antagonists & inhibitors|Hematologic Agents|Immunologic Factors|Kallikreins, antagonists & inhibitors|OCT2 Substrates|Peripheral Nervous System Agents|Protease Inhibitors|Sensory System Agents|Serine Proteinase Inhibitors|Trypsin Inhibitors
DB12601	Sonolisib	small molecule	investigational	Steroids
DB12602	Pentetreotide	small molecule	approved|investigational	Acetates|Acids, Acyclic|Amines|Amino Acids, Peptides, and Proteins|Diagnostic Uses of Chemicals|Fatty Acids|Fatty Acids, Volatile|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Indicators and Reagents|Indium Radioisotopes|Laboratory Chemicals|Lipids|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Peptides, Cyclic|Pituitary Hormone Release Inhibiting Hormones|Polyamines|Proteins|Radiopharmaceuticals|Terbium
DB12604	Sisomicin	small molecule	investigational	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Carbohydrates|Enzyme Inhibitors|Gentamicins|Glycosides|Narrow Therapeutic Index Drugs|Nephrotoxic agents|Protein Synthesis Inhibitors
DB12605	Etripamil	small molecule	investigational	
DB12606	Netivudine	small molecule	investigational	Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB12607	Diridavumab	biotech	investigational	
DB12608	Emixustat	small molecule	investigational	Alcohols|Amines|Amino Alcohols|Benzene Derivatives|Ethers|Phenols|Propanols
DB12609	Tovetumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12610	Ebselen	small molecule	investigational	Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Ulcer Agents|Antioxidants|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Gastrointestinal Agents|Neuroprotective Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents
DB12611	PF-477736	small molecule	investigational	Benzazepines
DB12612	Ozanimod	small molecule	investigational	Indenes|Oxazoles
DB12613	Davunetide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB12614	Reparixin	small molecule	investigational	Amides|Sulfones|Sulfur Compounds
DB12615	Plazomicin	small molecule	approved|investigational	Agents that produce neuromuscular block (indirect)|Aminoglycoside Antibacterials|Anti-Bacterial Agents|Carbohydrates|Gentamicins|Glycosides|MATE 1 Inhibitors|MATE 2 Inhibitors|MATE inhibitors|Narrow Therapeutic Index Drugs|Nephrotoxic agents
DB12616	Sprifermin	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB12617	Mizoribine	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Antibiotics, Antineoplastic|Antimalarials|Antineoplastic Agents|Antiparasitic Agents|Antiprotozoals|Carbohydrates|Central Nervous System Agents|Enzyme Inhibitors|Glycosides|Immunologic Factors|Immunosuppressive Agents|IMP Dehydrogenase, antagonists & inhibitors|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Peripheral Nervous System Agents|Sensory System Agents
DB12618	Apocynin	small molecule	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Antioxidants|Central Nervous System Agents|Enzyme Inhibitors|Ketones|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents
DB12619	BMS-188797	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes
DB12620	Nerve Growth Factor	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Intercellular Signaling Peptides and Proteins|Nerve Growth Factors|Nerve Tissue Proteins|Peptides|Proteins
DB12621	ST-101	small molecule	investigational	Indenes
DB12622	Lupeol	small molecule	investigational	Anti-Inflammatory Agents|Terpenes|Triterpenes
DB12623	Taprenepag	small molecule	investigational	Acids, Acyclic|Amides|Fatty Acids|Fatty Acids, Volatile|Lipids|Receptors, Prostaglandin E, EP2 Subtype, agonists|Sulfones|Sulfur Compounds
DB12624	Octenidine	small molecule	investigational	Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Quaternary Ammonium Compounds|Throat Preparations
DB12625	Evogliptin	small molecule	investigational	Agents causing angioedema|Blood Glucose Lowering Agents|Dipeptidyl Peptidase 4|DPP-IV Inhibitors|Oral Hypoglycemics
DB12626	Senrebotase	biotech	investigational	
DB12627	GSK-1292263	small molecule	investigational	
DB12628	Methyl-D9-choline	small molecule	investigational	
DB12629	3,5-diiodothyropropionic acid	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Fatty Acids|Fatty Acids, Volatile|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipids|Thyroid Products|Thyronines
DB12630	Isopentyl 2-cyanoacrylate	small molecule	investigational	
DB12631	Aclerastide	small molecule	investigational	
DB12632	JNJ-41443532	small molecule	investigational	Acids, Carbocyclic|Amides|Azetines|Benzene Derivatives|Benzoates
DB12633	BMS-184476	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes
DB12634	Navicixizumab	biotech	investigational	
DB12635	Aleplasinin	small molecule	investigational	
DB12636	Samalizumab	biotech	investigational	
DB12637	Onapristone	small molecule	investigational	Antineoplastic Agents|Fertility Agents|Fertility Agents, Female|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Reproductive Control Agents|Steroids
DB12638	PU-H71	small molecule	investigational	Dioxoles
DB12639	Telbermin	biotech	investigational	
DB12640	CP-609754	small molecule	investigational	Quinolines
DB12641	Tedatioxetine	small molecule	investigational	
DB12642	Olumacostat glasaretil	small molecule	investigational	
DB12643	Nelivaptan	small molecule	investigational	
DB12644	AZD-2066	small molecule	investigational	
DB12645	Givinostat	small molecule	investigational	Acids, Acyclic|Antineoplastic Agents|Histone Deacetylase Inhibitors|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB12647	Tocotrienol	small molecule	investigational	Antioxidants|Benzopyrans|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB12648	Nona-arginine	small molecule	investigational	Amino Acids, Peptides, and Proteins|Furin, antagonists & inhibitors|Peptides
DB12649	Ibipinabant	small molecule	investigational	Agents producing tachycardia|Amides|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB12650	L-deprenyl-D2 C-11	small molecule	investigational	
DB12651	Bardoxolone	small molecule	investigational	
DB12652	Endothelin-1	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Endothelins|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB12654	GSK-376501	small molecule	investigational	
DB12655	Patidegib	small molecule	investigational	Alkaloids
DB12656	Somatorelin	biotech	investigational	Diagnostic Agents|Tests for Pituitary Function
DB12657	JNJ-42396302	small molecule	investigational	
DB12658	AFN-1252	small molecule	investigational	Pyrans
DB12659	SJ-733	small molecule	investigational	
DB12660	Samatasvir	small molecule	investigational	Acids, Acyclic
DB12661	Urapidil	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Cardiovascular Agents|Central Nervous System Depressants|Neurotransmitter Agents|Serotonin Agents|Serotonin Receptor Agonists|Vasodilating Agents
DB12662	Naveglitazar	small molecule	investigational	Acids, Carbocyclic|PPAR alpha, agonists|PPAR gamma, agonists
DB12663	Letrazuril	small molecule	investigational	Nitriles
DB12664	Indantadol	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Indenes
DB12665	Isoquercetin	small molecule	investigational	Benzopyrans|Carbohydrates|Chromones|Flavonoids|Flavonols|Glycosides|Pyrans
DB12666	Emapunil	small molecule	investigational	
DB12667	Protionamide	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Isonicotinic Acids|Pyridines|Thiocarbamide Derivatives
DB12668	Metenkefalin	small molecule	investigational	
DB12669	4SC-203	small molecule	investigational	
DB12670	Rolofylline	small molecule	investigational	Alkaloids|Cardiovascular Agents|Diuretics|Natriuretic Agents|Purines|Purinones
DB12671	Beloranib	small molecule	investigational	Acids, Carbocyclic|Cycloparaffins|Ethers|Ethers, Cyclic|Terpenes
DB12672	Icaritin	small molecule	investigational	Benzopyrans|Chromones|Pyrans
DB12673	ATX-914	small molecule	investigational	Quinazolines
DB12674	Lurbinectedin	small molecule	investigational	Indoles|Pyridines
DB12675	PF-04995274	small molecule	investigational	
DB12676	Modufolin	small molecule	investigational	
DB12677	Soblidotin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Peptides
DB12678	Relamorelin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB12679	WP 1066	small molecule	investigational	
DB12680	Intepirdine	small molecule	investigational	Sulfur Compounds
DB12681	Salirasib	small molecule	investigational	Acids, Carbocyclic|Alcohols|Antineoplastic Agents|Benzene Derivatives|Benzoates|Calcium-Calmodulin-Dependent Protein Kinases, antagonists & inhibitors|Enzyme Inhibitors|Fatty Alcohols|Hydroxy Acids|Hydroxybenzoates|Lipids|Phenols|Sesquiterpenes|Terpenes
DB12682	Mubritinib	small molecule	investigational	
DB12683	Lumretuzumab	biotech	investigational	
DB12684	Aviscumine	biotech	investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Biological Factors|Biological Products|Complex Mixtures|Enzymes|Enzymes and Coenzymes|Glycoside Hydrolases|Hydrolases|Immunologic Factors|Lectins|N-Glycosyl Hydrolases|Plant Lectins|Plant Proteins|Proteins|Ribosome Inactivating Proteins
DB12685	K-134	small molecule	investigational	
DB12686	PHA-793887	small molecule	investigational	Cyclin-Dependent Kinases, antagonists & inhibitors
DB12687	Vesatolimod	small molecule	investigational	Antiviral Agents|Toll-Like Receptor 7, agonists
DB12688	Moxetumomab Pasudotox	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Immunotoxins|Proteins
DB12689	Azeliragon	small molecule	investigational	
DB12690	LY-2584702	small molecule	investigational	Ribosomal Protein S6 Kinases, 70-kDa, antagonists & inhibitors
DB12691	UK-432097	small molecule	investigational	Adenosine A2 Receptor Agonists|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB12692	Gusperimus	small molecule	investigational	Amidines|Antibiotics, Antineoplastic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Immunologic Factors|Immunosuppressive Agents|Protective Agents|Radiation-Protective Agents|Selective Immunosuppressants
DB12693	Ritanserin	small molecule	investigational	Anti-Anxiety Agents|Antidepressive Agents, Second-Generation|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Hypoglycemia-Associated Agents|Neurotoxic agents|Neurotransmitter Agents|Piperidines|Psychotropic Drugs|Pyrimidines|Pyrimidinones|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators|Serotonin Receptor Antagonists|Tranquilizing Agents
DB12694	CE-326597	small molecule	investigational	Benzazepines
DB12695	Phenethyl Isothiocyanate	small molecule	investigational	Aldehyde Dehydrogenase, antagonists & inhibitors|Anticarcinogenic Agents|Antineoplastic Agents|Carcinogens|Enzyme Inhibitors|Isocyanates|Noxae|Protective Agents|Sulfur Compounds|Toxic Actions
DB12696	BMS-582949	small molecule	investigational	Mitogen-Activated Protein Kinase 14, antagonists & inhibitors
DB12697	Methylselenocysteine	small molecule	investigational	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anticarcinogenic Agents|Antineoplastic Agents|Cysteine|Organoselenium Compounds|Protective Agents|Sulfhydryl Compounds|Sulfur Compounds
DB12698	Ibalizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|HIV Fusion Inhibitors|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12699	Balugrastim	biotech	investigational	Adjuvants, Immunologic|Albumins|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Blood Proteins|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins|Recombinant Proteins
DB12700	Solamargine	small molecule	investigational	Alkaloids
DB12701	Intetumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12702	Velusetrag	small molecule	investigational	Aza Compounds
DB12703	Omipalisib	small molecule	investigational	Amides|Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB12704	Spiradoline	small molecule	investigational	Analgesics|Antiarrhythmic agents|Cardiovascular Agents|Central Nervous System Agents|Diuretics|Natriuretic Agents|Peripheral Nervous System Agents|Receptors, Opioid, kappa, agonists|Sensory System Agents
DB12705	Cenerimod	small molecule	investigational	
DB12706	Seletalisib	small molecule	investigational	
DB12707	AR-42	small molecule	investigational	
DB12708	Sulprostone	small molecule	investigational	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Menstruation-Inducing Agents|Prostaglandins|Prostaglandins E|Reproductive Control Agents|Uterotonic agents
DB12709	Tributyrin	small molecule	investigational	Glycerides|Lipids
DB12710	Perazine	small molecule	approved|investigational	Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Phenothiazines|Phenothiazines With Piperazine Structure|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Tranquilizing Agents
DB12711	LTX-109	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides|Peptidomimetics
DB12712	Pilsicainide	small molecule	investigational	Acetanilides|Amides|Anilides|Antiarrhythmic agents|BSEP/ABCB11 Substrates|Cardiovascular Agents|Membrane Transport Modulators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Sodium Channel Blockers
DB12713	Sotagliflozin	small molecule	investigational	Blood Glucose Lowering Agents|Carbohydrates|Sodium-Glucose Transporter 1, antagonists & inhibitors
DB12714	Nerispirdine	small molecule	investigational	
DB12715	MSX-122	small molecule	investigational	Receptors, CXCR4, antagonists & inhibitors
DB12716	NB-001	small molecule	investigational	Adenine Nucleotides|Adenylyl Cyclase Inhibitors|Carbohydrates|Enzyme Inhibitors|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB12717	Mibampator	small molecule	investigational	Amides|Benzene Derivatives|Sulfones|Sulfur Compounds
DB12718	Carlumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12719	Turofexorate isopropyl	small molecule	investigational	
DB12720	Nivocasan	small molecule	investigational	
DB12721	RO-5028442	small molecule	investigational	
DB12722	N-sulfoglucosamine sulfohydrolase recombinant	biotech	investigational	
DB12724	AZD-7295	small molecule	investigational	
DB12725	TD-8954	small molecule	investigational	Central Nervous System Depressants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT4 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB12726	Monteplase	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Proteins|Endopeptidases|Enzymes|Enzymes and Coenzymes|Hydrolases|Peptide Hydrolases|Proteins|Serine Endopeptidases|Serine Proteases
DB12727	Perfosfamide	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Hydrocarbons, Halogenated|Ions|Mustard Compounds|Nitrogen Mustard Compounds|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB12728	Fenpropidin	small molecule	approved|experimental	
DB12729	ASP-3026	small molecule	investigational	Sulfur Compounds
DB12730	Dolastatin 10	small molecule	investigational	Amino Acids, Peptides, and Proteins|Antimitotic Agents|Antineoplastic Agents|Mitosis Modulators|Peptides|Peptides, Cyclic|Tubulin Modulators
DB12731	Daporinad	small molecule	investigational	Acids, Acyclic|Acrylates|Amides
DB12732	Firategrast	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anti-Inflammatory Agents|Antibodies|Blood Proteins|Globulins|Immunoproteins|Proteins|Serum Globulins
DB12733	Dipraglurant	small molecule	investigational	
DB12734	Demcizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12736	Etanidazole	small molecule	investigational	Antineoplastic Agents|Imidazoles|Nitro Compounds|Nitroimidazoles|Radiation-Sensitizing Agents
DB12737	Brontictuzumab	biotech	investigational	
DB12738	Tiplimotide	biotech	investigational	Amino Acids, Peptides, and Proteins|Membrane Proteins|Myelin Proteins|Nerve Tissue Proteins|Peptides|Proteins
DB12739	Bindarit	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Pyrazoles
DB12740	CC-115	small molecule	investigational	
DB12741	DTP-348	small molecule	investigational	
DB12742	Amuvatinib	small molecule	investigational	
DB12743	Z-160	small molecule	investigational	
DB12744	CGI-1842	small molecule	investigational	Benzene Derivatives|Receptor, EphB4, antagonists & inhibitors|Urea
DB12745	GSK-690693	small molecule	investigational	Oxazoles
DB12746	AKN-028	small molecule	investigational	
DB12747	Tertomotide	biotech	investigational	
DB12748	LTX-315	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB12749	Butylphthalide	small molecule	investigational	Antiplatelet agents|Central Nervous System Agents|Drugs, Chinese Herbal|Hematologic Agents|Neuroprotective Agents|Protective Agents
DB12750	N-omega-nitro-L-arginine methyl ester	small molecule	investigational	Amino Acids|Amino Acids, Basic|Amino Acids, Diamino|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Arginine|Enzyme Inhibitors
DB12751	Malic Acid	small molecule	investigational	Acids, Acyclic|Dicarboxylic Acids|Hydroxy Acids
DB12752	Bucindolol	small molecule	investigational	Adrenergic Agents|Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Autonomic Agents|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanols|Sympathomimetics|Vasodilating Agents
DB12753	Racivir	small molecule	investigational	Anti-Infective Agents|Antiviral Agents|Carbohydrates|Cytidine|Deoxycytidine|Deoxyribonucleosides|Dideoxynucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12754	Iodide	small molecule	approved|experimental	
DB12755	Zoptarelin doxorubicin	small molecule	investigational	Amino Acids, Peptides, and Proteins|Anthracyclines|Carbohydrates|Daunorubicin|Glycosides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Naphthacenes|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary Hormone-Releasing Hormones|Proteins
DB12756	TAK-901	small molecule	investigational	Indoles|Protein Kinase Inhibitors|Pyridines|Sulfur Compounds
DB12757	Pelitrexol	small molecule	investigational	Sulfur Compounds
DB12758	Atreleuton	small molecule	investigational	Enzyme Inhibitors|Lipoxygenase Inhibitors|Urea
DB12759	Suptavumab	biotech	investigational	
DB12760	GW-493838	small molecule	investigational	
DB12761	Timcodar	small molecule	investigational	
DB12762	Rabacfosadine	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins
DB12763	MK-1496	small molecule	investigational	
DB12764	ABC-294640	small molecule	investigational	Cycloparaffins
DB12765	Methyl isocyanate	small molecule	investigational	Antisickling Agents|Hematologic Agents
DB12766	Cicletanine	small molecule	investigational	Antiarrhythmic agents|Antihypertensive Agents|Cardiovascular Agents|Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB12767	Gaxilose	small molecule	approved|investigational	Carbohydrates|Oligosaccharides|Polysaccharides
DB12768	BCG vaccine	biotech	investigational	Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|Bacterial Vaccines|Biological Products|Complex Mixtures|Immunologic Factors|Live Attenuated Bacillus Calmette-Guerin Vaccine|Live vaccines|Tuberculosis Vaccines|Vaccines
DB12769	Lometrexol	small molecule	investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Biological Factors|Coenzymes|Enzyme Inhibitors|Enzymes and Coenzymes|Folic Acid|Folic Acid Analogues|Folic Acid Antagonists|Noxae|Pigments, Biological|Pteridines|Pterins|Toxic Actions
DB12770	Lafutidine	small molecule	investigational	Acetates|Acids, Acyclic|Alimentary Tract and Metabolism|Amides|Anti-Ulcer Agents|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Fatty Acids|Fatty Acids, Volatile|Gastric Acid Lowering Agents|Gastrointestinal Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Lipids|Neurotransmitter Agents
DB12771	Hydroxytyrosol	small molecule	investigational	Alcohols|Anti-Infective Agents|Antioxidants|Antiplatelet agents|Hematologic Agents|Protective Agents
DB12773	Sifalimumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12774	AZD-8055	small molecule	investigational	Oxazines
DB12775	Abituzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12776	E-6005	small molecule	investigational	Acids, Carbocyclic|Antipruritics|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors
DB12777	Somatoprim	small molecule	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hypothalamic Hormones|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Pituitary Hormone Release Inhibiting Hormones|Proteins
DB12778	Rivipansel	small molecule	investigational	Carbohydrates|Glycoconjugates|Lipids
DB12779	Higenamine	small molecule	investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Cardiotonic Agents|Cardiovascular Agents|Central Nervous System Agents|Fibrin Modulating Agents|Hematologic Agents|Isoquinolines|Neurotransmitter Agents|Peripheral Nervous System Agents|Protective Agents|Sensory System Agents
DB12780	Quinfamide	small molecule	investigational	
DB12781	Balaglitazone	small molecule	investigational	Blood Glucose Lowering Agents|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Sulfur Compounds|Thiazoles|Thiazolidinediones
DB12782	SCH-486757	small molecule	investigational	Aza Compounds
DB12783	Benserazide	small molecule	approved|investigational	Anti-Dyskinesia Agents|Anti-Parkinson Drugs|Central Nervous System Agents|Dopamine Agents|Enzyme Inhibitors|Hydrazines|Neurotransmitter Agents
DB12784	NS-018	small molecule	investigational	
DB12785	Furaprevir	small molecule	investigational	
DB12786	Alvircept Sudotox	biotech	investigational	
DB12787	Norethandrolone	small molecule	investigational	Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androstan Derivatives|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Norpregnanes|Norpregnenes|Norsteroids|Steroids
DB12788	Glucagon-like peptide II	biotech	investigational	
DB12789	Dinoprost	small molecule	approved|investigational	Abortifacient Agents|Abortifacient Agents, Nonsteroidal|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Unsaturated|Genito Urinary System and Sex Hormones|Inflammation Mediators|Lipids|Prostaglandins|Prostaglandins F|Reproductive Control Agents|Uterotonic agents
DB12791	Laninamivir	small molecule	investigational	Acids, Acyclic|Amidines|Amino Sugars|Carbohydrates|Guanidines|Hydroxy Acids|Neuraminic Acids|Neuraminidase, antagonists & inhibitors|Pyrans|Sialic Acids|Sugar Acids
DB12792	Boscalid	small molecule	approved|experimental	Benzene Derivatives|Nicotinic Acids|Pyridines
DB12793	Condoliase	biotech	investigational	
DB12794	p-Quaterphenyl	small molecule	investigational	
DB12795	CMX-2043	small molecule	investigational	Amino Acids, Peptides, and Proteins|Coenzymes|Enzymes and Coenzymes|Fatty Acids|Lipids|Oligopeptides|Peptides|Sulfur Compounds|Thiophenes
DB12796	MRX-I	small molecule	investigational	
DB12797	Ecromeximab	biotech	investigational	
DB12798	Relenopride	small molecule	investigational	Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12799	Laniquidar	small molecule	investigational	Carbon Radioisotopes|Drug Resistance, Multiple|P-Glycoprotein, antagonists & inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB12800	CHF-6001	small molecule	investigational	Acids, Carbocyclic|Amides|Aminobenzoates|Benzene Derivatives|Benzoates|Sulfones|Sulfur Compounds
DB12802	Picropodophyllin	small molecule	investigational	Benzene Derivatives|Benzyl Compounds|Insulin-Like Growth Factor I|Lignans|Naphthalenes|Podophyllum|Tetrahydronaphthalenes
DB12803	Dichloroisoproterenol	small molecule	investigational	Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Catecholamines|Ethanolamines
DB12804	Daniquidone	small molecule	investigational	
DB12805	Ataciguat	small molecule	investigational	Acids, Carbocyclic|Amides|Aminobenzoates|Benzene Derivatives|Benzoates|Guanylate Cyclase|Sulfones|Sulfur Compounds
DB12806	GSK-1004723	small molecule	investigational	Histamine Antagonists|Histamine H1 Antagonists|Pyridazines
DB12807	Naptumomab Estafenatox	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Biological Factors|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins|Toxins, Biological
DB12808	Trifarotene	small molecule	investigational	
DB12809	BK-MDA	small molecule	investigational	
DB12810	AN-2718	small molecule	investigational	
DB12812	Palomid 529	small molecule	investigational	Pyrans
DB12813	Radium Ra-223	small molecule	investigational	
DB12814	Cepeginterferon alfa-2B	biotech	investigational	Adjuvants, Immunologic|Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Interferons|Myelosuppressive Agents|Pegylated agents
DB12815	Crotedumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12816	Terpinen-4-ol	small molecule	investigational	
DB12817	Zoliflodacin	small molecule	investigational	Pyrimidines|Pyrimidinones
DB12818	NM-3	small molecule	investigational	
DB12819	GSI-136	small molecule	investigational	
DB12820	Concizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12821	Perflubutane	small molecule	approved|investigational	Anions|Contrast Media|Diagnostic Uses of Chemicals|Electrolytes|Elements|Hydrocarbons, Fluorinated|Hydrocarbons, Halogenated|Ions|Iron Compounds|Metals|Metals, Heavy|Organometallic Compounds|Oxygen Compounds|Transition Elements
DB12822	Pancreatic Polypeptide	biotech	investigational	Amino Acids, Peptides, and Proteins|Gastrointestinal Agents|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Pancreatic Hormones|Peptide Hormones|Peptides|Proteins
DB12823	Tecarfarin	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives|Benzopyrans|Coumarins|Pyrans
DB12824	Monalizumab	biotech	investigational	
DB12825	Lefamulin	small molecule	investigational	
DB12826	Depatuxizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12827	Indoximod	small molecule	investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Tryptophan Oxygenase, antagonists & inhibitors
DB12829	Amithiozone	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Systemic Use|Antimycobacterials|Antituberculosis Agents|Drugs for Treatment of Tuberculosis|Semicarbazides|Semicarbazones|Sulfur Compounds|Thiosemicarbazones
DB12830	Cebranopadol	small molecule	investigational	
DB12831	Gabexate	small molecule	investigational	Amidines|Anticoagulants|Enzyme Inhibitors|Guanidines|Hematologic Agents|Protease Inhibitors|Serine Proteinase Inhibitors
DB12832	Prednimustine	small molecule	investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Chlorambucil|Hydrocarbons, Halogenated|Mustard Compounds|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Toxic Actions
DB12833	Tandospirone	small molecule	investigational	Anti-Anxiety Agents|Central Nervous System Agents|Central Nervous System Depressants|Neurotransmitter Agents|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists|Tranquilizing Agents
DB12834	Secnidazole	small molecule	approved	Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Imidazoles|Nitro Compounds|Nitroimidazole Antimicrobial|Nitroimidazole Derivatives|Nitroimidazoles
DB12835	Olipudase alfa	biotech	investigational	Amino Acids, Peptides, and Proteins|Enzymes|Enzymes and Coenzymes|Esterases|Hydrolases|Phosphoric Diester Hydrolases|Proteins
DB12836	Grapiprant	small molecule	investigational|vet_approved	Amides|P-glycoprotein/ABCB1 Substrates|Sulfones|Sulfur Compounds|Urea
DB12837	UK-500001	small molecule	investigational	
DB12838	Tetrasul	small molecule	investigational	Benzene Derivatives|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated
DB12839	Pegvaliase	small molecule	approved|investigational	Pegylated agents
DB12840	Pirnabine	small molecule	investigational	
DB12841	Glial growth factor 2	biotech	investigational	
DB12842	Pegamotecan	small molecule	investigational	Alcohols|Alkaloids|Biomedical and Dental Materials|Ethylene Glycols|Glycols|Macromolecular Substances|Pegylated agents|Polymers
DB12843	Oleandrin	small molecule	experimental|investigational	Carbohydrates|Cardanolides|Cardiac Glycosides|Glycosides|Steroids
DB12844	Rontalizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12845	Amatuximab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12846	Reproterol	small molecule	investigational	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Adrenergics, Inhalants|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Alkaloids|Amines|Amino Alcohols|Anti-Asthmatic Agents|Autonomic Agents|Biogenic Amines|Biogenic Monoamines|Bronchodilator Agents|Catecholamines|Drugs for Obstructive Airway Diseases|Ethanolamines|Neurotransmitter Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Purines|Purinones|Respiratory System Agents|Selective Beta 2-adrenergic Agonists
DB12847	Pyroxamide	small molecule	investigational	Amines|Hydroxy Acids|Hydroxylamines|Pyridines
DB12848	PF-04217903	small molecule	investigational	
DB12849	Clazakizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12850	Etalocib	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives
DB12851	Miravirsen	biotech	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides|Polynucleotides
DB12852	MK-0752	small molecule	investigational	Acids, Acyclic|Amyloid Precursor Protein Secretases, antagonists & inhibitors|Fatty Acids|Fatty Acids, Volatile|Lipids|Sulfur Compounds
DB12853	DA-6886	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12854	BMS-908662	small molecule	investigational	
DB12855	Apricitabine	small molecule	investigational	Carbohydrates|Cytidine|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12856	Timonacic	small molecule	investigational	
DB12857	NVP-LEQ-506	small molecule	investigational	
DB12858	LY-377604	small molecule	investigational	
DB12859	Tantalum	small molecule	investigational	Elements|Metals|Metals, Heavy|Transition Elements
DB12860	Actinium	small molecule	investigational	Actinoid Series Elements|Elements|Elements, Radioactive|Metals|Metals, Heavy
DB12861	Rimeporide	small molecule	investigational	
DB12862	Glucose Oxidase	biotech	investigational	Alcohol Oxidoreductases|Enzymes|Enzymes and Coenzymes|Oxidoreductases
DB12863	Sivelestat	small molecule	investigational	Amides|Amino Acids|Amino Acids, Peptides, and Proteins|Enzyme Inhibitors|Protease Inhibitors|Serine Proteinase Inhibitors|Sulfones|Sulfur Compounds
DB12864	Melarsoprol	small molecule	investigational	Agents Against Leishmaniasis and Trypanosomiasis|Anti-Infective Agents|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals|Organometallic Compounds|Trypanocidal Agents
DB12865	Etelcalcetide	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Calcium-sensing Receptor Agonist|Increased Calcium-sensing Receptor Sensitivity
DB12866	Pradigastat	small molecule	investigational	Acids, Acyclic|Amines|Fatty Acids|Fatty Acids, Volatile|Lipids|OAT3/SLC22A8 Inhibitors|Pyridines
DB12867	Benperidol	small molecule	approved|investigational	Antipsychotic Agents|Butyrophenone Derivatives|Butyrophenones|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Ketones|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB12868	Intoplicine	small molecule	investigational	
DB12869	Eliprodil	small molecule	investigational	Central Nervous System Agents|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents|Receptors, Neurotransmitter
DB12870	Buthionine Sulfoximine	small molecule	investigational	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Methionine|Methionine Sulfoximine|Noxae|Protective Agents|Radiation-Protective Agents|Radiation-Sensitizing Agents|Sulfur Compounds|Toxic Actions
DB12871	Burlulipase	biotech	investigational	
DB12872	Vonicog Alfa	biotech	approved|investigational	
DB12873	Dianhydrogalactitol	small molecule	investigational	Alcohols|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Carbohydrates|Galactitol|Noxae|Sugar Alcohols|Toxic Actions
DB12874	Quizartinib	small molecule	investigational	Benzene Derivatives|Sulfur Compounds|Thiazoles|Urea
DB12875	Mavatrep	small molecule	investigational	
DB12876	GS-9256	small molecule	investigational	Acids|Acids, Noncarboxylic|Amino Acids, Peptides, and Proteins|Organophosphorus Compounds|Peptides|Phosphorus Acids|Phosphorus Compounds
DB12877	Oxatomide	small molecule	investigational	Anti-Allergic Agents|Anti-Asthmatic Agents|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Piperazine Derivatives|QTc Prolonging Agents|Respiratory System Agents
DB12878	AV-101	small molecule	investigational	Amino Acids|Amino Acids, Peptides, and Proteins|Sweetening Agents
DB12879	Omigapil	small molecule	investigational	Ethers|Ethers, Cyclic
DB12880	Interleukin-10	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Cytokines|Intercellular Signaling Peptides and Proteins|Interleukins|Peptides|Proteins
DB12881	Indole-3-carbinol	small molecule	investigational	Anticarcinogenic Agents|Antineoplastic Agents|Protective Agents
DB12882	Ombrabulin	small molecule	investigational	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins
DB12883	Eltoprazine	small molecule	investigational	Central Nervous System Depressants|Neurotransmitter Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Receptor Agonists
DB12884	Lavoltidine	small molecule	investigational	Gastric Acid Lowering Agents|Histamine Agents|Histamine Antagonists|Histamine H2 Antagonists|Neurotransmitter Agents
DB12885	CF-102	small molecule	investigational	
DB12886	GSK-1521498	small molecule	investigational	Indenes|Receptors, Opioid, mu
DB12887	Tazemetostat	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Pyridines
DB12888	Ezutromid	small molecule	investigational	
DB12889	Velneperit	small molecule	investigational	
DB12890	Dihydrexidine	small molecule	investigational	Dopamine Agents|Dopamine Agonists|Neurotransmitter Agents|Nonergot-derivative Dopamine Receptor Agonists
DB12891	Ozanezumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12892	MGB-BP-3	small molecule	investigational	
DB12893	Sacituzumab govitecan	biotech	investigational	Alkaloids|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12894	Raluridine	small molecule	investigational	Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides
DB12895	TD-139	small molecule	investigational	
DB12896	PSI-352938	small molecule	investigational	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides
DB12897	MK-7622	small molecule	investigational	
DB12898	Calcitonin eel	biotech	investigational	
DB12899	TT-301	small molecule	investigational	
DB12900	Irdabisant	small molecule	investigational	Receptors, Histamine H3
DB12901	Fiacitabine	small molecule	investigational	Anti-Infective Agents|Antineoplastic Agents|Antiviral Agents|Arabinonucleosides|Carbohydrates|Cytidine|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12902	Trofosfamide	small molecule	investigational	Acids|Acids, Noncarboxylic|Alkylating Drugs|Anions|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Electrolytes|Hydrocarbons, Halogenated|Immunologic Factors|Immunosuppressive Agents|Ions|Mustard Compounds|Mutagens|Nitrogen Mustard Analogues|Nitrogen Mustard Compounds|Noxae|Organophosphorus Compounds|Phosphoramide Mustards|Phosphoramides|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds|Toxic Actions
DB12903	DEBIO-1347	small molecule	investigational	
DB12904	ZSTK-474	small molecule	investigational	
DB12905	Samarium Sm-153	small molecule	investigational	
DB12906	LY-2334737	small molecule	investigational	Carbohydrates|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB12907	Mannose	small molecule	investigational	Carbohydrates|Hexoses|Monosaccharides
DB12908	Denenicokin	biotech	investigational	
DB12909	Factor XIII (human)	biotech	approved|investigational	Acyltransferases|Amino Acids, Peptides, and Proteins|Aminoacyltransferases|Biological Factors|Blood Coagulation Factors|Blood Proteins|Enzymes|Enzymes and Coenzymes|Hemostatics|Increased Coagulation Activity|Increased Fibrin Polymerization Activity|Proteins|Transferases|Transglutaminases
DB12910	Emicerfont	small molecule	investigational	Corticotropin-Releasing Hormone, antagonists & inhibitors
DB12911	Nicoboxil	small molecule	approved|investigational	Pyridines
DB12912	Nolatrexed	small molecule	investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Enzyme Inhibitors|Folic Acid Antagonists|Noxae|Thymidylate Synthase, antagonists & inhibitors|Toxic Actions
DB12914	MGL-3196	small molecule	investigational	Pyrimidines|Pyrimidinones
DB12915	Corticorelin acetate	biotech	investigational	
DB12916	Mitolactol	small molecule	investigational	Alcohols|Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Carbohydrates|Galactitol|Noxae|Sugar Alcohols|Toxic Actions
DB12917	Bimekizumab	biotech	investigational	
DB12919	T-62	small molecule	investigational	
DB12920	Pinometostat	small molecule	investigational	Antineoplastic Agents
DB12921	Chlorsulfaquinoxaline	small molecule	investigational	Amides|Amines|Aniline Compounds|Sulfonamides|Sulfones|Sulfur Compounds
DB12923	Gallopamil	small molecule	investigational	Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Phenethylamines|Phenylalkylamine Derivatives|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Selective Calcium Channel Blockers With Direct Cardiac Effects|Vasodilating Agents|Verapamil|Verapamil and analogues
DB12924	Ozenoxacin	small molecule	approved|investigational	Amines|Anti-Bacterial Agents|Pyridines|Quinolines|Quinolone Antimicrobial
DB12925	Crolibulin	small molecule	investigational	Pyrans
DB12926	Cafedrine	small molecule	investigational	Adrenergic and Dopaminergic Agents|Alcohols|Alkaloids|Amines|Amino Alcohols|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Substrates|Propanolamines|Propanols|Purines|Purinones|Vasodilating Agents|Xanthine derivatives
DB12927	Theodrenaline	small molecule	investigational	Adrenergic and Dopaminergic Agents|Agents that produce hypertension|Alcohols|Alkaloids|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cardiovascular Agents|Catecholamines|Cytochrome P-450 CYP1A2 Substrates|Epinephrine|Ethanolamines|Purines|Purinones|Xanthine derivatives
DB12928	GET-73	small molecule	investigational	
DB12929	JNJ-39220675	small molecule	investigational	Histamine H3 Antagonists
DB12930	Opipramol	small molecule	investigational	Adrenergic Agents|Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Dibenzazepines|Membrane Transport Modulators|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB12931	Fenobam	small molecule	investigational	
DB12932	Merotocin	small molecule	investigational	
DB12933	RO-4987655	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB12934	Granotapide	small molecule	investigational	Acids, Acyclic|Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates|Dicarboxylic Acids
DB12935	Remogliflozin etabonate	small molecule	investigational	Carbohydrates|Glycosides
DB12937	Quercetin-3'-O-phosphate	small molecule	investigational	
DB12938	Isoxaflutole	small molecule	approved|experimental|investigational	Amino Acids, Peptides, and Proteins|Membrane Proteins|Neoplasm Proteins|Proteins|Tumor Suppressor Proteins
DB12939	Nikkomycin Z	small molecule	investigational	Anti-Infective Agents|Antifungal Agents|Carbohydrates|Enzyme Inhibitors|Glycosides
DB12940	Helium He-3	small molecule	investigational	
DB12941	ODM-201	small molecule	investigational	
DB12942	Lactitol	small molecule	investigational	Alcohols|Alimentary Tract and Metabolism|Carbohydrates|Diet, Food, and Nutrition|Drugs for Constipation|Flavoring Agents|Food|Food Additives|Food and Beverages|Gastrointestinal Agents|Laxatives|Osmotic Laxative|Physiological Phenomena|Sweetening Agents
DB12943	Milatuzumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12944	Phloroglucinol	small molecule	investigational	Alimentary Tract and Metabolism|Benzene Derivatives|Drugs for Functional Gastrointestinal Disorders|Indicators and Reagents|Laboratory Chemicals|Phenols
DB12945	Dihydralazine	small molecule	approved|experimental	Antihypertensive Agents|Arteriolar Smooth Muscle, Agents Acting On|Cardiovascular Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 Enzyme Inhibitors|Hydralazine|Hydrazinophthalazine Derivatives|Hydrazinophthalazine Derivatives and Diuretics|Phthalazines|Pyridazines
DB12946	8-cyclopentyl-1,3-dipropylxanthine	small molecule	investigational	Adenosine A1 Receptor Antagonists|Alkaloids|Neurotransmitter Agents|Purinergic Agents|Purinergic Antagonists|Purinergic P1 Receptor Antagonists|Purines|Purinones
DB12947	Doxifluridine	small molecule	investigational	Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Appetite Stimulants|Carbohydrates|Central Nervous System Agents|Central Nervous System Stimulants|Deoxyribonucleosides|Deoxyuridine|Fluoropyrimidines|Fluorouracil and prodrugs|Glycosides|Immunologic Factors|Immunosuppressive Agents|Isomerism|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Toxic Actions|Uridine
DB12948	Didox	small molecule	investigational	Amines|Antineoplastic Agents|Enzyme Inhibitors|Hydroxy Acids|Hydroxylamines|Ribonucleotide Reductases, antagonists & inhibitors
DB12949	PF-03382792	small molecule	investigational	
DB12950	Albusomatropin	biotech	investigational	
DB12951	Pivagabine	small molecule	investigational	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|Butyrates|Central Nervous System Depressants|Fatty Acids|Fatty Acids, Volatile|Lipids|Nervous System|Psychoanaleptics
DB12952	Methylprednisone	small molecule	approved|investigational	Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates
DB12953	Disitertide	biotech	investigational	
DB12954	Terizidone	small molecule	approved|investigational	Antiinfectives for Systemic Use|Antimycobacterials|Drugs for Treatment of Tuberculosis|Oxazoles
DB12955	Delparantag	small molecule	investigational	
DB12956	Vantictumab	biotech	investigational	
DB12957	5-fluoro-2'-deoxycytidine	small molecule	investigational	Carbohydrates|Cytidine|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB12958	Prothipendyl	small molecule	investigational	Antipsychotic Agents|Central Nervous System Depressants|Nervous System|Neurotoxic agents|Psycholeptics|Sulfur Compounds
DB12959	IOWH-032	small molecule	investigational	
DB12960	INCB-9471	small molecule	investigational	Receptors, CCR4, antagonists & inhibitors
DB12961	Leukotriene B4	small molecule	investigational	Arachidonic Acids|Autacoids|Biological Factors|Eicosanoids|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Unsaturated|Inflammation Mediators|Leukotrienes|Lipids
DB12962	CP-547632	small molecule	investigational	Sulfur Compounds
DB12963	CCX-354	small molecule	investigational	
DB12964	Lerisetron	small molecule	investigational	
DB12965	Silver	small molecule	approved|investigational	Antiseptics and Disinfectants|Dermatologicals|Elements|Metals|Metals, Heavy|Silver Compounds|Transition Elements
DB12966	Falnidamol	small molecule	investigational	
DB12967	Mitoguazone	small molecule	investigational	Amidines|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Enzyme Inhibitors|Guanidines
DB12968	DONU	small molecule	investigational	Nitroso Compounds|Urea
DB12969	Methylinositol	small molecule	investigational	Alcohols|Carbohydrates|Sugar Alcohols
DB12970	Levoglucose	small molecule	investigational	Carbohydrates|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Hexoses|Monosaccharides|Physiological Phenomena|Sweetening Agents
DB12971	Pactimibe	small molecule	investigational	Indoles|Sterol O-Acyltransferase, antagonists & inhibitors
DB12972	Sepranolone	small molecule	investigational	Anesthetics|Central Nervous System Agents|Pregnanes|Steroids
DB12973	Serlopitant	small molecule	investigational	Neurokinin-1 Receptor Antagonists|Neurotransmitter Agents
DB12974	Roniciclib	small molecule	investigational	Sulfur Compounds
DB12975	Pyronaridine	small molecule	investigational	Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals
DB12976	Robatumumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB12977	Simenepag isopropyl	small molecule	investigational	
DB12978	Pexidartinib	small molecule	investigational	
DB12979	Nepicastat	small molecule	investigational	Dopamine beta-Hydroxylase, antagonists & inhibitors|Sulfur Compounds
DB12980	CHS-828	small molecule	investigational	Acids|Acids, Noncarboxylic|Amidines|Anions|Electrolytes|Hydrogen Cyanide|Ions|Nitrogen Compounds
DB12981	XL-888	small molecule	investigational	Acids, Carbocyclic|Aza Compounds|HSP90 Heat-Shock Proteins, antagonists & inhibitors
DB12982	Silicon	small molecule	approved|investigational	Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metalloids|Micronutrients|Minerals|Physiological Phenomena|Trace Elements
DB12983	Phthalocyanine	small molecule	investigational	Pigments, Biological|Radiation-Sensitizing Agents
DB12984	Larotaxel	small molecule	investigational	Cyclodecanes|Cycloparaffins|Diterpenes|Terpenes
DB12985	Quisinostat	small molecule	investigational	Amines|Hydroxy Acids|Hydroxylamines
DB12986	VS-5584	small molecule	investigational	Oxazines
DB12987	Penclomedine	small molecule	investigational	Antineoplastic Agents|Pyridines
DB12988	LY-518674	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB12989	Neosaxitoxin	small molecule	investigational	Agrochemicals|Biological Factors|Central Nervous System Depressants|Insecticides|Marine Toxins|Neuromuscular Agents|Neuromuscular Blocking Agents|Peripheral Nervous System Agents|Pesticides|Purines|Toxic Actions|Toxins, Biological
DB12990	Icosabutate	small molecule	investigational	
DB12991	Deoxyspergualin	small molecule	investigational	Amidines|Antibiotics, Antineoplastic|Antineoplastic Agents|Immunologic Factors|Immunosuppressive Agents|Protective Agents|Radiation-Protective Agents
DB12992	Bleomycin A6	small molecule	investigational	Amino Acids, Peptides, and Proteins|Carbohydrates|Glycoconjugates|Glycopeptides|Peptides
DB12993	Berkelium	small molecule	investigational	Actinoid Series Elements|Elements|Elements, Radioactive|Metals|Metals, Heavy
DB12994	MIP-1095 I-123	small molecule	investigational	
DB12996	Acteoside	small molecule	investigational	Anti-Infective Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antioxidants|Benzene Derivatives|Carbohydrates|Chelating Agents|Glycosides|Immunologic Factors|Immunosuppressive Agents|Protective Agents|Sequestering Agents|Verbenaceae
DB12997	Brilacidin	small molecule	investigational	
DB12998	PF-00217830	small molecule	investigational	
DB12999	MK-6186	small molecule	investigational	
DB13000	PCI-27483	small molecule	investigational	
DB13001	Tinoridine	small molecule	investigational	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Nephrotoxic agents|Peripheral Nervous System Agents|Pyridines|Sensory System Agents|Sulfur Compounds|Thiophenes
DB13002	HKI-357	small molecule	investigational	
DB13003	Cortivazol	small molecule	investigational	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnanes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB13004	Mavoglurant	small molecule	investigational	
DB13005	Rebastinib	small molecule	investigational	
DB13006	Cibinetide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB13007	Enfortumab vedotin	biotech	investigational	
DB13008	2,2-bis(4-hydroxy-3-tert-butylphenyl)propane	small molecule	investigational	
DB13009	Carbendazim	small molecule	investigational	Acids, Acyclic|Agrochemicals|Anthelmintics|Anti-Infective Agents|Antinematodal Agents|Antiparasitic Agents|Fungicides, Industrial|Mutagens|Noxae|Pesticides|Toxic Actions
DB13010	4-isothioureidobutyronitrile	small molecule	investigational	
DB13011	Diethylhomospermine	small molecule	investigational	
DB13012	AQX-1125	small molecule	investigational	Alcohols|Cyclohexanes|Cycloparaffins|Fatty Alcohols|Hexanols|Indenes|Lipids
DB13013	LFF-571	small molecule	investigational	Sulfur Compounds
DB13014	Hypericin	small molecule	investigational	Anti-Infective Agents|Antineoplastic Agents|Benz(a)Anthracenes|Central Nervous System Agents|Central Nervous System Depressants|Enzyme Inhibitors|Immunologic Factors|Immunosuppressive Agents|Phenalenes|Protein Kinase C, antagonists & inhibitors|Psychotropic Drugs|Radiation-Sensitizing Agents
DB13016	LY-2300559	small molecule	investigational	Acids, Carbocyclic|Benzene Derivatives|Ketones
DB13017	Rovalpituzumab Tesirine	biotech	investigational	
DB13018	Dimiracetam	small molecule	investigational	
DB13019	Henatinib	small molecule	investigational	Vascular Endothelial Growth Factors, antagonists & inhibitors
DB13020	Apratastat	small molecule	investigational	Oxazines
DB13021	123I-iodometomidate	small molecule	investigational	
DB13022	LY-2874455	small molecule	investigational	Pyrazoles|Receptors, Fibroblast Growth Factor, antagonists & inhibitors
DB13023	IPI-493	small molecule	investigational	Amides|HSP90 Heat-Shock Proteins, antagonists & inhibitors|Lactams|Protein-Serine-Threonine Kinases, antagonists & inhibitors|Quinones
DB13024	MK-8245	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids|Stearoyl-CoA Desaturase, antagonists & inhibitors
DB13025	Tiapride	small molecule	investigational	Acids, Carbocyclic|Amides|Amines|Antipsychotic Agents|Benzamides and benzamide derivatives|Benzene Derivatives|Benzoates|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Dopamine D2 Receptor Antagonists|Ethylamines|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB13026	Ornidazole	small molecule	investigational	Amebicides|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Antitrichomonal Agents|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Imidazole Derivatives|Imidazoles|Nitro Compounds|Nitroimidazole Derivatives|Nitroimidazoles|Radiation-Sensitizing Agents
DB13027	Tucaresol	small molecule	investigational	Acids, Carbocyclic|Aldehydes|Benzene Derivatives
DB13028	Biapenem	small molecule	investigational	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Carbapenems|Lactams|Sulfur Compounds
DB13029	MK-0873	small molecule	investigational	Enzyme Inhibitors|Phosphodiesterase 4 Inhibitors|Phosphodiesterase Inhibitors
DB13030	2'-fluoro-5-ethylarabinosyluracil	small molecule	investigational	Arabinonucleosides|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB13031	Niobium	small molecule	investigational	Elements|Metals|Metals, Heavy|Transition Elements
DB13032	Enecadin	small molecule	investigational	
DB13033	Urocortin-2	biotech	investigational	Amino Acids, Peptides, and Proteins|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nerve Tissue Proteins|Neuropeptides|Peptide Hormones|Peptides|Proteins
DB13034	Foxy-5	small molecule	investigational	
DB13035	AG-24322	small molecule	investigational	CDC2 Protein Kinase, antagonists & inhibitors|Cyclin-Dependent Kinase 2, antagonists & inhibitors|Cyclin-Dependent Kinase 4, antagonists & inhibitors|Pyrazoles
DB13036	Ramatroban	small molecule	investigational	Amides|Antiplatelet agents|Hematologic Agents|Indoles|Receptors, Thromboxane, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB13037	Namilumab	biotech	investigational	
DB13038	Glyceryl Trioleate	small molecule	investigational	Fats|Fats, Unsaturated|Glycerides|Lipids|Triglycerides
DB13039	Aminaphthone	small molecule	investigational	Acids, Carbocyclic|Aminobenzoates|Benzene Derivatives|Benzoates|Coagulants|Hematologic Agents|Hemostatics
DB13040	Gandotinib	small molecule	investigational	Janus Kinase 2, antagonists & inhibitors
DB13041	Odalasvir	small molecule	investigational	
DB13042	Fenoverine	small molecule	investigational	Alimentary Tract and Metabolism|Autonomic Agents|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Sulfur Compounds
DB13044	Gossypol	small molecule	investigational	Adrenal Cortex Hormones|Contraceptive Agents, Male|Hormonal Contraceptives for Systemic Use|Reproductive Control Agents|Sesquiterpenes|Terpenes
DB13045	Racotumomab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB13046	Tocladesine	small molecule	investigational	
DB13047	Pentavalent Antimony	small molecule	investigational	
DB13048	PAC-1	small molecule	investigational	
DB13049	Lobaplatin	small molecule	investigational	Cycloparaffins|Organometallic Compounds
DB13050	Tirilazad	small molecule	investigational	Antioxidants|Central Nervous System Agents|Nervous System|Neuroprotective Agents|Pregnanes|Protective Agents|Steroids
DB13051	CH-5132799	small molecule	investigational	Amides|Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB13052	Upamostat	small molecule	investigational	Amides|Sulfones|Sulfur Compounds|Urokinase-Type Plasminogen Activator, antagonists & inhibitors
DB13053	CP-195543	small molecule	investigational	Benzopyrans|Pyrans
DB13054	ACT-451840	small molecule	investigational	
DB13055	Oteseconazole	small molecule	investigational	
DB13056	Irsogladine	small molecule	investigational	Anti-Ulcer Agents|Anticarcinogenic Agents|Antineoplastic Agents|Gastrointestinal Agents|Protective Agents|Radiation-Protective Agents
DB13057	Torapsel	biotech	investigational	
DB13058	Methanesulfonyl Fluoride	small molecule	investigational	Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Neurotransmitter Agents|Sulfur Compounds
DB13059	PF-03814735	small molecule	investigational	Protein Kinase Inhibitors
DB13060	CEP-37440	small molecule	investigational	
DB13061	MLN8054	small molecule	investigational	Protein Kinase Inhibitors
DB13062	ME-344	small molecule	investigational	Benzopyrans|Chromones|Flavonoids|Pyrans
DB13063	Parthenolide	small molecule	approved|investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Asteraceae|Cell-mediated Immunity|Central Nervous System Agents|Increased Histamine Release|Magnoliaceae|NF-kappa B, antagonists & inhibitors|Peripheral Nervous System Agents|Sensory System Agents|Standardized Chemical Allergen|Terpenes
DB13064	Tramazoline	small molecule	investigational	Agents producing tachycardia|Agents that produce hypertension|Autonomic Agents|Nasal Preparations|Peripheral Nervous System Agents|Sympathomimetics|Sympathomimetics, Plain
DB13065	LY-2811376	small molecule	investigational	Sulfur Compounds
DB13066	Liarozole	small molecule	investigational	Antineoplastic Agents|Antineoplastic Agents, Hormonal|Dermatologicals|Enzyme Inhibitors|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists
DB13067	Rotigaptide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Peptides
DB13068	9-(N-methyl-L-isoleucine)-cyclosporin A	small molecule	investigational	Amino Acids, Peptides, and Proteins|Cyclosporins|Immunosuppressive Agents|Peptides|Peptides, Cyclic
DB13069	Nimustine	small molecule	investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Urea
DB13070	Surinabant	small molecule	investigational	Agents producing tachycardia|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Neurotransmitter Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors
DB13071	Creatinolfosfate	small molecule	investigational	Cardiac Therapy
DB13072	GDC-0349	small molecule	investigational	
DB13073	Tregalizumab	biotech	investigational	
DB13074	Macimorelin	small molecule	approved|investigational	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diagnostic Agents|Growth Hormone Secretagogue Receptor Agonist|Growth Hormone Secretagogue Receptor Agonists|Highest Risk QTc-Prolonging Agents|Peptides|QTc Prolonging Agents|Tests for Pituitary Function
DB13075	Menaquinone 7	small molecule	investigational	Coagulants|Diterpenes|Hematologic Agents|Hemostatics|Naphthalenes|Naphthoquinones|Phytol|Quinones|Terpenes|Vitamin K|Vitamins|Vitamins (Fat Soluble)
DB13076	Yttrium Y-90	small molecule	approved|investigational	Acids, Acyclic|Anti-Inflammatory Agents|Therapeutic Radiopharmaceuticals|Tricarboxylic Acids|Yttrium|Yttrium (90Y) Compounds|Yttrium Radioisotopes
DB13077	LCB01-0371	small molecule	investigational	
DB13078	KOSN-1724	small molecule	investigational	
DB13080	Roluperidone	small molecule	investigational	
DB13082	Nefiracetam	small molecule	investigational	Central Nervous System Agents|Central Nervous System Depressants|Neuroprotective Agents|Nootropic Agents|Protective Agents|Psychotropic Drugs|Pyrrolidines
DB13083	Talarozole	small molecule	investigational	Chemically-Induced Disorders|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Sulfur Compounds|Thiazoles
DB13084	Pyritinol	small molecule	investigational	Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Pyridines
DB13085	Riamet	small molecule	approved|investigational	
DB13086	SCYX-7158	small molecule	investigational	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB13087	Miridesap	small molecule	investigational	
DB13088	AZD-0424	small molecule	investigational	
DB13089	Enoxolone	small molecule	investigational	Anti-Inflammatory Agents|Cicatrizants|Dermatologicals|Pentacyclic Triterpenes|Preparations for Treatment of Wounds and Ulcers|Terpenes|Triterpenes
DB13090	Zidebactam	small molecule	investigational	
DB13091	Tiropramide	small molecule	investigational	Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Autonomic Agents|Drugs for Functional Gastrointestinal Disorders|Parasympatholytics|Peripheral Nervous System Agents|Synthetic Antispasmodics, Amides With Tertiary Amines
DB13092	Meclocycline	small molecule	experimental|investigational	Anti-Acne Preparations|Anti-Acne Preparations for Topical Use|Anti-Bacterial Agents|Anti-Infective Agents|Antiinfectives for Treatment of Acne|Dermatologicals|Naphthacenes|Tetracyclines
DB13093	TAK-593	small molecule	investigational	Aza Compounds|Receptors, Platelet-Derived Growth Factor, antagonists & inhibitors|Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors
DB13094	Pruvanserin	small molecule	investigational	
DB13095	JTK-853	small molecule	investigational	
DB13096	Gacyclidine	small molecule	investigational	Central Nervous System Agents|Cyclohexanes|Cycloparaffins|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Neuroprotective Agents|Neurotransmitter Agents|Protective Agents
DB13097	1alpha-Hydroxyvitamin D5	small molecule	investigational	Cholestanes|Cholestenes|Lipids|Membrane Lipids|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB13098	CT-2584	small molecule	investigational	Alkaloids|Phospholipase D, antagonists & inhibitors|Purines|Purinones
DB13099	Valnoctamide	small molecule	investigational	Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB13100	Biguanide	small molecule	approved|investigational	
DB13101	4SC-202	small molecule	investigational	
DB13102	AZD-8418	small molecule	investigational	
DB13103	GPX-150	small molecule	investigational	Anthracyclines|Carbohydrates|Daunorubicin|Glycosides|Naphthacenes
DB13104	X-396	small molecule	investigational	
DB13105	Resolvin E1	small molecule	investigational	Autacoids|Biological Factors|Diet, Food, and Nutrition|Dietary Fats|Dietary Fats, Unsaturated|Eicosanoids|Fats|Fatty Acids|Fatty Acids, Omega-3|Fatty Acids, Unsaturated|Fish Oils|Food|Food and Beverages|Inflammation Mediators|Lipids|Oils|Physiological Phenomena
DB13106	Glycovir	small molecule	investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB13107	QGC-001	small molecule	investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Gases|Glutamyl Aminopeptidase, antagonists & inhibitors|Hydrogen Sulfide|Ions|Sulfides|Sulfur Acids|Sulfur Compounds
DB13108	Mephedrone	small molecule	investigational	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Designer Drugs|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Street Drugs|Sympathomimetics
DB13109	PKI-179	small molecule	investigational	Oxazines
DB13110	Antimony	small molecule	investigational	Elements|Metalloids|Metals|Metals, Heavy
DB13111	Chromanol	small molecule	investigational	Antioxidants|Benzopyrans|Protective Agents|Pyrans
DB13112	Dolcanatide	biotech	investigational	
DB13113	JNJ-38877605	small molecule	investigational	
DB13114	Amitriptylinoxide	small molecule	approved|investigational	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Benzocycloheptenes|Central Nervous System Depressants|Dibenzocycloheptenes|Narrow Therapeutic Index Drugs|Neurotoxic agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13115	Saroglitazar	small molecule	investigational	Acids, Carbocyclic
DB13116	Norflurane	small molecule	approved|experimental	Aerosol Propellants|Aerosols|Anesthetics|Central Nervous System Agents|Colloids|Complex Mixtures|Hydrocarbons, Halogenated|Investigative Techniques|Pharmaceutical Preparations
DB13117	Pentafluoropropane	small molecule	approved|investigational	Hydrocarbons, Halogenated
DB13118	Paquinimod	small molecule	investigational	
DB13119	GSK-364735	small molecule	investigational	
DB13120	Deferitazole	small molecule	investigational	Ethers|Iron Chelating Agents|Sulfur Compounds
DB13121	Hydroxypropyl tetrahydropyrantriol	small molecule	investigational	
DB13122	Trabodenoson	small molecule	investigational	Acids|Acids, Noncarboxylic|Adenosine A1 Receptor Agonists|Anions|Carbohydrates|Electrolytes|Glycosides|Ions|Nitric Acid|Nitrogen Compounds|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB13123	OTX-008	small molecule	investigational	
DB13124	Troxerutin	small molecule	investigational	Anticoagulants|Benzopyrans|Capillary Stabilizing Agents|Chromones|Flavonoids|Flavonols|Hematologic Agents|Pyrans|Radiation-Protective Agents|Rutin|Vasoprotectives
DB13125	Lusutrombopag	small molecule	approved|investigational	BCRP/ABCG2 Substrates|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates
DB13126	BMS-986115	small molecule	investigational	
DB13127	Olokizumab	biotech	investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB13128	Sizofiran	small molecule	investigational	Adjuvants, Immunologic|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|beta-Glucans|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Glucans|Immunologic Factors|Macromolecular Substances|Polymers|Polysaccharides
DB13129	Trimegestone	small molecule	investigational	Genito Urinary System and Sex Hormones|Norpregnadienes|Norpregnanes|Norsteroids|Progestogens and Estrogens, Sequential Preparations|Sex Hormones and Modulators of the Genital System|Steroids
DB13131	Serrapeptase	biotech	investigational	Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Central Nervous System Agents|Enzymes|Enzymes and Coenzymes|Hydrolases|Peripheral Nervous System Agents|Sensory System Agents|Serratia
DB13132	Artemisinin	small molecule	investigational	Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Artemisia|Artemisinin and Derivatives, Plain|Cytochrome P-450 CYP2B6 Substrates|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Sesquiterpenes|Terpenes
DB13133	Von Willebrand Factor Human	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Hemostatics|Increased Coagulation Activity|Increased Platelet Aggregation|Proteins
DB13134	Fluorine F-18	small molecule	investigational	
DB13135	AGN-201904	small molecule	investigational	2-Pyridinylmethylsulfinylbenzimidazoles|Benzimidazoles|Pyridines|Sulfoxides|Sulfur Compounds
DB13136	Fluindione	small molecule	approved|investigational	Anticoagulants|Blood and Blood Forming Organs|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hematologic Agents|Indans|Indenes|Narrow Therapeutic Index Drugs|Vitamin K Antagonists
DB13137	PM-060184	small molecule	investigational	Lactones|Pyrans
DB13138	Neladenoson bialanate	small molecule	investigational	
DB13139	Levosalbutamol	small molecule	approved|investigational	Adrenergic Agonists|Adrenergic beta-2 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Agents to Treat Airway Disease|Albuterol|Alcohols|Amines|Amino Alcohols|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Ethanolamines|Ethylamines|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Phenethylamines
DB13140	Bezlotoxumab	biotech	approved|investigational	
DB13141	Ambroxol acefyllinate	small molecule	experimental|investigational	Alkaloids|Amines|Aniline Compounds|Bromhexine|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Purines|Purinones
DB13142	Calcium glubionate	small molecule	approved	Alimentary Tract and Metabolism|Calcium Salts|Carbohydrates|Infant Food|Mineral Supplements|Oligosaccharides|Polysaccharides
DB13143	Methallenestril	small molecule	experimental	Estrogens|Genito Urinary System and Sex Hormones|Sex Hormones and Modulators of the Genital System|Synthetic Estrogens, Plain
DB13144	Lenograstim	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Immunologic Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB13145	Nedaplatin	small molecule	approved|investigational	Antineoplastic Agents|Organometallic Compounds|Platinum Compounds
DB13146	Fluciclovine (18F)	small molecule	approved	Amino Acids, Peptides, and Proteins|Cycloparaffins|P-glycoprotein/ABCB1 Substrates|Positron Emitting Activity|Radioactive Diagnostic Agent
DB13147	Pancrelipase lipase	biotech	approved	
DB13148	Coagulation factor X human	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Hemostatics|Increased Coagulation Activity|Proteins
DB13149	Protein S human	biotech	approved	Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood Coagulation Factor Inhibitors|Blood Proteins|Carbohydrates|Glycoconjugates|Glycoproteins|Hematologic Agents|Proteins
DB13150	Coagulation factor VII human	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Increased Coagulation Activity|Proteins
DB13151	Anti-inhibitor coagulant complex	biotech	approved|investigational	Blood and Blood Forming Organs|Blood Coagulation Factors|Hemostatics|Reversed Anticoagulation Activity
DB13152	Coagulation Factor IX Human	biotech	approved	Blood Coagulation Factors|Hemostatics|Increased Coagulation Activity
DB13153	Levomenol	small molecule	approved|experimental	Biological Products|Complex Mixtures|Lipids|OATP1B1/SLCO1B1 Substrates|OATP1B3 substrates|Oils|Pharmaceutical Preparations|Plant Preparations|Terpenes
DB13154	Parachlorophenol	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Benzene Derivatives|Chlorobenzenes|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|OATP1B3 substrates|Phenols
DB13155	Esculin	small molecule	approved	Benzopyrans|Carbohydrates|Coumarins|Glucosides|Glycosides|Pyrans
DB13156	Inosine pranobex	small molecule	approved	Acetanilides|Adjuvants, Immunologic|Amides|Anilides|Anti-Infective Agents|Antiinfectives for Systemic Use|Antiviral Agents|Carbohydrates|Glycosides|Immunologic Factors|Inosine|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Purine Nucleosides|Purines|Ribonucleosides
DB13157	Sodium lauryl sulfoacetate	small molecule	approved|experimental	Alimentary Tract and Metabolism|Drugs for Constipation|Enemas
DB13158	Clobetasone	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Betamethasone|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Immunosuppressive Agents|Ointments|Ophthalmologicals|Pregnadienes|Pregnadienetriols|Pregnanes|Sensory Organs|Steroids|Steroids, Fluorinated
DB13160	Alphaprodine	small molecule	illicit	Analgesics|Central Nervous System Agents|Central Nervous System Depressants|Narcotics|Opioids|Peripheral Nervous System Agents|Piperidines|Sensory System Agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13161	Nusinersen	biotech	approved|investigational	Carbohydrates|Glycosides|Increased Protein Synthesis|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides, Antisense|Other Miscellaneous Therapeutic Agents|Polynucleotides|Survival Motor Neuron-2-directed RNA Interaction
DB13163	Terpin hydrate	small molecule	approved|experimental	Alcohols|Cyclohexanes|Cyclohexanols|Cycloparaffins|Expectorants|Fatty Alcohols|Hexanols|Lipids|Monoterpenes|Respiratory System Agents|Terpenes
DB13164	Olmutinib	small molecule	investigational	
DB13165	Ripasudil	small molecule	experimental	Amides|rho-Associated Kinases, antagonists & inhibitors|Sulfones|Sulfur Compounds
DB13166	Zofenopril	small molecule	experimental	ACE Inhibitors and Diuretics|Acids, Acyclic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Imines|Imino Acids|Proline|Protease Inhibitors
DB13167	Alclofenac	small molecule	approved|withdrawn	Acetic Acid Derivatives and Related Substances|Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents
DB13168	Omega-6 fatty acids	small molecule	nutraceutical	Fatty Acids|Fatty Acids, Unsaturated|Lipids
DB13169	Nandrolone	small molecule	experimental|investigational	Alimentary Tract and Metabolism|Anabolic Agents|Anabolic Agents for Systemic Use|Anabolic Steroids|Androgens|Estranes|Estren Derivatives|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Nandrolone|Ophthalmologicals|Sensory Organs|Steroids|Testosterone Congeners
DB13170	Plecanatide	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Enzyme Activators|Guanylate Cyclase Activators|Guanylate Cyclase-C Agonist|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Laxatives|Peptide Hormones|Peptides
DB13171	Glyceryl 1-oleate	small molecule	experimental	Lipids
DB13172	Tunicamycin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines
DB13173	Cerliponase alfa	biotech	approved|investigational	Hydrolytic Lysosomal N-terminal Tripeptidyl Peptidase|P-glycoprotein/ABCB1 Substrates
DB13174	Rhein	small molecule	experimental	Anthracenes|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 CYP2E1 Inhibitors|Cytochrome P-450 CYP2E1 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Mixed Function Oxygenases|NADH, NADPH Oxidoreductases, antagonists & inhibitors|Quinones
DB13175	Rheinanthrone	small molecule	experimental	
DB13178	Inositol	small molecule	approved|investigational|withdrawn	Alcohols|Alimentary Tract and Metabolism|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Other Nutritional Agents|Physiological Phenomena|Sugar Alcohols|Vitamin B Complex|Vitamins
DB13179	Troleandomycin	small molecule	approved	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (strong)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Inhibitors|Cytochrome P-450 CYP3A5 Inhibitors (strong)|Cytochrome P-450 CYP3A7 Inhibitors|Cytochrome P-450 CYP3A7 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Oleandomycin|P-glycoprotein/ABCB1 Inhibitors|Polyketides
DB13180	Gluconic Acid	small molecule	approved|investigational	Acids, Acyclic|Carbohydrates|Chelating Agents|Hydroxy Acids|Laxatives|Osmotic Laxative|Sugar Acids
DB13181	Methylbenactyzium	small molecule	experimental	Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds
DB13182	Daidzein	small molecule	experimental	Antineoplastic Agents|Benzopyrans|Chromones|Enzyme Inhibitors|Estrogens, Non-Steroidal|Flavonoids|Growth Inhibitors|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Phytoestrogens|Pyrans|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB13183	Technetium Tc-99m etifenin	small molecule	experimental	Diagnostic Radiopharmaceuticals|Hepatic and Reticulo Endothelial System|Technetium (99Mtc) Compounds
DB13185	Oxabolone cipionate	small molecule	experimental	Alimentary Tract and Metabolism|Anabolic Agents for Systemic Use|Anabolic Steroids|Estradiol Congeners|Estranes|Estren Derivatives|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB13189	Calcitonin porcine	biotech	experimental	Bone Density Conservation Agents|Calcitonin Preparations|Calcium Homeostasis|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB13191	Phosphocreatine	small molecule	nutraceutical	Amidines|Amino Acids|Amino Acids, Peptides, and Proteins|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Creatine|Guanidines|Phosphoamino Acids|Protective Agents
DB13192	Antihemophilic factor human	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Hemophilia A|Hemostatics|Human Antihemophilic Factor|Increased Coagulation Activity|Proteins
DB13193	Vitex agnus-castus fruit extract	biotech	experimental	Genito Urinary System and Sex Hormones
DB13195	Horse chestnut	biotech	experimental	Capillary Stabilizing Agents|Vasoprotectives
DB13196	Valerian	biotech	approved|experimental|investigational	Central Nervous System Depressants|Herbs and Natural Products|Hypnotics and Sedatives|Miscellaneous Anxiolytics Sedatives and Hypnotics|Nervous System|Psycholeptics
DB13198	Pepsin	biotech	approved|experimental|investigational	Alimentary Tract and Metabolism|Aspartic Acid Endopeptidases|Aspartic Acid Proteases|Digestives, Incl. Enzymes|Endopeptidases|Enzyme Preparations|Enzymes|Enzymes and Coenzymes|Gastrointestinal Agents|Hydrolases|Peptide Hydrolases
DB13200	Lipegfilgrastim	biotech	approved|investigational	Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Antineoplastic and Immunomodulating Agents|Biological Factors|Carbohydrates|Colony-Stimulating Factors|Cytokines|Glycoconjugates|Glycoproteins|Hematopoietic Cell Growth Factors|Intercellular Signaling Peptides and Proteins|Pegylated agents|Peptides|Proteins
DB13201	Trenonacog alfa	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood and Blood Forming Organs|Blood Coagulation Factors|Blood Proteins|Hemostatics|Proteins
DB13202	Piprozolin	small molecule	experimental	Alimentary Tract and Metabolism|Bile and Liver Therapy|Bile Therapy|Sulfur Compounds|Thiazoles
DB13203	Bamifylline	small molecule	experimental	Alkaloids|Analgesics|Anti-Asthmatic Agents|Autonomic Agents|Bronchodilator Agents|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP1A2 Substrates|Drugs for Obstructive Airway Diseases|Peripheral Nervous System Agents|Purines|Purinones|Respiratory System Agents|Sensory System Agents|Vasodilating Agents|Xanthine derivatives
DB13205	Teclozan	small molecule	experimental	Amines|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Benzene Derivatives|Benzyl Compounds|Dichloroacetamide Derivatives
DB13206	Bamethan	small molecule	experimental	2-Amino-1-Phenylethanol Derivatives|Alcohols|Amines|Amino Alcohols|Cardiovascular Agents|Ethylamines|Peripheral Vasodilators|Vasodilating Agents
DB13207	Arginine glutamate	small molecule	investigational	Alimentary Tract and Metabolism|Amino Acids, Peptides, and Proteins|Bile and Liver Therapy|Liver Therapy|Liver Therapy, Lipotropics|Oligopeptides|Peptides
DB13209	Bismuth subnitrate	small molecule	approved	Alimentary Tract and Metabolism|Antacids|Bismuth containing drugs|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Elements|Gastric Acid Lowering Agents|Gastrointestinal Agents|Metals|Metals, Heavy|Neurotoxic agents
DB13211	Guanoxan	small molecule	experimental	Amidines|Antiadrenergic Agents, Peripherally Acting|Antihypertensive Agents|Guanidine Derivatives
DB13214	Sulfadicramide	small molecule	experimental	Anti-Infective Agents|Ophthalmologicals|Sensory Organs|Sulfonamides
DB13217	Fentiazac	small molecule	experimental	Acetic Acid Derivatives and Related Substances|Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents|Sulfur Compounds|Topical Products for Joint and Muscular Pain
DB13226	Acetylleucine	small molecule	experimental	Amino Acids|Amino Acids, Branched-Chain|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Antivertigo Preparations|Nervous System
DB13227	Tribenoside	small molecule	experimental	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Capillary Stabilizing Agents|Carbohydrates|Central Nervous System Agents|Peripheral Nervous System Agents|Sensory System Agents|Vasoprotectives
DB13229	Enibomal	small molecule	experimental	Anesthetics|Anesthetics, General|Nervous System|Pyrimidines|Pyrimidinones
DB13231	Calcium lactate	small molecule	approved|investigational|vet_approved	Alimentary Tract and Metabolism|Calcium Salts|Hydroxy Acids|Mineral Supplements
DB13232	Suxibuzone	small molecule	experimental	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Pyrazoles|Pyrazolones|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB13233	Alaproclate	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Central Nervous System Agents|Central Nervous System Depressants|Hypoglycemia-Associated Agents|Membrane Transport Modulators|Nervous System|Neurotransmitter Agents|Neurotransmitter Uptake Inhibitors|Psychoanaleptics|Psychotropic Drugs|Selective Serotonin Reuptake Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin Agents|Serotonin Modulators
DB13234	Propanidid	small molecule	experimental	Acids, Carbocyclic|Amines|Anesthetics|Anesthetics, General|Anesthetics, Intravenous|Central Nervous System Agents|Central Nervous System Depressants|Diethylamines|Ethylamines|Nervous System|Phenylacetates
DB13235	Perboric acid	small molecule	approved	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Antiinfectives and Antiseptics for Local Oral Treatment|Boric Acids|Boron Compounds|Electrolytes|Ions|Stomatological Preparations|Tooth Bleaching
DB13237	Clofoctol	small molecule	experimental	Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Benzene Derivatives|Phenols
DB13238	Tuaminoheptane	small molecule	experimental	Nasal Preparations|Sympathomimetics, Plain
DB13239	Neltenexine	small molecule	experimental	Amines|Aniline Compounds|Bromhexine|Cough and Cold Preparations|Cyclohexanes|Cyclohexylamines|Cycloparaffins|Expectorants
DB13240	Cymarin	small molecule	experimental	Antiarrhythmic agents|Carbohydrates|Cardanolides|Cardenolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Glycosides|Protective Agents|Steroids|Strophanthins|Strophanthus Glycosides
DB13241	Begelomab	biotech	experimental|investigational	Antineoplastic and Immunomodulating Agents|Immunosuppressive Agents|Selective Immunosuppressants
DB13242	Bucladesine	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Cyclic AMP|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Nucleotides, Cyclic|Phosphodiesterase Inhibitors|Purine Nucleotides|Purines|Ribonucleotides
DB13249	Magnesium silicate	small molecule	approved	Acids|Acids, Noncarboxylic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Ions|Magnesium Compounds|Minerals|Oxides|Oxygen Compounds|Silicates|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB13255	Propatyl nitrate	small molecule	experimental|investigational	Alcohols|Antianginal Agents|Cardiac Therapy|Glycols|Organic Nitrates|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB13257	Ferrous sulfate anhydrous	small molecule	approved	Amino Acids, Peptides, and Proteins|Anemia, Iron-Deficiency|Carbohydrates|Delayed-Action Preparations|Glycoconjugates|Glycoproteins|Hematinics|Iron Compounds|Iron Preparations|Minerals|Mucoproteins|Organometallic Compounds|Pharmaceutical Preparations|Proteins|Reactive Oxygen Species
DB13259	Ethyl chloride	small molecule	approved|experimental|investigational	Anesthetics|Anesthetics, Local|Central Nervous System Agents|Central Nervous System Depressants|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Nervous System|Peripheral Nervous System Agents|Sensory System Agents
DB13260	Lysozyme	biotech	experimental|investigational	Anti-Infective Agents|Antiinfectives for Systemic Use|Dermatologicals|Enzymes|Enzymes and Coenzymes|Glycoside Hydrolases|Hydrolases
DB13261	Sitafloxacin	small molecule	experimental|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Moderate Risk QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB13263	Quassia	biotech	experimental	Antiparasitic Products, Insecticides and Repellents|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents
DB13266	Cefatrizine	small molecule	experimental	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalexin|Cephalosporins|First-Generation Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB13268	Acetarsol	small molecule	approved|withdrawn	Agents Against Leishmaniasis and Trypanosomiasis|Alimentary Tract and Metabolism|Anti-Infective Agents|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Arsenicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Intestinal Antiinfectives|Organometallic Compounds
DB13269	Dichlorobenzyl alcohol	small molecule	approved	Alcohols|Anti-Infective Agents, Local|Benzene Derivatives|Benzyl Compounds|Throat Preparations
DB13271	Wood creosote	small molecule	experimental|investigational	Benzene Derivatives|Cough and Cold Preparations|Cresols|Expectorants|Phenols
DB13281	Bromelains	biotech	investigational	Cysteine Endopeptidases|Cysteine Proteases|Dermatologicals|Endopeptidases|Enzymes|Enzymes and Coenzymes|Gastrointestinal Agents|Hydrolases|Musculo-Skeletal System|Peptide Hydrolases|Preparations for Treatment of Wounds and Ulcers
DB13293	Ipecac	small molecule	approved|withdrawn	Antidotes|Autonomic Agents|Biological Products|Central Nervous System Agents|Complex Mixtures|Cough and Cold Preparations|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Emetics|Expectorants|Gastrointestinal Agents|Peripheral Nervous System Agents|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB13295	Atracurium	small molecule	approved|experimental|investigational	Alkaloids|Anticholinergic Agents|Benzylisoquinolines|Central Nervous System Depressants|Cholinergic Agents|Isoquinolines|Muscle Relaxants|Muscle Relaxants, Peripherally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Neuromuscular Blocking Agents|Neuromuscular Nondepolarizing Blockade|Neuromuscular-Blocking Agents (Nondepolarizing)|Neurotransmitter Agents|Nicotinic Antagonists|Peripheral Nervous System Agents
DB13296	Propamidine	small molecule	experimental|investigational	Amidines|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals|Antiseptics and Disinfectants|Biguanides and Amidines|Dermatologicals|Ophthalmologicals|Sensory Organs
DB13297	Idrocilamide	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Musculo-Skeletal System|Topical Products for Joint and Muscular Pain
DB13307	Proscillaridin	small molecule	experimental	Bufanolides|Carbohydrates|Cardanolides|Cardiac Glycosides|Cardiac Therapy|Cardiotonic Agents|Cardiovascular Agents|Enzyme Inhibitors|Glycosides|Protective Agents|Scilla Glycosides|Steroids
DB13312	Delapril	small molecule	investigational	ACE Inhibitors and Calcium Channel Blockers|ACE Inhibitors and Diuretics|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Indenes|Protease Inhibitors
DB13314	Alminoprofen	small molecule	experimental	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Propionates|Sensory System Agents
DB13322	Hydrotalcite	small molecule	approved|experimental|investigational	Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Hydroxides|Ions|Magnesium Compounds
DB13323	Trichloroethylene	small molecule	approved	Agents that produce hypertension|Anesthetics|Anesthetics, General|Anesthetics, Inhalation|Central Nervous System Agents|Central Nervous System Depressants|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Nervous System|Solvents
DB13337	Pheneticillin	small molecule	approved	Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins
DB13345	Dihydroergocristine	small molecule	approved|experimental	Adrenergic Agents|Adrenergic Antagonists|Agents that produce hypertension|Alkaloids|BSEP/ABCB11 Substrates|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ergot Alkaloids and Derivatives|Ergotamines|Neurotransmitter Agents|Peripheral Vasodilators|Vasodilating Agents
DB13346	Bufexamac	small molecule	approved|withdrawn	Acetamides|Acetates|Acetic Acid Derivatives and Related Substances|Acids, Acyclic|Agents causing hyperkalemia|Amides|Amines|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Antiinflammatory Preparations, Non-Steroids for Topical Use|Antineoplastic Agents|Benzene Derivatives|Benzeneacetamides|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Histone Deacetylase Inhibitors|Hydroxamic Acids|Hydroxy Acids|Hydroxylamines|Lipids|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB13352	Deanol	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Anti-Dyskinesia Agents|Central Nervous System Agents|Central Nervous System Depressants|Ethanolamines|Methylamines|Nervous System|Psychoanaleptics|Psychostimulants, Agents Used for Adhd and Nootropics|Psychotropic Drugs
DB13355	Visnadine	small molecule	experimental|investigational	Benzopyrans|Peripheral Vasodilators|Pyrans
DB13359	Magnesium aspartate	small molecule	experimental	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Excitatory Amino Acids|Magnesium Compounds|Mineral Supplements
DB13374	Vincamine	small molecule	experimental	Alkaloids|Antihypertensive Agents|Antineoplastic Agents|Cardiovascular Agents|Indole Alkaloids|Indoles|Peripheral Vasodilators|Secologanin Tryptamine Alkaloids|Vasodilating Agents|Vinca Alkaloids
DB13375	Edrecolomab	biotech	experimental|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB13381	Sodium feredetate	small molecule	approved	Acetates|Acids, Acyclic|Amines|Antianemic Preparations|Blood and Blood Forming Organs|Diamines|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Iron Chelating Agents|Iron Compounds|Iron Preparations|Iron Trivalent, Oral Preparations|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Polyamines|Sequestering Agents
DB13384	Melitracen	small molecule	experimental|investigational	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13385	Dihydroergocryptine	small molecule	experimental	Agents that produce hypertension|Alkaloids|Anti-Parkinson Drugs|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dopamine Agents|Dopamine Agonists|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Ergotamines|Nervous System|Neurotransmitter Agents|Vasodilating Agents
DB13392	Mercurochrome	small molecule	experimental	Antiseptics and Disinfectants|Dermatologicals|Mercurial Products|Organomercury Compounds|Organometallic Compounds
DB13394	Adrenalone	small molecule	experimental	Alcohols|Alimentary Tract and Metabolism|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Blood and Blood Forming Organs|Cardiovascular Agents|Catecholamines|Coagulants|Ethanolamines|Hematologic Agents|Hemostatics|Local Hemostatics|Stomatological Preparations|Vasoconstrictor Agents
DB13404	Edetate sodium	small molecule	experimental	Ophthalmologicals|Sensory Organs
DB13416	Sulbutiamine	small molecule	experimental	Alimentary Tract and Metabolism|Pyrimidines|Sulfur Compounds|Thiazoles|Vitamin B Complex|Vitamins
DB13421	Edoxudine	small molecule	approved|investigational|withdrawn	Anti-Infective Agents|Antiviral Agents|Carbohydrates|Deoxyribonucleosides|Dermatologicals|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides|Uridine
DB13443	Esatenolol	small molecule	experimental	Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Antihypertensive Agents|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates
DB13444	Ioxitalamic acid	small molecule	approved|experimental	Acids, Carbocyclic|Alcohols|Amino Sugars|Benzene Derivatives|Benzoates|Carbohydrates|Contrast Media|Diagnostic Uses of Chemicals|Hexosamines|Iodobenzoates|Iothalamic Acid|Meglumine|Sorbitol|Sugar Alcohols|Triiodobenzoic Acids|Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB13456	Midecamycin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Lactones|Macrolides|Macrolides, Lincosamides and Streptogramins|Polyketides
DB13471	Nalfurafine	small molecule	experimental|investigational	Alkaloids|Opiate Alkaloids|Phenanthrenes|Receptors, Opioid, kappa, agonists
DB13480	Lentinan	small molecule	experimental|investigational	Adjuvants, Immunologic|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|beta-Glucans|Biomedical and Dental Materials|Biopolymers|Carbohydrates|Glucans|Immunologic Factors|Macromolecular Substances|Polymers|Polysaccharides
DB13488	Bencyclane	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cycloheptanes|Cycloparaffins|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Membrane Transport Modulators|Peripheral Vasodilators|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Vasodilating Agents
DB13492	Policresulen	small molecule	experimental|investigational	Antiseptics and Disinfectants|Benzene Derivatives|Dermatologicals|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Pharmaceutical Preparations|Phenol and Derivatives|Phenols
DB13500	Otilonium	small molecule	experimental|investigational	Agents causing hyperkalemia|Agents producing tachycardia|Alimentary Tract and Metabolism|Amines|Ammonium Compounds|Antiarrhythmic agents|Anticholinergic Agents|Autonomic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cholinergic Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Functional Gastrointestinal Disorders|Gastrointestinal Agents|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|Muscarinic Antagonists|Neurotransmitter Agents|Nitrogen Compounds|Onium Compounds|Parasympatholytics|Peripheral Nervous System Agents|QTc Prolonging Agents|Synthetic Anticholinergics, Quaternary Ammonium Compounds|Vasodilating Agents
DB13501	Bendazac	small molecule	approved|withdrawn	Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antiinflammatory Preparations, Non-Steroids for Topical Use|Central Nervous System Agents|Musculo-Skeletal System|Nephrotoxic agents|Ophthalmologicals|Peripheral Nervous System Agents|Pyrazoles|Sensory Organs|Sensory System Agents|Topical Products for Joint and Muscular Pain
DB13503	Tyrothricin	small molecule	approved	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Local|Antibiotics for Topical Use|Cholinesterase Inhibitors|Dermatologicals|Ophthalmologicals|Peptides|Peptides, Cyclic|Sensory Organs|Throat Preparations
DB13508	Cloranolol	small molecule	experimental	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antihypertensive Agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Propanols
DB13509	Aloxiprin	small molecule	experimental	Acids, Carbocyclic|Analgesics|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Hydroxy Acids|Hydroxybenzoates|Nervous System|Phenols|Platelet Aggregation Inhibitors Excl. Heparin|Salicylates|Salicylic Acid and Derivatives
DB13514	Pranoprofen	small molecule	experimental|investigational	Acids, Acyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Lipids|Nephrotoxic agents|Ophthalmologicals|Peripheral Nervous System Agents|Pyrans|Sensory Organs|Sensory System Agents
DB13518	Alginic acid	small molecule	approved|investigational	Acids, Acyclic|Acids, Aldehydic|Alimentary Tract and Metabolism|Bandages|Biocompatible Materials|Biomedical and Dental Materials|Carbohydrates|Coagulants|Dental Impression Materials|Drug Carriers|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Glucuronates|Hematologic Agents|Hemostatics|Hydroxy Acids|Polysaccharides|Protective Agents|Radiation-Protective Agents|Sugar Acids|Uronic Acids
DB13520	Metergoline	small molecule	experimental	Agents that produce hypertension|Alkaloids|Central Nervous System Depressants|Dopamine Agents|Dopamine Agonists|Ergolines|Ergot Alkaloids and Derivatives|Ergot-derivative Dopamine Receptor Agonists|Genito Urinary System and Sex Hormones|Neurotransmitter Agents|Prolactine Inhibitors|Serotonin Agents|Serotonin Receptor Agonists
DB13521	Alipogene tiparvovec	biotech	approved|investigational	Lipid Modifying Agents|Lipid Modifying Agents, Plain
DB13529	Dobesilic acid	small molecule	experimental|investigational	Acids|Acids, Noncarboxylic|Antivaricose Therapy|Arylsulfonates|Arylsulfonic Acids|Benzene Derivatives|Benzenesulfonates|Coagulants|Hematologic Agents|Hemostatics|Sulfonic Acids|Sulfur Acids|Sulfur Compounds|Vasoprotectives
DB13530	Mepindolol	small molecule	experimental	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Phenoxypropanolamines|Propanolamines|Propanols
DB13532	Cyclopenthiazide	small molecule	approved	Amides|Antihypertensive Agents|Benzothiadiazines|Cardiovascular Agents|Diuretics|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Hyperglycemia-Associated Agents|Low-Ceiling Diuretics and Potassium-Sparing Agents|Membrane Transport Modulators|Natriuretic Agents|Sodium Chloride Symporter Inhibitors|Sulfonamides|Sulfones|Sulfur Compounds|Thiazides
DB13538	Guacetisal	small molecule	experimental	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antitussive Agents|Benzene Derivatives|Benzoates|Central Nervous System Agents|Expectorants|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Phenols|Respiratory System Agents|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents
DB13539	Iodoxamic acid	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Hepatotropic X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB13549	4-dimethylaminophenol	small molecule	experimental	Amines|Aniline Compounds|Antidotes|Benzene Derivatives|Hydrogen Cyanide|Phenols|Protective Agents
DB13550	Bifemelane	small molecule	experimental	Benzene Derivatives|Central Nervous System Agents|Central Nervous System Depressants|Nervous System|Psychoanaleptics|Psychotropic Drugs|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13561	Clobenzorex	small molecule	experimental	Alimentary Tract and Metabolism|Amines|Antiobesity Preparations, Excl. Diet Products|Central Nervous System Stimulants|Centrally Acting Antiobesity Products|Ethylamines|Phenethylamines
DB13563	Norgestrienone	small molecule	experimental	Adrenal Cortex Hormones|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnatrienes|Norsteroids|Progestin Contraceptives|Progestins|Reproductive Control Agents|Sex Hormones and Modulators of the Genital System|Steroids
DB13583	Mephenesin	small molecule	approved	Alcohols|Central Nervous System Agents|Central Nervous System Depressants|Glycols|Muscle Relaxants|Muscle Relaxants, Centrally Acting Agents|Musculo-Skeletal System|Neuromuscular Agents|Peripheral Nervous System Agents|Propylene Glycols
DB13587	Mesterolone	small molecule	experimental	5-Androstanon (3) Derivatives|Anabolic Agents|Androgens|Androstanes|Androstanols|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Sex Hormones and Modulators of the Genital System|Steroids|Testosterone Congeners
DB13595	Almasilate	small molecule	approved|experimental	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Ions|Minerals|Oxides|Oxygen Compounds|Pharmaceutic Aids|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB13609	Umifenovir	small molecule	experimental|investigational	Antiinfectives for Systemic Use|Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals
DB13612	Carbaspirin calcium	small molecule	experimental|investigational	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Phenols|Platelet Aggregation Inhibitors Excl. Heparin|Salicylates|Salicylic Acid and Derivatives|Sensory System Agents
DB13615	Mifamurtide	small molecule	approved|experimental	Acids, Acyclic|Adjuvants, Immunologic|Amino Acids, Peptides, and Proteins|Amino Sugars|Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycerophosphates|Glycerophospholipids|Glycoconjugates|Glycopeptides|Hydroxy Acids|Immunologic Factors|Lipids|Membrane Lipids|Muramic Acids|Peptides|Phosphatidic Acids|Phospholipids|Sugar Acids|Sugar Phosphates
DB13620	Potassium gluconate	small molecule	approved	Alimentary Tract and Metabolism|Mineral Supplements|Potassium|Potassium Salt
DB13624	Methoxyphenamine	small molecule	approved	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-Agonists|Adrenergics for Systemic Use|Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Drugs for Obstructive Airway Diseases|Ethylamines|Neurotransmitter Agents|Non-selective Beta-adrenergic Agonists|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Sympathomimetics
DB13626	Aluminium glycinate	small molecule	experimental	Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Amino Acids|Amino Acids, Peptides, and Proteins|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Hydroxides|Ions
DB13627	Oxolinic acid	small molecule	experimental	4-Quinolones|Anti-Bacterial Agents|Anti-Infective Agents|Anti-Infective Agents, Urinary|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Renal Agents|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB13643	Loprazolam	small molecule	experimental	Anti-Anxiety Agents|Benzazepines|Benzodiazepine hypnotics and sedatives|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB13646	Saruplase	biotech	experimental	Agents causing angioedema|Amino Acids, Peptides, and Proteins|Anticoagulants|Biological Factors|Blood and Blood Forming Organs|Blood Proteins|Cardiovascular Agents|Endopeptidases|Enzyme Precursors|Enzymes|Enzymes and Coenzymes|Fibrin Modulating Agents|Fibrinolytic Agents|Hematologic Agents|Hydrolases|Peptide Hydrolases|Plasminogen Activators|Proteins|Serine Endopeptidases|Serine Proteases
DB13647	Semustine	small molecule	experimental|investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic and Immunomodulating Agents|Lomustine|Nitroso Compounds|Nitrosourea Compounds|Nitrosoureas|Noxae|Toxic Actions|Urea
DB13650	Aloglutamol	small molecule	experimental	Alcohols|Alimentary Tract and Metabolism|Alkalies|Aluminium Compounds|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Glycols|Hydroxides|Ions|Propylene Glycols
DB13654	Montmorillonite	small molecule	experimental|investigational	Acids|Acids, Noncarboxylic|Alimentary Tract and Metabolism|Aluminium Compounds|Aluminum Silicates|Anions|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antidotes|Electrolytes|Intestinal Adsorbents|Ions|Minerals|Oxides|Oxygen Compounds|Protective Agents|Silicates|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB13657	Benorilate	small molecule	approved	Acids, Carbocyclic|Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anilides|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Benzene Derivatives|Benzoates|Central Nervous System Agents|Hydroxy Acids|Hydroxybenzoates|Nephrotoxic agents|Nervous System|Peripheral Nervous System Agents|Phenols|Salicylic Acid and Derivatives|Sensory System Agents
DB13658	Hemoglobin raffimer	small molecule	experimental|investigational	Blood and Blood Forming Organs|Blood and Related Products|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions
DB13660	Propicillin	small molecule	experimental	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Lactams|Penicillins|Sulfur Compounds
DB13667	Cefozopran	small molecule	experimental	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Fourth-Generation Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB13679	Dexchlorpheniramine	small molecule	experimental|investigational	Agents that reduce seizure threshold|Antihistamines for Systemic Use|Histamine Agents|Histamine Antagonists|Histamine H1 Antagonists|Moderate Risk QTc-Prolonging Agents|Neurotransmitter Agents|Pheniramine|Pyridines|QTc Prolonging Agents|Stereoisomerism|Substituted Alkylamines
DB13682	Cefpirome	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Fourth-Generation Cephalosporins|Lactams|Nephrotoxic agents|Sulfur Compounds|Thiazines
DB13688	Drisapersen	small molecule	experimental|investigational	Carbohydrates|Glycosides|Musculo-Skeletal System|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Polynucleotides
DB13689	Tacalcitol	small molecule	experimental|investigational	Anti-Inflammatory Agents|Antipsoriatics|Antipsoriatics for Topical Use|Cholestanes|Cholestenes|Dermatologicals|Lipids|Membrane Lipids|Ointments|Psoriasis|Secosteroids|Steroids|Sterols|Vitamin D and Analogues|Vitamins|Vitamins (Fat Soluble)
DB13694	Distigmine	small molecule	experimental	Cholinergic Agents|Cholinesterase Inhibitors|Enzyme Inhibitors|Nervous System|Neurotransmitter Agents|Parasympathomimetics|Pyridines
DB13700	Protamine	small molecule	experimental|investigational	Antidotes|Heparin Binding Activity|Heparin Reversal Agent|Reversed Anticoagulation Activity
DB13704	Pristinamycin	small molecule	experimental|investigational	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Macrolides, Lincosamides and Streptogramins|Peptides|Peptides, Cyclic|Streptogramins
DB13707	Sodium tartrate	small molecule	approved	Acids, Acyclic|Alimentary Tract and Metabolism|Carbohydrates|Dicarboxylic Acids|Drugs for Constipation|Hydroxy Acids|Laxatives|Osmotic Laxative|Sugar Acids
DB13711	Tritoqualine	small molecule	approved	Antihistamines for Systemic Use|Cholagogues and Choleretics|Histamine Agents|Histamine Antagonists|Neurotransmitter Agents
DB13732	Meglumine antimoniate	small molecule	experimental|investigational	Agents Against Leishmaniasis and Trypanosomiasis|Alcohols|Amino Sugars|Anti-Infective Agents|Antimony|Antimony Compounds|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Carbohydrates|Hexosamines|Sorbitol|Sugar Alcohols
DB13735	Potassium Guaiacolsulfonate	small molecule	experimental	Benzene Derivatives|Catechols|Ethers|Laxatives|Methyl Ethers|Osmotic Laxative|Phenols|Phenyl Ethers|Potassium Salt
DB13739	Penamecillin	small molecule	experimental	Amides|Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|Beta-Lactamase Sensitive Penicillins|beta-Lactams|Lactams|Penicillins|Sulfur Compounds
DB13746	Bioallethrin	small molecule	approved|experimental	Agents causing hyperkalemia|Agrochemicals|Antiarrhythmic agents|Antiparasitic Products, Insecticides and Repellents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ectoparasiticides, Incl. Scabicides|Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents|Insecticides|Monoterpenes|Pesticides|Pyrethrines, Incl. Synthetic Compounds|Pyrethrins|Stereoisomerism|Terpenes|Toxic Actions
DB13747	Trolamine	small molecule	approved	Alcohols|Amines|Amino Alcohols|Cicatrizants|Dermatologicals|Preparations for Treatment of Wounds and Ulcers
DB13749	Magnesium gluconate	small molecule	approved|investigational	Acids, Acyclic|Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Carbohydrates|Hydroxy Acids|Magnesium Compounds|Mineral Supplements|Sugar Acids
DB13751	Glycyrrhizic acid	small molecule	approved|experimental	Alimentary Tract and Metabolism|Anti-Inflammatory Agents|Bile and Liver Therapy|BSEP/ABCB11 Substrates|Liver Therapy|Liver Therapy, Lipotropics|Pentacyclic Triterpenes|Terpenes|Triterpenes
DB13757	Epanolol	small molecule	experimental	Acetamides|Acetates|Acids, Acyclic|Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amides|Amines|Amino Alcohols|Antihypertensive Agents|Autonomic Agents|Benzene Derivatives|Beta Blocking Agents, Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Neurotransmitter Agents|Peripheral Nervous System Agents|Propanols|Sympathomimetics
DB13760	Niperotidine	small molecule	experimental|investigational	Alimentary Tract and Metabolism|Drugs for Acid Related Disorders|Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)|Gastric Acid Lowering Agents|Histamine Antagonists|Histamine H2 Antagonists
DB13761	Tilactase	biotech	approved|experimental	Alimentary Tract and Metabolism|Antifoaming Agents|beta-Galactosidase|Digestives, Incl. Enzymes|Enzyme Preparations|Enzymes|Enzymes and Coenzymes|Galactosidases|Gastrointestinal Agents|Glycoside Hydrolases|Hydrolases
DB13764	Monoxerutin	small molecule	experimental	Capillary Stabilizing Agents|Flavonoids|Vasoprotectives
DB13765	Mercuric chloride	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Chlorides|Chlorine Compounds|Dermatologicals|Disinfectants|Electrolytes|Hydrochloric Acid|Ions|Mercurial Products|Mercury Compounds
DB13767	Vorozole	small molecule	experimental	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Aromatase Inhibitors|Carbon Radioisotopes|Endocrine Therapy|Enzyme Inhibitors|Estrogen Antagonists|Hormone Antagonists|Hormone Antagonists and Related Agents|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroid Synthesis Inhibitors
DB13769	Emetonium iodide	small molecule	experimental	Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB13772	Rufloxacin	small molecule	experimental	Anti-Bacterial Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Fluoroquinolones|Potential QTc-Prolonging Agents|QTc Prolonging Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB13775	Tertatolol	small molecule	experimental	Adrenergic Agents|Adrenergic Antagonists|Adrenergic beta-Antagonists|Agents causing hyperkalemia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Antiarrhythmic agents|Beta Blocking Agents, Non-Selective|Bradycardia-Causing Agents|Cardiovascular Agents|Cytochrome P-450 CYP2D6 Substrates|Neurotransmitter Agents|Propanols|Sulfur Compounds
DB13781	Xamoterol	small molecule	experimental	Adrenergic Agents|Adrenergic Agonists|Adrenergic beta-1 Receptor Agonists|Adrenergic beta-Agonists|Agents producing tachycardia|Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Cardiac Stimulants Excl. Cardiac Glycosides|Cardiac Therapy|Morpholines|Neurotransmitter Agents|Oxazines|Phenoxypropanolamines|Propanolamines|Propanols
DB13782	Imipramine oxide	small molecule	experimental	Agents that produce hypertension|Agents that reduce seizure threshold|Antidepressive Agents, Tricyclic|Central Nervous System Depressants|Dibenzazepines|Narrow Therapeutic Index Drugs|Nervous System|Neurotoxic agents|Non-Selective Monoamine Reuptake Inhibitors|Psychoanaleptics|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13783	Acemetacin	small molecule	approved|experimental|investigational	Acetic Acid Derivatives and Related Substances|Agents causing hyperkalemia|Agents that produce hypertension|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Antigout Preparations|Antiinflammatory and Antirheumatic Products|Antiinflammatory and Antirheumatic Products, Non-Steroids|Central Nervous System Agents|Indoles|Musculo-Skeletal System|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents
DB13786	Magnesium orotate	small molecule	experimental	Agents that produce neuromuscular block (indirect)|Alimentary Tract and Metabolism|Magnesium Compounds|Mineral Supplements|Pyrimidines|Pyrimidinones|Uracil
DB13792	Clopamide	small molecule	experimental	Amides|Cardiovascular Agents|Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Natriuretic Agents|Piperidines|Sulfonamides|Sulfones|Sulfur Compounds
DB13795	Brodimoprim	small molecule	experimental	Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Enzyme Inhibitors|Folic Acid Antagonists|Pyrimidines|Trimethoprim and Derivatives
DB13800	Calcium levulinate	small molecule	approved|experimental	Alimentary Tract and Metabolism|Calcium Salts|Enzyme Inhibitors|Keto Acids|Mineral Supplements
DB13805	Reposal	small molecule	experimental	Barbiturates, Plain|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB13809	Paclitaxel poliglumex	small molecule	experimental|investigational	Amino Acids|Amino Acids, Acidic|Amino Acids, Dicarboxylic|Amino Acids, Peptides, and Proteins|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Cardiotoxic antineoplastic agents|Cyclodecanes|Cycloparaffins|Diterpenes|Glutamates|Peptides|Taxoids|Terpenes
DB13811	Oblimersen	small molecule	experimental|investigational	Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Oligonucleotides, Antisense|Sulfur Compounds
DB13813	Iodoform	small molecule	approved|experimental|vet_approved	Dermatologicals|Hydrocarbons, Halogenated|Medicated Dressings|Medicated Dressings With Antiinfectives|Miscellaneous Local Anti-infectives
DB13827	Indanazoline	small molecule	experimental	Nasal Preparations|Sympathomimetics, Plain
DB13831	Potassium permanganate	small molecule	experimental|investigational	Antidotes|Antiseptics and Disinfectants|Dermatologicals|Indicators and Reagents|Laboratory Chemicals|Manganese Compounds|Potassium Compounds|Potassium Salt
DB13832	Ranimustine	small molecule	experimental	Alkylating Drugs|Antineoplastic Agents|Antineoplastic and Immunomodulating Agents|Nitroso Compounds|Nitrosoureas|Urea
DB13835	Caroverine	small molecule	experimental	Agents causing hyperkalemia|Alimentary Tract and Metabolism|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs for Functional Gastrointestinal Disorders|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Membrane Transport Modulators|Neurotransmitter Agents|Vasodilating Agents
DB13836	Metampicillin	small molecule	experimental	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Aza Compounds|Azabicyclo Compounds|Beta-Lactam Antibacterials|beta-Lactams|Lactams|Penicillin G|Penicillins|Penicillins With Extended Spectrum|Sulfur Compounds
DB13837	Doxefazepam	small molecule	experimental	Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB13838	Noxytiolin	small molecule	approved	Anti-Infective Agents|Anti-Infective Agents, Local|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Irrigating Solutions|Sulfur Compounds|Thiourea|Urea
DB13841	Clopenthixol	small molecule	experimental	Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Dopamine Agents|Dopamine Antagonists|Nervous System|Neurotoxic agents|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Sulfur Compounds|Thioxanthene Derivatives|Thioxanthenes|Tranquilizing Agents|Xanthenes
DB13842	Etofylline nicotinate	small molecule	experimental	Peripheral Vasodilators|Purine Derivatives
DB13843	Cloprednol	small molecule	experimental	Adrenal Cortex Hormones|Corticosteroids|Corticosteroids for Systemic Use|Corticosteroids for Systemic Use, Plain|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnanes|Pregnenes|Steroids|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
DB13845	Etafenone	small molecule	experimental	Cardiac Therapy|Cardiovascular Agents|Ketones|Propiophenones|Vasodilating Agents|Vasodilators Used in Cardiac Diseases
DB13849	Clofibride	small molecule	experimental	Acids, Acyclic|Benzene Derivatives|Butyrates|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Isobutyrates|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Phenols|Phenyl Ethers
DB13850	Timepidium	small molecule	experimental	Agents producing tachycardia|Alimentary Tract and Metabolism|Anticholinergic Agents|Drugs for Functional Gastrointestinal Disorders|Muscarinic Antagonists|Synthetic Anticholinergics, Quaternary Ammonium Compounds
DB13851	Artemotil	small molecule	approved	Amebicides|Anions|Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiplatyhelmintic Agents|Antiprotozoals|Artemisinin and Derivatives, Plain|Electrolytes|Free Radicals|Ions|Oxides|Oxygen Compounds|Peroxides|Reactive Oxygen Species|Schistosomicides|Sesquiterpenes|Terpenes
DB13853	Anethole trithione	small molecule	approved|experimental	Alimentary Tract and Metabolism|Anisoles|Benzene Derivatives|EENT Drugs, Miscellaneous|Ethers|Gastrointestinal Agents|Methyl Ethers|Phenols|Phenyl Ethers|Sulfur Compounds|Thiones|Various Alimentary Tract and Metabolism Products
DB13854	Gamolenic acid	small molecule	approved|investigational	Agents that reduce seizure threshold|Dermatologicals|Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Linolenic Acids|Lipids
DB13857	Demegestone	small molecule	experimental	Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Pregnadien Derivatives|Progesterone Congeners|Progestin Contraceptives|Progestins|Sex Hormones and Modulators of the Genital System|Steroids
DB13858	Dimazole	small molecule	approved|withdrawn	Antifungals for Dermatological Use|Antifungals for Topical Use|Dermatologicals|Sulfur Compounds
DB13861	Iopentol	small molecule	experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Contrast Media|Diagnostic Uses of Chemicals|Iodobenzoates|Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media|X-Ray Contrast Media, Iodinated
DB13863	Fosfructose	small molecule	experimental	Antiarrhythmic agents|Carbohydrates|Cardiac Therapy|Cardiovascular Agents|Central Nervous System Agents|Fructosephosphates|Hexosediphosphates|Hexosephosphates|Immunologic Factors|Neuroprotective Agents|Protective Agents|Sugar Phosphates
DB13864	Hemoglobin crosfumaril	biotech	experimental	Acids, Carbocyclic|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Benzoates|Blood and Blood Forming Organs|Blood and Related Products|Blood Proteins|Blood Substitutes|Blood Substitutes and Perfusion Solutions|Blood Substitutes and Plasma Protein Fractions|Globins|Hemeproteins|Hydroxy Acids|Hydroxybenzoates|Phenols|Proteins
DB13865	Dehydroemetine	small molecule	investigational	Alkaloids|Isoquinolines
DB13866	Etynodiol	small molecule	experimental	Adrenal Cortex Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Estren Derivatives|Genito Urinary System and Sex Hormones|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progestins|Sex Hormones and Modulators of the Genital System|Steroids
DB13867	Fluticasone	small molecule	approved|experimental	Adrenal Cortex Hormones|Adrenergics, Inhalants|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Anti-Asthmatic Agents|Anti-Inflammatory Agents|Autonomic Agents|Bronchodilator Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Dermatologicals|Drugs for Obstructive Airway Diseases|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Nasal Preparations|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peripheral Nervous System Agents|Respiratory System Agents|Steroids
DB13868	Adefovir	small molecule	investigational	Anti-Infective Agents|Antiviral Agents|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleoside Reverse Transcriptase Inhibitors|Organophosphorus Compounds|Purines|Reverse Transcriptase Inhibitors
DB13869	2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol	small molecule	experimental	
DB13871	Albendazole oxide	small molecule	experimental	Acids, Acyclic|Anthelmintics|Anti-Infective Agents|Anticestodal Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|Benzimidazoles|Carbamates
DB13872	Lormetazepam	small molecule	approved	Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives|Nervous System|Psycholeptics
DB13873	Fenofibric acid	small molecule	approved	Acids, Acyclic|Anticholesteremic Agents|Benzene Derivatives|Benzhydryl Compounds|Benzophenones|Butyrates|Ethers|Fatty Acids|Fatty Acids, Volatile|Fibric Acids|Hypolipidemic Agents|Isobutyrates|Ketones|Lipid Modifying Agents|Lipid Modifying Agents, Plain|Lipid Regulating Agents|Lipids|Noxae|Peroxisome Proliferator Receptor alpha Agonist|Phenols|Phenyl Ethers|Toxic Actions
DB13874	Enasidenib	small molecule	approved|investigational	Amines|BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Isocitrate Dehydrogenase 2 Inhibitor|Isocitrate Dehydrogenase 2 Inhibitors|OAT3/SLC22A8 Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|Pyridines|UGT1A1 Inhibitors|UGT1A1 Substrates|UGT1A9 Substrates
DB13875	Harmaline	small molecule	experimental	Agents that produce hypertension|Agents that reduce seizure threshold|Alkaloids|Carbolines|Central Nervous System Agents|Central Nervous System Depressants|Central Nervous System Stimulants|Enzyme Inhibitors|Indole Alkaloids|Indoles|Monoamine Oxidase Inhibitors|Pyridines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13876	Brofaromine	small molecule	experimental	Central Nervous System Depressants|Enzyme Inhibitors|Monoamine Oxidase Inhibitors|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13877	Iniparib	small molecule	investigational	Acids, Carbocyclic|Amides|Antineoplastic Agents|Benzene Derivatives|Benzoates|Enzyme Inhibitors|Poly(ADP-ribose) Polymerase Inhibitors
DB13878	Pibrentasvir	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 3A Inhibitors|Hepatitis C Virus NS5A Inhibitor|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|UGT1A1 Inhibitors
DB13879	Glecaprevir	small molecule	approved|investigational	BCRP/ABCG2 Inhibitors|BCRP/ABCG2 Substrates|Breast Cancer Resistance Protein Inhibitors|Cytochrome P450 1A2 Inhibitors|Cytochrome P450 3A Inhibitors|HCV NS3/4A Protease Inhibitors|NS3/4A Protease Inhibitors|OATP1B1/SLCO1B1 Inhibitors|OATP1B1/SLCO1B1 Substrates|OATP1B3 inhibitors|OATP1B3 substrates|Organic Anion Transporting Polypeptide 1B1 Inhibitors|Organic Anion Transporting Polypeptide 1B3 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|UGT1A1 Inhibitors
DB13881	Tisagenlecleucel	biotech	approved|investigational	
DB13882	Methyl nicotinate	small molecule	approved	Anti-Inflammatory Agents|Erythema|Inflammation|Nicotinic Acids|Pyridines
DB13883	Coral snake (micrurus fulvius) immune globulin antivenin (equine)	biotech	approved|experimental	
DB13884	Albutrepenonacog alfa	biotech	approved	Hemostatics
DB13885	Ferric subsulfate	small molecule	approved|experimental	Acids|Acids, Noncarboxylic|Anions|Coagulants|Electrolytes|Hematologic Agents|Hemostatics|Ions|Iron Compounds|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB13886	Human cytomegalovirus immune globulin	biotech	approved	Amino Acids, Peptides, and Proteins|Antiinfectives for Systemic Use|Blood Proteins|Cytomegalovirus|Globulins|Human Immunoglobulin G|Immune Sera and Immunoglobulins|Immunization, Passive|Immunoglobulins|Immunoproteins|Passively Acquired Immunity|Proteins|Serum|Serum Globulins|Specific Immunoglobulins|Virus Neutralization|Virus-specific Hyperimmune Globulins
DB13887	Meningococcal polysaccharide vaccine group W-135	biotech	approved|experimental|investigational	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB13888	Meningococcal polysaccharide vaccine group Y	biotech	approved|experimental|investigational	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB13889	Meningococcal polysaccharide vaccine group A	biotech	approved|experimental|investigational	Actively Acquired Immunity|Antigens|Antigens, Bacterial|Biological Factors|Carbohydrates|Inactivated Meningococcal Vaccine|Polysaccharides
DB13890	Meningococcal polysaccharide vaccine group C	biotech	approved|experimental|investigational	Actively Acquired Immunity|Antigens|Antigens, Bacterial|Biological Factors|Carbohydrates|Inactivated Meningococcal Vaccine|Neisseria meningitidis|Polysaccharides
DB13891	Crotalus scutulatus antivenin	biotech	approved|experimental	Antivenin|Antivenins|Passively Acquired Immunity|Venom Neutralization
DB13892	Crotalus atrox antivenin	biotech	approved|experimental	Antivenin|Antivenins|Passively Acquired Immunity|Venom Neutralization
DB13893	Crotalus adamanteus antivenin	biotech	approved|experimental	Antivenin|Antivenins|Passively Acquired Immunity|Venom Neutralization
DB13894	Agkistrodon piscivorus antivenin	biotech	approved|experimental	Antivenin|Antivenins|Passively Acquired Immunity|Venom Neutralization
DB13895	Rhus Glabra Pollen	biotech	approved|experimental	
DB13896	Talimogene laherparepvec	biotech	approved|experimental|investigational	
DB13897	Equine Botulinum Neurotoxin E Immune FAB2	biotech	approved|experimental|investigational	
DB13898	Equine Botulinum Neurotoxin C Immune FAB2	biotech	approved|experimental|investigational	
DB13899	Equine Botulinum Neurotoxin G Immune FAB2	biotech	approved|experimental|investigational	
DB13900	Equine Botulinum Neurotoxin A Immune FAB2	biotech	approved|experimental|investigational	
DB13901	Equine Botulinum Neurotoxin F Immune FAB2	biotech	approved|experimental|investigational	
DB13902	Equine Botulinum Neurotoxin D Immune FAB2	biotech	approved|experimental|investigational	
DB13903	Equine Botulinum Neurotoxin B Immune FAB2	biotech	approved|experimental|investigational	
DB13904	Cat dander extract	biotech	approved	Allergenic Extracts
DB13905	Scorpion (centruroides) immune Fab2 antivenin (equine)	biotech	approved	Antivenin|Passively Acquired Immunity|Venom Neutralization
DB13906	Aloe Vera Leaf	biotech	approved|experimental	
DB13907	Fusarium graminearum	biotech	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Fungal Allergenic Extract
DB13908	Amylmetacresol	small molecule	approved	Benzene Derivatives|Miscellaneous Anti-infectives|Phenols
DB13909	Bismuth subgallate	small molecule	approved	Acids, Carbocyclic|Anti-Infective Agents|Benzene Derivatives|Benzoates|Bismuth containing drugs|Coagulants|Hematologic Agents|Hemostatics|Hydroxy Acids|Hydroxybenzoates|Neurotoxic agents|Phenols
DB13910	Valproate bismuth	small molecule	approved	Bismuth containing drugs|EENT Drugs, Miscellaneous|Neurotoxic agents|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
DB13911	Phloxine B	small molecule	approved	Coloring Agents|Dental Agents|Fluoresceins|Fluorescent Dyes|Indicators and Reagents|Laboratory Chemicals|Luminescent Agents|Spiro Compounds|Xanthenes
DB13912	Coumermycin A1	small molecule	experimental	Antineoplastic Agents|Benzopyrans|Coumarins|Enzyme Inhibitors|Pyrans|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB13913	Belladonna	biotech	approved|experimental	Antimuscarinics Antispasmodics
DB13914	Volixibat	small molecule	experimental|investigational	
DB13915	Axicabtagene ciloleucel	biotech	approved	
DB13916	Toyocamycin	small molecule	experimental	Antibiotics, Antineoplastic|Antimetabolites|Antimetabolites, Antineoplastic|Antineoplastic Agents|Carbohydrates|Glycosides|Noxae|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Ribonucleosides|Toxic Actions
DB13917	Deoxyepinephrine	small molecule	experimental	Agents that produce hypertension|Alcohols|Amines|Amino Alcohols|Biogenic Amines|Biogenic Monoamines|Catecholamines|Epinephrine|Ethanolamines
DB13918	Diclofop-methyl	small molecule	experimental	Benzene Derivatives|Ethers|Phenols|Phenyl Ethers
DB13919	Candesartan	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin 2 Receptor Blocker|Angiotensin II Antagonists and Calcium Channel Blockers|Angiotensin II Antagonists and Diuretics|Angiotensin II Antagonists, Plain|Angiotensin II Type 2 Receptor Blockers|Angiotensin Receptor Antagonists|Antihypertensive Agents|Cardiovascular Agents|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 Enzyme Inhibitors|OATP1B1/SLCO1B1 Inhibitors|P-glycoprotein/ABCB1 Inhibitors
DB13920	Valopicitabine	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidines
DB13921	2'-C-methylcytidine	small molecule	experimental	Carbohydrates|Cytidine|Deoxyribonucleosides|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleosides|Pyrimidine Nucleosides|Pyrimidines|Ribonucleosides
DB13923	Emicizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Coagulation Factors|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB13924	Varicella Zoster Vaccine (Recombinant)	biotech	approved|investigational	
DB13925	Dotatate gallium Ga-68	small molecule	approved|investigational	Gallium|Positron Emitting Activity|Radioactive Diagnostic Agent
DB13926	Cenegermin	biotech	approved|investigational	
DB13927	anle138b	small molecule	experimental	Dioxoles
DB13928	Semaglutide	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Gastrointestinal Hormones|GLP-1 Agonists|Glucagon-like Peptide-1 (GLP-1) Agonists|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Incretin Mimetics|OATP1B1/SLCO1B1 Inhibitors|OATP1B3 inhibitors|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins
DB13929	Relcovaptan	small molecule	investigational	Antiplatelet agents|Hematologic Agents|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists
DB13930	Ulixertinib	small molecule	investigational	
DB13931	Netarsudil	small molecule	approved	Acids, Carbocyclic|Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Rho Kinase Inhibitor|Rho Kinase Inhibitors
DB13932	Voretigene Neparvovec	biotech	approved	
DB13933	Nonacog beta pegol	biotech	approved|investigational	Alcohols|Amino Acids, Peptides, and Proteins|Biological Factors|Biomedical and Dental Materials|Blood Coagulation Factors|Blood Proteins|Ethylene Glycols|Glycols|Hemostatics|Macromolecular Substances|Pegylated agents|Polymers|Proteins
DB13934	Ligandrol	small molecule	investigational	
DB13935	AC-262536	small molecule	experimental	Aza Compounds
DB13936	JNJ-28330835	small molecule	experimental	
DB13937	LGD-3303	small molecule	experimental	Quinolines
DB13938	S-40503	small molecule	experimental	
DB13939	RAD-140	small molecule	experimental|investigational	
DB13940	2,5-Dimethoxy-4-ethylthioamphetamine	small molecule	experimental	Agents producing tachycardia|Agents that produce hypertension|Amines|Amphetamines|Central Nervous System Depressants|Ethylamines|Phenethylamines|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Sympathomimetics
DB13941	Piperaquine	small molecule	experimental|investigational	Anti-Infective Agents|Antimalarials|Antiparasitic Agents|Antiparasitic Products, Insecticides and Repellents|Antiprotozoals|Cytochrome P-450 CYP2B6 Inhibitors|Cytochrome P-450 CYP2B6 Inhibitors (weak)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP2E1 Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (weak)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors
DB13943	Testosterone cypionate	small molecule	approved	Anabolic Agents|Androgens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Delayed-Action Preparations|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein/ABCB1 Inhibitors|Steroids|Testosterone Congeners
DB13944	Testosterone enanthate	small molecule	approved	Adrenal Cortex Hormones|Androgens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Contraceptive Agents, Male|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein/ABCB1 Inhibitors|Steroids|Testosterone Congeners
DB13946	Testosterone undecanoate	small molecule	approved|investigational	Androgens|Androstanes|Androstenes|Androstenols|BCRP/ABCG2 Substrates|Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2B6 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OAT3/SLC22A8 Inducers|P-glycoprotein/ABCB1 Inhibitors|Steroids|Testosterone Congeners
DB13947	Testosterone enantate benzilic acid hydrazone	small molecule	approved|experimental	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB13948	N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine	small molecule	experimental	Central Nervous System Depressants|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists
DB13949	Ferric cation	small molecule	approved	Iron Compounds|Parenteral Iron Replacement|Phosphate Binder|Phosphate Chelating Activity
DB13950	WIN 55212-2	small molecule	experimental	Agents causing hyperkalemia|Agents producing tachycardia|Analgesics|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cannabinoid Receptor Antagonists|Cannabinoids and similars|Cardiovascular Agents|Central Nervous System Agents|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Oxazines|Peripheral Nervous System Agents|Receptor, Cannabinoid, CB1, antagonists & inhibitors|Sensory System Agents
DB13951	Stanolone acetate	small molecule	experimental	P-glycoprotein/ABCB1 Substrates
DB13952	Estradiol acetate	small molecule	approved|investigational|vet_approved	BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estrogens|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|UGT1A1 Substrates
DB13953	Estradiol benzoate	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estranes|Estrenes|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Reproductive Control Agents|Steroids|UGT1A1 Substrates
DB13954	Estradiol cypionate	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Contraceptive Agents, Female|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estranes|Estrenes|Estrogen Contraceptives|Estrogens|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Reproductive Control Agents|Steroids|UGT1A1 Substrates
DB13955	Estradiol dienanthate	small molecule	approved|investigational|vet_approved	BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Steroids|UGT1A1 Substrates
DB13956	Estradiol valerate	small molecule	approved|investigational|vet_approved	Adrenal Cortex Hormones|BCRP/ABCG2 Inhibitors|Contraceptive Agents, Female|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Estradiol Congeners|Estranes|Estrenes|Estrogen Contraceptives|Estrogens|Estrogens, Conjugated (USP)|Gonadal Hormones|Gonadal Steroid Hormones|Hormonal Contraceptives for Systemic Use|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|OATP1B1/SLCO1B1 Inhibitors|OCT2 Inhibitors|P-glycoprotein/ABCB1 Substrates|Reproductive Control Agents|Steroids|UGT1A1 Substrates
DB13957	J147	small molecule	experimental	
DB13958	Trestolone acetate	small molecule	experimental	Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB13959	Medium-chain triglycerides	small molecule	approved	
DB13960	Bronopol	small molecule	approved	Alcohols|Anti-Infective Agents|Anti-Infective Agents, Local|Cell-mediated Immunity|Glycols|Increased Histamine Release|Indicators and Reagents|Laboratory Chemicals|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB13961	Fish oil	biotech	approved|nutraceutical	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Lipids|Oils|Vasodilating Agents
DB13962	Calcium saccharate	small molecule	approved|experimental	Acids, Acyclic|Carbohydrates|Hydroxy Acids|Sugar Acids
DB13963	1,2-dichlorobenzene	small molecule	experimental	Agrochemicals|Benzene Derivatives|Hydrocarbons, Chlorinated|Hydrocarbons, Halogenated|Insecticides|Pesticides|Toxic Actions
DB13964	Peanut oil	biotech	approved	Arachis|Basic Ointments and Protectants|Biological Products|Complex Mixtures|Detergents|Lipids|Oils|Plant Preparations
DB13965	Sarracenia Purpurea	biotech	approved|experimental	Miscellaneous Analgesics and Antipyretics
DB13966	Isopropyl myristate	small molecule	approved|experimental	Fatty Acids|Lipids|Myristic Acids|Scabicides and Pediculicides
DB13967	Patent Blue	small molecule	approved	Amines|Aniline Compounds|Coloring Agents|Other Diagnostics
DB13968	Plasma protein fraction (human)	biotech	approved	Albumins|Amino Acids, Peptides, and Proteins|Biomimetic Materials|Blood Derivatives|Blood Proteins|Blood Substitutes|Globulins|Hematologic Agents|Hemostatics|Plasma Substitutes|Proteins
DB13969	Quaternium-24	small molecule	approved|experimental	
DB13970	Dioctyldimonium	small molecule	approved|experimental	Amines|Ammonium Compounds|Nitrogen Compounds|Onium Compounds
DB13971	Vanadium	small molecule	approved|experimental	Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Trace Elements|Transition Elements
DB13972	Racemethionine	small molecule	approved|experimental	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Methionine|Sulfur Compounds
DB13973	Remestemcel-L	biotech	approved|investigational	
DB13974	Passiflora incarnata flower	biotech	approved|experimental	Herbs and Natural Products
DB13975	Cimicifuga racemosa	biotech	approved|experimental	Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Herbs and Natural Products
DB13976	Sulesomab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Diagnostic Radiopharmaceuticals|Globulins|Immunoglobulins|Immunoproteins|Inflammation and Infection Detection|Proteins|Serum Globulins|Technetium (99Mtc) Compounds
DB13977	Potassium carbonate	small molecule	approved	Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Electrolytes|Elements|Ions|Metals|Metals, Alkali|Metals, Light|Potassium Salt
DB13978	Selisistat	small molecule	experimental	Indoles|Sirtuin 1, antagonists & inhibitors
DB13979	Besilesomab	biotech	approved	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Radiopharmaceuticals|Serum Globulins
DB13980	Copper Cu-64	small molecule	approved	
DB13981	Nomegestrol acetate	small molecule	investigational	Adrenal Cortex Hormones|Antineoplastic Agents, Hormonal|Combination Contraceptives (with Estrogen and derivatives)|Contraceptive Agents, Female|Contraceptives, Oral|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norsteroids|Pregnadienes|Pregnanes|Progesterone Congeners|Progestin Contraceptives|Progestins|Steroids
DB13982	Lutetium Lu-177	small molecule	approved	
DB13983	5,7,2â²-trihydroxy-6,8-dimethoxyflavone	small molecule	experimental	
DB13984	Cyclopropane	small molecule	experimental	Anesthetics|Central Nervous System Agents|Central Nervous System Depressants|Cycloparaffins
DB13985	Lutetium Lu 177 dotatate	small molecule	approved|investigational	Amino Acids, Peptides, and Proteins|Lutetium|Organometallic Compounds|Peptides|Peptides, Cyclic
DB13987	Strontium chloride	small molecule	approved	Elements|Metals|Metals, Alkaline Earth|Metals, Heavy|Strontium Radioisotopes
DB13988	SB-269970	small molecule	investigational	Amides|Benzene Derivatives|Sulfones|Sulfur Compounds
DB13989	Epitizide	small molecule	experimental	Diuretics|Low-Ceiling Diuretics and Potassium-Sparing Agents|Sodium Chloride Symporter Inhibitors
DB13990	Dipropyl-4-hydroxytryptamine	small molecule	experimental	
DB13991	Pipequaline	small molecule	experimental	Central Nervous System Agents
DB13992	Azintamide	small molecule	investigational	
DB13993	MRK-409	small molecule	experimental	Anti-Anxiety Agents|Central Nervous System Depressants|Hydrocarbons, Halogenated
DB13994	AZD-7325	small molecule	investigational	GABA Modulators
DB13995	Ferric pyrophosphate citrate	small molecule	approved|investigational	Enzymes|Enzymes and Coenzymes|Hydrolases|Parenteral Iron Replacement|Peptide Hydrolases|Phosphate Binder|Phosphate salts
DB13996	Magnesium acetate	small molecule	approved	Agents that produce neuromuscular block (indirect)|Calculi Dissolution Agent|Laxatives|Osmotic Laxative
DB13997	Baloxavir marboxil	small molecule	approved|investigational	Antiviral Agents|Antivirals for Systemic Use|Direct Acting Antivirals
DB13998	Lonoctocog alfa	biotech	approved|investigational	Hemostatics
DB13999	Moroctocog alfa	biotech	approved	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Hemostatics|Proteins|Recombinant Proteins
DB14000	Tetraglyme	small molecule	experimental	Alcohols|Glycols
DB14001	alpha-Tocopherol succinate	small molecule	approved|nutraceutical|vet_approved	Antioxidants|Benzopyrans|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB14002	D-alpha-Tocopherol acetate	small molecule	approved|nutraceutical|vet_approved	Antioxidants|Benzopyrans|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB14003	alpha-Tocopherol acetate	small molecule	approved	Antioxidants|Benzopyrans|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Protective Agents|Pyrans|Tocopherols|Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB14004	Tildrakizumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Interleukin-23 Antagonist|Interleukin-23 Antagonists|Proteins|Serum Globulins
DB14005	Dimethicone 410	small molecule	approved	
DB14006	Choline salicylate	small molecule	approved|nutraceutical	Acids, Carbocyclic|Alcohols|Amines|Amino Alcohols|Ammonium Compounds|Analgesics|Benzene Derivatives|Benzoates|Ethanolamines|Hydroxy Acids|Hydroxybenzoates|Nervous System|Nitrogen Compounds|OCT2 Inhibitors|OCT2 Substrates|Onium Compounds|Pharmaceutical Preparations|Phenols|Quaternary Ammonium Compounds|Salicylates|Salicylic Acid and Derivatives|Trimethyl Ammonium Compounds
DB14007	Pentetic acid	small molecule	approved	Acetates|Acids, Acyclic|Amines|Antidotes|Chelating Agents|Fatty Acids|Fatty Acids, Volatile|Iron Chelating Agents|Lead Chelating Activity|Lead Chelator|Lipids|Polyamines|Protective Agents|Sequestering Agents
DB14008	Hispidulin	small molecule	experimental	Benzopyrans|Chromones|Flavonoids|Pyrans
DB14009	Medical Cannabis	biotech	experimental|investigational	Agents producing tachycardia|BCRP/ABCG2 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Pharmaceutical Preparations
DB14010	5-methoxy-N,N-dimethyltryptamine	small molecule	experimental|illicit	Agents that produce hypertension|Amines|Amphibian Venoms|Autacoids|Biogenic Amines|Biogenic Monoamines|Biological Factors|Bodily Secretions|Central Nervous System Depressants|Complex Mixtures|Fluids and Secretions|Indoles|Inflammation Mediators|N,N-Dimethyltryptamine|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT1 Receptor Agonists|Serotonin 5-HT2 Receptor Agonists|Serotonin Agents|Serotonin Receptor Agonists|Toxins, Biological|Tryptamines|Venoms
DB14011	Nabiximols	small molecule	investigational	Agents producing tachycardia|Analgesics|BCRP/ABCG2 Inhibitors|Biological Products|Cannabinoid Receptor Agonists|Cannabinoids and similars|Complex Mixtures|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Pharmaceutical Preparations|Plant Preparations|Terpenes
DB14012	Burosumab	biotech	approved|investigational	
DB14013	SR-9009	small molecule	experimental	Sulfur Compounds
DB14014	SR-9011	small molecule	experimental	Sulfur Compounds
DB14015	Sodium bisulfite	small molecule	approved	Anions|Anti-Infective Agents|Anti-Infective Agents, Local|Antioxidants|Electrolytes|Ions|Mutagens|Noxae|Protective Agents|Sulfur Compounds|Toxic Actions
DB14016	Ox bile extract	biotech	approved|experimental|investigational	Bile Acids and Salts|Cholanes|Cholates|Cholic Acids|Steroids
DB14017	H3B-8800	small molecule	investigational	
DB14018	Bromotheophylline	small molecule	approved	Alcohols|Alkaloids|Amines|Amino Alcohols|Cytochrome P-450 CYP1A2 Substrates|Diuretics|Drugs for Obstructive Airway Diseases|Pharmaceutical Preparations|Propanols|Purines|Purinones|Xanthine derivatives
DB14019	Fosnetupitant	small molecule	approved	Cytochrome P-450 CYP3A Inhibitors|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inhibitors|Cytochrome P-450 CYP3A4 Inhibitors (moderate)|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inhibitors|Substance P/Neurokinin-1 Receptor Antagonist
DB14020	Benzoin	small molecule	approved|experimental	Acetophenones|Ketones
DB14025	Clinafloxacin	small molecule	investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antineoplastic Agents|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (moderate)|Cytochrome P-450 CYP2D6 Inhibitors|Cytochrome P-450 CYP2D6 Inhibitors (moderate)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Hypoglycemia-Associated Agents|Quinolines|Quinolones|Topoisomerase II Inhibitors|Topoisomerase Inhibitors
DB14026	Thiosalicylic acid	small molecule	experimental	Acids, Carbocyclic|Alkylmercury Compounds|Analgesics|Analgesics, Non-Narcotic|Benzene Derivatives|Benzoates|Central Nervous System Agents|Ethylmercury Compounds|Hydroxy Acids|Hydroxybenzoates|Organomercury Compounds|Organometallic Compounds|Peripheral Nervous System Agents|Phenols|Salicylates|Sensory System Agents|Sulfur Compounds
DB14027	Taspoglutide	small molecule	investigational	Amino Acids, Peptides, and Proteins|Blood Glucose Lowering Agents|Gastrointestinal Hormones|GLP-1 Agonists|Glucagon-Like Peptides|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pancreatic Hormones|Peptide Hormones|Peptides|Proglucagon|Protein Precursors|Proteins
DB14028	Nordazepam	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Anti-Anxiety Agents|Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Agents|Central Nervous System Depressants|GABA Agents|GABA Modulators|Nervous System|Neurotransmitter Agents|Psycholeptics|Psychotropic Drugs|Tranquilizing Agents
DB14029	Furafylline	small molecule	experimental	Alkaloids|Chemically-Induced Disorders|Cytochrome P-450 CYP1A2 Inhibitors|Cytochrome P-450 CYP1A2 Inhibitors (strong)|Cytochrome P-450 Enzyme Inhibitors|Enzyme Inhibitors|Purines|Purinones|Xanthine derivatives
DB14030	PZM21	small molecule	experimental	
DB14031	Tretamine	small molecule	experimental	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Aziridines|Azirines|Cholinesterase Inhibitors|Noxae|Toxic Actions|Triazines
DB14033	Acetyl sulfisoxazole	small molecule	approved|vet_approved	Amides|Amines|Aniline Compounds|Anti-Bacterial Agents|Cytochrome P-450 CYP2C9 Inhibitors|Cytochrome P-450 CYP2C9 Inhibitors (weak)|Cytochrome P-450 Enzyme Inhibitors|Genito Urinary System and Sex Hormones|Gynecological Antiinfectives and Antiseptics|Sulfanilamides|Sulfonamide Antibacterial|Sulfonamides|Sulfones|Sulfur Compounds
DB14034	Darglitazone	small molecule	experimental	Sulfur Compounds|Thiazoles
DB14035	Englitazone	small molecule	experimental	Blood Glucose Lowering Agents|Pyrans|Sulfur Compounds|Thiazoles
DB14037	Madecassic acid	small molecule	experimental	Terpenes
DB14038	beta-Sitosterol	small molecule	experimental	Cholestanes|Cholestenes|Hypolipidemic Agents|Lipid Regulating Agents|Lipids|Membrane Lipids|Noxae|Phytosterols|Steroids|Sterols|Toxic Actions
DB14039	Erenumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB14040	Eptinezumab	biotech	investigational	
DB14041	Fremanezumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB14042	Galcanezumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Immunoglobulins|Serum Globulins
DB14043	Palmidrol	small molecule	experimental|nutraceutical	Agents producing tachycardia|Alcohols|Amines|Amino Alcohols|Analgesics|Analgesics, Non-Narcotic|Anti-Infective Agents|Anti-Inflammatory Agents|Cannabinoids and similars|Central Nervous System Agents|Fatty Acids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Lipids|Neurotransmitter Agents|Peripheral Nervous System Agents|Sensory System Agents
DB14044	Hopantenic acid	small molecule	experimental	Acids, Acyclic|Alanine|Amino Acids|Amino Acids, Peptides, and Proteins|Aminobutyrates|beta-Alanine|Butyrates|Central Nervous System Agents|Fatty Acids|Fatty Acids, Volatile|Imides|Lipids|Nootropic Agents
DB14045	Cholesteryl chloride	small molecule	experimental	Cholestanes|Steroids
DB14046	Dichlorobenzene	small molecule	approved|experimental	
DB14048	Sodium zirconium cyclosilicate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB14049	Nitrate	small molecule	experimental|investigational	Acids|Acids, Noncarboxylic|Anions|Antianginal Agents|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds|Organic Nitrates|Vasodilating Agents
DB14050	Cannabidivarin	small molecule	investigational	Anticonvulsants|Central Nervous System Depressants|Terpenes
DB14051	Malacidin A	small molecule	experimental	Malacidins
DB14052	Malacidin B	small molecule	experimental	Malacidins
DB14054	Asiatic acid	small molecule	experimental	Terpenes|Triterpenes
DB14055	(S)-Warfarin	small molecule	experimental|investigational	Anticoagulants|Cytochrome P-450 CYP2C19 Substrates|Cytochrome P-450 CYP2C8 Substrates|Cytochrome P-450 CYP2C9 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Vitamin K Antagonists
DB14056	Nigericin	small molecule	experimental	Anti-Bacterial Agents|Anti-Infective Agents|Furans|Ionophores|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Pyrans
DB14057	Valinomycin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Bacterial Agents|Anti-Infective Agents|BSEP/ABCB11 Inhibitors|Depsipeptides|Ionophores|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Peptides|Peptides, Cyclic
DB14058	Basifungin	small molecule	experimental	Amino Acids, Peptides, and Proteins|Anti-Infective Agents|Antifungal Agents|Enzyme Inhibitors|Peptides|Peptides, Cyclic
DB14059	SC-236	small molecule	experimental|investigational	Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Nephrotoxic agents|Peripheral Nervous System Agents|Sensory System Agents|Sulfones|Sulfur Compounds
DB14060	NS-398	small molecule	experimental	Agents causing hyperkalemia|Agents that produce hypertension|Amides|Analgesics|Analgesics, Non-Narcotic|Anti-Inflammatory Agents|Anti-Inflammatory Agents, Non-Steroidal|Benzene Derivatives|Central Nervous System Agents|Cyclooxygenase Inhibitors|Enzyme Inhibitors|Nephrotoxic agents|Nitro Compounds|Peripheral Nervous System Agents|Sensory System Agents|Sulfones|Sulfur Compounds
DB14061	Hycanthone	small molecule	experimental	Anthelmintics|Anti-Infective Agents|Antiparasitic Agents|Antiplatyhelmintic Agents|P-glycoprotein/ABCB1 Inhibitors|Schistosomicides|Sulfur Compounds|Thioxanthenes|Xanthenes
DB14062	Concanamycin A	small molecule	experimental	Anti-Infective Agents|Enzyme Inhibitors|Lactones|P-glycoprotein/ABCB1 Inhibitors|Polyketides|Proton-Translocating ATPases, antagonists & inhibitors
DB14063	Dexverapamil	small molecule	experimental	Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Membrane Transport Modulators|Moderate Risk QTc-Prolonging Agents|P-glycoprotein/ABCB1 Inhibitors|Phenethylamines|QTc Prolonging Agents|Vasodilating Agents
DB14064	Emopamil	small molecule	experimental	Agents causing hyperkalemia|Amines|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Ethylamines|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Phenethylamines
DB14065	Lomerizine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors
DB14066	Tetrandrine	small molecule	experimental	Agents causing hyperkalemia|Alkaloids|Anti-Infective Agents|Antiarrhythmic agents|Antimalarials|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Antiparasitic Agents|Antiprotozoals|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drugs, Chinese Herbal|Immunologic Factors|Immunosuppressive Agents|Isoquinolines|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors
DB14067	Dofequidar	small molecule	experimental|investigational	Antineoplastic Agents|P-glycoprotein/ABCB1 Inhibitors
DB14068	Dexniguldipine	small molecule	experimental	Agents causing hyperkalemia|Antiarrhythmic agents|Antihypertensive Agents|Antineoplastic Agents|Bradycardia-Causing Agents|Calcium Channel Blockers|Cardiovascular Agents|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Membrane Transport Modulators|P-glycoprotein/ABCB1 Inhibitors|Pyridines
DB14069	ONT-093	small molecule	investigational	Drug Resistance, Multiple|P-glycoprotein/ABCB1 Inhibitors
DB14070	HM-30181	small molecule	experimental	P-Glycoprotein, antagonists & inhibitors|P-glycoprotein/ABCB1 Inhibitors|Pyrans
DB14071	Desmethylsertraline	small molecule	experimental	1-Naphthylamine|Agents that reduce seizure threshold|Amines|Naphthalenes|P-glycoprotein/ABCB1 Inhibitors
DB14072	Reversin 121	small molecule	experimental	Amino Acids, Peptides, and Proteins|Drug Resistance, Multiple|P-glycoprotein/ABCB1 Inhibitors|Peptides
DB14073	Gondoic acid	small molecule	experimental	Fatty Acids|Fatty Acids, Unsaturated|Lipids
DB14074	Icaridin	small molecule	experimental	Insect Repellents|Piperidines
DB14075	Imidurea	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Pharmaceutic Aids|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB14077	Magnesium stearate	small molecule	investigational	Agents that produce neuromuscular block (indirect)|Fatty Acids|Lipids
DB14078	Medronic acid	small molecule	approved|investigational	
DB14079	Hydroxybutyloxide	small molecule	experimental	
DB14080	Acetylcysteine magnesium	small molecule	experimental	
DB14081	Asiaticoside	small molecule	experimental	Anti-Infective Agents|Terpenes
DB14082	Betiatide	small molecule	approved|experimental	
DB14083	Bisphenol A diglycidyl ether	small molecule	approved|experimental	Benzene Derivatives|Carcinogens|Cell-mediated Immunity|Ethers|Ethers, Cyclic|Increased Histamine Release|Noxae|Standardized Chemical Allergen|Toxic Actions
DB14084	Butylparaben	small molecule	approved|experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Phenols|Standardized Chemical Allergen
DB14085	Cadmium	small molecule	experimental	Elements|Metals|Metals, Heavy|Transition Elements
DB14086	Cianidanol	small molecule	approved|withdrawn	Benzopyrans|Chromans|Chromones|Flavonoids|Pyrans
DB14087	Morrhuic acid	small molecule	experimental	Cardiovascular Agents|Fatty Acids|Lipids|Pharmaceutical Preparations|Pharmaceutical Solutions|Sclerosing Solutions|Solutions
DB14088	Osbond acid	small molecule	experimental	
DB14089	Dimercaptosuccinic acid	small molecule	approved|experimental	Acids, Acyclic|Antidotes|Chelating Agents|Dicarboxylic Acids|Protective Agents|Sequestering Agents|Succinates|Sulfhydryl Compounds|Sulfur Compounds
DB14090	Dimethyl sulfone	small molecule	experimental|investigational	Anti-Inflammatory Agents|Sulfoxides|Sulfur Compounds
DB14091	Carbomer homopolymer type C	small molecule	experimental|investigational	Anti-Infective Agents|Antineoplastic Agents|Biomedical and Dental Materials|Dental Cavity Preparation|Dental Materials|Dentin-Bonding Agents|Macromolecular Substances|Ophthalmic Solutions|Pharmaceutical Preparations|Pharmaceutical Solutions|Plastics|Polymers|Resins, Synthetic|Solutions
DB14092	8-epi-Cyanocobalamin	small molecule	experimental	
DB14093	(1,2,6,7-3H)Testosterone	small molecule	experimental	
DB14094	Tocopherylquinone	small molecule	experimental|investigational	Anticoagulants|Antihypertensive Agents|Antioxidants|Benzopyrans|Cardiovascular Agents|Hematologic Agents|Protective Agents|Pyrans
DB14096	1,2-icosapentoyl-sn-glycero-3-phosphoserine	small molecule	approved|experimental	
DB14097	13-cis-12-(3'-Carboxyphenyl)retinoic acid	small molecule	experimental	Alkenes|Biological Factors|Carotenoids|Cyclohexanes|Cyclohexenes|Cycloparaffins|Hydrocarbons, Acyclic|Phospholipases A, antagonists & inhibitors|Pigments, Biological|Polyenes|Retinoids|Terpenes|Vitamin A|Vitamins|Vitamins (Fat Soluble)
DB14098	Cobalamin	small molecule	experimental	Corrinoids|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Micronutrients|Physiological Phenomena|Vitamin B Complex|Vitamins
DB14099	1,2-Distearoyllecithin	small molecule	approved|experimental	Carbohydrates|Glycerophosphates|Glycerophospholipids|Lipids|Membrane Lipids|Phosphatidic Acids|Phospholipids|Sugar Phosphates
DB14100	Pork Collagen	biotech	approved|investigational	
DB14101	Soy isoflavones	small molecule	approved|experimental	
DB14102	Triethylhexanoin	small molecule	experimental	
DB14103	Methionine sulfoximine	small molecule	experimental	Amino Acids|Amino Acids, Essential|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Methionine|Sulfur Compounds
DB14104	Linoleic acid	small molecule	approved|experimental	Fatty Acids|Fatty Acids, Essential|Fatty Acids, Omega-6|Fatty Acids, Unsaturated|Linoleic Acids|Lipids
DB14105	Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)	small molecule	approved|experimental	
DB14106	Tetrakis(2-methoxyisobutylisocyanide)copper(I) tetrafluoroborate	small molecule	approved|experimental	
DB14107	7-Aminodesacetoxycephalosporanic acid	small molecule	experimental	Amides|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Lactams|Sulfur Compounds|Thiazines
DB14108	1,2-Hexanediol	small molecule	experimental	Alcohols|Alkanes|Hydrocarbons, Acyclic
DB14109	alpha-Arbutin	small molecule	approved|experimental	
DB14110	Butylene glycol	small molecule	approved|experimental	Alcohols|Glycols
DB14111	Ceramide NP	small molecule	experimental	Antigens, Neoplasm|Carbohydrates|Glycoconjugates|Glycolipids|Lipids|Membrane Lipids|Sphingolipids
DB14112	Human vaccinia virus immune globulin	biotech	approved	Human Immunoglobulin G|Immunoglobulins|Passively Acquired Immunity|Serum Globulins|Virus Neutralization|Virus-specific Hyperimmune Globulins
DB14113	Black widow spider antivenin (equine)	biotech	approved	Antivenin|Antivenins|Passively Acquired Immunity|Venom Neutralization
DB14114	Viper antivenom	biotech	approved	
DB14115	Human botulinum neurotoxin A/B immune globulin	biotech	approved	Bacterial Neurotoxin Neutralization|Human Immunoglobulin G|Passively Acquired Immunity
DB14116	Silodrate	small molecule	approved|experimental	
DB14117	Silica dimethyl silylate	small molecule	experimental	
DB14119	Phytosphingosine	small molecule	experimental	Alcohols|Amines|Amino Alcohols|Glycols
DB14120	Phenylethyl resorcinol	small molecule	approved|experimental	
DB14121	Parasorbic acid	small molecule	experimental	
DB14122	Dihydroxymethoxychalcone	small molecule	experimental	Benzopyrans|Chromones|Flavonoids|Ketones|Propiophenones|Pyrans|Zingiberaceae
DB14123	Racementhol	small molecule	approved|experimental	
DB14124	Cyclomethicone	small molecule	experimental	Biomedical and Dental Materials|Macromolecular Substances|Organosilicon Compounds|Polymers|Silicon Compounds
DB14125	Benazeprilat	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Decreased Blood Pressure|Enzyme Inhibitors
DB14126	Tenofovir	small molecule	experimental|investigational	Anti-HIV Agents|Anti-Infective Agents|Anti-Retroviral Agents|Antiviral Agents|Enzyme Inhibitors|Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor|Nephrotoxic agents|Nucleic Acid Synthesis Inhibitors|Nucleoside Analog|Nucleoside Reverse Transcriptase Inhibitors|Organophosphonates|Organophosphorus Compounds|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|Purines|Reverse Transcriptase Inhibitors|Tenofovir and prodrugs
DB14127	Sacubitrilat	small molecule	experimental	Acids, Acyclic|Amino Acids|Amino Acids, Peptides, and Proteins|Benzene Derivatives|Butyrates|Fatty Acids|Fatty Acids, Volatile|Lipids|Neprilysin Inhibitor|Neprilysin Inhibitors
DB14128	Nadide	small molecule	experimental	Adenine Nucleotides|Carbohydrates|Coenzymes|Enzymes and Coenzymes|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides|Purine Nucleotides|Purines|Ribonucleotides
DB14129	Macelignan	small molecule	experimental	Benzene Derivatives|Benzyl Compounds
DB14130	Methyl salicylate 2-ethylbutyrate	small molecule	experimental	
DB14131	Basic Fibroblast Growth Factor	biotech	investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Fibroblast Growth Factors|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB14132	8-chlorotheophylline	small molecule	experimental	Alkaloids|Cytochrome P-450 CYP1A2 Substrates|Purines|Purinones|Xanthine derivatives
DB14134	Octyldodecanol	small molecule	experimental	Alcohols|Lipids
DB14135	Hypochlorous acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Electrolytes|Free Radicals|Ions|Noxae|Oxidants|Oxides|Oxygen Compounds|Reactive Oxygen Species|Toxic Actions
DB14136	(-)-menthol 1-propylene glycol carbonate	small molecule	experimental	
DB14137	Palmitoyl tetrapeptide-7	small molecule	experimental	
DB14138	Silicic acid	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Silicon Compounds|Silicon Dioxide
DB14139	Hydroxyethyl ethylcellulose	small molecule	approved|experimental	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Glucans|Macromolecular Substances|Polymers|Polysaccharides
DB14140	Dipropylene glycol	small molecule	experimental	
DB14141	p-Phenylenediamine	small molecule	approved|experimental	Amines|Aniline Compounds|Antigens|Antigens, Bacterial|Azo Compounds|Biological Factors|Cell-mediated Immunity|Coloring Agents|Diamines|Increased Histamine Release|Indicators and Reagents|Laboratory Chemicals|Polyamines|Standardized Chemical Allergen
DB14142	Methoxy PEG-12 retinamide	small molecule	experimental	Pegylated agents
DB14143	Distearyldimonium	small molecule	approved|experimental	Adjuvants, Immunologic|Amines|Ammonium Compounds|Anti-Infective Agents|Immunologic Factors|Nitrogen Compounds|Onium Compounds|Surface-Active Agents
DB14144	p-Aminophenol	small molecule	experimental	Amines|Aniline Compounds|Benzene Derivatives|Mutagens|Noxae|Phenols|Toxic Actions
DB14145	Nepidermin	biotech	experimental	Amino Acids, Peptides, and Proteins|Biological Factors|EGF Family of Proteins|Gastrointestinal Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Intercellular Signaling Peptides and Proteins|Peptides|Proteins
DB14146	Loxicodegol	small molecule	investigational	
DB14148	Human albumin microspheres	biotech	approved|experimental	Ultrasound Contrast Activity|Ultrasound Contrast Media
DB14149	Glyceryl stearate SE	small molecule	experimental	
DB14150	Chloric acid	small molecule	experimental	Agrochemicals|Anions|Chlorine Compounds|Electrolytes|Herbicides|Ions|Pesticides|Toxic Actions
DB14151	Phosphorus	small molecule	approved|experimental	Elements
DB14152	Ginsenosides	small molecule	experimental	Carbohydrates|Glycosides|Saponins|Terpenes|Triterpenes
DB14153	Polysorbate 60	small molecule	experimental	
DB14154	Gold	small molecule	experimental	Cell-mediated Immunity|Elements|Gold Compounds|Increased Histamine Release|Metals|Metals, Heavy|Standardized Chemical Allergen|Transition Elements
DB14155	Chitosan low molecular weight (20-200 mpa.s)	small molecule	experimental	
DB14156	Synthetic Camphor	small molecule	approved|experimental	
DB14157	Hydrogenated soybean lecithin	small molecule	experimental	
DB14158	Microcrystalline cellulose	small molecule	approved|experimental|investigational	Biomedical and Dental Materials|Biopolymers|Carbohydrates|Drug Delivery Systems|Excipients|Glucans|Macromolecular Substances|Pharmaceutic Aids|Pharmaceutical Preparations|Pharmaceutical Vehicles|Polymers|Polysaccharides
DB14159	Oxidronic acid	small molecule	approved	Organophosphonates|Organophosphorus Compounds
DB14160	Titanium	small molecule	experimental	Elements|Metals|Metals, Light|Transition Elements
DB14161	Lecithin, soybean	small molecule	experimental	
DB14162	Northern bluefin tuna	biotech	approved	Non-Standardized Food Allergenic Extract
DB14163	Anthoxanthum odoratum	biotech	approved	Allergenic Extracts|Non-Standardized Food Allergenic Extract
DB14164	Betula lenta whole	biotech	approved	Non-Standardized Food Allergenic Extract
DB14165	Culex pipiens	biotech	approved	Non-Standardized Food Allergenic Extract
DB14166	Rumex acetosella whole	biotech	approved	Non-Standardized Food Allergenic Extract
DB14167	Rumex crispus top	biotech	approved	Non-Standardized Food Allergenic Extract
DB14168	Sarocladium strictum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Food Allergenic Extract|Non-Standardized Fungal Allergenic Extract
DB14169	Salix nigra bark	biotech	approved	Non-Standardized Food Allergenic Extract
DB14170	Artemisia vulgaris root	biotech	approved|investigational	Non-Standardized Food Allergenic Extract
DB14171	Penicillium glaucum	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Food Allergenic Extract|Non-Standardized Fungal Allergenic Extract
DB14172	Evernia prunastri	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14173	Diazolidinylurea	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14174	Dipentamethylenethiuram disulfide	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14175	alpha-Amyl cinnamaldehyde	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Perfume|Standardized Chemical Allergen
DB14176	Benzylparaben	small molecule	approved|experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Phenols|Standardized Chemical Allergen
DB14177	Propylparaben	small molecule	approved|experimental	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Phenols|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB14178	Tetramethylthiuram monosulfide	small molecule	approved|experimental	Acids, Acyclic|Carbamates|Cell-mediated Immunity|Dimethyldithiocarbamate|Increased Histamine Release|Standardized Chemical Allergen|Sulfur Compounds|Thiocarbamates
DB14179	Phleum pratense top	biotech	approved	
DB14180	Nickel sulfate	small molecule	approved|experimental	Elements|Irritants|Metals|Metals, Heavy|Noxae|Toxic Actions|Transition Elements
DB14181	Lanolin alcohols	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14182	Dichromate	small molecule	approved|investigational	Anions|Caustics|Chromates|Chromium Compounds|Coloring Agents|Electrolytes|Ions|Noxae|Potassium Compounds|Toxic Actions
DB14183	Geraniol	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14184	Cinnamaldehyde	small molecule	approved|experimental	Aldehydes|Antimutagenic Agents|Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Cell-mediated Immunity|Diet, Food, and Nutrition|Flavoring Agents|Food|Food Additives|Food and Beverages|Increased Histamine Release|Physiological Phenomena|Protective Agents|Standardized Chemical Allergen
DB14185	Aripiprazole lauroxil	small molecule	approved|investigational	Adrenergic alpha-1 Receptor Antagonists|Adrenergic alpha-Antagonists|Adrenergic Antagonists|Agents that produce hypertension|Antipsychotic Agents|Central Nervous System Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2D6 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Histamine Antagonists|Histamine H1 Antagonists|Neurotoxic agents|Piperazines|Potential QTc-Prolonging Agents|Psychotropic Drugs|QTc Prolonging Agents|Quinolines|Quinolones|Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome|Serotonin 5-HT2 Receptor Antagonists|Serotonin Agents|Serotonin Receptor Antagonists|Tranquilizing Agents
DB14186	Cinnamyl alcohol	small molecule	approved|experimental	Alcohols|Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14187	Hydroxycitronellal	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Perfume|Standardized Chemical Allergen
DB14188	Isoeugenol	small molecule	approved|experimental	Acids, Carbocyclic|Caffeic Acids|Cell-mediated Immunity|Cinnamates|Increased Histamine Release|Standardized Chemical Allergen
DB14189	Ethylenediamine	small molecule	approved|experimental	Allergens|Amines|Cell-mediated Immunity|Dermatitis, Contact|Diamines|Increased Histamine Release|Polyamines|Standardized Chemical Allergen
DB14190	P-Tert-Butylphenol-Formaldehyde Resin (Low Molecular Weight)	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14191	Diphenylguanidine	small molecule	approved|experimental	Amidines|Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14192	N,N'-diphenyl-1,4-phenylenediamine	small molecule	approved|experimental	Amines|Aniline Compounds|Antioxidants|Cell-mediated Immunity|Diamines|Increased Histamine Release|Polyamines|Protective Agents|Standardized Chemical Allergen
DB14193	Ditiocarb Zinc	small molecule	approved|experimental	Acids, Acyclic|Adjuvants, Immunologic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Allergens|Anti-Infective Agents|Carbamates|Cell-mediated Immunity|Chelating Agents|Immunologic Factors|Increased Histamine Release|Sequestering Agents|Standardized Chemical Allergen|Sulfur Compounds|Thiocarbamates|Vasoprotectives|Zinc Compounds
DB14194	Zinc Dibutyldithiocarbamate	small molecule	approved|experimental	Acids, Acyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Carbamates|Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen|Sulfur Compounds|Vasoprotectives|Zinc Compounds
DB14195	4-(Isopropylamino)diphenylamine	small molecule	approved|experimental	Amines|Aniline Compounds|Antioxidants|Cell-mediated Immunity|Diamines|Increased Histamine Release|Polyamines|Protective Agents|Standardized Chemical Allergen
DB14196	N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine	small molecule	approved|experimental	Amines|Aniline Compounds|Cell-mediated Immunity|Diamines|Increased Histamine Release|Polyamines|Standardized Chemical Allergen
DB14197	Methylchloroisothiazolinone	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14198	Quaternium-15	small molecule	approved|experimental	Adamantane|Amines|Cell-mediated Immunity|Cycloparaffins|Increased Histamine Release|Polyamines|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB14199	Bromothalonil	small molecule	approved|experimental	Allergens|Cell-mediated Immunity|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB14200	Thiohexam	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles
DB14201	2,2'-Dibenzothiazyl disulfide	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Latex Hypersensitivity|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles
DB14202	Morpholinylmercaptobenzothiazole	small molecule	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Oxazines|Standardized Chemical Allergen|Sulfur Compounds|Thiazoles
DB14203	Disperse Blue 106	small molecule	approved|experimental	Allergens|Cell-mediated Immunity|Increased Histamine Release|Standardized Chemical Allergen
DB14204	Nickel cation	small molecule	experimental	
DB14205	Cobaltous cation	small molecule	experimental	
DB14206	Cobalt chloride	small molecule	approved|experimental	Antimutagenic Agents|Elements|Metals|Metals, Heavy|Protective Agents|Transition Elements
DB14207	Fosinoprilat	small molecule	experimental	Acids|Acids, Acyclic|Acids, Noncarboxylic|Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Amino Acids|Amino Acids, Cyclic|Amino Acids, Peptides, and Proteins|Angiotensin-Converting Enzyme Inhibitors|Antiarrhythmic agents|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Imines|Imino Acids|Organophosphorus Compounds|Phosphinic Acids|Phosphorus Acids|Phosphorus Compounds|Prodrugs|Proline|Protease Inhibitors
DB14208	Ramiprilat	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors
DB14209	Trandolaprilat	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors
DB14210	Moexiprilat	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Isoquinolines
DB14211	Fanolesomab	biotech	approved|experimental	Amino Acids, Peptides, and Proteins|Antibodies|Antigens, CD15|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB14212	Methylparaben	small molecule	approved	Acids, Carbocyclic|Benzene Derivatives|Benzoates|Cell-mediated Immunity|Hydroxy Acids|Hydroxybenzoates|Increased Histamine Release|Pharmaceutic Aids|Pharmaceutical Preparations|Phenols|Preservatives, Pharmaceutical|Standardized Chemical Allergen
DB14213	Perindoprilat	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Protease Inhibitors
DB14214	Rose bengal lactone	small molecule	experimental	
DB14215	Rose Bengal AT	small molecule	experimental	
DB14217	Quinaprilat	small molecule	experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents causing hyperkalemia|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors|Antihypertensive Agents|Cardiovascular Agents|Enzyme Inhibitors|Isoquinolines|Protease Inhibitors
DB14218	Telotristat	small molecule	experimental	Amino Acids|Amino Acids, Aromatic|Amino Acids, Cyclic|Amino Acids, Essential|Amino Acids, Peptides, and Proteins|Tryptophan Hydroxylase Inhibitor|Tryptophan Hydroxylase Inhibitors
DB14219	Monomethyl fumarate	small molecule	experimental|investigational	Acids, Acyclic|Dicarboxylic Acids|Immunosuppressive Agents
DB14221	Beclomethasone 17-monopropionate	small molecule	experimental	Adrenal Cortex Hormones|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Chlorinated
DB14222	Bifidobacterium longum infantis	biotech	approved|experimental	
DB14223	Clostridium botulinum	biotech	experimental	
DB14224	Lactobacillus reuteri	biotech	experimental|investigational	
DB14225	Enterococcus faecium	biotech	experimental	
DB14226	Lactobacillus helveticus	biotech	experimental	
DB14227	Technetium Tc-99m	small molecule	experimental	Elements|Elements, Radioactive|Metals|Metals, Heavy|Transition Elements
DB14228	Threonic acid	small molecule	experimental	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB14229	Lowbush blueberry	biotech	experimental	
DB14230	Albumin Aggregated	biotech	approved	
DB14231	Quinoline Yellow WS	small molecule	approved|experimental	Agents Acting on the Renin-Angiotensin System|Agents causing angioedema|Agents that produce hypertension|Angiotensin-Converting Enzyme Inhibitors
DB14232	Deacetylbisacodyl	small molecule	experimental	Benzene Derivatives|Contact Laxatives|Cresols|Increased Large Intestinal Motility|Laxatives|Phenols|Stimulation Large Intestine Fluid/Electrolyte Secretion
DB14233	Egg phospholipids	biotech	approved|experimental|investigational	
DB14234	Sus scrofa stomach	biotech	experimental	
DB14235	Bilberry	biotech	approved|experimental	Herbs and Natural Products
DB14236	Aloe vera leaf polysaccharides	biotech	experimental	
DB14237	Echinacea angustifolia root	biotech	approved|experimental	
DB14238	Echinacea purpurea flowering top	biotech	approved|experimental	
DB14239	Echinacea purpurea	biotech	approved|experimental	Herbs and Natural Products
DB14240	Echinacea	biotech	approved|experimental	Herbs and Natural Products
DB14241	Caviar, unspecified	biotech	approved|experimental	
DB14242	Honey	biotech	approved|experimental	
DB14243	Sus scrofa placenta	biotech	experimental	
DB14244	Garden snail mucin	biotech	experimental	
DB14245	Snail, unspecified	biotech	approved|experimental	
DB14246	Marine collagen, soluble	biotech	experimental	
DB14247	Moschus berezovskii musk sac resin	biotech	experimental	
DB14248	Bos taurus gallstone	biotech	experimental	Biological Products|Complex Mixtures|Gallstones|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14249	Pearl (hyriopsis cumingii)	biotech	experimental	
DB14250	Royal jelly	biotech	experimental	Bees|Insect Hormones|Lipids
DB14251	Ostrea edulis shell	biotech	experimental	
DB14252	Jojoba oil	biotech	approved|experimental|investigational	Cosmetics|Lipids|Plant Extracts
DB14253	Avena sativa flowering top	biotech	approved|experimental	
DB14254	Aloe vera flower	biotech	approved|experimental	
DB14255	Angelica dahurica root	biotech	experimental	
DB14256	Centella asiatica	biotech	approved|experimental|investigational	Agents that reduce seizure threshold|Plant Extracts|Terpenes
DB14257	Aloe ferox leaf	biotech	approved|experimental	
DB14258	Elm	biotech	approved|experimental	
DB14259	Eucommia ulmoides bark	biotech	experimental	
DB14260	Stypocaulon scoparium	biotech	experimental	
DB14261	Panax ginseng fruit	biotech	experimental	
DB14262	Bird pepper	biotech	approved|experimental	
DB14263	Calendula officinalis flower	biotech	approved|experimental	
DB14264	Maclura tricuspidata whole	biotech	experimental	
DB14265	Momordica charantia fruit	biotech	experimental	
DB14266	Tribulus terrestris root	biotech	experimental	
DB14267	Rumex crispus whole	biotech	approved|experimental	
DB14268	Swertia japonica whole flowering	biotech	experimental	
DB14269	Nardostachys chinensis whole	biotech	experimental	
DB14270	Simmondsia chinensis seed	biotech	experimental	
DB14271	Morus alba root bark	biotech	experimental	
DB14272	Rosemary	biotech	experimental	
DB14273	Ocimum tenuiflorum top	biotech	approved|experimental	
DB14274	Salix alba bark	biotech	approved|experimental	Herbs and Natural Products
DB14275	Indian frankincense	biotech	approved|experimental|investigational	
DB14276	Turmeric	biotech	approved|experimental|investigational	Angiosperms|Antioxidants|Biological Products|Complex Mixtures|Condiments|Embryophyta|Eukaryota|Food Coloring Agents|Pharmaceutical Preparations|Plant Oils|Plant Preparations|Plants|Protective Agents|Streptophyta|Viridiplantae|Zingiberaceae|Zingiberales
DB14277	Tripterygium wilfordii whole	biotech	experimental	
DB14278	Carthamus tinctorius flower bud	biotech	approved|experimental	
DB14279	Corydalis ambigua tuber	biotech	approved|experimental	
DB14280	Lonicera caprifolium flower	biotech	approved|experimental	
DB14281	Lagerstroemia indica whole	biotech	experimental	
DB14282	Phellinus linteus mycelium	biotech	experimental	
DB14283	Angelica archangelica root	biotech	approved|experimental	
DB14284	Panax ginseng whole	biotech	experimental	
DB14285	Ginkgo biloba leaf oil	biotech	experimental	
DB14286	Panax ginseng root oil	biotech	experimental	
DB14287	Trametes versicolor fruiting body	biotech	experimental	
DB14288	Kaempferia galanga root	biotech	approved|experimental	
DB14289	Larix sibirica wood	biotech	approved|experimental	
DB14290	Rehmannia glutinosa root	biotech	experimental	
DB14291	Wormwood	biotech	approved|experimental	Lipids|Oils
DB14292	Acorus calamus root	biotech	experimental	
DB14293	Eutrema japonicum whole	biotech	experimental	
DB14294	Styphnolobium japonicum flower bud	biotech	experimental	
DB14295	Reynoutria multiflora root	biotech	experimental	
DB14296	Panax quinquefolius whole	biotech	experimental|investigational	
DB14297	Arnica montana	biotech	experimental|investigational	
DB14298	Gambir	biotech	experimental	
DB14299	Mucuna pruriens seed	biotech	experimental	
DB14300	Erythroxylum catuaba bark	biotech	experimental	
DB14301	Epimedium grandiflorum top	biotech	experimental	
DB14302	Turnera diffusa leaf	biotech	experimental	
DB14303	Eleuthero	biotech	approved|experimental	Herbs and Natural Products
DB14304	Panax notoginseng root	biotech	experimental|investigational	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14305	Tribulus terrestris fruit	biotech	experimental	
DB14306	Juglans regia shell	biotech	experimental	
DB14307	Green tea leaf	biotech	experimental|investigational	Beverages|Biological Products|Complex Mixtures|Diet, Food, and Nutrition|Food and Beverages|Physiological Phenomena|Plant Preparations
DB14308	Camellia japonica seed oil	biotech	experimental	
DB14309	Meadowfoam seed oil	biotech	experimental	Biological Products|Complex Mixtures|Lipids|Oils|Plant Preparations
DB14310	Argan oil	biotech	experimental	Biological Products|Complex Mixtures|Lipids|Oils|Plant Preparations
DB14311	Shea butter	biotech	experimental	
DB14312	Glycyrrhiza glabra	biotech	approved|experimental	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract|Non-Standardized Plant Allergenic Extract
DB14313	Lawsonia inermis leaf	biotech	experimental	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Plant Allergenic Extract
DB14314	Indigofera tinctoria leaf	biotech	experimental	
DB14315	Calendula officinalis whole	biotech	experimental	
DB14316	Tangerine peel	biotech	experimental	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14317	Pomegranate	biotech	experimental|investigational	
DB14318	Macadamia seed oil glycereth-8 esters	biotech	experimental	
DB14319	Magnolia kobus flowering top	biotech	experimental	
DB14320	Eucalyptus globulus leaf	biotech	approved|experimental	
DB14321	Bambusa vulgaris top	biotech	experimental	
DB14322	Coconut oil	biotech	experimental	Biological Products|Cocos|Complex Mixtures|Dietary Fats|Lipids|Oils|Plant Preparations
DB14323	Grape seed oil	biotech	experimental	
DB14324	Apricot kernel oil	biotech	approved|experimental	
DB14325	Schisandra chinensis fruit	biotech	experimental	
DB14326	Amber	biotech	experimental	Biological Products|Biomedical and Dental Materials|Biopolymers|Complex Mixtures|Macromolecular Substances|Plant Exudates|Polymers|Resins, Plant
DB14327	Purslane	biotech	approved|experimental	
DB14328	Chamaemelum nobile flower	biotech	experimental	
DB14329	Sunflower oil	biotech	experimental|investigational	Biological Products|Complex Mixtures|Dietary Fats, Unsaturated|Helianthus|Lipids|Oils|Pharmaceutic Aids|Plant Preparations
DB14330	Macadamia oil	biotech	experimental	
DB14331	Heterotheca inuloides flower	biotech	approved|experimental	
DB14332	Inonotus obliquus fruiting body	biotech	approved|experimental	
DB14333	Nelumbo nucifera flower	biotech	approved|experimental	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14334	Hydrogenated coconut oil	biotech	experimental	
DB14335	Bergamot oil	biotech	experimental	Biological Products|Complex Mixtures|Lipids|Oils|Perfume|Plant Preparations
DB14336	Angelica sinensis root	biotech	experimental	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14337	Salvia miltiorrhiza root	biotech	experimental	Drugs, Chinese Herbal|Herbs (Hypotensive Properties)|Herbs and Natural Products|Plant Preparations
DB14338	Atractylodes lancea root oil	biotech	approved|experimental	
DB14339	Scutellaria lateriflora	biotech	approved|experimental	
DB14340	Prunus armeniaca seed	biotech	experimental	
DB14341	Chamaecyparis obtusa wood oil	biotech	experimental	
DB14342	Taraxacum officinale leaf	biotech	experimental	
DB14343	Arnica montana flower	biotech	approved|experimental	
DB14344	Lonicera confusa flower	biotech	experimental	
DB14345	Forsythia suspensa fruit	biotech	experimental	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14346	Mentha arvensis top	biotech	experimental	
DB14347	Platycodon grandiflorus root	biotech	experimental	
DB14348	Citrus junos fruit	biotech	experimental	
DB14349	Equisetum arvense top	biotech	approved|experimental	
DB14350	Inula helenium root	biotech	approved|experimental	
DB14351	Usnea barbata	biotech	approved|experimental	
DB14352	Azadirachta indica leaf	biotech	approved|experimental	
DB14353	Zanthoxylum clava-herculis whole	biotech	approved|experimental	
DB14354	Salix alba bark volatile oil	biotech	experimental	
DB14355	Apple fruit oil	biotech	experimental	
DB14356	Platycodon grandiflorus leaf	biotech	experimental	
DB14357	Chamomile	biotech	approved|experimental|investigational	
DB14358	Tribulus terrestris	biotech	experimental	
DB14359	Tremella fuciformis whole	biotech	experimental	
DB14360	Saw palmetto	biotech	approved|experimental|investigational	Biological Products|Complex Mixtures|Estrogen Antagonists|Herbs and Natural Products|Hormone Antagonists|Hormones, Hormone Substitutes, and Hormone Antagonists|Pharmaceutical Preparations|Plant Preparations|Prostatic Hyperplasia|Serenoa
DB14361	Rice bran	biotech	approved|experimental	
DB14362	Moringa oleifera leaf	biotech	experimental	
DB14363	Rosa centifolia flower oil	biotech	experimental	
DB14364	Scutellaria baicalensis root	biotech	experimental	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Preparations|Scutellaria baicalensis
DB14365	Garcinia gummi-gutta fruit	biotech	experimental	
DB14366	Ilex paraguariensis leaf	biotech	experimental	
DB14367	Chondrus crispus	biotech	experimental	
DB14368	Capsicum annuum whole	biotech	experimental	
DB14369	Typhonium giganteum whole	biotech	experimental	
DB14370	Phellodendron amurense bark	biotech	experimental	
DB14371	Mangostin	biotech	experimental	Protein Kinase Inhibitors|Xanthenes
DB14372	Melaleuca alternifolia leaf	biotech	experimental	
DB14373	Quercus acutissima whole	biotech	experimental	
DB14374	Pumice	biotech	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Minerals|Oxides|Oxygen Compounds|Silicic Acid|Silicon Compounds|Silicon Dioxide
DB14375	Milk thistle	biotech	approved|experimental|investigational	Herbs and Natural Products
DB14376	Chicory leaf	biotech	experimental	
DB14377	Palm oil	biotech	experimental	Biological Products|Complex Mixtures|Dietary Fats, Unsaturated|Lipids|Oils|Plant Preparations
DB14378	Camphor leaf oil	biotech	experimental	
DB14379	Zanthoxylum clava-herculis bark	biotech	experimental	
DB14380	Influenza A virus	biotech	approved	
DB14381	Influenza B virus	biotech	approved	
DB14382	Influenza a virus a/california/7/2009 (h1n1)-like hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14383	Influenza a virus a/california/7/2009 x-179a (h1n1) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14384	Influenza a virus a/victoria/210/2009 x-187 (h3n2) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	Inactivated Influenza A Virus Vaccine
DB14385	Influenza b virus b/brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)	biotech	approved|investigational	Inactivated Influenza B Virus Vaccine
DB14386	Influenza a virus a/victoria/361/2011 ivr-165 (h3n2) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14387	Influenza b virus b/texas/6/2011 hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14388	Bordetella pertussis toxoid antigen (formaldehyde inactivated)	biotech	approved	
DB14389	Influenza a virus a/texas/50/2012 x-223a (h3n2) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14390	Influenza b virus b/massachusetts/2/2012 hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14391	Influenza a virus a/christchurch/16/2010 nib-74 (h1n1) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14392	Influenza a virus a/texas/50/2012 x-223 (h3n2) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14393	Influenza b virus b/massachusetts/2/2012 hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14394	Influenza a virus a/california/7/2009 (h1n1) live (attenuated) antigen	biotech	approved	Actively Acquired Immunity|Live Attenuated Influenza A Virus Vaccine
DB14395	Influenza a virus a/victoria/361/2011 (h3n2) live (attenuated) antigen	biotech	approved	
DB14396	Influenza b virus b/wisconsin/1/2010 live (attenuated) antigen	biotech	approved	
DB14397	Influenza b virus b/massachusetts/2/2012 bx-51b hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14398	Influenza a virus a/brisbane/10/2010 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14399	Influenza a virus a/texas/50/2012 x-223a (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14400	Influenza b virus b/massachusetts/2/2012 hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14401	Influenza b virus b/massachusetts/2/2012 bx-51b hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14402	Influenza a virus a/switzerland/9715293/2013 nib-88 (h3n2) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14403	Influenza b virus b/phuket/3073/2013 hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14404	Influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14405	Influenza a virus a/switzerland/9715293/2013 nib-88 (h3n2) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14406	Influenza b virus b/brisbane/9/2014 hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14407	Influenza b virus b/phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14408	Influenza a virus a/south australia/55/2014 ivr-175 (h3n2) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14409	Human adenovirus e serotype 4 strain cl-68578 antigen	biotech	approved	Actively Acquired Immunity|Adenovirus Vaccines|Live Human Adenovirus Type 4 Vaccine|Live vaccines|Vaccines
DB14410	Human adenovirus b serotype 7	biotech	approved	
DB14411	Influenza a virus a/victoria/361/2011 ivr-165 (h3n2) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14412	Influenza b virus b/hubei-wujiagang/158/2009 bx-39 hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14413	Influenza a virus a/hong kong/4801/2014 x-263b (h3n2) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14414	Influenza a virus a/california/7/2009 x-179a (h1n1) hemagglutinin antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14415	Influenza a virus a/switzerland/9715293/2013 nib-88 (h3n2) hemagglutinin antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14416	Influenza b virus b/phuket/3073/2013 hemagglutinin antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14417	Influenza a virus a/hong kong/4801/2014 (h3n2) recombinant hemagglutinin antigen	biotech	approved	
DB14418	Influenza b virus b/brisbane/60/2008 recombinant hemagglutinin antigen	biotech	approved	
DB14419	Influenza a virus a/christchurch/16/2010 nib-74xp (h1n1) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14420	Influenza a virus a/south australia/55/2014 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14421	Influenza b virus b/utah/9/2014 hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14422	Influenza a virus a/michigan/45/2015 x-275 (h1n1) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14423	Influenza a virus a/michigan/45/2015 (h1n1) recombinant hemagglutinin antigen	biotech	approved	
DB14424	Influenza a virus a/hong kong/4801/2014 x-263b (h3n2) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14425	Influenza a virus a/slovenia/2903/2015 (h1n1) live (attenuated) antigen	biotech	approved	
DB14426	Influenza a virus a/new caledonia/71/2014 (h3n2) live (attenuated) antigen	biotech	approved	
DB14427	Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB14428	Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB14429	Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB14430	Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen	biotech	approved	Actively Acquired Immunity|Inactivated Meningococcal Vaccine
DB14431	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14432	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (formaldehyde inactivated)	biotech	approved	
DB14433	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14434	Influenza a virus a/singapore/gp2050/2015 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14435	Influenza b virus b/hong kong/259/2010 hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14436	Influenza a virus a/hong kong/4801/2014 (h3n2) hemagglutinin antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14437	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) hemagglutinin antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14438	Influenza a virus a/hong kong/4801/2014 x-263b (h3n2) hemagglutinin antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14439	Influenza b virus b/brisbane/60/2008 hemagglutinin antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14440	Influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14441	Influenza b virus b/brisbane/46/2015 hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14442	Influenza b virus b/phuket/3073/2013 bvr-1b hemagglutinin antigen (propiolactone inactivated)	biotech	approved	
DB14443	Vibrio cholerae CVD 103-HgR strain live antigen	biotech	approved|investigational	Live Attenuated Cholera Vaccine|Live vaccines|Vaccines
DB14444	Influenza a virus a/california/7/2009 (h1n1)-like antigen (propiolactone inactivated)	biotech	approved	
DB14445	Influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated)	biotech	approved	Actively Acquired Immunity|Inactivated Influenza A Virus Vaccine
DB14446	Influenza a virus a/south dakota/6/2007 (h1n1) live (attenuated) antigen	biotech	approved	
DB14447	Influenza a virus a/uruguay/716/2007(h3n2) live (attenuated) antigen	biotech	approved	
DB14449	Influenza a virus a/perth/16/2009 (h3n2) live (attenuated) antigen	biotech	approved	Actively Acquired Immunity|Live Attenuated Influenza A Virus Vaccine
DB14450	Influenza a virus a/victoria/361/2011 ivr-165 (h3n2) antigen (formaldehyde inactivated)	biotech	approved	
DB14451	Influenza b virus b/texas/6/2011 antigen (formaldehyde inactivated)	biotech	approved	
DB14452	Influenza a virus a/texas/50/2012 x-223a (h3n2) antigen (formaldehyde inactivated)	biotech	approved	
DB14453	Influenza b virus b/massachusetts/2/2012 antigen (formaldehyde inactivated)	biotech	approved	
DB14454	Influenza b virus b/massachusetts/2/2012 bx-51b antigen (formaldehyde inactivated)	biotech	approved	
DB14455	Influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated)	biotech	approved	
DB14456	Influenza b virus b/brisbane/9/2014 antigen (formaldehyde inactivated)	biotech	approved	
DB14457	Influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (formaldehyde inactivated)	biotech	approved	
DB14458	Influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated)	biotech	approved	
DB14459	Influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (propiolactone inactivated)	biotech	approved	
DB14460	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (propiolactone inactivated)	biotech	approved	
DB14461	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (formaldehyde inactivated)	biotech	approved	
DB14462	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14463	Influenza a virus a/singapore/gp2050/2015 (h3n2) antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14464	Influenza b virus b/hong kong/259/2010 antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14465	Influenza a virus a/hong kong/4801/2014 (h3n2) antigen (mdck cell derived, propiolactone inactivated)	biotech	approved	
DB14466	Influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14467	Influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (uv, formaldehyde inactivated)	biotech	approved	
DB14468	Influenza a virus a/singapore/gp1908/2015 ivr-180a (h1n1) antigen (propiolactone inactivated)	biotech	approved	
DB14469	Influenza b virus b/brisbane/46/2015 antigen (propiolactone inactivated)	biotech	approved	
DB14470	Influenza b virus b/phuket/3073/2013 bvr-1b antigen (propiolactone inactivated)	biotech	approved	
DB14471	2-Ethylhexyl 4-phenylbenzophenone-2'-carboxylate	small molecule	experimental	
DB14472	Insulin-like growth factor II	biotech	experimental	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Proteins|Intercellular Signaling Peptides and Proteins|Peptides|Proteins|Somatomedins
DB14473	Beroctocog alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Coagulants|Hematologic Agents|Human Antihemophilic Factor|Proteins
DB14474	Sorbitan	small molecule	experimental	
DB14475	L-Lactic acid	small molecule	experimental	Hydroxy Acids|Lactates
DB14476	DL-alpha-Tocopherol	small molecule	approved|experimental|investigational	Vitamin E|Vitamins|Vitamins (Fat Soluble)
DB14477	DL-alpha tocopheryl acetate	small molecule	approved|experimental	
DB14478	Povidone K30	small molecule	approved|experimental	
DB14479	Acetylcysteine zinc	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Anti-Infective Agents|Antioxidants|Copper Absorption Inhibitor|Cysteine|Expectorants|Free Radical Scavengers|Protective Agents|Respiratory System Agents|Sulfhydryl Compounds|Sulfur Compounds|Zinc Compounds
DB14480	Acetylcysteine amide	small molecule	experimental	Amino Acids|Amino Acids, Neutral|Amino Acids, Peptides, and Proteins|Amino Acids, Sulfur|Cysteine|Sulfhydryl Compounds|Sulfur Compounds
DB14481	Calcium phosphate dihydrate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Calcium Compounds|Electrolytes|Ions|Phosphate salts|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB14482	Sodium ascorbate	small molecule	approved|nutraceutical	Acids, Acyclic|Antioxidants|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Laxatives|Micronutrients|Osmotic Laxative|Physiological Phenomena|Protective Agents|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins
DB14483	Calcium ascorbate	small molecule	approved|nutraceutical	Acids, Acyclic|Antioxidants|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Micronutrients|Physiological Phenomena|Protective Agents|Sugar Acids|Urinary Acidifying Agents|Vitamin C and analogues|Vitamins
DB14484	Magnesium ascorbate	small molecule	approved|nutraceutical	Acids, Acyclic|Antioxidants|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Micronutrients|Physiological Phenomena|Protective Agents|Sugar Acids|Urinary Acidifying Agents
DB14485	Zinc ascorbate	small molecule	approved|nutraceutical	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Urinary Acidifying Agents|Vasoprotectives|Vitamin C and analogues|Vitamins|Zinc Compounds
DB14486	Niacinamide ascorbate	small molecule	approved|nutraceutical	Urinary Acidifying Agents|Vitamin C and analogues|Vitamins
DB14487	Zinc acetate	small molecule	approved|investigational	Acetates|Acetic Acid|Acids, Acyclic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Alimentary Tract and Metabolism|Copper Absorption Inhibitor|Fatty Acids|Fatty Acids, Volatile|Lipids|Various Alimentary Tract and Metabolism Products|Vasoprotectives|Zinc Compounds
DB14488	Ferrous gluconate	small molecule	approved	Anemia, Iron-Deficiency|Antianemia Drugs|Antianemic Preparations|Blood and Blood Forming Organs|Hematinics|Hematologic Agents|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Minerals|Organometallic Compounds
DB14489	Ferrous succinate	small molecule	approved	Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Organometallic Compounds
DB14490	Ferrous ascorbate	small molecule	approved	Acids, Acyclic|Antianemic Preparations|Antioxidants|Blood and Blood Forming Organs|Carbohydrates|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Hydroxy Acids|Iron Bivalent, Oral Preparations|Iron Preparations|Micronutrients|Physiological Phenomena|Protective Agents|Sugar Acids|Urinary Acidifying Agents
DB14491	Ferrous fumarate	small molecule	approved	Antianemic Preparations|Blood and Blood Forming Organs|Diet, Food, and Nutrition|Food|Food and Beverages|Growth Substances|Iron Bivalent, Oral Preparations|Iron Compounds|Iron Preparations|Micronutrients|Minerals|Organometallic Compounds|Physiological Phenomena|Trace Elements
DB14492	Potassium triiodide	small molecule	experimental	Anions|Coagulants|Coloring Agents|Electrolytes|Hematologic Agents|Hemostatics|Iodine Compounds|Ions|Irritants|Noxae|Potassium Salt|Toxic Actions
DB14493	Zinc glycinate	small molecule	experimental	Amino Acids|Amino Acids, Peptides, and Proteins|Antigens, Neoplasm|Biomarkers, Tumor|Copper Absorption Inhibitor|Zinc Compounds
DB14494	Zinc carbonate	small molecule	experimental	Acids|Acids, Noncarboxylic|Alkalies|Anions|Carbon Compounds, Inorganic|Carbonic Acid|Copper Absorption Inhibitor|Electrolytes|Ions|Zinc Compounds
DB14495	Manganese citrate	small molecule	experimental	Paramagnetic Contrast Agent
DB14496	Sodium molybdate	small molecule	approved|experimental	Elements|Metals|Metals, Heavy|Transition Elements
DB14497	Calcium magnesium potassium carbonate chloride hydroxide	small molecule	experimental	
DB14498	Potassium acetate	small molecule	approved|investigational	Acetates|Acetic Acid|Acids, Acyclic|Agents causing hyperkalemia|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Electrolyte Solutions|Fatty Acids|Fatty Acids, Volatile|I.V. Solution Additives|Laxatives|Lipids|Osmotic Laxative|Potassium Compounds|Potassium Salt|Replacement Preparations
DB14499	Potassium sulfate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Laxatives|Osmotic Laxative|Potassium Salt|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB14500	Potassium	small molecule	approved|experimental	Diuretics|Elements|High-Ceiling Diuretics|Low-Ceiling Diuretics, Excl. Thiazides|Metals|Metals, Alkali|Metals, Light|Minerals|Potassium Salt|Replacement Preparations
DB14501	Ferrous glycine sulfate	small molecule	approved	Antianemic Preparations|Blood and Blood Forming Organs|Iron Bivalent, Oral Preparations|Iron Preparations
DB14502	Sodium phosphate, dibasic	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Laxatives|Osmotic Laxative|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB14503	Sodium phosphate, monobasic, unspecified form	small molecule	approved	Laxatives|Osmotic Laxative
DB14504	Sodium phosphate, dibasic, unspecified form	small molecule	approved|experimental	Laxatives|Osmotic Laxative
DB14505	Sodium borate	small molecule	approved|experimental	Acids|Acids, Noncarboxylic|Anions|Anti-Infective Agents|Boric Acids|Boron Compounds|Electrolytes|Ions|Ophthalmologicals|Sensory Organs
DB14506	Lithium hydroxide	small molecule	approved|experimental	Mood Stabilizer|Narrow Therapeutic Index Drugs
DB14507	Lithium citrate	small molecule	approved	Acids, Acyclic|Antimanic Agents|Lithium Compounds|Mood Stabilizer|Narrow Therapeutic Index Drugs|Tricarboxylic Acids
DB14508	Lithium succinate	small molecule	experimental	Acids, Acyclic|Dermatologicals|Dicarboxylic Acids|Lithium Compounds|Narrow Therapeutic Index Drugs|Ointments
DB14509	Lithium carbonate	small molecule	approved	Acids|Acids, Noncarboxylic|Alkalies|Anions|Antimanic Agents|Carbon Compounds, Inorganic|Carbonates|Carbonic Acid|Central Nervous System Agents|Central Nervous System Depressants|Electrolytes|Enzyme Inhibitors|Ions|Lithium Compounds|Mood Stabilizer|Narrow Therapeutic Index Drugs|Psychotropic Drugs|Tranquilizing Agents
DB14510	Ferrous cation	small molecule	experimental	
DB14511	Acetate ion	small molecule	experimental	
DB14512	Mometasone furoate	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Adrenals|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Cytochrome P-450 CYP2C8 Inhibitors|Cytochrome P-450 CYP2C8 Inhibitors (strong)|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Dermatologicals|Glucocorticoids|Hyperglycemia-Associated Agents|Immunosuppressive Agents|Pregnadienediols|Pregnadienes|Pregnanes|Steroids
DB14513	Magnesium	small molecule	approved|experimental|investigational	Calculi Dissolution Agent|Elements|Laxatives|Magnesium Compounds|Metals|Metals, Alkaline Earth|Metals, Light|Minerals|Osmotic Laxative
DB14514	Magnesium levulinate	small molecule	nutraceutical	Alimentary Tract and Metabolism|Enzyme Inhibitors|Keto Acids|Magnesium Compounds|Mineral Supplements
DB14515	Magnesium lactate	small molecule	nutraceutical	Alimentary Tract and Metabolism|Magnesium Compounds|Mineral Supplements
DB14516	Sodium cation	small molecule	experimental	Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Laxatives|Osmotic Activity|Osmotic Laxative
DB14517	Aluminium phosphate	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Adjuvants, Immunologic|Alimentary Tract and Metabolism|Aluminium Compounds|Anions|Antacids|Drugs for Acid Related Disorders|Electrolytes|Gastric Acid Lowering Agents|Gastrointestinal Agents|Immunologic Factors|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB14518	Aluminum acetate	small molecule	approved|investigational	Acids, Acyclic|Fatty Acids|Fatty Acids, Volatile|Lipids
DB14519	Aluminum cation	small molecule	experimental	
DB14520	Tetraferric tricitrate decahydrate	small molecule	approved	Drugs for Treatment of Hyperkalemia and Hyperphosphatemia|Iron Compounds|Organometallic Compounds|Parenteral Iron Replacement|Phosphate Binder
DB14521	Silver cation	small molecule	experimental	Anti-Bacterial Agents
DB14522	Hydroxide ion	small molecule	experimental	Alkalies|Anions|Electrolytes|Ions
DB14523	Phosphate ion	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB14524	Gallium cation	small molecule	experimental	
DB14525	Chromic cation	small molecule	experimental	
DB14526	Chromic citrate	small molecule	experimental	
DB14527	Chromic nitrate	small molecule	approved	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Nitric Acid|Nitrogen Compounds
DB14528	Chromium gluconate	small molecule	approved	
DB14529	Chromium nicotinate	small molecule	experimental	Nicotinic Acids
DB14530	Chromous sulfate	small molecule	approved	
DB14531	Carbonate ion	small molecule	experimental	
DB14532	Zinc cation	small molecule	experimental	Copper Absorption Inhibitor|Decreased Copper Ion Absorption|Zinc Compounds
DB14533	Zinc chloride	small molecule	approved|investigational	Acids|Acids, Noncarboxylic|Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Anions|Basic Ointments and Protectants|Biomedical and Dental Materials|Blood and Blood Forming Organs|Blood Substitutes and Perfusion Solutions|Chlorine Compounds|Copper Absorption Inhibitor|Cosmetics|Dental Agents|EENT Drugs, Miscellaneous|Electrolyte Solutions|Electrolytes|Household Products|Hydrochloric Acid|I.V. Solution Additives|Ions|Mouthwashes|Skin Ulcer, drug therapy|Vasoprotectives|Zinc Compounds
DB14534	Gold cation (1+)	small molecule	experimental	
DB14535	Indium cation In-111	small molecule	experimental	
DB14536	Strontium cation Sr-89	small molecule	experimental	Radioactive Therapeutic Agent|Radiopharmaceutical Activity
DB14537	Chromate ion Cr-51	small molecule	experimental	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB14538	Hydrocortisone aceponate	small molecule	experimental|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14539	Hydrocortisone acetate	small molecule	approved|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Administration, Topical|Adrenal Cortex Hormones|Aerosols|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14540	Hydrocortisone butyrate	small molecule	approved|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Administration, Topical|Adrenal Cortex Hormones|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14541	Hydrocortisone cypionate	small molecule	approved|investigational|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14542	Hydrocortisone phosphate	small molecule	approved|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14543	Hydrocortisone probutate	small molecule	approved|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Moderately Potent (Group II)|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Dermatologicals|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14544	Hydrocortisone valerate	small molecule	approved|vet_approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14545	Hydrocortisone succinate	small molecule	approved	11-Hydroxycorticosteroids|17-Hydroxycorticosteroids|Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 CYP3A5 Substrates|Cytochrome P-450 CYP3A7 Substrates|Cytochrome P-450 Enzyme Inducers|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxycorticosteroids|Immunosuppressive Agents|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14546	Sulfate ion	small molecule	experimental|investigational	Increased Large Intestinal Motility|Inhibition Large Intestine Fluid/Electrolyte Absorption|Laxatives|Osmotic Activity|Osmotic Laxative
DB14547	Chloride ion	small molecule	experimental	Adrenergic Agonists
DB14548	Zinc sulfate, unspecified form	small molecule	approved|experimental	Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use|Copper Absorption Inhibitor|Vasoprotectives|Zinc Compounds
DB14549	Gallium cation Ga-67	small molecule	experimental	
DB14550	Gallium chloride Ga-67	small molecule	approved|experimental	
DB14551	Phosphorus P-32	small molecule	experimental	
DB14552	Cupric cation	small molecule	experimental	
DB14553	Borate ion	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Boric Acids|Boron Compounds|Electrolytes|Ions
DB14554	Dotatate	small molecule	approved|experimental	
DB14555	Ursadiol	small molecule	approved|experimental	
DB14556	Peracetic acid	small molecule	experimental	Acetates|Acids, Acyclic|Anti-Infective Agents|Disinfectants|Fatty Acids|Fatty Acids, Volatile|Lipids|Noxae|Oxidants|Toxic Actions
DB14557	Ethylhexylglycerin	small molecule	experimental	Alcohols|Carbohydrates|Ethers|Glycerol|Sugar Alcohols
DB14558	Influenza A virus A/singapore/infimh-16-0019/2016 nib-104 (h3n2) antigen (formaldehyde inactivated)	biotech	approved	
DB14559	Influenza B virus B/maryland/15/2016 bx-69a antigen (formaldehyde inactivated)	biotech	approved	
DB14560	Influenza A virus A/singapore/infimh-16-0019/2016 ivr-186 (h3n2) antigen (UV, formaldehyde inactivated)	biotech	approved	
DB14561	Influenza B virus B/maryland/15/2016 bx-69a antigen (UV, formaldehyde inactivated)	biotech	approved	
DB14562	Andexanet alfa	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Biological Factors|Blood Coagulation Factors|Blood Proteins|Coagulants|Endopeptidases|Enzymes|Enzymes and Coenzymes|Factor X|Hydrolases|Peptide Hydrolases|Proteins|Serine Endopeptidases|Serine Proteases
DB14563	Magnolia kobus bark	biotech	experimental	
DB14564	Kale	biotech	experimental	
DB14565	Sophora flavescens root	biotech	experimental	Biological Products|Complex Mixtures|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14566	Lavender oil	biotech	approved|experimental	Biological Products|Complex Mixtures|Lavandula|Lipids|Oils|Plant Preparations
DB14567	Brown iron oxide	small molecule	approved|experimental	
DB14568	Ivosidenib	small molecule	approved|investigational	Cytochrome P-450 CYP2B6 Inducers|Cytochrome P-450 CYP2C8 Inducers|Cytochrome P-450 CYP2C9 Inducers|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Substrates|Cytochrome P-450 Enzyme Inducers|Moderate Risk QTc-Prolonging Agents|OAT3/SLC22A8 Inhibitors|P-glycoprotein/ABCB1 Inhibitors|P-glycoprotein/ABCB1 Substrates|QTc Prolonging Agents
DB14569	Tedizolid	small molecule	approved|investigational	Anti-Bacterial Agents|Anti-Infective Agents|Antibacterials for Systemic Use|Antiinfectives for Systemic Use|Breast Cancer Resistance Protein Inhibitors|Oxazoles|Oxazolidinone Antibacterial
DB14570	Hydroxyprogesterone	small molecule	experimental	Adrenal Cortex Hormones|Corpus Luteum Hormones|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Genito Urinary System and Sex Hormones|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydroxyprogesterones|Pregnanes|Pregnen (4) Derivatives|Pregnenediones|Pregnenes|Progesterone|Progesterone Congeners|Progestins|Sex Hormones and Modulators of the Genital System|Steroids
DB14571	Radium Ra-223 cation	small molecule	experimental	alpha-Particle Emitting Activity|Radioactive alpha-Particle Emitting Therapeutic Agent
DB14572	Bismuth cation	small molecule	experimental	
DB14573	Phosphate ion P-32	small molecule	experimental	Radioactive Therapeutic Agent|Radiopharmaceutical Activity
DB14574	Cobalt	small molecule	approved|experimental	Cell-mediated Immunity|Diet, Food, and Nutrition|Elements|Food|Food and Beverages|Growth Substances|Increased Histamine Release|Metals|Metals, Heavy|Micronutrients|Physiological Phenomena|Standardized Chemical Allergen|Trace Elements|Transition Elements
DB14575	Eslicarbazepine	small molecule	approved	Anticonvulsants|Carboxamide Derivatives|Cardiovascular Agents|Central Nervous System Depressants|Cytochrome P-450 CYP2C19 Inhibitors|Cytochrome P-450 CYP2C19 Inhibitors (moderate)|Cytochrome P-450 CYP3A Inducers|Cytochrome P-450 CYP3A4 Inducers|Cytochrome P-450 CYP3A4 Inducers (weak)|Cytochrome P-450 Enzyme Inducers|Cytochrome P-450 Enzyme Inhibitors|Membrane Transport Modulators|Nervous System|Sodium Channel Blockers|UGT1A1 Substrates|Voltage-Gated Sodium Channel Blockers
DB14576	Thallous cation Tl-201	small molecule	experimental	Radioactive Diagnostic Agent|Radiopharmaceutical Activity
DB14577	Calcium cation	small molecule	experimental	Blood Coagulation Factors|Calcium Salts|Increased Coagulation Factor Activity
DB14578	Gadolinium cation (3+)	small molecule	experimental	Gadolinium-based Contrast Agent|Magnetic Resonance Contrast Activity
DB14579	Lanthanum III cation	small molecule	experimental	Phosphate Binder|Phosphate Chelating Activity
DB14580	BAN-2401	biotech	investigational	
DB14581	CPI-1205	small molecule	investigational	
DB14582	Patisiran	biotech	approved|investigational	Antisense Elements (Genetics)|Diagnostic Uses of Chemicals|Laboratory Chemicals|Molecular Probes|Nucleic Acid Probes|Nucleic Acids|Nucleic Acids, Nucleotides, and Nucleosides|RNA|RNA, Antisense|RNA, Small Untranslated|RNA, Untranslated
DB14583	Segesterone acetate	small molecule	experimental|investigational	Adrenal Cortex Hormones|Contraceptive Agents, Female|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|Drug Implants|Hormonal Contraceptives for Systemic Use|Intravaginal Contraceptives|Norpregnanes|Norpregnenes|Norsteroids|Reproductive Control Agents|Steroids
DB14584	Segesterone	small molecule	experimental	
DB14585	Plantago ovata seed	biotech	approved|experimental|investigational	Alimentary Tract and Metabolism|Biological Products|Bulk-Forming Laxatives|Complex Mixtures|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Pharmaceutical Preparations|Plant Extracts|Plant Preparations
DB14586	Citrus bioflavonoids	small molecule	approved|experimental	Benzopyrans|Chromones|Pyrans
DB14587	INFLUENZA A VIRUS A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14588	Bambusa arundinacea stem	biotech	experimental	
DB14589	Caprylyl glycol	small molecule	experimental	Alcohols|Fatty Alcohols|Lipids
DB14590	Anemarrhena asphodeloides root	biotech	experimental	
DB14591	INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14592	INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)	biotech	approved	
DB14593	INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (PROPIOLACTONE INACTIVATED)	biotech	approved	
DB14594	INFLUENZA A VIRUS A/Singapore/INFIMH-16-0019/2016 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN	biotech	approved	
DB14595	INFLUENZA B VIRUS B/Maryland/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN	biotech	approved	
DB00873	Loteprednol	small molecule	approved|experimental	Adrenal Cortex Hormones|Androstadienes|Androstanes|Androstenes|Anti-Allergic Agents|Anti-Inflammatory Agents|Corticosteroid Hormone Receptor Agonists|Corticosteroids|Ophthalmologicals|Sensory Organs|Steroids
DB14597	Lanadelumab	biotech	approved|investigational	Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Antibodies, Monoclonal, Humanized|Blood Proteins|Globulins|Immunoglobulins|Immunoproteins|Proteins|Serum Globulins
DB14598	Edetate calcium disodium anhydrous	small molecule	approved	Acetates|Acids, Acyclic|Amines|Anticoagulants|Calcium Chelating Agents|Chelating Agents|Diamines|Diet, Food, and Nutrition|Ethylenediamines|Fatty Acids|Fatty Acids, Volatile|Food|Food Additives|Food and Beverages|Hematologic Agents|Lead Chelator|Lipids|Physiological Phenomena|Polyamines|Sequestering Agents
DB14599	Edetate copper disodium	small molecule	experimental	
DB14600	Edetate disodium anhydrous	small molecule	approved|vet_approved	Anticoagulants|Lead Chelator
DB14601	Barley malt syrup	biotech	approved	
DB14602	INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14603	INFLUENZA B VIRUS B/HUBEI-WUJIAGANG/158/2009 BX-39 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14604	INFLUENZA A VIRUS A/TEXAS/50/2012 X-223A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14605	INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 BX-51B ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14606	INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) LIVE (ATTENUATED) ANTIGEN	biotech	approved	
DB14607	INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE (ATTENUATED) ANTIGEN	biotech	approved	
DB14608	INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	biotech	approved	
DB14609	INFLUENZA B VIRUS B/WISCONSIN/1/2010) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)	biotech	approved	
DB14610	INFLUENZA B VIRUS B/HUBEI-WUJIAGANG/158/2009 BX-39 ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14611	INFLUENZA A VIRUS A/VICTORIA/210/2009 X-187 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14612	INFLUENZA A VIRUS A/CALIFORNIA/7/2009 X-181 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14613	Serum, horse	biotech	approved	
DB14614	INFLUENZA A VIRUS A/VICTORIA/210/2009 X-187 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14615	INFLUENZA A VIRUS A/URUGUAY/716/2007(H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14616	INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14617	INFLUENZA A VIRUS A/URUGUAY/716/2007(H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved|investigational	
DB14618	INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)	biotech	approved|investigational	
DB14619	INFLUENZA A VIRUS A/URUGUAY/716/2007(H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)	biotech	approved	Actively Acquired Immunity|Inactivated Influenza A Virus Vaccine
DB14620	INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)	biotech	approved	Actively Acquired Immunity|Inactivated Influenza A Virus Vaccine|Influenza Vaccines|Vaccines, Inactivated
DB14622	Sodium phosphate tribasic dodecahydrate	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Electrolytes|Ions|Phosphoric Acids|Phosphorus Acids|Phosphorus Compounds
DB14623	Acetyl chloride	small molecule	experimental	Acids|Acids, Acyclic|Acids, Noncarboxylic|Anions|Chlorine Compounds|Electrolytes|Fatty Acids|Fatty Acids, Volatile|Hydrochloric Acid|Ions|Lipids
DB14624	Nandrolone hydrogen sulfate	small molecule	experimental|investigational	
DB14625	Meprednisone acetate	small molecule	experimental	
DB14626	Pregnenolone acetate	small molecule	investigational	
DB14627	Oxyphenisatin acetate	small molecule	approved|investigational|withdrawn	Gastrointestinal Agents|Indoles|Laxatives
DB14628	Pseudosaccharin chloride	small molecule	experimental	
DB14629	Trifluoroethyl acetate	small molecule	experimental	
DB14630	Tyramine O-sulfate	small molecule	experimental	Amines|Biogenic Amines|Biogenic Monoamines
DB14631	Prednisolone phosphate	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids
DB14632	Prednisolone tebutate	small molecule	approved|vet_approved	Pregnadienes|Pregnadienetriols|Pregnanes|Steroids
DB14633	Prednisolone hemisuccinate	small molecule	experimental	Adrenal Cortex Hormones|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids
DB14634	Fluprednidene acetate	small molecule	experimental	Adrenal Cortex Hormones|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnanes|Steroids
DB14635	Curcumin sulfate	small molecule	experimental	
DB14636	Triciribine phosphate	small molecule	investigational	Carbohydrates|Glycosides|Naphthalenes|Nucleic Acids, Nucleotides, and Nucleosides|Nucleotides
DB14637	Fluprednisolone acetate	small molecule	experimental	
DB14638	Diloxanide furoate	small molecule	approved	Amebicides|Anti-Infective Agents|Antiparasitic Agents|Antiprotozoals
DB14639	Boldenone undecylenate	small molecule	illicit|vet_approved	Androstanes|Androstenes|Androstenols|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids|Testosterone Congeners
DB14640	Isoflupredone acetate	small molecule	vet_approved	Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB14641	Estriol tripropionate	small molecule	experimental	
DB14642	Lypressin	small molecule	approved	Amino Acids, Peptides, and Proteins|Antidiuretic Agents|Cardiovascular Agents|Coagulants|Hematologic Agents|Hemostatics|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Natriuretic Agents|Nerve Tissue Proteins|Neuropeptides|Oligopeptides|Peptide Hormones|Peptides|Pituitary and Hypothalamic Hormones and Analogues|Pituitary Hormones|Pituitary Hormones, Posterior|Posterior Pituitary Lobe Hormones|Proteins|Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins|Vasoconstrictor Agents|Vasopressin and Analogues|Vasopressins
DB14643	Methylprednisolone aceponate	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Corticosteroids, Dermatological Preparations|Corticosteroids, Potent (Group III)|Dermatologicals|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids
DB14644	Methylprednisolone hemisuccinate	small molecule	approved	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Central Nervous System Agents|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Methylprednisolone|Neuroprotective Agents|Prednisolone|Pregnadienes|Pregnadienetriols|Pregnanes|Protective Agents|Steroids
DB14645	Nitrogen trichloride	small molecule	experimental	Acids|Acids, Noncarboxylic|Anions|Chlorine Compounds|Electrolytes|Hydrochloric Acid|Ions
DB14646	Prednisone acetate	small molecule	approved|experimental|investigational	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Antineoplastic Agents|Antineoplastic Agents, Hormonal|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienediols|Pregnadienes|Pregnanes|Steroids
DB14647	Sulfur chloride	small molecule	experimental	
DB14648	Acetyl simvastatin	small molecule	experimental	
DB14649	Dexamethasone acetate	small molecule	approved|investigational|vet_approved	Anti-Inflammatory Agents|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB14650	Menadiol diphosphate	small molecule	approved|nutraceutical	Diterpenes|Naphthalenes|Naphthoquinones|Phytol|Quinones|Terpenes
DB14651	Perphenazine enanthate	small molecule	experimental	Antipsychotic Agents|Central Nervous System Depressants|Neurotoxic agents|Phenothiazines|Sulfur Compounds
DB14652	Clocortolone acetate	small molecule	experimental	Adrenal Cortex Hormones|Anti-Inflammatory Agents|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienediols|Pregnadienes|Pregnanes|Steroids|Steroids, Fluorinated
DB14653	Clocortolone caproate	small molecule	experimental	
DB14654	Bisoxatin acetate	small molecule	experimental	
DB14655	Drostanolone propionate	small molecule	approved|illicit	Androstanes|Steroids
DB14656	Chlorphenesin carbamate	small molecule	approved|vet_approved|withdrawn	Alcohols|Glycols|Propylene Glycols
DB14657	Paramethasone acetate	small molecule	approved	Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB14658	Chloramphenicol palmitate	small molecule	approved|vet_approved	Alcohols|Benzene Derivatives|Glycols|Nitro Compounds|Nitrobenzenes|Propylene Glycols
DB14659	Melengestrol acetate	small molecule	experimental	Adrenal Cortex Hormones|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnanes|Steroids
DB14660	Trenbolone acetate	small molecule	vet_approved	Anabolic Agents|Estranes|Estrenes|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Steroids
DB14661	Loperamide oxide	small molecule	experimental	Alimentary Tract and Metabolism|Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents|Antipropulsives|Piperidines
DB14662	Flunisolide acetate	small molecule	experimental	
DB14663	Ribavirin monophosphate	small molecule	experimental	Carbohydrates|Glycosides|Nucleic Acids, Nucleotides, and Nucleosides
DB14664	Difluocortolone pivalate	small molecule	experimental	
DB14665	Bornyl acetate	small molecule	experimental	Monoterpenes|Norbornanes|Terpenes
DB14666	Oleoyl chloride	small molecule	experimental	
DB14667	Phenyl hydrogen sulfate	small molecule	experimental	Acids|Acids, Noncarboxylic|Sulfur Acids|Sulfur Compounds|Sulfuric Acids
DB14668	Dienestrol diacetate	small molecule	experimental	Benzene Derivatives|Phenols
DB14669	Betamethasone phosphate	small molecule	approved|vet_approved	Adrenal Cortex Hormones|Corticosteroids|Glucocorticoids|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB14670	Lauroyl chloride	small molecule	experimental	
DB14671	Temazepam acetate	small molecule	experimental	
DB14672	Oxazepam acetate	small molecule	experimental	Benzazepines|Benzodiazepines and benzodiazepine derivatives|Benzodiazepinones|Central Nervous System Depressants
DB14673	Flurandrenolide acetate	small molecule	experimental	
DB14674	Estramustine phosphate	small molecule	approved|investigational	Alkylating Drugs|Antineoplastic Agents|Antineoplastic Agents, Alkylating|Antineoplastic Agents, Hormonal|Estradiol|Estradiol Congeners|Estranes|Estrenes|Gonadal Hormones|Gonadal Steroid Hormones|Hormones|Hormones, Hormone Substitutes, and Hormone Antagonists|Hydrocarbons, Halogenated|Mustard Compounds|Nitrogen Mustard Compounds|Noxae|Steroids|Toxic Actions
DB14675	Temsavir	small molecule	investigational	HIV Fusion Inhibitors
DB14676	Fagrocorat	small molecule	experimental	
DB14677	Gestonorone caproate	small molecule	approved	Norpregnanes|Norpregnenes|Norsteroids|Pregnanes|Pregnenediones|Pregnenes|Steroids
DB14678	Norethindrone enanthate	small molecule	experimental	Adrenal Cortex Hormones|Contraceptive Agents, Female|Contraceptives, Oral|Contraceptives, Oral, Synthetic|Hormonal Contraceptives for Systemic Use|Norpregnanes|Norpregnenes|Norsteroids|Progesterone Congeners|Progestins|Reproductive Control Agents|Steroids
DB14679	Quingestanol acetate	small molecule	experimental	Adrenal Cortex Hormones|Norpregnanes|Norsteroids|Progestins|Steroids
DB14680	Combretastatin A4	small molecule	experimental	Antineoplastic Agents|Antineoplastic Agents, Phytogenic|Benzene Derivatives|Benzylidene Compounds
DB14681	Cortisone	small molecule	experimental	Adrenal Cortex Hormones|Corticosteroid Hormone Receptor Agonists|Corticosteroids
DB14682	Dextrorphan	small molecule	experimental	Alkaloids|Central Nervous System Agents|Excitatory Amino Acid Agents|Excitatory Amino Acid Antagonists|Morphinans|Neuroprotective Agents|Neurotransmitter Agents|Opiate Alkaloids|Phenanthrenes|Protective Agents
DB14683	Prezatide copper	small molecule	experimental	Amino Acids, Peptides, and Proteins|Growth Substances|Peptides
DB14684	Calcium polycarbophil	small molecule	approved	Alimentary Tract and Metabolism|Antidiarrheals|Biomedical and Dental Materials|Bulk-Forming Laxatives|Calcium Salts|Dental Materials|Drug Carriers|Drugs for Constipation|Gastrointestinal Agents|Laxatives|Macromolecular Substances|Phosphate Binder|Plastics|Polymers|Resins, Synthetic
DB14685	Adenovirus type 7 vaccine live	biotech	approved	Actively Acquired Immunity|Adenovirus Vaccines|Live Human Adenovirus Type 7 Vaccine|Live vaccines|Vaccines
DB14686	Chamaecyparis obtusa leaf	biotech	experimental	
DB14687	Centella asiatica leaf	biotech	experimental	
DB14688	Sambucus nigra flower	biotech	experimental	
DB14689	Rosemary oil	biotech	approved|experimental	Lipids|Oils
DB14690	Ginger oil	biotech	approved|experimental	
DB14691	Willow bark	biotech	approved|experimental	Herbs and Natural Products
DB14692	Turmeric oil	biotech	approved|experimental	
DB14693	Atractylodes lancea root	biotech	approved|experimental	
DB14694	Beef liver	biotech	approved|experimental	Allergens|Cell-mediated Immunity|Dietary Proteins|Increased Histamine Release|Meat Proteins|Non-Standardized Food Allergenic Extract
DB14695	Ferric oxyhydroxide	small molecule	approved|experimental	Iron Compounds|Organometallic Compounds|Phosphate Binder|Phosphate Chelating Activity
DB14696	INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 (H3N2) LIVE (ATTENUATED) ANTIGEN	biotech	approved	
DB14697	INFLUENZA B VIRUS B/COLORADO/06/2017 LIVE (ATTENUATED) ANTIGEN	biotech	approved	
DB14698	INFLUENZA A VIRUS A/BRISBANE/59/2007(H1N1) HEMAGGLUTININ ANTIGEN (UV,FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14699	INFLUENZA A VIRUS A/URUGUAY/716/2007(H3N2) HEMAGGLUTININ ANTIGEN (UV,FORMALDEHYDE INACTIVATED)	biotech	approved	
DB14700	Damoctocog alfa pegol	biotech	approved|investigational	Blood Coagulation Factors|Pegylated agents
DB14701	Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate	small molecule	experimental	
DB14702	Sodium metavanadate	small molecule	approved|experimental	Anions|Electrolytes|Ions|Vanadium Compounds
DB14703	Dexamethasone metasulfobenzoate	small molecule	approved|experimental	Pregnadienes|Pregnadienetriols|Pregnanes|Steroids|Steroids, Fluorinated
DB14704	Ribitol	small molecule	experimental	Alcohols|Carbohydrates|Sugar Alcohols
DB14705	Ceramide AP	small molecule	experimental	Amides|Carbohydrates|Glycoconjugates|Glycolipids|Glycosphingolipids|Lipids|Membrane Lipids|Neutral Glycosphingolipids|Sphingolipids
DB14706	Ceramide NG	small molecule	experimental	Amides|Carbohydrates|Glycoconjugates|Glycolipids|Glycosphingolipids|Lipids|Membrane Lipids|Neutral Glycosphingolipids|Sphingolipids
DB14707	Cemiplimab	biotech	approved|investigational	
DB14708	Tosylchloramide	small molecule	experimental	Amides|Anti-Infective Agents|Anti-Infective Agents, Local|Antiseptics and Disinfectants|Benzene Derivatives|Dermatologicals|Disinfectants|Indicators and Reagents|Laboratory Chemicals|Noxae|Oxidants|Sulfonamides|Sulfones|Sulfur Compounds|Toluene|Toxic Actions
DB14709	Bean	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Non-Standardized Food Allergenic Extract
DB14710	Camponotus pennsylvanicus	biotech	approved	Cell-mediated Immunity|Increased Histamine Release|Increased IgG Production|Non-Standardized Insect Venom Allergenic Extract
DB14711	Vaccinia virus strain new york city board of health live antigen	biotech	approved	Actively Acquired Immunity|Live Vaccinia Virus Vaccine|Vaccines
DB14712	Elapegademase	biotech	approved	Enzyme Replacement Therapy|Pegylated agents|Proteins|Recombinant Proteins
DB14713	Inotersen	biotech	approved|investigational	Nephrotoxic agents|Potential QTc-Prolonging Agents|QTc Prolonging Agents
DB14714	Tenivastatin	small molecule	experimental	
DB14715	Cinazepam	small molecule	experimental	Benzazepines|Benzodiazepines and benzodiazepine derivatives|Central Nervous System Depressants
DB14716	Clonazolam	small molecule	experimental	
DB14717	Nitrazolam	small molecule	experimental	
DB14718	Pyrazolam	small molecule	experimental	
DB14719	Bentazepam	small molecule	experimental	Central Nervous System Agents|Central Nervous System Depressants|Hypnotics and Sedatives
DB14720	Brovanexine	small molecule	experimental	Acids, Carbocyclic|Amides|Benzene Derivatives|Benzoates
DB14721	MK-1454	small molecule	investigational	
DB14722	ADU-S100	small molecule	investigational	
DB14723	Larotrectinib	small molecule	approved	BCRP/ABCG2 Substrates|Cytochrome P-450 CYP3A Substrates|Cytochrome P-450 CYP3A4 Substrates|P-glycoprotein/ABCB1 Substrates|Tyrosine Kinase Inhibitors
DB14724	Emapalumab	biotech	approved|investigational	Agents reducing cytokine levels|Amino Acids, Peptides, and Proteins|Antibodies|Antibodies, Monoclonal|Globulins|Immunoglobulins|Immunoproteins|Interferon-gamma|Proteins|Serum Globulins
DB14725	Cefamandole nafate	small molecule	approved	Amides|Anti-Bacterial Agents|Anti-Infective Agents|Aza Compounds|Azabicyclo Compounds|beta-Lactams|Cephalosporins|Lactams|Sulfur Compounds|Thiazines
DB14726	Dabigatran	small molecule	investigational	Anticoagulants|Antithrombins|Benzimidazoles|Enzyme Inhibitors|Hematologic Agents|Protease Inhibitors|Pyridines|Serine Proteinase Inhibitors
DB14727	Riboflavin tetrabutyrate	small molecule	experimental	Biological Factors|Coenzymes|Enzymes and Coenzymes|Flavins|Pigments, Biological|Pteridines
DB14728	Mebenil	small molecule	experimental	Amides
DB14729	Rebeccamycin	small molecule	experimental	Indoles
